1	From	IN	O	from	_	0	SENT_1	[p1l92t1266r155b1288],
2	the	DT	O	the	det	3	SENT_1	[p1l168t1264r208b1288],
3	Departments	NNP	O	Departments	pobj	1	SENT_1	[p1l223t1266r389b1295],
4	of	IN	O	of	_	0	SENT_1	[p1l402t1263r430b1288],
5	Molecular	JJ	O	molecular	amod	8	SENT_1	[p1l440t1264r567b1288],
6	and	CC	O	and	_	0	SENT_1	[p1l580t1264r625b1288],
7	Medical	JJ	O	medical	conj_and	5	SENT_1	[p1l92t1301r190b1325],
8	Pharmacology	NN	O	pharmacology	prep_of	3	SENT_1	[p1l222t1301r403b1332],
9	and	CC	O	and	_	0	SENT_1	[p1l432t1301r477b1325],
10	Medicine	NN	O	medicine	nn	12	SENT_1	[p1l510t1301r626b1325],
11	(	CD	NUMBER	(	num	12	SENT_1	[p1l93t1341r184b1370],
12	|	NN	O	|	prep_of	3	SENT_1	[p1l93t1341r184b1370],
13	.	.	O	.	_	0	SENT_1	[p1l93t1341r184b1370],

1	K.M.	NNP	PERSON	K.M.	_	0	SENT_2	[p1l93t1341r184b1370],
2	,	,	O	,	_	0	SENT_2	[p1l93t1341r184b1370],
3	C.L.S.	NNP	O	C.L.S.	appos	1	SENT_2	[p1l196t1340r286b1370],
4	)	CD	NUMBER	)	num	3	SENT_2	[p1l196t1340r286b1370],
5	,	,	O	,	_	0	SENT_2	[p1l196t1340r286b1370],
6	Pathology	NN	O	pathology	appos	1	SENT_2	[p1l299t1339r424b1370],
7	and	CC	O	and	_	0	SENT_2	[p1l433t1339r478b1362],
8	Laboratory	NN	ORGANIZATION	laboratory	appos	1	SENT_2	[p1l492t1339r627b1370],
9	Medicine	NN	ORGANIZATION	medicine	nn	11	SENT_2	[p1l92t1376r207b1400],
10	(	CD	NUMBER	(	num	11	SENT_2	[p1l217t1378r317b1407],
11	M.Y.W.	NNP	O	M.Y.W.	dep	6	SENT_2	[p1l217t1378r317b1407],
12	,	,	O	,	_	0	SENT_2	[p1l217t1378r317b1407],
13	S.Z.	NNP	O	S.Z.	nn	15	SENT_2	[p1l327t1378r381b1404],
14	,	,	O	,	_	0	SENT_2	[p1l327t1378r381b1404],
15	E.Q.D.	NNP	O	E.Q.D.	appos	1	SENT_2	[p1l392t1378r480b1406],
16	,	,	O	,	_	0	SENT_2	[p1l392t1378r480b1406],
17	K.	NNP	O	K.	dep	18	SENT_2	[p1l492t1378r565b1404],
18	\	NNP	O	\	dep	15	SENT_2	[p1l492t1378r565b1404],
19	/	:	O	/	punct	18	SENT_2	[p1l492t1378r565b1404],
20	.	.	O	.	_	0	SENT_2	[p1l492t1378r565b1404],

1	L.	NNP	O	L.	_	0	SENT_3	[p1l492t1378r565b1404],
2	,	,	O	,	_	0	SENT_3	[p1l492t1378r565b1404],
3	K.Y.	NNP	PERSON	K.Y.	nn	11	SENT_3	[p1l576t1378r625b1404],
4	,	,	O	,	_	0	SENT_3	[p1l576t1378r625b1404],
5	D.j.C.	NNP	O	D.j.C.	appos	11	SENT_3	[p1l92t1416r169b1444],
6	,	,	O	,	_	0	SENT_3	[p1l92t1416r169b1444],
7	B.L.R.	NNP	O	B.L.R.	appos	11	SENT_3	[p1l180t1416r259b1442],
8	,	,	O	,	_	0	SENT_3	[p1l180t1416r259b1442],
9	P.N.R.	NNP	O	P.N.R.	appos	11	SENT_3	[p1l271t1416r356b1442],
10	,	,	O	,	_	0	SENT_3	[p1l271t1416r356b1442],
11	P.S.M.	NNP	O	P.S.M.	appos	1	SENT_3	[p1l368t1416r467b1445],
12	)	CD	NUMBER	)	num	11	SENT_3	[p1l368t1416r467b1445],
13	,	,	O	,	_	0	SENT_3	[p1l368t1416r467b1445],
14	Human	JJ	O	human	amod	15	SENT_3	[p1l479t1416r573b1438],
15	Genetics	NNP	O	Genetics	appos	1	SENT_3	[p1l583t1416r626b1438, p1l91t1453r163b1475],
16	(	CD	NUMBER	(	num	17	SENT_3	[p1l175t1453r289b1482],
17	J.H.Y.H.	NNP	O	J.H.Y.H.	dep	15	SENT_3	[p1l175t1453r289b1482],
18	,	,	O	,	_	0	SENT_3	[p1l175t1453r289b1482],
19	S.H.	NNP	LOCATION	S.H.	nn	20	SENT_3	[p1l299t1453r370b1482],
20	)	NNP	O	)	appos	1	SENT_3	[p1l299t1453r370b1482],
21	,	,	O	,	_	0	SENT_3	[p1l299t1453r370b1482],
22	Biostatistics	NNP	O	Biostatistics	nn	25	SENT_3	[p1l382t1453r533b1475],
23	(	NNP	O	(	nn	25	SENT_3	[p1l545t1453r625b1482],
24	S.H.	NNP	LOCATION	S.H.	nn	25	SENT_3	[p1l545t1453r625b1482],
25	)	NNP	O	)	appos	1	SENT_3	[p1l545t1453r625b1482],
26	,	,	O	,	_	0	SENT_3	[p1l545t1453r625b1482],
27	Neurosurgery	NNP	O	Neurosurgery	appos	1	SENT_3	[p1l92t1490r266b1519],
28	(	CD	NUMBER	(	num	27	SENT_3	[p1l292t1490r398b1519],
29	L.M.L.	NNP	O	L.M.L.	dep	27	SENT_3	[p1l292t1490r398b1519],
30	)	CD	NUMBER	)	num	29	SENT_3	[p1l292t1490r398b1519],
31	,	,	O	,	_	0	SENT_3	[p1l292t1490r398b1519],
32	and	CC	O	and	_	0	SENT_3	[p1l423t1488r468b1512],
33	Neurology	NNP	O	Neurology	appos	1	SENT_3	[p1l495t1488r627b1519],
34	(	CD	NUMBER	(	num	36	SENT_3	[p1l93t1527r185b1557],
35	T.F.C.	NNP	O	T.F.C.	nn	36	SENT_3	[p1l93t1527r185b1557],
36	)	NN	O	)	dep	33	SENT_3	[p1l93t1527r185b1557],
37	;	:	O	;	_	0	SENT_3	[p1l93t1527r185b1557],
38	the	DT	O	the	det	44	SENT_3	[p1l193t1526r232b1549],
39	Henry	NNP	PERSON	Henry	nn	44	SENT_3	[p1l241t1528r314b1557],
40	E.	NNP	PERSON	E.	nn	44	SENT_3	[p1l323t1528r342b1549],
41	Singleton	NNP	PERSON	Singleton	nn	44	SENT_3	[p1l351t1526r466b1557],
42	Brain	NN	O	brain	nn	44	SENT_3	[p1l477t1528r538b1549],
43	Tumor	NN	O	tumor	nn	44	SENT_3	[p1l545t1528r627b1549],
44	Program	NN	O	program	dep	1	SENT_3	[p1l92t1565r199b1594],
45	(	CD	NUMBER	(	num	46	SENT_3	[p1l219t1565r310b1594],
46	|	NN	O	|	dep	44	SENT_3	[p1l219t1565r310b1594],
47	.	.	O	.	_	0	SENT_3	[p1l219t1565r310b1594],

1	K.M.	NNP	PERSON	K.M.	nn	7	SENT_4	[p1l219t1565r310b1594],
2	,	,	O	,	_	0	SENT_4	[p1l219t1565r310b1594],
3	L.M.L.	NNP	O	L.M.L.	appos	7	SENT_4	[p1l329t1565r413b1591],
4	,	,	O	,	_	0	SENT_4	[p1l329t1565r413b1591],
5	T.F.C.	NNP	O	T.F.C.	appos	7	SENT_4	[p1l429t1565r507b1591],
6	,	,	O	,	_	0	SENT_4	[p1l429t1565r507b1591],
7	P.S.M.	NNP	O	P.S.M.	_	0	SENT_4	[p1l525t1565r625b1594],
8	)	CD	NUMBER	)	num	7	SENT_4	[p1l525t1565r625b1594],
9	;	:	O	;	_	0	SENT_4	[p1l525t1565r625b1594],
10	the	DT	O	the	det	15	SENT_4	[p1l89t1600r128b1624],
11	Molecular	JJ	ORGANIZATION	molecular	amod	15	SENT_4	[p1l138t1600r261b1624],
12	Biology	NNP	ORGANIZATION	Biology	nn	15	SENT_4	[p1l269t1600r359b1631],
13	Institute	NNP	ORGANIZATION	Institute	nn	15	SENT_4	[p1l367t1602r468b1624],
14	(	NN	O	(	nn	15	SENT_4	[p1l479t1602r529b1631],
15	|	NN	O	|	dep	7	SENT_4	[p1l479t1602r529b1631],
16	.	.	O	.	_	0	SENT_4	[p1l479t1602r529b1631],

1	\	NN	O	\	nsubj	2	SENT_5	[p1l479t1602r529b1631],
2	/	:	O	/	_	0	SENT_5	[p1l479t1602r529b1631],
3	.	.	O	.	_	0	SENT_5	[p1l479t1602r529b1631],

1	,	,	O	,	_	0	SENT_6	[p1l479t1602r529b1631],
2	C.L.S.	NNP	O	C.L.S.	dep	15	SENT_6	[p1l538t1602r625b1631],
3	)	CD	NUMBER	)	dep	2	SENT_6	[p1l538t1602r625b1631],
4	;	:	O	;	_	0	SENT_6	[p1l538t1602r625b1631],
5	and	CC	O	and	_	0	SENT_6	[p1l90t1638r135b1661],
6	the	DT	O	the	det	11	SENT_6	[p1l144t1638r184b1661],
7	Howard	NNP	ORGANIZATION	Howard	nn	11	SENT_6	[p1l194t1638r293b1661],
8	Hughes	NNP	ORGANIZATION	Hughes	nn	11	SENT_6	[p1l304t1638r401b1669],
9	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_6	[p1l412t1638r510b1661],
10	Institute	NNP	ORGANIZATION	Institute	nn	11	SENT_6	[p1l521t1640r626b1661],
11	(	NN	O	(	dep	2	SENT_6	[p1l93t1677r183b1706],
12	C.L.S.	NNP	O	C.L.S.	dep	11	SENT_6	[p1l93t1677r183b1706],
13	)	CD	NUMBER	)	num	12	SENT_6	[p1l93t1677r183b1706],
14	—	CD	NUMBER	—	dep	15	SENT_6	[p1l195t1690r227b1692],
15	all	DT	O	all	dep	30	SENT_6	[p1l237t1675r263b1699],
16	at	IN	O	at	_	0	SENT_6	[p1l276t1680r299b1699],
17	the	DT	O	the	det	21	SENT_6	[p1l309t1675r349b1699],
18	David	NNP	PERSON	David	nn	21	SENT_6	[p1l362t1675r432b1699],
19	Geffen	NNP	PERSON	Geffen	nn	21	SENT_6	[p1l445t1675r527b1699],
20	School	NNP	O	School	nn	21	SENT_6	[p1l540t1675r625b1699],
21	ofMedicine	NNP	O	ofMedicine	prep_at	15	SENT_6	[p1l90t1713r240b1737],
22	at	IN	O	at	dep	15	SENT_6	[p1l249t1717r272b1737],
23	the	DT	O	the	det	27	SENT_6	[p1l279t1713r319b1737],
24	University	NNP	O	University	nn	27	SENT_6	[p1l329t1715r456b1744],
25	ofCa	NN	O	ofca	nn	27	SENT_6	[p1l464t1713r624b1741],
26	|	NN	O	|	nn	27	SENT_6	[p1l464t1713r624b1741],
27	ifornia	NN	O	ifornium	pobj	22	SENT_6	[p1l464t1713r624b1741],
28	,	,	O	,	_	0	SENT_6	[p1l464t1713r624b1741],
29	Los	NNP	LOCATION	Los	nn	30	SENT_6	[p1l92t1752r133b1774],
30	Angeles	NNP	LOCATION	Angeles	_	0	SENT_6	[p1l141t1750r248b1781],
31	,	,	O	,	_	0	SENT_6	[p1l141t1750r248b1781],
32	Los	NNP	LOCATION	Los	nn	33	SENT_6	[p1l260t1752r301b1774],
33	Angeles	NNP	LOCATION	Angeles	appos	30	SENT_6	[p1l309t1750r416b1781],
34	;	:	O	;	_	0	SENT_6	[p1l309t1750r416b1781],
35	the	DT	O	the	det	36	SENT_6	[p1l425t1750r464b1774],
36	Department	NNP	ORGANIZATION	Department	dep	30	SENT_6	[p1l475t1752r627b1781],
37	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l90t1787r118b1811],
38	Neurological	JJ	ORGANIZATION	neurological	amod	39	SENT_6	[p1l138t1788r301b1819],
39	Surgery	NN	ORGANIZATION	surgery	prep_of	36	SENT_6	[p1l326t1789r426b1819],
40	,	,	O	,	_	0	SENT_6	[p1l326t1789r426b1819],
41	University	NNP	ORGANIZATION	University	appos	39	SENT_6	[p1l451t1790r580b1818],
42	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l602t1787r630b1811],
43	California	NNP	ORGANIZATION	California	prep_of	41	SENT_6	[p1l90t1825r219b1853],
44	,	,	O	,	_	0	SENT_6	[p1l90t1825r219b1853],
45	San	NNP	LOCATION	San	nn	46	SENT_6	[p1l236t1827r281b1849],
46	Francisco	NNP	LOCATION	Francisco	conj_and	39	SENT_6	[p1l300t1827r425b1853],
47	,	,	O	,	_	0	SENT_6	[p1l300t1827r425b1853],
48	San	NNP	LOCATION	San	nn	51	SENT_6	[p1l443t1827r488b1849],
49	Francisco	NNP	LOCATION	Francisco	nn	51	SENT_6	[p1l507t1827r625b1849],
50	(	NN	O	(	nn	51	SENT_6	[p1l93t1864r224b1893],
51	D.A.H.-K.	NN	O	d.a.h.-k.	appos	46	SENT_6	[p1l93t1864r224b1893],
52	,	,	O	,	_	0	SENT_6	[p1l93t1864r224b1893],
53	D.S.	NNP	O	D.S.	prep_of	36	SENT_6	[p1l235t1864r290b1890],
54	,	,	O	,	_	0	SENT_6	[p1l235t1864r290b1890],
55	M.P.	NNP	O	M.P.	nn	56	SENT_6	[p1l301t1864r373b1893],
56	)	NNP	O	)	appos	53	SENT_6	[p1l301t1864r373b1893],
57	;	:	O	;	_	0	SENT_6	[p1l301t1864r373b1893],
58	the	DT	O	the	det	60	SENT_6	[p1l380t1862r420b1886],
59	Ludwig	NNP	ORGANIZATION	Ludwig	nn	60	SENT_6	[p1l429t1862r517b1893],
60	Institute	NNP	ORGANIZATION	Institute	prep_of	36	SENT_6	[p1l525t1864r626b1886],
61	for	IN	ORGANIZATION	for	_	0	SENT_6	[p1l89t1895r125b1919],
62	Cancer	NNP	ORGANIZATION	Cancer	nn	63	SENT_6	[p1l139t1897r226b1919],
63	Research	NNP	ORGANIZATION	Research	prep_for	60	SENT_6	[p1l242t1895r354b1919],
64	at	IN	O	at	_	0	SENT_6	[p1l370t1900r393b1919],
65	the	DT	O	the	det	66	SENT_6	[p1l406t1895r446b1919],
66	University	NNP	ORGANIZATION	University	prep_at	63	SENT_6	[p1l462t1897r589b1926],
67	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l602t1895r630b1919],
68	California	NNP	ORGANIZATION	California	prep_of	66	SENT_6	[p1l90t1932r218b1960],
69	,	,	O	,	_	0	SENT_6	[p1l90t1932r218b1960],
70	San	NNP	LOCATION	San	nn	71	SENT_6	[p1l228t1934r273b1956],
71	Diego	NNP	LOCATION	Diego	prep_of	36	SENT_6	[p1l285t1934r365b1963],
72	,	,	O	,	_	0	SENT_6	[p1l285t1934r365b1963],
73	San	NNP	LOCATION	San	nn	74	SENT_6	[p1l375t1934r420b1956],
74	Diego	NNP	LOCATION	Diego	appos	71	SENT_6	[p1l432t1934r505b1963],
75	(	CD	NUMBER	(	num	77	SENT_6	[p1l516t1934r625b1963],
76	W.K.C.	NNP	O	W.K.C.	nn	77	SENT_6	[p1l516t1934r625b1963],
77	)	NN	O	)	dep	74	SENT_6	[p1l516t1934r625b1963],
78	;	:	O	;	_	0	SENT_6	[p1l516t1934r625b1963],
79	and	CC	O	and	_	0	SENT_6	[p1l90t1970r135b1993],
80	the	DT	O	the	det	81	SENT_6	[p1l144t1970r184b1993],
81	Department	NNP	ORGANIZATION	Department	prep_of	36	SENT_6	[p1l195t1972r348b2000],
82	of	IN	ORGANIZATION	of	_	0	SENT_6	[p1l357t1969r385b1993],
83	Medical	NNP	ORGANIZATION	Medical	nn	84	SENT_6	[p1l391t1970r488b1993],
84	Oncology	NNP	ORGANIZATION	Oncology	prep_of	81	SENT_6	[p1l499t1970r624b2001],
85	,	,	O	,	_	0	SENT_6	[p1l499t1970r624b2001],
86	Dana	NNP	PERSON	Dana	appos	84	SENT_6	[p1l92t2007r255b2031],
87	.	.	O	.	_	0	SENT_6	[p1l92t2007r255b2031],

1	—	NN	O	—	_	0	SENT_7	[p1l92t2007r255b2031],
2	.	.	O	.	_	0	SENT_7	[p1l92t2007r255b2031],

1	Farber	NNP	ORGANIZATION	Farber	nn	3	SENT_8	[p1l92t2007r255b2031],
2	Cancer	NNP	ORGANIZATION	Cancer	nn	3	SENT_8	[p1l263t2009r351b2031],
3	Institute	NNP	ORGANIZATION	Institute	_	0	SENT_8	[p1l361t2009r472b2035],
4	,	,	O	,	_	0	SENT_8	[p1l361t2009r472b2035],
5	the	DT	O	the	det	7	SENT_8	[p1l481t2007r521b2031],
6	Department	NNP	O	Department	nn	7	SENT_8	[p1l532t2009r626b2038, p1l91t2049r155b2068],
7	ofMedicine	NN	O	ofmedicine	conj_and	3	SENT_8	[p1l162t2044r313b2072],
8	,	,	O	,	_	0	SENT_8	[p1l162t2044r313b2072],
9	Harvard	NNP	ORGANIZATION	Harvard	nn	11	SENT_8	[p1l323t2044r421b2068],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_8	[p1l432t2044r527b2068],
11	School	NNP	ORGANIZATION	School	conj_and	3	SENT_8	[p1l536t2044r625b2072],
12	,	,	O	,	_	0	SENT_8	[p1l536t2044r625b2072],
13	and	CC	O	and	_	0	SENT_8	[p1l90t2082r135b2105],
14	the	DT	O	the	det	16	SENT_8	[p1l152t2082r191b2105],
15	Broad	NNP	ORGANIZATION	Broad	nn	16	SENT_8	[p1l209t2082r281b2105],
16	Institute	NNP	ORGANIZATION	Institute	conj_and	3	SENT_8	[p1l300t2084r405b2105],
17	of	IN	ORGANIZATION	of	dep	3	SENT_8	[p1l421t2081r449b2105],
18	Harvard	NNP	ORGANIZATION	Harvard	pobj	17	SENT_8	[p1l462t2082r562b2105],
19	and	CC	O	and	_	0	SENT_8	[p1l580t2082r625b2105],
20	the	DT	O	the	det	23	SENT_8	[p1l89t2119r129b2143],
21	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	23	SENT_8	[p1l140t2119r328b2143],
22	Institute	NNP	ORGANIZATION	Institute	nn	23	SENT_8	[p1l339t2121r443b2143],
23	ofTechnology	NN	O	oftechnology	conj_and	18	SENT_8	[p1l452t2119r627b2151],
24	—	CD	NUMBER	—	num	23	SENT_8	[p1l89t2171r120b2174],
25	all	DT	O	all	advmod	26	SENT_8	[p1l144t2157r170b2181],
26	in	IN	O	in	dep	3	SENT_8	[p1l196t2159r216b2180],
27	Boston	NNP	LOCATION	Boston	nn	33	SENT_8	[p1l244t2159r331b2181],
28	(	NNP	O	(	nn	33	SENT_8	[p1l359t2159r424b2188],
29	R.B.	NNP	LOCATION	R.B.	nn	33	SENT_8	[p1l359t2159r424b2188],
30	,	,	O	,	_	0	SENT_8	[p1l359t2159r424b2188],
31	T.C.P.	NNP	O	T.C.P.	appos	33	SENT_8	[p1l449t2159r527b2185],
32	,	,	O	,	_	0	SENT_8	[p1l449t2159r527b2185],
33	J.C.L.	NNP	O	J.C.L.	pobj	26	SENT_8	[p1l548t2159r624b2187],
34	,	,	O	,	_	0	SENT_8	[p1l548t2159r624b2187],

1	W.R.S.	NNP	O	W.R.S.	_	0	SENT_9	[p1l89t2266r188b2295],
2	)	CD	NUMBER	)	dep	1	SENT_9	[p1l89t2266r188b2295],
3	.	.	O	.	_	0	SENT_9	[p1l89t2266r188b2295],

1	Address	NN	O	address	nsubj	2	SENT_10	[p1l204t2264r308b2288],
2	reprint	VB	O	reprint	conj_or	2	SENT_10	[p1l326t2266r410b2295],
3	requests	NNS	O	request	dobj	2	SENT_10	[p1l426t2269r533b2295],
4	to	TO	O	to	_	0	SENT_10	[p1l549t2269r574b2288],
5	Dr.	NNP	O	Dr.	nn	6	SENT_10	[p1l592t2266r625b2288],
6	Mischel	NNP	PERSON	Mischel	prep_to	2	SENT_10	[p1l92t2302r188b2325],
7	at	IN	O	at	_	0	SENT_10	[p1l204t2306r227b2325],
8	the	DT	O	the	det	9	SENT_10	[p1l240t2302r280b2325],
9	Department	NNP	ORGANIZATION	Department	prep_at	6	SENT_10	[p1l296t2304r449b2333],
10	of	IN	ORGANIZATION	of	_	0	SENT_10	[p1l462t2301r490b2325],
11	Pathology	NNP	ORGANIZATION	Pathology	nn	14	SENT_10	[p1l502t2302r627b2333],
12	and	CC	ORGANIZATION	and	_	0	SENT_10	[p1l90t2339r135b2363],
13	Laboratory	NNP	ORGANIZATION	Laboratory	conj_and	11	SENT_10	[p1l156t2339r291b2370],
14	Medicine	NNP	ORGANIZATION	Medicine	prep_of	9	SENT_10	[p1l310t2339r432b2367],
15	,	,	O	,	_	0	SENT_10	[p1l310t2339r432b2367],
16	David	NNP	PERSON	David	nn	18	SENT_10	[p1l453t2339r523b2363],
17	Geffen	NNP	PERSON	Geffen	nn	18	SENT_10	[p1l542t2339r625b2363],
18	School	NNP	O	School	npadvmod	2	SENT_10	[p1l91t2377r175b2401],
19	of	IN	O	of	_	0	SENT_10	[p1l193t2377r221b2401],
20	Medicine	NNP	O	Medicine	prep_of	18	SENT_10	[p1l235t2377r351b2401],
21	at	IN	O	at	_	0	SENT_10	[p1l368t2381r391b2401],
22	UCLA	NNP	ORGANIZATION	UCLA	prep_at	2	SENT_10	[p1l409t2379r487b2405],
23	,	,	O	,	_	0	SENT_10	[p1l409t2379r487b2405],
24	10833	CD	NUMBER	10833	num	27	SENT_10	[p1l507t2378r579b2401],
25	Le	NNP	ORGANIZATION	Le	nn	27	SENT_10	[p1l600t2379r626b2401],
26	Conte	NNP	ORGANIZATION	Conte	nn	27	SENT_10	[p1l90t2416r163b2438],
27	Ave.	NNP	ORGANIZATION	Ave.	appos	22	SENT_10	[p1l170t2416r230b2442],
28	,	,	O	,	_	0	SENT_10	[p1l170t2416r230b2442],
29	Center	NNP	O	Center	nn	32	SENT_10	[p1l239t2416r321b2438],
30	forthe	NNP	O	forthe	nn	32	SENT_10	[p1l328t2414r409b2438],
31	Health	NNP	ORGANIZATION	Health	nn	32	SENT_10	[p1l418t2414r500b2438],
32	Sciences	NNPS	ORGANIZATION	Sciences	appos	27	SENT_10	[p1l509t2416r625b2442],
33	,	,	O	,	_	0	SENT_10	[p1l509t2416r625b2442],
34	Room	NNP	O	Room	appos	27	SENT_10	[p1l92t2454r163b2476],
35	13-321	CD	NUMBER	13-321	num	34	SENT_10	[p1l174t2454r261b2480],
36	,	,	O	,	_	0	SENT_10	[p1l174t2454r261b2480],
37	Los	NNP	LOCATION	Los	nn	38	SENT_10	[p1l272t2454r312b2476],
38	Angeles	NNP	LOCATION	Angeles	appos	27	SENT_10	[p1l320t2452r424b2483],
39	,	,	O	,	_	0	SENT_10	[p1l320t2452r424b2483],
40	CA	NNP	LOCATION	CA	appos	27	SENT_10	[p1l433t2453r469b2476],
41	90095-1732	CD	NUMBER	90095-1732	num	40	SENT_10	[p1l476t2453r625b2480],
42	,	,	O	,	_	0	SENT_10	[p1l476t2453r625b2480],
43	or	CC	O	or	_	0	SENT_10	[p1l90t2498r116b2513],
44	at	IN	O	at	_	0	SENT_10	[p1l125t2494r147b2513],
45	pmischel@mednet.ucla.edu	NN	O	pmischel@mednet.ucla.edu	prep_at	2	SENT_10	[p1l158t2489r527b2520],
46	.	.	O	.	_	0	SENT_10	[p1l158t2489r527b2520],

1	Drs.	NNP	O	Drs.	nn	2	SENT_11	[p1l92t2566r141b2588],
2	Mellinghoff	NNP	PERSON	Mellinghoff	nsubj	8	SENT_11	[p1l154t2564r306b2595],
3	,	,	O	,	_	0	SENT_11	[p1l154t2564r306b2595],
4	Wang	NNP	PERSON	Wang	conj_and	2	SENT_11	[p1l316t2566r394b2595],
5	,	,	O	,	_	0	SENT_11	[p1l316t2566r394b2595],
6	and	CC	O	and	_	0	SENT_11	[p1l405t2564r450b2588],
7	Vivanco	NNP	PERSON	Vivanco	nsubj	8	SENT_11	[p1l461t2566r562b2588],
8	contributed	VBD	O	contribute	_	0	SENT_11	[p1l572t2572r626b2588, p1l89t2601r189b2625],
9	equally	RB	O	equally	advmod	8	SENT_11	[p1l200t2601r289b2632],
10	to	TO	O	to	_	0	SENT_11	[p1l296t2606r321b2625],
11	the	DT	O	the	det	12	SENT_11	[p1l330t2601r370b2625],
12	article	NN	O	article	prep_to	8	SENT_11	[p1l380t2601r463b2625],
13	.	.	O	.	_	0	SENT_11	[p1l380t2601r463b2625],

1	N	NN	MISC	n	nn	3	SENT_12	[p1l92t2678r110b2700],
2	Englj	NNP	MISC	Englj	nn	3	SENT_12	[p1l123t2676r191b2707],
3	Med	NNP	O	Med	_	0	SENT_12	[p1l204t2676r258b2700],
4	2005	CD	DATE	2005	num	3	SENT_12	[p1l268t2678r501b2704],
5	;	:	O	;	_	0	SENT_12	[p1l268t2678r501b2704],
6	353:2012	CD	NUMBER	353:2012	number	7	SENT_12	[p1l268t2678r501b2704],
7	-24	CD	NUMBER	-24	dep	3	SENT_12	[p1l268t2678r501b2704],
8	.	.	O	.	_	0	SENT_12	[p1l268t2678r501b2704],

1	Copyright	NN	O	copyright	_	0	SENT_13	[p1l90t2718r183b2743],
2	©	CD	NUMBER	©	num	6	SENT_13	[p1l191t2720r212b2741],
3	2005	CD	DATE	2005	num	6	SENT_13	[p1l221t2719r270b2737],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_13	[p1l278t2718r418b2737],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_13	[p1l426t2718r503b2737],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_13	[p1l510t2719r581b2743],
7	.	.	O	.	_	0	SENT_13	[p1l510t2719r581b2743],

1	The	DT	O	the	det	3	SENT_14	[p1l998t81r1036b103],
2	NEW	NNP	O	NEW	nn	3	SENT_14	[p1l1048t83r1128b103],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_14	[p1l1142t83r1317b103],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_14	[p1l1331t83r1497b110],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_14	[p1l1511t81r1727b109],

1	1	CD	NUMBER	1	_	0	SENT_15	[p1l663t187r665b312],
2	ORIGINAL	NNP	O	ORIGINAL	nn	3	SENT_15	[p1l1134t234r1376b261],
3	ARTICLE	NN	O	article	dep	1	SENT_15	[p1l1392t234r1592b261],
4	l	NN	O	l	tmod	3	SENT_15	[p1l2063t185r2066b312],

1	Molecular	JJ	O	molecular	amod	2	SENT_16	[p1l762t387r1061b443],
2	Determinants	NNS	O	determinant	_	0	SENT_16	[p1l1075t388r1479b442],
3	of	IN	O	of	_	0	SENT_16	[p1l1499t387r1569b442],
4	the	DT	O	the	det	5	SENT_16	[p1l1574t388r1664b442],
5	Response	NN	O	response	prep_of	2	SENT_16	[p1l1681t392r1966b457],
6	of	IN	O	of	_	0	SENT_16	[p1l717t469r787b525],
7	Glioblastomas	NNS	O	glioblastoma	prep_of	2	SENT_16	[p1l791t470r1221b525],
8	to	TO	O	to	_	0	SENT_16	[p1l1241t481r1296b525],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_16	[p1l1313t474r1494b528],
10	Kinase	NN	O	kinase	nn	11	SENT_16	[p1l1504t470r1703b526],
11	Inhibitors	NNS	O	inhibitor	prep_to	7	SENT_16	[p1l1719t470r2012b525],

1	Ingo	NNP	PERSON	Ingo	nn	3	SENT_17	[p1l724t606r796b645],
2	K.	NNP	PERSON	K.	nn	3	SENT_17	[p1l812t606r839b635],
3	Mellinghoff	NNP	PERSON	Mellinghoff	_	0	SENT_17	[p1l856t603r1058b645],
4	,	,	O	,	_	0	SENT_17	[p1l856t603r1058b645],
5	M.D.	NNP	O	M.D.	appos	3	SENT_17	[p1l1075t606r1165b641],
6	,	,	O	,	_	0	SENT_17	[p1l1075t606r1165b641],
7	Maria	NNP	PERSON	Maria	nn	9	SENT_17	[p1l1182t606r1276b635],
8	Y.	NNP	PERSON	Y.	nn	9	SENT_17	[p1l1289t606r1313b635],
9	Wang	NNP	PERSON	Wang	appos	3	SENT_17	[p1l1326t606r1430b645],
10	,	,	O	,	_	0	SENT_17	[p1l1326t606r1430b645],
11	M.D.	NNP	O	M.D.	appos	3	SENT_17	[p1l1447t606r1537b641],
12	,	,	O	,	_	0	SENT_17	[p1l1447t606r1537b641],
13	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_17	[p1l1554t603r1653b641],
14	,	,	O	,	_	0	SENT_17	[p1l1554t603r1653b641],
15	Igor	NNP	PERSON	Igor	nn	16	SENT_17	[p1l1671t606r1736b645],
16	Vivanco	NNP	PERSON	Vivanco	appos	3	SENT_17	[p1l1746t606r1890b641],
17	,	,	O	,	_	0	SENT_17	[p1l1746t606r1890b641],
18	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_17	[p1l1907t603r2006b641],
19	,	,	O	,	_	0	SENT_17	[p1l1907t603r2006b641],
20	Daphne	NNP	PERSON	Daphne	nn	22	SENT_17	[p1l759t653r889b693],
21	A.	NNP	PERSON	A.	nn	22	SENT_17	[p1l901t655r933b684],
22	Haas-Kogan	NNP	PERSON	Haas-Kogan	appos	3	SENT_17	[p1l950t656r1165b694],
23	,	,	O	,	_	0	SENT_17	[p1l950t656r1165b694],
24	M.D.	NNP	O	M.D.	appos	3	SENT_17	[p1l1182t656r1272b690],
25	,	,	O	,	_	0	SENT_17	[p1l1182t656r1272b690],
26	Shaojun	NNP	PERSON	Shaojun	nn	27	SENT_17	[p1l1287t653r1424b694],
27	Zhu	NNP	PERSON	Zhu	appos	3	SENT_17	[p1l1438t653r1514b690],
28	,	,	O	,	_	0	SENT_17	[p1l1438t653r1514b690],
29	M.S.	NNP	LOCATION	M.S.	appos	3	SENT_17	[p1l1531t655r1614b690],
30	,	,	O	,	_	0	SENT_17	[p1l1531t655r1614b690],
31	Ederlyn	NNP	PERSON	Ederlyn	nn	33	SENT_17	[p1l1631t653r1751b694],
32	Q.	NNP	PERSON	Q.	nn	33	SENT_17	[p1l1766t655r1804b693],
33	Dia	NNP	PERSON	Dia	appos	3	SENT_17	[p1l1821t656r1883b690],
34	,	,	O	,	_	0	SENT_17	[p1l1821t656r1883b690],
35	B.S.	NNP	O	B.S.	appos	3	SENT_17	[p1l1900t655r1971b690],
36	,	,	O	,	_	0	SENT_17	[p1l1900t655r1971b690],
37	Kan	NNP	PERSON	Kan	nn	39	SENT_17	[p1l777t705r836b733],
38	V.	NNP	PERSON	V.	nn	39	SENT_17	[p1l850t705r876b733],
39	Lu	NNP	PERSON	Lu	appos	3	SENT_17	[p1l893t705r940b739],
40	,	,	O	,	_	0	SENT_17	[p1l893t705r940b739],
41	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_17	[p1l957t702r1056b739],
42	,	,	O	,	_	0	SENT_17	[p1l957t702r1056b739],
43	Koji	NNP	PERSON	Koji	nn	44	SENT_17	[p1l1073t705r1132b743],
44	Yoshimoto	NNP	PERSON	Yoshimoto	appos	3	SENT_17	[p1l1145t702r1337b739],
45	,	,	O	,	_	0	SENT_17	[p1l1145t702r1337b739],
46	M.D.	NNP	O	M.D.	appos	3	SENT_17	[p1l1355t705r1445b739],
47	,	,	O	,	_	0	SENT_17	[p1l1355t705r1445b739],
48	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_17	[p1l1462t702r1647b742],
49	,	,	O	,	_	0	SENT_17	[p1l1462t702r1647b742],
50	julie	NNP	PERSON	julie	nn	52	SENT_17	[p1l1462t702r1647b742],
51	H.Y.	NNP	PERSON	H.Y.	nn	52	SENT_17	[p1l1663t705r1726b733],
52	Huang	NNP	PERSON	Huang	appos	3	SENT_17	[p1l1743t705r1864b743],
53	,	,	O	,	_	0	SENT_17	[p1l1743t705r1864b743],
54	B.S.	NNP	O	B.S.	nn	57	SENT_17	[p1l1882t704r1952b739],
55	,	,	O	,	_	0	SENT_17	[p1l1882t704r1952b739],
56	Dennis	NNP	PERSON	Dennis	appos	57	SENT_17	[p1l795t754r944b791],
57	]	NNP	O	]	appos	3	SENT_17	[p1l795t754r944b791],
58	.	.	O	.	_	0	SENT_17	[p1l795t754r944b791],

1	Chute	NN	O	chute	_	0	SENT_18	[p1l959t751r1067b788],
2	,	,	O	,	_	0	SENT_18	[p1l959t751r1067b788],
3	M.D.	NNP	O	M.D.	dep	1	SENT_18	[p1l1084t754r1174b788],
4	,	,	O	,	_	0	SENT_18	[p1l1084t754r1174b788],
5	Bridget	NNP	PERSON	Bridget	nn	7	SENT_18	[p1l1191t751r1311b792],
6	L.	NNP	PERSON	L.	nn	7	SENT_18	[p1l1326t754r1350b782],
7	Riggs	NNP	PERSON	Riggs	appos	3	SENT_18	[p1l1367t754r1465b792],
8	,	,	O	,	_	0	SENT_18	[p1l1367t754r1465b792],
9	B.S.	NNP	LOCATION	B.S.	appos	3	SENT_18	[p1l1483t753r1553b788],
10	,	,	O	,	_	0	SENT_18	[p1l1483t753r1553b788],
11	Steve	NNP	PERSON	Steve	nn	12	SENT_18	[p1l1568t753r1658b782],
12	Horvath	NNP	PERSON	Horvath	appos	3	SENT_18	[p1l1673t751r1818b788],
13	,	,	O	,	_	0	SENT_18	[p1l1673t751r1818b788],
14	Ph.D.	NNP	O	Ph.D.	appos	3	SENT_18	[p1l1835t751r1934b788],
15	,	,	O	,	_	0	SENT_18	[p1l1835t751r1934b788],

1	Linda	NNP	PERSON	Linda	nn	11	SENT_19	[p1l702t800r792b831],
2	M.	NNP	PERSON	M.	nn	11	SENT_19	[p1l808t803r848b831],
3	Liau	NNP	PERSON	Liau	nn	11	SENT_19	[p1l865t803r941b837],
4	,	,	O	,	_	0	SENT_19	[p1l865t803r941b837],
5	M.D.	NNP	O	M.D.	appos	11	SENT_19	[p1l958t803r1048b837],
6	,	,	O	,	_	0	SENT_19	[p1l958t803r1048b837],
7	Ph.D.	NNP	O	Ph.D.	appos	11	SENT_19	[p1l1066t800r1165b837],
8	,	,	O	,	_	0	SENT_19	[p1l1066t800r1165b837],
9	Webster	NNP	PERSON	Webster	appos	11	SENT_19	[p1l1178t800r1318b831],
10	K.	NNP	PERSON	K.	nn	11	SENT_19	[p1l1332t803r1359b831],
11	Cavenee	NNP	PERSON	Cavenee	_	0	SENT_19	[p1l1373t802r1522b837],
12	,	,	O	,	_	0	SENT_19	[p1l1373t802r1522b837],
13	Ph.D.	NNP	O	Ph.D.	appos	11	SENT_19	[p1l1540t800r1639b837],
14	,	,	O	,	_	0	SENT_19	[p1l1540t800r1639b837],
15	P.	NNP	PERSON	P.	nn	17	SENT_19	[p1l1656t803r1682b831],
16	Nagesh	NNP	PERSON	Nagesh	nn	17	SENT_19	[p1l1699t800r1825b841],
17	Rao	NNP	PERSON	Rao	appos	11	SENT_19	[p1l1842t803r1911b837],
18	,	,	O	,	_	0	SENT_19	[p1l1842t803r1911b837],
19	Ph.D.	NNP	O	Ph.D.	appos	17	SENT_19	[p1l1928t800r2028b837],
20	,	,	O	,	_	0	SENT_19	[p1l1928t800r2028b837],

1	Rameen	NNP	PERSON	Rameen	nn	2	SENT_20	[p1l782t852r915b881],
2	Beroukhim	NNP	PERSON	Beroukhim	_	0	SENT_20	[p1l933t849r1126b886],
3	,	,	O	,	_	0	SENT_20	[p1l933t849r1126b886],
4	M.D.	NNP	O	M.D.	dep	2	SENT_20	[p1l1143t852r1233b887],
5	,	,	O	,	_	0	SENT_20	[p1l1143t852r1233b887],
6	Timothy	NNP	PERSON	Timothy	nn	8	SENT_20	[p1l1246t849r1388b891],
7	C.	NNP	PERSON	C.	nn	8	SENT_20	[p1l1400t852r1431b881],
8	Peck	NNP	PERSON	Peck	appos	4	SENT_20	[p1l1448t849r1531b887],
9	,	,	O	,	_	0	SENT_20	[p1l1448t849r1531b887],
10	B.S.	NNP	O	B.S.	appos	4	SENT_20	[p1l1548t849r1737b891],
11	,	,	O	,	_	0	SENT_20	[p1l1548t849r1737b891],
12	Jeffrey	NNP	PERSON	Jeffrey	nn	14	SENT_20	[p1l1548t849r1737b891],
13	C.	NNP	PERSON	C.	nn	14	SENT_20	[p1l1749t852r1780b881],
14	Lee	NNP	PERSON	Lee	appos	4	SENT_20	[p1l1797t852r1860b886],
15	,	,	O	,	_	0	SENT_20	[p1l1797t852r1860b886],
16	B.S.	NNP	O	B.S.	appos	4	SENT_20	[p1l1877t852r1948b887],
17	,	,	O	,	_	0	SENT_20	[p1l1877t852r1948b887],
18	William	NNP	PERSON	William	nn	20	SENT_20	[p1l776t899r904b930],
19	R.	NNP	PERSON	R.	nn	20	SENT_20	[p1l921t902r949b930],
20	Sellers	NNPS	PERSON	Sellers	appos	4	SENT_20	[p1l964t899r1083b936],
21	,	,	O	,	_	0	SENT_20	[p1l964t899r1083b936],
22	M.D.	NNP	O	M.D.	appos	4	SENT_20	[p1l1100t902r1190b936],
23	,	,	O	,	_	0	SENT_20	[p1l1100t902r1190b936],
24	David	NNP	PERSON	David	nn	25	SENT_20	[p1l1207t899r1301b930],
25	Stokoe	NNP	PERSON	Stokoe	appos	4	SENT_20	[p1l1316t899r1439b936],
26	,	,	O	,	_	0	SENT_20	[p1l1316t899r1439b936],
27	Ph.D.	NNP	O	Ph.D.	appos	4	SENT_20	[p1l1456t899r1555b936],
28	,	,	O	,	_	0	SENT_20	[p1l1456t899r1555b936],
29	Michael	NNP	PERSON	Michael	nn	30	SENT_20	[p1l1572t899r1702b930],
30	Prados	NNP	PERSON	Prados	appos	4	SENT_20	[p1l1719t899r1842b936],
31	,	,	O	,	_	0	SENT_20	[p1l1719t899r1842b936],
32	M.D.	NNP	O	M.D.	appos	4	SENT_20	[p1l1860t902r1950b936],
33	,	,	O	,	_	0	SENT_20	[p1l1860t902r1950b936],

1	Timothy	NNP	PERSON	Timothy	nn	3	SENT_21	[p1l670t949r812b990],
2	F.	NNP	PERSON	F.	nn	3	SENT_21	[p1l826t952r851b980],
3	Cloughesy	NNP	PERSON	Cloughesy	_	0	SENT_21	[p1l866t949r1046b990],
4	,	,	O	,	_	0	SENT_21	[p1l866t949r1046b990],
5	M.D.	NNP	O	M.D.	conj_and	3	SENT_21	[p1l1064t952r1154b986],
6	,	,	O	,	_	0	SENT_21	[p1l1064t952r1154b986],
7	Charles	NNP	PERSON	Charles	nn	9	SENT_21	[p1l1169t949r1294b980],
8	L.	NNP	PERSON	L.	nn	9	SENT_21	[p1l1310t952r1334b980],
9	Sawyers	NNP	PERSON	Sawyers	conj_and	3	SENT_21	[p1l1349t951r1493b990],
10	,	,	O	,	_	0	SENT_21	[p1l1349t951r1493b990],
11	M.D.	NNP	O	M.D.	conj_and	3	SENT_21	[p1l1510t952r1600b986],
12	,	,	O	,	_	0	SENT_21	[p1l1510t952r1600b986],
13	and	CC	O	and	_	0	SENT_21	[p1l1615t949r1675b980],
14	Paul	NNP	PERSON	Paul	nn	18	SENT_21	[p1l1692t949r1760b980],
15	S.	NNP	PERSON	S.	nn	18	SENT_21	[p1l1775t951r1803b980],
16	Mischel	NNP	PERSON	Mischel	nn	18	SENT_21	[p1l1820t949r1959b986],
17	,	,	O	,	_	0	SENT_21	[p1l1820t949r1959b986],
18	M.D.	NNP	O	M.D.	conj_and	3	SENT_21	[p1l1976t952r2056b980],

1	ABSTRACT	NN	O	abstract	_	0	SENT_22	[p1l1253t1097r1471b1120],

1	BAC	NN	O	bac	nn	8	SENT_23	[p1l667t1223r724b1243],
2	K	NN	O	k	nn	8	SENT_23	[p1l731t1223r745b1243],
3	G	NN	O	g	nn	8	SENT_23	[p1l751t1223r770b1243],
4	R	NN	O	r	nn	8	SENT_23	[p1l777t1223r792b1243],
5	o	NN	O	o	nn	8	SENT_23	[p1l797t1223r818b1243],
6	u	NN	O	u	nn	8	SENT_23	[p1l825t1223r841b1243],
7	N	NN	O	n	nn	8	SENT_23	[p1l850t1223r867b1243],
8	D	NN	O	d	nsubjpass	24	SENT_23	[p1l876t1223r894b1243],
9	The	DT	O	the	det	16	SENT_23	[p1l664t1256r727b1287],
10	epidermal	JJ	O	epidermal	amod	16	SENT_23	[p1l738t1256r903b1296],
11	growth	NN	O	growth	nn	16	SENT_23	[p1l914t1256r1032b1296],
12	factor	NN	O	factor	nn	16	SENT_23	[p1l1043t1256r1139b1287],
13	receptor	NN	O	receptor	nn	16	SENT_23	[p1l1149t1263r1285b1296],
14	(	CD	NUMBER	(	num	16	SENT_23	[p1l1297t1259r1416b1292],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_23	[p1l1297t1259r1416b1292],
16	)	NN	O	)	dep	8	SENT_23	[p1l1297t1259r1416b1292],
17	is	VBZ	O	be	auxpass	19	SENT_23	[p1l1429t1257r1454b1287],
18	frequently	RB	O	frequently	advmod	19	SENT_23	[p1l1466t1256r1633b1296],
19	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_23	[p1l1643t1256r1808b1296],
20	,	,	O	,	_	0	SENT_23	[p1l1643t1256r1808b1296],
21	overexpressed	VBN	O	overexpress	conj_or	19	SENT_23	[p1l1822t1256r2062b1296],
22	,	,	O	,	_	0	SENT_23	[p1l1822t1256r2062b1296],
23	or	CC	O	or	_	0	SENT_23	[p1l665t1316r700b1337],
24	mutated	VBN	O	mutate	conj_or	19	SENT_23	[p1l710t1306r847b1337],
25	in	IN	O	in	_	0	SENT_23	[p1l857t1307r889b1337],
26	glioblastomas	NNS	O	glioblastoma	prep_in	24	SENT_23	[p1l900t1306r1141b1346],
27	,	,	O	,	_	0	SENT_23	[p1l900t1306r1141b1346],
28	but	CC	O	but	_	0	SENT_23	[p1l1155t1306r1210b1337],
29	only	RB	O	only	quantmod	32	SENT_23	[p1l1219t1306r1290b1345],
30	10	CD	NUMBER	10	number	32	SENT_23	[p1l1301t1309r1338b1337],
31	to	TO	O	to	dep	32	SENT_23	[p1l1350t1313r1381b1337],
32	20	CD	PERCENT	20	num	33	SENT_23	[p1l1393t1309r1432b1337],
33	percent	NN	PERCENT	percent	nsubj	36	SENT_23	[p1l1443t1313r1567b1346],
34	of	IN	O	of	_	0	SENT_23	[p1l1577t1306r1616b1337],
35	patients	NNS	O	patient	prep_of	33	SENT_23	[p1l1620t1307r1750b1346],
36	have	VBP	O	have	conj_but	19	SENT_23	[p1l1762t1306r1835b1337],
37	a	DT	O	a	det	38	SENT_23	[p1l1846t1317r1863b1337],
38	response	NN	O	response	dobj	36	SENT_23	[p1l1874t1316r2021b1346],
39	to	TO	O	to	_	0	SENT_23	[p1l2033t1313r2064b1337],
40	EGFRkinase	NN	O	egfrkinase	nn	41	SENT_23	[p1l665t1357r877b1389],
41	inhibitors	NNS	O	inhibitor	prep_to	36	SENT_23	[p1l888t1357r1059b1387],
42	.	.	O	.	_	0	SENT_23	[p1l888t1357r1059b1387],

1	The	DT	O	the	det	2	SENT_24	[p1l1071t1357r1134b1387],
2	mechanism	NN	O	mechanism	nsubj	11	SENT_24	[p1l1145t1357r1336b1387],
3	of	IN	O	of	_	0	SENT_24	[p1l1348t1356r1387b1387],
4	responsiveness	NN	O	responsiveness	prep_of	2	SENT_24	[p1l1391t1357r1638b1396],
5	of	IN	O	of	_	0	SENT_24	[p1l1651t1356r1690b1387],
6	glioblastomas	NNS	O	glioblastoma	prep_of	4	SENT_24	[p1l1694t1357r1924b1396],
7	to	TO	O	to	_	0	SENT_24	[p1l1937t1363r1967b1387],
8	these	DT	O	these	det	9	SENT_24	[p1l1979t1357r2064b1387],
9	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_24	[p1l665t1407r826b1437],
10	is	VBZ	O	be	cop	11	SENT_24	[p1l836t1407r861b1437],
11	unknown	JJ	O	unknown	_	0	SENT_24	[p1l871t1407r1037b1438],
12	.	.	O	.	_	0	SENT_24	[p1l871t1407r1037b1438],

1	M	NN	O	m	nn	3	SENT_25	[p1l668t1516r688b1535],
2	ET	NNP	O	ET	nn	3	SENT_25	[p1l698t1516r731b1535],
3	H	NNP	O	H	nsubj	6	SENT_25	[p1l737t1516r755b1535],
4	o	NN	O	o	nn	5	SENT_25	[p1l762t1516r783b1535],
5	D	NN	O	d	dep	3	SENT_25	[p1l790t1516r808b1535],
6	s	VBZ	O	s	_	0	SENT_25	[p1l813t1516r827b1535],
7	We	PRP	O	we	nsubj	24	SENT_25	[p1l664t1559r716b1586],
8	sequenced	VBN	O	sequence	ccomp	6	SENT_25	[p1l728t1556r900b1595],
9	kinase	NN	O	kinase	nn	10	SENT_25	[p1l912t1556r1017b1587],
10	domains	NNS	O	domain	dobj	8	SENT_25	[p1l1030t1556r1171b1587],
11	in	IN	O	in	_	0	SENT_25	[p1l1184t1556r1216b1586],
12	the	DT	O	the	det	13	SENT_25	[p1l1228t1556r1278b1586],
13	EGFR	NN	ORGANIZATION	egfr	prep_in	8	SENT_25	[p1l1289t1558r1372b1587],
14	and	CC	O	and	_	0	SENT_25	[p1l1381t1556r1442b1586],
15	human	JJ	O	human	amod	17	SENT_25	[p1l1454t1556r1570b1587],
16	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_25	[p1l1581t1558r1682b1588],
17	type	NN	O	type	prep_in	8	SENT_25	[p1l1690t1562r1756b1595],
18	2	CD	NUMBER	2	number	19	SENT_25	[p1l1768t1558r1787b1586],
19	(	CD	NUMBER	(	num	22	SENT_25	[p1l1801t1559r1956b1594],
20	Her2/neu	NN	O	her2/neu	nn	22	SENT_25	[p1l1801t1559r1956b1594],
21	)	NN	O	)	nn	22	SENT_25	[p1l1801t1559r1956b1594],
22	genes	NNS	O	gene	dep	17	SENT_25	[p1l1970t1566r2063b1595],
23	and	CC	O	and	_	0	SENT_25	[p1l665t1605r725b1636],
24	analyzed	VBD	O	analyze	ccomp	6	SENT_25	[p1l733t1605r874b1644],
25	the	DT	O	the	det	26	SENT_25	[p1l882t1606r932b1636],
26	expression	NN	O	expression	dobj	24	SENT_25	[p1l941t1606r1115b1645],
27	of	IN	O	of	_	0	SENT_25	[p1l1123t1605r1162b1636],
28	EGFR	NN	ORGANIZATION	egfr	prep_of	26	SENT_25	[p1l1163t1608r1268b1643],
29	,	,	O	,	_	0	SENT_25	[p1l1163t1608r1268b1643],
30	EGFR	NN	ORGANIZATION	egfr	nn	31	SENT_25	[p1l1277t1608r1377b1638],
31	deletion	NN	O	deletion	dobj	24	SENT_25	[p1l1382t1605r1513b1636],
32	mutantvariant	JJ	O	mutantvariant	amod	36	SENT_25	[p1l1521t1606r1759b1636],
33	III	CD	NUMBER	iii	number	34	SENT_25	[p1l1765t1608r1802b1636],
34	(	CD	NUMBER	(	dep	32	SENT_25	[p1l1811t1608r1994b1643],
35	EGFRVIII	NN	O	egfrviius	nn	36	SENT_25	[p1l1811t1608r1994b1643],
36	)	NN	O	)	dep	31	SENT_25	[p1l1811t1608r1994b1643],
37	,	,	O	,	_	0	SENT_25	[p1l1811t1608r1994b1643],
38	and	CC	O	and	_	0	SENT_25	[p1l2004t1605r2065b1636],
39	the	DT	O	the	det	44	SENT_25	[p1l665t1656r715b1686],
40	tumor	NN	O	tumor	nn	44	SENT_25	[p1l724t1662r1020b1695],
41	—	NN	O	—	nn	44	SENT_25	[p1l724t1662r1020b1695],
42	suppressor	NN	O	suppressor	nn	44	SENT_25	[p1l724t1662r1020b1695],
43	protein	NN	O	protein	nn	44	SENT_25	[p1l1027t1656r1145b1695],
44	PTEN	NN	ORGANIZATION	pten	dobj	24	SENT_25	[p1l1154t1658r1248b1686],
45	in	IN	O	in	_	0	SENT_25	[p1l1256t1656r1288b1686],
46	recurrent	JJ	O	recurrent	amod	48	SENT_25	[p1l1297t1662r1447b1687],
47	malignant	JJ	O	malignant	amod	48	SENT_25	[p1l1455t1656r1623b1695],
48	gliomas	NNS	O	glioma	prep_in	44	SENT_25	[p1l1629t1656r1758b1695],
49	from	IN	O	from	_	0	SENT_25	[p1l1768t1655r1848b1686],
50	patients	NNS	O	patient	prep_from	24	SENT_25	[p1l1857t1656r1985b1695],
51	who	WP	O	who	nsubj	53	SENT_25	[p1l1993t1656r2064b1687],
52	had	VBD	O	have	aux	53	SENT_25	[p1l665t1706r726b1736],
53	received	VBN	O	receive	rcmod	50	SENT_25	[p1l735t1706r868b1737],
54	EGFRkinase	NN	O	egfrkinase	nn	55	SENT_25	[p1l876t1706r1087b1738],
55	inhibitors	NNS	O	inhibitor	dobj	53	SENT_25	[p1l1097t1706r1267b1736],
56	.	.	O	.	_	0	SENT_25	[p1l1097t1706r1267b1736],

1	We	PRP	O	we	nsubj	2	SENT_26	[p1l1277t1709r1329b1736],
2	determined	VBD	O	determine	_	0	SENT_26	[p1l1339t1706r1527b1736],
3	the	DT	O	the	det	5	SENT_26	[p1l1537t1706r1587b1736],
4	molecular	JJ	O	molecular	amod	5	SENT_26	[p1l1596t1706r1762b1737],
5	correlates	NNS	O	correlate	nsubj	10	SENT_26	[p1l1770t1706r1928b1736],
6	of	IN	O	of	_	0	SENT_26	[p1l1939t1705r1978b1737],
7	clinical	JJ	O	clinical	amod	8	SENT_26	[p1l1981t1706r2064b1736, p1l665t1755r710b1786],
8	response	NN	O	response	prep_of	5	SENT_26	[p1l722t1765r878b1794],
9	,	,	O	,	_	0	SENT_26	[p1l722t1765r878b1794],
10	validated	VBD	O	validate	ccomp	2	SENT_26	[p1l891t1755r1039b1786],
11	them	PRP	O	they	dobj	10	SENT_26	[p1l1051t1755r1135b1786],
12	in	IN	O	in	_	0	SENT_26	[p1l1147t1756r1179b1785],
13	an	DT	O	a	det	16	SENT_26	[p1l1191t1765r1230b1786],
14	independent	JJ	O	independent	amod	16	SENT_26	[p1l1241t1755r1450b1794],
15	data	NN	O	datum	nn	16	SENT_26	[p1l1460t1755r1530b1786],
16	set	NN	O	set	prep_in	10	SENT_26	[p1l1542t1762r1596b1792],
17	,	,	O	,	_	0	SENT_26	[p1l1542t1762r1596b1792],
18	and	CC	O	and	_	0	SENT_26	[p1l1610t1755r1670b1786],
19	identiﬁed	JJ	O	identiﬁed	amod	20	SENT_26	[p1l1682t1755r1839b1786],
20	effects	NNS	O	effect	prep_in	10	SENT_26	[p1l1851t1755r1956b1786],
21	of	IN	O	of	_	0	SENT_26	[p1l1970t1755r2009b1786],
22	the	DT	O	the	det	24	SENT_26	[p1l2014t1755r2064b1786],
23	molecular	JJ	O	molecular	amod	24	SENT_26	[p1l665t1805r830b1836],
24	abnormalities	NNS	O	abnormality	prep_of	20	SENT_26	[p1l838t1805r1065b1836],
25	in	FW	O	in	nn	26	SENT_26	[p1l1075t1806r1107b1835],
26	vitro	FW	O	vitro	advmod	10	SENT_26	[p1l1115t1806r1199b1836],
27	.	.	O	.	_	0	SENT_26	[p1l1115t1806r1199b1836],

1	R	NN	O	r	nn	2	SENT_27	[p1l667t1911r682b1930],
2	E	NN	O	e	nsubj	5	SENT_27	[p1l688t1911r701b1930],
3	s	VBZ	O	s	cop	5	SENT_27	[p1l706t1911r721b1930],
4	u	FW	O	u	nn	5	SENT_27	[p1l727t1911r744b1930],
5	LTS	FW	O	lts	_	0	SENT_27	[p1l752t1911r802b1930],
6	Of	IN	O	of	_	0	SENT_27	[p1l665t1950r712b1981],
7	49	CD	NUMBER	49	num	8	SENT_27	[p1l713t1952r752b1981],
8	patients	NNS	O	patient	prep_of	21	SENT_27	[p1l761t1950r890b1989],
9	with	IN	O	with	_	0	SENT_27	[p1l898t1950r971b1981],
10	recurrent	JJ	O	recurrent	amod	12	SENT_27	[p1l980t1956r1132b1981],
11	malignant	JJ	O	malignant	amod	12	SENT_27	[p1l1139t1950r1309b1989],
12	glioma	NN	O	glioma	prep_with	8	SENT_27	[p1l1315t1950r1430b1989],
13	who	WP	O	who	nsubjpass	15	SENT_27	[p1l1436t1950r1507b1981],
14	were	VBD	O	be	auxpass	15	SENT_27	[p1l1514t1960r1592b1981],
15	treated	VBN	O	treat	rcmod	12	SENT_27	[p1l1601t1950r1713b1980],
16	with	IN	O	with	_	0	SENT_27	[p1l1720t1950r1793b1981],
17	EGFRkinase	NN	MISC	egfrkinase	nn	18	SENT_27	[p1l1801t1950r2011b1982],
18	inhibitors	NNS	O	inhibitor	prep_with	15	SENT_27	[p1l2019t1950r2064b1980, p1l665t2000r802b2037],
19	,	,	O	,	_	0	SENT_27	[p1l2019t1950r2064b1980, p1l665t2000r802b2037],
20	9	CD	NUMBER	9	nsubj	21	SENT_27	[p1l817t2002r835b2031],
21	had	VBD	O	have	rcmod	5	SENT_27	[p1l847t2000r908b2031],
22	tumor	NN	O	tumor	nn	23	SENT_27	[p1l920t2006r1022b2031],
23	shrinkage	NN	O	shrinkage	dobj	21	SENT_27	[p1l1033t2000r1195b2039],
24	of	IN	O	of	_	0	SENT_27	[p1l1207t2000r1247b2031],
25	at	IN	O	at	quantmod	27	SENT_27	[p1l1251t2006r1282b2030],
26	least	JJS	O	least	mwe	25	SENT_27	[p1l1291t2000r1368b2030],
27	25	CD	PERCENT	25	num	28	SENT_27	[p1l1378t2002r1416b2031],
28	percent	NN	PERCENT	percent	prep_of	23	SENT_27	[p1l1429t2006r1560b2039],
29	.	.	O	.	_	0	SENT_27	[p1l1429t2006r1560b2039],

1	Pretreatment	NN	O	pretreatment	nn	2	SENT_28	[p1l1574t2002r1789b2030],
2	tissue	NN	O	tissue	nsubj	4	SENT_28	[p1l1799t2000r1892b2031],
3	was	VBD	O	be	cop	4	SENT_28	[p1l1903t2010r1965b2031],
4	available	JJ	O	available	_	0	SENT_28	[p1l1978t2000r2064b2031, p1l665t2049r732b2080],
5	for	IN	O	for	_	0	SENT_28	[p1l742t2049r790b2080],
6	molecular	JJ	O	molecular	amod	7	SENT_28	[p1l799t2049r964b2080],
7	analysis	NN	O	analysis	prep_for	4	SENT_28	[p1l972t2049r1101b2088],
8	from	IN	O	from	_	0	SENT_28	[p1l1111t2049r1192b2080],
9	26	CD	NUMBER	26	num	10	SENT_28	[p1l1202t2052r1241b2080],
10	patients	NNS	O	patient	prep_from	4	SENT_28	[p1l1251t2050r1391b2089],
11	,	,	O	,	_	0	SENT_28	[p1l1251t2050r1391b2089],
12	7	CD	NUMBER	7	nsubj	16	SENT_28	[p1l1403t2052r1421b2080],
13	of	IN	O	of	_	0	SENT_28	[p1l1432t2049r1471b2080],
14	whom	WP	O	whom	prep_of	12	SENT_28	[p1l1472t2049r1578b2080],
15	had	VBD	O	have	aux	16	SENT_28	[p1l1588t2049r1648b2080],
16	had	VBN	O	have	rcmod	10	SENT_28	[p1l1658t2049r1719b2080],
17	a	DT	O	a	det	18	SENT_28	[p1l1728t2060r1746b2080],
18	response	NN	O	response	dobj	16	SENT_28	[p1l1755t2059r1902b2089],
19	and	CC	O	and	_	0	SENT_28	[p1l1912t2049r1973b2080],
20	19	CD	NUMBER	19	conj_and	18	SENT_28	[p1l1984t2052r2022b2080],
21	of	IN	O	of	_	0	SENT_28	[p1l2032t2049r2071b2080],
22	whom	WP	O	whom	nsubj	23	SENT_28	[p1l664t2100r769b2131],
23	had	VBD	O	have	prepc_of	20	SENT_28	[p1l780t2100r840b2130],
24	rapid	JJ	O	rapid	amod	25	SENT_28	[p1l852t2100r935b2139],
25	progression	NN	O	progression	dobj	23	SENT_28	[p1l946t2100r1140b2139],
26	during	IN	O	during	_	0	SENT_28	[p1l1151t2100r1260b2139],
27	therapy	NN	O	therapy	prep_during	25	SENT_28	[p1l1270t2100r1395b2139],
28	.	.	O	.	_	0	SENT_28	[p1l1270t2100r1395b2139],

1	No	DT	O	no	det	2	SENT_29	[p1l1408t2102r1456b2130],
2	mutations	NNS	O	mutation	nsubjpass	10	SENT_29	[p1l1468t2100r1632b2131],
3	in	IN	O	in	_	0	SENT_29	[p1l1644t2100r1675b2130],
4	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_29	[p1l1686t2102r1767b2131],
5	or	CC	O	or	_	0	SENT_29	[p1l1776t2110r1810b2130],
6	Her2/neu	NN	O	her2/neu	nn	8	SENT_29	[p1l1820t2102r1950b2138],
7	kinase	NN	O	kinase	nn	8	SENT_29	[p1l1961t2100r2064b2131],
8	domains	NNS	O	domain	prep_in	2	SENT_29	[p1l665t2150r805b2180],
9	were	VBD	O	be	auxpass	10	SENT_29	[p1l814t2160r894b2181],
10	detected	VBN	O	detect	_	0	SENT_29	[p1l905t2150r1044b2180],
11	in	IN	O	in	_	0	SENT_29	[p1l1055t2150r1087b2180],
12	the	DT	O	the	det	13	SENT_29	[p1l1098t2150r1149b2180],
13	tumors	NNS	O	tumor	prep_in	10	SENT_29	[p1l1161t2156r1290b2181],
14	.	.	O	.	_	0	SENT_29	[p1l1161t2156r1290b2181],

1	Coexpression	NN	O	coexpression	nsubj	7	SENT_30	[p1l1303t2150r1530b2189],
2	of	IN	O	of	_	0	SENT_30	[p1l1542t2149r1581b2180],
3	EGFRVIII	NN	O	egfrviius	nn	6	SENT_30	[p1l1585t2152r1739b2182],
4	and	CC	O	and	_	0	SENT_30	[p1l1750t2150r1811b2180],
5	PT	NN	O	pt	nn	6	SENT_30	[p1l1822t2152r1866b2180],
6	EN	NN	O	en	prep_of	1	SENT_30	[p1l1867t2153r1918b2181],
7	was	VBD	O	be	_	0	SENT_30	[p1l1927t2160r1990b2181],
8	signiﬁcantly	RB	O	signiﬁcantly	advmod	7	SENT_30	[p1l2003t2150r2063b2189, p1l665t2269r823b2308],

1	associated	VBN	O	associate	dep	12	SENT_31	[p1l831t2269r1001b2300],
2	with	IN	O	with	_	0	SENT_31	[p1l1009t2269r1082b2300],
3	a	DT	O	a	det	5	SENT_31	[p1l1091t2280r1109b2300],
4	clinical	JJ	O	clinical	amod	5	SENT_31	[p1l1117t2269r1234b2300],
5	response	NN	O	response	prep_with	1	SENT_31	[p1l1243t2279r1390b2309],
6	(	CD	NUMBER	(	num	7	SENT_31	[p1l1401t2272r1558b2307],
7	P	NN	O	p	npadvmod	8	SENT_31	[p1l1401t2272r1558b2307],
8	<	JJR	O	<	amod	5	SENT_31	[p1l1401t2272r1558b2307],
9	0.001	CD	NUMBER	0.001	tmod	1	SENT_31	[p1l1401t2272r1558b2307],
10	;	:	O	;	_	0	SENT_31	[p1l1401t2272r1558b2307],
11	odds	NNS	O	odds	nn	12	SENT_31	[p1l1569t2269r1647b2300],
12	ratio	NN	O	ratio	_	0	SENT_31	[p1l1657t2270r1741b2307],
13	,	,	O	,	_	0	SENT_31	[p1l1657t2270r1741b2307],
14	51	CD	NUMBER	51	appos	12	SENT_31	[p1l1753t2272r1801b2306],
15	;	:	O	;	_	0	SENT_31	[p1l1753t2272r1801b2306],
16	95	CD	PERCENT	95	num	19	SENT_31	[p1l1812t2272r1850b2300],
17	percent	NN	PERCENT	percent	nn	19	SENT_31	[p1l1860t2276r1985b2309],
18	conﬁdence	NN	O	conﬁdence	nn	19	SENT_31	[p1l1992t2279r2064b2300, p1l665t2319r784b2350],
19	interval	NN	O	interval	dep	12	SENT_31	[p1l796t2320r926b2357],
20	,	,	O	,	_	0	SENT_31	[p1l796t2320r926b2357],
21	4	CD	NUMBER	4	dep	12	SENT_31	[p1l940t2322r959b2350],
22	to	TO	O	to	dep	12	SENT_31	[p1l971t2326r1002b2350],
23	669	CD	NUMBER	669	number	24	SENT_31	[p1l1015t2322r1097b2355],
24	)	CD	NUMBER	)	pobj	22	SENT_31	[p1l1015t2322r1097b2355],
25	.	.	O	.	_	0	SENT_31	[p1l1015t2322r1097b2355],

1	These	DT	O	these	det	2	SENT_32	[p1l1109t2320r1207b2350],
2	ﬁndings	NNS	O	ﬁndings	nsubjpass	4	SENT_32	[p1l1219t2319r1354b2359],
3	were	VBD	O	be	auxpass	4	SENT_32	[p1l1366t2330r1444b2351],
4	validated	VBN	O	validate	_	0	SENT_32	[p1l1454t2320r1602b2350],
5	in	IN	O	in	_	0	SENT_32	[p1l1613t2320r1645b2350],
6	33	CD	NUMBER	33	num	7	SENT_32	[p1l1657t2322r1695b2350],
7	patients	NNS	O	patient	prep_in	4	SENT_32	[p1l1707t2320r1837b2359],
8	who	WP	O	who	nsubj	9	SENT_32	[p1l1848t2320r1919b2351],
9	received	VBD	O	receive	rcmod	7	SENT_32	[p1l1932t2320r2064b2351],
10	similar	JJ	O	similar	amod	11	SENT_32	[p1l666t2370r780b2400],
11	treatment	NN	O	treatment	dobj	9	SENT_32	[p1l788t2376r947b2400],
12	for	IN	O	for	_	0	SENT_32	[p1l954t2369r1001b2400],
13	glioblastoma	NN	O	glioblastoma	prep_for	9	SENT_32	[p1l1008t2370r1221b2409],
14	at	IN	O	at	_	0	SENT_32	[p1l1228t2376r1259b2400],
15	a	DT	O	a	det	17	SENT_32	[p1l1265t2380r1282b2400],
16	diﬁerent	JJ	O	diﬁerent	amod	17	SENT_32	[p1l1290t2369r1431b2400],
17	institution	NN	O	institution	prep_at	9	SENT_32	[p1l1437t2370r1606b2401],
18	(	CD	NUMBER	(	num	19	SENT_32	[p1l1616t2372r1777b2407],
19	P	NN	O	p	dep	17	SENT_32	[p1l1616t2372r1777b2407],
20	=	JJ	O	=	amod	19	SENT_32	[p1l1616t2372r1777b2407],
21	0.001	CD	NUMBER	0.001	tmod	20	SENT_32	[p1l1616t2372r1777b2407],
22	;	:	O	;	_	0	SENT_32	[p1l1616t2372r1777b2407],
23	odds	NNS	O	odds	nn	24	SENT_32	[p1l1787t2370r1864b2400],
24	ratio	NN	O	ratio	dep	19	SENT_32	[p1l1873t2370r1957b2407],
25	,	,	O	,	_	0	SENT_32	[p1l1873t2370r1957b2407],
26	40	CD	NUMBER	40	appos	24	SENT_32	[p1l1966t2372r2016b2407],
27	;	:	O	;	_	0	SENT_32	[p1l1966t2372r2016b2407],
28	95	CD	PERCENT	95	num	31	SENT_32	[p1l2025t2372r2063b2400],
29	percent	NN	PERCENT	percent	nn	31	SENT_32	[p1l665t2426r788b2459],
30	conﬁdence	NN	O	conﬁdence	nn	31	SENT_32	[p1l799t2419r979b2450],
31	interval	NN	O	interval	dep	19	SENT_32	[p1l992t2419r1123b2457],
32	,	,	O	,	_	0	SENT_32	[p1l992t2419r1123b2457],
33	3	CD	NUMBER	3	number	36	SENT_32	[p1l1139t2422r1156b2450],
34	to	TO	O	to	dep	36	SENT_32	[p1l1171t2426r1201b2450],
35	468	CD	NUMBER	468	number	36	SENT_32	[p1l1215t2422r1298b2455],
36	)	CD	NUMBER	)	appos	31	SENT_32	[p1l1215t2422r1298b2455],
37	.	.	O	.	_	0	SENT_32	[p1l1215t2422r1298b2455],

1	In	FW	O	in	nn	2	SENT_33	[p1l1313t2422r1347b2450],
2	vitro	FW	O	vitro	_	0	SENT_33	[p1l1359t2420r1443b2457],
3	,	,	O	,	_	0	SENT_33	[p1l1359t2420r1443b2457],
4	coexpression	NN	O	coexpression	appos	2	SENT_33	[p1l1458t2420r1673b2459],
5	of	IN	O	of	_	0	SENT_33	[p1l1687t2419r1726b2450],
6	EGFRVIII	NN	O	egfrviius	prep_of	4	SENT_33	[p1l1732t2422r1883b2452],
7	and	CC	O	and	_	0	SENT_33	[p1l1896t2419r1957b2450],
8	PTEN	NN	ORGANIZATION	pten	prep_of	4	SENT_33	[p1l1970t2422r2065b2450],
9	sensitized	VBN	O	sensitize	partmod	4	SENT_33	[p1l666t2470r829b2500],
10	glioblastoma	NN	O	glioblastoma	nn	11	SENT_33	[p1l838t2470r1053b2509],
11	cells	NNS	O	cell	dobj	9	SENT_33	[p1l1063t2470r1134b2500],
12	to	TO	O	to	_	0	SENT_33	[p1l1144t2476r1175b2500],
13	erlotinib	NN	O	erlotinib	prep_to	9	SENT_33	[p1l1185t2470r1334b2500],
14	.	.	O	.	_	0	SENT_33	[p1l1185t2470r1334b2500],

1	CONCLUSIONS	NNS	O	conclusion	nn	2	SENT_34	[p1l666t2580r904b2599],
2	Coexpression	NN	O	coexpression	nsubjpass	11	SENT_34	[p1l665t2619r888b2658],
3	of	IN	O	of	_	0	SENT_34	[p1l899t2619r938b2649],
4	EGFRVIII	NN	O	egfrviius	prep_of	2	SENT_34	[p1l942t2621r1094b2651],
5	and	CC	O	and	_	0	SENT_34	[p1l1104t2619r1165b2649],
6	PTEN	NN	ORGANIZATION	pten	conj_and	4	SENT_34	[p1l1176t2621r1271b2650],
7	by	IN	O	by	_	0	SENT_34	[p1l1282t2619r1319b2658],
8	glioblastoma	NN	O	glioblastoma	nn	9	SENT_34	[p1l1329t2619r1544b2658],
9	cells	NNS	O	cell	prep_by	4	SENT_34	[p1l1555t2619r1626b2649],
10	is	VBZ	O	be	auxpass	11	SENT_34	[p1l1638t2619r1663b2649],
11	associated	VBN	O	associate	_	0	SENT_34	[p1l1675t2619r1844b2650],
12	with	IN	O	with	_	0	SENT_34	[p1l1854t2619r1927b2650],
13	responsiveness	NN	O	responsiveness	prep_with	11	SENT_34	[p1l1938t2629r2064b2658, p1l666t2669r798b2700],
14	to	TO	O	to	_	0	SENT_34	[p1l809t2675r840b2699],
15	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_34	[p1l849t2671r950b2701],
16	kinase	NN	O	kinase	nn	17	SENT_34	[p1l955t2669r1060b2700],
17	inhibitors	NNS	O	inhibitor	prep_to	11	SENT_34	[p1l1070t2669r1240b2699],
18	.	.	O	.	_	0	SENT_34	[p1l1070t2669r1240b2699],

1	N	NN	O	n	nn	3	SENT_35	[p1l953t2820r967b2835],
2	ENGLJ	NN	O	englj	nn	3	SENT_35	[p1l982t2819r1066b2841],
3	MED	NN	O	med	_	0	SENT_35	[p1l1081t2820r1134b2835],
4	353	CD	NUMBER	353	num	6	SENT_35	[p1l1146t2819r1224b2841],
5	;	:	O	;	_	0	SENT_35	[p1l1146t2819r1224b2841],
6	19	CD	NUMBER	19	dep	3	SENT_35	[p1l1146t2819r1224b2841],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_35	[p1l1259t2819r1471b2841],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	3	SENT_35	[p1l1510t2819r1651b2835],
9	10	CD	DATE	10	num	8	SENT_35	[p1l1664t2819r1700b2839],
10	,	,	DATE	,	_	0	SENT_35	[p1l1664t2819r1700b2839],
11	2005	CD	DATE	2005	num	8	SENT_35	[p1l1713t2819r1776b2841],

1	The	DT	O	the	det	5	SENT_36	[p1l878t2916r929b2940],
2	New	NNP	O	New	nn	5	SENT_36	[p1l938t2917r1000b2940],
3	England	NNP	O	England	nn	5	SENT_36	[p1l1009t2916r1120b2947],
4	J	NNP	O	J	nn	5	SENT_36	[p1l1128t2917r1141b2940],
5	oumal	NN	O	oumal	_	0	SENT_36	[p1l1142t2916r1226b2940],
6	of	IN	O	of	_	0	SENT_36	[p1l1236t2916r1264b2940],
7	Medicine	NN	O	medicine	prep_of	5	SENT_36	[p1l1271t2916r1396b2940],

1	Downloaded	VBN	O	download	_	0	SENT_37	[p1l320t2957r490b2980],
2	from	IN	O	from	_	0	SENT_37	[p1l498t2957r563b2980],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_37	[p1l572t2957r690b2987],
4	at	IN	O	at	_	0	SENT_37	[p1l700t2961r723b2980],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_37	[p1l732t2957r914b2980],
6	on	IN	O	on	_	0	SENT_37	[p1l924t2964r956b2980],
7	January	NNP	DATE	January	prep_on	1	SENT_37	[p1l965t2957r1068b2987],
8	5	CD	DATE	5	num	7	SENT_37	[p1l1078t2957r1100b2985],
9	,	,	DATE	,	_	0	SENT_37	[p1l1078t2957r1100b2985],
10	2014	CD	DATE	2014	num	7	SENT_37	[p1l1111t2957r1183b2980],
11	.	.	O	.	_	0	SENT_37	[p1l1111t2957r1183b2980],

1	For	IN	O	for	_	0	SENT_38	[p1l1194t2957r1240b2980],
2	personal	JJ	O	personal	amod	3	SENT_38	[p1l1248t2957r1361b2987],
3	use	NN	O	use	pobj	1	SENT_38	[p1l1370t2964r1413b2980],
4	only	RB	O	only	advmod	3	SENT_38	[p1l1423t2957r1488b2987],
5	.	.	O	.	_	0	SENT_38	[p1l1423t2957r1488b2987],

1	No	DT	O	no	det	3	SENT_39	[p1l1498t2957r1538b2980],
2	other	JJ	O	other	amod	3	SENT_39	[p1l1548t2957r1616b2980],
3	uses	NNS	O	use	_	0	SENT_39	[p1l1624t2964r1680b2980],
4	without	IN	O	without	_	0	SENT_39	[p1l1691t2957r1792b2980],
5	permission	NN	O	permission	prep_without	3	SENT_39	[p1l1800t2957r1953b2987],
6	.	.	O	.	_	0	SENT_39	[p1l1800t2957r1953b2987],

1	Copyright	NN	O	copyright	_	0	SENT_40	[p1l670t2998r805b3029],
2	©	CD	NUMBER	©	num	6	SENT_40	[p1l814t2998r837b3022],
3	2005	CD	DATE	2005	num	6	SENT_40	[p1l847t2998r911b3022],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_40	[p1l922t2998r1113b3022],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_40	[p1l1123t2998r1231b3022],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_40	[p1l1241t2998r1346b3029],
7	.	.	O	.	_	0	SENT_40	[p1l1241t2998r1346b3029],

1	All	DT	O	all	det	2	SENT_41	[p1l1357t2998r1399b3022],
2	rights	NNS	O	rights	nsubj	3	SENT_41	[p1l1408t2998r1483b3029],
3	reserved	VBN	O	reserve	_	0	SENT_41	[p1l1492t2998r1611b3022],
4	.	.	O	.	_	0	SENT_41	[p1l1492t2998r1611b3022],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_42	[p1l672t3104r759b3123],
2	KINASE	NN	O	kinase	nn	3	SENT_42	[p1l771t3104r895b3123],
3	INHIBITORS	NNS	O	inhibitor	dep	1	SENT_42	[p1l910t3104r1118b3123],
4	FOR	IN	O	for	_	0	SENT_42	[p1l1133t3104r1199b3123],
5	GLIOBLASTOMAS	NNS	O	glioblastoma	prep_for	3	SENT_42	[p1l1210t3104r1488b3123],

1	YROSIN	NNP	O	YROSIN	nn	3	SENT_43	[p1l376t3331r726b3388],
2	E	NNP	O	E	nn	3	SENT_43	[p1l739t3332r788b3387],
3	KINASES	NNP	O	KINASES	nsubj	6	SENT_43	[p1l842t3332r1234b3390],
4	ARE	VBP	O	be	cop	6	SENT_43	[p1l1283t3332r1463b3388],
5	KEY	NN	O	key	nn	6	SENT_43	[p1l1517t3332r1687b3390],
6	REGULAtors	NNS	O	regulator	_	0	SENT_43	[p1l1736t3331r2140b3388, p1l381t3455r542b3518],

1	of	IN	O	of	_	0	SENT_44	[p1l583t3438r685b3518],
2	intracellular	JJ	O	intracellular	amod	4	SENT_44	[p1l704t3439r1220b3519],
3	signaling	NN	O	signaling	nn	4	SENT_44	[p1l1256t3440r1781b3540],
4	.1	NN	NUMBER	.1	pobj	1	SENT_44	[p1l1256t3440r1781b3540],
5	>	RBR	O	>	amod	4	SENT_44	[p1l1256t3440r1781b3540],
6	2	CD	NUMBER	2	dep	5	SENT_44	[p1l1256t3440r1781b3540],
7	OvereXpressed	VBN	O	overexpress	partmod	4	SENT_44	[p1l1819t3445r2141b3519, p1l379t3569r704b3669],
8	or	CC	O	or	_	0	SENT_44	[p1l735t3594r824b3647],
9	mutated	VBN	O	mutate	conj_or	1	SENT_44	[p1l850t3569r1196b3648],
10	tyrosine	NN	O	tyrosine	nn	11	SENT_44	[p1l1223t3569r1552b3669],
11	kinases	NNS	O	kinase	nsubj	19	SENT_44	[p1l1579t3568r1886b3648],
12	occur	VBP	O	occur	ccomp	9	SENT_44	[p1l1916t3594r2147b3648],
13	in	IN	O	in	_	0	SENT_44	[p1l10t3698r90b3775],
14	many	JJ	O	many	amod	15	SENT_44	[p1l116t3723r348b3798],
15	types	NNS	O	type	prep_in	12	SENT_44	[p1l370t3714r578b3798],
16	of	IN	O	of	_	0	SENT_44	[p1l607t3697r707b3776],
17	cancer	NN	O	cancer	prep_of	15	SENT_44	[p1l715t3723r985b3776],
18	and	CC	O	and	_	0	SENT_44	[p1l1008t3698r1162b3776],
19	contribute	VBP	O	contribute	conj_and	12	SENT_44	[p1l1188t3698r1615b3777],
20	to	TO	O	to	_	0	SENT_44	[p1l1641t3714r1720b3776],
21	the	DT	O	the	det	22	SENT_44	[p1l1748t3698r1875b3776],
22	development	NN	O	development	prep_to	19	SENT_44	[p1l1902t3697r2143b3777, p2l11t37r339b121],

1	and	CC	O	and	dep	120	SENT_45	[p2l367t21r521b99],
2	progression	NN	O	progression	dep	120	SENT_45	[p2l553t21r1052b121],
3	of	IN	O	of	dep	120	SENT_45	[p2l1087t20r1186b99],
4	tumors	NNS	O	tumor	dep	120	SENT_45	[p2l1201t27r1630b100],
5	.3	NN	NUMBER	.3	dep	120	SENT_45	[p2l1201t27r1630b100],
6	‘	CD	NUMBER	‘	dep	120	SENT_45	[p2l1201t27r1630b100],
7	5	CD	NUMBER	5	dep	120	SENT_45	[p2l1201t27r1630b100],
8	The	DT	O	the	dep	120	SENT_45	[p2l1664t21r1824b99],
9	depen	NN	O	depen	dep	120	SENT_45	[p2l1859t21r2142b121],
10	—	NN	O	—	dep	120	SENT_45	[p2l1859t21r2142b121],
11	dence	NN	O	dence	dep	120	SENT_45	[p2l11t148r252b227],
12	of	IN	O	of	dep	120	SENT_45	[p2l324t148r424b227],
13	tumor	NN	O	tumor	dep	120	SENT_45	[p2l477t165r737b228],
14	cells	NNS	O	cell	dep	120	SENT_45	[p2l806t148r985b227],
15	on	IN	O	on	dep	120	SENT_45	[p2l1059t174r1165b227],
16	persistently	RB	O	persistently	dep	120	SENT_45	[p2l1235t148r1716b249],
17	activated	VBN	O	activate	dep	120	SENT_45	[p2l1782t149r2144b228],
18	tyrosine	NN	O	tyrosine	dep	120	SENT_45	[p2l11t277r340b377],
19	kinases	NNS	O	kinase	dep	120	SENT_45	[p2l375t277r682b356],
20	may	MD	O	may	dep	120	SENT_45	[p2l719t303r895b377],
21	render	VB	O	render	dep	120	SENT_45	[p2l925t277r1199b355],
22	tumors	NNS	O	tumor	dep	120	SENT_45	[p2l1231t293r1528b356],
23	susceptible	JJ	O	susceptible	dep	120	SENT_45	[p2l1567t277r2029b377],
24	to	TO	O	to	dep	120	SENT_45	[p2l2065t293r2143b355],
25	inhibitors	NNS	O	inhibitor	dep	120	SENT_45	[p2l10t405r415b483],
26	of	IN	O	of	dep	120	SENT_45	[p2l437t404r537b483],
27	these	DT	O	these	dep	120	SENT_45	[p2l538t405r752b483],
28	l	NN	O	l	dep	120	SENT_45	[p2l772t405r1213b484],
29	<	JJR	O	<	dep	120	SENT_45	[p2l772t405r1213b484],
30	inases	NNS	O	inase	dep	120	SENT_45	[p2l772t405r1213b484],
31	.3	NN	NUMBER	.3	dep	120	SENT_45	[p2l772t405r1213b484],
32	‘	NN	O	‘	dep	120	SENT_45	[p2l772t405r1213b484],
33	7	CD	NUMBER	7	dep	120	SENT_45	[p2l772t405r1213b484],
34	The	DT	O	the	dep	120	SENT_45	[p2l1229t405r1389b483],
35	epidermal	JJ	O	epidermal	dep	120	SENT_45	[p2l1410t404r1827b505],
36	growth	NN	O	growth	dep	120	SENT_45	[p2l1846t405r2144b505],
37	factor	NN	O	factor	dep	120	SENT_45	[p2l11t532r252b611],
38	receptor	NN	O	receptor	dep	120	SENT_45	[p2l269t549r615b633],
39	(	CD	NUMBER	(	dep	120	SENT_45	[p2l636t538r966b628],
40	EGFR	NN	ORGANIZATION	egfr	dep	120	SENT_45	[p2l636t538r966b628],
41	)	NN	O	)	dep	120	SENT_45	[p2l636t538r966b628],
42	,	,	O	,	_	0	SENT_45	[p2l636t538r966b628],
43	a	DT	O	a	dep	120	SENT_45	[p2l990t559r1035b611],
44	receptor	NN	O	receptor	dep	120	SENT_45	[p2l1053t549r1398b633],
45	tyrosine	NN	O	tyrosine	dep	120	SENT_45	[p2l1416t533r1744b633],
46	kinase	NN	O	kinase	dep	120	SENT_45	[p2l1764t533r2053b628],
47	,	,	O	,	_	0	SENT_45	[p2l1764t533r2053b628],
48	is	VBZ	O	be	dep	120	SENT_45	[p2l2078t533r2142b611],
49	a	DT	O	a	dep	120	SENT_45	[p2l10t687r54b739],
50	target	NN	O	target	dep	120	SENT_45	[p2l86t677r331b761],
51	for	IN	O	for	dep	120	SENT_45	[p2l358t660r480b739],
52	such	JJ	O	such	dep	120	SENT_45	[p2l511t660r703b740],
53	inhibitors	NNS	O	inhibitor	dep	120	SENT_45	[p2l735t661r1141b739],
54	because	IN	O	because	dep	120	SENT_45	[p2l1176t661r1502b740],
55	it	PRP	O	it	dep	120	SENT_45	[p2l1535t661r1594b739],
56	is	VBZ	O	be	dep	120	SENT_45	[p2l1621t661r1684b739],
57	amplified	VBN	O	amplify	dep	120	SENT_45	[p2l1719t660r2138b761],
58	,	,	O	,	_	0	SENT_45	[p2l1719t660r2138b761],
59	mutated	VBN	O	mutate	dep	120	SENT_45	[p2l11t788r379b884],
60	,	,	O	,	_	0	SENT_45	[p2l11t788r379b884],
61	or	CC	O	or	dep	120	SENT_45	[p2l431t814r520b867],
62	both	DT	O	both	dep	120	SENT_45	[p2l564t789r754b867],
63	in	IN	O	in	dep	120	SENT_45	[p2l800t789r880b866],
64	a	DT	O	a	dep	120	SENT_45	[p2l925t815r970b867],
65	number	NN	O	number	dep	120	SENT_45	[p2l1015t788r1347b868],
66	of	IN	O	of	dep	120	SENT_45	[p2l1391t788r1490b867],
67	neoplasms	NNS	O	neoplasm	dep	120	SENT_45	[p2l1518t788r2036b889],
68	.3	NN	NUMBER	.3	dep	120	SENT_45	[p2l1518t788r2036b889],
69	A	DT	O	a	dep	120	SENT_45	[p2l2080t796r2147b866],
70	small	JJ	O	small	dep	120	SENT_45	[p2l12t917r236b995],
71	subgroup	NN	O	subgroup	dep	120	SENT_45	[p2l266t916r663b1017],
72	of	IN	O	of	dep	120	SENT_45	[p2l694t916r794b995],
73	patients	NNS	O	patient	dep	120	SENT_45	[p2l803t917r1131b1017],
74	with	IN	O	with	dep	120	SENT_45	[p2l1158t917r1344b996],
75	lung	NN	O	lung	dep	120	SENT_45	[p2l1372t917r1564b1017],
76	cancer	NN	O	cancer	dep	120	SENT_45	[p2l1590t942r1861b995],
77	have	VBP	O	have	dep	120	SENT_45	[p2l1887t916r2073b996],
78	a	DT	O	a	dep	120	SENT_45	[p2l2101t943r2145b995],
79	response	NN	O	response	dep	120	SENT_45	[p2l11t1070r384b1145],
80	to	TO	O	to	dep	120	SENT_45	[p2l417t1061r495b1123],
81	EGFR	NN	ORGANIZATION	egfr	dep	120	SENT_45	[p2l528t1050r784b1128],
82	inhibitors	NNS	O	inhibitor	dep	120	SENT_45	[p2l806t1044r1387b1140],
83	,9	CD	NUMBER	,9	dep	120	SENT_45	[p2l806t1044r1387b1140],
84	‘	CD	NUMBER	‘	dep	120	SENT_45	[p2l806t1044r1387b1140],
85	11	CD	NUMBER	11	dep	120	SENT_45	[p2l806t1044r1387b1140],
86	and	CC	O	and	dep	120	SENT_45	[p2l1420t1044r1573b1123],
87	mutations	NNS	O	mutation	dep	120	SENT_45	[p2l1606t1045r2029b1124],
88	in	IN	O	in	dep	120	SENT_45	[p2l2063t1045r2144b1122],
89	the	DT	O	the	dep	120	SENT_45	[p2l11t1173r138b1251],
90	EGFRkinase	NN	MISC	egfrkinase	dep	120	SENT_45	[p2l164t1172r701b1256],
91	domain	NN	O	domain	dep	120	SENT_45	[p2l728t1173r1047b1251],
92	have	VBP	O	have	dep	120	SENT_45	[p2l1073t1173r1259b1252],
93	been	VBN	O	be	dep	120	SENT_45	[p2l1286t1173r1482b1251],
94	associated	VBN	O	associate	dep	120	SENT_45	[p2l1508t1172r1936b1251],
95	with	IN	O	with	dep	120	SENT_45	[p2l1957t1173r2144b1252],
96	responsiveness	NN	O	responsiveness	dep	120	SENT_45	[p2l11t1301r854b1401],
97	.12	CD	NUMBER	.12	dep	120	SENT_45	[p2l11t1301r854b1401],
98	‘	CD	NUMBER	‘	dep	120	SENT_45	[p2l11t1301r854b1401],
99	14	CD	NUMBER	14	dep	120	SENT_45	[p2l11t1301r854b1401],
100	It	PRP	O	it	dep	120	SENT_45	[p2l920t1308r985b1379],
101	is	VBZ	O	be	dep	120	SENT_45	[p2l1048t1301r1112b1379],
102	not	RB	O	not	dep	120	SENT_45	[p2l1183t1317r1325b1379],
103	known	VBN	O	know	dep	120	SENT_45	[p2l1388t1301r1699b1396],
104	,	,	O	,	_	0	SENT_45	[p2l1388t1301r1699b1396],
105	however	RB	O	however	dep	120	SENT_45	[p2l1773t1300r2138b1396],
106	,	,	O	,	_	0	SENT_45	[p2l1773t1300r2138b1396],
107	whether	IN	O	whether	dep	120	SENT_45	[p2l6t1428r352b1508],
108	such	JJ	O	such	dep	120	SENT_45	[p2l389t1429r581b1508],
109	mutations	NNS	O	mutation	dep	120	SENT_45	[p2l620t1429r1043b1508],
110	affect	VBP	O	affect	dep	120	SENT_45	[p2l1083t1428r1315b1507],
111	the	DT	O	the	dep	120	SENT_45	[p2l1349t1429r1476b1507],
112	responsiveness	NN	O	responsiveness	dep	120	SENT_45	[p2l1516t1429r2142b1529],
113	of	IN	O	of	dep	120	SENT_45	[p2l11t1556r111b1635],
114	other	JJ	O	other	dep	120	SENT_45	[p2l116t1557r336b1635],
115	types	NNS	O	type	dep	120	SENT_45	[p2l357t1573r566b1657],
116	of	IN	O	of	dep	120	SENT_45	[p2l591t1556r691b1635],
117	cancer	NN	O	cancer	dep	120	SENT_45	[p2l696t1582r967b1635],
118	to	TO	O	to	dep	120	SENT_45	[p2l987t1573r1066b1635],
119	EGFRkinase	NN	O	egfrkinase	dep	120	SENT_45	[p2l1089t1557r1624b1640],
120	inhibitors	NNS	O	inhibitor	_	0	SENT_45	[p2l1646t1557r2077b1635],
121	.	.	O	.	_	0	SENT_45	[p2l1646t1557r2077b1635],

1	Among	IN	O	among	_	0	SENT_46	[p2l137t1692r457b1785],
2	patients	NNS	O	patient	prep_among	48	SENT_46	[p2l501t1685r836b1785],
3	with	IN	O	with	_	0	SENT_46	[p2l882t1685r1072b1764],
4	glioblastoma	NN	O	glioblastoma	prep_with	2	SENT_46	[p2l1120t1685r1699b1785],
5	,	,	O	,	_	0	SENT_46	[p2l1120t1685r1699b1785],
6	the	DT	O	the	det	8	SENT_46	[p2l1753t1685r1883b1763],
7	most	RBS	O	most	advmod	8	SENT_46	[p2l1931t1701r2148b1763],
8	common	JJ	O	common	dep	19	SENT_46	[p2l11t1838r393b1891],
9	primary	JJ	O	primary	amod	12	SENT_46	[p2l414t1813r752b1913],
10	malignant	JJ	O	malignant	amod	12	SENT_46	[p2l770t1812r1209b1913],
11	brain	NN	O	brain	nn	12	SENT_46	[p2l1227t1813r1447b1891],
12	tumor	NN	O	tumor	nsubj	19	SENT_46	[p2l1469t1829r1734b1892],
13	of	IN	O	of	_	0	SENT_46	[p2l1754t1812r1854b1891],
14	adults	NNS	O	adult	prep_of	12	SENT_46	[p2l1858t1813r2138b1908],
15	,	,	O	,	_	0	SENT_46	[p2l1858t1813r2138b1908],
16	a	DT	O	a	det	18	SENT_46	[p2l10t1967r54b2019],
17	small	JJ	O	small	amod	18	SENT_46	[p2l84t1941r312b2019],
18	subgroup	NN	O	subgroup	appos	14	SENT_46	[p2l341t1941r746b2041],
19	seems	VBZ	O	seem	dep	48	SENT_46	[p2l778t1967r1036b2019],
20	to	TO	O	to	_	0	SENT_46	[p2l1068t1957r1147b2019],
21	beneﬁt	JJ	O	beneﬁt	amod	27	SENT_46	[p2l1178t1940r1475b2019],
22	from	IN	O	from	_	0	SENT_46	[p2l1499t1940r1707b2019],
23	the	DT	O	the	det	24	SENT_46	[p2l1736t1941r1866b2019],
24	EGFR	NN	ORGANIZATION	egfr	prep_from	21	SENT_46	[p2l1894t1946r2153b2024],
25	kinase	NN	O	kinase	nn	27	SENT_46	[p2l10t2069r282b2148],
26	inhibitors	NNS	O	inhibitor	nn	27	SENT_46	[p2l305t2069r720b2147],
27	erlotinib	NN	O	erlotinib	prep_to	19	SENT_46	[p2l747t2069r1107b2147],
28	and	CC	O	and	_	0	SENT_46	[p2l1130t2068r1287b2147],
29	geﬁtinib	NN	O	geﬁtinib	prep_to	19	SENT_46	[p2l1310t2068r1881b2169],
30	.15	CD	NUMBER	.15	num	29	SENT_46	[p2l1310t2068r1881b2169],
31	»	CD	NUMBER	»	number	32	SENT_46	[p2l1310t2068r1881b2169],
32	16	CD	NUMBER	16	dep	29	SENT_46	[p2l1310t2068r1881b2169],
33	However	RB	O	however	advmod	19	SENT_46	[p2l1904t2076r2139b2148, p2l11t2223r204b2292],
34	,	,	O	,	_	0	SENT_46	[p2l1904t2076r2139b2148, p2l11t2223r204b2292],
35	the	DT	O	the	det	36	SENT_46	[p2l251t2197r383b2275],
36	infrequency	NN	O	infrequency	nsubj	48	SENT_46	[p2l423t2196r945b2297],
37	of	IN	O	of	_	0	SENT_46	[p2l981t2196r1084b2275],
38	mutations	NNS	O	mutation	prep_of	36	SENT_46	[p2l1105t2197r1550b2276],
39	in	IN	O	in	_	0	SENT_46	[p2l1591t2197r1674b2274],
40	the	DT	O	the	det	43	SENT_46	[p2l1715t2197r1848b2275],
41	EGFR	NN	ORGANIZATION	egfr	nn	43	SENT_46	[p2l1887t2202r2152b2280],
42	kinase	NN	O	kinase	nn	43	SENT_46	[p2l10t2325r282b2404],
43	domain	NN	O	domain	prep_in	38	SENT_46	[p2l311t2325r636b2403],
44	in	IN	O	in	_	0	SENT_46	[p2l663t2325r744b2402],
45	glioblastomas17	NN	O	glioblastomas17	prep_in	43	SENT_46	[p2l772t2325r1556b2425],
46	»	CD	NUMBER	»	number	47	SENT_46	[p2l772t2325r1556b2425],
47	18	CD	NUMBER	18	num	45	SENT_46	[p2l772t2325r1556b2425],
48	suggests	VBZ	O	suggest	_	0	SENT_46	[p2l1586t2341r1950b2425],
49	that	IN	O	that	complm	55	SENT_46	[p2l1981t2324r2148b2403],
50	such	JJ	O	such	amod	52	SENT_46	[p2l12t2453r207b2532],
51	EGFR	NN	ORGANIZATION	egfr	nn	52	SENT_46	[p2l244t2459r457b2532],
52	mutations	NNS	O	mutation	nsubj	55	SENT_46	[p2l489t2453r921b2532],
53	can	MD	O	can	aux	55	SENT_46	[p2l963t2469r1256b2531],
54	not	RB	O	not	neg	55	SENT_46	[p2l963t2469r1256b2531],
55	account	VB	O	account	ccomp	48	SENT_46	[p2l1288t2469r1625b2532],
56	for	IN	O	for	_	0	SENT_46	[p2l1658t2452r1782b2531],
57	responsiveness	NN	O	responsiveness	prep_for	55	SENT_46	[p2l1817t2478r2142b2553, p2l12t2581r354b2660],
58	to	TO	O	to	_	0	SENT_46	[p2l410t2597r489b2659],
59	EGFR	NN	ORGANIZATION	egfr	nn	61	SENT_46	[p2l540t2586r799b2664],
60	kinase	NN	O	kinase	nn	61	SENT_46	[p2l839t2580r1108b2660],
61	inhibitors	NNS	O	inhibitor	prep_to	57	SENT_46	[p2l1158t2581r1679b2659],
62	.19	CD	NUMBER	.19	tmod	55	SENT_46	[p2l1158t2581r1679b2659],
63	The	DT	O	the	det	64	SENT_46	[p2l1727t2581r1888b2659],
64	EGFR	NN	ORGANIZATION	egfr	dep	62	SENT_46	[p2l1938t2587r2149b2660],

1	gene	NN	O	gene	nsubjpass	4	SENT_47	[p2l10t2734r209b2809],
2	is	VBZ	O	be	auxpass	4	SENT_47	[p2l230t2709r295b2787],
3	commonly	RB	O	commonly	advmod	4	SENT_47	[p2l320t2709r776b2809],
4	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_47	[p2l792t2708r1196b2809],
5	in	IN	O	in	_	0	SENT_47	[p2l1217t2709r1298b2786],
6	glioblastoma	NN	O	glioblastoma	nn	8	SENT_47	[p2l1319t2708r1984b2809],
7	,2	CD	NUMBER	,2	num	8	SENT_47	[p2l1319t2708r1984b2809],
8	°	NN	O	°	prep_in	4	SENT_47	[p2l1319t2708r1984b2809],
9	but	CC	O	but	cc	15	SENT_47	[p2l2006t2709r2148b2788],
10	this	DT	O	this	det	11	SENT_47	[p2l11t2837r164b2915],
11	abnormality	NN	O	abnormality	nsubj	15	SENT_47	[p2l213t2836r721b2937],
12	also	RB	O	also	advmod	15	SENT_47	[p2l762t2837r927b2915],
13	does	VBZ	O	do	aux	15	SENT_47	[p2l976t2836r1165b2915],
14	not	RB	O	not	neg	15	SENT_47	[p2l1214t2853r1355b2915],
15	correlate	VB	O	correlate	ccomp	4	SENT_47	[p2l1398t2837r1757b2915],
16	with	IN	O	with	_	0	SENT_47	[p2l1799t2837r1986b2916],
17	responsiveness	NN	O	responsiveness	prep_with	15	SENT_47	[p2l2033t2863r2143b2915, p2l12t2965r555b3065],
18	to	TO	O	to	_	0	SENT_47	[p2l578t2981r656b3043],
19	EGFRkinase	NN	O	egfrkinase	nn	20	SENT_47	[p2l675t2964r1207b3048],
20	inhibitors	NNS	O	inhibitor	prep_to	17	SENT_47	[p2l1227t2965r1741b3043],
21	.16	CD	NUMBER	.16	nsubj	26	SENT_47	[p2l1227t2965r1741b3043],
22	Glioblas	FW	O	glioblas	nn	24	SENT_47	[p2l1762t2964r2142b3043],
23	—	FW	O	—	nn	24	SENT_47	[p2l1762t2964r2142b3043],
24	tomas	NNS	O	toma	dep	21	SENT_47	[p2l11t3109r264b3171],
25	often	RB	O	often	advmod	26	SENT_47	[p2l287t3092r501b3171],
26	express	VBP	O	express	rcmod	20	SENT_47	[p2l522t3119r828b3193],
27	EGFRVIII	NN	O	egfrviius	dobj	26	SENT_47	[p2l850t3098r1257b3188],
28	,	,	O	,	_	0	SENT_47	[p2l850t3098r1257b3188],
29	a	DT	O	a	det	34	SENT_47	[p2l1283t3119r1327b3171],
30	constitutively	RB	O	constitutively	advmod	31	SENT_47	[p2l1347t3093r1898b3193],
31	active	JJ	O	active	amod	34	SENT_47	[p2l1913t3093r2144b3172],
32	genomic	JJ	O	genomic	amod	34	SENT_47	[p2l10t3221r374b3321],
33	deletion	NN	O	deletion	nn	34	SENT_47	[p2l399t3220r734b3299],
34	variant	NN	O	variant	appos	27	SENT_47	[p2l754t3221r1045b3300],
35	of	IN	O	of	_	0	SENT_47	[p2l1066t3220r1165b3299],
36	EGFR	NN	ORGANIZATION	egfr	prep_of	34	SENT_47	[p2l1171t3226r1627b3304],
37	.21	CD	NUMBER	.21	num	36	SENT_47	[p2l1171t3226r1627b3304],
38	‘	CD	NUMBER	‘	number	39	SENT_47	[p2l1171t3226r1627b3304],
39	25	CD	NUMBER	25	num	41	SENT_47	[p2l1171t3226r1627b3304],
40	This	DT	O	this	det	41	SENT_47	[p2l1653t3221r1836b3299],
41	variant	NN	O	variant	dep	34	SENT_47	[p2l1859t3221r2149b3300],
42	of	IN	O	of	_	0	SENT_47	[p2l11t3348r111b3427],
43	EGFR	NN	ORGANIZATION	egfr	prep_of	41	SENT_47	[p2l110t3354r366b3432],
44	strongly	RB	O	strongly	advmod	43	SENT_47	[p2l376t3349r716b3449],
45	and	CC	O	and	_	0	SENT_47	[p2l730t3348r883b3427],
46	persistently	RB	O	persistently	advmod	47	SENT_47	[p2l901t3349r1380b3449],
47	activates	VBZ	O	activate	rcmod	20	SENT_47	[p2l1394t3349r1740b3428],
48	the	DT	O	the	det	49	SENT_47	[p2l1762t3348r1888b3427],
49	phosphatidylinositol	NN	O	phosphatidylinositol	dobj	47	SENT_47	[p2l1907t3349r2143b3449, p2l9t3476r661b3577],
50	3	CD	NUMBER	3	num	49	SENT_47	[p2l687t3482r755b3555],
51	'	''	O	'	_	0	SENT_47	[p2l687t3482r755b3555],
52	kinase	NN	O	kinase	nn	55	SENT_47	[p2l784t3477r1050b3556],
53	(	CD	NUMBER	(	num	55	SENT_47	[p2l1081t3482r1336b3568],
54	PI3K	NN	O	pi3k	nn	55	SENT_47	[p2l1081t3482r1336b3568],
55	)	NN	O	)	dep	17	SENT_47	[p2l1081t3482r1336b3568],
56	signaling	NN	O	signaling	nn	57	SENT_47	[p2l1369t3476r1757b3577],
57	pathway	NN	O	pathway	dep	55	SENT_47	[p2l1778t3477r2139b3577],
58	,	,	O	,	_	0	SENT_47	[p2l1778t3477r2139b3577],
59	which	WDT	O	which	nsubj	60	SENT_47	[p2l6t3604r264b3684],
60	provides	VBZ	O	provide	rcmod	57	SENT_47	[p2l287t3604r638b3705],
61	critical	JJ	O	critical	amod	62	SENT_47	[p2l666t3605r944b3683],
62	information	NN	O	information	dobj	60	SENT_47	[p2l968t3604r1471b3683],
63	for	IN	O	for	_	0	SENT_47	[p2l1495t3604r1617b3683],
64	cell	NN	O	cell	nn	65	SENT_47	[p2l1640t3604r1779b3683],
65	survival	NN	O	survival	prep_for	62	SENT_47	[p2l1805t3604r2139b3700],
66	,	,	O	,	_	0	SENT_47	[p2l1805t3604r2139b3700],

1	proliferation	NN	O	proliferation	nsubjpass	17	SENT_48	[p3l9t20r555b121],
2	,	,	O	,	_	0	SENT_48	[p3l9t20r555b121],
3	and	CC	O	and	_	0	SENT_48	[p3l590t21r744b99],
4	motility	NN	O	motility	conj_and	1	SENT_48	[p3l774t20r1298b121],
5	.25	CD	NUMBER	.25	num	4	SENT_48	[p3l774t20r1298b121],
6	‘	CD	NUMBER	‘	number	7	SENT_48	[p3l774t20r1298b121],
7	30	CD	NUMBER	30	num	10	SENT_48	[p3l774t20r1298b121],
8	Persistent	JJ	O	persistent	amod	10	SENT_48	[p3l1327t21r1738b99],
9	PI3K	NN	O	pi3k	nn	10	SENT_48	[p3l1761t26r1965b102],
10	sig	NN	O	sig	dep	4	SENT_48	[p3l1993t21r2142b121],
11	—	CD	NUMBER	—	num	13	SENT_48	[p3l1993t21r2142b121],
12	naling	JJ	O	naling	amod	13	SENT_48	[p3l11t149r277b249],
13	—	NN	O	—	npadvmod	14	SENT_48	[p3l301t194r409b201],
14	as	IN	O	as	advmod	17	SENT_48	[p3l436t175r519b227],
15	would	MD	O	would	aux	17	SENT_48	[p3l548t149r810b228],
16	be	VB	O	be	auxpass	17	SENT_48	[p3l842t149r937b227],
17	instigated	VBN	O	instigate	_	0	SENT_48	[p3l968t149r1378b249],
18	by	IN	O	by	_	0	SENT_48	[p3l1410t148r1506b249],
19	EGFRVIII	NN	O	egfrviius	nn	20	SENT_48	[p3l1531t154r1916b232],
20	—	NN	O	—	agent	17	SENT_48	[p3l1943t194r2051b201],
21	is	VBZ	O	be	auxpass	22	SENT_48	[p3l2078t149r2142b227],
22	believed	VBN	O	believe	rcmod	20	SENT_48	[p3l11t276r347b356],
23	to	TO	O	to	aux	24	SENT_48	[p3l388t293r466b355],
24	cause	VB	O	cause	xcomp	22	SENT_48	[p3l508t303r735b356],
25	“	NN	O	“	nn	27	SENT_48	[p3l780t277r1172b377],
26	pathway	NN	O	pathway	nn	27	SENT_48	[p3l780t277r1172b377],
27	addiction	NN	O	addiction	dobj	24	SENT_48	[p3l1207t277r1747b372],
28	”	SYM	O	”	dep	30	SENT_48	[p3l1207t277r1747b372],
29	-	:	O	-	_	0	SENT_48	[p3l1207t277r1747b372],
30	°	NN	O	°	dep	24	SENT_48	[p3l1207t277r1747b372],
31	>	JJR	O	>	amod	20	SENT_48	[p3l1207t277r1747b372],
32	1	CD	NUMBER	1	dep	31	SENT_48	[p3l1207t277r1747b372],
33	;	:	O	;	_	0	SENT_48	[p3l1207t277r1747b372],
34	addicted	VBN	O	addict	amod	36	SENT_48	[p3l1791t276r2144b355],
35	tumor	NN	O	tumor	nn	36	SENT_48	[p3l11t421r270b484],
36	cells	NNS	O	cell	nsubj	37	SENT_48	[p3l301t404r480b483],
37	die	VBP	O	die	parataxis	17	SENT_48	[p3l516t404r638b483],
38	if	IN	O	if	mark	42	SENT_48	[p3l671t404r746b482],
39	the	DT	O	the	det	40	SENT_48	[p3l761t404r888b483],
40	pathway	NN	O	pathway	nsubjpass	42	SENT_48	[p3l920t404r1271b505],
41	is	VBZ	O	be	auxpass	42	SENT_48	[p3l1299t405r1363b483],
42	disrupted	VBN	O	disrupt	advcl	37	SENT_48	[p3l1399t404r1793b505],
43	by	IN	O	by	_	0	SENT_48	[p3l1828t405r1924b505],
44	tyrosine	NN	O	tyrosine	nn	46	SENT_48	[p3l1953t421r2143b505, p3l12t533r177b611],
45	kinase	NN	O	kinase	nn	46	SENT_48	[p3l197t533r463b612],
46	inhibitors	NNS	O	inhibitor	agent	42	SENT_48	[p3l482t532r913b611],
47	.	.	O	.	_	0	SENT_48	[p3l482t532r913b611],

1	By	IN	O	by	_	0	SENT_49	[p3l937t539r1041b633],
2	promoting	VBG	O	promote	prepc_by	11	SENT_49	[p3l1055t533r1508b633],
3	chronic	JJ	O	chronic	amod	4	SENT_49	[p3l1525t533r1840b611],
4	dependence	NN	O	dependence	dobj	2	SENT_49	[p3l1859t533r2143b633, p3l11t660r252b739],
5	on	IN	O	on	_	0	SENT_49	[p3l296t686r402b739],
6	PI3K	NN	O	pi3k	nn	7	SENT_49	[p3l444t666r648b742],
7	signaling	NN	O	signaling	prep_on	2	SENT_49	[p3l690t661r1096b761],
8	,	,	O	,	_	0	SENT_49	[p3l690t661r1096b761],
9	EGFRVIII	NN	O	egfrviius	nsubj	11	SENT_49	[p3l1144t666r1529b744],
10	may	MD	O	may	aux	11	SENT_49	[p3l1571t687r1747b761],
11	sensitize	VB	O	sensitize	_	0	SENT_49	[p3l1787t661r2144b739],
12	glioblastoma	NN	O	glioblastoma	nn	13	SENT_49	[p3l10t788r555b889],
13	cells	NNS	O	cell	dobj	11	SENT_49	[p3l578t788r756b867],
14	to	TO	O	to	_	0	SENT_49	[p3l782t805r860b867],
15	EGFRl	NN	O	egfrl	prep_to	11	SENT_49	[p3l884t789r1418b872],
16	<	JJR	O	<	amod	18	SENT_49	[p3l884t789r1418b872],
17	inase	NN	O	inase	nn	18	SENT_49	[p3l884t789r1418b872],
18	inhibitors	NNS	O	inhibitor	dep	15	SENT_49	[p3l1441t788r1871b867],
19	.	.	O	.	_	0	SENT_49	[p3l1441t788r1871b867],

1	The	DT	O	the	det	2	SENT_50	[p3l137t917r299b995],
2	PT	NN	O	pt	npadvmod	29	SENT_50	[p3l322t922r436b994],
3	EN	IN	O	en	_	0	SENT_50	[p3l436t924r568b995],
4	(	CD	NUMBER	(	num	5	SENT_50	[p3l596t917r1165b1017],
5	phosphatase	NN	O	phosphatase	prep_en	29	SENT_50	[p3l596t917r1165b1017],
6	and	CC	O	and	_	0	SENT_50	[p3l1189t917r1346b995],
7	tensin	NN	O	tensin	nn	8	SENT_50	[p3l1371t917r1630b995],
8	homologue	NN	O	homologue	conj_and	5	SENT_50	[p3l1655t916r2143b1017],
9	deleted	VBN	O	delete	partmod	8	SENT_50	[p3l11t1044r309b1123],
10	in	IN	O	in	_	0	SENT_50	[p3l335t1045r415b1122],
11	chromosome	NN	O	chromosome	prep_in	9	SENT_50	[p3l443t1045r998b1123],
12	10	CD	NUMBER	10	number	13	SENT_50	[p3l1029t1050r1154b1136],
13	)	CD	NUMBER	)	num	17	SENT_50	[p3l1029t1050r1154b1136],
14	tumor	NN	O	tumor	nn	17	SENT_50	[p3l1187t1061r1945b1145],
15	—	NN	O	—	nn	17	SENT_50	[p3l1187t1061r1945b1145],
16	suppressor	NN	O	suppressor	nn	17	SENT_50	[p3l1187t1061r1945b1145],
17	protein	NN	O	protein	nsubjpass	29	SENT_50	[p3l1968t1070r2143b1145, p3l11t1173r189b1268],
18	,	,	O	,	_	0	SENT_50	[p3l1968t1070r2143b1145, p3l11t1173r189b1268],
19	an	DT	O	a	det	20	SENT_50	[p3l221t1198r321b1251],
20	inhibitor	NN	O	inhibitor	appos	17	SENT_50	[p3l348t1172r725b1251],
21	of	IN	O	of	_	0	SENT_50	[p3l751t1172r852b1251],
22	the	DT	O	the	det	25	SENT_50	[p3l862t1173r992b1251],
23	PI3K	NN	O	pi3k	nn	25	SENT_50	[p3l1019t1178r1227b1254],
24	signaling	NN	O	signaling	nn	25	SENT_50	[p3l1254t1172r1650b1273],
25	pathway	NN	O	pathway	prep_of	20	SENT_50	[p3l1674t1173r2042b1273],
26	,	,	O	,	_	0	SENT_50	[p3l1674t1173r2042b1273],
27	is	VBZ	O	be	auxpass	29	SENT_50	[p3l2076t1173r2141b1251],
28	commonly	RB	O	commonly	advmod	29	SENT_50	[p3l11t1300r468b1401],
29	lost	VBN	O	lose	_	0	SENT_50	[p3l507t1300r666b1379],
30	in	IN	O	in	_	0	SENT_50	[p3l704t1301r786b1378],
31	glioblastoma	NN	O	glioblastoma	nn	32	SENT_50	[p3l830t1301r1704b1401],
32	.2	NN	NUMBER	.2	prep_in	29	SENT_50	[p3l830t1301r1704b1401],
33	°	CD	NUMBER	°	number	34	SENT_50	[p3l830t1301r1704b1401],
34	»	CD	NUMBER	»	dep	32	SENT_50	[p3l830t1301r1704b1401],
35	27	CD	NUMBER	27	num	36	SENT_50	[p3l830t1301r1704b1401],
36	»	NN	O	»	dep	34	SENT_50	[p3l830t1301r1704b1401],
37	32	CD	NUMBER	32	dobj	29	SENT_50	[p3l830t1301r1704b1401],
38	This	DT	O	this	det	39	SENT_50	[p3l1745t1301r1931b1379],
39	loss	NN	O	loss	nsubj	41	SENT_50	[p3l1977t1301r2140b1379],
40	may	MD	O	may	aux	41	SENT_50	[p3l11t1455r188b1529],
41	promote	VB	O	promote	rcmod	37	SENT_50	[p3l212t1445r576b1529],
42	cellular	JJ	O	cellular	amod	43	SENT_50	[p3l606t1428r920b1508],
43	resistance	NN	O	resistance	dobj	41	SENT_50	[p3l949t1429r1383b1507],
44	to	TO	O	to	_	0	SENT_50	[p3l1415t1445r1495b1507],
45	EGFR	NN	ORGANIZATION	egfr	nn	47	SENT_50	[p3l1527t1434r1790b1512],
46	kinaseinhibitor	NN	O	kinaseinhibitor	nn	47	SENT_50	[p3l1811t1429r2145b1508, p3l10t1557r396b1635],
47	therapy	NN	O	therapy	prep_to	41	SENT_50	[p3l424t1557r749b1657],
48	by	IN	O	by	_	0	SENT_50	[p3l777t1557r875b1657],
49	dissociating	VBG	O	dissociate	agent	29	SENT_50	[p3l903t1556r1418b1657],
50	EGFR	NN	ORGANIZATION	egfr	nn	51	SENT_50	[p3l1443t1562r1703b1640],
51	inhibition	NN	O	inhibition	dobj	49	SENT_50	[p3l1721t1557r2143b1635],
52	from	IN	O	from	_	0	SENT_50	[p3l11t1684r219b1763],
53	downstream	JJ	O	downstream	amod	58	SENT_50	[p3l265t1685r793b1764],
54	PI3K	NN	O	pi3k	nn	58	SENT_50	[p3l837t1690r1045b1766],
55	pathway	NN	O	pathway	nn	58	SENT_50	[p3l1085t1685r1442b1785],
56	inhibition	NN	O	inhibition	nn	58	SENT_50	[p3l1482t1685r1904b1763],
57	(	CD	NUMBER	(	num	58	SENT_50	[p3l1953t1685r2138b1785],
58	Fig	NN	O	fig	prep_from	49	SENT_50	[p3l1953t1685r2138b1785],
59	.	.	O	.	_	0	SENT_50	[p3l1953t1685r2138b1785],

1	1	CD	NUMBER	1	number	2	SENT_51	[p3l14t1818r203b1904],
2	)	CD	NUMBER	)	_	0	SENT_51	[p3l14t1818r203b1904],
3	.33	CD	NUMBER	.33	dep	2	SENT_51	[p3l14t1818r203b1904],
4	We	PRP	O	we	nsubj	5	SENT_51	[p3l237t1820r371b1891],
5	hypothesized	VBD	O	hypothesize	dep	2	SENT_51	[p3l408t1812r967b1913],
6	that	IN	O	that	complm	9	SENT_51	[p3l1000t1813r1165b1891],
7	EGFRVIII	NN	O	egfrviius	nsubj	9	SENT_51	[p3l1192t1818r1577b1896],
8	would	MD	O	would	aux	9	SENT_51	[p3l1605t1812r1867b1892],
9	sensitize	VB	O	sensitize	ccomp	5	SENT_51	[p3l1902t1813r2143b1891, p3l11t1941r155b2019],
10	tumors	NNS	O	tumor	dobj	9	SENT_51	[p3l204t1957r501b2020],
11	to	TO	O	to	_	0	SENT_51	[p3l552t1957r630b2019],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_51	[p3l679t1946r936b2024],
13	kinase	NN	O	kinase	nn	14	SENT_51	[p3l975t1940r1247b2020],
14	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_51	[p3l1298t1941r1739b2036],
15	,	,	O	,	_	0	SENT_51	[p3l1298t1941r1739b2036],
16	whereas	IN	O	whereas	mark	20	SENT_51	[p3l1792t1941r2141b2020],
17	PTEN	NN	ORGANIZATION	pten	nn	18	SENT_51	[p3l9t2075r255b2148],
18	loss	NN	O	loss	nsubj	20	SENT_51	[p3l287t2070r452b2148],
19	would	MD	O	would	aux	20	SENT_51	[p3l484t2069r750b2149],
20	impair	VB	O	impair	advcl	9	SENT_51	[p3l784t2070r1068b2170],
21	the	DT	O	the	det	22	SENT_51	[p3l1100t2070r1230b2148],
22	response	NN	O	response	dobj	20	SENT_51	[p3l1265t2095r1645b2170],
23	to	TO	O	to	_	0	SENT_51	[p3l1681t2086r1760b2148],
24	such	JJ	O	such	advmod	28	SENT_51	[p3l1798t2069r1993b2149],
25	in	IN	O	in	_	0	SENT_51	[p3l2027t2070r2142b2147],
26	—	CD	NUMBER	—	num	27	SENT_51	[p3l2027t2070r2142b2147],
27	hibitors	NNS	O	hibitor	prep_in	24	SENT_51	[p3l11t2198r450b2276],
28	.33	CD	NUMBER	.33	prep_to	20	SENT_51	[p3l11t2198r450b2276],
29	To	TO	O	to	aux	30	SENT_51	[p3l502t2203r607b2276],
30	test	VB	O	test	xcomp	20	SENT_51	[p3l661t2214r814b2276],
31	this	DT	O	this	det	32	SENT_51	[p3l862t2198r1015b2276],
32	hypothesis	NN	O	hypothesis	dobj	30	SENT_51	[p3l1069t2197r1550b2298],
33	,	,	O	,	_	0	SENT_51	[p3l1069t2197r1550b2298],
34	we	PRP	O	we	nsubj	35	SENT_51	[p3l1604t2224r1722b2277],
35	analyzed	VBD	O	analyze	dep	2	SENT_51	[p3l1775t2197r2143b2298],
36	EGFRVIII	NN	O	egfrviius	dobj	35	SENT_51	[p3l9t2331r402b2409],
37	and	CC	O	and	_	0	SENT_51	[p3l432t2325r588b2404],
38	PTEN	NN	ORGANIZATION	pten	dobj	35	SENT_51	[p3l617t2331r863b2404],
39	at	IN	O	at	_	0	SENT_51	[p3l892t2342r971b2404],
40	the	DT	O	the	det	44	SENT_51	[p3l998t2326r1127b2404],
41	gene	NN	O	gene	nn	44	SENT_51	[p3l1158t2351r1358b2426],
42	and	CC	O	and	_	0	SENT_51	[p3l1389t2325r1545b2404],
43	protein	NN	O	protein	conj_and	41	SENT_51	[p3l1574t2326r1882b2426],
44	levels	NNS	O	level	prep_at	35	SENT_51	[p3l1912t2325r2140b2405],
45	in	IN	O	in	_	0	SENT_51	[p3l10t2454r92b2531],
46	glioblastomas	NNS	O	glioblastoma	prep_in	44	SENT_51	[p3l137t2454r734b2554],
47	from	IN	O	from	_	0	SENT_51	[p3l781t2453r989b2532],
48	patients	NNS	O	patient	prep_from	46	SENT_51	[p3l1034t2454r1370b2554],
49	before	IN	O	before	_	0	SENT_51	[p3l1419t2453r1686b2532],
50	treatment	NN	O	treatment	prep_before	48	SENT_51	[p3l1732t2470r2148b2532],
51	with	IN	O	with	_	0	SENT_51	[p3l6t2582r196b2661],
52	EGFRl	NN	O	egfrl	prep_with	35	SENT_51	[p3l221t2582r766b2665],
53	<	JJR	O	<	amod	55	SENT_51	[p3l221t2582r766b2665],
54	inase	NN	O	inase	nn	55	SENT_51	[p3l221t2582r766b2665],
55	inhibitors	NNS	O	inhibitor	dep	52	SENT_51	[p3l793t2581r1232b2660],
56	.	.	O	.	_	0	SENT_51	[p3l793t2581r1232b2660],

1	We	PRP	O	we	nsubj	27	SENT_52	[p3l1261t2589r1394b2660],
2	also	RB	O	also	advmod	3	SENT_52	[p3l1420t2582r1588b2660],
3	searched	VBD	O	search	conj_and	3	SENT_52	[p3l1617t2581r1989b2660],
4	for	IN	O	for	_	0	SENT_52	[p3l2015t2581r2138b2660],
5	mutations	NNS	O	mutation	prep_for	3	SENT_52	[p3l11t2710r441b2789],
6	in	IN	O	in	_	0	SENT_52	[p3l486t2710r567b2787],
7	EGFR	NN	ORGANIZATION	egfr	prep_in	5	SENT_52	[p3l608t2716r821b2789],
8	and	CC	O	and	_	0	SENT_52	[p3l857t2710r1013b2788],
9	in	IN	O	in	_	0	SENT_52	[p3l1055t2710r1136b2787],
10	its	PRP$	O	its	poss	13	SENT_52	[p3l1179t2710r1274b2788],
11	heterodimerization	NN	O	heterodimerization	nn	13	SENT_52	[p3l1320t2709r2135b2788],
12	partner	NN	O	partner	nn	13	SENT_52	[p3l9t2854r321b2938],
13	Her2/neu	NN	O	her2/neu	prep_in	3	SENT_52	[p3l361t2844r726b2935],
14	,	,	O	,	_	0	SENT_52	[p3l361t2844r726b2935],
15	which	WDT	O	which	nsubjpass	18	SENT_52	[p3l772t2837r1032b2917],
16	has	VBZ	O	have	aux	18	SENT_52	[p3l1077t2838r1218b2916],
17	been	VBN	O	be	auxpass	18	SENT_52	[p3l1265t2838r1465b2916],
18	reported	VBN	O	report	rcmod	13	SENT_52	[p3l1509t2837r1868b2938],
19	to	TO	O	to	aux	21	SENT_52	[p3l1914t2854r1993b2916],
20	be	VB	O	be	auxpass	21	SENT_52	[p3l2039t2838r2135b2916],
21	mutated	VBN	O	mutate	xcomp	18	SENT_52	[p3l11t2965r361b3045],
22	in	IN	O	in	_	0	SENT_52	[p3l393t2966r474b3043],
23	glioblastoma	NN	O	glioblastoma	prep_in	21	SENT_52	[p3l505t2965r1060b3066],
24	and	CC	O	and	_	0	SENT_52	[p3l1091t2965r1246b3044],
25	could	MD	O	could	aux	27	SENT_52	[p3l1279t2965r1511b3045],
26	also	RB	O	also	advmod	27	SENT_52	[p3l1542t2966r1709b3044],
27	affect	VB	O	affect	conj_and	3	SENT_52	[p3l1742t2965r1978b3044],
28	the	DT	O	the	det	29	SENT_52	[p3l2006t2966r2135b3044],
29	response	NN	O	response	dobj	27	SENT_52	[p3l11t3119r389b3194],
30	to	TO	O	to	_	0	SENT_52	[p3l419t3110r498b3172],
31	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_52	[p3l526t3099r785b3177],
32	kinase	NN	O	kinase	nn	33	SENT_52	[p3l803t3094r1073b3173],
33	inhibitors	NNS	O	inhibitor	prep_to	27	SENT_52	[p3l1101t3093r1628b3172],
34	.34	CD	NUMBER	.34	tmod	27	SENT_52	[p3l1101t3093r1628b3172],
35	We	PRP	O	we	nsubj	36	SENT_52	[p3l1652t3101r1785b3172],
36	found	VBD	O	find	rcmod	34	SENT_52	[p3l1814t3093r2064b3173],
37	a	DT	O	a	det	39	SENT_52	[p3l2092t3120r2136b3172],
38	strong	JJ	O	strong	amod	39	SENT_52	[p3l12t3238r287b3322],
39	association	NN	O	association	dobj	36	SENT_52	[p3l331t3222r806b3300],
40	between	IN	O	between	_	0	SENT_52	[p3l855t3222r1204b3301],
41	the	DT	O	the	det	42	SENT_52	[p3l1252t3222r1383b3300],
42	coexpression	NN	O	coexpression	prep_between	39	SENT_52	[p3l1435t3222r2000b3322],
43	of	IN	O	of	_	0	SENT_52	[p3l2051t3221r2153b3300],
44	EGFRVIII	NN	O	egfrviius	prep_of	42	SENT_52	[p3l9t3355r408b3433],
45	and	CC	O	and	_	0	SENT_52	[p3l441t3350r599b3428],
46	PTEN	NN	ORGANIZATION	pten	conj_and	44	SENT_52	[p3l632t3355r880b3428],
47	in	IN	O	in	_	0	SENT_52	[p3l913t3350r995b3427],
48	glioblastoma	NN	O	glioblastoma	nn	49	SENT_52	[p3l1029t3349r1588b3450],
49	cells	NNS	O	cell	prep_in	36	SENT_52	[p3l1619t3349r1801b3428],
50	and	CC	O	and	_	0	SENT_52	[p3l1835t3350r1991b3428],
51	responsiveness	NN	O	responsiveness	prep_in	36	SENT_52	[p3l2023t3376r2134b3428, p3l12t3478r566b3577],
52	to	TO	O	to	_	0	SENT_52	[p3l593t3493r672b3555],
53	EGFRl	NN	O	egfrl	prep_to	36	SENT_52	[p3l697t3478r1241b3560],
54	<	JJR	O	<	amod	56	SENT_52	[p3l697t3478r1241b3560],
55	inase	NN	O	inase	nn	56	SENT_52	[p3l697t3478r1241b3560],
56	inhibitors	NNS	O	inhibitor	dobj	3	SENT_52	[p3l1265t3478r1705b3555],
57	.	.	O	.	_	0	SENT_52	[p3l1265t3478r1705b3555],

1	METHODS	NNS	O	method	_	0	SENT_53	[p4l790t37r1341b96],

1	T	NN	O	t	nn	2	SENT_54	[p4l8t266r50b314],
2	E	NN	O	e	_	0	SENT_54	[p4l64t266r98b314],
3	ST	JJ	O	st	amod	4	SENT_54	[p4l110t265r199b315],
4	s	NNS	O	s	dep	2	SENT_54	[p4l235t265r273b315],
5	E	NN	O	e	nn	6	SENT_54	[p4l290t266r323b314],
6	T	NN	O	t	dep	2	SENT_54	[p4l334t266r375b314],

1	Since	IN	O	since	_	0	SENT_55	[p4l13t362r232b440],
2	2001	CD	DATE	2001	prep_since	11	SENT_55	[p4l252t367r481b457],
3	,	,	O	,	_	0	SENT_55	[p4l252t367r481b457],
4	49	CD	NUMBER	49	num	5	SENT_55	[p4l506t367r607b440],
5	patients	NNS	O	patient	nsubjpass	11	SENT_55	[p4l627t362r958b462],
6	with	IN	O	with	_	0	SENT_55	[p4l976t361r1164b441],
7	recurrent	JJ	O	recurrent	amod	8	SENT_55	[p4l1185t378r1573b441],
8	glioblastoma	NN	O	glioblastoma	prep_with	5	SENT_55	[p4l1588t361r2138b462],
9	have	VBP	O	have	aux	11	SENT_55	[p4l11t490r199b569],
10	been	VBN	O	be	auxpass	11	SENT_55	[p4l241t489r440b568],
11	treated	VBN	O	treat	_	0	SENT_55	[p4l482t489r771b568],
12	at	IN	O	at	_	0	SENT_55	[p4l811t506r890b568],
13	the	DT	O	the	det	14	SENT_55	[p4l927t490r1056b568],
14	University	NNP	ORGANIZATION	University	prep_at	11	SENT_55	[p4l1097t490r1525b590],
15	of	IN	ORGANIZATION	of	_	0	SENT_55	[p4l1563t489r1663b568],
16	California	NNP	ORGANIZATION	California	prep_of	14	SENT_55	[p4l1686t489r2130b585],
17	,	,	O	,	_	0	SENT_55	[p4l1686t489r2130b585],
18	Los	NNP	LOCATION	Los	nn	21	SENT_55	[p4l9t625r155b696],
19	Angeles	NNP	LOCATION	Angeles	nn	21	SENT_55	[p4l194t618r530b718],
20	(	CD	NUMBER	(	num	21	SENT_55	[p4l578t623r886b709],
21	UCLA	NNP	ORGANIZATION	UCLA	conj_and	14	SENT_55	[p4l578t623r886b709],
22	)	CD	NUMBER	)	number	23	SENT_55	[p4l578t623r886b709],
23	—	CD	NUMBER	—	num	24	SENT_55	[p4l928t663r1036b670],
24	37	CD	NUMBER	37	dep	21	SENT_55	[p4l1074t623r1173b696],
25	with	IN	O	with	_	0	SENT_55	[p4l1211t617r1400b697],
26	geﬁtinib	NN	O	geﬁtinib	prep_with	24	SENT_55	[p4l1441t617r1796b718],
27	and	CC	O	and	_	0	SENT_55	[p4l1838t618r1993b696],
28	12	CD	NUMBER	12	conj_and	14	SENT_55	[p4l2038t623r2134b695],
29	with	IN	O	with	_	0	SENT_55	[p4l6t746r196b825],
30	erlotinib	JJ	O	erlotinib	amod	31	SENT_55	[p4l218t746r576b824],
31	—	NN	O	—	prep_with	28	SENT_55	[p4l596t790r704b798],
32	as	IN	O	as	_	0	SENT_55	[p4l721t772r805b824],
33	part	NN	O	part	prep_as	31	SENT_55	[p4l828t762r1001b846],
34	of	IN	O	of	_	0	SENT_55	[p4l1018t745r1118b824],
35	three	CD	NUMBER	three	num	36	SENT_55	[p4l1122t746r1335b824],
36	multi	NNS	O	multus	prep_of	33	SENT_55	[p4l1357t746r2136b825],
37	—	CD	NUMBER	—	num	40	SENT_55	[p4l1357t746r2136b825],
38	institutional	JJ	O	institutional	amod	40	SENT_55	[p4l1357t746r2136b825],
39	clinical	JJ	O	clinical	amod	40	SENT_55	[p4l11t874r312b952],
40	trials	NNS	O	trial	dobj	11	SENT_55	[p4l348t874r556b952],
41	approved	VBN	O	approve	partmod	40	SENT_55	[p4l593t874r984b974],
42	by	IN	O	by	_	0	SENT_55	[p4l1021t874r1118b974],
43	the	DT	O	the	det	46	SENT_55	[p4l1150t873r1279b952],
44	institutional	JJ	O	institutional	amod	46	SENT_55	[p4l1315t873r1832b953],
45	review	NN	O	review	nn	46	SENT_55	[p4l1867t874r2139b953],
46	board	NN	O	board	agent	41	SENT_55	[p4l11t1001r276b1080],
47	.	.	O	.	_	0	SENT_55	[p4l11t1001r276b1080],

1	The	DT	O	the	det	3	SENT_56	[p4l299t1002r459b1080],
2	clinical	JJ	O	clinical	amod	3	SENT_56	[p4l482t1001r779b1080],
3	studies	NNS	O	study	nsubjpass	5	SENT_56	[p4l801t1001r1091b1081],
4	were	VBD	O	be	auxpass	5	SENT_56	[p4l1110t1028r1311b1081],
5	performed	VBN	O	perform	_	0	SENT_56	[p4l1331t1001r1776b1102],
6	through	IN	O	through	_	0	SENT_56	[p4l1797t1002r2136b1102],
7	the	DT	O	the	det	11	SENT_56	[p4l11t1130r140b1208],
8	Cancer	NN	O	cancer	nn	11	SENT_56	[p4l167t1135r463b1208],
9	Therapy	NN	O	therapy	nn	11	SENT_56	[p4l483t1129r832b1230],
10	Evaluation	NN	O	evaluation	nn	11	SENT_56	[p4l853t1130r1298b1209],
11	Program	NN	O	program	prep_through	5	SENT_56	[p4l1323t1136r1690b1230],
12	of	IN	O	of	_	0	SENT_56	[p4l1718t1129r1818b1208],
13	the	DT	O	the	det	14	SENT_56	[p4l1827t1130r1956b1208],
14	N	NN	O	n	prep_of	11	SENT_56	[p4l1980t1137r2055b1208],
15	ational	JJ	O	ational	amod	16	SENT_56	[p4l2058t1156r2134b1208, p4l11t1258r253b1336],
16	Institutes	NNPS	O	Institutes	dobj	5	SENT_56	[p4l282t1258r677b1337],
17	of	IN	O	of	_	0	SENT_56	[p4l712t1257r812b1336],
18	Health	NNP	O	Health	prep_of	16	SENT_56	[p4l825t1257r1108b1336],
19	or	CC	O	or	_	0	SENT_56	[p4l1141t1283r1230b1336],
20	Genentech	NNP	ORGANIZATION	Genentech	conj_or	18	SENT_56	[p4l1260t1258r1740b1336],
21	.	.	O	.	_	0	SENT_56	[p4l1260t1258r1740b1336],

1	The	DT	O	the	det	2	SENT_57	[p4l1775t1258r1936b1336],
2	correlative	JJ	O	correlative	_	0	SENT_57	[p4l1970t1283r2134b1336, p4l11t1386r312b1465],

1	study	NN	O	study	nsubj	2	SENT_58	[p4l346t1386r572b1486],
2	described	VBD	O	describe	_	0	SENT_58	[p4l601t1385r1007b1464],
3	here	RB	O	here	nsubjpass	5	SENT_58	[p4l1039t1386r1222b1464],
4	was	VBD	O	be	auxpass	5	SENT_58	[p4l1250t1412r1411b1465],
5	conducted	VBN	O	conduct	ccomp	2	SENT_58	[p4l1447t1385r1886b1465],
6	independently	RB	O	independently	dep	5	SENT_58	[p4l1918t1386r2134b1464, p4l9t1514r426b1614],
7	and	CC	O	and	_	0	SENT_58	[p4l442t1514r597b1592],
8	without	IN	O	without	dep	5	SENT_58	[p4l613t1514r945b1593],
9	industry	NN	O	industry	nn	10	SENT_58	[p4l961t1514r1307b1614],
10	support	NN	O	support	pobj	8	SENT_58	[p4l1326t1530r1672b1614],
11	.	.	O	.	_	0	SENT_58	[p4l1326t1530r1672b1614],

1	Diagnoses	NNS	O	diagnosis	nsubjpass	8	SENT_59	[p4l1697t1514r2134b1614],
2	were	VBD	O	be	auxpass	3	SENT_59	[p4l6t1668r205b1721],
3	established	VBN	O	establish	_	0	SENT_59	[p4l226t1641r695b1720],
4	by	IN	O	by	_	0	SENT_59	[p4l716t1642r812b1742],
5	two	CD	NUMBER	two	num	6	SENT_59	[p4l828t1658r978b1721],
6	neuropathologists	NNS	O	neuropathologist	agent	3	SENT_59	[p4l999t1641r1757b1742],
7	and	CC	O	and	_	0	SENT_59	[p4l1779t1641r1933b1720],
8	conﬁrmed	VBN	O	conﬁrmed	conj_and	3	SENT_59	[p4l1953t1667r2135b1720, p4l11t1769r293b1848],
9	by	IN	O	by	_	0	SENT_59	[p4l323t1770r420b1870],
10	a	DT	O	a	det	12	SENT_59	[p4l446t1796r490b1848],
11	third	JJ	ORDINAL	third	amod	12	SENT_59	[p4l519t1770r723b1848],
12	pathologist	NN	O	pathologist	prep_by	8	SENT_59	[p4l752t1769r1239b1870],
13	who	WP	O	who	nsubj	15	SENT_59	[p4l1260t1770r1443b1849],
14	was	VBD	O	be	cop	15	SENT_59	[p4l1470t1796r1632b1849],
15	unaware	JJ	O	unaware	rcmod	12	SENT_59	[p4l1664t1795r2022b1849],
16	of	IN	O	of	_	0	SENT_59	[p4l2053t1769r2153b1848],
17	the	DT	O	the	det	18	SENT_59	[p4l11t1898r138b1976],
18	results	NNS	O	result	prep_of	15	SENT_59	[p4l161t1898r432b1977],
19	of	IN	O	of	_	0	SENT_59	[p4l457t1897r557b1976],
20	molecular	JJ	O	molecular	amod	21	SENT_59	[p4l560t1898r979b1977],
21	analyses	NNS	O	analysis	prep_of	18	SENT_59	[p4l997t1898r1365b1998],
22	.	.	O	.	_	0	SENT_59	[p4l997t1898r1365b1998],

1	Tumor	NN	O	tumor	nn	2	SENT_60	[p4l1389t1903r1677b1977],
2	specimens	NNS	O	specimen	nsubjpass	4	SENT_60	[p4l1697t1898r2134b1998],
3	were	VBD	O	be	auxpass	4	SENT_60	[p4l6t2052r208b2105],
4	obtained	VBN	O	obtain	_	0	SENT_60	[p4l234t2025r606b2104],
5	according	VBG	O	accord	_	0	SENT_60	[p4l630t2026r1053b2126],
6	to	TO	O	to	prepc_according_to	4	SENT_60	[p4l1074t2042r1153b2104],
7	a	DT	O	a	det	8	SENT_60	[p4l1179t2052r1223b2104],
8	protocol	NN	O	protocol	pobj	4	SENT_60	[p4l1246t2026r1603b2126],
9	approved	VBN	O	approve	partmod	8	SENT_60	[p4l1626t2026r2018b2126],
10	by	IN	O	by	_	0	SENT_60	[p4l2043t2026r2140b2126],
11	the	DT	O	the	det	14	SENT_60	[p4l11t2154r140b2232],
12	institutional	JJ	O	institutional	amod	14	SENT_60	[p4l162t2154r678b2233],
13	review	NN	O	review	nn	14	SENT_60	[p4l700t2154r972b2233],
14	board	NN	O	board	agent	9	SENT_60	[p4l992t2154r1236b2232],
15	of	IN	O	of	_	0	SENT_60	[p4l1259t2153r1358b2232],
16	UCLA	NNP	ORGANIZATION	UCLA	prep_of	14	SENT_60	[p4l1362t2159r1635b2232],
17	.	.	O	.	_	0	SENT_60	[p4l1362t2159r1635b2232],

1	All	DT	O	all	det	2	SENT_61	[p4l1659t2154r1778b2231],
2	patients	NNS	O	patient	nsubj	15	SENT_61	[p4l1799t2154r2134b2254],
3	had	VBD	O	have	_	0	SENT_61	[p4l11t2281r168b2360],
4	measurable	JJ	O	measurable	amod	5	SENT_61	[p4l211t2282r707b2361],
5	disease	NN	O	disease	dobj	3	SENT_61	[p4l751t2282r1060b2360],
6	on	IN	O	on	_	0	SENT_61	[p4l1104t2307r1212b2360],
7	magnetic	JJ	O	magnetic	amod	9	SENT_61	[p4l1255t2282r1654b2382],
8	resonance	NN	O	resonance	nn	9	SENT_61	[p4l1696t2307r2134b2360],
9	imaging	NN	O	imaging	prep_on	5	SENT_61	[p4l10t2410r365b2510],
10	(	CD	NUMBER	(	num	12	SENT_61	[p4l393t2416r633b2501],
11	MRI	NNP	O	MRI	nn	12	SENT_61	[p4l393t2416r633b2501],
12	)	NN	O	)	dep	9	SENT_61	[p4l393t2416r633b2501],
13	and	CC	O	and	_	0	SENT_61	[p4l664t2409r820b2488],
14	had	VBD	O	have	aux	15	SENT_61	[p4l846t2409r1001b2488],
15	stopped	VBN	O	stop	conj_and	3	SENT_61	[p4l1029t2409r1365b2510],
16	receiving	VBG	O	receive	xcomp	15	SENT_61	[p4l1392t2410r1774b2510],
17	any	DT	O	any	det	20	SENT_61	[p4l1797t2435r1944b2510],
18	previous	JJ	O	previous	amod	20	SENT_61	[p4l1965t2436r2134b2510, p4l6t2538r227b2617],
19	cancer	NN	O	cancer	nn	20	SENT_61	[p4l267t2563r542b2616],
20	treatment	NN	O	treatment	dobj	16	SENT_61	[p4l576t2554r992b2616],
21	at	IN	DURATION	at	advmod	20	SENT_61	[p4l1023t2554r1102b2616],
22	least	JJS	DURATION	least	pobj	21	SENT_61	[p4l1133t2538r1330b2616],
23	four	CD	DURATION	four	num	24	SENT_61	[p4l1362t2537r1539b2617],
24	weeks	NNS	NUMBER	week	tmod	20	SENT_61	[p4l1569t2538r1828b2617],
25	before	IN	O	before	_	0	SENT_61	[p4l1869t2537r2135b2616],
26	the	DT	O	the	det	27	SENT_61	[p4l11t2666r140b2744],
27	start	NN	O	start	prep_before	16	SENT_61	[p4l167t2682r358b2744],
28	of	IN	O	of	_	0	SENT_61	[p4l379t2665r480b2744],
29	monotherapy	NN	O	monotherapy	prep_of	27	SENT_61	[p4l486t2666r1058b2766],
30	with	IN	O	with	_	0	SENT_61	[p4l1073t2666r1263b2745],
31	an	DT	O	a	det	33	SENT_61	[p4l1287t2691r1388b2744],
32	EGFR	NN	ORGANIZATION	egfr	nn	33	SENT_61	[p4l1411t2671r1671b2749],
33	inhibitor	NN	O	inhibitor	prep_with	16	SENT_61	[p4l1684t2665r2076b2744],
34	.	.	O	.	_	0	SENT_61	[p4l1684t2665r2076b2744],

1	MRI	NNP	O	MRI	nsubjpass	6	SENT_62	[p4l136t2800r321b2877],
2	and	CC	O	and	_	0	SENT_62	[p4l346t2793r502b2872],
3	clinical	JJ	O	clinical	amod	4	SENT_62	[p4l528t2793r829b2872],
4	assessment	NN	O	assessment	conj_and	1	SENT_62	[p4l854t2810r1344b2872],
5	were	VBD	O	be	auxpass	6	SENT_62	[p4l1360t2820r1562b2873],
6	performed	VBN	O	perform	_	0	SENT_62	[p4l1587t2793r2036b2894],
7	at	IN	O	at	_	0	SENT_62	[p4l2061t2810r2140b2872],
8	baseline	NN	O	baseline	prep_at	6	SENT_62	[p4l11t2921r380b3017],
9	,	,	O	,	_	0	SENT_62	[p4l11t2921r380b3017],
10	every	DT	SET	every	det	12	SENT_62	[p4l425t2948r638b3022],
11	two	CD	SET	two	num	12	SENT_62	[p4l673t2938r825b3001],
12	months	NNS	NUMBER	month	npadvmod	13	SENT_62	[p4l865t2922r1189b3000],
13	thereafter	RB	O	thereafter	dep	6	SENT_62	[p4l1230t2921r1656b3017],
14	,	,	O	,	_	0	SENT_62	[p4l1230t2921r1656b3017],
15	and	CC	O	and	_	0	SENT_62	[p4l1700t2921r1855b3000],
16	at	IN	O	at	_	0	SENT_62	[p4l1893t2938r1972b3000],
17	the	DT	O	the	det	18	SENT_62	[p4l2006t2922r2135b3000],
18	time	NN	O	time	prep_at	6	SENT_62	[p4l11t3050r197b3128],
19	of	IN	O	of	_	0	SENT_62	[p4l243t3049r343b3128],
20	progression	NN	O	progression	prep_of	18	SENT_62	[p4l367t3050r876b3150],
21	by	IN	O	by	_	0	SENT_62	[p4l921t3049r1018b3150],
22	a	DT	O	a	det	23	SENT_62	[p4l1056t3076r1101b3128],
23	neuroradiologist	NN	O	neuroradiologist	agent	6	SENT_62	[p4l1144t3050r1855b3150],
24	and	CC	O	and	_	0	SENT_62	[p4l1893t3049r2049b3128],
25	a	DT	O	a	det	28	SENT_62	[p4l2092t3076r2137b3128],
26	neuro	NN	O	neuro	nn	28	SENT_62	[p4l11t3178r746b3278],
27	—	NN	O	—	nn	28	SENT_62	[p4l11t3178r746b3278],
28	oncologist	NN	O	oncologist	conj_and	23	SENT_62	[p4l11t3178r746b3278],
29	who	WP	O	who	nsubj	31	SENT_62	[p4l764t3178r948b3257],
30	were	VBD	O	be	cop	31	SENT_62	[p4l972t3204r1174b3257],
31	unaware	JJ	O	unaware	rcmod	28	SENT_62	[p4l1202t3203r1560b3257],
32	of	IN	O	of	_	0	SENT_62	[p4l1589t3177r1689b3256],
33	the	DT	O	the	det	34	SENT_62	[p4l1699t3178r1828b3256],
34	results	NNS	O	result	prep_of	31	SENT_62	[p4l1856t3178r2133b3257],
35	of	IN	O	of	_	0	SENT_62	[p4l11t3305r112b3384],
36	the	DT	O	the	det	38	SENT_62	[p4l122t3306r251b3384],
37	molecular	JJ	O	molecular	amod	38	SENT_62	[p4l279t3305r705b3385],
38	analyses	NNS	O	analysis	prep_of	34	SENT_62	[p4l730t3306r1104b3406],
39	.	.	O	.	_	0	SENT_62	[p4l730t3306r1104b3406],

1	A	DT	O	a	det	2	SENT_63	[p4l1134t3313r1200b3383],
2	response	NN	O	response	nsubjpass	4	SENT_63	[p4l1225t3331r1604b3406],
3	was	VBD	O	be	auxpass	4	SENT_63	[p4l1628t3332r1789b3385],
4	deﬁned	VBN	O	deﬁned	_	0	SENT_63	[p4l1820t3305r2135b3384],
5	as	IN	O	as	_	0	SENT_63	[p4l10t3460r94b3512],
6	a	DT	O	a	det	7	SENT_63	[p4l130t3460r174b3512],
7	decrease	NN	O	decrease	prep_as	4	SENT_63	[p4l207t3433r567b3512],
8	of	IN	O	of	_	0	SENT_63	[p4l602t3433r703b3512],
9	at	IN	O	at	quantmod	11	SENT_63	[p4l718t3450r797b3512],
10	least	JJS	O	least	mwe	9	SENT_63	[p4l824t3434r1021b3512],
11	25	CD	PERCENT	25	num	12	SENT_63	[p4l1050t3439r1148b3512],
12	percent	NN	PERCENT	percent	prep_of	7	SENT_63	[p4l1184t3450r1504b3534],
13	in	IN	O	in	_	0	SENT_63	[p4l1532t3434r1614b3511],
14	the	DT	O	the	det	16	SENT_63	[p4l1648t3433r1777b3512],
15	bidirectional	JJ	O	bidirectional	amod	16	SENT_63	[p4l1812t3434r2134b3512, p4l11t3561r250b3640],
16	area	NN	O	area	prep_in	4	SENT_63	[p4l269t3588r442b3640],
17	of	IN	O	of	_	0	SENT_63	[p4l461t3561r561b3640],
18	the	DT	O	the	det	20	SENT_63	[p4l564t3562r691b3640],
19	contrast	NN	O	contrast	nn	20	SENT_63	[p4l713t3562r1534b3662],
20	—	NN	O	—	prep_of	16	SENT_63	[p4l713t3562r1534b3662],
21	enhancing	VBG	O	enhance	partmod	20	SENT_63	[p4l713t3562r1534b3662],
22	tumor	NN	O	tumor	dobj	21	SENT_63	[p4l1551t3578r1811b3641],
23	on	IN	O	on	_	0	SENT_63	[p4l1830t3587r1935b3640],
24	MRI	NNP	O	MRI	prep_on	22	SENT_63	[p4l1953t3568r2137b3645],
25	in	IN	O	in	_	0	SENT_63	[p4l10t3691r91b3768],
26	the	DT	O	the	det	27	SENT_63	[p4l126t3690r255b3769],
27	absence	NN	O	absence	prep_in	21	SENT_63	[p4l289t3691r624b3769],
28	of	IN	O	of	_	0	SENT_63	[p4l660t3690r760b3769],
29	an	DT	O	a	det	31	SENT_63	[p4l775t3716r876b3769],
30	increased	VBN	O	increase	amod	31	SENT_63	[p4l909t3691r1311b3769],
31	dose	NN	O	dose	prep_of	27	SENT_63	[p4l1345t3690r1539b3769],
32	of	IN	O	of	_	0	SENT_63	[p4l1574t3690r1674b3769],
33	corticosteroids	NNS	O	corticosteroid	prep_of	31	SENT_63	[p4l1691t3691r2134b3769, p5l11t32r253b110],
34	.	.	O	.	_	0	SENT_63	[p4l1691t3691r2134b3769, p5l11t32r253b110],

1	Progression	NN	O	progression	nsubjpass	3	SENT_64	[p5l293t32r810b132],
2	was	VBD	O	be	auxpass	3	SENT_64	[p5l842t58r1005b111],
3	deﬁned	VBN	O	deﬁned	_	0	SENT_64	[p5l1044t31r1366b110],
4	as	IN	O	as	_	0	SENT_64	[p5l1402t58r1486b110],
5	an	DT	O	a	det	6	SENT_64	[p5l1524t57r1625b110],
6	increase	NN	O	increase	prep_as	3	SENT_64	[p5l1661t32r2014b110],
7	of	IN	O	of	_	0	SENT_64	[p5l2051t31r2153b110],
8	at	IN	O	at	quantmod	10	SENT_64	[p5l10t176r90b238],
9	least	JJS	O	least	mwe	8	SENT_64	[p5l115t160r312b238],
10	25	CD	PERCENT	25	num	11	SENT_64	[p5l336t165r434b238],
11	percent	NN	PERCENT	percent	prep_of	6	SENT_64	[p5l465t176r786b260],
12	in	IN	O	in	_	0	SENT_64	[p5l810t160r891b237],
13	the	DT	O	the	det	16	SENT_64	[p5l921t159r1050b238],
14	bidirectional	JJ	O	bidirectional	amod	16	SENT_64	[p5l1080t159r1615b238],
15	tumor	NN	O	tumor	nn	16	SENT_64	[p5l1644t176r1907b239],
16	area	NN	O	area	prep_in	3	SENT_64	[p5l1933t186r2130b238],
17	.	.	O	.	_	0	SENT_64	[p5l1933t186r2130b238],

1	Thirty	CD	NUMBER	thirty	num	4	SENT_65	[p5l7t288r532b388],
2	—	CD	NUMBER	—	num	4	SENT_65	[p5l7t288r532b388],
3	seven	CD	NUMBER	seven	num	4	SENT_65	[p5l7t288r532b388],
4	patients	NNS	O	patient	nsubj	18	SENT_65	[p5l555t288r915b388],
5	,	,	O	,	_	0	SENT_65	[p5l555t288r915b388],
6	26	CD	NUMBER	26	appos	4	SENT_65	[p5l944t293r1045b366],
7	with	IN	O	with	_	0	SENT_65	[p5l1065t288r1255b367],
8	clear	JJ	O	clear	amod	11	SENT_65	[p5l1280t287r1648b367],
9	—	JJ	O	—	amod	11	SENT_65	[p5l1280t287r1648b367],
10	cut	NN	O	cut	nn	11	SENT_65	[p5l1280t287r1648b367],
11	evidence	NN	O	evidence	prep_with	6	SENT_65	[p5l1668t288r2028b367],
12	of	IN	O	of	_	0	SENT_65	[p5l2053t287r2153b366],
13	a	DT	O	a	det	14	SENT_65	[p5l10t442r54b494],
14	response	NN	O	response	prep_of	11	SENT_65	[p5l77t441r456b516],
15	or	CC	O	or	_	0	SENT_65	[p5l481t441r570b494],
16	progression	NN	O	progression	conj_or	14	SENT_65	[p5l590t416r1122b516],
17	,	,	O	,	_	0	SENT_65	[p5l590t416r1122b516],
18	had	VBD	O	have	_	0	SENT_65	[p5l1152t415r1307b494],
19	sufficient	JJ	O	sufficient	amod	20	SENT_65	[p5l1332t415r1730b495],
20	tissue	NN	O	tissue	dobj	18	SENT_65	[p5l1750t416r1991b495],
21	for	IN	O	for	_	0	SENT_65	[p5l2015t415r2138b494],
22	molecular	JJ	O	molecular	amod	23	SENT_65	[p5l11t544r445b623],
23	analysis	NN	O	analysis	prep_for	20	SENT_65	[p5l474t544r812b644],
24	(	CD	NUMBER	(	num	25	SENT_65	[p5l851t544r1153b635],
25	Tables	NNS	O	table	dep	23	SENT_65	[p5l851t544r1153b635],
26	1	CD	NUMBER	1	num	29	SENT_65	[p5l1192t549r1236b621],
27	and	CC	O	and	_	0	SENT_65	[p5l1268t544r1426b622],
28	2	CD	NUMBER	2	num	29	SENT_65	[p5l1459t549r1566b635],
29	)	NN	O	)	dep	25	SENT_65	[p5l1459t549r1566b635],
30	.	.	O	.	_	0	SENT_65	[p5l1459t549r1566b635],

1	Ten	CD	NUMBER	ten	num	2	SENT_66	[p5l1602t549r1759b622],
2	patients	NNS	O	patient	nsubj	3	SENT_66	[p5l1790t544r2132b644],
3	fell	VBD	O	fall	_	0	SENT_66	[p5l11t671r141b750],
4	between	IN	O	between	_	0	SENT_66	[p5l181t672r531b751],
5	these	DT	O	these	det	6	SENT_66	[p5l571t672r790b750],
6	extremes	NNS	O	extreme	prep_between	3	SENT_66	[p5l831t688r1207b750],
7	of	IN	O	of	_	0	SENT_66	[p5l1251t671r1351b750],
8	response	NN	O	response	prep_of	6	SENT_66	[p5l1372t697r1752b772],
9	to	TO	O	to	_	0	SENT_66	[p5l1793t688r1872b750],
10	treatment	NN	O	treatment	prep_to	3	SENT_66	[p5l1913t688r2134b750, p5l11t816r251b895],
11	,	,	O	,	_	0	SENT_66	[p5l1913t688r2134b750, p5l11t816r251b895],
12	with	IN	O	with	mark	25	SENT_66	[p5l286t800r476b879],
13	tumor	NN	O	tumor	nn	14	SENT_66	[p5l510t816r773b879],
14	growth	NN	O	growth	nsubjpass	25	SENT_66	[p5l803t800r1107b900],
15	or	CC	O	or	_	0	SENT_66	[p5l1141t825r1231b878],
16	shrinkage	NN	O	shrinkage	conj_or	14	SENT_66	[p5l1263t799r1681b900],
17	of	IN	O	of	_	0	SENT_66	[p5l1715t799r1816b878],
18	25	CD	PERCENT	25	num	19	SENT_66	[p5l1831t805r1929b878],
19	percent	NN	PERCENT	percent	prep_of	14	SENT_66	[p5l1965t826r2134b900, p5l11t944r191b1006],
20	or	CC	O	or	_	0	SENT_66	[p5l220t953r309b1006],
21	less	JJR	O	less	amod	23	SENT_66	[p5l339t928r493b1006],
22	(	NN	O	(	nn	23	SENT_66	[p5l534t927r837b1019],
23	details	NNS	O	detail	conj_or	19	SENT_66	[p5l534t927r837b1019],
24	are	VBP	O	be	auxpass	25	SENT_66	[p5l873t954r998b1006],
25	provided	VBN	O	provide	advcl	3	SENT_66	[p5l1031t927r1402b1028],
26	in	IN	O	in	_	0	SENT_66	[p5l1435t928r1516b1005],
27	Table	NNP	O	Table	prep_in	25	SENT_66	[p5l1546t928r1774b1006],
28	1	CD	NUMBER	1	num	27	SENT_66	[p5l1811t933r1855b1005],
29	of	IN	O	of	_	0	SENT_66	[p5l1890t927r1991b1006],
30	the	DT	O	the	det	32	SENT_66	[p5l2006t928r2135b1006],
31	Supplementary	NNP	O	Supplementary	nn	32	SENT_66	[p5l13t1056r668b1156],
32	Appendix	NNP	O	Appendix	prep_of	27	SENT_66	[p5l699t1056r1139b1156],
33	,	,	O	,	_	0	SENT_66	[p5l699t1056r1139b1156],
34	available	JJ	O	available	acomp	25	SENT_66	[p5l1183t1056r1556b1135],
35	with	IN	O	with	_	0	SENT_66	[p5l1590t1056r1783b1135],
36	the	DT	O	the	det	38	SENT_66	[p5l1822t1056r1953b1134],
37	full	JJ	O	full	amod	38	SENT_66	[p5l1992t1055r2135b1135],
38	text	NN	O	text	prep_with	34	SENT_66	[p5l11t1200r170b1262],
39	of	IN	O	of	_	0	SENT_66	[p5l196t1183r298b1262],
40	this	DT	O	this	det	41	SENT_66	[p5l309t1184r465b1262],
41	article	NN	O	article	prep_of	38	SENT_66	[p5l497t1184r761b1262],
42	at	IN	O	at	_	0	SENT_66	[p5l792t1200r872b1262],
43	wvvw.nejm.org	JJ	O	wvvw.nejm.org	amod	44	SENT_66	[p5l892t1184r1595b1284],
44	)	NN	O	)	prep_at	41	SENT_66	[p5l892t1184r1595b1284],
45	.	.	O	.	_	0	SENT_66	[p5l892t1184r1595b1284],

1	One	CD	NUMBER	one	num	2	SENT_67	[p5l1631t1189r1805b1262],
2	patient	NN	O	patient	nsubjpass	4	SENT_67	[p5l1834t1184r2139b1284],
3	was	VBD	O	be	auxpass	4	SENT_67	[p5l6t1338r167b1391],
4	excluded	VBN	O	exclude	_	0	SENT_67	[p5l201t1311r573b1391],
5	because	IN	O	because	mark	8	SENT_67	[p5l603t1312r935b1391],
6	a	DT	O	a	det	7	SENT_67	[p5l965t1338r1009b1390],
7	response	NN	O	response	nsubj	8	SENT_67	[p5l1038t1337r1417b1412],
8	occurred	VBD	O	occur	advcl	4	SENT_67	[p5l1448t1311r1818b1391],
9	coincidently	RB	O	coincidently	advmod	8	SENT_67	[p5l1848t1312r2134b1390, p5l11t1440r271b1540],
10	with	IN	O	with	_	0	SENT_67	[p5l303t1440r493b1519],
11	an	DT	O	a	det	12	SENT_67	[p5l533t1465r633b1518],
12	increase	NN	O	increase	prep_with	8	SENT_67	[p5l674t1440r1019b1518],
13	in	IN	O	in	_	0	SENT_67	[p5l1060t1440r1142b1517],
14	the	DT	O	the	det	15	SENT_67	[p5l1183t1440r1312b1518],
15	dose	NN	O	dose	prep_in	12	SENT_67	[p5l1354t1439r1548b1518],
16	of	IN	O	of	_	0	SENT_67	[p5l1590t1439r1690b1518],
17	decadron	NN	O	decadron	prep_of	15	SENT_67	[p5l1714t1439r2130b1518],
18	.	.	O	.	_	0	SENT_67	[p5l1714t1439r2130b1518],

1	The	DT	O	the	det	3	SENT_68	[p5l7t1568r169b1646],
2	statistical	JJ	O	statistical	amod	3	SENT_68	[p5l207t1568r607b1646],
3	methods	NNS	O	method	nsubjpass	6	SENT_68	[p5l643t1567r1012b1646],
4	used	VBN	O	use	partmod	3	SENT_68	[p5l1051t1567r1246b1647],
5	are	VBP	O	be	auxpass	6	SENT_68	[p5l1282t1594r1407b1646],
6	described	VBN	O	describe	_	0	SENT_68	[p5l1446t1567r1851b1646],
7	in	IN	O	in	_	0	SENT_68	[p5l1887t1568r1969b1645],
8	the	DT	O	the	prep_in	6	SENT_68	[p5l2006t1568r2135b1646],

1	Supplementary	NNP	O	Supplementary	nn	2	SENT_69	[p5l13t1695r655b1796],
2	Appendix	NNP	O	Appendix	_	0	SENT_69	[p5l672t1696r1104b1796],
3	.	.	O	.	_	0	SENT_69	[p5l672t1696r1104b1796],

1	N	NN	O	n	nn	3	SENT_70	[p5l475t1865r489b1880],
2	ENGLJ	NN	O	englj	nn	3	SENT_70	[p5l504t1864r588b1886],
3	MED	NN	O	med	_	0	SENT_70	[p5l603t1865r656b1880],
4	353	CD	NUMBER	353	num	6	SENT_70	[p5l668t1864r746b1886],
5	;	:	O	;	_	0	SENT_70	[p5l668t1864r746b1886],
6	19	CD	NUMBER	19	dep	3	SENT_70	[p5l668t1864r746b1886],
7	WWW.NEJM.ORG	NNP	O	WWW.NEJM.ORG	nn	8	SENT_70	[p5l781t1864r993b1886],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	6	SENT_70	[p5l1032t1864r1173b1880],
9	10	CD	DATE	10	num	8	SENT_70	[p5l1186t1864r1222b1884],
10	,	,	DATE	,	_	0	SENT_70	[p5l1186t1864r1222b1884],
11	2005	CD	DATE	2005	num	8	SENT_70	[p5l1235t1864r1298b1886],
12	2013	CD	DATE	2013	dep	3	SENT_70	[p5l1940t1863r2016b1885],

1	The	DT	O	the	det	4	SENT_71	[p5l702t1897r753b1921],
2	New	NNP	O	New	nn	4	SENT_71	[p5l762t1898r824b1921],
3	England	NNP	O	England	nn	4	SENT_71	[p5l833t1897r944b1928],
4	Journal	NNP	O	Journal	_	0	SENT_71	[p5l953t1897r1050b1921],
5	of	IN	O	of	_	0	SENT_71	[p5l1060t1897r1089b1921],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_71	[p5l1095t1897r1221b1921],

1	Downloaded	VBN	O	download	_	0	SENT_72	[p5l144t1938r314b1961],
2	from	IN	O	from	_	0	SENT_72	[p5l323t1938r387b1961],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_72	[p5l396t1938r514b1968],
4	at	IN	O	at	_	0	SENT_72	[p5l525t1942r548b1961],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_72	[p5l556t1938r739b1961],
6	on	IN	O	on	_	0	SENT_72	[p5l748t1945r780b1961],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_72	[p5l789t1938r850b1961],
8	5	CD	DATE	5	num	7	SENT_72	[p5l902t1938r925b1965],
9	,	,	DATE	,	_	0	SENT_72	[p5l902t1938r925b1965],
10	2014	CD	DATE	2014	num	7	SENT_72	[p5l935t1938r1007b1961],
11	.	.	O	.	_	0	SENT_72	[p5l935t1938r1007b1961],

1	For	IN	O	for	_	0	SENT_73	[p5l1018t1938r1065b1961],
2	personal	JJ	O	personal	amod	3	SENT_73	[p5l1073t1938r1185b1968],
3	use	NN	O	use	pobj	1	SENT_73	[p5l1194t1945r1238b1961],
4	only	RB	O	only	advmod	3	SENT_73	[p5l1247t1938r1312b1968],
5	.	.	O	.	_	0	SENT_73	[p5l1247t1938r1312b1968],

1	No	DT	O	no	det	3	SENT_74	[p5l1323t1938r1363b1961],
2	other	JJ	O	other	amod	3	SENT_74	[p5l1373t1938r1441b1961],
3	uses	NNS	O	use	_	0	SENT_74	[p5l1449t1945r1505b1961],
4	without	IN	O	without	_	0	SENT_74	[p5l1515t1938r1616b1961],
5	permission	NN	O	permission	prep_without	3	SENT_74	[p5l1624t1938r1777b1968],
6	.	.	O	.	_	0	SENT_74	[p5l1624t1938r1777b1968],

1	Copyright	NN	O	copyright	_	0	SENT_75	[p5l494t1979r629b2010],
2	©	CD	NUMBER	©	num	3	SENT_75	[p5l638t1979r661b2003],
3	2005	CD	DATE	2005	dep	1	SENT_75	[p5l672t1979r736b2003],
4	Massa	NNP	PERSON	Massa	dep	3	SENT_75	[p5l746t1980r831b2003],
5	u	FW	O	u	nn	6	SENT_75	[p5l863t1987r878b2003],
6	etts	FW	O	etts	dep	1	SENT_75	[p5l893t1983r937b2003],
7	Medical	JJ	O	medical	amod	8	SENT_75	[p5l947t1979r1055b2003],
8	Soci	NNP	O	Soci	dep	6	SENT_75	[p5l1066t1979r1123b2003],
9	.	.	O	.	_	0	SENT_75	[p5l1167t1999r1171b2003],

1	All	DT	O	all	det	2	SENT_76	[p5l1182t1979r1223b2003],
2	rights	NNS	O	rights	nsubj	3	SENT_76	[p5l1232t1979r1307b2010],
3	reserved	VBN	O	reserve	_	0	SENT_76	[p5l1317t1979r1436b2003],
4	.	.	O	.	_	0	SENT_76	[p5l1317t1979r1436b2003],

1	The	DT	O	the	det	4	SENT_77	[p5l715t2021r752b2042],
2	NEW	NNP	O	NEW	nn	4	SENT_77	[p5l764t2023r844b2042],
3	ENGLAND	NNP	LOCATION	ENGLAND	nn	4	SENT_77	[p5l858t2023r1033b2042],
4	JOU	NNP	O	JOU	_	0	SENT_77	[p5l1047t2023r1112b2049],
5	AL	NNP	O	AL	nn	6	SENT_77	[p5l1171t2023r1213b2042],
6	ofMEDICINE	NNP	O	ofMEDICINE	dep	4	SENT_77	[p5l1227t2021r1443b2048],

1	Proliferation	NN	O	proliferation	_	0	SENT_78	[p6l1131t1307r1296b1332],

1	Figure	NNP	O	Figure	_	0	SENT_79	[p6l264t1484r348b1516],
2	1	CD	NUMBER	1	dep	1	SENT_79	[p6l358t1485r380b1508],
3	.	.	O	.	_	0	SENT_79	[p6l358t1485r380b1508],

1	The	DT	O	the	det	2	SENT_80	[p6l389t1483r440b1508],
2	Pl3K	NN	O	pl3k	_	0	SENT_80	[p6l451t1483r575b1508],
3	.	.	O	.	_	0	SENT_80	[p6l451t1483r575b1508],

1	—	NN	O	—	_	0	SENT_81	[p6l451t1483r575b1508],
2	.	.	O	.	_	0	SENT_81	[p6l451t1483r575b1508],

1	Akt	NNP	O	Akt	_	0	SENT_82	[p6l451t1483r575b1508],
2	Signaling	NN	O	signaling	nn	3	SENT_82	[p6l583t1483r711b1516],
3	Pathway	NN	O	pathway	dep	1	SENT_82	[p6l721t1483r840b1516],
4	.	.	O	.	_	0	SENT_82	[p6l721t1483r840b1516],

1	The	DT	O	the	det	2	SENT_83	[p6l261t1533r311b1558],
2	EGFR	NN	ORGANIZATION	egfr	nsubj	12	SENT_83	[p6l323t1535r397b1558],
3	becomes	VBZ	O	become	auxpass	4	SENT_83	[p6l409t1533r529b1558],
4	activated	VBN	O	activate	_	0	SENT_83	[p6l540t1533r660b1558],
5	on	IN	O	on	_	0	SENT_83	[p6l671t1542r703b1558],
6	binding	VBG	O	bind	prep_on	4	SENT_83	[p6l716t1533r819b1566],
7	to	TO	O	to	_	0	SENT_83	[p6l827t1538r854b1558],
8	epidermal	JJ	O	epidermal	amod	10	SENT_83	[p6l864t1533r999b1566],
9	growth	NN	O	growth	nn	10	SENT_83	[p6l1011t1533r1103b1566],
10	factor	NN	O	factor	prep_to	6	SENT_83	[p6l1114t1533r1193b1558],
11	and	CC	O	and	_	0	SENT_83	[p6l1202t1533r1250b1558],
12	recruits	VBZ	O	recruit	conj_and	4	SENT_83	[p6l1263t1535r1363b1558],
13	P	NN	O	p	nn	14	SENT_83	[p6l1376t1535r1436b1558],
14	|	NN	O	|	dobj	12	SENT_83	[p6l1376t1535r1436b1558],
15	3K	CD	NUMBER	3k	num	14	SENT_83	[p6l1376t1535r1436b1558],
16	to	TO	O	to	_	0	SENT_83	[p6l1444t1538r1471b1558],
17	the	DT	O	the	det	19	SENT_83	[p6l1480t1533r1523b1558],
18	cell	NN	O	cell	nn	19	SENT_83	[p6l1533t1533r1575b1558],
19	membrane	NN	O	membrane	prep_to	12	SENT_83	[p6l1588t1533r1743b1558],
20	.	.	O	.	_	0	SENT_83	[p6l1588t1533r1743b1558],

1	P	NN	O	p	nsubj	4	SENT_84	[p6l1756t1535r1816b1558],
2	|	CD	NUMBER	|	num	3	SENT_84	[p6l1756t1535r1816b1558],
3	3K	NN	O	3k	dep	1	SENT_84	[p6l1756t1535r1816b1558],
4	converts	VBZ	O	convert	_	0	SENT_84	[p6l1826t1542r1883b1558, p6l261t1579r326b1600],
5	phosphatidylinositol-4	NN	O	phosphatidylinositol-4	dobj	4	SENT_84	[p6l338t1574r863b1607],
6	,5	CD	NUMBER	,5	num	5	SENT_84	[p6l338t1574r863b1607],
7	-	:	O	-	_	0	SENT_84	[p6l338t1574r863b1607],
8	bisphosphate	NN	O	bisphosphate	nn	11	SENT_84	[p6l338t1574r863b1607],
9	(	CD	NUMBER	(	num	11	SENT_84	[p6l876t1577r953b1607],
10	PIPZ	NN	O	pipz	nn	11	SENT_84	[p6l876t1577r953b1607],
11	)	NN	O	)	dep	5	SENT_84	[p6l876t1577r953b1607],
12	to	TO	O	to	_	0	SENT_84	[p6l965t1579r991b1600],
13	the	DT	O	the	det	16	SENT_84	[p6l1001t1574r1043b1600],
14	second-messenger	NN	O	second-messenger	nn	16	SENT_84	[p6l1054t1574r1312b1608],
15	molecule	NN	O	molecule	nn	16	SENT_84	[p6l1322t1574r1444b1600],
16	PIP3	NN	O	pip3	prep_to	11	SENT_84	[p6l1457t1577r1512b1606],
17	(	CD	NUMBER	(	num	19	SENT_84	[p6l1524t1574r1590b1607],
18	blue	JJ	O	blue	amod	19	SENT_84	[p6l1524t1574r1590b1607],
19	arrows	NNS	O	arrow	dep	11	SENT_84	[p6l1600t1576r1710b1607],
20	)	RB	O	)	advmod	4	SENT_84	[p6l1600t1576r1710b1607],
21	.	.	O	.	_	0	SENT_84	[p6l1600t1576r1710b1607],

1	This	DT	DATE	this	det	3	SENT_85	[p6l1720t1574r1777b1600],
2	second	JJ	DATE	second	amod	3	SENT_85	[p6l1789t1574r1884b1600],
3	messenger	NN	O	messenger	nsubj	5	SENT_85	[p6l263t1625r412b1649],
4	then	RB	O	then	advmod	5	SENT_85	[p6l420t1616r479b1641],
5	activates	VBZ	O	activate	_	0	SENT_85	[p6l491t1618r609b1641],
6	downstream	JJ	O	downstream	amod	8	SENT_85	[p6l619t1616r788b1641],
7	effector	NN	O	effector	nn	8	SENT_85	[p6l799t1616r902b1641],
8	molecules	NNS	O	molecule	dobj	5	SENT_85	[p6l913t1616r1057b1646],
9	,	,	O	,	_	0	SENT_85	[p6l913t1616r1057b1646],
10	such	JJ	O	such	_	0	SENT_85	[p6l1069t1616r1130b1641],
11	as	IN	O	as	_	0	SENT_85	[p6l1142t1625r1169b1641],
12	Akt	NN	O	akt	prep_such_as	16	SENT_85	[p6l1179t1616r1224b1641],
13	and	CC	O	and	_	0	SENT_85	[p6l1234t1616r1282b1641],
14	the	DT	O	the	det	15	SENT_85	[p6l1292t1616r1335b1641],
15	mammalian	JJ	O	mammalian	conj_and	12	SENT_85	[p6l1346t1616r1507b1641],
16	et	FW	O	et	appos	8	SENT_85	[p6l1573t1621r1597b1641],
17	of	IN	O	of	_	0	SENT_85	[p6l1607t1616r1636b1641],
18	rapamycin	NN	O	rapamycin	nn	21	SENT_85	[p6l1643t1618r1782b1649],
19	(	CD	NUMBER	(	num	21	SENT_85	[p6l265t1660r382b1691],
20	mTOR	NN	O	mtor	nn	21	SENT_85	[p6l265t1660r382b1691],
21	)	NN	O	)	prep_of	16	SENT_85	[p6l265t1660r382b1691],
22	,	,	O	,	_	0	SENT_85	[p6l265t1660r382b1691],
23	which	WDT	O	which	nsubj	24	SENT_85	[p6l392t1658r471b1683],
24	help	VBP	O	help	rcmod	21	SENT_85	[p6l483t1658r539b1691],
25	induce	VB	O	induce	xcomp	24	SENT_85	[p6l551t1658r640b1683],
26	cellular	JJ	O	cellular	amod	27	SENT_85	[p6l650t1658r748b1683],
27	proliferation	NN	O	proliferation	dobj	25	SENT_85	[p6l759t1658r923b1691],
28	and	CC	O	and	_	0	SENT_85	[p6l935t1658r983b1683],
29	block	NN	O	block	nn	30	SENT_85	[p6l996t1658r1066b1683],
30	apoptosis	NN	O	apoptosis	conj_and	27	SENT_85	[p6l1076t1660r1217b1691],
31	.	.	O	.	_	0	SENT_85	[p6l1076t1660r1217b1691],

1	PTEN	NN	ORGANIZATION	pten	nsubj	2	SENT_86	[p6l1230t1660r1303b1683],
2	terminates	VBZ	O	terminate	_	0	SENT_86	[p6l1314t1660r1461b1683],
3	the	DT	O	the	det	6	SENT_86	[p6l1471t1658r1513b1683],
4	3	CD	NUMBER	3	num	6	SENT_86	[p6l1571t1675r1581b1689],
5	signal	NN	O	signal	nn	6	SENT_86	[p6l1591t1658r1668b1691],
6	(	NN	O	(	dobj	2	SENT_86	[p6l1683t1658r1733b1691],
7	red	JJ	O	red	amod	8	SENT_86	[p6l1683t1658r1733b1691],
8	arrows	NNS	O	arrow	tmod	2	SENT_86	[p6l1745t1660r1855b1691],
9	)	RB	O	)	advmod	8	SENT_86	[p6l1745t1660r1855b1691],
10	.	.	O	.	_	0	SENT_86	[p6l1745t1660r1855b1691],

1	abse	NN	O	abse	_	0	SENT_87	[p6l1091t1699r1152b1725],

1	The	DT	O	the	det	4	SENT_88	[p6l261t1699r311b1725],
2	mutant	JJ	O	mutant	amod	4	SENT_88	[p6l322t1704r420b1725],
3	receptor	NN	O	receptor	nn	4	SENT_88	[p6l429t1704r542b1732],
4	EGFRv	NN	O	egfrv	nsubjpass	10	SENT_88	[p6l552t1701r669b1725],
5	|	CD	NUMBER	|	num	7	SENT_88	[p6l552t1701r669b1725],
6	|	CD	NUMBER	|	num	7	SENT_88	[p6l552t1701r669b1725],
7	|	NN	O	|	dep	4	SENT_88	[p6l552t1701r669b1725],
8	is	VBZ	O	be	auxpass	10	SENT_88	[p6l681t1702r700b1725],
9	persistently	RB	O	persistently	advmod	10	SENT_88	[p6l711t1699r867b1732],
10	activated	VBN	O	activate	_	0	SENT_88	[p6l876t1699r996b1725],
11	in	IN	O	in	_	0	SENT_88	[p6l1008t1702r1029b1724],
12	the	DT	O	the	det	15	SENT_88	[p6l1039t1699r1081b1725],
13	extracellular	JJ	O	extracellular	amod	15	SENT_88	[p6l262t1741r427b1766],
14	ligand-binding	JJ	O	ligand-binding	amod	15	SENT_88	[p6l437t1741r634b1774],
15	domain	NN	O	domain	prep_in	10	SENT_88	[p6l643t1741r754b1766],
16	.	.	O	.	_	0	SENT_88	[p6l643t1741r754b1766],

1	nce	NN	O	nce	nn	2	SENT_89	[p6l1156t1708r1201b1725],
2	ofligand	NN	O	ofligand	_	0	SENT_89	[p6l1210t1699r1334b1733],
3	,	,	O	,	_	0	SENT_89	[p6l1210t1699r1334b1733],
4	owing	VBG	O	owe	partmod	2	SENT_89	[p6l1345t1702r1426b1733],
5	to	TO	O	to	_	0	SENT_89	[p6l1434t1704r1460b1725],
6	an	DT	O	a	det	8	SENT_89	[p6l1470t1708r1500b1725],
7	in-frame	RB	O	in-frame	advmod	8	SENT_89	[p6l1512t1699r1624b1725],
8	deletion	NN	O	deletion	prep_to	4	SENT_89	[p6l1634t1699r1742b1725],
9	within	IN	O	within	advmod	8	SENT_89	[p6l1751t1699r1834b1725],
10	the	DT	O	the	dep	9	SENT_89	[p6l1843t1699r1886b1725],

1	VALIDATION	NNP	O	VALIDATION	nn	2	SENT_90	[p6l8t2019r523b2068],
2	SET	NNP	O	SET	nsubj	4	SENT_90	[p6l569t2019r710b2068],
3	We	PRP	O	we	dep	2	SENT_90	[p6l7t2125r141b2196],
4	obtained	VBD	O	obtain	_	0	SENT_90	[p6l169t2118r544b2196],
5	parafﬁn	JJ	O	parafﬁn	amod	8	SENT_90	[p6l570t2117r1391b2218],
6	—	NN	O	—	nn	8	SENT_90	[p6l570t2117r1391b2218],
7	embedded	JJ	O	embedded	amod	8	SENT_90	[p6l570t2117r1391b2218],
8	slides	NNS	O	slide	dobj	4	SENT_90	[p6l1421t2118r1657b2196],
9	from	IN	O	from	_	0	SENT_90	[p6l1687t2117r1895b2196],
10	biopsy	NN	O	biopsy	nn	11	SENT_90	[p6l1924t2118r2147b2218, p6l12t2272r96b2346],
11	specimens	NNS	O	specimen	prep_from	4	SENT_90	[p6l116t2246r558b2346],
12	of	IN	O	of	_	0	SENT_90	[p6l585t2245r685b2324],
13	malignant	JJ	O	malignant	amod	14	SENT_90	[p6l690t2246r1125b2346],
14	glioma	NN	O	glioma	prep_of	11	SENT_90	[p6l1144t2246r1438b2346],
15	from	IN	O	from	_	0	SENT_90	[p6l1460t2245r1666b2324],
16	33	CD	NUMBER	33	num	17	SENT_90	[p6l1691t2251r1788b2324],
17	patients	NNS	O	patient	prep_from	4	SENT_90	[p6l1813t2246r2146b2346],
18	Who	WP	O	who	nsubj	19	SENT_90	[p6l6t2374r190b2453],
19	received	VBD	O	receive	rcmod	17	SENT_90	[p6l222t2374r566b2452],
20	erlotinib	NN	O	erlotinib	dobj	19	SENT_90	[p6l596t2374r956b2452],
21	at	IN	O	at	_	0	SENT_90	[p6l988t2390r1068b2452],
22	the	DT	O	the	det	29	SENT_90	[p6l1094t2374r1223b2452],
23	University	NNP	ORGANIZATION	University	dep	29	SENT_90	[p6l1253t2374r1685b2474],
24	of	IN	ORGANIZATION	of	_	0	SENT_90	[p6l1711t2373r1812b2452],
25	California	NNP	ORGANIZATION	California	nn	28	SENT_90	[p6l1824t2373r2147b2452, p6l11t2503r162b2598],
26	,	,	O	,	_	0	SENT_90	[p6l1824t2373r2147b2452, p6l11t2503r162b2598],
27	San	NNP	LOCATION	San	appos	28	SENT_90	[p6l206t2508r355b2581],
28	Francisco	NNP	LOCATION	Francisco	prep_of	23	SENT_90	[p6l390t2503r798b2581],
29	(	NN	O	(	prep_at	19	SENT_90	[p6l839t2508r1166b2594],
30	UCSF	NNP	ORGANIZATION	UCSF	tmod	19	SENT_90	[p6l839t2508r1166b2594],
31	)	CD	NUMBER	)	num	30	SENT_90	[p6l839t2508r1166b2594],
32	.	.	O	.	_	0	SENT_90	[p6l839t2508r1166b2594],

1	Frozen	JJ	O	frozen	amod	2	SENT_91	[p6l1205t2509r1500b2581],
2	tissue	NN	O	tissue	nsubj	5	SENT_91	[p6l1536t2503r1778b2582],
3	Was	VBD	O	be	cop	5	SENT_91	[p6l1809t2529r1971b2582],
4	not	RB	O	not	neg	5	SENT_91	[p6l2009t2519r2153b2581],
5	available	JJ	O	available	_	0	SENT_91	[p6l10t2631r376b2710],
6	from	IN	O	from	_	0	SENT_91	[p6l399t2630r607b2709],
7	these	DT	O	these	det	8	SENT_91	[p6l630t2631r850b2709],
8	patients	NNS	O	patient	prep_from	5	SENT_91	[p6l870t2631r1233b2731],
9	.	.	O	.	_	0	SENT_91	[p6l870t2631r1233b2731],

1	Immunohistochemi	NN	O	immunohistochemus	npadvmod	3	SENT_92	[p6l1259t2631r2147b2709],
2	—	CD	NUMBER	—	num	1	SENT_92	[p6l1259t2631r2147b2709],
3	cal	JJ	O	cal	amod	4	SENT_92	[p6l11t2759r127b2837],
4	evaluation	NN	O	evaluation	nsubjpass	10	SENT_92	[p6l167t2759r599b2838],
5	of	IN	O	of	_	0	SENT_92	[p6l640t2758r741b2837],
6	EGFRVIII	NN	O	egfrviius	prep_of	4	SENT_92	[p6l760t2764r1154b2842],
7	and	CC	O	and	_	0	SENT_92	[p6l1192t2759r1348b2837],
8	PTEN	NN	ORGANIZATION	pten	prep_of	4	SENT_92	[p6l1386t2764r1633b2837],
9	was	VBD	O	be	auxpass	10	SENT_92	[p6l1666t2785r1827b2838],
10	scored	VBN	O	score	_	0	SENT_92	[p6l1871t2759r2148b2837],
11	semiquantitatively	RB	O	semiquantitatively	advmod	10	SENT_92	[p6l12t2888r792b2988],
12	by	IN	O	by	_	0	SENT_92	[p6l819t2888r916b2988],
13	two	CD	NUMBER	two	num	15	SENT_92	[p6l943t2904r1095b2967],
14	UCLA	NNP	ORGANIZATION	UCLA	nn	15	SENT_92	[p6l1127t2893r1381b2966],
15	pathologists	NNS	O	pathologist	agent	10	SENT_92	[p6l1408t2888r1934b2988],
16	who	WP	O	who	nsubj	18	SENT_92	[p6l1962t2888r2147b2967],
17	Were	VBD	O	be	cop	18	SENT_92	[p6l6t3042r209b3095],
18	unaware	JJ	O	unaware	rcmod	15	SENT_92	[p6l234t3042r594b3095],
19	of	IN	O	of	_	0	SENT_92	[p6l621t3015r721b3094],
20	the	DT	O	the	det	22	SENT_92	[p6l729t3016r859b3094],
21	clinical	JJ	O	clinical	amod	22	SENT_92	[p6l885t3016r1187b3094],
22	results	NNS	O	result	prep_of	18	SENT_92	[p6l1212t3016r1517b3094],
23	.	.	O	.	_	0	SENT_92	[p6l1212t3016r1517b3094],

1	MOLECULAR	JJ	O	molecular	amod	2	SENT_93	[p6l18t3290r520b3339],
2	STUDIES	NNS	O	study	_	0	SENT_93	[p6l560t3290r912b3339],

1	Sequencing	NN	O	sequencing	dep	2	SENT_94	[p6l12t3399r472b3497],
2	of	IN	O	of	_	0	SENT_94	[p6l498t3394r590b3497],
3	Genomic	JJ	O	genomic	amod	6	SENT_94	[p6l599t3399r960b3472],
4	Tumor	NN	O	tumor	nn	6	SENT_94	[p6l991t3403r1251b3472],
5	DNA	NN	O	dna	nn	6	SENT_94	[p6l1278t3400r1479b3472],
6	Exons	NNS	O	exon	pobj	2	SENT_94	[p6l9t3529r265b3600],
7	and	CC	O	and	_	0	SENT_94	[p6l312t3522r468b3600],
8	ﬂanking	VBG	O	ﬂanking	conj_and	2	SENT_94	[p6l513t3521r872b3622],
9	intronic	JJ	O	intronic	amod	10	SENT_94	[p6l914t3522r1251b3600],
10	sequences	NNS	O	sequence	dobj	8	SENT_94	[p6l1297t3547r1729b3622],
11	for	IN	O	for	_	0	SENT_94	[p6l1776t3521r1900b3600],
12	EGFR	NN	ORGANIZATION	egfr	nn	14	SENT_94	[p6l1940t3529r2153b3602],
13	(	NN	O	(	nn	14	SENT_94	[p6l15t3651r316b3742],
14	kinase	NN	O	kinase	prep_for	10	SENT_94	[p6l15t3651r316b3742],
15	domain	NN	O	domain	dep	14	SENT_94	[p6l359t3651r742b3746],
16	)	CD	NUMBER	)	num	15	SENT_94	[p6l359t3651r742b3746],
17	,	,	O	,	_	0	SENT_94	[p6l359t3651r742b3746],
18	HERZ/neu	NN	O	herz/neu	nn	20	SENT_94	[p6l786t3657r1173b3747],
19	(	NN	O	(	nn	20	SENT_94	[p6l1218t3651r1520b3742],
20	kinase	NN	O	kinase	appos	14	SENT_94	[p6l1218t3651r1520b3742],
21	domain	NN	O	domain	dep	20	SENT_94	[p6l1562t3651r1946b3746],
22	)	CD	NUMBER	)	num	21	SENT_94	[p6l1562t3651r1946b3746],
23	,	,	O	,	_	0	SENT_94	[p6l1562t3651r1946b3746],
24	and	CC	O	and	cc	8	SENT_94	[p6l1991t3651r2148b3729],

1	PT	NN	O	pt	nsubjpass	8	SENT_95	[p7l9t29r122b100],
2	EN	IN	O	en	_	0	SENT_95	[p7l118t30r237b101],
3	(	CD	NUMBER	(	prep_en	8	SENT_95	[p7l278t23r408b114],
4	all	DT	O	all	det	6	SENT_95	[p7l278t23r408b114],
5	exons	NNS	O	exon	nn	6	SENT_95	[p7l449t30r727b114],
6	)	NN	O	)	nsubjpass	8	SENT_95	[p7l449t30r727b114],
7	were	VBD	O	be	auxpass	8	SENT_95	[p7l768t49r973b102],
8	ampliﬁed	VBN	O	ampliﬁed	_	0	SENT_95	[p7l1014t22r1426b123],
9	with	IN	O	with	_	0	SENT_95	[p7l1463t23r1654b102],
10	the	DT	O	the	det	11	SENT_95	[p7l1696t23r1827b101],
11	use	NN	O	use	prep_with	8	SENT_95	[p7l1868t49r2009b101],
12	of	IN	O	of	_	0	SENT_95	[p7l2051t22r2152b101],
13	speciﬁc	NN	O	speciﬁc	nn	14	SENT_95	[p7l13t150r331b251],
14	primers	NNS	O	primer	prep_of	11	SENT_95	[p7l368t151r697b251],
15	in	IN	O	in	_	0	SENT_95	[p7l738t151r820b228],
16	a	DT	O	a	det	20	SENT_95	[p7l858t177r902b229],
17	384	CD	NUMBER	384	num	20	SENT_95	[p7l941t151r1303b230],
18	—	RB	O	—	advmod	19	SENT_95	[p7l941t151r1303b230],
19	well	RB	O	well	amod	20	SENT_95	[p7l941t151r1303b230],
20	format	NN	O	format	prep_in	8	SENT_95	[p7l1342t150r1632b229],
21	involving	VBG	O	involve	_	0	SENT_95	[p7l1666t151r2057b251],
22	a	DT	O	a	det	29	SENT_95	[p7l2092t177r2137b229],
23	nested	JJ	O	nested	amod	29	SENT_95	[p7l12t279r291b356],
24	polymerase	NN	O	polymerase	nn	29	SENT_95	[p7l327t279r821b378],
25	chain	NN	O	chain	nn	29	SENT_95	[p7l860t279r1093b356],
26	reaction	NN	O	reaction	nn	29	SENT_95	[p7l1131t279r1480b356],
27	(	CD	NUMBER	(	num	29	SENT_95	[p7l1522t284r1795b373],
28	PCR	NN	O	pcr	nn	29	SENT_95	[p7l1522t284r1795b373],
29	)	NN	O	)	prep_involving	20	SENT_95	[p7l1522t284r1795b373],
30	,	,	O	,	_	0	SENT_95	[p7l1522t284r1795b373],
31	as	IN	O	as	mark	32	SENT_95	[p7l1837t304r1923b356],
32	performed	VBN	O	perform	dep	29	SENT_95	[p7l1961t304r2133b378, p7l12t406r325b485],
33	by	IN	O	by	_	0	SENT_95	[p7l354t407r452b507],
34	Agencourt	NNP	ORGANIZATION	Agencourt	nn	35	SENT_95	[p7l472t414r929b507],
35	Bioscience	NNP	ORGANIZATION	Bioscience	prep_by	32	SENT_95	[p7l951t407r1436b485],
36	.	.	O	.	_	0	SENT_95	[p7l951t407r1436b485],

1	Details	NNS	O	detail	nsubjpass	3	SENT_96	[p7l1468t407r1768b485],
2	are	VBP	O	be	auxpass	3	SENT_96	[p7l1797t433r1925b485],
3	provided	VBN	O	provide	_	0	SENT_96	[p7l1952t432r2133b507, p7l7t535r234b613],
4	in	IN	O	in	_	0	SENT_96	[p7l258t535r339b611],
5	the	DT	O	the	det	7	SENT_96	[p7l364t535r493b612],
6	Supplementary	NNP	O	Supplementary	nn	7	SENT_96	[p7l521t535r1163b634],
7	Appendix	NNP	O	Appendix	prep_in	3	SENT_96	[p7l1180t535r1612b634],
8	.	.	O	.	_	0	SENT_96	[p7l1180t535r1612b634],

1	Fluorescence	NN	O	fluorescence	nsubjpass	16	SENT_97	[p7l16t790r512b866],
2	in	IN	O	in	_	0	SENT_97	[p7l543t793r611b865],
3	Situ	NNP	O	Situ	nn	8	SENT_97	[p7l644t793r798b866],
4	Hybridization	NNP	O	Hybridization	nn	8	SENT_97	[p7l834t790r1372b889],
5	Dual	JJ	O	dual	amod	8	SENT_97	[p7l10t916r501b1016],
6	—	NN	O	—	nn	8	SENT_97	[p7l10t916r501b1016],
7	probe	NN	O	probe	nn	8	SENT_97	[p7l10t916r501b1016],
8	ﬂuorescence	NN	O	ﬂuorescence	prep_in	1	SENT_97	[p7l570t915r1114b995],
9	in	FW	O	in	prep	1	SENT_97	[p7l1182t916r1264b993],
10	situ	FW	O	situ	pobj	9	SENT_97	[p7l1334t916r1488b994],
11	hybridization	NN	O	hybridization	nn	14	SENT_97	[p7l1557t916r2134b1016],
12	(	CD	NUMBER	(	num	14	SENT_97	[p7l16t1049r291b1135],
13	FISH	NN	O	fish	nn	14	SENT_97	[p7l16t1049r291b1135],
14	)	NN	O	)	dep	10	SENT_97	[p7l16t1049r291b1135],
15	was	VBD	O	be	auxpass	16	SENT_97	[p7l323t1070r483b1123],
16	performed	VBN	O	perform	_	0	SENT_97	[p7l514t1043r963b1144],
17	on	IN	O	on	_	0	SENT_97	[p7l992t1069r1098b1122],
18	parafﬁn	NN	O	parafﬁn	prep_on	16	SENT_97	[p7l1126t1043r1942b1144],
19	—	CD	NUMBER	—	num	21	SENT_97	[p7l1126t1043r1942b1144],
20	embedded	JJ	O	embedded	amod	21	SENT_97	[p7l1126t1043r1942b1144],
21	sections	NNS	O	section	dep	18	SENT_97	[p7l1973t1070r2133b1122, p7l12t1173r219b1250],
22	with	IN	O	with	_	0	SENT_97	[p7l253t1172r442b1251],
23	locus	NN	O	locus	nn	26	SENT_97	[p7l477t1171r1058b1272],
24	—	NN	O	—	nn	26	SENT_97	[p7l477t1171r1058b1272],
25	speciﬁc	NN	O	speciﬁc	nn	26	SENT_97	[p7l477t1171r1058b1272],
26	probes	NNS	O	probe	prep_with	21	SENT_97	[p7l1092t1172r1379b1272],
27	for	IN	O	for	_	0	SENT_97	[p7l1418t1171r1541b1250],
28	EGFR	NN	ORGANIZATION	egfr	prep_for	26	SENT_97	[p7l1571t1179r1783b1252],
29	and	CC	O	and	_	0	SENT_97	[p7l1813t1172r1969b1250],
30	the	DT	O	the	det	31	SENT_97	[p7l2006t1172r2134b1250],
31	centromere	NN	O	centromere	conj_and	18	SENT_97	[p7l12t1316r494b1378],
32	of	IN	O	of	_	0	SENT_97	[p7l520t1299r621b1378],
33	chromosome	NN	O	chromosome	nn	36	SENT_97	[p7l628t1300r1189b1378],
34	7	CD	NUMBER	7	num	36	SENT_97	[p7l1215t1307r1261b1378],
35	(	NN	O	(	nn	36	SENT_97	[p7l1293t1307r1550b1391],
36	CEP7	NN	O	cep7	prep_of	31	SENT_97	[p7l1293t1307r1550b1391],
37	)	CD	NUMBER	)	number	38	SENT_97	[p7l1293t1307r1550b1391],
38	(	CD	NUMBER	(	dep	31	SENT_97	[p7l1586t1301r1884b1400],
39	Vysis	NNP	ORGANIZATION	Vysis	nn	40	SENT_97	[p7l1586t1301r1884b1400],
40	)	NN	O	)	dep	38	SENT_97	[p7l1586t1301r1884b1400],
41	.	.	O	.	_	0	SENT_97	[p7l1586t1301r1884b1400],

1	Standard	NNP	O	Standard	nn	3	SENT_98	[p7l1917t1305r2133b1378, p7l12t1428r205b1506],
2	FISH	NN	O	fish	nn	3	SENT_98	[p7l234t1433r450b1506],
3	protocols	NNS	O	protocol	nsubjpass	12	SENT_98	[p7l480t1428r887b1528],
4	for	IN	O	for	_	0	SENT_98	[p7l921t1427r1046b1506],
5	pretreatment	NN	O	pretreatment	prep_for	3	SENT_98	[p7l1073t1444r1659b1528],
6	,	,	O	,	_	0	SENT_98	[p7l1073t1444r1659b1528],
7	hybridization	NN	O	hybridization	prep_for	3	SENT_98	[p7l1696t1428r2133b1528, p7l12t1556r205b1651],
8	,	,	O	,	_	0	SENT_98	[p7l1696t1428r2133b1528, p7l12t1556r205b1651],
9	and	CC	O	and	_	0	SENT_98	[p7l243t1556r399b1634],
10	analyses	NNS	O	analysis	prep_for	3	SENT_98	[p7l430t1556r779b1656],
11	were	VBD	O	be	auxpass	12	SENT_98	[p7l809t1582r1010b1635],
12	followed	VBN	O	follow	_	0	SENT_98	[p7l1043t1555r1410b1635],
13	according	VBG	O	accord	_	0	SENT_98	[p7l1441t1556r1863b1656],
14	to	TO	O	to	prepc_according_to	12	SENT_98	[p7l1894t1572r1972b1634],
15	the	DT	O	the	det	16	SENT_98	[p7l2006t1556r2135b1634],
16	manufacturer	NN	O	manufacturer	poss	20	SENT_98	[p7l11t1683r653b1763],
17	’s	POS	O	’s	_	0	SENT_98	[p7l11t1683r653b1763],
18	instructions	NNS	O	instruction	nn	20	SENT_98	[p7l680t1684r1298b1763],
19	.2	NN	NUMBER	.2	nn	20	SENT_98	[p7l680t1684r1298b1763],
20	°	NN	O	°	pobj	12	SENT_98	[p7l680t1684r1298b1763],

1	2014	CD	DATE	2014	num	4	SENT_99	[p7l149t1838r226b1859],
2	N	NN	O	n	nn	4	SENT_99	[p7l868t1840r881b1855],
3	ENGL	NN	ORGANIZATION	engl	nn	4	SENT_99	[p7l897t1839r963b1855],
4	MED	NN	O	med	_	0	SENT_99	[p7l996t1840r1048b1855],
5	353	CD	NUMBER	353	dep	4	SENT_99	[p7l1060t1839r1139b1861],
6	;	:	O	;	_	0	SENT_99	[p7l1060t1839r1139b1861],
7	19	CD	NUMBER	19	num	9	SENT_99	[p7l1060t1839r1139b1861],
8	WWW.NEjM.ORG	NN	O	www.nejm.org	nn	9	SENT_99	[p7l1174t1839r1385b1861],
9	NOVEMBER10	NN	O	november10	dep	5	SENT_99	[p7l1424t1839r1691b1861],
10	,2005	CD	NUMBER	,2005	dep	9	SENT_99	[p7l1424t1839r1691b1861],

1	e	LS	O	e	dep	4	SENT_100	[p7l974t1880r987b1896],
2	New	NNP	O	New	nn	4	SENT_100	[p7l996t1873r1058b1896],
3	England	NNP	O	England	nn	4	SENT_100	[p7l1068t1873r1178b1903],
4	Journal	NNP	O	Journal	_	0	SENT_100	[p7l1187t1873r1284b1896],
5	of	IN	O	of	prep	4	SENT_100	[p7l1294t1873r1323b1896],
6	Medicine	NNP	O	Medicine	dep	4	SENT_100	[p7l1330t1873r1455b1896],

1	Downloaded	VBN	O	download	_	0	SENT_101	[p7l378t1913r548b1936],
2	from	IN	O	from	_	0	SENT_101	[p7l557t1913r621b1936],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_101	[p7l630t1913r748b1943],
4	at	IN	O	at	_	0	SENT_101	[p7l758t1917r782b1936],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_101	[p7l790t1913r973b1936],
6	on	IN	O	on	_	0	SENT_101	[p7l983t1920r1014b1936],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_101	[p7l1023t1913r1084b1936],
8	5	CD	DATE	5	num	7	SENT_101	[p7l1136t1913r1159b1940],
9	,	,	DATE	,	_	0	SENT_101	[p7l1136t1913r1159b1940],
10	2014	CD	DATE	2014	num	7	SENT_101	[p7l1169t1913r1242b1936],
11	.	.	O	.	_	0	SENT_101	[p7l1169t1913r1242b1936],

1	For	IN	O	for	_	0	SENT_102	[p7l1252t1913r1299b1936],
2	personal	JJ	O	personal	amod	3	SENT_102	[p7l1307t1913r1419b1943],
3	use	NN	O	use	pobj	1	SENT_102	[p7l1428t1920r1472b1936],
4	only	RB	O	only	advmod	3	SENT_102	[p7l1482t1913r1546b1943],
5	.	.	O	.	_	0	SENT_102	[p7l1482t1913r1546b1943],

1	No	DT	O	no	det	3	SENT_103	[p7l1557t1913r1597b1936],
2	other	JJ	O	other	amod	3	SENT_103	[p7l1607t1913r1675b1936],
3	uses	NNS	O	use	_	0	SENT_103	[p7l1683t1920r1739b1936],
4	without	IN	O	without	_	0	SENT_103	[p7l1749t1913r1850b1936],
5	permission	NN	O	permission	prep_without	3	SENT_103	[p7l1859t1913r2011b1943],
6	.	.	O	.	_	0	SENT_103	[p7l1859t1913r2011b1943],

1	Copyri	NNP	O	Copyri	nn	5	SENT_104	[p7l728t1954r820b1984],
2	©	CD	NUMBER	©	num	5	SENT_104	[p7l872t1954r895b1978],
3	2005	CD	DATE	2005	num	5	SENT_104	[p7l906t1954r970b1978],
4	Massac	NNP	LOCATION	Massac	nn	5	SENT_104	[p7l980t1955r1079b1977],
5	usetts	NNP	O	usetts	_	0	SENT_104	[p7l1097t1958r1172b1977],
6	Medical	NNP	ORGANIZATION	Medical	nn	7	SENT_104	[p7l1181t1954r1290b1977],
7	Society	NNP	ORGANIZATION	Society	dep	5	SENT_104	[p7l1300t1954r1405b1984],
8	.	.	O	.	_	0	SENT_104	[p7l1300t1954r1405b1984],

1	All	DT	O	all	det	2	SENT_105	[p7l1416t1954r1457b1977],
2	rights	NNS	O	rights	nsubj	3	SENT_105	[p7l1466t1954r1541b1984],
3	reserved	VBN	O	reserve	_	0	SENT_105	[p7l1551t1954r1670b1977],
4	.	.	O	.	_	0	SENT_105	[p7l1551t1954r1670b1977],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_106	[p7l526t1997r613b2016],
2	KINASE	NN	O	kinase	_	0	SENT_106	[p7l626t1997r750b2016],
3	IN	IN	O	in	dep	2	SENT_106	[p7l764t1997r803b2015],
4	ITORS	NNP	MISC	ITORS	pobj	3	SENT_106	[p7l875t1997r972b2016],
5	FOR	IN	O	for	dep	2	SENT_106	[p7l987t1997r1053b2016],
6	GLIOBLASTOMAS	NNS	O	glioblastoma	pobj	5	SENT_106	[p7l1065t1997r1342b2015],

1	Table	NNP	O	Table	_	0	SENT_107	[p8l119t32r190b57],
2	1	CD	NUMBER	1	dep	1	SENT_107	[p8l200t34r222b57],
3	.	.	O	.	_	0	SENT_107	[p8l200t34r222b57],

1	Characteristics	NNS	O	characteristic	_	0	SENT_108	[p8l232t32r435b57],
2	of	IN	O	of	_	0	SENT_108	[p8l444t32r475b57],
3	the	DT	O	the	det	4	SENT_108	[p8l478t32r522b57],
4	Patients	NNS	O	patient	prep_of	1	SENT_108	[p8l532t33r666b57],
5	.	.	O	.	_	0	SENT_108	[p8l532t33r666b57],

1	*	NN	O	*	_	0	SENT_109	[p8l532t33r666b57],

1	Change	NNP	O	Change	_	0	SENT_110	[p8l1440t103r1544b136],
2	in	IN	O	in	dep	1	SENT_110	[p8l1554t104r1577b128],

1	Bidirectional	JJ	O	bidirectional	amod	3	SENT_111	[p8l1376t140r1546b166],
2	Tumor	NN	O	tumor	nn	3	SENT_111	[p8l1555t143r1644b166],
3	Volume	NN	O	volume	_	0	SENT_111	[p8l1402t178r1506b203],
4	on	IN	O	on	_	0	SENT_111	[p8l1515t186r1547b203],
5	MRI	NNP	MISC	MRI	prep_on	3	SENT_111	[p8l1560t180r1613b203],

1	Survival	NN	O	survival	nn	2	SENT_112	[p8l1904t103r2011b128],
2	Time	NN	O	time	_	0	SENT_112	[p8l1714t141r1783b166],
3	to	TO	O	to	_	0	SENT_112	[p8l1791t145r1818b166],
4	(	CD	NUMBER	(	prep_to	2	SENT_112	[p8l1884t141r1961b174],
5	Time	NNP	O	Time	dep	2	SENT_112	[p8l1884t141r1961b174],
6	from	IN	O	from	_	0	SENT_112	[p8l1968t140r2032b166],
7	Progression	NNP	O	Progression	nn	9	SENT_112	[p8l1687t179r1846b211],
8	Treatment	NN	O	treatment	nn	9	SENT_112	[p8l1883t180r2031b211],
9	)	NN	O	)	prep_from	5	SENT_112	[p8l1883t180r2031b211],

1	Prior	RB	O	prior	_	0	SENT_113	[p8l714t141r778b166],

1	Sex	NN	O	sex	nn	6	SENT_114	[p8l329t180r377b203],
2	Age	NN	MISC	age	nn	6	SENT_114	[p8l412t180r464b211],
3	Diagnosis	NN	MISC	diagnosis	nn	6	SENT_114	[p8l503t179r637b211],
4	Therapy'i	NN	MISC	therapy'us	nn	6	SENT_114	[p8l679t178r808b211],
5	'	''	O	'	_	0	SENT_114	[p8l679t178r808b211],
6	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_114	[p8l858t178r1118b203],
7	|	VBD	O	|	rcmod	6	SENT_114	[p8l858t178r1118b203],
8	nhibitorand	NN	O	nhibitorand	nn	10	SENT_114	[p8l858t178r1118b203],
9	Dose	NN	O	dose	nn	10	SENT_114	[p8l1131t180r1199b203],
10	EIAED	NN	O	eiaed	dobj	7	SENT_114	[p8l1248t180r1334b203],

1	yr	NN	DURATION	yr	nn	2	SENT_115	[p8l427t253r452b276],
2	mo	NN	DURATION	mo	_	0	SENT_115	[p8l1841t253r1882b269],

1	Response	NN	O	response	_	0	SENT_116	[p8l122t300r253b330],

1	47	CD	NUMBER	47	num	2	SENT_117	[p8l422t354r453b377],
2	Erlotinib	NN	O	erlotinib	_	0	SENT_117	[p8l850t352r970b382],
3	,	,	O	,	_	0	SENT_117	[p8l850t352r970b382],
4	300-500	CD	NUMBER	300-500	dep	12	SENT_117	[p8l982t354r1096b377],
5	mg	NN	O	mg	nn	7	SENT_117	[p8l1107t361r1149b385],
6	60	CD	NUMBER	60	num	7	SENT_117	[p8l423t408r454b431],
7	Erlotinib	NNP	O	Erlotinib	dep	4	SENT_117	[p8l850t406r970b436],
8	,	,	O	,	_	0	SENT_117	[p8l850t406r970b436],
9	150-200	CD	NUMBER	150-200	appos	7	SENT_117	[p8l983t408r1102b431],
10	mg	NN	O	mg	dep	12	SENT_117	[p8l1113t415r1155b439],
11	19	CD	NUMBER	19	num	10	SENT_117	[p8l424t462r453b486],
12	Gefitinib	NNP	O	Gefitinib	dep	24	SENT_117	[p8l848t460r972b490],
13	,	,	O	,	_	0	SENT_117	[p8l848t460r972b490],
14	1500	CD	DATE	1500	appos	12	SENT_117	[p8l985t462r1055b490],
15	,	,	DATE	,	_	0	SENT_117	[p8l985t462r1055b490],
16	1000	CD	DATE	1000	num	17	SENT_117	[p8l1071t462r1134b485],
17	mgi	NNS	O	mgus	appos	12	SENT_117	[p8l1145t463r1205b493],
18	27	CD	NUMBER	27	num	19	SENT_117	[p8l423t517r453b539],
19	Gefitinib	NNP	O	Gefitinib	dep	17	SENT_117	[p8l848t514r972b544],
20	,	,	O	,	_	0	SENT_117	[p8l848t514r972b544],
21	500	CD	NUMBER	500	appos	12	SENT_117	[p8l983t516r1031b540],
22	mg	NN	O	mg	nn	24	SENT_117	[p8l1042t523r1085b548],
23	41	CD	NUMBER	41	num	24	SENT_117	[p8l422t571r452b593],
24	Geﬁtinib	NNP	O	Geﬁtinib	dep	35	SENT_117	[p8l848t568r972b598],
25	,	,	O	,	_	0	SENT_117	[p8l848t568r972b598],
26	500	CD	NUMBER	500	appos	24	SENT_117	[p8l984t570r1041b598],
27	,	,	O	,	_	0	SENT_117	[p8l984t570r1041b598],
28	250	CD	NUMBER	250	num	29	SENT_117	[p8l1055t570r1103b594],
29	mgj	NN	O	mgj	appos	24	SENT_117	[p8l1114t571r1174b602],
30	:	:	O	:	_	0	SENT_117	[p8l1114t571r1174b602],
31	60	CD	NUMBER	60	num	32	SENT_117	[p8l423t624r454b648],
32	Gefitinib	NNP	O	Gefitinib	dep	29	SENT_117	[p8l848t622r972b652],
33	,	,	O	,	_	0	SENT_117	[p8l848t622r972b652],
34	500-750	CD	NUMBER	500-750	appos	24	SENT_117	[p8l984t624r1104b648],
35	mg	NN	O	mg	dep	37	SENT_117	[p8l1115t632r1157b656],
36	65	CD	NUMBER	65	num	35	SENT_117	[p8l423t679r452b702],
37	Erlotinib	NNP	O	Erlotinib	dep	2	SENT_117	[p8l850t677r970b707],
38	,	,	O	,	_	0	SENT_117	[p8l850t677r970b707],
39	150-200	CD	NUMBER	150-200	num	40	SENT_117	[p8l983t679r1102b702],
40	mg	NN	O	mg	dep	2	SENT_117	[p8l1113t686r1155b710],

1	Yes	UH	O	yes	dep	2	SENT_118	[p8l1268t354r1311b377],
2	No	DT	MISC	no	_	0	SENT_118	[p8l1272t408r1311b431],
3	Yes	UH	MISC	yes	dep	2	SENT_118	[p8l1268t463r1311b485],
4	No	DT	MISC	no	det	7	SENT_118	[p8l1272t517r1311b540],
5	No	DT	MISC	no	dep	6	SENT_118	[p8l1272t571r1311b594],
6	No	DT	MISC	no	advmod	7	SENT_118	[p8l1272t625r1311b648],
7	No	DT	MISC	no	dobj	2	SENT_118	[p8l1272t679r1311b702],

1	§	NN	O	§	_	0	SENT_119	[p8l341t354r364b702],
2	‘	CD	NUMBER	‘	num	1	SENT_119	[p8l341t354r364b702],
3	I	PRP	O	I	nsubj	5	SENT_119	[p8l341t354r364b702],
4	'	''	O	'	_	0	SENT_119	[p8l341t354r364b702],
5	I	PRP	O	I	rcmod	1	SENT_119	[p8l341t354r364b702],
6	'	''	O	'	_	0	SENT_119	[p8l341t354r364b702],
7	I	PRP	O	I	dobj	5	SENT_119	[p8l341t354r364b702],
8	'	''	O	'	_	0	SENT_119	[p8l341t354r364b702],
9	I	PRP	O	I	nsubj	10	SENT_119	[p8l341t354r364b702],
10	§	VBP	O	§	rcmod	7	SENT_119	[p8l341t354r364b702],
11	'	''	O	'	_	0	SENT_119	[p8l341t354r364b702],
12	I	PRP	O	I	dobj	10	SENT_119	[p8l341t354r364b702],
13	'	''	O	'	_	0	SENT_119	[p8l341t354r364b702],
14	I	PRP	O	I	nsubj	15	SENT_119	[p8l341t354r364b702],
15	§	VBP	O	§	rcmod	1	SENT_119	[p8l341t354r364b702],
16	§	CD	NUMBER	§	dobj	15	SENT_119	[p8l341t354r364b702],

1	No	DT	O	no	det	2	SENT_120	[p8l122t733r161b756],
2	response	NN	O	response	_	0	SENT_120	[p8l171t739r295b764],

1	50	CD	NUMBER	50	_	0	SENT_121	[p8l423t787r454b810],
2	Gefitinib	NNP	O	Gefitinib	dep	1	SENT_121	[p8l848t785r972b815],
3	,	,	O	,	_	0	SENT_121	[p8l848t785r972b815],
4	150	CD	NUMBER	150	appos	2	SENT_121	[p8l985t787r1031b810],
5	mg	NN	O	mg	nn	7	SENT_121	[p8l1042t794r1084b818],
6	39	CD	NUMBER	39	num	7	SENT_121	[p8l423t842r453b865],
7	Erlotinib	NNP	O	Erlotinib	rcmod	4	SENT_121	[p8l850t839r970b869],
8	,	,	O	,	_	0	SENT_121	[p8l850t839r970b869],
9	150-200	CD	NUMBER	150-200	appos	7	SENT_121	[p8l983t841r1102b865],
10	mg	NN	O	mg	nn	12	SENT_121	[p8l1113t848r1155b873],
11	64	CD	NUMBER	64	num	12	SENT_121	[p8l423t896r453b919],
12	Erlotinib	NNP	O	Erlotinib	dep	9	SENT_121	[p8l850t894r970b923],
13	,	,	O	,	_	0	SENT_121	[p8l850t894r970b923],
14	300-450	CD	NUMBER	300-450	appos	7	SENT_121	[p8l982t895r1102b919],
15	mg	NN	O	mg	nn	17	SENT_121	[p8l1113t902r1155b927],
16	56	CD	NUMBER	56	num	17	SENT_121	[p8l423t950r453b973],
17	Gefitinib	NNP	O	Gefitinib	dep	14	SENT_121	[p8l848t947r972b977],
18	,	,	O	,	_	0	SENT_121	[p8l848t947r972b977],
19	500-750	CD	NUMBER	500-750	appos	7	SENT_121	[p8l984t949r1104b973],
20	mg	NN	O	mg	nn	22	SENT_121	[p8l1115t957r1157b981],
21	38	CD	NUMBER	38	num	22	SENT_121	[p8l423t1004r453b1027],
22	Geﬁtinib	NNP	O	Geﬁtinib	dep	19	SENT_121	[p8l848t1002r972b1032],
23	,	,	O	,	_	0	SENT_121	[p8l848t1002r972b1032],
24	500	CD	NUMBER	500	appos	7	SENT_121	[p8l984t1004r1031b1027],
25	mg	NN	O	mg	nn	27	SENT_121	[p8l1042t1011r1084b1035],
26	46	CD	NUMBER	46	num	27	SENT_121	[p8l422t1058r453b1081],
27	Erlotinib	NNP	O	Erlotinib	dep	24	SENT_121	[p8l850t1056r970b1086],
28	,	,	O	,	_	0	SENT_121	[p8l850t1056r970b1086],
29	300-350	CD	NUMBER	300-350	num	30	SENT_121	[p8l982t1058r1102b1081],
30	mg	NN	O	mg	appos	7	SENT_121	[p8l1113t1065r1155b1089],
31	40	CD	NUMBER	40	num	32	SENT_121	[p8l422t1112r454b1135],
32	Erlotinib	NN	O	erlotinib	dep	30	SENT_121	[p8l850t1110r1029b1140],
33	,150	CD	NUMBER	,150	dep	30	SENT_121	[p8l850t1110r1029b1140],
34	mg	NN	O	mg	nn	36	SENT_121	[p8l1040t1119r1082b1143],
35	60	CD	NUMBER	60	num	36	SENT_121	[p8l423t1166r454b1190],
36	Gefitinib	NNP	O	Gefitinib	dep	33	SENT_121	[p8l848t1164r972b1194],
37	,	,	O	,	_	0	SENT_121	[p8l848t1164r972b1194],
38	500-1000	CD	NUMBER	500-1000	num	39	SENT_121	[p8l983t1166r1120b1190],
39	mg	NN	O	mg	appos	7	SENT_121	[p8l1131t1173r1173b1198],
40	58	CD	NUMBER	58	num	43	SENT_121	[p8l423t1220r453b1244],
41	Er	NN	O	er	nn	43	SENT_121	[p8l850t1219r1029b1248],
42	|	NN	O	|	nn	43	SENT_121	[p8l850t1219r1029b1248],
43	otinib	NN	O	otinib	dep	39	SENT_121	[p8l850t1219r1029b1248],
44	,150	CD	NUMBER	,150	dep	39	SENT_121	[p8l850t1219r1029b1248],
45	mg	NN	O	mg	nn	47	SENT_121	[p8l1040t1227r1082b1252],
46	57	CD	NUMBER	57	num	47	SENT_121	[p8l423t1275r453b1298],
47	Gefitinib	NNP	O	Gefitinib	dep	44	SENT_121	[p8l848t1272r972b1302],
48	,	,	O	,	_	0	SENT_121	[p8l848t1272r972b1302],
49	500	CD	NUMBER	500	appos	7	SENT_121	[p8l984t1274r1031b1298],
50	mg	NN	O	mg	nn	52	SENT_121	[p8l1042t1282r1084b1306],
51	42	CD	NUMBER	42	num	52	SENT_121	[p8l422t1329r453b1352],
52	Gefitinib	NNP	O	Gefitinib	dep	49	SENT_121	[p8l848t1327r972b1357],
53	,	,	O	,	_	0	SENT_121	[p8l848t1327r972b1357],
54	500	CD	NUMBER	500	num	55	SENT_121	[p8l984t1329r1031b1352],
55	mg	NN	O	mg	appos	7	SENT_121	[p8l1042t1336r1084b1360],
56	55	CD	NUMBER	55	num	57	SENT_121	[p8l423t1383r452b1406],
57	Gefitinib	NNP	O	Gefitinib	dep	55	SENT_121	[p8l848t1381r1031b1411],
58	,150	CD	NUMBER	,150	num	57	SENT_121	[p8l848t1381r1031b1411],
59	mg	NN	O	mg	nn	61	SENT_121	[p8l1042t1390r1084b1414],
60	52	CD	NUMBER	52	num	61	SENT_121	[p8l423t1438r453b1460],
61	Gefitinib	NNP	O	Gefitinib	dep	55	SENT_121	[p8l848t1435r972b1465],
62	,	,	O	,	_	0	SENT_121	[p8l848t1435r972b1465],
63	150-200	CD	NUMBER	150-200	num	64	SENT_121	[p8l985t1437r1104b1460],
64	mg	NN	O	mg	appos	7	SENT_121	[p8l1115t1444r1157b1468],
65	39	CD	NUMBER	39	num	66	SENT_121	[p8l423t1492r453b1515],
66	Gefitinib	NNP	O	Gefitinib	dep	64	SENT_121	[p8l848t1489r1031b1519],
67	,150	CD	NUMBER	,150	num	66	SENT_121	[p8l848t1489r1031b1519],
68	mg	NN	O	mg	nn	70	SENT_121	[p8l1042t1498r1085b1523],
69	31	CD	NUMBER	31	num	70	SENT_121	[p8l423t1546r452b1569],
70	Geﬁtinib	NNP	O	Geﬁtinib	dep	64	SENT_121	[p8l848t1543r972b1573],
71	,	,	O	,	_	0	SENT_121	[p8l848t1543r972b1573],
72	500	CD	NUMBER	500	appos	7	SENT_121	[p8l983t1545r1031b1569],
73	mg	NN	O	mg	nn	75	SENT_121	[p8l1042t1552r1084b1577],
74	32	CD	NUMBER	32	num	75	SENT_121	[p8l423t1600r453b1623],
75	Gefitinib	NNP	O	Gefitinib	dep	72	SENT_121	[p8l848t1597r972b1627],
76	,	,	O	,	_	0	SENT_121	[p8l848t1597r972b1627],
77	500	CD	NUMBER	500	appos	7	SENT_121	[p8l984t1599r1031b1623],
78	mg	NN	O	mg	nn	80	SENT_121	[p8l1042t1607r1084b1631],
79	41	CD	NUMBER	41	num	80	SENT_121	[p8l422t1654r452b1677],
80	Geﬁtinib	NNP	O	Geﬁtinib	dep	77	SENT_121	[p8l848t1652r972b1682],
81	,	,	O	,	_	0	SENT_121	[p8l848t1652r972b1682],
82	500	CD	NUMBER	500	appos	7	SENT_121	[p8l984t1654r1031b1677],
83	mg	NN	O	mg	nn	85	SENT_121	[p8l1042t1661r1084b1685],
84	58	CD	NUMBER	58	num	85	SENT_121	[p8l423t1708r453b1732],
85	Erlotinib	NNP	O	Erlotinib	dep	82	SENT_121	[p8l850t1706r970b1736],
86	,	,	O	,	_	0	SENT_121	[p8l850t1706r970b1736],
87	150-200	CD	NUMBER	150-200	appos	7	SENT_121	[p8l983t1708r1102b1731],
88	mg	NN	O	mg	nn	90	SENT_121	[p8l1113t1715r1155b1739],
89	26	CD	NUMBER	26	num	90	SENT_121	[p8l423t1762r453b1785],
90	Gefitinib	NNP	O	Gefitinib	dep	87	SENT_121	[p8l848t1760r972b1790],
91	,	,	O	,	_	0	SENT_121	[p8l848t1760r972b1790],
92	500	CD	NUMBER	500	num	93	SENT_121	[p8l984t1762r1031b1785],
93	mg	NN	O	mg	dep	1	SENT_121	[p8l1042t1769r1084b1793],

1	No	DT	O	no	_	0	SENT_122	[p8l1272t788r1311b810],
2	No	DT	O	no	dep	1	SENT_122	[p8l1272t842r1311b865],

1	No	DT	O	no	_	0	SENT_123	[p8l1272t950r1311b973],
2	No	DT	O	no	dep	1	SENT_123	[p8l1272t1004r1311b1027],

1	No	DT	MISC	no	dep	2	SENT_124	[p8l1272t1113r1311b1135],
2	No	DT	MISC	no	_	0	SENT_124	[p8l1272t1167r1311b1190],
3	No	DT	MISC	no	dep	4	SENT_124	[p8l1272t1221r1311b1244],
4	No	DT	MISC	no	dep	2	SENT_124	[p8l1272t1275r1311b1298],
5	No	DT	MISC	no	dep	6	SENT_124	[p8l1272t1329r1311b1352],
6	No	DT	MISC	no	advmod	7	SENT_124	[p8l1272t1383r1311b1406],
7	No	DT	MISC	no	amod	4	SENT_124	[p8l1272t1438r1311b1460],

1	No	DT	O	no	dep	2	SENT_125	[p8l1272t1546r1311b1569],
2	No	DT	O	no	_	0	SENT_125	[p8l1272t1600r1311b1623],
3	No	DT	O	no	dep	4	SENT_125	[p8l1272t1654r1311b1677],
4	No	DT	O	no	dep	2	SENT_125	[p8l1272t1708r1311b1731],
5	No	DT	O	no	det	6	SENT_125	[p8l1272t1763r1311b1785],
6	2311	CD	DATE	2311	rcmod	4	SENT_125	[p8l183t1595r225b1631],
7	24	CD	NUMBER	24	dep	6	SENT_125	[p8l183t1650r225b1686],
8	:	:	O	:	_	0	SENT_125	[p8l183t1650r225b1686],
9	:	:	O	:	_	0	SENT_125	[p8l183t1650r225b1686],
10	25	CD	NUMBER	25	num	11	SENT_125	[p8l183t1708r212b1731],
11	zen	NN	O	zen	dep	4	SENT_125	[p8l183t1758r225b1794],

1	M	NN	O	m	nn	3	SENT_126	[p8l341t788r364b810],
2	F	NN	O	f	nn	3	SENT_126	[p8l347t842r360b864],
3	M	NN	O	m	_	0	SENT_126	[p8l341t896r364b918],
4	F	NN	O	f	nn	6	SENT_126	[p8l347t950r360b973],
5	M	NN	O	m	nn	6	SENT_126	[p8l341t1004r364b1027],
6	M	NN	O	m	dep	3	SENT_126	[p8l341t1058r364b1081],
7	M	NN	O	m	nn	19	SENT_126	[p8l341t1113r364b1135],
8	M	NN	O	m	nn	19	SENT_126	[p8l341t1167r364b1189],
9	M	NN	O	m	nn	19	SENT_126	[p8l341t1221r364b1243],
10	M	NN	O	m	nn	19	SENT_126	[p8l341t1275r364b1298],
11	F	NN	O	f	nn	19	SENT_126	[p8l347t1329r360b1352],
12	M	NN	O	m	nn	19	SENT_126	[p8l341t1383r364b1406],
13	F	NN	O	f	nn	19	SENT_126	[p8l347t1438r360b1460],
14	M	NN	O	m	nn	19	SENT_126	[p8l341t1492r364b1514],
15	F	NN	O	f	nn	19	SENT_126	[p8l347t1546r360b1568],
16	F	NN	O	f	nn	19	SENT_126	[p8l347t1600r360b1623],
17	F	NN	O	f	nn	19	SENT_126	[p8l347t1654r360b1677],
18	F	NN	O	f	nn	19	SENT_126	[p8l347t1708r360b1731],
19	M	NN	O	m	dep	3	SENT_126	[p8l341t1763r364b1785],

1	*	NN	O	*	nn	2	SENT_127	[p8l93t1854r108b1869],
2	EIAED	NN	O	eiaed	nsubj	3	SENT_127	[p8l120t1854r205b1877],
3	denotes	VBZ	O	denote	_	0	SENT_127	[p8l215t1852r323b1877],
4	enzyme-inducing	JJ	O	enzyme-inducing	amod	6	SENT_127	[p8l334t1852r568b1885],
5	antiepileptic	JJ	O	antiepileptic	amod	6	SENT_127	[p8l578t1852r746b1885],
6	drugs	NNS	O	drug	dobj	3	SENT_127	[p8l755t1852r839b1885],
7	,	,	O	,	_	0	SENT_127	[p8l755t1852r839b1885],
8	GBM	NNP	O	GBM	nn	9	SENT_127	[p8l850t1854r918b1877],
9	glioblastoma	NN	O	glioblastoma	dobj	3	SENT_127	[p8l931t1852r1115b1885],
10	,	,	O	,	_	0	SENT_127	[p8l931t1852r1115b1885],
11	AO	JJ	O	ao	amod	13	SENT_127	[p8l1125t1854r1169b1877],
12	anaplastic	JJ	O	anaplastic	amod	13	SENT_127	[p8l1180t1852r1318b1885],
13	oligodendroglioma	NN	O	oligodendroglioma	dobj	3	SENT_127	[p8l1327t1852r1594b1885],
14	,	,	O	,	_	0	SENT_127	[p8l1327t1852r1594b1885],
15	and	CC	O	and	_	0	SENT_127	[p8l1606t1852r1654b1877],
16	NA	NNP	O	NA	conj_and	6	SENT_127	[p8l1668t1854r1709b1877],
17	not	RB	O	not	neg	18	SENT_127	[p8l1720t1857r1763b1877],
18	applicable	JJ	O	applicable	amod	16	SENT_127	[p8l1773t1852r1917b1885],
19	.	.	O	.	_	0	SENT_127	[p8l1773t1852r1917b1885],

1	1	CD	NUMBER	1	num	2	SENT_128	[p8l94t1891r109b1922],
2	‘	CD	NUMBER	‘	nsubj	8	SENT_128	[p8l94t1891r109b1922],
3	All	DT	O	all	det	4	SENT_128	[p8l117t1889r150b1914],
4	patients	NNS	O	patient	dep	2	SENT_128	[p8l162t1891r269b1922],
5	underwent	VBD	O	undergo	_	0	SENT_128	[p8l280t1889r425b1914],
6	surgery	NN	O	surgery	dobj	5	SENT_128	[p8l433t1898r533b1922],
7	and	CC	O	and	_	0	SENT_128	[p8l541t1889r589b1914],
8	received	VBD	O	receive	conj_and	5	SENT_128	[p8l601t1889r710b1914],
9	radiation	NN	O	radiation	dobj	8	SENT_128	[p8l722t1889r840b1914],
10	as	IN	O	as	_	0	SENT_128	[p8l851t1898r878b1914],
11	ﬁrst-line	JJ	O	ﬁrst-line	amod	12	SENT_128	[p8l888t1889r999b1914],
12	therapy	NN	O	therapy	prep_as	8	SENT_128	[p8l1007t1889r1113b1922],
13	.	.	O	.	_	0	SENT_128	[p8l1007t1889r1113b1922],

1	Additional	JJ	O	additional	amod	2	SENT_129	[p8l1122t1889r1262b1914],
2	treatments	NNS	O	treatment	nsubj	10	SENT_129	[p8l1271t1894r1420b1914],
3	before	IN	O	before	_	0	SENT_129	[p8l1431t1889r1514b1914],
4	therapy	NN	O	therapy	prep_before	2	SENT_129	[p8l1522t1889r1624b1922],
5	with	IN	O	with	_	0	SENT_129	[p8l1631t1889r1687b1914],
6	an	DT	O	a	det	9	SENT_129	[p8l1698t1898r1728b1914],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_129	[p8l1741t1891r1815b1914],
8	kinase	NN	O	kinase	nn	9	SENT_129	[p8l1825t1889r1909b1914],
9	inhibitor	NN	O	inhibitor	prep_with	4	SENT_129	[p8l1919t1889r2034b1914],
10	included	VBD	O	include	_	0	SENT_129	[p8l119t1926r233b1951],
11	farnesyl	JJ	O	farnesyl	amod	13	SENT_129	[p8l244t1926r348b1959],
12	transferase	NN	O	transferase	nn	13	SENT_129	[p8l358t1926r510b1951],
13	inhibitor	NN	O	inhibitor	dep	19	SENT_129	[p8l521t1926r637b1951],
14	(	NN	O	(	nn	15	SENT_129	[p8l648t1926r781b1959],
15	tipifarnib	NN	O	tipifarnib	dep	13	SENT_129	[p8l648t1926r781b1959],
16	[	CD	NUMBER	[	num	17	SENT_129	[p8l792t1928r845b1959],
17	F	NN	O	f	dep	19	SENT_129	[p8l792t1928r845b1959],
18	]	CD	NUMBER	]	num	19	SENT_129	[p8l792t1928r845b1959],
19	)	NN	O	)	dep	45	SENT_129	[p8l792t1928r845b1959],
20	,	,	O	,	_	0	SENT_129	[p8l792t1928r845b1959],
21	temozolomide	NN	O	temozolomide	nn	24	SENT_129	[p8l855t1926r1055b1951],
22	(	CD	NUMBER	(	num	24	SENT_129	[p8l1067t1928r1111b1959],
23	T	NN	O	t	nn	24	SENT_129	[p8l1067t1928r1111b1959],
24	)	NN	O	)	appos	19	SENT_129	[p8l1067t1928r1111b1959],
25	,	,	O	,	_	0	SENT_129	[p8l1067t1928r1111b1959],
26	cis-retinoic	JJ	O	cis-retinoic	amod	30	SENT_129	[p8l1123t1927r1268b1951],
27	acid	NN	O	acid	nn	30	SENT_129	[p8l1277t1926r1330b1951],
28	(	NN	O	(	nn	30	SENT_129	[p8l1345t1928r1391b1959],
29	A	NN	O	a	nn	30	SENT_129	[p8l1345t1928r1391b1959],
30	)	NN	O	)	appos	19	SENT_129	[p8l1345t1928r1391b1959],
31	,	,	O	,	_	0	SENT_129	[p8l1345t1928r1391b1959],
32	procarbazine	NN	O	procarbazine	appos	19	SENT_129	[p8l1403t1926r1587b1959],
33	,	,	O	,	_	0	SENT_129	[p8l1403t1926r1587b1959],
34	lomustine	NN	O	lomustine	appos	19	SENT_129	[p8l1599t1926r1742b1956],
35	,	,	O	,	_	0	SENT_129	[p8l1599t1926r1742b1956],
36	and	CC	O	and	_	0	SENT_129	[p8l1754t1926r1802b1951],
37	vincristine	NN	O	vincristine	nn	40	SENT_129	[p8l1812t1928r1954b1951],
38	(	CD	NUMBER	(	num	40	SENT_129	[p8l1967t1928r2011b1959],
39	P	NN	O	p	nn	40	SENT_129	[p8l1967t1928r2011b1959],
40	)	NN	O	)	conj_and	34	SENT_129	[p8l1967t1928r2011b1959],
41	,	,	O	,	_	0	SENT_129	[p8l1967t1928r2011b1959],
42	irinotecan	JJ	O	irinotecan	amod	43	SENT_129	[p8l119t1965r253b1988],
43	(	NN	O	(	appos	19	SENT_129	[p8l267t1965r304b1996],
44	I	PRP	O	I	nsubj	45	SENT_129	[p8l267t1965r304b1996],
45	)	VBP	O	)	dep	10	SENT_129	[p8l267t1965r304b1996],
46	,	,	O	,	_	0	SENT_129	[p8l267t1965r304b1996],
47	and	CC	O	and	_	0	SENT_129	[p8l315t1963r363b1988],
48	carmustine	NN	O	carmustine	nn	51	SENT_129	[p8l375t1965r528b1988],
49	(	NN	O	(	nn	51	SENT_129	[p8l541t1965r587b1996],
50	C	NN	O	c	nn	51	SENT_129	[p8l541t1965r587b1996],
51	)	NN	O	)	dep	10	SENT_129	[p8l541t1965r587b1996],
52	.	.	O	.	_	0	SENT_129	[p8l541t1965r587b1996],

1	It	PRP	O	it	nsubjpass	4	SENT_130	[p8l94t2002r109b2033],
2	Dose	NN	O	dose	nsubjpass	4	SENT_130	[p8l120t2002r188b2025],
3	was	VBD	O	be	auxpass	4	SENT_130	[p8l197t2009r248b2025],
4	reduced	VBN	O	reduce	_	0	SENT_130	[p8l260t2000r375b2025],
5	.	.	O	.	_	0	SENT_130	[p8l260t2000r375b2025],

1	§	NN	O	§	nsubjpass	5	SENT_131	[p8l93t2037r104b2070],
2	This	DT	O	this	det	3	SENT_131	[p8l117t2037r174b2062],
3	patient	NN	O	patient	dep	1	SENT_131	[p8l186t2039r280b2070],
4	was	VBD	O	be	auxpass	5	SENT_131	[p8l288t2046r339b2062],
5	excluded	VBN	O	exclude	_	0	SENT_131	[p8l350t2037r468b2062],
6	from	IN	O	from	_	0	SENT_131	[p8l479t2037r542b2062],
7	the	DT	O	the	det	10	SENT_131	[p8l553t2037r595b2062],
8	analysis	NN	O	analysis	nn	10	SENT_131	[p8l606t2037r712b2070],
9	ofthe	NN	O	ofthe	nn	10	SENT_131	[p8l722t2037r799b2062],
10	time	NN	O	time	prep_from	5	SENT_131	[p8l808t2039r869b2062],
11	to	TO	O	to	_	0	SENT_131	[p8l878t2042r905b2062],
12	progression	NN	O	progression	prep_to	5	SENT_131	[p8l916t2039r1076b2070],
13	and	CC	O	and	_	0	SENT_131	[p8l1088t2037r1136b2062],
14	survival	NN	O	survival	conj_and	12	SENT_131	[p8l1148t2037r1258b2062],
15	.	.	O	.	_	0	SENT_131	[p8l1148t2037r1258b2062],

1	1	CD	NUMBER	1	number	2	SENT_132	[p8l94t2074r174b2106],
2	]	CD	NUMBER	]	num	4	SENT_132	[p8l94t2074r174b2106],
3	This	DT	O	this	det	4	SENT_132	[p8l94t2074r174b2106],
4	patient	NN	O	patient	nsubj	5	SENT_132	[p8l186t2076r280b2107],
5	died	VBD	O	die	_	0	SENT_132	[p8l289t2074r345b2099],
6	ofan	JJ	O	ofan	amod	7	SENT_132	[p8l357t2074r422b2099],
7	unrelated	JJ	O	unrelated	amod	9	SENT_132	[p8l435t2074r561b2099],
8	cardiac	JJ	O	cardiac	amod	9	SENT_132	[p8l572t2074r669b2099],
9	arrhythmia	NN	O	arrhythmium	dobj	5	SENT_132	[p8l679t2074r834b2107],
10	.	.	O	.	_	0	SENT_132	[p8l679t2074r834b2107],

1	Minimal	JJ	O	minimal	amod	3	SENT_133	[p8l847t2074r957b2099],
2	residual	JJ	O	residual	amod	3	SENT_133	[p8l970t2074r1075b2099],
3	tumor	NN	O	tumor	nsubjpass	5	SENT_133	[p8l1085t2079r1171b2099],
4	was	VBD	O	be	auxpass	5	SENT_133	[p8l1179t2083r1230b2099],
5	Found	VBN	O	find	_	0	SENT_133	[p8l1240t2074r1318b2099],
6	at	IN	O	at	_	0	SENT_133	[p8l1330t2079r1354b2099],
7	autopsy	NN	O	autopsy	prep_at	5	SENT_133	[p8l1364t2079r1474b2107],
8	.	.	O	.	_	0	SENT_133	[p8l1364t2079r1474b2107],

1	H	NN	O	h	nn	2	SENT_134	[p8l97t2109r102b2145],
2	Glioblastoma	NN	O	glioblastoma	nsubj	3	SENT_134	[p8l118t2111r301b2137],
3	developed	VBD	O	develop	_	0	SENT_134	[p8l312t2111r450b2144],
4	in	IN	O	in	_	0	SENT_134	[p8l462t2113r484b2136],
5	this	DT	O	this	det	6	SENT_134	[p8l495t2111r544b2137],
6	patient	NN	O	patient	prep_in	3	SENT_134	[p8l556t2113r649b2144],
7	from	IN	O	from	_	0	SENT_134	[p8l658t2111r722b2137],
8	lower-grade	JJ	O	lower-grade	amod	9	SENT_134	[p8l735t2111r893b2145],
9	glioma	NN	O	glioma	prep_from	3	SENT_134	[p8l903t2111r1003b2145],
10	.	.	O	.	_	0	SENT_134	[p8l903t2111r1003b2145],

1	Therapy	NN	O	therapy	nsubjpass	8	SENT_135	[p8l1013t2111r1123b2144],
2	with	IN	O	with	_	0	SENT_135	[p8l1131t2111r1187b2137],
3	an	DT	O	a	det	6	SENT_135	[p8l1199t2120r1229b2136],
4	EGFR	NN	ORGANIZATION	egfr	nn	6	SENT_135	[p8l1242t2113r1316b2137],
5	kinase	NN	O	kinase	nn	6	SENT_135	[p8l1328t2111r1412b2137],
6	inhibitor	NN	O	inhibitor	prep_with	1	SENT_135	[p8l1423t2111r1539b2137],
7	was	VBD	O	be	auxpass	8	SENT_135	[p8l1547t2120r1597b2137],
8	given	VBN	O	give	_	0	SENT_135	[p8l1609t2113r1678b2145],
9	afterthe	JJ	O	afterthe	amod	10	SENT_135	[p8l1690t2111r1802b2137],
10	tumor	NN	O	tumor	nsubj	12	SENT_135	[p8l1811t2116r1896b2137],
11	had	VBD	O	have	aux	12	SENT_135	[p8l1906t2111r1953b2137],
12	progressed	VBN	O	progress	ccomp	8	SENT_135	[p8l1966t2120r2018b2144, p8l118t2148r222b2181],
13	to	TO	O	to	_	0	SENT_135	[p8l232t2153r259b2173],
14	glioblastoma	NN	O	glioblastoma	prep_to	12	SENT_135	[p8l269t2148r453b2181],
15	.	.	O	.	_	0	SENT_135	[p8l269t2148r453b2181],

1	All	DT	O	all	det	3	SENT_136	[p8l464t2148r497b2173],
2	other	JJ	O	other	amod	3	SENT_136	[p8l508t2148r580b2173],
3	patients	NNS	O	patient	nsubj	6	SENT_136	[p8l590t2150r697b2181],
4	with	IN	O	with	_	0	SENT_136	[p8l707t2148r763b2173],
5	glioblastoma	NN	O	glioblastoma	prep_with	3	SENT_136	[p8l775t2148r951b2181],
6	had	VBD	O	have	_	0	SENT_136	[p8l963t2148r1010b2173],
7	primary	JJ	O	primary	amod	8	SENT_136	[p8l1022t2150r1126b2181],
8	glioblastoma	NN	O	glioblastoma	dobj	6	SENT_136	[p8l1135t2148r1320b2181],
9	.	.	O	.	_	0	SENT_136	[p8l1135t2148r1320b2181],

1	Reverse	JJ	MISC	reverse	amod	2	SENT_137	[p8l95t2252r206b2279],
2	Trariscriptase	NN	MISC	trariscriptase	_	0	SENT_137	[p8l220t2251r507b2288],
3	.	.	O	.	_	0	SENT_137	[p8l220t2251r507b2288],

1	—	NN	O	—	_	0	SENT_138	[p8l220t2251r507b2288],
2	.	.	O	.	_	0	SENT_138	[p8l220t2251r507b2288],

1	PCR	NN	O	pcr	_	0	SENT_139	[p8l220t2251r507b2288],
2	For	IN	O	for	dep	1	SENT_139	[p8l93t2297r149b2325],
3	the	DT	O	the	det	4	SENT_139	[p8l157t2294r207b2325],
4	reverse	NN	O	reverse	pobj	2	SENT_139	[p8l216t2295r654b2333],
5	.	.	O	.	_	0	SENT_139	[p8l216t2295r654b2333],

1	—	NN	O	—	_	0	SENT_140	[p8l216t2295r654b2333],
2	.	.	O	.	_	0	SENT_140	[p8l216t2295r654b2333],

1	transcriptase	NN	O	transcriptase	_	0	SENT_141	[p8l216t2295r654b2333],
2	.	.	O	.	_	0	SENT_141	[p8l216t2295r654b2333],

1	—	NN	O	—	_	0	SENT_142	[p8l216t2295r654b2333],
2	.	.	O	.	_	0	SENT_142	[p8l216t2295r654b2333],

1	PCR	NN	O	pcr	_	0	SENT_143	[p8l216t2295r654b2333],
2	(	CD	NUMBER	(	num	3	SENT_143	[p8l660t2296r813b2329],
3	RT	NN	O	rt	dep	1	SENT_143	[p8l660t2296r813b2329],
4	.	.	O	.	_	0	SENT_143	[p8l660t2296r813b2329],

1	—	NN	O	—	_	0	SENT_144	[p8l660t2296r813b2329],
2	.	.	O	.	_	0	SENT_144	[p8l660t2296r813b2329],

1	PCR	NN	O	pcr	nn	3	SENT_145	[p8l660t2296r813b2329],
2	)	NN	O	)	nn	3	SENT_145	[p8l660t2296r813b2329],
3	assay	NN	O	assay	nsubj	16	SENT_145	[p8l823t2304r915b2333],
4	,	,	O	,	_	0	SENT_145	[p8l823t2304r915b2333],
5	high	JJ	O	high	amod	7	SENT_145	[p8l93t2338r292b2377],
6	—	JJ	O	—	amod	7	SENT_145	[p8l93t2338r292b2377],
7	quality	NN	O	quality	amod	9	SENT_145	[p8l93t2338r292b2377],
8	total	JJ	O	total	amod	9	SENT_145	[p8l298t2338r371b2369],
9	RNAwas	NN	O	rnawa	appos	3	SENT_145	[p8l378t2341r525b2371],
10	extracted	VBN	O	extract	partmod	9	SENT_145	[p8l534t2338r680b2369],
11	from	IN	O	from	_	0	SENT_145	[p8l687t2338r767b2369],
12	13	CD	NUMBER	13	num	15	SENT_145	[p8l776t2340r813b2369],
13	freshfrozen	NN	O	freshfrozen	nn	15	SENT_145	[p8l822t2338r917b2369, p8l93t2382r199b2413],
14	tumor	NN	O	tumor	nn	15	SENT_145	[p8l212t2389r314b2413],
15	samples	NNS	O	sample	prep_from	10	SENT_145	[p8l327t2382r460b2421],
16	(	VBP	O	(	_	0	SENT_145	[p8l476t2385r507b2417],
17	4	CD	NUMBER	4	dobj	16	SENT_145	[p8l476t2385r507b2417],
18	from	IN	O	from	_	0	SENT_145	[p8l520t2382r601b2413],
19	patients	NNS	O	patient	prep_from	16	SENT_145	[p8l613t2383r743b2421],
20	with	IN	O	with	_	0	SENT_145	[p8l756t2382r830b2413],
21	a	DT	O	a	det	22	SENT_145	[p8l843t2392r860b2413],
22	response	NN	O	response	prep_with	19	SENT_145	[p8l873t2392r916b2413, p8l94t2437r208b2466],
23	and	CC	O	and	_	0	SENT_145	[p8l223t2427r283b2458],
24	9	CD	NUMBER	9	conj_and	19	SENT_145	[p8l298t2429r317b2458],
25	from	IN	O	from	_	0	SENT_145	[p8l332t2426r412b2458],
26	patients	NNS	O	patient	prep_from	24	SENT_145	[p8l427t2427r557b2466],
27	without	IN	O	without	_	0	SENT_145	[p8l571t2427r701b2458],
28	a	DT	O	a	det	30	SENT_145	[p8l713t2437r731b2457],
29	response	NN	O	response	nn	30	SENT_145	[p8l745t2429r915b2466],
30	)	NN	O	)	prep_without	16	SENT_145	[p8l745t2429r915b2466],
31	.	.	O	.	_	0	SENT_145	[p8l745t2429r915b2466],

1	Complementary	JJ	O	complementary	amod	3	SENT_146	[p8l93t2471r365b2510],
2	DNA	NN	O	dna	nn	3	SENT_146	[p8l384t2474r468b2502],
3	(	NN	O	(	_	0	SENT_146	[p8l490t2474r613b2506],
4	CDNA	NN	ORGANIZATION	cdna	nn	5	SENT_146	[p8l490t2474r613b2506],
5	)	NN	O	)	nsubjpass	9	SENT_146	[p8l490t2474r613b2506],
6	was	VBD	O	be	auxpass	7	SENT_146	[p8l635t2481r698b2502],
7	synthesized	VBN	O	synthesize	rcmod	3	SENT_146	[p8l721t2471r917b2510],
8	and	CC	O	and	_	0	SENT_146	[p8l93t2515r154b2546],
9	ampliﬁed	VBN	O	ampliﬁed	rcmod	3	SENT_146	[p8l170t2515r330b2554],
10	with	IN	O	with	_	0	SENT_146	[p8l343t2515r418b2546],
11	the	DT	O	the	det	12	SENT_146	[p8l434t2515r485b2546],
12	use	NN	O	use	prep_with	7	SENT_146	[p8l501t2525r556b2546],
13	of	IN	O	of	_	0	SENT_146	[p8l572t2515r611b2546],
14	primers	NNS	O	primer	prep_of	3	SENT_146	[p8l619t2516r750b2554],
15	designed	VBN	O	design	partmod	14	SENT_146	[p8l766t2515r917b2554],

1	N	NN	O	n	nn	2	SENT_147	[p8l525t2631r539b2646],
2	ENGLJ	NN	O	englj	_	0	SENT_147	[p8l554t2630r638b2652],
3	MED	NN	O	med	dep	2	SENT_147	[p8l653t2631r705b2646],
4	353	CD	NUMBER	353	num	3	SENT_147	[p8l718t2630r796b2652],
5	;	:	O	;	_	0	SENT_147	[p8l718t2630r796b2652],
6	19	CD	NUMBER	19	num	7	SENT_147	[p8l718t2630r796b2652],
7	WWW.NEjM.ORG	NN	O	www.nejm.org	dep	3	SENT_147	[p8l831t2630r1042b2652],

1	speciﬁcally	RB	O	speciﬁcally	_	0	SENT_148	[p8l957t2250r1138b2289],
2	to	TO	O	to	aux	3	SENT_148	[p8l1146t2257r1177b2281],
3	amplify	VB	O	amplify	xcomp	1	SENT_148	[p8l1187t2250r1312b2289],
4	EGFR	NN	ORGANIZATION	egfr	dobj	3	SENT_148	[p8l1319t2253r1401b2281],
5	(	CD	NUMBER	(	number	6	SENT_148	[p8l1410t2250r1558b2289],
6	1044	CD	DATE	1044	dep	4	SENT_148	[p8l1410t2250r1558b2289],
7	—	CD	NUMBER	—	num	10	SENT_148	[p8l1410t2250r1558b2289],
8	bp	NN	O	bp	nn	10	SENT_148	[p8l1410t2250r1558b2289],
9	product	NN	O	product	nn	10	SENT_148	[p8l1568t2250r1708b2289],
10	)	NN	O	)	dep	6	SENT_148	[p8l1568t2250r1708b2289],
11	and	CC	O	and	_	0	SENT_148	[p8l1719t2250r1780b2281],
12	EGFRUHI	NN	O	egfruhus	nn	13	SENT_148	[p8l955t2297r1088b2325],
13	(	NN	O	(	dobj	3	SENT_148	[p8l1100t2294r1227b2333],
14	243	CD	NUMBER	243	number	15	SENT_148	[p8l1100t2294r1227b2333],
15	—	CD	NUMBER	—	dep	13	SENT_148	[p8l1100t2294r1227b2333],
16	bp	NN	O	bp	nn	18	SENT_148	[p8l1100t2294r1227b2333],
17	product	NN	O	product	nn	18	SENT_148	[p8l1240t2294r1391b2333],
18	)	NN	O	)	dep	15	SENT_148	[p8l1240t2294r1391b2333],
19	.	.	O	.	_	0	SENT_148	[p8l1240t2294r1391b2333],

1	Details	NNS	O	detail	nsubjpass	3	SENT_149	[p8l1405t2294r1518b2325],
2	are	VBP	O	be	auxpass	3	SENT_149	[p8l1531t2304r1580b2325],
3	provided	VBN	O	provide	_	0	SENT_149	[p8l1592t2294r1736b2333],
4	in	IN	O	in	_	0	SENT_149	[p8l1748t2295r1780b2324],
5	the	DT	O	the	det	7	SENT_149	[p8l956t2338r1006b2369],
6	Supplementary	NNP	O	Supplementary	nn	7	SENT_149	[p8l1017t2338r1266b2377],
7	Appendix	NNP	O	Appendix	prep_in	3	SENT_149	[p8l1272t2338r1440b2377],
8	.	.	O	.	_	0	SENT_149	[p8l1272t2338r1440b2377],

1	Real-Time	JJ	MISC	real-time	amod	2	SENT_150	[p8l958t2426r1113b2456],
2	PCR	NN	MISC	pcr	nsubjpass	6	SENT_150	[p8l1127t2428r1192b2456],
3	Genomic	JJ	MISC	genomic	amod	4	SENT_150	[p8l956t2472r1107b2502],
4	DNA	NN	MISC	dna	dep	2	SENT_150	[p8l1121t2474r1203b2502],
5	was	VBD	O	be	auxpass	6	SENT_150	[p8l1215t2481r1277b2502],
6	extracted	VBN	O	extract	_	0	SENT_150	[p8l1293t2471r1441b2502],
7	from	IN	O	from	_	0	SENT_150	[p8l1455t2471r1536b2502],
8	samples	NNS	O	sample	prep_from	6	SENT_150	[p8l1551t2471r1684b2510],
9	from	IN	O	from	_	0	SENT_150	[p8l1699t2471r1780b2502],
10	15	CD	NUMBER	15	num	11	SENT_150	[p8l957t2517r994b2546],
11	patients	NNS	O	patient	prep_from	8	SENT_150	[p8l1007t2516r1137b2554],
12	(	IN	O	(	_	0	SENT_150	[p8l1152t2518r1181b2550],
13	7	CD	NUMBER	7	prep_(	11	SENT_150	[p8l1152t2518r1181b2550],
14	with	IN	O	with	_	0	SENT_150	[p8l1192t2515r1266b2546],
15	a	DT	O	a	det	16	SENT_150	[p8l1277t2525r1295b2546],
16	response	NN	O	response	prep_with	6	SENT_150	[p8l1306t2525r1453b2554],
17	and	CC	O	and	_	0	SENT_150	[p8l1465t2515r1526b2546],
18	8	CD	NUMBER	8	prep_with	6	SENT_150	[p8l1538t2517r1556b2546],
19	without	IN	O	without	_	0	SENT_150	[p8l1567t2515r1697b2546],
20	a	DT	O	a	det	21	SENT_150	[p8l1707t2525r1724b2546],
21	reNOVEMBER	NN	O	renovember	prep_without	6	SENT_150	[p8l1736t2525r1779b2546, p8l1082t2630r1223b2646],

1	‘	NN	O	‘	_	0	SENT_151	[p8l1236t2630r1271b2650],
2	Io	NNP	O	Io	dep	1	SENT_151	[p8l1236t2630r1271b2650],
3	,	,	O	,	_	0	SENT_151	[p8l1236t2630r1271b2650],
4	2005	CD	DATE	2005	appos	2	SENT_151	[p8l1285t2630r1348b2652],

1	The	DT	O	the	det	5	SENT_152	[p8l752t2727r802b2751],
2	New	NNP	O	New	nn	5	SENT_152	[p8l812t2728r874b2751],
3	England	NNP	O	England	nn	5	SENT_152	[p8l883t2727r994b2758],
4	J	NNP	O	J	nn	5	SENT_152	[p8l1002t2728r1015b2751],
5	oumal	NN	O	oumal	_	0	SENT_152	[p8l1016t2727r1100b2751],
6	of	IN	O	of	_	0	SENT_152	[p8l1110t2727r1138b2751],
7	Medicine	NN	O	medicine	prep_of	5	SENT_152	[p8l1145t2727r1270b2751],

1	Downloaded	VBN	O	download	_	0	SENT_153	[p8l194t2768r364b2791],
2	from	IN	O	from	_	0	SENT_153	[p8l372t2768r437b2791],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_153	[p8l446t2768r564b2798],
4	at	IN	O	at	_	0	SENT_153	[p8l574t2772r597b2791],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_153	[p8l606t2768r788b2791],
6	on	IN	O	on	_	0	SENT_153	[p8l798t2775r830b2791],
7	January	NNP	DATE	January	prep_on	1	SENT_153	[p8l839t2768r942b2798],
8	5	CD	DATE	5	num	7	SENT_153	[p8l952t2768r974b2795],
9	,	,	DATE	,	_	0	SENT_153	[p8l952t2768r974b2795],
10	2014	CD	DATE	2014	num	7	SENT_153	[p8l985t2768r1057b2791],
11	.	.	O	.	_	0	SENT_153	[p8l985t2768r1057b2791],

1	For	IN	O	for	_	0	SENT_154	[p8l1068t2768r1114b2791],
2	personal	JJ	O	personal	amod	3	SENT_154	[p8l1122t2768r1234b2798],
3	use	NN	O	use	pobj	1	SENT_154	[p8l1244t2775r1287b2791],
4	only	RB	O	only	advmod	3	SENT_154	[p8l1297t2768r1362b2798],
5	.	.	O	.	_	0	SENT_154	[p8l1297t2768r1362b2798],

1	No	DT	O	no	det	3	SENT_155	[p8l1372t2768r1412b2791],
2	other	JJ	O	other	amod	3	SENT_155	[p8l1422t2768r1490b2791],
3	uses	NNS	O	use	_	0	SENT_155	[p8l1498t2775r1554b2791],
4	without	IN	O	without	_	0	SENT_155	[p8l1565t2768r1666b2791],
5	permission	NN	O	permission	prep_without	3	SENT_155	[p8l1674t2768r1827b2798],
6	.	.	O	.	_	0	SENT_155	[p8l1674t2768r1827b2798],

1	Copyright	NN	O	copyright	_	0	SENT_156	[p8l544t2809r678b2840],
2	©	CD	NUMBER	©	num	6	SENT_156	[p8l688t2809r711b2833],
3	2005	CD	DATE	2005	num	6	SENT_156	[p8l721t2809r785b2833],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_156	[p8l796t2809r987b2833],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_156	[p8l997t2809r1105b2833],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_156	[p8l1115t2809r1220b2840],
7	.	.	O	.	_	0	SENT_156	[p8l1115t2809r1220b2840],

1	All	DT	O	all	det	2	SENT_157	[p8l1231t2809r1272b2833],
2	rights	NNS	O	rights	nsubj	3	SENT_157	[p8l1282t2809r1356b2840],
3	reserved	VBN	O	reserve	_	0	SENT_157	[p8l1366t2809r1485b2833],
4	.	.	O	.	_	0	SENT_157	[p8l1366t2809r1485b2833],

1	The	DT	O	the	det	3	SENT_158	[p8l715t2851r752b2873],
2	NEW	NNP	O	NEW	nn	3	SENT_158	[p8l764t2853r844b2873],
3	ENGLAND	NNP	O	ENGLAND	_	0	SENT_158	[p8l858t2853r1033b2873],
4	JOURNAL	NNP	O	JOURNAL	nn	5	SENT_158	[p8l1047t2853r1213b2880],
5	afMEDICINE	NNP	O	afMEDICINE	dep	3	SENT_158	[p8l1227t2851r1443b2879],

1	Table	NNP	O	Table	_	0	SENT_159	[p9l264t33r334b58],
2	2	CD	NUMBER	2	dep	1	SENT_159	[p9l343t36r366b58],
3	.	.	O	.	_	0	SENT_159	[p9l343t36r366b58],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_160	[p9l378t35r453b58],
2	and	CC	O	and	_	0	SENT_160	[p9l462t33r511b58],
3	PTEN	NN	O	pten	conj_and	1	SENT_160	[p9l524t36r598b58],
4	Status	NN	O	status	dep	1	SENT_160	[p9l609t35r695b58],
5	in	IN	O	in	_	0	SENT_160	[p9l705t34r728b58],
6	Tumor	NN	O	tumor	nn	7	SENT_160	[p9l738t36r827b58],
7	issue	NN	O	issue	prep_in	4	SENT_160	[p9l854t34r924b58],
8	"	''	O	"	punct	7	SENT_160	[p9l933t35r949b43],
9	‘	SYM	O	‘	dep	4	SENT_160	[p9l933t35r949b43],

1	EGFRwH	NN	O	egfrwh	nn	2	SENT_161	[p9l1371t146r1489b169],
2	PTENIHC	NN	O	ptenihc	_	0	SENT_161	[p9l1755t146r1895b169],

1	Analysis	NN	O	analysis	_	0	SENT_162	[p9l525t211r636b244],
2	for	IN	O	for	_	0	SENT_162	[p9l646t211r684b237],
3	KD	NN	O	kd	nn	4	SENT_162	[p9l695t214r733b236],
4	Mutations	NNS	O	mutation	prep_for	1	SENT_162	[p9l746t214r883b237],
5	IHC	NNP	O	IHC	nn	7	SENT_162	[p9l1206t213r1257b237],
6	RT-PCR	NN	O	rt-pcr	nn	7	SENT_162	[p9l1296t213r1396b237],
7	Immunoblotting	NN	O	immunoblotting	dep	1	SENT_162	[p9l1434t211r1658b245],

1	Response	NN	O	response	_	0	SENT_163	[p9l266t270r397b300],

1	N	NN	O	n	_	0	SENT_164	[p9l1324t326r1342b349],
2	D	NN	O	d	dep	1	SENT_164	[p9l1349t326r1368b349],
3	+	CC	O	+	rcmod	2	SENT_164	[p9l1537t332r1553b349],

1	NA	NNP	O	NA	nn	2	SENT_165	[p9l1325t438r1367b461],
2	NA	NNP	O	NA	_	0	SENT_165	[p9l1525t438r1567b461],

1	+	CC	O	+	cc	2	SENT_166	[p9l1337t557r1353b574],
2	NA	NNP	O	NA	dep	4	SENT_166	[p9l1525t551r1567b574],
3	NA	NNP	O	NA	dep	2	SENT_166	[p9l1325t607r1367b630],
4	NA	NNP	O	NA	_	0	SENT_166	[p9l1525t607r1567b630],

1	Notamplified	JJ	MISC	notamplified	amod	3	SENT_167	[p9l921t1674r1103b1707],
2	Ampliﬁed	JJ	MISC	ampliﬁed	amod	3	SENT_167	[p9l947t1730r1078b1763],
3	NT	NN	MISC	nt	_	0	SENT_167	[p9l995t1789r1035b1812],

1	*	NN	O	*	nn	5	SENT_168	[p9l237t1882r252b1896],
2	KD	NN	O	kd	nn	5	SENT_168	[p9l265t1882r302b1904],
3	deno	NN	O	deno	nn	5	SENT_168	[p9l312t1880r378b1905],
4	inase	NN	O	inase	nn	5	SENT_168	[p9l443t1882r511b1905],
5	domain	NN	O	domain	nsubj	20	SENT_168	[p9l520t1880r629b1909],
6	,	,	O	,	_	0	SENT_168	[p9l520t1880r629b1909],
7	fluorescence	NN	O	fluorescence	appos	5	SENT_168	[p9l715t1879r884b1905],
8	in	FW	O	in	nn	9	SENT_168	[p9l894t1882r915b1904],
9	situ	FW	O	situ	advmod	10	SENT_168	[p9l927t1882r973b1905],
10	hybridization	NN	O	hybridization	rcmod	7	SENT_168	[p9l984t1880r1164b1913],
11	,	,	O	,	_	0	SENT_168	[p9l984t1880r1164b1913],
12	IHC	NNP	ORGANIZATION	IHC	nn	14	SENT_168	[p9l1177t1882r1227b1905],
13	immunohistochemical	JJ	O	immunohistochemical	amod	14	SENT_168	[p9l1237t1880r1538b1905],
14	analysis	NN	O	analysis	appos	10	SENT_168	[p9l1549t1880r1660b1913],
15	,	,	O	,	_	0	SENT_168	[p9l1549t1880r1660b1913],
16	ND	NN	O	nd	nn	17	SENT_168	[p9l1672t1882r1716b1905],
17	RNA	NN	O	rna	appos	10	SENT_168	[p9l1728t1881r1788b1905],
18	de	IN	O	de	_	0	SENT_168	[p9l1796t1880r1827b1905],
19	r	NN	O	r	prep_de	7	SENT_168	[p9l1847t1888r1856b1904],
20	ed	VBD	O	ed	_	0	SENT_168	[p9l1890t1895r1897b1898, p9l263t1917r300b1947],
21	,	,	O	,	_	0	SENT_168	[p9l1890t1895r1897b1898, p9l263t1917r300b1947],
22	NA	NNP	O	NA	nsubjpass	53	SENT_168	[p9l313t1919r354b1942],
23	no	DT	O	no	det	25	SENT_168	[p9l364t1926r396b1942],
24	rozen	NN	O	rozen	nn	25	SENT_168	[p9l416t1926r488b1942],
25	tissue	NN	O	tissue	dep	53	SENT_168	[p9l498t1919r577b1942],
26	avai	IN	O	avai	mark	53	SENT_168	[p9l586t1919r636b1942],
27	a	DT	O	a	det	30	SENT_168	[p9l648t1926r660b1942],
28	e	LS	O	e	dep	30	SENT_168	[p9l688t1926r708b1947],
29	,	,	O	,	_	0	SENT_168	[p9l688t1926r708b1947],
30	NT	NNP	O	NT	nsubjpass	53	SENT_168	[p9l721t1919r760b1942],
31	no	DT	O	no	det	33	SENT_168	[p9l770t1926r802b1942],
32	tissue	NN	O	tissue	nn	33	SENT_168	[p9l810t1919r889b1942],
33	slide	NN	O	slide	npadvmod	34	SENT_168	[p9l899t1917r960b1942],
34	available	JJ	O	available	amod	30	SENT_168	[p9l969t1917r1091b1947],
35	,	,	O	,	_	0	SENT_168	[p9l969t1917r1091b1947],
36	plus	CC	O	plus	_	0	SENT_168	[p9l1103t1917r1156b1950],
37	si	FW	O	si	nsubjpass	53	SENT_168	[p9l1167t1919r1186b1942],
38	n	NN	O	n	nn	40	SENT_168	[p9l1207t1926r1220b1942],
39	positive	JJ	O	positive	amod	40	SENT_168	[p9l1232t1919r1334b1950],
40	results	NNS	O	result	rcmod	37	SENT_168	[p9l1345t1917r1439b1947],
41	,	,	O	,	_	0	SENT_168	[p9l1345t1917r1439b1947],
42	and	CC	O	and	_	0	SENT_168	[p9l1450t1917r1497b1942],
43	minus	CC	O	minus	advmod	40	SENT_168	[p9l1510t1919r1591b1942],
44	sign	NN	O	sign	nn	46	SENT_168	[p9l1602t1919r1655b1950],
45	negative	JJ	O	negative	amod	46	SENT_168	[p9l1667t1919r1777b1950],
46	resu	NN	O	resu	conj_and	40	SENT_168	[p9l1788t1926r1841b1942],
47	s.	NN	O	s.	dep	46	SENT_168	[p9l1863t1926r1882b1942],
48	1	CD	NUMBER	1	num	47	SENT_168	[p9l238t1956r254b1987],
49	'	''	O	'	_	0	SENT_168	[p9l238t1956r254b1987],
50	The	DT	O	the	det	51	SENT_168	[p9l261t1954r312b1979],
51	results	NNS	O	result	dep	37	SENT_168	[p9l323t1954r412b1979],
52	were	VBD	O	be	auxpass	53	SENT_168	[p9l422t1963r485b1979],
53	confirmed	VBN	O	confirm	xcomp	20	SENT_168	[p9l495t1954r633b1979],
54	by	IN	O	by	_	0	SENT_168	[p9l646t1954r674b1987],
55	a	DT	O	a	det	56	SENT_168	[p9l683t1963r696b1979],
56	ratio	NN	O	ratio	agent	53	SENT_168	[p9l708t1956r768b1979],
57	of	IN	O	of	_	0	SENT_168	[p9l778t1954r807b1979],
58	EGFR	NN	ORGANIZATION	egfr	nn	59	SENT_168	[p9l815t1956r889b1979],
59	exon	NN	O	exon	prep_of	56	SENT_168	[p9l899t1963r960b1979],
60	9	CD	NUMBER	9	num	61	SENT_168	[p9l972t1956r986b1979],
61	DNA	NN	O	dna	advmod	56	SENT_168	[p9l998t1956r1063b1979],
62	to	TO	O	to	_	0	SENT_168	[p9l1072t1959r1098b1979],
63	exon	NN	O	exon	nn	65	SENT_168	[p9l1108t1963r1170b1979],
64	NA	NN	O	na	nn	65	SENT_168	[p9l1231t1956r1273b1979],
65	of4	NN	O	of4	prep_to	61	SENT_168	[p9l1282t1954r1380b1979],
66	.79	CD	NUMBER	.79	dep	56	SENT_168	[p9l1282t1954r1380b1979],
67	.	.	O	.	_	0	SENT_168	[p9l1282t1954r1380b1979],

1	sponse	JJ	O	sponse	amod	2	SENT_169	[p9l10t2221r342b2315],
2	)	NN	O	)	_	0	SENT_169	[p9l10t2221r342b2315],
3	and	CC	O	and	_	0	SENT_169	[p9l384t2213r543b2293],
4	subjected	VBN	O	subject	conj_and	2	SENT_169	[p9l582t2214r989b2315],
5	to	TO	O	to	_	0	SENT_169	[p9l1025t2230r1106b2293],
6	real	JJ	O	real	amod	9	SENT_169	[p9l1144t2213r1536b2293],
7	—	NN	O	—	nn	9	SENT_169	[p9l1144t2213r1536b2293],
8	time	NN	O	time	nn	9	SENT_169	[p9l1144t2213r1536b2293],
9	PCR	NN	O	pcr	prep_to	4	SENT_169	[p9l1572t2219r1767b2298],
10	with	IN	O	with	_	0	SENT_169	[p9l1789t2214r1983b2294],
11	the	DT	O	the	det	12	SENT_169	[p9l2020t2214r2153b2293],
12	use	NN	O	use	prep_with	4	SENT_169	[p9l8t2370r148b2424],
13	of	IN	O	of	_	0	SENT_169	[p9l174t2343r276b2423],
14	the	DT	O	the	det	15	SENT_169	[p9l282t2344r413b2423],
15	iCycler	NN	O	icycler	prep_of	12	SENT_169	[p9l437t2344r731b2445],
16	thermocycler	NN	O	thermocycler	nn	18	SENT_169	[p9l753t2344r1314b2445],
17	(	CD	NUMBER	(	num	18	SENT_169	[p9l1341t2343r1715b2436],
18	Bio	NNP	O	Bio	dep	15	SENT_169	[p9l1341t2343r1715b2436],
19	.	.	O	.	_	0	SENT_169	[p9l1341t2343r1715b2436],

1	—	NN	O	—	_	0	SENT_170	[p9l1341t2343r1715b2436],
2	.	.	O	.	_	0	SENT_170	[p9l1341t2343r1715b2436],

1	Rad	NNP	O	Rad	nn	2	SENT_171	[p9l1341t2343r1715b2436],
2	Laboratories	NNPS	O	Laboratories	_	0	SENT_171	[p9l1739t2344r2153b2423, p9l7t2474r215b2566],
3	)	NN	O	)	dep	2	SENT_171	[p9l1739t2344r2153b2423, p9l7t2474r215b2566],
4	.	.	O	.	_	0	SENT_171	[p9l1739t2344r2153b2423, p9l7t2474r215b2566],

1	All	DT	O	all	det	2	SENT_172	[p9l239t2474r358b2552],
2	measurements	NNS	O	measurement	nsubjpass	4	SENT_172	[p9l381t2490r1002b2554],
3	were	VBD	O	be	auxpass	4	SENT_172	[p9l1022t2500r1224b2554],
4	made	VBN	O	make	_	0	SENT_172	[p9l1247t2474r1478b2553],
5	in	IN	O	in	_	0	SENT_172	[p9l1501t2474r1582b2552],
6	triplicate	NN	O	triplicate	prep_in	4	SENT_172	[p9l1605t2474r1976b2575],
7	and	CC	O	and	_	0	SENT_172	[p9l1999t2473r2154b2553],
8	conﬁrmed	VBN	O	conﬁrmed	conj_and	4	SENT_172	[p9l8t2603r451b2683],
9	by	IN	O	by	_	0	SENT_172	[p9l484t2604r582b2705],
10	independent	JJ	O	independent	amod	11	SENT_172	[p9l609t2603r1152b2705],
11	experiments	NNS	O	experiment	prep_by	8	SENT_172	[p9l1180t2604r1729b2705],
12	.	.	O	.	_	0	SENT_172	[p9l1180t2604r1729b2705],

1	The	DT	O	the	det	3	SENT_173	[p9l1763t2604r1926b2683],
2	Supplementary	NNP	O	Supplementary	nn	3	SENT_173	[p9l1961t2609r2152b2705, p9l6t2734r504b2835],
3	Appendix	NNP	O	Appendix	nsubj	10	SENT_173	[p9l533t2734r956b2835],
4	lists	VBZ	O	list	_	0	SENT_173	[p9l990t2733r1164b2813],
5	the	DT	O	the	det	7	SENT_173	[p9l1204t2734r1337b2813],
6	primer	NN	O	primer	nn	7	SENT_173	[p9l1373t2734r1672b2835],
7	sequences	NNS	O	sequence	dobj	4	SENT_173	[p9l1709t2759r2150b2835],
8	used	VBN	O	use	partmod	7	SENT_173	[p9l8t2864r204b2944],
9	and	CC	O	and	_	0	SENT_173	[p9l229t2864r387b2943],
10	provides	VBZ	O	provide	conj_and	4	SENT_173	[p9l410t2863r771b2965],
11	complete	JJ	O	complete	amod	12	SENT_173	[p9l800t2864r1191b2965],
12	details	NNS	O	detail	dobj	10	SENT_173	[p9l1218t2863r1519b2943],
13	.	.	O	.	_	0	SENT_173	[p9l1218t2863r1519b2943],

1	Immunohistochemistry	NN	O	immunohistochemistry	nn	8	SENT_174	[p9l12t3122r941b3223],
2	and	CC	O	and	_	0	SENT_174	[p9l969t3122r1122b3199],
3	Immunoblotting	NN	O	immunoblotting	nn	8	SENT_174	[p9l1153t3122r1816b3224],
4	Parafﬁn	NN	O	parafﬁn	nn	8	SENT_174	[p9l6t3254r829b3334],
5	—	CD	NUMBER	—	num	8	SENT_174	[p9l6t3254r829b3334],
6	embedded	JJ	O	embedded	amod	8	SENT_174	[p9l6t3254r829b3334],
7	tissue	NN	O	tissue	nn	8	SENT_174	[p9l861t3255r1105b3335],
8	sections	NNS	O	section	nsubj	9	SENT_174	[p9l1139t3255r1483b3334],
9	underwent	VBD	O	undergo	_	0	SENT_174	[p9l1517t3254r1981b3335],
10	immunohistochemical	JJ	O	immunohistochemical	amod	11	SENT_174	[p9l2007t3255r2152b3333, p9l7t3384r864b3465],
11	analysis	NN	O	analysis	dobj	9	SENT_174	[p9l904t3385r1237b3486],
12	in	IN	O	in	_	0	SENT_174	[p9l1279t3385r1361b3463],
13	which	WDT	O	which	rel	17	SENT_174	[p9l1397t3385r1660b3465],
14	the	DT	O	the	det	15	SENT_174	[p9l1701t3385r1831b3464],
15	results	NNS	O	result	nsubjpass	17	SENT_174	[p9l1872t3385r2152b3465],
16	were	VBD	O	be	auxpass	17	SENT_174	[p9l6t3540r206b3593],
17	scored	VBN	O	score	rcmod	11	SENT_174	[p9l230t3513r503b3592],
18	independently	RB	O	independently	advmod	17	SENT_174	[p9l524t3513r1125b3614],
19	by	IN	O	by	_	0	SENT_174	[p9l1143t3514r1240b3614],
20	two	CD	NUMBER	two	num	21	SENT_174	[p9l1258t3530r1409b3593],
21	pathologists	NNS	O	pathologist	agent	17	SENT_174	[p9l1431t3514r1949b3614],
22	who	WP	O	who	nsubj	24	SENT_174	[p9l1968t3514r2150b3593],
23	Were	VBD	O	be	cop	24	SENT_174	[p9l6t3668r212b3721],
24	unaware	JJ	O	unaware	rcmod	21	SENT_174	[p9l261t3667r628b3721],
25	of	IN	O	of	_	0	SENT_174	[p9l678t3641r780b3720],
26	the	DT	O	the	det	27	SENT_174	[p9l810t3642r942b3720],
27	ﬁndings	NNS	O	ﬁndings	prep_of	24	SENT_174	[p9l991t3641r1351b3742],
28	of	IN	O	of	_	0	SENT_174	[p9l1402t3641r1504b3720],
29	the	DT	O	the	det	31	SENT_174	[p9l1535t3642r1667b3720],
30	molecular	JJ	O	molecular	amod	31	SENT_174	[p9l1716t3642r2153b3721],
31	analyses	NNS	O	analysis	prep_of	27	SENT_174	[p10l10t21r387b121],
32	.	.	O	.	_	0	SENT_174	[p10l10t21r387b121],

1	Scores	NNS	O	score	nsubjpass	7	SENT_175	[p10l417t26r689b99],
2	of	IN	O	of	_	0	SENT_175	[p10l713t20r815b99],
3	O	NN	O	o	prep_of	1	SENT_175	[p10l819t26r866b99],
4	and	CC	O	and	_	0	SENT_175	[p10l888t20r1045b99],
5	1	CD	NUMBER	1	prep_of	1	SENT_175	[p10l1071t26r1115b98],
6	were	VBD	O	be	auxpass	7	SENT_175	[p10l1133t47r1336b100],
7	considered	VBN	O	consider	_	0	SENT_175	[p10l1360t21r1826b99],
8	to	TO	O	to	aux	9	SENT_175	[p10l1848t37r1928b99],
9	indicate	VB	O	indicate	xcomp	7	SENT_175	[p10l1951t21r2150b99, p10l11t165r175b227],
10	PTEN	NNP	ORGANIZATION	PTEN	nn	11	SENT_175	[p10l202t154r448b227],
11	loss	NN	O	loss	dobj	9	SENT_175	[p10l473t149r750b227],
12	.27	CD	NUMBER	.27	num	11	SENT_175	[p10l473t149r750b227],
13	If	IN	O	if	mark	18	SENT_175	[p10l777t148r858b226],
14	staining	VBG	O	stain	csubj	18	SENT_175	[p10l868t149r1217b249],
15	for	IN	O	for	_	0	SENT_175	[p10l1241t148r1365b227],
16	PTEN	NNP	ORGANIZATION	PTEN	prep_for	14	SENT_175	[p10l1388t154r1634b228],
17	was	VBD	O	be	cop	18	SENT_175	[p10l1656t175r1817b228],
18	heterogeneous	JJ	O	heterogeneous	advcl	35	SENT_175	[p10l1847t149r2150b227, p10l10t302r388b377],
19	,	,	O	,	_	0	SENT_175	[p10l1847t149r2150b227, p10l10t302r388b377],
20	tumors	NNS	O	tumor	nsubjpass	35	SENT_175	[p10l423t293r727b356],
21	With	IN	O	with	_	0	SENT_175	[p10l753t277r944b356],
22	diminished	VBN	O	diminish	amod	25	SENT_175	[p10l974t276r1458b355],
23	or	CC	O	or	_	0	SENT_175	[p10l1488t302r1578b355],
24	absent	JJ	O	absent	amod	25	SENT_175	[p10l1603t277r1886b355],
25	staining	NN	O	staining	prep_with	20	SENT_175	[p10l1912t277r2150b355, p10l10t405r152b505],
26	in	IN	O	in	_	0	SENT_175	[p10l202t405r285b482],
27	at	IN	O	at	quantmod	29	SENT_175	[p10l339t421r420b483],
28	least	JJS	O	least	mwe	27	SENT_175	[p10l469t405r671b483],
29	25	CD	PERCENT	25	num	30	SENT_175	[p10l721t410r820b483],
30	percent	NN	PERCENT	percent	prep_in	25	SENT_175	[p10l877t421r1207b505],
31	of	IN	O	of	_	0	SENT_175	[p10l1258t404r1360b483],
32	the	DT	O	the	det	33	SENT_175	[p10l1396t405r1529b483],
33	section	NN	O	section	prep_of	30	SENT_175	[p10l1586t405r1893b483],
34	were	VBD	O	be	auxpass	35	SENT_175	[p10l1943t431r2150b484],
35	considered	VBN	O	consider	rcmod	11	SENT_175	[p10l11t533r487b613],
36	PTEN	NNP	O	PTEN	nsubj	38	SENT_175	[p10l518t533r1209b614],
37	—	CD	NUMBER	—	num	38	SENT_175	[p10l518t533r1209b614],
38	deﬁcient	NN	O	deﬁcient	xcomp	35	SENT_175	[p10l518t533r1209b614],
39	.	.	O	.	_	0	SENT_175	[p10l518t533r1209b614],

1	Tumors	NNS	O	tumor	_	0	SENT_176	[p10l1243t539r1581b614],
2	demonstrating	VBG	O	demonstrate	partmod	1	SENT_176	[p10l1616t534r2149b613, p10l10t663r152b763],

1	focal	JJ	O	focal	amod	8	SENT_177	[p10l171t662r399b758],
2	,	,	O	,	_	0	SENT_177	[p10l171t662r399b758],
3	moderate	JJ	O	moderate	amod	8	SENT_177	[p10l427t663r1270b763],
4	—	CD	NUMBER	—	number	6	SENT_177	[p10l427t663r1270b763],
5	to	TO	O	to	dep	6	SENT_177	[p10l427t663r1270b763],
6	—	CD	NUMBER	—	dep	3	SENT_177	[p10l427t663r1270b763],
7	strong	JJ	O	strong	amod	8	SENT_177	[p10l427t663r1270b763],
8	immunostaining	NN	O	immunostaining	nsubjpass	12	SENT_177	[p10l1288t663r2011b763],
9	for	IN	O	for	_	0	SENT_177	[p10l2030t662r2154b741],
10	EGFRVIII	NN	O	egfrviius	prep_for	8	SENT_177	[p10l9t796r403b874],
11	were	VBD	O	be	auxpass	12	SENT_177	[p10l429t817r632b870],
12	considered	VBN	O	consider	_	0	SENT_177	[p10l664t791r1131b869],
13	positiVe	JJ	O	positive	amod	17	SENT_177	[p10l1160t791r1599b891],
14	.27	CD	NUMBER	.27	tmod	13	SENT_177	[p10l1160t791r1599b891],
15	Quantitative	JJ	O	quantitative	amod	17	SENT_177	[p10l1631t791r2150b889],
16	image	NN	O	image	nn	17	SENT_177	[p10l10t919r269b1019],
17	analysis	NN	O	analysis	dobj	12	SENT_177	[p10l307t919r640b1019],
18	to	TO	O	to	aux	19	SENT_177	[p10l681t935r760b997],
19	conﬁrm	VB	O	conﬁrm	xcomp	12	SENT_177	[p10l800t918r1140b997],
20	the	DT	O	the	det	21	SENT_177	[p10l1178t919r1308b997],
21	pathologists	NNS	O	pathologist	nsubj	22	SENT_177	[p10l1345t919r1898b1019],
22	’	VBP	O	’	ccomp	19	SENT_177	[p10l1345t919r1898b1019],
23	scor2o16	NN	O	scor2o16	dobj	22	SENT_177	[p10l1942t944r2150b997, p10l149t1094r226b1116],

1	N	NN	O	n	nn	3	SENT_178	[p10l868t1097r881b1112],
2	ENGLJ	NN	O	englj	nn	3	SENT_178	[p10l897t1096r981b1118],
3	MED	NN	O	med	_	0	SENT_178	[p10l996t1097r1048b1112],
4	353	CD	NUMBER	353	dep	3	SENT_178	[p10l1061t1096r1139b1118],
5	;	:	O	;	_	0	SENT_178	[p10l1061t1096r1139b1118],
6	19	CD	NUMBER	19	dep	3	SENT_178	[p10l1061t1096r1139b1118],
7	WWW	NNP	O	WWW	dep	6	SENT_178	[p10l1174t1097r1268b1112],
8	.	.	O	.	_	0	SENT_178	[p10l1174t1097r1268b1112],

1	N	NN	O	n	nn	2	SENT_179	[p10l1174t1097r1268b1112],
2	E	NN	O	e	_	0	SENT_179	[p10l1276t1097r1294b1118],
3	)	CD	NUMBER	)	dep	2	SENT_179	[p10l1276t1097r1294b1118],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_179	[p10l1302t1096r1385b1112],
5	NOVEMBER	NNP	DATE	NOVEMBER	dep	2	SENT_179	[p10l1424t1096r1566b1112],
6	10	CD	DATE	10	num	5	SENT_179	[p10l1579t1096r1614b1116],
7	,	,	DATE	,	_	0	SENT_179	[p10l1579t1096r1614b1116],
8	2005	CD	DATE	2005	num	5	SENT_179	[p10l1628t1096r1691b1118],

1	The	DT	O	the	det	4	SENT_180	[p10l936t1129r987b1153],
2	New	NNP	O	New	nn	4	SENT_180	[p10l996t1130r1058b1153],
3	England	NNP	O	England	nn	4	SENT_180	[p10l1067t1129r1178b1160],
4	Joumal	NNP	O	Joumal	_	0	SENT_180	[p10l1187t1129r1284b1153],
5	of	IN	O	of	_	0	SENT_180	[p10l1294t1129r1323b1153],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_180	[p10l1330t1129r1455b1153],

1	Downloaded	VBN	O	download	_	0	SENT_181	[p10l378t1170r548b1193],
2	from	IN	O	from	_	0	SENT_181	[p10l557t1170r621b1193],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_181	[p10l630t1170r748b1200],
4	at	IN	O	at	_	0	SENT_181	[p10l759t1174r782b1193],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_181	[p10l790t1170r973b1193],
6	on	IN	O	on	_	0	SENT_181	[p10l982t1177r1015b1193],
7	January	NNP	DATE	January	prep_on	1	SENT_181	[p10l1023t1170r1126b1200],
8	5	CD	DATE	5	num	7	SENT_181	[p10l1136t1170r1159b1197],
9	,	,	DATE	,	_	0	SENT_181	[p10l1136t1170r1159b1197],
10	2014	CD	DATE	2014	num	7	SENT_181	[p10l1170t1170r1242b1193],
11	.	.	O	.	_	0	SENT_181	[p10l1170t1170r1242b1193],

1	For	IN	O	for	_	0	SENT_182	[p10l1252t1170r1299b1193],
2	personal	JJ	O	personal	amod	3	SENT_182	[p10l1307t1170r1419b1200],
3	use	NN	O	use	pobj	1	SENT_182	[p10l1428t1177r1472b1193],
4	only	RB	O	only	advmod	3	SENT_182	[p10l1482t1170r1546b1200],
5	.	.	O	.	_	0	SENT_182	[p10l1482t1170r1546b1200],

1	No	DT	O	no	det	3	SENT_183	[p10l1557t1170r1597b1193],
2	other	JJ	O	other	amod	3	SENT_183	[p10l1607t1170r1675b1193],
3	uses	NNS	O	use	_	0	SENT_183	[p10l1683t1177r1739b1193],
4	without	IN	O	without	_	0	SENT_183	[p10l1749t1170r1850b1193],
5	permission	NN	O	permission	prep_without	3	SENT_183	[p10l1859t1170r2011b1200],
6	.	.	O	.	_	0	SENT_183	[p10l1859t1170r2011b1200],

1	Copyright	NN	O	copyright	_	0	SENT_184	[p10l728t1211r863b1242],
2	©	CD	NUMBER	©	num	6	SENT_184	[p10l872t1211r896b1235],
3	2005	CD	DATE	2005	num	6	SENT_184	[p10l906t1211r970b1235],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_184	[p10l980t1211r1171b1235],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_184	[p10l1181t1211r1289b1235],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_184	[p10l1300t1211r1405b1242],
7	.	.	O	.	_	0	SENT_184	[p10l1300t1211r1405b1242],

1	All	DT	O	all	det	2	SENT_185	[p10l1416t1211r1457b1235],
2	rights	NNS	O	rights	nsubj	3	SENT_185	[p10l1466t1211r1541b1242],
3	reserved	VBN	O	reserve	_	0	SENT_185	[p10l1551t1211r1670b1235],
4	.	.	O	.	_	0	SENT_185	[p10l1551t1211r1670b1235],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_186	[p10l527t1254r614b1273],
2	KINASE	NN	O	kinase	nn	3	SENT_186	[p10l627t1254r751b1273],
3	INHIBITORS	NNS	O	inhibitor	dep	1	SENT_186	[p10l765t1254r973b1273],
4	FOR	IN	O	for	_	0	SENT_186	[p10l988t1254r1054b1273],
5	GLIOBLASTOMAS	NNS	O	glioblastoma	prep_for	3	SENT_186	[p10l1066t1254r1343b1272],

1	Table	NNP	O	Table	_	0	SENT_187	[p10l120t1378r191b1403],
2	3	CD	NUMBER	3	dep	1	SENT_187	[p10l200t1380r223b1403],
3	.	.	O	.	_	0	SENT_187	[p10l200t1380r223b1403],

1	Biomarkers	NNS	O	biomarker	_	0	SENT_188	[p10l235t1378r388b1403],
2	of	IN	O	of	_	0	SENT_188	[p10l398t1377r429b1403],
3	a	DT	O	a	det	4	SENT_188	[p10l433t1386r446b1403],
4	Response	NN	O	response	prep_of	1	SENT_188	[p10l458t1380r589b1410],
5	to	TO	O	to	_	0	SENT_188	[p10l597t1382r624b1403],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_188	[p10l635t1380r710b1403],
7	Kinase	NN	O	kinase	nn	8	SENT_188	[p10l721t1378r810b1403],
8	lnhibitors	NNS	O	lnhibitor	prep_to	4	SENT_188	[p10l820t1378r976b1403],
9	.	.	O	.	_	0	SENT_188	[p10l820t1378r976b1403],
10	'	''	O	'	_	0	SENT_188	[p10l820t1378r976b1403],

1	~	NN	O	~	_	0	SENT_189	[p10l820t1378r976b1403],
2	'	''	O	'	_	0	SENT_189	[p10l820t1378r976b1403],
3	*	SYM	O	*	dep	1	SENT_189	[p10l820t1378r976b1403],

1	Odds	NNS	MISC	odds	_	0	SENT_190	[p10l1585t1443r1658b1469],
2	Ratio	NNP	MISC	Ratio	nn	8	SENT_190	[p10l1670t1444r1738b1469],
3	Group	NNP	MISC	Group	nn	8	SENT_190	[p10l121t1483r207b1514],
4	Response	NNP	MISC	Response	nn	8	SENT_190	[p10l878t1483r1009b1514],
5	No	NNP	MISC	No	nn	8	SENT_190	[p10l1120t1483r1159b1506],
6	Response	NN	MISC	response	nn	8	SENT_190	[p10l1170t1483r1301b1514],
7	P	NN	O	p	nn	8	SENT_190	[p10l1390t1483r1406b1506],
8	Value	NN	O	value	dep	1	SENT_190	[p10l1414t1481r1488b1506],
9	(	CD	PERCENT	(	number	10	SENT_190	[p10l1603t1482r1672b1514],
10	95	CD	PERCENT	95	num	11	SENT_190	[p10l1603t1482r1672b1514],
11	%	NN	PERCENT	%	dep	8	SENT_190	[p10l1603t1482r1672b1514],
12	CI	NN	O	ci	nn	13	SENT_190	[p10l1681t1483r1719b1514],
13	)	NN	O	)	dep	1	SENT_190	[p10l1681t1483r1719b1514],

1	no.	RB	O	no.	dep	3	SENT_191	[p10l1018t1551r1054b1567],
2	(	CD	PERCENT	(	num	3	SENT_191	[p10l1069t1543r1114b1575],
3	%	NN	PERCENT	%	dep	4	SENT_191	[p10l1069t1543r1114b1575],
4	)	CD	NUMBER	)	_	0	SENT_191	[p10l1069t1543r1114b1575],

1	UCLA	NNP	ORGANIZATION	UCLA	nn	2	SENT_192	[p10l122t1593r200b1616],
2	patients	NNS	O	patient	_	0	SENT_192	[p10l209t1591r318b1623],
3	Clinical	JJ	O	clinical	amod	4	SENT_192	[p10l122t1640r219b1665],
4	variables	NNS	O	variable	dep	2	SENT_192	[p10l230t1640r350b1665],
5	Total	JJ	O	total	amod	6	SENT_192	[p10l120t1689r184b1714],
6	no.	NN	O	no.	dep	4	SENT_192	[p10l197t1698r237b1714],
7	.	.	O	.	_	0	SENT_192	[p10l197t1698r237b1714],

1	Median	JJ	MISC	median	amod	2	SENT_193	[p10l173t1738r273b1764],
2	age	NN	O	age	_	0	SENT_193	[p10l285t1747r331b1772],
3	—	CD	NUMBER	—	num	5	SENT_193	[p10l339t1754r373b1756],
4	yr	NN	DURATION	yr	nn	5	SENT_193	[p10l381t1747r405b1771],
5	Sex	NN	O	sex	dep	2	SENT_193	[p10l172t1790r258b1813],
6	—	CD	NUMBER	—	num	7	SENT_193	[p10l172t1790r258b1813],
7	no.	NN	O	no.	dep	5	SENT_193	[p10l268t1796r308b1813],
8	.	.	O	.	_	0	SENT_193	[p10l268t1796r308b1813],

1	Male	JJ	O	male	_	0	SENT_194	[p10l223t1837r288b1862],
2	Female	JJ	O	female	dep	1	SENT_194	[p10l224t1886r319b1911],

1	Mean	NN	O	mean	nn	2	SENT_195	[p10l173t1937r247b1960],
2	Karnofsky	NNP	PERSON	Karnofsky	dep	16	SENT_195	[p10l260t1935r392b1968],
3	performance-status	JJ	O	performance-status	amod	10	SENT_195	[p10l402t1935r667b1968],
4	score	NN	DATE	score	nn	10	SENT_195	[p10l679t1944r750b1960],
5	Gross	NNP	DATE	Gross	nn	10	SENT_195	[p10l172t1986r251b2010],
6	total	JJ	O	total	amod	10	SENT_195	[p10l261t1984r320b2010],
7	surgical	JJ	O	surgical	amod	10	SENT_195	[p10l332t1984r436b2018],
8	resection	NN	O	resection	nn	10	SENT_195	[p10l449t1987r570b2010],
9	—	NN	O	—	nn	10	SENT_195	[p10l580t2000r614b2002],
10	no.	NN	O	no.	dep	2	SENT_195	[p10l624t1993r664b2010],
11	(	CD	PERCENT	(	num	12	SENT_195	[p10l678t1986r722b2017],
12	%	NN	PERCENT	%	dep	16	SENT_195	[p10l678t1986r722b2017],
13	)	CD	NUMBER	)	num	16	SENT_195	[p10l678t1986r722b2017],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_195	[p10l174t2036r247b2059],
15	inhibitor	NN	O	inhibitor	nn	16	SENT_195	[p10l259t2034r374b2059],
16	Erlotinib	NN	O	erlotinib	_	0	SENT_195	[p10l223t2083r336b2108],
17	3	CD	NUMBER	3	number	18	SENT_195	[p10l920t2085r932b2108],
18	7	CD	NUMBER	7	num	19	SENT_195	[p10l1187t2085r1200b2108],
19	Gefitinib	NN	ORGANIZATION	gefitinib	dep	16	SENT_195	[p10l222t2132r338b2157],
20	4	CD	NUMBER	4	number	21	SENT_195	[p10l919t2134r933b2157],
21	12	CD	NUMBER	12	num	24	SENT_195	[p10l1171t2134r1200b2157],
22	Enzyme-inducing	JJ	O	enzyme-inducing	amod	24	SENT_195	[p10l173t2181r408b2214],
23	antiepileptic	JJ	O	antiepileptic	amod	24	SENT_195	[p10l418t2181r586b2214],
24	drugs	NNS	O	drug	dep	19	SENT_195	[p10l595t2181r671b2214],

1	No.	NN	O	no.	dep	10	SENT_196	[p10l223t2233r269b2256],
2	2	CD	NUMBER	2	number	3	SENT_196	[p10l919t2233r933b2255],
3	3	CD	NUMBER	3	dep	1	SENT_196	[p10l1186t2232r1198b2255],
4	Mean	NN	O	mean	nn	6	SENT_196	[p10l224t2282r297b2305],
5	dose	NN	O	dose	nn	6	SENT_196	[p10l308t2280r372b2305],
6	oferlotinib	NN	O	oferlotinib	dep	3	SENT_196	[p10l382t2279r530b2305],
7	—	CD	NUMBER	—	num	8	SENT_196	[p10l538t2295r572b2297],
8	mg	NN	O	mg	dep	10	SENT_196	[p10l582t2288r625b2313],
9	(	CD	NUMBER	(	num	10	SENT_196	[p10l637t2282r697b2313],
10	no.	NN	O	no.	dep	18	SENT_196	[p10l637t2282r697b2313],
11	)	CD	NUMBER	)	number	12	SENT_196	[p10l637t2282r697b2313],
12	500	CD	NUMBER	500	num	13	SENT_196	[p10l886t2281r979b2313],
13	(	NN	O	(	dep	10	SENT_196	[p10l886t2281r979b2313],
14	1	CD	NUMBER	1	number	15	SENT_196	[p10l886t2281r979b2313],
15	)	CD	NUMBER	)	num	17	SENT_196	[p10l886t2281r979b2313],
16	Mean	NN	O	mean	nn	17	SENT_196	[p10l223t2331r297b2354],
17	dose	NN	O	dose	dep	13	SENT_196	[p10l308t2329r372b2354],
18	ofgeﬁtinib	NN	O	ofgeﬁtinib	dep	20	SENT_196	[p10l382t2328r527b2362],
19	—	CD	NUMBER	—	num	18	SENT_196	[p10l536t2344r570b2347],
20	mg	NN	O	mg	dep	22	SENT_196	[p10l580t2338r622b2362],
21	(	CD	NUMBER	(	num	20	SENT_196	[p10l634t2331r695b2362],
22	no.	NN	O	no.	dep	25	SENT_196	[p10l634t2331r695b2362],
23	)	CD	NUMBER	)	num	22	SENT_196	[p10l634t2331r695b2362],
24	1500	CD	DATE	1500	num	25	SENT_196	[p10l871t2330r979b2362],
25	(	NN	O	(	dep	28	SENT_196	[p10l871t2330r979b2362],
26	1	CD	NUMBER	1	num	28	SENT_196	[p10l871t2330r979b2362],
27	)	NN	O	)	nn	28	SENT_196	[p10l871t2330r979b2362],
28	o	NN	O	o	dep	38	SENT_196	[p10l1186t2330r1201b2354],
29	No	DT	O	no	det	33	SENT_196	[p10l174t2380r212b2403],
30	enzyme-inducing	JJ	O	enzyme-inducing	amod	33	SENT_196	[p10l222t2378r457b2411],
31	antiepileptic	JJ	O	antiepileptic	amod	33	SENT_196	[p10l467t2378r634b2411],
32	drugs	NNS	O	drug	nn	33	SENT_196	[p10l644t2378r720b2411],
33	No.	NN	O	no.	dep	28	SENT_196	[p10l223t2429r269b2452],
34	5	CD	NUMBER	5	number	35	SENT_196	[p10l920t2429r932b2452],
35	16	CD	NUMBER	16	num	37	SENT_196	[p10l1171t2429r1200b2452],
36	Mean	NN	O	mean	nn	37	SENT_196	[p10l223t2479r297b2501],
37	dose	NN	O	dose	dep	33	SENT_196	[p10l308t2476r372b2501],
38	oferlotinib	NN	O	oferlotinib	dep	43	SENT_196	[p10l382t2476r530b2501],
39	—	CD	NUMBER	—	num	38	SENT_196	[p10l538t2492r572b2494],
40	mg	NN	O	mg	nn	43	SENT_196	[p10l582t2485r625b2509],
41	(	CD	NUMBER	(	num	43	SENT_196	[p10l637t2478r697b2509],
42	no.	NN	O	no.	nn	43	SENT_196	[p10l637t2478r697b2509],
43	)	NN	O	)	dep	47	SENT_196	[p10l637t2478r697b2509],
44	200	CD	NUMBER	200	num	45	SENT_196	[p10l885t2478r979b2509],
45	(	NN	O	(	dep	43	SENT_196	[p10l885t2478r979b2509],
46	2	CD	NUMBER	2	num	47	SENT_196	[p10l885t2478r979b2509],
47	)	NN	O	)	dep	57	SENT_196	[p10l885t2478r979b2509],
48	175	CD	NUMBER	175	num	49	SENT_196	[p10l1154t2479r1198b2501],
49	(	NN	O	(	dep	47	SENT_196	[p10l1213t2478r1246b2509],
50	4	CD	NUMBER	4	number	51	SENT_196	[p10l1213t2478r1246b2509],
51	)	CD	NUMBER	)	num	55	SENT_196	[p10l1213t2478r1246b2509],
52	NC	NN	O	nc	nn	55	SENT_196	[p10l1641t2478r1683b2501],
53	Mean	NN	O	mean	nn	55	SENT_196	[p10l223t2528r297b2551],
54	dose	NN	O	dose	nn	55	SENT_196	[p10l308t2525r372b2551],
55	ofgeﬁtinib	NN	O	ofgeﬁtinib	dep	49	SENT_196	[p10l382t2525r527b2559],
56	—	CD	NUMBER	—	num	57	SENT_196	[p10l536t2541r570b2543],
57	mg	NN	O	mg	dep	59	SENT_196	[p10l580t2534r622b2559],
58	(	CD	NUMBER	(	num	59	SENT_196	[p10l634t2528r695b2558],
59	no.	NN	O	no.	dep	60	SENT_196	[p10l634t2528r695b2558],
60	)	NN	O	)	dep	62	SENT_196	[p10l634t2528r695b2558],
61	583	CD	NUMBER	583	num	60	SENT_196	[p10l886t2527r932b2551],
62	(	NN	O	(	dep	64	SENT_196	[p10l946t2528r979b2558],
63	3	CD	NUMBER	3	num	62	SENT_196	[p10l946t2528r979b2558],
64	)	NN	O	)	dep	66	SENT_196	[p10l946t2528r979b2558],
65	479	CD	NUMBER	479	num	64	SENT_196	[p10l1152t2528r1200b2551],
66	(	NN	O	(	dep	69	SENT_196	[p10l1213t2528r1263b2558],
67	12	CD	NUMBER	12	num	66	SENT_196	[p10l1213t2528r1263b2558],
68	)	CD	NUMBER	)	num	69	SENT_196	[p10l1213t2528r1263b2558],
69	NC	NN	O	nc	_	0	SENT_196	[p10l1642t2527r1683b2551],

1	Molecular	JJ	O	molecular	amod	2	SENT_197	[p10l123t2575r259b2600],
2	biomarkers	NNS	O	biomarker	nsubj	3	SENT_197	[p10l268t2575r420b2600],
3	—	VBP	O	—	_	0	SENT_197	[p10l428t2590r462b2593],
4	no.	RB	O	no.	advmod	3	SENT_197	[p10l472t2575r587b2608],
5	/	:	O	/	punct	7	SENT_197	[p10l472t2575r587b2608],
6	total	JJ	O	total	dep	7	SENT_197	[p10l472t2575r587b2608],
7	no.	JJ	O	no.	dep	4	SENT_197	[p10l599t2583r639b2600],
8	(	CD	PERCENT	(	num	9	SENT_197	[p10l650t2576r695b2608],
9	%	NN	PERCENT	%	dep	7	SENT_197	[p10l650t2576r695b2608],
10	)	CD	NUMBER	)	dobj	3	SENT_197	[p10l650t2576r695b2608],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_198	[p10l173t2626r247b2649],
2	ampliﬁcation	NN	O	ampliﬁcation	dep	19	SENT_198	[p10l258t2623r435b2657],
3	or	CC	O	or	_	0	SENT_198	[p10l447t2633r474b2649],
4	polysomy	NN	O	polysomy	dep	19	SENT_198	[p10l485t2624r614b2657],
5	6/7	CD	NUMBER	6/7	number	6	SENT_198	[p10l888t2626r932b2657],
6	(	CD	NUMBER	(	dep	2	SENT_198	[p10l945t2625r994b2657],
7	86	CD	NUMBER	86	num	8	SENT_198	[p10l945t2625r994b2657],
8	)	NN	O	)	dep	6	SENT_198	[p10l945t2625r994b2657],
9	13/18	CD	NUMBER	13/18	number	10	SENT_198	[p10l1123t2625r1198b2657],
10	(	CD	NUMBER	(	dep	6	SENT_198	[p10l1212t2626r1261b2657],
11	72	CD	NUMBER	72	num	14	SENT_198	[p10l1212t2626r1261b2657],
12	)	NN	O	)	nn	14	SENT_198	[p10l1212t2626r1261b2657],
13	NC	NN	O	nc	nn	14	SENT_198	[p10l1642t2626r1683b2649],
14	EGFRVIII	NN	O	egfrviius	dep	10	SENT_198	[p10l173t2675r290b2698],
15	expression	NN	O	expression	dep	19	SENT_198	[p10l302t2675r447b2706],
16	5/7	CD	NUMBER	5/7	num	15	SENT_198	[p10l888t2675r932b2706],
17	(	CD	NUMBER	(	num	19	SENT_198	[p10l945t2675r994b2706],
18	86	CD	NUMBER	86	num	19	SENT_198	[p10l945t2675r994b2706],
19	)	NN	O	)	dep	25	SENT_198	[p10l945t2675r994b2706],
20	5/19	CD	NUMBER	5/19	number	21	SENT_198	[p10l1138t2675r1198b2706],
21	(	CD	NUMBER	(	dep	19	SENT_198	[p10l1211t2675r1261b2706],
22	32	CD	NUMBER	32	num	23	SENT_198	[p10l1211t2675r1261b2706],
23	)	CD	NUMBER	)	dep	21	SENT_198	[p10l1211t2675r1261b2706],
24	13	CD	NUMBER	13	num	25	SENT_198	[p10l1590t2675r1617b2698],
25	(	NN	O	(	dep	33	SENT_198	[p10l1632t2675r1731b2706],
26	1	CD	NUMBER	1	number	27	SENT_198	[p10l1632t2675r1731b2706],
27	—	CD	NUMBER	—	dep	25	SENT_198	[p10l1632t2675r1731b2706],
28	13o	NN	O	13o	nn	31	SENT_198	[p10l1632t2675r1731b2706],
29	)	CD	NUMBER	)	num	31	SENT_198	[p10l1632t2675r1731b2706],
30	PTEN	NN	ORGANIZATION	pten	nn	31	SENT_198	[p10l173t2724r247b2747],
31	expression	NN	O	expression	dep	27	SENT_198	[p10l259t2725r403b2755],
32	7/7	CD	NUMBER	7/7	num	33	SENT_198	[p10l889t2724r932b2755],
33	(	NN	O	(	dep	37	SENT_198	[p10l945t2724r1011b2755],
34	100	CD	NUMBER	100	number	35	SENT_198	[p10l945t2724r1011b2755],
35	)	CD	NUMBER	)	dep	33	SENT_198	[p10l945t2724r1011b2755],
36	6/19	CD	NUMBER	6/19	dep	35	SENT_198	[p10l1138t2724r1198b2755],
37	(	NN	O	(	dep	41	SENT_198	[p10l1212t2724r1261b2755],
38	32	CD	NUMBER	32	num	37	SENT_198	[p10l1212t2724r1261b2755],
39	)	CD	NUMBER	)	num	41	SENT_198	[p10l1212t2724r1261b2755],
40	NCT	NNP	MISC	NCT	nn	41	SENT_198	[p10l1642t2724r1701b2755],
41	Coexpression	NN	MISC	coexpression	dep	46	SENT_198	[p10l172t2773r353b2804],
42	of	IN	MISC	of	_	0	SENT_198	[p10l364t2771r394b2797],
43	EGFRv	NNP	MISC	EGFRv	prep_of	41	SENT_198	[p10l401t2773r518b2797],
44	|	CD	NUMBER	|	num	43	SENT_198	[p10l401t2773r518b2797],
45	|	CD	NUMBER	|	num	46	SENT_198	[p10l401t2773r518b2797],
46	|	NN	O	|	dep	50	SENT_198	[p10l401t2773r518b2797],
47	and	CC	O	and	_	0	SENT_198	[p10l531t2771r579b2797],
48	PTEN	NN	O	pten	conj_and	46	SENT_198	[p10l592t2774r686b2804],
49	:	:	O	:	_	0	SENT_198	[p10l592t2774r686b2804],
50	§	CD	NUMBER	§	_	0	SENT_198	[p10l592t2774r686b2804],
51	:	:	O	:	_	0	SENT_198	[p10l592t2774r686b2804],
52	6/7	CD	NUMBER	6/7	dep	61	SENT_198	[p10l887t2773r931b2804],
53	(	CD	NUMBER	(	number	54	SENT_198	[p10l944t2773r994b2804],
54	86	CD	NUMBER	86	dep	52	SENT_198	[p10l944t2773r994b2804],
55	)	CD	NUMBER	)	num	56	SENT_198	[p10l944t2773r994b2804],
56	2/19	CD	NUMBER	2/19	dep	54	SENT_198	[p10l1137t2774r1198b2804],
57	(	NN	O	(	dep	61	SENT_198	[p10l1211t2773r1261b2804],
58	11	CD	NUMBER	11	num	57	SENT_198	[p10l1211t2773r1261b2804],
59	)	CD	NUMBER	)	num	61	SENT_198	[p10l1211t2773r1261b2804],
60	51	CD	NUMBER	51	num	61	SENT_198	[p10l1588t2774r1617b2797],
61	(	NN	O	(	dep	65	SENT_198	[p10l1631t2773r1731b2804],
62	4	CD	NUMBER	4	num	63	SENT_198	[p10l1631t2773r1731b2804],
63	—	NN	O	—	dep	61	SENT_198	[p10l1631t2773r1731b2804],
64	669	CD	NUMBER	669	num	65	SENT_198	[p10l1631t2773r1731b2804],
65	)	NN	O	)	dep	50	SENT_198	[p10l1631t2773r1731b2804],

1	UCSF	NNP	ORGANIZATION	UCSF	nn	2	SENT_199	[p10l122t2822r198b2846],
2	patients	NNS	O	patient	_	0	SENT_199	[p10l208t2821r317b2853],
3	Clinical	JJ	O	clinical	amod	4	SENT_199	[p10l122t2870r219b2895],
4	variables	NNS	O	variable	dep	2	SENT_199	[p10l230t2870r350b2895],
5	Total	JJ	O	total	amod	6	SENT_199	[p10l120t2919r184b2944],
6	no.	NN	O	no.	dep	4	SENT_199	[p10l197t2928r237b2944],
7	25	CD	NUMBER	25	num	9	SENT_199	[p10l1169t2921r1199b2944],
8	Median	JJ	MISC	median	amod	9	SENT_199	[p10l173t2968r273b2993],
9	age	NN	O	age	dep	2	SENT_199	[p10l285t2977r405b3001],
10	—	CD	NUMBER	—	num	11	SENT_199	[p10l285t2977r405b3001],
11	yr	NN	DURATION	yr	dep	9	SENT_199	[p10l285t2977r405b3001],
12	53	CD	NUMBER	53	num	13	SENT_199	[p10l1169t2970r1198b2993],
13	Sex	NN	O	sex	dep	2	SENT_199	[p10l172t3019r258b3043],
14	—	CD	NUMBER	—	num	15	SENT_199	[p10l172t3019r258b3043],
15	no.	NN	O	no.	dep	13	SENT_199	[p10l268t3026r308b3043],
16	.	.	O	.	_	0	SENT_199	[p10l268t3026r308b3043],

1	Male	JJ	O	male	_	0	SENT_200	[p10l224t3066r288b3092],
2	10	CD	NUMBER	10	tmod	1	SENT_200	[p10l1171t3068r1201b3092],
3	Female	JJ	O	female	dep	1	SENT_200	[p10l223t3116r319b3141],
4	2	CD	NUMBER	2	number	5	SENT_200	[p10l919t3118r933b3140],
5	15	CD	NUMBER	15	dep	3	SENT_200	[p10l1171t3118r1199b3141],

1	Concurrent	JJ	O	concurrent	amod	2	SENT_201	[p10l172t3167r324b3190],
2	temozolomide	NN	O	temozolomide	_	0	SENT_201	[p10l333t3165r575b3190],
3	—	CD	NUMBER	—	num	4	SENT_201	[p10l333t3165r575b3190],
4	no.	NN	O	no.	dep	2	SENT_201	[p10l585t3165r638b3198],
5	§	CD	NUMBER	§	number	6	SENT_201	[p10l585t3165r638b3198],
6	4	CD	NUMBER	4	dep	4	SENT_201	[p10l1185t3167r1200b3190],
7	0.61	CD	NUMBER	0.61	num	11	SENT_201	[p10l1401t3167r1456b3190],
8	NC	NN	MISC	nc	nn	11	SENT_201	[p10l1641t3167r1683b3190],
9	Enzyme-inducing	JJ	MISC	enzyme-inducing	amod	11	SENT_201	[p10l173t3214r408b3247],
10	antiepileptic	JJ	O	antiepileptic	amod	11	SENT_201	[p10l418t3214r586b3247],
11	drugs	NNS	O	drug	dep	2	SENT_201	[p10l595t3214r671b3247],

1	Mean	NN	O	mean	nn	3	SENT_202	[p10l223t3266r297b3288],
2	dose	NN	O	dose	nn	3	SENT_202	[p10l308t3263r372b3288],
3	oferlotinib	NN	O	oferlotinib	dep	12	SENT_202	[p10l382t3263r530b3288],
4	—	CD	NUMBER	—	num	5	SENT_202	[p10l538t3279r572b3281],
5	mg	NN	O	mg	dep	3	SENT_202	[p10l582t3272r625b3296],
6	(	CD	NUMBER	(	num	7	SENT_202	[p10l637t3265r697b3296],
7	no.	NN	O	no.	dep	5	SENT_202	[p10l637t3265r697b3296],
8	)	NN	O	)	dep	12	SENT_202	[p10l637t3265r697b3296],
9	267	CD	NUMBER	267	num	8	SENT_202	[p10l1153t3265r1200b3289],
10	(	CD	NUMBER	(	number	11	SENT_202	[p10l1213t3265r1263b3296],
11	15	CD	NUMBER	15	num	12	SENT_202	[p10l1213t3265r1263b3296],
12	)	NN	O	)	dep	14	SENT_202	[p10l1213t3265r1263b3296],
13	0.12	CD	NUMBER	0.12	dep	12	SENT_202	[p10l1402t3265r1457b3289],
14	NC	NN	O	nc	_	0	SENT_202	[p10l1642t3265r1683b3288],

1	No	DT	O	no	det	2	SENT_203	[p10l173t3315r212b3338],
2	enzyme-inducing	JJ	O	enzyme-inducing	_	0	SENT_203	[p10l222t3312r457b3346],
3	antiepileptic	JJ	O	antiepileptic	amod	4	SENT_203	[p10l467t3312r634b3345],
4	drugs	NNS	O	drug	dep	2	SENT_203	[p10l644t3312r720b3346],

1	Mean	NN	O	mean	nn	3	SENT_204	[p10l224t3364r297b3387],
2	dose	NN	O	dose	nn	3	SENT_204	[p10l308t3362r372b3387],
3	oferlotinib	NN	O	oferlotinib	dep	10	SENT_204	[p10l382t3361r530b3387],
4	—	CD	NUMBER	—	num	5	SENT_204	[p10l538t3377r572b3380],
5	mg	NN	O	mg	dep	3	SENT_204	[p10l582t3370r625b3395],
6	(	CD	NUMBER	(	num	7	SENT_204	[p10l637t3364r697b3395],
7	no.	NN	O	no.	dep	10	SENT_204	[p10l637t3364r697b3395],
8	)	NN	O	)	nn	10	SENT_204	[p10l637t3364r697b3395],
9	180	CD	NUMBER	180	num	10	SENT_204	[p10l1154t3363r1201b3387],
10	(	NN	O	(	_	0	SENT_204	[p10l1213t3363r1263b3395],
11	10	CD	NUMBER	10	number	12	SENT_204	[p10l1213t3363r1263b3395],
12	)	CD	NUMBER	)	dep	10	SENT_204	[p10l1213t3363r1263b3395],
13	1.0	CD	NUMBER	1.0	num	14	SENT_204	[p10l1404t3363r1442b3387],
14	NC	NN	O	nc	dep	12	SENT_204	[p10l1642t3364r1683b3387],

1	Molecular	JJ	O	molecular	amod	2	SENT_205	[p10l123t3411r258b3436],
2	biomarkers	NNS	O	biomarker	nsubj	3	SENT_205	[p10l268t3411r420b3436],
3	—	VBP	O	—	_	0	SENT_205	[p10l428t3426r462b3429],
4	no.	RB	O	no.	advmod	3	SENT_205	[p10l472t3411r587b3444],
5	/	:	O	/	punct	7	SENT_205	[p10l472t3411r587b3444],
6	total	JJ	O	total	dep	7	SENT_205	[p10l472t3411r587b3444],
7	no.	JJ	O	no.	dep	4	SENT_205	[p10l599t3419r639b3436],
8	(	CD	PERCENT	(	num	9	SENT_205	[p10l650t3412r695b3444],
9	%	NN	PERCENT	%	dep	7	SENT_205	[p10l650t3412r695b3444],
10	)	CD	NUMBER	)	dobj	3	SENT_205	[p10l650t3412r695b3444],

1	EGFRVIII	NN	O	egfrviius	nn	2	SENT_206	[p10l174t3462r290b3485],
2	expression	NN	O	expression	dep	13	SENT_206	[p10l302t3462r447b3493],
3	11/25	CD	NUMBER	11/25	number	4	SENT_206	[p10l1148t3462r1222b3493],
4	(	CD	NUMBER	(	dep	2	SENT_206	[p10l1237t3462r1286b3493],
5	44	CD	NUMBER	44	num	6	SENT_206	[p10l1237t3462r1286b3493],
6	)	NN	O	)	dep	4	SENT_206	[p10l1237t3462r1286b3493],
7	0.05	CD	NUMBER	0.05	num	8	SENT_206	[p10l1402t3462r1456b3485],
8	9	CD	NUMBER	9	dep	4	SENT_206	[p10l1605t3462r1619b3485],
9	(	NN	O	(	dep	13	SENT_206	[p10l1632t3462r1715b3493],
10	1-34	CD	NUMBER	1-34	num	9	SENT_206	[p10l1632t3462r1715b3493],
11	)	CD	NUMBER	)	num	13	SENT_206	[p10l1632t3462r1715b3493],
12	PTEN	NN	ORGANIZATION	pten	nn	13	SENT_206	[p10l173t3511r247b3534],
13	expression	NN	O	expression	dep	17	SENT_206	[p10l259t3512r403b3542],
14	4/25	CD	NUMBER	4/25	number	15	SENT_206	[p10l1162t3511r1222b3542],
15	(	CD	NUMBER	(	dep	13	SENT_206	[p10l1237t3511r1286b3542],
16	16	CD	NUMBER	16	dep	15	SENT_206	[p10l1237t3511r1286b3542],
17	)	NN	O	)	dep	20	SENT_206	[p10l1237t3511r1286b3542],
18	0.02	CD	NUMBER	0.02	num	17	SENT_206	[p10l1402t3511r1457b3534],
19	9	CD	NUMBER	9	num	20	SENT_206	[p10l1605t3511r1619b3535],
20	(	NN	O	(	dep	22	SENT_206	[p10l1632t3511r1740b3542],
21	1.5	CD	NUMBER	1.5	number	22	SENT_206	[p10l1632t3511r1740b3542],
22	—	CD	NUMBER	—	dep	30	SENT_206	[p10l1632t3511r1740b3542],
23	52	CD	NUMBER	52	num	25	SENT_206	[p10l1632t3511r1740b3542],
24	)	NN	O	)	nn	25	SENT_206	[p10l1632t3511r1740b3542],
25	Coexpression	NN	O	coexpression	dep	22	SENT_206	[p10l172t3560r353b3591],
26	of	IN	O	of	_	0	SENT_206	[p10l364t3558r394b3584],
27	EGFRv	NNP	O	EGFRv	prep_of	22	SENT_206	[p10l401t3560r518b3584],
28	|	CD	NUMBER	|	num	27	SENT_206	[p10l401t3560r518b3584],
29	|	CD	NUMBER	|	num	30	SENT_206	[p10l401t3560r518b3584],
30	|	NN	O	|	dep	35	SENT_206	[p10l401t3560r518b3584],
31	and	CC	O	and	_	0	SENT_206	[p10l531t3558r579b3584],
32	PTENﬁ	NN	O	ptenﬁ	dep	35	SENT_206	[p10l592t3558r686b3591],
33	]	CD	NUMBER	]	num	32	SENT_206	[p10l592t3558r686b3591],
34	1/25	CD	NUMBER	1/25	num	35	SENT_206	[p10l1164t3561r1222b3591],
35	(	NN	O	(	dep	40	SENT_206	[p10l1237t3560r1270b3591],
36	4	CD	NUMBER	4	number	37	SENT_206	[p10l1237t3560r1270b3591],
37	)	CD	NUMBER	)	dep	35	SENT_206	[p10l1237t3560r1270b3591],
38	0.001	CD	NUMBER	0.001	num	39	SENT_206	[p10l1402t3560r1473b3584],
39	40	CD	NUMBER	40	dep	37	SENT_206	[p10l1587t3560r1619b3584],
40	(	NN	O	(	dep	42	SENT_206	[p10l1632t3560r1732b3591],
41	3	CD	NUMBER	3	num	40	SENT_206	[p10l1632t3560r1732b3591],
42	—	NN	O	—	_	0	SENT_206	[p10l1632t3560r1732b3591],
43	468	CD	NUMBER	468	num	42	SENT_206	[p10l1632t3560r1732b3591],
44	)	NN	O	)	dep	42	SENT_206	[p10l1632t3560r1732b3591],
45	'	''	O	'	_	0	SENT_206	[p11l96t31r106b36],

1	~	NN	O	~	nn	2	SENT_207	[p11l96t31r106b36],
2	CI	NN	O	ci	nsubj	3	SENT_207	[p11l119t22r145b45],
3	denotes	VBZ	O	denote	_	0	SENT_207	[p11l157t20r265b45],
4	conﬁdence	NN	O	conﬁdence	nn	5	SENT_207	[p11l275t19r424b45],
5	interval	NN	O	interval	dobj	3	SENT_207	[p11l435t20r541b49],
6	,	,	O	,	_	0	SENT_207	[p11l435t20r541b49],
7	and	CC	O	and	_	0	SENT_207	[p11l552t20r601b45],
8	NC	NN	O	nc	nsubj	10	SENT_207	[p11l614t22r655b45],
9	not	RB	O	not	neg	8	SENT_207	[p11l667t24r710b45],
10	calculated	VBN	O	calculate	conj_and	3	SENT_207	[p11l719t20r863b45],
11	.	.	O	.	_	0	SENT_207	[p11l719t20r863b45],

1	1	CD	NUMBER	1	dep	9	SENT_208	[p11l95t59r110b90],
2	'	''	O	'	_	0	SENT_208	[p11l95t59r110b90],
3	An	DT	O	a	det	5	SENT_208	[p11l118t59r153b82],
4	odds	NNS	O	odds	nn	5	SENT_208	[p11l165t57r231b82],
5	ratio	NN	O	ratio	nsubjpass	9	SENT_208	[p11l243t60r302b82],
6	could	MD	O	could	aux	9	SENT_208	[p11l313t57r385b82],
7	not	RB	O	not	neg	9	SENT_208	[p11l398t62r441b82],
8	be	VB	O	be	auxpass	9	SENT_208	[p11l452t57r482b82],
9	calculated	VBN	O	calculate	_	0	SENT_208	[p11l492t57r627b82],
10	because	IN	O	because	mark	19	SENT_208	[p11l640t57r749b82],
11	none	NN	O	none	nn	12	SENT_208	[p11l760t66r827b82],
12	ofthe	NN	O	ofthe	nsubj	19	SENT_208	[p11l837t57r913b82],
13	UCLA	NNP	ORGANIZATION	UCLA	nn	14	SENT_208	[p11l925t59r1001b83],
14	patien	NN	O	patien	nsubj	15	SENT_208	[p11l1012t60r1093b90],
15	s	VBZ	O	s	rcmod	12	SENT_208	[p11l1108t66r1119b82],
16	with	IN	O	with	_	0	SENT_208	[p11l1129t57r1185b82],
17	PTEN-deficient	JJ	O	pten-deficient	amod	18	SENT_208	[p11l1198t57r1402b82],
18	tumors	NNS	O	tumor	prep_with	15	SENT_208	[p11l1411t62r1509b82],
19	had	VBD	O	have	advcl	9	SENT_208	[p11l1521t57r1568b82],
20	a	DT	O	a	det	21	SENT_208	[p11l1580t66r1592b82],
21	response	NN	O	response	dobj	19	SENT_208	[p11l1604t66r1734b90],
22	,	,	O	,	_	0	SENT_208	[p11l1604t66r1734b90],
23	but	CC	O	but	_	0	SENT_208	[p11l121t94r163b120],
24	if0	NN	O	if0	nsubjpass	27	SENT_208	[p11l174t94r236b120],
25	.5	CD	NUMBER	.5	num	24	SENT_208	[p11l174t94r236b120],
26	is	VBZ	O	be	auxpass	27	SENT_208	[p11l249t97r268b119],
27	added	VBN	O	add	conj_but	19	SENT_208	[p11l279t94r360b119],
28	to	TO	O	to	_	0	SENT_208	[p11l371t99r397b119],
29	each	DT	O	each	det	31	SENT_208	[p11l408t94r468b119],
30	cell	NN	O	cell	nn	31	SENT_208	[p11l480t94r522b119],
31	count	NN	O	count	prep_to	27	SENT_208	[p11l534t99r618b124],
32	,	,	O	,	_	0	SENT_208	[p11l534t99r618b124],
33	the	DT	O	the	det	35	SENT_208	[p11l628t94r671b119],
34	odds	NNS	O	odds	nn	35	SENT_208	[p11l681t94r746b119],
35	ratio	NN	O	ratio	nsubj	41	SENT_208	[p11l758t97r818b119],
36	is	VBZ	O	be	cop	41	SENT_208	[p11l829t97r848b119],
37	31	CD	PERCENT	31	advmod	41	SENT_208	[p11l859t96r889b119],
38	(	CD	PERCENT	(	number	39	SENT_208	[p11l903t96r942b127],
39	95	CD	PERCENT	95	num	41	SENT_208	[p11l903t96r942b127],
40	percent	NN	PERCENT	percent	nn	41	SENT_208	[p11l955t99r1055b127],
41	con	NN	O	con	parataxis	27	SENT_208	[p11l1065t103r1112b119],
42	I	PRP	O	I	nsubj	43	SENT_208	[p11l1126t103r1129b119],
43	ence	VBP	O	ence	rcmod	41	SENT_208	[p11l1151t103r1213b119],
44	interval	NN	O	interval	dobj	43	SENT_208	[p11l1224t94r1330b124],
45	,	,	O	,	_	0	SENT_208	[p11l1224t94r1330b124],
46	.	.	O	.	_	0	SENT_208	[p11l1359t115r1363b119],

1	o	NN	O	o	_	0	SENT_209	[p11l1401t103r1417b119],
2	633.0	CD	NUMBER	633.0	num	3	SENT_209	[p11l1427t96r1519b127],
3	)	NN	O	)	dep	1	SENT_209	[p11l1427t96r1519b127],
4	.	.	O	.	_	0	SENT_209	[p11l1427t96r1519b127],

1	ad	NN	O	ad	_	0	SENT_210	[p11l256t132r285b157],
2	a	DT	O	a	det	3	SENT_210	[p11l297t141r310b157],
3	sen	NN	O	sen	dep	1	SENT_210	[p11l321t141r365b157],

1	5A	NN	O	5a	_	0	SENT_211	[p11l95t134r110b144],
2	+	CC	O	+	_	0	SENT_211	[p11l95t134r110b144],
3	e	LS	O	e	dep	8	SENT_211	[p11l155t141r168b157],
4	test	NN	O	test	nn	8	SENT_211	[p11l177t137r228b157],
5	h	NN	O	h	nn	8	SENT_211	[p11l238t132r252b157],
6	sitivity	NN	O	sitivity	nn	8	SENT_211	[p11l370t134r456b165],
7	of86	NN	PERCENT	of86	nn	8	SENT_211	[p11l466t132r531b157],
8	percent	NN	PERCENT	percent	conj_+	1	SENT_211	[p11l543t137r644b165],
9	and	CC	O	and	_	0	SENT_211	[p11l654t132r702b157],
10	a	DT	O	a	det	11	SENT_211	[p11l713t141r726b157],
11	specificity	NN	O	specificity	conj_+	1	SENT_211	[p11l737t132r871b165],
12	of	IN	O	of	_	0	SENT_211	[p11l881t132r910b157],
13	89	CD	PERCENT	89	num	14	SENT_211	[p11l916t134r946b157],
14	percent	NN	PERCENT	percent	prep_of	8	SENT_211	[p11l958t137r1059b165],
15	in	IN	O	in	_	0	SENT_211	[p11l1069t134r1091b157],
16	the	DT	O	the	det	17	SENT_211	[p11l1101t132r1144b157],
17	UCLA	NNP	ORGANIZATION	UCLA	prep_in	14	SENT_211	[p11l1156t134r1232b157],
18	group	NN	O	group	dep	1	SENT_211	[p11l1242t141r1321b165],
19	an	DT	O	a	det	23	SENT_211	[p11l1332t141r1362b157],
20	a	DT	O	a	dep	21	SENT_211	[p11l1391t141r1404b157],
21	positive	JJ	O	positive	amod	23	SENT_211	[p11l1416t134r1521b165],
22	predictive	JJ	O	predictive	amod	23	SENT_211	[p11l1532t132r1663b165],
23	value	NN	O	value	dep	18	SENT_211	[p11l1673t132r1744b157],

1	75	CD	NUMBER	75	num	2	SENT_212	[p11l156t171r184b194],
2	p	NN	O	p	_	0	SENT_212	[p11l197t178r211b202],
3	t.	IN	O	t.	dep	2	SENT_212	[p11l288t174r304b194],

1	§	NN	O	§	nn	3	SENT_213	[p11l94t207r105b240],
2	A	NN	O	a	nn	3	SENT_213	[p11l118t209r138b232],
3	subgroup	NN	O	subgroup	nsubj	10	SENT_213	[p11l147t207r277b240],
4	of	IN	O	of	_	0	SENT_213	[p11l287t207r317b232],
5	patients	NNS	O	patient	prep_of	3	SENT_213	[p11l323t209r430b240],
6	in	IN	O	in	_	0	SENT_213	[p11l442t209r464b232],
7	the	DT	O	the	det	9	SENT_213	[p11l474t207r517b232],
8	UCSF	NNP	ORGANIZATION	UCSF	nn	9	SENT_213	[p11l528t209r603b232],
9	study	NN	O	study	prep_in	5	SENT_213	[p11l614t207r686b240],
10	received	VBD	O	receive	_	0	SENT_213	[p11l697t207r806b232],
11	concurrent	JJ	O	concurrent	amod	12	SENT_213	[p11l817t212r965b232],
12	temozolomide	NN	O	temozolomide	dobj	10	SENT_213	[p11l974t207r1181b232],
13	.	.	O	.	_	0	SENT_213	[p11l974t207r1181b232],

1	All	DT	O	all	det	3	SENT_214	[p11l1191t207r1224b232],
2	UCLA	NNP	ORGANIZATION	UCLA	nn	3	SENT_214	[p11l1237t209r1314b232],
3	patients	NNS	O	patient	nsubj	4	SENT_214	[p11l1324t209r1431b240],
4	received	VBD	O	receive	dep	12	SENT_214	[p11l1443t207r1552b232],
5	monotherapy	NN	O	monotherapy	nn	6	SENT_214	[p11l1565t207r1747b240],
6	h	NN	O	h	iobj	4	SENT_214	[p11l161t244r174b268],
7	an	DT	O	a	det	8	SENT_214	[p11l186t252r216b269],
8	EGFR	NN	ORGANIZATION	egfr	dobj	4	SENT_214	[p11l230t246r304b269],
9	kin	FW	O	kin	dep	8	SENT_214	[p11l315t244r352b268],
10	e	SYM	O	e	dep	11	SENT_214	[p11l155t290r169b306],
11	test	NN	O	test	dep	8	SENT_214	[p11l177t286r228b306],
12	had	VBD	O	have	_	0	SENT_214	[p11l239t281r285b306],
13	a	DT	O	a	det	14	SENT_214	[p11l297t290r310b306],
14	s	NNS	O	s	dobj	12	SENT_214	[p11l321t290r332b306],
15	wit	NN	O	wit	nn	17	SENT_214	[p11l118t246r158b269],
16	ase	NN	O	ase	nn	17	SENT_214	[p11l356t252r399b269],
17	inhi	NN	O	inhus	nsubj	12	SENT_214	[p11l410t244r458b268],
18	i	FW	O	i	nn	19	SENT_214	[p11l481t246r484b268],
19	r.	FW	O	r.	dep	17	SENT_214	[p11l517t253r529b269],
20	1	CD	NUMBER	1	number	21	SENT_214	[p11l95t281r151b313],
21	|	CD	NUMBER	|	num	25	SENT_214	[p11l95t281r151b313],
22	Th	NN	O	th	nn	25	SENT_214	[p11l95t281r151b313],
23	ensitivity	NN	O	ensitivity	nn	25	SENT_214	[p11l335t284r456b314],
24	o	NN	O	o	nn	25	SENT_214	[p11l465t290r481b306],
25	percent	NN	O	percent	dep	19	SENT_214	[p11l543t286r650b314],
26	,	,	O	,	_	0	SENT_214	[p11l543t286r650b314],
27	a	DT	O	a	det	30	SENT_214	[p11l662t290r675b306],
28	specificity	NN	O	specificity	nn	30	SENT_214	[p11l686t281r820b314],
29	of96	NN	PERCENT	of96	nn	30	SENT_214	[p11l829t281r895b306],
30	percent	NN	PERCENT	percent	nsubj	12	SENT_214	[p11l907t286r1014b314],
31	,	,	O	,	_	0	SENT_214	[p11l907t286r1014b314],
32	and	CC	O	and	_	0	SENT_214	[p11l1026t281r1074b306],
33	a	DT	O	a	det	36	SENT_214	[p11l1085t290r1098b306],
34	positive	JJ	O	positive	amod	36	SENT_214	[p11l1110t284r1215b314],
35	predictive	JJ	O	predictive	amod	36	SENT_214	[p11l1226t281r1357b314],
36	value	NN	O	value	conj_and	17	SENT_214	[p11l1367t281r1438b306],
37	of	IN	O	of	_	0	SENT_214	[p11l1447t281r1477b306],
38	89	CD	PERCENT	89	num	39	SENT_214	[p11l1483t283r1513b307],
39	percent	NN	PERCENT	percent	prep_of	36	SENT_214	[p11l1525t286r1632b314],
40	.	.	O	.	_	0	SENT_214	[p11l1525t286r1632b314],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_215	[p11l555t420r639b442],
2	MED	NNP	O	MED	_	0	SENT_215	[p11l654t421r706b436],
3	353	CD	NUMBER	353	num	5	SENT_215	[p11l719t420r797b442],
4	;	:	O	;	_	0	SENT_215	[p11l719t420r797b442],
5	19	CD	NUMBER	19	dep	2	SENT_215	[p11l719t420r797b442],
6	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	7	SENT_215	[p11l832t420r1043b442],
7	NOVEMBER	NNP	DATE	NOVEMBER	dep	5	SENT_215	[p11l1083t420r1224b436],
8	10	CD	DATE	10	num	7	SENT_215	[p11l1237t420r1272b440],
9	,	,	DATE	,	_	0	SENT_215	[p11l1237t420r1272b440],
10	2005	CD	DATE	2005	num	7	SENT_215	[p11l1286t420r1349b442],
11	2017	CD	DATE	2017	dep	2	SENT_215	[p11l1991t419r2067b440],

1	The	DT	O	the	det	5	SENT_216	[p11l753t517r803b541],
2	New	NNP	O	New	nn	5	SENT_216	[p11l813t518r875b541],
3	England	NNP	O	England	nn	5	SENT_216	[p11l884t517r995b548],
4	J	NNP	O	J	nn	5	SENT_216	[p11l1003t518r1016b541],
5	oumal	NN	O	oumal	_	0	SENT_216	[p11l1017t517r1101b541],
6	of	IN	O	of	_	0	SENT_216	[p11l1111t517r1139b541],
7	Medicine	NN	O	medicine	prep_of	5	SENT_216	[p11l1146t517r1271b541],

1	Downloaded	VBN	O	download	_	0	SENT_217	[p11l195t558r365b581],
2	from	IN	O	from	_	0	SENT_217	[p11l373t558r438b581],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_217	[p11l447t558r565b588],
4	at	IN	O	at	_	0	SENT_217	[p11l575t562r598b581],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_217	[p11l607t558r789b581],
6	on	IN	O	on	_	0	SENT_217	[p11l799t565r831b581],
7	January	NNP	DATE	January	prep_on	1	SENT_217	[p11l840t558r942b588],
8	5	CD	DATE	5	num	7	SENT_217	[p11l953t558r975b585],
9	,	,	DATE	,	_	0	SENT_217	[p11l953t558r975b585],
10	2014	CD	DATE	2014	num	7	SENT_217	[p11l986t558r1058b581],
11	.	.	O	.	_	0	SENT_217	[p11l986t558r1058b581],

1	For	IN	O	for	_	0	SENT_218	[p11l1069t558r1115b581],
2	personal	JJ	O	personal	amod	3	SENT_218	[p11l1123t558r1236b588],
3	use	NN	O	use	pobj	1	SENT_218	[p11l1245t565r1288b581],
4	only	RB	O	only	advmod	3	SENT_218	[p11l1298t558r1363b588],
5	.	.	O	.	_	0	SENT_218	[p11l1298t558r1363b588],

1	No	DT	O	no	det	3	SENT_219	[p11l1373t558r1413b581],
2	other	JJ	O	other	amod	3	SENT_219	[p11l1423t558r1491b581],
3	uses	NNS	O	use	_	0	SENT_219	[p11l1499t565r1555b581],
4	without	IN	O	without	_	0	SENT_219	[p11l1566t558r1667b581],
5	permission	NN	O	permission	prep_without	3	SENT_219	[p11l1675t558r1828b588],
6	.	.	O	.	_	0	SENT_219	[p11l1675t558r1828b588],

1	Copyright	NN	O	copyright	_	0	SENT_220	[p11l545t599r679b630],
2	©	CD	NUMBER	©	num	6	SENT_220	[p11l689t599r712b623],
3	2005	CD	DATE	2005	num	6	SENT_220	[p11l722t599r786b623],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_220	[p11l797t599r988b623],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_220	[p11l998t599r1106b623],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_220	[p11l1116t599r1221b630],
7	.	.	O	.	_	0	SENT_220	[p11l1116t599r1221b630],

1	All	DT	O	all	det	2	SENT_221	[p11l1232t599r1273b623],
2	rights	NNS	O	rights	nsubj	3	SENT_221	[p11l1283t599r1357b630],
3	reserved	VBN	O	reserve	_	0	SENT_221	[p11l1367t599r1486b623],
4	.	.	O	.	_	0	SENT_221	[p11l1367t599r1486b623],

1	The	DT	O	the	det	4	SENT_222	[p11l715t705r752b726],
2	NEW	NNP	O	NEW	nn	4	SENT_222	[p11l764t707r845b726],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_222	[p11l859t707r1034b726],
4	IOURNAL	NNP	O	IOURNAL	_	0	SENT_222	[p11l1048t707r1214b733],
5	ofMEDICINE	NN	O	ofmedicine	dep	4	SENT_222	[p11l1228t705r1444b732],

1	ing	NN	O	ing	nsubjpass	4	SENT_223	[p11l11t928r149b1028],
2	was	VBD	O	be	auxpass	4	SENT_223	[p11l171t954r331b1007],
3	also	RB	O	also	advmod	4	SENT_223	[p11l362t928r529b1006],
4	performed	VBN	O	perform	dep	17	SENT_223	[p11l558t927r1008b1028],
5	with	IN	O	with	_	0	SENT_223	[p11l1032t928r1221b1007],
6	the	DT	O	the	det	7	SENT_223	[p11l1250t928r1380b1006],
7	use	NN	O	use	prep_with	4	SENT_223	[p11l1409t954r1548b1007],
8	of	IN	O	of	_	0	SENT_223	[p11l1578t927r1679b1006],
9	Soft	NNP	O	Soft	nn	13	SENT_223	[p11l1691t927r1861b1006],
10	Imaging	NNP	O	Imaging	nn	13	SENT_223	[p11l1883t935r2134b1028, p11l11t1056r149b1156],
11	System	NNP	O	System	nn	13	SENT_223	[p11l171t1061r466b1156],
12	softvvare	JJ	O	softvvare	amod	13	SENT_223	[p11l491t1055r849b1135],
13	(	NN	O	(	prep_of	7	SENT_223	[p11l877t1055r1296b1156],
14	complete	JJ	O	complete	amod	15	SENT_223	[p11l877t1055r1296b1156],
15	details	NNS	O	detail	nsubjpass	17	SENT_223	[p11l1319t1056r1592b1134],
16	are	VBP	O	be	auxpass	17	SENT_223	[p11l1617t1082r1742b1134],
17	provided	VBN	O	provide	_	0	SENT_223	[p11l1764t1056r2135b1156],
18	in	IN	O	in	_	0	SENT_223	[p11l11t1184r92b1261],
19	the	DT	O	the	det	22	SENT_223	[p11l117t1184r246b1262],
20	Supplementary	NNP	O	Supplementary	nn	22	SENT_223	[p11l274t1184r915b1284],
21	Appendix	NNP	O	Appendix	nn	22	SENT_223	[p11l933t1184r1399b1284],
22	)	NN	O	)	prep_in	17	SENT_223	[p11l933t1184r1399b1284],
23	.	.	O	.	_	0	SENT_223	[p11l933t1184r1399b1284],

1	CELL-LINE	JJ	O	cell-line	amod	2	SENT_224	[p11l12t1468r433b1517],
2	MODELS	NNS	O	model	nsubjpass	14	SENT_224	[p11l479t1468r817b1517],
3	U	NNP	O	U	dep	2	SENT_224	[p11l18t1586r79b1656],
4	8	CD	NUMBER	8	number	5	SENT_224	[p11l86t1584r131b1656],
5	7	CD	NUMBER	7	num	7	SENT_224	[p11l142t1587r188b1655],
6	M	NN	O	m	nn	7	SENT_224	[p11l190t1586r269b1655],
7	G	NN	O	g	dep	2	SENT_224	[p11l278t1585r341b1656],
8	Model	NNP	O	Model	nn	9	SENT_224	[p11l376t1579r624b1656],
9	EGFR	NN	ORGANIZATION	egfr	dep	7	SENT_224	[p11l9t1712r225b1785],
10	and	CC	O	and	_	0	SENT_224	[p11l264t1706r422b1784],
11	EGFRUHI	NN	O	egfruhus	nn	12	SENT_224	[p11l466t1712r815b1785],
12	cDNAs	NNS	O	cdna	dep	7	SENT_224	[p11l857t1712r1154b1785],
13	were	VBD	O	be	auxpass	14	SENT_224	[p11l1198t1732r1403b1785],
14	introduced	VBN	O	introduce	_	0	SENT_224	[p11l1449t1706r1919b1785],
15	into	IN	O	into	_	0	SENT_224	[p11l1964t1706r2132b1784],
16	U87MG	NN	O	u87mg	nn	17	SENT_224	[p11l11t1840r346b1913],
17	cells	NNS	O	cell	prep_into	14	SENT_224	[p11l372t1835r554b1913],
18	and	CC	O	and	_	0	SENT_224	[p11l580t1835r736b1913],
19	U87MG	NN	O	u87mg	prep_into	14	SENT_224	[p11l759t1840r1378b1913],
20	.	.	O	.	_	0	SENT_224	[p11l759t1840r1378b1913],

1	—	NN	O	—	_	0	SENT_225	[p11l759t1840r1378b1913],
2	.	.	O	.	_	0	SENT_225	[p11l759t1840r1378b1913],

1	PTEN	NN	O	pten	nn	2	SENT_226	[p11l759t1840r1378b1913],
2	cells	NNS	O	cell	nsubj	3	SENT_226	[p11l1402t1835r1584b1913],
3	(	VBP	O	(	_	0	SENT_226	[p11l1615t1834r1901b1926],
4	Which	WDT	O	which	nsubj	5	SENT_226	[p11l1615t1834r1901b1926],
5	overexpress	VBP	O	overexpress	ccomp	3	SENT_226	[p11l1926t1860r2134b1914, p11l12t1989r323b2063],
6	PTEN	NN	O	pten	dobj	5	SENT_226	[p11l345t1968r617b2054],
7	)	CD	NUMBER	)	num	6	SENT_226	[p11l345t1968r617b2054],
8	by	IN	O	by	_	0	SENT_226	[p11l644t1963r741b2063],
9	means	NNS	O	means	_	0	SENT_226	[p11l758t1988r1032b2041],
10	of	IN	O	of	_	0	SENT_226	[p11l1055t1962r1156b2041],
11	a	DT	O	a	det	13	SENT_226	[p11l1158t1989r1202b2041],
12	retroviral	JJ	O	retroviral	amod	13	SENT_226	[p11l1222t1963r1606b2042],
13	vector	NN	O	vector	prep_by_means_of	6	SENT_226	[p11l1622t1979r1903b2058],
14	;	:	O	;	_	0	SENT_226	[p11l1622t1979r1903b2058],
15	1000	CD	NUMBER	1000	num	16	SENT_226	[p11l1931t1968r2134b2041],
16	cells	NNS	O	cell	nsubjpass	20	SENT_226	[p11l12t2091r194b2169],
17	per	IN	O	per	_	0	SENT_226	[p11l220t2117r358b2191],
18	Well	NNP	O	Well	prep_per	16	SENT_226	[p11l376t2091r550b2170],
19	were	VBD	O	be	auxpass	20	SENT_226	[p11l569t2117r771b2170],
20	seeded	VBN	O	seed	parataxis	3	SENT_226	[p11l798t2090r1083b2169],
21	into	IN	O	into	_	0	SENT_226	[p11l1107t2091r1272b2169],
22	eight	CD	NUMBER	eight	num	23	SENT_226	[p11l1299t2091r1515b2191],
23	sets	NNS	O	set	prep_into	20	SENT_226	[p11l1536t2107r1691b2169],
24	of	IN	O	of	_	0	SENT_226	[p11l1718t2090r1819b2169],
25	96-well	JJ	O	96-well	amod	26	SENT_226	[p11l1825t2091r2135b2170],
26	plates	NNS	O	plate	prep_of	23	SENT_226	[p11l10t2219r281b2319],
27	.	.	O	.	_	0	SENT_226	[p11l10t2219r281b2319],

1	Twenty	CD	NUMBER	twenty	num	2	SENT_227	[p11l313t2218r833b2319],
2	—	CD	NUMBER	—	tmod	9	SENT_227	[p11l313t2218r833b2319],
3	four	CD	DATE	four	num	4	SENT_227	[p11l313t2218r833b2319],
4	hours	NNS	DATE	hour	npadvmod	5	SENT_227	[p11l859t2219r1100b2298],
5	later	RB	DATE	later	advmod	2	SENT_227	[p11l1130t2219r1335b2314],
6	,	,	O	,	_	0	SENT_227	[p11l1130t2219r1335b2314],
7	erlotinib	NN	O	erlotinib	nsubjpass	9	SENT_227	[p11l1371t2219r1729b2297],
8	was	VBD	O	be	auxpass	9	SENT_227	[p11l1756t2245r1916b2298],
9	added	VBN	O	add	_	0	SENT_227	[p11l1948t2218r2134b2297, p11l12t2347r108b2425],
10	at	IN	O	at	_	0	SENT_227	[p11l130t2363r209b2425],
11	ﬁnal	JJ	O	ﬁnal	amod	12	SENT_227	[p11l227t2346r416b2425],
12	concentrations	NNS	O	concentration	prep_at	9	SENT_227	[p11l439t2347r1067b2425],
13	ranging	VBG	O	range	partmod	12	SENT_227	[p11l1092t2347r1426b2447],
14	from	IN	O	from	_	0	SENT_227	[p11l1446t2346r1653b2425],
15	o	NN	O	o	prep_from	13	SENT_227	[p11l1676t2352r1723b2425],
16	to	TO	O	to	_	0	SENT_227	[p11l1748t2363r1827b2425],
17	10	CD	TIME	10	num	18	SENT_227	[p11l1855t2352r1951b2425],
18	pM	NN	TIME	pm	prep_to	13	SENT_227	[p11l1977t2354r2130b2447],
19	.	.	O	.	_	0	SENT_227	[p11l1977t2354r2130b2447],

1	Plates	NNS	O	plate	nsubjpass	22	SENT_228	[p11l10t2475r251b2553],
2	were	VBD	O	be	auxpass	3	SENT_228	[p11l269t2501r469b2554],
3	incubated	VBN	O	incubate	_	0	SENT_228	[p11l489t2475r901b2554],
4	for	IN	O	for	mark	12	SENT_228	[p11l921t2474r1043b2553],
5	7	CD	DURATION	7	number	7	SENT_228	[p11l1062t2482r1107b2553],
6	to	TO	DURATION	to	dep	7	SENT_228	[p11l1129t2491r1208b2553],
7	10	CD	DURATION	10	num	8	SENT_228	[p11l1233t2480r1329b2553],
8	days	NNS	NUMBER	day	nsubj	12	SENT_228	[p11l1352t2475r1556b2575],
9	,	,	O	,	_	0	SENT_228	[p11l1352t2475r1556b2575],
10	fixed	VBN	O	fix	partmod	8	SENT_228	[p11l1582t2474r1807b2570],
11	,	,	O	,	_	0	SENT_228	[p11l1582t2474r1807b2570],
12	stained	VBD	O	stain	advcl	3	SENT_228	[p11l1835t2475r2136b2553],
13	With	IN	O	with	_	0	SENT_228	[p11l7t2603r196b2682],
14	0.25	CD	PERCENT	0.25	num	17	SENT_228	[p11l236t2608r415b2680],
15	percent	NN	PERCENT	percent	nn	17	SENT_228	[p11l457t2618r777b2702],
16	crystal	NN	O	crystal	nn	17	SENT_228	[p11l812t2603r1084b2702],
17	violet	NN	O	violet	prep_with	12	SENT_228	[p11l1119t2603r1354b2681],
18	in	IN	O	in	_	0	SENT_228	[p11l1387t2603r1468b2679],
19	methanol	NN	O	methanol	prep_in	12	SENT_228	[p11l1508t2603r1935b2697],
20	,	,	O	,	_	0	SENT_228	[p11l1508t2603r1935b2697],
21	and	CC	O	and	_	0	SENT_228	[p11l1980t2603r2135b2680],
22	quantiﬁed	VBN	O	quantiﬁed	conj_and	3	SENT_228	[p11l12t2730r466b2831],
23	.	.	O	.	_	0	SENT_228	[p11l12t2730r466b2831],

1	The	DT	O	the	det	2	SENT_229	[p11l505t2731r666b2809],
2	results	NNS	O	result	nsubjpass	4	SENT_229	[p11l705t2731r981b2810],
3	were	VBD	O	be	auxpass	4	SENT_229	[p11l1017t2757r1218b2810],
4	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_229	[p11l1257t2730r1694b2809],
5	in	IN	O	in	_	0	SENT_229	[p11l1731t2731r1813b2808],
6	several	JJ	O	several	amod	8	SENT_229	[p11l1851t2731r2135b2809],
7	independent	JJ	O	independent	amod	8	SENT_229	[p11l11t2859r548b2959],
8	clones	NNS	O	clone	prep_in	4	SENT_229	[p11l568t2859r860b2937],
9	.	.	O	.	_	0	SENT_229	[p11l568t2859r860b2937],

1	Other	JJ	O	other	amod	3	SENT_230	[p11l15t3115r251b3191],
2	Cell-Line	NNP	O	Cell-Line	nn	3	SENT_230	[p11l276t3115r614b3191],
3	Models	NNS	O	model	nsubj	4	SENT_230	[p11l649t3115r930b3191],
4	Mouse	NN	O	mouse	_	0	SENT_230	[p11l8t3241r803b3341],
5	—	CD	NUMBER	—	num	7	SENT_230	[p11l8t3241r803b3341],
6	embryonic	JJ	O	embryonic	amod	7	SENT_230	[p11l8t3241r803b3341],
7	fibroblasts	NNS	O	fibroblast	nsubjpass	16	SENT_230	[p11l862t3240r1327b3319],
8	with	IN	O	with	_	0	SENT_230	[p11l1384t3241r1578b3320],
9	deletion	NN	O	deletion	prep_with	7	SENT_230	[p11l1638t3241r1990b3319],
10	of	IN	O	of	_	0	SENT_230	[p11l2050t3240r2152b3319],
11	the	DT	O	the	det	13	SENT_230	[p11l12t3369r143b3447],
12	PTEN	NN	ORGANIZATION	pten	nn	13	SENT_230	[p11l170t3375r398b3447],
13	locus	NN	O	locus	prep_of	9	SENT_230	[p11l421t3369r645b3448],
14	were	VBD	O	be	auxpass	16	SENT_230	[p11l672t3395r877b3448],
15	kindly	RB	O	kindly	advmod	16	SENT_230	[p11l906t3369r1176b3469],
16	provided	VBN	O	provide	ccomp	4	SENT_230	[p11l1200t3368r1578b3469],
17	by	IN	O	by	_	0	SENT_230	[p11l1609t3369r1706b3469],
18	Dr.	NNP	O	Dr.	nn	20	SENT_230	[p11l1730t3375r1857b3447],
19	Hong	NNP	PERSON	Hong	nn	20	SENT_230	[p11l1891t3376r2137b3469],
20	Wu	NNP	PERSON	Wu	agent	16	SENT_230	[p11l8t3503r154b3575],
21	(	CD	NUMBER	(	num	22	SENT_230	[p11l184t3502r527b3587],
22	UCLA	NNP	ORGANIZATION	UCLA	dep	20	SENT_230	[p11l184t3502r527b3587],
23	)	CD	NUMBER	)	num	22	SENT_230	[p11l184t3502r527b3587],
24	.	.	O	.	_	0	SENT_230	[p11l184t3502r527b3587],

1	A431	NN	O	a431	nn	3	SENT_231	[p11l554t3502r779b3574],
2	cell	NN	O	cell	nn	3	SENT_231	[p11l805t3497r950b3574],
3	lines	NNS	O	line	nsubj	4	SENT_231	[p11l974t3497r1175b3574],
4	stably	RB	O	stably	_	0	SENT_231	[p11l1204t3497r1458b3596],
5	expressing	VBG	O	express	xcomp	4	SENT_231	[p11l1480t3497r1946b3596],
6	vec	NN	O	vec	nn	13	SENT_231	[p11l1963t3522r2133b3575],
7	—	NN	O	—	nn	13	SENT_231	[p11l1963t3522r2133b3575],
8	tor	NN	O	tor	nn	13	SENT_231	[p11l12t3641r135b3703],
9	RNA	NN	O	rna	nn	13	SENT_231	[p11l165t3631r372b3708],
10	interference	NN	O	interference	nn	13	SENT_231	[p11l404t3624r922b3703],
11	(	CD	NUMBER	(	num	13	SENT_231	[p11l962t3625r1284b3720],
12	RNAi	NN	MISC	rnaus	nn	13	SENT_231	[p11l962t3625r1284b3720],
13	)	NN	O	)	dobj	5	SENT_231	[p11l962t3625r1284b3720],
14	,	,	O	,	_	0	SENT_231	[p11l962t3625r1284b3720],
15	short	JJ	O	short	amod	17	SENT_231	[p11l1326t3625r1554b3703],
16	hairpin	NN	O	hairpin	nn	17	SENT_231	[p11l1583t3625r1897b3725],
17	RNA	NN	MISC	rna	appos	13	SENT_231	[p11l1930t3631r2137b3708],

1	(	NN	O	(	_	0	SENT_232	[p12l16t21r376b112],
2	shRNA	NN	O	shrna	nn	3	SENT_232	[p12l16t21r376b112],
3	)	NN	O	)	dep	1	SENT_232	[p12l16t21r376b112],
4	to	TO	O	to	_	0	SENT_232	[p12l426t37r505b99],
5	human	JJ	O	human	amod	6	SENT_232	[p12l550t21r848b100],
6	PTEN	NN	O	pten	prep_to	3	SENT_232	[p12l890t26r1136b100],
7	(	CD	NUMBER	(	number	8	SENT_232	[p12l1182t26r2134b112],
8	5	CD	NUMBER	5	num	12	SENT_232	[p12l1182t26r2134b112],
9	’	NN	O	’	nn	12	SENT_232	[p12l1182t26r2134b112],
10	ATAGCTACCTGTT	NN	O	atagctacctgtt	nn	12	SENT_232	[p12l1182t26r2134b112],
11	—	CD	NUMBER	—	num	12	SENT_232	[p12l1182t26r2134b112],
12	AAAGAA3	NN	O	aaagaa3	dep	6	SENT_232	[p12l8t154r537b243],
13	'	''	O	'	_	0	SENT_232	[p12l8t154r537b243],
14	)	RB	O	)	advmod	3	SENT_232	[p12l8t154r537b243],
15	,	,	O	,	_	0	SENT_232	[p12l8t154r537b243],
16	or	CC	O	or	_	0	SENT_232	[p12l573t173r662b226],
17	pWZL	NN	O	pwzl	dep	1	SENT_232	[p12l687t149r1604b248],
18	.	.	O	.	_	0	SENT_232	[p12l687t149r1604b248],

1	—	NN	O	—	_	0	SENT_233	[p12l687t149r1604b248],
2	.	.	O	.	_	0	SENT_233	[p12l687t149r1604b248],

1	MyrAl	NN	O	myral	_	0	SENT_234	[p12l687t149r1604b248],
2	<	JJR	O	<	amod	3	SENT_234	[p12l687t149r1604b248],
3	tA4	NN	O	ta4	dep	1	SENT_234	[p12l687t149r1604b248],
4	.	.	O	.	_	0	SENT_234	[p12l687t149r1604b248],

1	—	NN	O	—	_	0	SENT_235	[p12l687t149r1604b248],
2	.	.	O	.	_	0	SENT_235	[p12l687t149r1604b248],

1	129	CD	NUMBER	129	num	2	SENT_236	[p12l687t149r1604b248],
2	(	NN	O	(	nsubj	4	SENT_236	[p12l1639t149r1933b248],
3	kindly	RB	O	kindly	advmod	4	SENT_236	[p12l1639t149r1933b248],
4	provided	VBN	O	provide	partmod	11	SENT_236	[p12l1956t173r2133b248, p12l7t276r234b356],
5	by	IN	O	by	_	0	SENT_236	[p12l262t277r358b377],
6	Dr.	NNP	O	Dr.	nn	8	SENT_236	[p12l381t283r505b355],
7	Russell	NNP	PERSON	Russell	nn	8	SENT_236	[p12l537t276r843b360],
8	Pieper	NNP	PERSON	Pieper	agent	4	SENT_236	[p12l869t277r1151b377],
9	,	,	O	,	_	0	SENT_236	[p12l869t277r1151b377],
10	UCSF	NNP	ORGANIZATION	UCSF	nsubj	11	SENT_236	[p12l1184t282r1451b368],
11	)	VBD	O	)	_	0	SENT_236	[p12l1184t282r1451b368],
12	Were	VBD	O	be	auxpass	13	SENT_236	[p12l1480t303r1681b356],
13	derived	VBN	O	derive	ccomp	11	SENT_236	[p12l1710t276r2014b356],
14	by	IN	O	by	_	0	SENT_236	[p12l2043t277r2139b377],
15	retroviral	JJ	O	retroviral	amod	16	SENT_236	[p12l11t405r406b484],
16	infection	NN	O	infection	agent	13	SENT_236	[p12l443t404r828b483],
17	and	CC	O	and	_	0	SENT_236	[p12l866t405r1025b483],
18	selection	NN	O	selection	agent	13	SENT_236	[p12l1065t405r1470b483],
19	.	.	O	.	_	0	SENT_236	[p12l1065t405r1470b483],

1	PTEN	NN	O	pten	nn	2	SENT_237	[p12l1513t410r1762b483],
2	shRNAi	NN	O	shrnaus	nsubj	14	SENT_237	[p12l1801t405r2135b488],
3	and	CC	O	and	_	0	SENT_237	[p12l11t533r168b611],
4	vector	NN	O	vector	nn	5	SENT_237	[p12l203t549r468b612],
5	shRNA	NN	O	shrna	conj_and	2	SENT_237	[p12l505t533r813b616],
6	were	VBD	O	be	auxpass	9	SENT_237	[p12l844t559r1049b612],
7	also	RB	O	also	advmod	9	SENT_237	[p12l1089t533r1258b611],
8	stably	RB	O	stably	advmod	9	SENT_237	[p12l1301t533r1555b633],
9	expressed	VBN	O	express	rcmod	2	SENT_237	[p12l1590t532r2014b633],
10	in	IN	O	in	_	0	SENT_237	[p12l2052t533r2134b610],
11	amphotropic	JJ	O	amphotropic	amod	13	SENT_237	[p12l11t661r572b760],
12	293T	NN	O	293t	nn	13	SENT_237	[p12l609t666r829b738],
13	cells	NNS	O	cell	prep_in	9	SENT_237	[p12l866t661r1052b738],
14	(	VBP	O	(	_	0	SENT_237	[p12l1098t661r1542b760],
15	Orbigen	NN	O	orbigen	nn	16	SENT_237	[p12l1098t661r1542b760],
16	)	NN	O	)	dobj	14	SENT_237	[p12l1098t661r1542b760],
17	.	.	O	.	_	0	SENT_237	[p12l1098t661r1542b760],

1	PKI	NN	O	pkus	nn	2	SENT_238	[p12l1584t666r1934b741],
2	—	NN	O	—	nsubjpass	5	SENT_238	[p12l1584t666r1934b741],
3	166	CD	NUMBER	166	dep	2	SENT_238	[p12l1584t666r1934b741],
4	Was	VBD	O	be	auxpass	5	SENT_238	[p12l1969t686r2132b739],
5	provided	VBN	O	provide	_	0	SENT_238	[p12l10t789r385b889],
6	by	IN	O	by	_	0	SENT_238	[p12l409t789r506b889],
7	N	NN	O	n	nn	8	SENT_238	[p12l523t796r598b868],
8	ovartis	NN	O	ovarti	agent	5	SENT_238	[p12l602t789r904b868],
9	.	.	O	.	_	0	SENT_238	[p12l602t789r904b868],

1	Cell	NN	O	cell	nn	2	SENT_239	[p12l933t789r1096b867],
2	viability	NN	O	viability	nsubjpass	4	SENT_239	[p12l1115t789r1449b889],
3	was	VBD	O	be	auxpass	4	SENT_239	[p12l1463t815r1625b868],
4	determined	VBN	O	determine	_	0	SENT_239	[p12l1651t788r2135b867],
5	in	IN	O	in	_	0	SENT_239	[p12l11t917r92b994],
6	triplicate	NN	O	triplicate	prep_in	4	SENT_239	[p12l116t917r487b1017],
7	by	IN	O	by	_	0	SENT_239	[p12l512t917r609b1017],
8	means	NNS	O	means	_	0	SENT_239	[p12l628t942r902b995],
9	of	IN	O	of	_	0	SENT_239	[p12l929t916r1030b995],
10	trypan	NN	O	trypan	nn	12	SENT_239	[p12l1035t933r1302b1017],
11	blue	JJ	O	blue	amod	12	SENT_239	[p12l1326t917r1504b996],
12	exclusion	NN	O	exclusion	prep_by_means_of	4	SENT_239	[p12l1529t917r1951b1012],
13	,	,	O	,	_	0	SENT_239	[p12l1529t917r1951b1012],
14	and	CC	O	and	_	0	SENT_239	[p12l1980t917r2135b995],
15	the	DT	O	the	det	16	SENT_239	[p12l12t1045r140b1123],
16	results	NNS	O	result	nsubjpass	18	SENT_239	[p12l183t1045r460b1124],
17	were	VBD	O	be	auxpass	18	SENT_239	[p12l501t1071r702b1124],
18	conﬁrmed	VBN	O	conﬁrmed	conj_and	4	SENT_239	[p12l746t1044r1184b1123],
19	in	IN	O	in	_	0	SENT_239	[p12l1225t1045r1306b1122],
20	three	CD	NUMBER	three	num	22	SENT_239	[p12l1349t1045r1561b1123],
21	independent	JJ	O	independent	amod	22	SENT_239	[p12l1604t1045r2140b1145],
22	experiments	NNS	O	experiment	prep_in	18	SENT_239	[p12l12t1173r546b1273],
23	.	.	O	.	_	0	SENT_239	[p12l12t1173r546b1273],

1	Cells	NNS	O	cell	nsubjpass	3	SENT_240	[p12l572t1173r771b1251],
2	were	VBD	O	be	auxpass	3	SENT_240	[p12l788t1199r987b1252],
3	plated	VBN	O	plate	_	0	SENT_240	[p12l1006t1173r1262b1273],
4	at	IN	O	at	_	0	SENT_240	[p12l1281t1189r1359b1251],
5	a	DT	O	a	det	6	SENT_240	[p12l1373t1199r1418b1251],
6	density	NN	O	density	prep_at	3	SENT_240	[p12l1436t1173r1734b1273],
7	of	IN	O	of	_	0	SENT_240	[p12l1751t1172r1850b1251],
8	50,000	CD	NUMBER	50,000	num	9	SENT_240	[p12l1854t1178r2135b1268],
9	cells	NNS	O	cell	prep_of	6	SENT_240	[p12l12t1301r194b1379],
10	per	IN	O	per	prep	9	SENT_240	[p12l222t1327r361b1401],
11	well	RB	O	well	pcomp	10	SENT_240	[p12l380t1301r554b1380],
12	in	IN	O	in	_	0	SENT_240	[p12l580t1301r661b1378],
13	six	CD	NUMBER	six	prep_in	3	SENT_240	[p12l689t1301r1011b1380],
14	.	.	O	.	_	0	SENT_240	[p12l689t1301r1011b1380],

1	—	NN	O	—	_	0	SENT_241	[p12l689t1301r1011b1380],
2	.	.	O	.	_	0	SENT_241	[p12l689t1301r1011b1380],

1	Well	UH	O	well	dep	2	SENT_242	[p12l689t1301r1011b1380],
2	plates	NNS	O	plate	nsubj	9	SENT_242	[p12l1036t1301r1307b1401],
3	,	,	O	,	_	0	SENT_242	[p12l1036t1301r1307b1401],
4	recounted	VBN	O	recount	partmod	2	SENT_242	[p12l1339t1301r1763b1380],
5	after	IN	O	after	_	0	SENT_242	[p12l1788t1300r1982b1379],
6	the	DT	O	the	det	7	SENT_242	[p12l2006t1301r2135b1379],
7	cells	NNS	O	cell	prep_after	4	SENT_242	[p12l12t1429r192b1507],
8	had	VBD	O	have	aux	9	SENT_242	[p12l217t1429r371b1507],
9	adhered	VBN	O	adhere	_	0	SENT_242	[p12l393t1429r730b1507],
10	to	TO	O	to	_	0	SENT_242	[p12l753t1445r831b1507],
11	the	DT	O	the	det	12	SENT_242	[p12l856t1428r984b1507],
12	plate	NN	O	plate	prep_to	9	SENT_242	[p12l1005t1429r1231b1529],
13	,	,	O	,	_	0	SENT_242	[p12l1005t1429r1231b1529],
14	and	CC	O	and	_	0	SENT_242	[p12l1258t1429r1413b1507],
15	then	RB	O	then	advmod	9	SENT_242	[p12l1436t1429r1621b1507],
16	treated	VBN	O	treat	conj_and	9	SENT_242	[p12l1645t1429r1930b1507],
17	With	IN	O	with	_	0	SENT_242	[p12l1948t1429r2135b1508],
18	vehicle	NN	O	vehicle	prep_with	16	SENT_242	[p12l7t1557r299b1636],
19	or	CC	O	or	_	0	SENT_242	[p12l334t1582r423b1635],
20	an	DT	O	a	det	23	SENT_242	[p12l453t1582r554b1635],
21	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_242	[p12l587t1562r846b1640],
22	kinase	NN	O	kinase	nn	23	SENT_242	[p12l869t1557r1140b1636],
23	inhibitor	NN	O	inhibitor	prep_with	16	SENT_242	[p12l1173t1557r1565b1635],
24	.	.	O	.	_	0	SENT_242	[p12l1173t1557r1565b1635],

1	After	IN	O	after	_	0	SENT_243	[p12l1601t1556r1814b1635],
2	four	CD	DURATION	four	number	4	SENT_243	[p12l1845t1556r2023b1636],
3	to	TO	DURATION	to	dep	4	SENT_243	[p12l2055t1573r2134b1635],
4	five	CD	DURATION	five	num	5	SENT_243	[p12l11t1684r156b1764],
5	days	NNS	NUMBER	day	prep_after	23	SENT_243	[p12l191t1684r372b1785],
6	of	IN	O	of	_	0	SENT_243	[p12l409t1684r509b1763],
7	incubation	NN	O	incubation	prep_of	5	SENT_243	[p12l525t1685r1003b1780],
8	,	,	O	,	_	0	SENT_243	[p12l525t1685r1003b1780],
9	the	DT	O	the	det	11	SENT_243	[p12l1043t1685r1172b1763],
10	supernatant	JJ	O	supernatant	amod	11	SENT_243	[p12l1208t1701r1719b1785],
11	(	NN	O	(	nsubjpass	23	SENT_243	[p12l1753t1685r2134b1776, p12l11t1813r148b1913],
12	containing	VBG	O	contain	partmod	11	SENT_243	[p12l1753t1685r2134b1776, p12l11t1813r148b1913],
13	ﬂoating	NN	O	ﬂoating	nn	14	SENT_243	[p12l167t1812r495b1913],
14	cells	NNS	O	cell	dobj	12	SENT_243	[p12l514t1813r724b1904],
15	)	CD	NUMBER	)	dep	14	SENT_243	[p12l514t1813r724b1904],
16	and	CC	O	and	_	0	SENT_243	[p12l751t1813r906b1891],
17	trypsin	NN	O	trypsin	nn	18	SENT_243	[p12l928t1813r1540b1913],
18	—	NN	O	—	dobj	12	SENT_243	[p12l928t1813r1540b1913],
19	treated	VBN	O	treat	partmod	18	SENT_243	[p12l928t1813r1540b1913],
20	adherent	JJ	O	adherent	amod	21	SENT_243	[p12l1561t1813r1936b1891],
21	cells	NNS	O	cell	dobj	19	SENT_243	[p12l1953t1813r2134b1891],
22	were	VBD	O	be	auxpass	23	SENT_243	[p12l7t1967r208b2020],
23	pooled	VBN	O	pool	_	0	SENT_243	[p12l230t1940r544b2041],
24	,	,	O	,	_	0	SENT_243	[p12l230t1940r544b2041],
25	spun	VBD	O	spin	parataxis	23	SENT_243	[p12l573t1966r779b2041],
26	at	IN	O	at	_	0	SENT_243	[p12l800t1957r879b2019],
27	1500	CD	DATE	1500	num	28	SENT_243	[p12l899t1946r1102b2019],
28	rpm	NN	O	rpm	prep_at	25	SENT_243	[p12l1125t1967r1301b2041],
29	for	IN	O	for	_	0	SENT_243	[p12l1324t1940r1446b2019],
30	90	CD	DURATION	90	num	31	SENT_243	[p12l1466t1946r1566b2019],
31	seconds	NNS	NUMBER	seconds	prep_for	25	SENT_243	[p12l1591t1941r1952b2036],
32	,	,	O	,	_	0	SENT_243	[p12l1591t1941r1952b2036],
33	and	CC	O	and	_	0	SENT_243	[p12l1979t1941r2135b2019],
34	resuspended	VBN	O	resuspend	conj_and	23	SENT_243	[p12l11t2069r548b2169],
35	in	IN	O	in	_	0	SENT_243	[p12l581t2069r661b2146],
36	trypan	NN	O	trypan	nn	37	SENT_243	[p12l696t2085r962b2169],
37	blue	NN	O	blue	prep_in	34	SENT_243	[p12l996t2069r1174b2148],
38	for	IN	O	for	_	0	SENT_243	[p12l1208t2068r1331b2147],
39	cell	NN	O	cell	nn	40	SENT_243	[p12l1362t2069r1503b2147],
40	counting	NN	O	counting	prep_for	37	SENT_243	[p12l1538t2069r1938b2169],
41	.	.	O	.	_	0	SENT_243	[p12l1538t2069r1938b2169],

1	The	DT	O	the	det	2	SENT_244	[p12l1974t2069r2134b2147],
2	occurrence	NN	O	occurrence	nsubjpass	6	SENT_244	[p12l12t2222r469b2276],
3	of	IN	O	of	_	0	SENT_244	[p12l493t2196r593b2275],
4	apoptosis	NN	O	apoptosis	prep_of	2	SENT_244	[p12l596t2197r999b2297],
5	was	VBD	O	be	auxpass	6	SENT_244	[p12l1020t2223r1180b2276],
6	conﬁrmed	VBN	O	conﬁrmed	_	0	SENT_244	[p12l1205t2196r1639b2275],
7	in	IN	O	in	_	0	SENT_244	[p12l1661t2197r1741b2274],
8	independent	JJ	O	independent	amod	9	SENT_244	[p12l1764t2197r2134b2297, p12l12t2325r201b2403],
9	experiments	NNS	O	experiment	prep_in	6	SENT_244	[p12l226t2325r744b2425],
10	by	IN	O	by	_	0	SENT_244	[p12l776t2325r872b2425],
11	immunoblotting	VBG	O	immunoblot	conj_and	11	SENT_244	[p12l896t2324r1604b2425],
12	for	IN	O	for	_	0	SENT_244	[p12l1629t2324r1752b2403],
13	caspasecleaved	JJ	O	caspasecleaved	amod	22	SENT_244	[p12l1778t2351r2134b2425, p12l12t2453r323b2532],
14	poly	NN	O	poly	nn	22	SENT_244	[p12l347t2453r1008b2553],
15	(	NN	O	(	nn	22	SENT_244	[p12l347t2453r1008b2553],
16	adenosine	NN	O	adenosine	nn	22	SENT_244	[p12l347t2453r1008b2553],
17	diphosphate	NN	O	diphosphate	nn	22	SENT_244	[p12l1035t2453r1573b2553],
18	ribose	NN	O	ribose	nn	22	SENT_244	[p12l1599t2453r1894b2544],
19	)	CD	NUMBER	)	num	22	SENT_244	[p12l1599t2453r1894b2544],
20	polymerase	NN	O	polymerase	nn	22	SENT_244	[p12l1925t2453r2135b2553, p12l11t2606r308b2658],
21	(	NN	O	(	nn	22	SENT_244	[p12l347t2581r706b2671],
22	number	NN	O	number	prep_for	11	SENT_244	[p12l347t2581r706b2671],
23	9546	CD	DATE	9546	dep	22	SENT_244	[p12l738t2586r964b2675],
24	,	,	O	,	_	0	SENT_244	[p12l738t2586r964b2675],
25	Cell	NN	O	cell	nn	28	SENT_244	[p12l1004t2581r1163b2658],
26	Signaling	NN	O	signaling	nn	28	SENT_244	[p12l1200t2581r1594b2680],
27	Technology	NN	O	technology	nn	28	SENT_244	[p12l1621t2581r2130b2680],
28	)	NN	O	)	appos	22	SENT_244	[p12l1621t2581r2130b2680],
29	and	CC	O	and	_	0	SENT_244	[p12l11t2709r166b2787],
30	by	IN	O	by	_	0	SENT_244	[p12l191t2709r287b2809],
31	ﬂow	NN	O	ﬂow	nn	32	SENT_244	[p12l309t2708r496b2788],
32	cytometry	NN	O	cytometry	prep_by	11	SENT_244	[p12l518t2725r945b2809],
33	.	.	O	.	_	0	SENT_244	[p12l518t2725r945b2809],

1	RESULTS	NNS	O	result	_	0	SENT_245	[p12l828t3024r1306b3083],

1	PATI	NN	O	patus	nn	4	SENT_246	[p12l17t3253r185b3301],
2	E	NN	O	e	nn	4	SENT_246	[p12l207t3253r240b3301],
3	N	NN	O	n	nn	4	SENT_246	[p12l260t3253r304b3301],
4	TS	NN	O	t	_	0	SENT_246	[p12l320t3252r408b3302],

1	For	IN	O	for	_	0	SENT_247	[p12l10t3356r154b3427],
2	the	DT	O	the	det	3	SENT_247	[p12l191t3349r320b3427],
3	purposes	NNS	O	purpose	prep_for	9	SENT_247	[p12l359t3374r745b3449],
4	of	IN	O	of	_	0	SENT_247	[p12l787t3348r887b3427],
5	this	DT	O	this	det	6	SENT_247	[p12l909t3349r1061b3427],
6	study	NN	O	study	prep_of	3	SENT_247	[p12l1104t3349r1341b3449],
7	,	,	O	,	_	0	SENT_247	[p12l1104t3349r1341b3449],
8	We	PRP	O	we	nsubj	9	SENT_247	[p12l1382t3375r1500b3428],
9	selected	VBD	O	select	_	0	SENT_247	[p12l1542t3349r1876b3427],
10	7	CD	NUMBER	7	num	11	SENT_247	[p12l1916t3356r1962b3427],
11	patients	NNS	O	patient	dobj	9	SENT_247	[p12l2001t3375r2134b3449, p12l12t3477r242b3555],
12	With	IN	O	with	_	0	SENT_247	[p12l265t3477r453b3556],
13	unequivocal	JJ	O	unequivocal	amod	14	SENT_247	[p12l479t3477r988b3577],
14	evidence	NN	O	evidence	prep_with	11	SENT_247	[p12l1014t3476r1374b3556],
15	of	IN	O	of	_	0	SENT_247	[p12l1400t3476r1501b3555],
16	a	DT	O	a	det	17	SENT_247	[p12l1507t3503r1551b3555],
17	response	NN	O	response	prep_of	14	SENT_247	[p12l1575t3502r1955b3577],
18	and	CC	O	and	_	0	SENT_247	[p12l1979t3477r2135b3555],
19	19	CD	NUMBER	19	prep_of	14	SENT_247	[p12l15t3610r111b3683],
20	who	WP	O	who	nsubj	21	SENT_247	[p12l141t3605r324b3684],
21	had	VBD	O	have	rcmod	11	SENT_247	[p12l359t3604r514b3683],
22	no	DT	O	no	det	23	SENT_247	[p12l546t3630r652b3683],
23	response	NN	O	response	dobj	21	SENT_247	[p12l687t3630r1066b3705],
24	(	RB	O	(	advmod	21	SENT_247	[p12l1103t3612r1217b3696],
25	as	IN	O	as	mark	26	SENT_247	[p12l1103t3612r1217b3696],
26	reﬂected	VBN	O	reﬂected	advcl	21	SENT_247	[p12l1252t3604r1614b3683],
27	by	IN	O	by	_	0	SENT_247	[p12l1649t3605r1746b3705],
28	evidence	NN	O	evidence	prep_by	26	SENT_247	[p12l1774t3604r2134b3684],
29	of	IN	O	of	_	0	SENT_247	[p13l12t20r113b99],
30	tumor	NN	O	tumor	nn	31	SENT_247	[p13l129t37r393b100],
31	progression	NN	O	progression	prep_of	28	SENT_247	[p13l423t21r932b121],
32	on	IN	O	on	_	0	SENT_247	[p13l968t46r1074b99],
33	MRI	NNP	O	MRI	prep_on	26	SENT_247	[p13l1107t27r1291b104],
34	Within	IN	O	within	_	0	SENT_247	[p13l1321t21r1596b100],
35	eight	CD	DURATION	eight	num	36	SENT_247	[p13l1632t21r1848b121],
36	Weeks	NNS	DURATION	week	prep_within	21	SENT_247	[p13l1874t21r2133b100],

1	Figure	NN	O	figure	_	0	SENT_248	[p13l84t412r301b495],
2	2	CD	NUMBER	2	number	3	SENT_248	[p13l324t416r362b474],
3	(	CD	NUMBER	(	dep	1	SENT_248	[p13l392t409r626b495],
4	facing	VBG	O	face	partmod	1	SENT_248	[p13l392t409r626b495],
5	page	NN	O	page	nn	6	SENT_248	[p13l652t416r862b495],
6	)	NN	O	)	dobj	4	SENT_248	[p13l652t416r862b495],
7	.	.	O	.	_	0	SENT_248	[p13l652t416r862b495],

1	EGFRVIII	NN	O	egfrviius	_	0	SENT_249	[p13l894t416r1199b475],
2	and	CC	O	and	_	0	SENT_249	[p13l1228t411r1355b475],
3	PTEN	NN	ORGANIZATION	pten	conj_and	1	SENT_249	[p13l1387t416r1577b474],
4	in	IN	O	in	_	0	SENT_249	[p13l80t519r139b581],
5	Glioblastomas	NNS	O	glioblastoma	prep_in	1	SENT_249	[p13l167t518r696b582],
6	.	.	O	.	_	0	SENT_249	[p13l167t518r696b582],

1	Panel	NN	O	panel	nn	2	SENT_250	[p13l85t647r266b711],
2	A	NN	O	a	nsubj	3	SENT_250	[p13l293t651r344b710],
3	shows	VBZ	O	show	_	0	SENT_250	[p13l369t647r585b711],
4	the	DT	O	the	det	5	SENT_250	[p13l611t647r720b711],
5	detection	NN	O	detection	dobj	3	SENT_250	[p13l746t647r1069b711],
6	of	IN	O	of	_	0	SENT_250	[p13l1099t646r1176b711],
7	EGFRVIII	NN	O	egfrviius	prep_of	5	SENT_250	[p13l1195t652r1494b711],
8	in	IN	O	in	_	0	SENT_250	[p13l1530t653r1585b710],
9	fresh-frozen	JJ	O	fresh-frozen	amod	11	SENT_250	[p13l1613t646r2032b711],
10	tumor	NN	O	tumor	nn	11	SENT_250	[p13l77t766r297b819],
11	specimens	NNS	O	specimen	prep_in	7	SENT_250	[p13l322t760r696b838],
12	from	IN	O	from	_	0	SENT_250	[p13l722t754r886b818],
13	patients	NNS	O	patient	prep_from	3	SENT_250	[p13l919t760r1195b838],
14	with	IN	O	with	_	0	SENT_250	[p13l1220t754r1364b819],
15	glioblastomas	NNS	O	glioblastoma	prep_with	13	SENT_250	[p13l1395t754r1888b839],
16	by	IN	O	by	_	0	SENT_250	[p13l1918t754r1992b839],
17	RT-PCR	NN	O	rt-pcr	prep_by	15	SENT_250	[p13l85t867r344b927],
18	and	CC	O	and	_	0	SENT_250	[p13l371t862r494b926],
19	immunoblotting	NN	O	immunoblotting	conj_and	17	SENT_250	[p13l527t862r1119b947],
20	.	.	O	.	_	0	SENT_250	[p13l527t862r1119b947],

1	In	IN	O	in	_	0	SENT_251	[p13l1154t867r1211b925],
2	the	DT	O	the	det	6	SENT_251	[p13l1239t862r1348b927],
3	upper	JJ	O	upper	amod	6	SENT_251	[p13l1377t884r1580b946],
4	part	NN	O	part	nn	6	SENT_251	[p13l1606t874r1742b946],
5	ofthe	NN	O	ofthe	nn	6	SENT_251	[p13l1766t861r1964b927],
6	panel	NN	O	panel	prep_in	21	SENT_251	[p13l83t969r287b1053],
7	,	,	O	,	_	0	SENT_251	[p13l83t969r287b1053],
8	primers	NNS	O	primer	nsubj	21	SENT_251	[p13l320t975r586b1053],
9	ﬂanking	VBG	O	ﬂanking	partmod	8	SENT_251	[p13l612t968r893b1054],
10	the	DT	O	the	det	14	SENT_251	[p13l915t969r1025b1034],
11	deleted	VBN	O	delete	amod	14	SENT_251	[p13l1050t969r1301b1034],
12	portion	NN	O	portion	nn	14	SENT_251	[p13l1335t975r1583b1053],
13	(	NN	O	(	nn	14	SENT_251	[p13l1620t974r1842b1053],
14	exons	NNS	O	exon	dobj	9	SENT_251	[p13l1620t974r1842b1053],
15	2	CD	NUMBER	2	advmod	14	SENT_251	[p13l1871t975r1906b1033],
16	through	IN	O	through	_	0	SENT_251	[p13l77t1076r356b1162],
17	7	CD	NUMBER	7	num	18	SENT_251	[p13l390t1082r448b1161],
18	)	NN	O	)	prep_through	15	SENT_251	[p13l390t1082r448b1161],
19	of	IN	O	of	_	0	SENT_251	[p13l482t1076r559b1141],
20	EGFRVIII	NN	O	egfrviius	prep_of	14	SENT_251	[p13l579t1081r883b1141],
21	amplified	VBD	O	amplify	_	0	SENT_251	[p13l916t1076r1244b1160],
22	cDNA	NN	O	cdna	nn	23	SENT_251	[p13l1274t1081r1487b1141],
23	fragments	NNS	O	fragment	dobj	21	SENT_251	[p13l1511t1076r1870b1162],
24	from	IN	O	from	_	0	SENT_251	[p13l78t1183r239b1249],
25	both	DT	O	both	det	28	SENT_251	[p13l270t1184r419b1249],
26	full-length	JJ	O	full-length	amod	28	SENT_251	[p13l445t1183r788b1270],
27	EG	NN	O	eg	nn	28	SENT_251	[p13l822t1189r911b1249],
28	FR	NN	O	fr	prep_from	21	SENT_251	[p13l928t1190r1010b1248],
29	(	CD	NUMBER	(	number	30	SENT_251	[p13l1041t1188r1227b1269],
30	1044	CD	DATE	1044	num	32	SENT_251	[p13l1041t1188r1227b1269],
31	bp	NN	O	bp	nn	32	SENT_251	[p13l1255t1184r1360b1269],
32	)	NN	O	)	dep	28	SENT_251	[p13l1255t1184r1360b1269],
33	and	CC	O	and	_	0	SENT_251	[p13l1393t1184r1515b1249],
34	the	DT	O	the	conj_and	28	SENT_251	[p13l1540t1184r1648b1249],
35	truncated	VBN	O	truncate	partmod	34	SENT_251	[p13l1670t1184r1997b1249],
36	EGFRVIII	NN	O	egfrviius	nn	37	SENT_251	[p13l85t1297r385b1356],
37	(	NN	O	(	nsubj	40	SENT_251	[p13l425t1297r567b1376],
38	243	CD	NUMBER	243	num	40	SENT_251	[p13l425t1297r567b1376],
39	bp	NN	O	bp	nn	40	SENT_251	[p13l601t1291r708b1376],
40	)	NN	O	)	xcomp	35	SENT_251	[p13l601t1291r708b1376],
41	on	IN	O	on	_	0	SENT_251	[p13l741t1314r824b1356],
42	RT-PCR	NN	O	rt-pcr	prep_on	40	SENT_251	[p13l859t1297r1137b1356],
43	.	.	O	.	_	0	SENT_251	[p13l859t1297r1137b1356],

1	Plasmid	NN	O	plasmid	nn	2	SENT_252	[p13l1171t1291r1444b1356],
2	cDNAs	NNS	O	cdna	nsubjpass	20	SENT_252	[p13l1474t1295r1720b1356],
3	for	IN	O	for	_	0	SENT_252	[p13l1747t1290r1844b1356],
4	wildtype	JJ	O	wildtype	amod	7	SENT_252	[p13l1864t1291r2030b1356, p13l77t1411r223b1484],
5	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_252	[p13l256t1404r448b1463],
6	(	CD	NUMBER	(	num	7	SENT_252	[p13l482t1399r650b1484],
7	lane	NN	O	lane	prep_for	2	SENT_252	[p13l482t1399r650b1484],
8	1	CD	NUMBER	1	num	9	SENT_252	[p13l682t1405r738b1484],
9	)	NN	O	)	dep	15	SENT_252	[p13l682t1405r738b1484],
10	and	CC	O	and	_	0	SENT_252	[p13l773t1399r897b1463],
11	EGFRVIII	NN	O	egfrviius	conj_and	9	SENT_252	[p13l934t1404r1237b1463],
12	(	CD	NUMBER	(	num	13	SENT_252	[p13l1277t1399r1445b1484],
13	lane	NN	O	lane	dep	15	SENT_252	[p13l1277t1399r1445b1484],
14	2	CD	NUMBER	2	num	15	SENT_252	[p13l1472t1405r1534b1484],
15	)	NN	O	)	dep	2	SENT_252	[p13l1472t1405r1534b1484],
16	in	IN	O	in	_	0	SENT_252	[p13l1570t1405r1626b1462],
17	U87MG	NN	O	u87mg	nn	18	SENT_252	[p13l1662t1403r1931b1464],
18	cells	NNS	O	cell	prep_in	15	SENT_252	[p13l79t1507r233b1571],
19	were	VBD	O	be	auxpass	20	SENT_252	[p13l260t1529r426b1571],
20	included	VBN	O	include	_	0	SENT_252	[p13l457t1507r757b1571],
21	as	IN	O	as	_	0	SENT_252	[p13l789t1529r860b1571],
22	size	NN	O	size	nn	23	SENT_252	[p13l892t1512r1026b1571],
23	controls	NNS	O	control	prep_as	20	SENT_252	[p13l1054t1507r1364b1571],
24	.	.	O	.	_	0	SENT_252	[p13l1054t1507r1364b1571],

1	In	IN	O	in	_	0	SENT_253	[p13l1401t1512r1458b1570],
2	the	DT	O	the	det	6	SENT_253	[p13l1488t1507r1599b1571],
3	lower	JJR	O	lower	amod	6	SENT_253	[p13l1630t1507r1820b1571],
4	portion	NN	O	portion	nn	6	SENT_253	[p13l1849t1529r1986b1591, p13l77t1620r212b1679],
5	ofthe	NN	O	ofthe	nn	6	SENT_253	[p13l243t1613r442b1679],
6	panel	NN	O	panel	prep_in	17	SENT_253	[p13l471t1614r675b1698],
7	,	,	O	,	_	0	SENT_253	[p13l471t1614r675b1698],
8	immunoblotting	VBG	O	immunoblot	amod	10	SENT_253	[p13l707t1614r1283b1699],
9	oftumor	NN	O	oftumor	nn	10	SENT_253	[p13l1307t1613r1614b1679],
10	lysates	NNS	O	lysate	nsubj	17	SENT_253	[p13l1641t1614r1870b1699],
11	with	IN	O	with	_	0	SENT_253	[p13l1895t1614r2040b1679],
12	an	DT	O	a	det	13	SENT_253	[p13l80t1744r157b1786],
13	antibody	NN	O	antibody	prep_with	10	SENT_253	[p13l189t1721r491b1806],
14	against	IN	O	against	_	0	SENT_253	[p13l516t1727r769b1806],
15	EG	NNP	O	EG	nn	16	SENT_253	[p13l799t1726r890b1786],
16	FR	NN	O	fr	prep_against	13	SENT_253	[p13l907t1727r990b1785],
17	detected	VBD	O	detect	_	0	SENT_253	[p13l1016t1721r1311b1786],
18	full-length	JJ	O	full-length	amod	20	SENT_253	[p13l1339t1721r1691b1806],
19	EG	NN	O	eg	nn	20	SENT_253	[p13l1726t1726r1817b1786],
20	FR	NN	O	fr	nsubj	28	SENT_253	[p13l1833t1727r1917b1785],
21	(	CD	NUMBER	(	dep	20	SENT_253	[p13l87t1829r608b1914],
22	approximately	RB	O	approximately	quantmod	23	SENT_253	[p13l87t1829r608b1914],
23	170	CD	NUMBER	170	num	24	SENT_253	[p13l637t1833r755b1894],
24	kDa	NN	O	kda	dep	20	SENT_253	[p13l784t1829r940b1913],
25	)	NN	O	)	dep	24	SENT_253	[p13l784t1829r940b1913],
26	and	CC	O	and	_	0	SENT_253	[p13l974t1829r1097b1894],
27	the	DT	O	the	conj_and	25	SENT_253	[p13l1125t1829r1234b1894],
28	truncated	VBN	O	truncate	ccomp	17	SENT_253	[p13l1258t1829r1591b1894],
29	EGFRVIII	NN	O	egfrviius	nsubj	34	SENT_253	[p13l1627t1834r1927b1894],
30	(	CD	NUMBER	(	num	29	SENT_253	[p13l87t1936r607b2021],
31	approximately	RB	O	approximately	quantmod	32	SENT_253	[p13l87t1936r607b2021],
32	140	CD	NUMBER	140	num	34	SENT_253	[p13l636t1940r755b2001],
33	kDa	NN	O	kda	nn	34	SENT_253	[p13l784t1936r966b2021],
34	)	NN	O	)	xcomp	28	SENT_253	[p13l784t1936r966b2021],
35	.	.	O	.	_	0	SENT_253	[p13l784t1936r966b2021],

1	Whole-cell	JJ	O	whole-cell	amod	2	SENT_254	[p13l992t1936r1355b2001],
2	lysates	NNS	O	lysate	dep	8	SENT_254	[p13l1388t1936r1617b2021],
3	ofwild-type	JJ	O	ofwild-type	amod	4	SENT_254	[p13l1645t1935r2046b2022],
4	EGFR	NN	ORGANIZATION	egfr	dep	2	SENT_254	[p13l85t2049r276b2108],
5	(	CD	NUMBER	(	num	6	SENT_254	[p13l307t2044r474b2129],
6	lane	NN	O	lane	dep	8	SENT_254	[p13l307t2044r474b2129],
7	1	CD	NUMBER	1	num	8	SENT_254	[p13l502t2050r558b2129],
8	)	NN	O	)	dep	14	SENT_254	[p13l502t2050r558b2129],
9	and	CC	O	and	_	0	SENT_254	[p13l590t2044r714b2108],
10	EGFRVIII	NN	O	egfrviius	nn	12	SENT_254	[p13l747t2049r1048b2108],
11	(	CD	NUMBER	(	num	12	SENT_254	[p13l1085t2044r1252b2129],
12	lane	NN	O	lane	conj_and	8	SENT_254	[p13l1085t2044r1252b2129],
13	2	CD	NUMBER	2	num	14	SENT_254	[p13l1276t2050r1336b2129],
14	)	NN	O	)	dep	20	SENT_254	[p13l1276t2050r1336b2129],
15	in	IN	O	in	_	0	SENT_254	[p13l1370t2050r1426b2107],
16	U87MG	NN	O	u87mg	nn	18	SENT_254	[p13l1458t2048r1725b2109],
17	cell	NN	O	cell	nn	18	SENT_254	[p13l1754t2044r1863b2108],
18	lines	NNS	O	line	prep_in	14	SENT_254	[p13l1895t2044r2050b2108],
19	were	VBD	O	be	auxpass	20	SENT_254	[p13l77t2174r241b2216],
20	included	VBN	O	include	_	0	SENT_254	[p13l268t2152r562b2216],
21	as	IN	O	as	_	0	SENT_254	[p13l591t2174r661b2216],
22	controls	NNS	O	control	prep_as	20	SENT_254	[p13l688t2152r992b2216],
23	.	.	O	.	_	0	SENT_254	[p13l688t2152r992b2216],

1	Tubulin	NNP	MISC	Tubulin	nsubjpass	3	SENT_255	[p13l1016t2152r1274b2216],
2	was	VBD	O	be	auxpass	3	SENT_255	[p13l1300t2174r1431b2216],
3	used	VBN	O	use	_	0	SENT_255	[p13l1461t2152r1620b2216],
4	as	IN	O	as	_	0	SENT_255	[p13l1649t2174r1719b2216],
5	a	DT	O	a	det	6	SENT_255	[p13l1747t2174r1779b2216],
6	control	NN	O	control	prep_as	3	SENT_255	[p13l1805t2152r2048b2216],
7	for	IN	O	for	_	0	SENT_255	[p13l78t2258r175b2323],
8	gel	NN	O	gel	nn	9	SENT_255	[p13l194t2259r287b2344],
9	loading	NN	O	loading	prep_for	6	SENT_255	[p13l317t2259r589b2344],
10	.	.	O	.	_	0	SENT_255	[p13l317t2259r589b2344],

1	Additional	JJ	O	additional	amod	2	SENT_256	[p13l611t2259r967b2323],
2	details	NNS	O	detail	nsubjpass	4	SENT_256	[p13l993t2259r1217b2323],
3	are	VBP	O	be	auxpass	4	SENT_256	[p13l1242t2282r1344b2323],
4	provided	VBN	O	provide	_	0	SENT_256	[p13l1370t2259r1668b2343],
5	in	IN	O	in	_	0	SENT_256	[p13l1697t2265r1751b2322],
6	Figure	NNP	O	Figure	nn	10	SENT_256	[p13l1783t2265r1995b2344],
7	3	CD	NUMBER	3	num	10	SENT_256	[p13l2018t2264r2049b2323],
8	ofthe	NN	O	ofthe	nn	10	SENT_256	[p13l79t2366r273b2431],
9	Supplementary	NNP	O	Supplementary	nn	10	SENT_256	[p13l297t2366r830b2451],
10	Appendix	NNP	O	Appendix	prep_in	4	SENT_256	[p13l848t2366r1197b2450],
11	.	.	O	.	_	0	SENT_256	[p13l848t2366r1197b2450],

1	Panel	NN	O	panel	nn	2	SENT_257	[p13l1228t2366r1409b2431],
2	B	NN	O	b	nsubj	3	SENT_257	[p13l1441t2372r1479b2429],
3	shows	VBZ	O	show	_	0	SENT_257	[p13l1506t2366r1722b2431],
4	immunohistochemical	JJ	O	immunohistochemical	amod	5	SENT_257	[p13l1749t2372r2070b2431, p13l83t2474r566b2539],
5	detection	NN	O	detection	nsubj	14	SENT_257	[p13l596t2474r918b2539],
6	and	CC	O	and	_	0	SENT_257	[p13l950t2474r1073b2539],
7	quantification	NN	O	quantification	nsubj	14	SENT_257	[p13l1102t2473r1585b2558],
8	of	IN	O	of	_	0	SENT_257	[p13l1614t2473r1691b2539],
9	EGFRVIII	NN	O	egfrviius	prep_of	5	SENT_257	[p13l1710t2479r2010b2539],
10	in	IN	O	in	_	0	SENT_257	[p13l82t2587r138b2645],
11	parafﬁn-embedded	JJ	O	parafﬁn-embedded	amod	13	SENT_257	[p13l171t2580r834b2665],
12	tumor	NN	O	tumor	nn	13	SENT_257	[p13l861t2594r1081b2646],
13	samples	NNS	O	sample	prep_in	9	SENT_257	[p13l1106t2581r1395b2665],
14	(	VBP	O	(	ccomp	3	SENT_257	[p13l1430t2586r1645b2665],
15	mean	JJ	O	mean	amod	16	SENT_257	[p13l1430t2586r1645b2665],
16	saturation	NN	O	saturation	nsubj	22	SENT_257	[p13l1676t2587r2027b2646],
17	per	IN	O	per	_	0	SENT_257	[p13l83t2711r193b2772],
18	cell	NN	O	cell	prep_per	16	SENT_257	[p13l216t2688r326b2753],
19	in	IN	O	in	_	0	SENT_257	[p13l358t2695r413b2752],
20	arbitrary	JJ	O	arbitrary	amod	21	SENT_257	[p13l444t2688r736b2774],
21	units	NNS	O	unit	prep_in	18	SENT_257	[p13l763t2694r984b2773],
22	)	VBP	O	)	ccomp	14	SENT_257	[p13l763t2694r984b2773],
23	.	.	O	.	_	0	SENT_257	[p13l763t2694r984b2773],

1	Tumor	NN	O	tumor	nn	2	SENT_258	[p13l1009t2695r1241b2753],
2	samples	NNS	O	sample	nsubjpass	9	SENT_258	[p13l1266t2688r1555b2773],
3	and	CC	O	and	_	0	SENT_258	[p13l1583t2688r1707b2753],
4	adjacent	JJ	O	adjacent	amod	7	SENT_258	[p13l1738t2688r2033b2774],
5	normal	JJ	O	normal	amod	7	SENT_258	[p13l83t2796r326b2861],
6	brain	NN	O	brain	nn	7	SENT_258	[p13l359t2796r529b2861],
7	tissue	NN	O	tissue	conj_and	2	SENT_258	[p13l556t2802r764b2861],
8	were	VBD	O	be	auxpass	9	SENT_258	[p13l787t2819r951b2861],
9	stained	VBN	O	stain	_	0	SENT_258	[p13l979t2796r1229b2861],
10	with	IN	O	with	_	0	SENT_258	[p13l1255t2796r1400b2861],
11	antibody	NN	O	antibody	prep_with	9	SENT_258	[p13l1431t2796r1733b2881],
12	against	IN	O	against	_	0	SENT_258	[p13l1758t2802r2012b2882],
13	EGFRVIII	CD	NUMBER	egfrviii	num	15	SENT_258	[p13l85t2909r385b2968],
14	(	CD	NUMBER	(	num	15	SENT_258	[p13l425t2908r647b2988],
15	L8A4	NN	O	l8a4	prep_against	9	SENT_258	[p13l425t2908r647b2988],
16	)	CD	NUMBER	)	number	17	SENT_258	[p13l425t2908r647b2988],
17	(	CD	NUMBER	(	dep	18	SENT_258	[p13l687t2904r1039b2988],
18	explained	VBN	O	explain	partmod	15	SENT_258	[p13l687t2904r1039b2988],
19	in	IN	O	in	_	0	SENT_258	[p13l1072t2910r1127b2967],
20	detail	NN	O	detail	prep_in	18	SENT_258	[p13l1157t2904r1343b2968],
21	in	IN	O	in	_	0	SENT_258	[p13l1375t2910r1431b2967],
22	Fig	NN	O	fig	prep_in	18	SENT_258	[p13l1467t2910r1583b2989],
23	.	.	O	.	_	0	SENT_258	[p13l1467t2910r1583b2989],

1	3	CD	NUMBER	3	num	2	SENT_259	[p13l1613t2909r1644b2968],
2	ofthe	NN	O	ofthe	_	0	SENT_259	[p13l1675t2902r1872b2968],
3	Supplementary	NNP	O	Supplementary	nn	4	SENT_259	[p13l1899t2909r2054b2988, p13l83t3011r474b3096],
4	Appendix	NNP	O	Appendix	dep	2	SENT_259	[p13l490t3011r823b3095],
5	at	IN	O	at	_	0	SENT_259	[p13l843t3023r905b3075],
6	www.nejm.org	NNP	O	www.nejm.org	prep_at	4	SENT_259	[p13l921t3017r1476b3096],
7	)	CD	NUMBER	)	num	6	SENT_259	[p13l921t3017r1476b3096],
8	.	.	O	.	_	0	SENT_259	[p13l921t3017r1476b3096],

1	The	DT	O	the	det	2	SENT_260	[p13l1497t3011r1626b3075],
2	inset	NN	O	inset	nsubj	3	SENT_260	[p13l1650t3017r1816b3075],
3	shows	VBZ	O	show	_	0	SENT_260	[p13l1837t3011r2054b3076],
4	a	DT	O	a	det	6	SENT_260	[p13l80t3141r113b3183],
5	higher	JJR	O	higher	amod	6	SENT_260	[p13l144t3119r363b3204],
6	magnification	NN	O	magnification	dobj	3	SENT_260	[p13l390t3118r890b3204],
7	.	.	O	.	_	0	SENT_260	[p13l390t3118r890b3204],

1	Representative	NNP	O	Representative	nsubjpass	7	SENT_261	[p13l924t3124r1439b3203],
2	“	CD	NUMBER	“	num	5	SENT_261	[p13l1468t3118r1898b3184],
3	false-color	JJ	O	false-color	amod	5	SENT_261	[p13l1468t3118r1898b3184],
4	”	NN	O	”	nn	5	SENT_261	[p13l1468t3118r1898b3184],
5	images	NNS	O	image	dep	1	SENT_261	[p13l1931t3125r2039b3182, p13l80t3249r234b3311],
6	were	VBD	O	be	auxpass	7	SENT_261	[p13l260t3249r424b3291],
7	generated	VBN	O	generate	_	0	SENT_261	[p13l450t3226r794b3311],
8	with	IN	O	with	_	0	SENT_261	[p13l822t3226r966b3291],
9	the	DT	O	the	det	11	SENT_261	[p13l993t3226r1102b3291],
10	use	NN	O	use	nn	11	SENT_261	[p13l1132t3249r1248b3291],
11	ofthe	NN	O	ofthe	prep_with	7	SENT_261	[p13l1274t3225r1471b3291],
12	Soft	NNP	O	Soft	nn	16	SENT_261	[p13l1498t3225r1635b3291],
13	Imaging	NNP	O	Imaging	nn	16	SENT_261	[p13l1665t3232r1950b3311],
14	Systems	NNPS	O	Systems	nn	16	SENT_261	[p13l80t3338r368b3418],
15	image-analysis	NN	O	image-analysis	nn	16	SENT_261	[p13l400t3333r914b3419],
16	software	NN	O	software	dep	11	SENT_261	[p13l943t3333r1257b3398],
17	.	.	O	.	_	0	SENT_261	[p13l943t3333r1257b3398],

1	Panel	NN	O	panel	nn	2	SENT_262	[p13l1292t3333r1473b3398],
2	C	NN	O	c	nsubj	3	SENT_262	[p13l1503t3338r1550b3398],
3	shows	VBZ	O	show	_	0	SENT_262	[p13l1576t3333r1792b3398],
4	the	DT	O	the	det	5	SENT_262	[p13l1818t3333r1928b3398],
5	detection	NN	O	detection	dobj	3	SENT_262	[p13l1954t3333r2058b3398, p13l77t3447r315b3506],
6	of	IN	O	of	_	0	SENT_262	[p13l345t3440r421b3506],
7	PTEN	NNP	O	PTEN	prep_of	5	SENT_262	[p13l441t3447r629b3505],
8	in	IN	O	in	_	0	SENT_262	[p13l663t3447r719b3505],
9	glioblastomas	NNS	O	glioblastoma	prep_in	3	SENT_262	[p13l752t3441r1274b3527],
10	.	.	O	.	_	0	SENT_262	[p13l752t3441r1274b3527],

1	Representative	NNP	O	Representative	nn	4	SENT_263	[p13l1310t3447r1833b3525],
2	immunohistochemical	JJ	O	immunohistochemical	amod	4	SENT_263	[p13l1863t3447r1973b3505, p13l83t3548r789b3613],
3	staining	NN	O	staining	nn	4	SENT_263	[p13l822t3555r1102b3634],
4	(	NN	O	(	_	0	SENT_263	[p13l1133t3554r1363b3633],
5	upper	JJ	O	upper	amod	9	SENT_263	[p13l1133t3554r1363b3633],
6	portion	NN	O	portion	nn	9	SENT_263	[p13l1391t3555r1639b3633],
7	ofthe	NN	O	ofthe	nn	9	SENT_263	[p13l1668t3547r1866b3613],
8	panel	NN	O	panel	nn	9	SENT_263	[p13l1895t3571r2044b3633, p13l79t3656r158b3741],
9	)	NN	O	)	dep	4	SENT_263	[p13l1895t3571r2044b3633, p13l79t3656r158b3741],
10	and	CC	O	and	_	0	SENT_263	[p13l193t3656r316b3720],
11	immunoblotting	NN	O	immunoblotting	dep	4	SENT_263	[p13l349t3656r924b3741],
12	(	CD	NUMBER	(	num	15	SENT_263	[p13l956t3656r1169b3741],
13	lower	JJR	O	lower	amod	15	SENT_263	[p13l956t3656r1169b3741],
14	portion	NN	O	portion	nn	15	SENT_263	[p13l1196t3662r1445b3740],
15	ofthe	NN	O	ofthe	rcmod	9	SENT_263	[p13l1475t3655r1672b3720],
16	panel	NN	O	panel	dobj	15	SENT_263	[p13l1702t3656r1911b3741],
17	)	CD	NUMBER	)	num	16	SENT_263	[p13l1702t3656r1911b3741],
18	from	IN	O	from	_	0	SENT_263	[p13l78t3763r242b3828],
19	a	DT	O	a	det	21	SENT_263	[p13l272t3786r305b3828],
20	PTEN-deﬁcient	JJ	O	pten-deﬁcient	amod	21	SENT_263	[p13l338t3763r862b3828],
21	tumor	NN	O	tumor	prep_from	16	SENT_263	[p13l885t3776r1105b3828],
22	(	CD	NUMBER	(	npadvmod	15	SENT_263	[p13l1135t3763r1321b3834],
23	from	IN	O	from	_	0	SENT_263	[p13l1135t3763r1321b3834],
24	Patient	NN	O	patient	prep_from	15	SENT_263	[p13l1356t3769r1597b3828],
25	16	CD	NUMBER	16	num	24	SENT_263	[p13l1627t3769r1725b3834],
26	)	NN	O	)	dep	4	SENT_263	[p13l1627t3769r1725b3834],
27	and	CC	O	and	_	0	SENT_263	[p13l1760t3764r1883b3828],
28	a	DT	O	a	conj_and	26	SENT_263	[p13l1913t3786r1946b3828],

1	PTEN-positive	JJ	O	pten-positive	amod	2	SENT_264	[p14l85t49r581b127],
2	tumor	NN	O	tumor	nsubjpass	9	SENT_264	[p14l601t56r821b108],
3	(	CD	NUMBER	(	num	2	SENT_264	[p14l848t42r1034b127],
4	from	IN	O	from	_	0	SENT_264	[p14l848t42r1034b127],
5	Patient	NN	O	patient	nn	7	SENT_264	[p14l1066t49r1306b108],
6	23	CD	NUMBER	23	num	7	SENT_264	[p14l1326t48r1430b127],
7	)	NN	O	)	prep_from	2	SENT_264	[p14l1326t48r1430b127],
8	are	VBP	O	be	auxpass	9	SENT_264	[p14l1461t66r1564b108],
9	shown	VBN	O	show	_	0	SENT_264	[p14l1588t43r1834b108],
10	.	.	O	.	_	0	SENT_264	[p14l1588t43r1834b108],

1	In	IN	O	in	_	0	SENT_265	[p14l1864t49r1921b106],
2	the	DT	O	the	det	3	SENT_265	[p14l1945t43r2054b108],
3	specimen	NN	O	specimen	prep_in	11	SENT_265	[p14l81t156r415b234],
4	from	IN	O	from	_	0	SENT_265	[p14l442t150r605b215],
5	Patient	NN	O	patient	prep_from	3	SENT_265	[p14l639t156r879b215],
6	16	CD	NUMBER	16	num	5	SENT_265	[p14l907t156r1000b226],
7	,	,	O	,	_	0	SENT_265	[p14l907t156r1000b226],
8	PTEN	NN	ORGANIZATION	pten	nn	9	SENT_265	[p14l1035t156r1222b215],
9	staining	NN	O	staining	nsubj	11	SENT_265	[p14l1255t156r1534b235],
10	is	VBZ	O	be	cop	11	SENT_265	[p14l1560t156r1609b215],
11	absent	JJ	O	absent	_	0	SENT_265	[p14l1637t150r1870b215],
12	in	IN	O	in	prep	11	SENT_265	[p14l1896t156r1951b214],
13	tumor	NN	O	tumor	nn	14	SENT_265	[p14l1977t163r2070b215, p14l83t280r224b323],
14	cells	NNS	O	cell	pobj	12	SENT_265	[p14l247t258r417b334],
15	,	,	O	,	_	0	SENT_265	[p14l247t258r417b334],
16	but	CC	O	but	_	0	SENT_265	[p14l448t258r559b323],
17	not	RB	O	not	conj_but	12	SENT_265	[p14l586t270r697b323],
18	in	IN	O	in	dep	12	SENT_265	[p14l724t264r780b322],
19	vascular	JJ	O	vascular	amod	21	SENT_265	[p14l807t258r1098b323],
20	endothelial	JJ	O	endothelial	amod	21	SENT_265	[p14l1120t258r1506b323],
21	cells	NNS	O	cell	pobj	18	SENT_265	[p14l1535t258r1706b323],
22	.	.	O	.	_	0	SENT_265	[p14l1535t258r1706b323],

1	PTEN	NN	ORGANIZATION	pten	nn	4	SENT_266	[p14l1739t264r1928b322],
2	immunoblotting	NN	O	immunoblotting	nn	4	SENT_266	[p14l1962t264r2070b322, p14l83t365r563b451],
3	ofwhole-cell	NN	O	ofwhole-cell	nn	4	SENT_266	[p14l588t364r1022b430],
4	lysates	NNS	O	lysate	nsubj	22	SENT_266	[p14l1055t365r1284b450],
5	from	IN	O	from	_	0	SENT_266	[p14l1310t364r1474b430],
6	isogenic	JJ	O	isogenic	amod	8	SENT_266	[p14l1507t372r1795b451],
7	U87MG	NN	O	u87mg	nn	8	SENT_266	[p14l83t477r352b538],
8	cells	NNS	O	cell	prep_from	4	SENT_266	[p14l382t473r532b537],
9	that	WDT	O	that	nsubj	10	SENT_266	[p14l558t472r696b537],
10	overexpressed	VBD	O	overexpress	rcmod	8	SENT_266	[p14l720t473r1218b557],
11	PTEN	NNP	O	PTEN	dobj	10	SENT_266	[p14l1254t479r1442b537],
12	(	CD	NUMBER	(	num	14	SENT_266	[p14l1481t477r2035b558],
13	U87MG-PTEN	NN	O	u87mg-pten	nn	14	SENT_266	[p14l1481t477r2035b558],
14	)	NN	O	)	dep	11	SENT_266	[p14l1481t477r2035b558],
15	and	CC	O	and	_	0	SENT_266	[p14l80t581r204b645],
16	cells	NNS	O	cell	conj_and	11	SENT_266	[p14l234t581r384b645],
17	that	WDT	O	that	nsubj	20	SENT_266	[p14l409t581r548b645],
18	did	VBD	O	do	aux	20	SENT_266	[p14l572t581r676b645],
19	not	RB	O	not	neg	20	SENT_266	[p14l710t592r821b645],
20	express	VB	O	express	rcmod	16	SENT_266	[p14l845t603r1105b665],
21	PTEN	NN	ORGANIZATION	pten	dobj	20	SENT_266	[p14l1138t586r1327b644],
22	demonstrates	VBZ	O	demonstrate	_	0	SENT_266	[p14l1359t581r1843b645],
23	the	DT	O	the	det	24	SENT_266	[p14l1868t581r1978b645],
24	specificity	NN	O	specificity	dobj	22	SENT_266	[p14l81t687r426b773],
25	of	IN	O	of	_	0	SENT_266	[p14l451t687r527b752],
26	the	DT	O	the	det	27	SENT_266	[p14l538t688r648b752],
27	antibody	NN	O	antibody	prep_of	24	SENT_266	[p14l675t688r987b773],
28	.	.	O	.	_	0	SENT_266	[p14l675t688r987b773],

1	after	IN	O	after	mark	2	SENT_267	[p14l9t1065r203b1144],
2	initiating	VBG	O	initiate	_	0	SENT_267	[p14l225t1066r613b1166],
3	therapy	NN	O	therapy	dobj	2	SENT_267	[p14l635t1066r977b1166],
4	)	CD	NUMBER	)	dep	2	SENT_267	[p14l635t1066r977b1166],
5	(	CD	NUMBER	(	num	6	SENT_267	[p14l1013t1066r1195b1166],
6	Fig	NN	O	fig	dep	4	SENT_267	[p14l1013t1066r1195b1166],
7	.	.	O	.	_	0	SENT_267	[p14l1013t1066r1195b1166],

1	1A	NN	O	1a	_	0	SENT_268	[p14l1230t1071r1342b1143],
2	and	CC	O	and	_	0	SENT_268	[p14l1364t1066r1519b1144],
3	1B	NN	O	1b	conj_and	1	SENT_268	[p14l1547t1071r1651b1144],
4	of	IN	O	of	_	0	SENT_268	[p14l1679t1065r1779b1144],
5	the	DT	O	the	det	8	SENT_268	[p14l1787t1066r1916b1144],
6	Supplementary	NNP	O	Supplementary	nn	8	SENT_268	[p14l1943t1071r2133b1166, p14l8t1194r501b1294],
7	Appendix	NNP	O	Appendix	nn	8	SENT_268	[p14l529t1194r1006b1294],
8	)	NN	O	)	prep_of	1	SENT_268	[p14l529t1194r1006b1294],
9	.	.	O	.	_	0	SENT_268	[p14l529t1194r1006b1294],

1	Median	JJ	MISC	median	amod	2	SENT_269	[p14l1045t1193r1369b1272],
2	survival	NN	O	survival	nsubj	12	SENT_269	[p14l1408t1194r1733b1273],
3	after	IN	O	after	_	0	SENT_269	[p14l1769t1193r1966b1272],
4	the	DT	O	the	det	5	SENT_269	[p14l2001t1194r2133b1272],
5	initiation	NN	O	initiation	prep_after	2	SENT_269	[p14l9t1322r395b1400],
6	of	IN	O	of	_	0	SENT_269	[p14l423t1321r523b1400],
7	treatment	NN	O	treatment	prep_of	5	SENT_269	[p14l532t1338r947b1400],
8	with	IN	O	with	_	0	SENT_269	[p14l964t1322r1154b1401],
9	an	DT	O	a	det	11	SENT_269	[p14l1180t1347r1280b1400],
10	EGFRkinase	NN	MISC	egfrkinase	nn	11	SENT_269	[p14l1306t1321r1851b1405],
11	inhibitor	NN	O	inhibitor	prep_with	7	SENT_269	[p14l1878t1322r2133b1400, p14l9t1450r159b1528],
12	Was	VBD	O	be	_	0	SENT_269	[p14l176t1476r337b1529],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	12	SENT_269	[p14l365t1449r886b1550],
14	longer	RBR	O	longer	advmod	12	SENT_269	[p14l905t1450r1181b1550],
15	among	IN	O	among	_	0	SENT_269	[p14l1202t1475r1502b1550],
16	patients	NNS	O	patient	prep_among	14	SENT_269	[p14l1521t1450r1856b1550],
17	with	IN	O	with	_	0	SENT_269	[p14l1878t1450r2067b1529],
18	a	DT	O	a	det	19	SENT_269	[p14l2091t1476r2135b1528],
19	response	NN	O	response	prep_with	16	SENT_269	[p14l10t1604r397b1679],
20	than	IN	O	than	dep	12	SENT_269	[p14l439t1580r630b1657],
21	among	IN	O	among	_	0	SENT_269	[p14l671t1604r976b1679],
22	those	DT	O	those	prep_among	12	SENT_269	[p14l1014t1580r1245b1657],
23	without	IN	O	without	_	0	SENT_269	[p14l1284t1580r1625b1659],
24	a	DT	O	a	det	26	SENT_269	[p14l1661t1606r1706b1657],
25	response	NN	O	response	nn	26	SENT_269	[p14l1746t1604r2133b1679],
26	(	NN	O	(	prep_without	22	SENT_269	[p14l15t1712r226b1797],
27	21.7	CD	NUMBER	21.7	num	30	SENT_269	[p14l15t1712r226b1797],
28	VS.	NNP	O	VS.	nn	30	SENT_269	[p14l254t1733r363b1786],
29	5.8	CD	DURATION	5.8	num	30	SENT_269	[p14l401t1712r527b1785],
30	months	NNS	NUMBER	month	dep	26	SENT_269	[p14l560t1707r910b1801],
31	,	,	O	,	_	0	SENT_269	[p14l560t1707r910b1801],
32	P	NN	O	p	appos	26	SENT_269	[p14l945t1712r1315b1801],
33	=	JJ	O	=	amod	35	SENT_269	[p14l945t1712r1315b1801],
34	0.01	CD	NUMBER	0.01	tmod	33	SENT_269	[p14l945t1712r1315b1801],
35	)	NN	O	)	dep	32	SENT_269	[p14l945t1712r1315b1801],
36	,	,	O	,	_	0	SENT_269	[p14l945t1712r1315b1801],
37	as	IN	O	as	dep	41	SENT_269	[p14l1351t1733r1435b1784],
38	Was	VBD	O	be	cop	41	SENT_269	[p14l1463t1733r1625b1785],
39	the	DT	O	the	det	41	SENT_269	[p14l1658t1707r1787b1784],
40	median	JJ	O	median	amod	41	SENT_269	[p14l1818t1707r2134b1785],
41	time	NN	O	time	advcl	12	SENT_269	[p14l11t1835r197b1912],
42	to	TO	O	to	_	0	SENT_269	[p14l227t1850r306b1912],
43	progression	NN	O	progression	nn	44	SENT_269	[p14l336t1835r844b1934],
44	(	NN	O	(	prep_to	41	SENT_269	[p14l878t1840r1037b1925],
45	9.7	CD	NUMBER	9.7	num	48	SENT_269	[p14l878t1840r1037b1925],
46	VS.	NNP	O	VS.	nn	48	SENT_269	[p14l1062t1860r1172b1913],
47	1.7	CD	DURATION	1.7	num	48	SENT_269	[p14l1210t1840r1336b1912],
48	months	NNS	NUMBER	month	nsubj	41	SENT_269	[p14l1366t1835r1716b1929],
49	,	,	O	,	_	0	SENT_269	[p14l1366t1835r1716b1929],
50	P	NN	O	p	dep	51	SENT_269	[p14l1749t1840r2129b1925],
51	<	JJR	O	<	appos	48	SENT_269	[p14l1749t1840r2129b1925],
52	0.001	CD	NUMBER	0.001	num	53	SENT_269	[p14l1749t1840r2129b1925],
53	)	NN	O	)	dep	51	SENT_269	[p14l1749t1840r2129b1925],
54	(	CD	NUMBER	(	num	55	SENT_269	[p14l15t1963r269b2054],
55	Table	NNP	O	Table	dep	51	SENT_269	[p14l15t1963r269b2054],
56	1	CD	NUMBER	1	num	55	SENT_269	[p14l297t1968r366b2058],
57	,	,	O	,	_	0	SENT_269	[p14l297t1968r366b2058],
58	and	CC	O	and	_	0	SENT_269	[p14l395t1963r551b2041],
59	Fig	NN	O	fig	appos	48	SENT_269	[p14l574t1963r729b2063],
60	.	.	O	.	_	0	SENT_269	[p14l574t1963r729b2063],

1	1C	NN	O	1c	_	0	SENT_270	[p14l763t1968r870b2041],
2	of	IN	O	of	_	0	SENT_270	[p14l898t1962r999b2041],
3	the	DT	O	the	det	6	SENT_270	[p14l1006t1963r1135b2041],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_270	[p14l1162t1963r1804b2063],
5	Appendix	NNP	O	Appendix	nn	6	SENT_270	[p14l1821t1970r2133b2063, p14l11t2091r190b2182],
6	)	NN	O	)	prep_of	1	SENT_270	[p14l1821t1970r2133b2063, p14l11t2091r190b2182],
7	.	.	O	.	_	0	SENT_270	[p14l1821t1970r2133b2063, p14l11t2091r190b2182],

1	There	EX	O	there	expl	2	SENT_271	[p14l212t2091r453b2169],
2	were	VBD	O	be	ccomp	32	SENT_271	[p14l470t2117r669b2170],
3	no	DT	O	no	det	5	SENT_271	[p14l689t2116r794b2169],
4	signiﬁcant	JJ	O	signiﬁcant	amod	5	SENT_271	[p14l817t2090r1260b2191],
5	correlations	NNS	O	correlation	nsubj	2	SENT_271	[p14l1275t2091r1768b2169],
6	between	IN	O	between	_	0	SENT_271	[p14l1791t2091r2134b2170],
7	response	NN	O	response	prep_between	5	SENT_271	[p14l10t2244r389b2319],
8	and	CC	O	and	_	0	SENT_271	[p14l415t2219r571b2297],
9	age	NN	O	age	prep_between	5	SENT_271	[p14l596t2245r763b2319],
10	,	,	O	,	_	0	SENT_271	[p14l596t2245r763b2319],
11	sex	NN	O	sex	nsubj	32	SENT_271	[p14l796t2245r950b2314],
12	,	,	O	,	_	0	SENT_271	[p14l796t2245r950b2314],
13	the	DT	O	the	det	14	SENT_271	[p14l982t2219r1111b2297],
14	extent	NN	O	extent	appos	11	SENT_271	[p14l1139t2235r1397b2297],
15	of	IN	O	of	_	0	SENT_271	[p14l1419t2218r1520b2297],
16	surgical	JJ	O	surgical	amod	17	SENT_271	[p14l1529t2219r1861b2319],
17	resection	NN	O	resection	prep_of	14	SENT_271	[p14l1887t2245r2133b2297, p14l11t2347r199b2442],
18	,	,	O	,	_	0	SENT_271	[p14l1887t2245r2133b2297, p14l11t2347r199b2442],
19	Karnofsky	NNP	PERSON	Karnofsky	nn	21	SENT_271	[p14l231t2346r668b2447],
20	performance	NN	O	performance	nn	21	SENT_271	[p14l688t2346r1231b2447],
21	status	NN	O	status	prep_of	14	SENT_271	[p14l1259t2363r1529b2442],
22	,	,	O	,	_	0	SENT_271	[p14l1259t2363r1529b2442],
23	or	CC	O	or	_	0	SENT_271	[p14l1562t2372r1652b2425],
24	the	DT	O	the	det	25	SENT_271	[p14l1675t2347r1804b2425],
25	dose	NN	O	dose	prep_of	14	SENT_271	[p14l1832t2347r2025b2425],
26	of	IN	O	of	_	0	SENT_271	[p14l2052t2346r2152b2425],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_271	[p14l8t2481r268b2559],
28	inhibitor	NN	O	inhibitor	nn	29	SENT_271	[p14l282t2476r657b2554],
29	(	NN	O	(	prep_of	25	SENT_271	[p14l684t2476r937b2567],
30	Table	NNP	O	Table	dep	32	SENT_271	[p14l684t2476r937b2567],
31	3	CD	NUMBER	3	num	32	SENT_271	[p14l964t2481r1069b2567],
32	)	NN	O	)	_	0	SENT_271	[p14l964t2481r1069b2567],
33	.	.	O	.	_	0	SENT_271	[p14l964t2481r1069b2567],

1	MUTATIONS	NNS	O	mutation	nsubj	8	SENT_272	[p14l17t2760r513b2809],
2	IN	IN	O	in	_	0	SENT_272	[p14l558t2760r638b2809],
3	THE	DT	O	the	det	6	SENT_272	[p14l681t2760r842b2809],
4	EGFR	NN	O	egfr	nn	6	SENT_272	[p14l883t2760r1089b2809],
5	KINASE	NN	O	kinase	nn	6	SENT_272	[p14l1135t2760r1432b2809],
6	DOMAIN	NN	O	domain	prep_in	8	SENT_272	[p14l1476t2760r1822b2809],
7	We	PRP	O	we	nsubj	8	SENT_272	[p14l7t2866r140b2937],
8	sequenced	VBD	O	sequence	_	0	SENT_272	[p14l182t2858r625b2959],
9	the	DT	O	the	det	11	SENT_272	[p14l667t2859r796b2937],
10	kinase	NN	O	kinase	nn	11	SENT_272	[p14l836t2859r1107b2938],
11	domain	NN	O	domain	dobj	8	SENT_272	[p14l1150t2859r1472b2937],
12	of	IN	O	of	_	0	SENT_272	[p14l1515t2858r1614b2937],
13	EGFR	NN	ORGANIZATION	egfr	prep_of	11	SENT_272	[p14l1635t2865r1848b2938],
14	in	IN	O	in	_	0	SENT_272	[p14l1881t2859r1963b2936],
15	the	DT	O	the	det	16	SENT_272	[p14l2004t2859r2133b2937],
16	glioblastomas	NNS	O	glioblastoma	prep_in	8	SENT_272	[p14l10t2985r604b3085],
17	from	IN	O	from	_	0	SENT_272	[p14l635t2984r843b3063],
18	the	DT	O	the	det	20	SENT_272	[p14l872t2985r1001b3063],
19	26	CD	NUMBER	26	num	20	SENT_272	[p14l1030t2990r1130b3063],
20	patients	NNS	O	patient	prep_from	8	SENT_272	[p14l1159t2985r1519b3085],
21	.	.	O	.	_	0	SENT_272	[p14l1159t2985r1519b3085],

1	The	DT	O	the	det	2	SENT_273	[p14l1550t2985r1711b3063],
2	quality	NN	O	quality	_	0	SENT_273	[p14l1742t2985r2027b3085],
3	of	IN	O	of	prep	2	SENT_273	[p14l2052t2984r2152b3063],

1	2018	CD	DATE	2018	num	4	SENT_274	[p14l149t3160r225b3181],
2	N	NN	O	n	nn	4	SENT_274	[p14l868t3162r881b3177],
3	ENGL	NN	ORGANIZATION	engl	nn	4	SENT_274	[p14l897t3161r963b3177],
4	MED	NN	O	med	_	0	SENT_274	[p14l996t3162r1048b3177],
5	353	CD	NUMBER	353	dep	4	SENT_274	[p14l1060t3161r1139b3183],
6	;	:	O	;	_	0	SENT_274	[p14l1060t3161r1139b3183],
7	19	CD	NUMBER	19	dep	4	SENT_274	[p14l1060t3161r1139b3183],
8	WWW	NNP	O	WWW	dep	7	SENT_274	[p14l1174t3162r1268b3177],
9	.	.	O	.	_	0	SENT_274	[p14l1174t3162r1268b3177],

1	N	NN	O	n	_	0	SENT_275	[p14l1174t3162r1268b3177],
2	E	NN	O	e	dep	1	SENT_275	[p14l1276t3162r1294b3183],
3	]	CD	NUMBER	]	num	5	SENT_275	[p14l1276t3162r1294b3183],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_275	[p14l1302t3161r1385b3177],
5	NOVEMBER	NNP	DATE	NOVEMBER	dobj	2	SENT_275	[p14l1424t3161r1566b3177],
6	10	CD	DATE	10	nn	5	SENT_275	[p14l1579t3161r1614b3181],
7	,	,	O	,	_	0	SENT_275	[p14l1579t3161r1614b3181],
8	mos	FW	DURATION	mos	dep	5	SENT_275	[p14l1628t3161r1691b3183],
9	e	SYM	O	e	dep	5	SENT_275	[p14l973t3202r987b3218],
10	New	NNP	O	New	nn	12	SENT_275	[p14l996t3195r1058b3218],
11	England	NNP	O	England	nn	12	SENT_275	[p14l1067t3194r1178b3225],
12	Journal	NNP	O	Journal	dep	1	SENT_275	[p14l1187t3194r1284b3218],
13	of	IN	O	of	_	0	SENT_275	[p14l1294t3194r1323b3218],
14	Medicine	NNP	O	Medicine	prep_of	12	SENT_275	[p14l1330t3194r1455b3218],

1	Downloaded	VBN	O	download	_	0	SENT_276	[p14l378t3235r548b3258],
2	from	IN	O	from	_	0	SENT_276	[p14l557t3235r621b3258],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_276	[p14l630t3235r748b3265],
4	at	IN	O	at	_	0	SENT_276	[p14l759t3239r782b3258],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_276	[p14l790t3235r973b3258],
6	on	IN	O	on	_	0	SENT_276	[p14l982t3242r1015b3258],
7	January	NNP	DATE	January	prep_on	1	SENT_276	[p14l1023t3235r1126b3265],
8	5	CD	DATE	5	num	7	SENT_276	[p14l1136t3235r1159b3262],
9	,	,	DATE	,	_	0	SENT_276	[p14l1136t3235r1159b3262],
10	2014	CD	DATE	2014	num	7	SENT_276	[p14l1170t3235r1242b3258],
11	.	.	O	.	_	0	SENT_276	[p14l1170t3235r1242b3258],

1	For	IN	O	for	_	0	SENT_277	[p14l1252t3235r1299b3258],
2	personal	JJ	O	personal	amod	3	SENT_277	[p14l1307t3235r1419b3265],
3	use	NN	O	use	pobj	1	SENT_277	[p14l1428t3242r1472b3258],
4	only	RB	O	only	advmod	3	SENT_277	[p14l1482t3235r1546b3265],
5	.	.	O	.	_	0	SENT_277	[p14l1482t3235r1546b3265],

1	No	DT	O	no	det	3	SENT_278	[p14l1557t3235r1597b3258],
2	other	JJ	O	other	amod	3	SENT_278	[p14l1607t3235r1675b3258],
3	uses	NNS	O	use	_	0	SENT_278	[p14l1683t3242r1739b3258],
4	without	IN	O	without	_	0	SENT_278	[p14l1749t3235r1850b3258],
5	permission	NN	O	permission	prep_without	3	SENT_278	[p14l1859t3235r2011b3265],
6	.	.	O	.	_	0	SENT_278	[p14l1859t3235r2011b3265],

1	Copyright	NN	O	copyright	_	0	SENT_279	[p14l728t3276r863b3307],
2	©	CD	NUMBER	©	num	6	SENT_279	[p14l872t3276r896b3300],
3	2005	CD	DATE	2005	num	6	SENT_279	[p14l906t3276r970b3300],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_279	[p14l980t3276r1171b3300],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_279	[p14l1181t3276r1289b3300],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_279	[p14l1300t3276r1405b3307],
7	.	.	O	.	_	0	SENT_279	[p14l1300t3276r1405b3307],

1	All	DT	O	all	det	2	SENT_280	[p14l1416t3276r1457b3300],
2	rights	NNS	O	rights	nsubj	3	SENT_280	[p14l1466t3276r1541b3307],
3	reserved	VBN	O	reserve	_	0	SENT_280	[p14l1551t3276r1670b3300],
4	.	.	O	.	_	0	SENT_280	[p14l1551t3276r1670b3300],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_281	[p14l675t3319r762b3338],
2	KINASE	NN	O	kinase	nn	3	SENT_281	[p14l774t3319r898b3338],
3	INHIBITORS	NNS	O	inhibitor	dep	1	SENT_281	[p14l913t3319r1120b3338],
4	FOR	IN	O	for	_	0	SENT_281	[p14l1135t3319r1201b3338],
5	GLIOBLASTOMAS	NNS	O	glioblastoma	prep_for	3	SENT_281	[p14l1213t3319r1491b3337],

1	RT-PCR	NN	MISC	rt-pcr	nn	3	SENT_282	[p15l357t285r452b307],
2	Wild-type	JJ	MISC	wild-type	amod	3	SENT_282	[p15l383t327r496b356],
3	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_282	[p15l507t329r571b349],
4	(	CD	NUMBER	(	number	5	SENT_282	[p15l584t328r648b356],
5	1044	CD	DATE	1044	dep	3	SENT_282	[p15l584t328r648b356],
6	bp	NN	O	bp	nn	7	SENT_282	[p15l658t327r694b356],
7	)	NN	O	)	dep	5	SENT_282	[p15l658t327r694b356],

1	EGFRv	NN	O	egfrv	nn	4	SENT_283	[p15l482t550r584b571],
2	|	CD	NUMBER	|	num	4	SENT_283	[p15l482t550r584b571],
3	|	NN	O	|	nn	4	SENT_283	[p15l482t550r584b571],
4	l	NN	O	l	_	0	SENT_283	[p15l482t550r584b571],
5	(	CD	NUMBER	(	number	6	SENT_283	[p15l598t550r646b577],
6	243	CD	NUMBER	243	dep	4	SENT_283	[p15l598t550r646b577],
7	bp	NN	O	bp	nn	8	SENT_283	[p15l658t549r694b577],
8	)	NN	O	)	dep	6	SENT_283	[p15l658t549r694b577],

1	<	JJR	O	<	_	0	SENT_284	[p15l872t785r894b805, p15l825t795r876b856],
2	2zwé	CD	NUMBER	2zwé	dep	1	SENT_284	[p15l872t785r894b805, p15l825t795r876b856],
3	x	NN	O	x	nn	6	SENT_284	[p15l1004t844r1024b862],
4	x	NN	O	x	nn	6	SENT_284	[p15l1125t843r1144b863],
5	xx	NN	O	xx	nn	6	SENT_284	[p15l1261t843r1275b860],
6	o	NN	O	o	dep	2	SENT_284	[p15l1311t833r1341b863],
7	'	''	O	'	_	0	SENT_284	[p15l1374t834r1402b863],
8	9	CD	NUMBER	9	num	9	SENT_284	[p15l1374t834r1402b863],
9	’	NN	O	’	dep	1	SENT_284	[p15l1374t834r1402b863],
10	4	CD	NUMBER	4	dep	9	SENT_284	[p15l1438t831r1464b862],
11	,	,	O	,	_	0	SENT_284	[p15l1438t831r1464b862],
12	‘	CD	NUMBER	‘	num	17	SENT_284	[p15l1438t831r1464b862],
13	x3	NN	O	x3	nn	17	SENT_284	[p15l1502t831r1531b862],
14	’	NN	O	’	nn	17	SENT_284	[p15l1502t831r1531b862],
15	'	''	O	'	_	0	SENT_284	[p15l1566t834r1596b863],
16	9	CD	NUMBER	9	num	17	SENT_284	[p15l1566t834r1596b863],
17	‘	NN	O	‘	appos	1	SENT_284	[p15l1641t843r1659b862],
18	b	NN	O	b	dep	17	SENT_284	[p15l1641t843r1659b862],
19	'	''	O	'	_	0	SENT_284	[p15l1694t833r1722b863],
20	9	CD	NUMBER	9	dep	1	SENT_284	[p15l1694t833r1722b863],
21	x	CC	O	x	_	0	SENT_284	[p15l884t852r911b879],
22	\	CD	NUMBER	\	num	23	SENT_284	[p15l884t852r911b879],
23	‘	NN	O	‘	dep	1	SENT_284	[p15l884t852r911b879],
24	.	.	O	.	_	0	SENT_284	[p15l966t860r1009b900],

1	&	CC	O	&	dep	10	SENT_285	[p15l966t860r1009b900],
2	e	SYM	O	e	dep	10	SENT_285	[p15l966t860r1009b900],
3	.3	NN	NUMBER	.3	nsubj	10	SENT_285	[p15l1086t860r1129b900],
4	,	,	O	,	_	0	SENT_285	[p15l1219t860r1315b893],
5	a	DT	O	a	appos	3	SENT_285	[p15l1219t860r1315b893],
6	&	CC	O	&	_	0	SENT_285	[p15l1219t860r1315b893],
7	i	FW	PERCENT	i	conj_and	5	SENT_285	[p15l1219t860r1315b893],
8	%	NN	PERCENT	%	nn	9	SENT_285	[p15l1219t860r1315b893],
9	s	NNS	O	s	dep	7	SENT_285	[p15l1219t860r1315b893],
10	~	VBP	O	~	_	0	SENT_285	[p15l1219t860r1315b893],
11	.5	CD	NUMBER	.5	num	12	SENT_285	[p15l1336t860r1379b893],
12	.3	NN	NUMBER	.3	dobj	10	SENT_285	[p15l1400t860r1443b893],
13	.	.	O	.	_	0	SENT_285	[p15l1464t860r1507b893],

1	oo	NN	O	oo	_	0	SENT_286	[p15l1464t860r1507b893],
2	‘	NN	O	‘	dep	1	SENT_286	[p15l1464t860r1507b893],
3	.	.	O	.	_	0	SENT_286	[p15l1528t860r1571b893],

1	oo	NN	O	oo	_	0	SENT_287	[p15l1528t860r1571b893],
2	‘	NN	O	‘	dep	1	SENT_287	[p15l1528t860r1571b893],
3	.	.	O	.	_	0	SENT_287	[p15l1602t860r1699b900],

1	§	NN	O	§	nsubj	4	SENT_288	[p15l1602t860r1699b900],
2	,	,	O	,	_	0	SENT_288	[p15l1602t860r1699b900],
3	@s	NNS	O	@s	appos	1	SENT_288	[p15l1602t860r1699b900],
4	~	VBP	O	~	_	0	SENT_288	[p15l1602t860r1699b900],

1	‘	NN	O	‘	nn	3	SENT_289	[p15l962t893r977b905],
2	K.	NNP	O	K.	nn	3	SENT_289	[p15l962t893r977b905],
3	X	NNP	O	X	_	0	SENT_289	[p15l1059t893r1097b927],
4	T	NN	O	t	dep	3	SENT_289	[p15l1059t893r1097b927],
5	+	CC	O	+	rcmod	4	SENT_289	[p15l1059t893r1097b927],

1	K.	NNP	O	K.	_	0	SENT_290	[p15l1214t889r1234b905],
2	‘	CD	NUMBER	‘	number	3	SENT_290	[p15l1214t889r1234b905],
3	*	CD	NUMBER	*	dep	1	SENT_290	[p15l1268t889r1287b905],
4	o	NN	O	o	nn	5	SENT_290	[p15l1268t889r1287b905],
5	K	NN	O	k	dep	3	SENT_290	[p15l1331t889r1351b905],
6	}	CD	NUMBER	}	num	7	SENT_290	[p15l1331t889r1351b905],
7	K	NNP	O	K	dep	1	SENT_290	[p15l1395t889r1415b905],
8	}	CD	NUMBER	}	num	7	SENT_290	[p15l1395t889r1415b905],
9	‘	CD	NUMBER	‘	num	11	SENT_290	[p15l1459t889r1479b905],
10	O	NN	O	o	nn	11	SENT_290	[p15l1459t889r1479b905],
11	K.	NNP	O	K.	dep	7	SENT_290	[p15l1523t889r1543b905],
12	‘	CD	NUMBER	‘	num	13	SENT_290	[p15l1523t889r1543b905],
13	K	NNP	O	K	dep	1	SENT_290	[p15l1597t889r1617b905],
14	}	CD	NUMBER	}	num	13	SENT_290	[p15l1597t889r1617b905],
15	K.	NNP	O	K.	nn	17	SENT_290	[p15l1651t892r1666b905],
16	’D	NNP	O	’D	nn	17	SENT_290	[p15l955t901r971b916],
17	Q	NNP	O	Q	dep	13	SENT_290	[p15l1191t901r1223b927],
18	?	.	O	?	_	0	SENT_290	[p15l1191t901r1223b927],

1	»	NN	O	»	nn	2	SENT_291	[p15l1191t901r1223b927],
2	Q	NNP	O	Q	_	0	SENT_291	[p15l1245t901r1276b927],
3	‘	CD	NUMBER	‘	number	4	SENT_291	[p15l1245t901r1276b927],
4	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1245t901r1276b927],
5	Q	NNP	O	Q	dep	4	SENT_291	[p15l1309t901r1340b927],
6	‘	CD	NUMBER	‘	number	7	SENT_291	[p15l1309t901r1340b927],
7	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1309t901r1340b927],
8	Q	NNP	O	Q	dep	7	SENT_291	[p15l1373t901r1404b927],
9	’	CD	NUMBER	’	number	10	SENT_291	[p15l1373t901r1404b927],
10	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1373t901r1404b927],
11	Q	NNP	O	Q	dep	10	SENT_291	[p15l1437t901r1468b927],
12	’	CD	NUMBER	’	number	13	SENT_291	[p15l1437t901r1468b927],
13	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1437t901r1468b927],
14	Q	NNP	O	Q	dep	13	SENT_291	[p15l1501t901r1532b927],
15	’	CD	NUMBER	’	number	16	SENT_291	[p15l1501t901r1532b927],
16	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1501t901r1532b927],
17	Q	NNP	O	Q	dep	16	SENT_291	[p15l1575t901r1606b927],
18	‘	CD	NUMBER	‘	number	19	SENT_291	[p15l1575t901r1606b927],
19	)	CD	NUMBER	)	dep	2	SENT_291	[p15l1575t901r1606b927],
20	Q	NNP	O	Q	dep	19	SENT_291	[p15l1628t901r1660b927],
21	?	.	O	?	_	0	SENT_291	[p15l1628t901r1660b927],

1	»	NN	O	»	_	0	SENT_292	[p15l1628t901r1660b927],

1	lmmunoblotting	VBG	O	lmmunoblott	_	0	SENT_293	[p15l357t906r565b936],

1	.	.	O	.	_	0	SENT_294	[p15l767t895r782b910],

1	\	NN	O	\	_	0	SENT_295	[p15l767t895r782b910],
2	,	,	O	,	_	0	SENT_295	[p15l796t880r801b885],
3	Wild-type	JJ	O	wild-type	amod	4	SENT_295	[p15l370t965r482b994],
4	EGFR	NN	ORGANIZATION	egfr	appos	1	SENT_295	[p15l493t967r558b987],
5	(	CD	NUMBER	(	num	6	SENT_295	[p15l570t966r636b994],
6	~	NN	O	~	dep	4	SENT_295	[p15l570t966r636b994],
7	17o	CD	NUMBER	17o	num	8	SENT_295	[p15l570t966r636b994],
8	kDa	NN	O	kda	dep	1	SENT_295	[p15l646t965r699b994],
9	)	CD	NUMBER	)	num	10	SENT_295	[p15l646t965r699b994],
10	_	NN	O	_	dep	8	SENT_295	[p15l801t985r813b993],

1	EGFRvl	NN	O	egfrvl	nn	3	SENT_296	[p15l454t1009r556b1030],
2	|	CD	NUMBER	|	num	3	SENT_296	[p15l454t1009r556b1030],
3	|	NN	O	|	_	0	SENT_296	[p15l454t1009r556b1030],
4	(	CD	NUMBER	(	num	5	SENT_296	[p15l570t1009r636b1037],
5	~	NN	O	~	dep	3	SENT_296	[p15l570t1009r636b1037],
6	14o	CD	NUMBER	14o	num	9	SENT_296	[p15l570t1009r636b1037],
7	kDa	NN	O	kda	nn	9	SENT_296	[p15l646t1008r699b1037],
8	)	NN	O	)	nn	9	SENT_296	[p15l646t1008r699b1037],
9	D	NN	O	d	dep	3	SENT_296	[p15l1342t991r1416b1064],

1	lmmunohistochemical	JJ	O	lmmunohistochemical	amod	2	SENT_297	[p15l584t1299r871b1322],
2	Analysis	NN	O	analysis	_	0	SENT_297	[p15l881t1299r987b1330],
3	Adjacent	JJ	O	adjacent	dep	2	SENT_297	[p15l855t1350r960b1379],

1	(	FW	O	(	_	0	SENT_298	[p15l268t1871r341b1898],
2	mean	VB	O	mean	dep	1	SENT_298	[p15l268t1871r341b1898],
3	saturation/cell	JJ	O	saturation/cell	amod	5	SENT_298	[p15l353t1869r534b1898],
4	)	NN	O	)	nn	5	SENT_298	[p15l353t1869r534b1898],
5	o	NN	O	o	dobj	2	SENT_298	[p15l563t1871r576b1891],
6	12	CD	NUMBER	12	number	7	SENT_298	[p15l641t1871r666b1891],
7	24	CD	NUMBER	24	amod	5	SENT_298	[p15l723t1871r750b1891],
8	30	CD	NUMBER	30	dep	7	SENT_298	[p15l780t1871r807b1891],

1	Tumor	NN	O	tumor	dep	10	SENT_299	[p15l587t1920r736b1940],
2	=	JJ	O	=	amod	4	SENT_299	[p15l587t1920r736b1940],
3	l3	NN	O	l3	nn	4	SENT_299	[p15l587t1920r736b1940],
4	.2	NN	NUMBER	.2	dep	1	SENT_299	[p15l587t1920r736b1940],
5	Adjacent	JJ	O	adjacent	amod	6	SENT_299	[p15l791t1918r896b1947],
6	brain	NN	O	brain	dep	10	SENT_299	[p15l906t1918r1022b1940],
7	=	JJ	O	=	amod	10	SENT_299	[p15l906t1918r1022b1940],
8	7.2	CD	NUMBER	7.2	number	7	SENT_299	[p15l906t1918r1022b1940],
9	Ratio	NN	O	ratio	nn	10	SENT_299	[p15l568t1958r626b1978],
10	oftumor	NN	O	oftumor	_	0	SENT_299	[p15l636t1955r741b1978],
11	to	TO	O	to	_	0	SENT_299	[p15l750t1960r774b1978],
12	normal	JJ	O	normal	amod	13	SENT_299	[p15l784t1956r867b1978],
13	tissuethe	NN	O	tissuethe	prep_to	10	SENT_299	[p15l876t1958r966b1978, p15l8t2212r138b2290],

1	DNA	NN	O	dna	nsubj	3	SENT_300	[p15l163t2218r377b2290],
2	was	VBD	O	be	cop	3	SENT_300	[p15l395t2238r558b2291],
3	sufficient	JJ	O	sufficient	_	0	SENT_300	[p15l588t2211r989b2291],
4	to	TO	O	to	aux	5	SENT_300	[p15l1011t2228r1090b2290],
5	allow	VB	O	allow	xcomp	3	SENT_300	[p15l1117t2211r1349b2291],
6	us	PRP	O	we	dobj	5	SENT_300	[p15l1371t2238r1463b2291],
7	to	TO	O	to	_	0	SENT_300	[p15l1492t2228r1572b2290],
8	sequence	NN	O	sequence	prep_to	5	SENT_300	[p15l1601t2237r1991b2312],
9	the	DT	O	the	det	12	SENT_300	[p15l2018t2212r2148b2290],
10	entire	JJ	O	entire	amod	12	SENT_300	[p15l8t2340r250b2418],
11	kinase	NN	O	kinase	nn	12	SENT_300	[p15l290t2339r563b2419],
12	domain	NN	O	domain	dep	17	SENT_300	[p15l605t2340r930b2418],
13	of	IN	O	of	_	0	SENT_300	[p15l971t2339r1073b2418],
14	EGFR	NN	ORGANIZATION	egfr	prep_of	12	SENT_300	[p15l1092t2346r1307b2419],
15	(	CD	NUMBER	(	num	16	SENT_300	[p15l1345t2347r1619b2431],
16	exons	NNS	O	exon	dep	17	SENT_300	[p15l1345t2347r1619b2431],
17	18	CD	NUMBER	18	dep	5	SENT_300	[p15l1664t2345r1761b2418],
18	through	IN	O	through	_	0	SENT_300	[p15l1803t2340r2148b2440],
19	24	CD	NUMBER	24	num	20	SENT_300	[p15l8t2473r141b2559],
20	)	NN	O	)	prep_through	17	SENT_300	[p15l8t2473r141b2559],
21	in	IN	O	in	_	0	SENT_300	[p15l185t2468r268b2545],
22	six	CD	TIME	six	prep_in	20	SENT_300	[p15l310t2468r427b2546],
23	of	IN	TIME	of	_	0	SENT_300	[p15l464t2467r566b2546],
24	seven	CD	TIME	seven	num	25	SENT_300	[p15l589t2493r825b2547],
25	patients	NNS	O	patient	prep_of	22	SENT_300	[p15l862t2468r1207b2568],
26	with	IN	O	with	_	0	SENT_300	[p15l1244t2468r1438b2547],
27	a	DT	O	a	det	28	SENT_300	[p15l1477t2494r1522b2546],
28	response	NN	O	response	prep_with	5	SENT_300	[p15l1560t2493r1949b2568],
29	and	CC	O	and	_	0	SENT_300	[p15l1988t2467r2148b2546],
30	exon	NN	O	exon	conj_and	28	SENT_300	[p15l8t2622r210b2676],
31	21	CD	NUMBER	21	npadvmod	32	SENT_300	[p15l239t2602r340b2675],
32	alone	RB	O	alone	advmod	28	SENT_300	[p15l369t2597r600b2676],
33	in	IN	O	in	_	0	SENT_300	[p15l628t2597r710b2675],
34	Patient	NN	O	patient	prep_in	28	SENT_300	[p15l737t2597r1037b2676],
35	6	CD	NUMBER	6	num	34	SENT_300	[p15l1061t2602r1132b2676],
36	.	.	O	.	_	0	SENT_300	[p15l1061t2602r1132b2676],

1	No	DT	O	no	det	2	SENT_301	[p15l1165t2604r1293b2677],
2	mutations	NNS	O	mutation	nsubjpass	4	SENT_301	[p15l1323t2597r1757b2677],
3	were	VBD	O	be	auxpass	4	SENT_301	[p15l1784t2623r1987b2677],
4	detected	VBN	O	detect	_	0	SENT_301	[p15l2017t2597r2147b2676, p15l8t2726r259b2804],
5	in	IN	O	in	_	0	SENT_301	[p15l295t2726r377b2803],
6	the	DT	O	the	det	8	SENT_301	[p15l414t2726r544b2804],
7	seven	CD	NUMBER	seven	num	8	SENT_301	[p15l581t2751r813b2805],
8	patients	NNS	O	patient	prep_in	4	SENT_301	[p15l848t2726r1185b2826],
9	with	IN	O	with	_	0	SENT_301	[p15l1219t2726r1410b2805],
10	a	DT	O	a	det	11	SENT_301	[p15l1445t2752r1490b2804],
11	response	NN	O	response	prep_with	8	SENT_301	[p15l1525t2751r1906b2826],
12	or	CC	O	or	_	0	SENT_301	[p15l1944t2751r2034b2804],
13	in	IN	O	in	_	0	SENT_301	[p15l2067t2726r2148b2803],
14	eight	CD	NUMBER	eight	prep_in	4	SENT_301	[p15l8t2854r227b2954],
15	of	IN	O	of	_	0	SENT_301	[p15l260t2853r362b2932],
16	the	DT	O	the	det	17	SENT_301	[p15l382t2854r512b2932],
17	patients	NNS	O	patient	prep_of	14	SENT_301	[p15l550t2854r887b2954],
18	with	IN	O	with	_	0	SENT_301	[p15l923t2854r1113b2933],
19	no	DT	O	no	det	20	SENT_301	[p15l1152t2879r1259b2932],
20	response	NN	O	response	prep_with	4	SENT_301	[p15l1299t2879r1680b2954],
21	for	IN	O	for	_	0	SENT_301	[p15l1719t2853r1844b2932],
22	whom	WP	O	whom	dobj	25	SENT_301	[p15l1875t2854r2148b2933],
23	DNA	NN	O	dna	nsubj	25	SENT_301	[p15l7t2988r220b3061],
24	was	VBD	O	be	cop	25	SENT_301	[p15l238t3008r401b3061],
25	available	JJ	O	available	prepc_for	20	SENT_301	[p15l428t2982r795b3061],
26	for	IN	O	for	_	0	SENT_301	[p15l822t2981r946b3060],
27	sequencing	NN	O	sequencing	nn	29	SENT_301	[p15l970t2982r1458b3082],
28	(	CD	NUMBER	(	num	29	SENT_301	[p15l1486t2982r1741b3073],
29	Table	NNP	O	Table	prep_for	25	SENT_301	[p15l1486t2982r1741b3073],
30	2	CD	NUMBER	2	number	31	SENT_301	[p15l1768t2987r1875b3073],
31	)	CD	NUMBER	)	dep	29	SENT_301	[p15l1768t2987r1875b3073],
32	.	.	O	.	_	0	SENT_301	[p15l1768t2987r1875b3073],

1	Thus	RB	O	thus	advmod	10	SENT_302	[p15l1903t2982r2143b3077],
2	,	,	O	,	_	0	SENT_302	[p15l1903t2982r2143b3077],
3	mutations	NNS	O	mutation	nsubj	10	SENT_302	[p15l8t3110r441b3189],
4	in	IN	O	in	_	0	SENT_302	[p15l475t3110r557b3187],
5	the	DT	O	the	det	8	SENT_302	[p15l589t3110r719b3188],
6	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_302	[p15l750t3116r964b3189],
7	kinase	NN	O	kinase	nn	8	SENT_302	[p15l989t3109r1262b3189],
8	domain	NN	O	domain	prep_in	3	SENT_302	[p15l1295t3109r1622b3188],
9	are	VBP	O	be	cop	10	SENT_302	[p15l1653t3136r1780b3188],
10	unlikely	JJ	O	unlikely	_	0	SENT_302	[p15l1812t3109r2152b3210],
11	to	TO	O	to	aux	12	SENT_302	[p15l8t3254r89b3316],
12	determine	VB	O	determine	xcomp	10	SENT_302	[p15l136t3238r577b3316],
13	the	DT	O	the	det	14	SENT_302	[p15l623t3238r755b3316],
14	sensitivity	NN	O	sensitivity	dobj	12	SENT_302	[p15l801t3238r1235b3338],
15	of	IN	O	of	_	0	SENT_302	[p15l1277t3237r1379b3316],
16	glioblastomas	NNS	O	glioblastoma	prep_of	14	SENT_302	[p15l1405t3237r2018b3338],
17	to	TO	O	to	_	0	SENT_302	[p15l2066t3254r2146b3316],
18	EGFRkinase	NN	O	egfrkinase	nn	19	SENT_302	[p15l7t3365r554b3449],
19	inhibitors	NNS	O	inhibitor	prep_to	12	SENT_302	[p15l580t3365r1022b3444],
20	.	.	O	.	_	0	SENT_302	[p15l580t3365r1022b3444],

1	We	PRP	O	we	nsubj	10	SENT_303	[p15l1051t3373r1185b3444],
2	also	RB	O	also	advmod	3	SENT_303	[p15l1210t3365r1379b3444],
3	sequenced	VBD	O	sequence	_	0	SENT_303	[p15l1408t3366r1854b3466],
4	the	DT	O	the	det	6	SENT_303	[p15l1880t3366r2010b3444],
5	kinase	NN	O	kinase	nn	6	SENT_303	[p15l2036t3366r2147b3445, p15l8t3519r198b3572],
6	domain	NN	O	domain	dobj	3	SENT_303	[p15l224t3493r551b3572],
7	of	IN	O	of	_	0	SENT_303	[p15l576t3493r678b3572],
8	Her2/neu	NN	O	her2/neu	prep_of	6	SENT_303	[p15l683t3500r1026b3590],
9	and	CC	O	and	_	0	SENT_303	[p15l1051t3493r1208b3572],
10	found	VBD	O	find	conj_and	3	SENT_303	[p15l1233t3493r1485b3573],
11	no	DT	O	no	det	12	SENT_303	[p15l1511t3519r1617b3572],
12	mutations	NNS	O	mutation	dobj	10	SENT_303	[p15l1643t3494r2103b3573],
13	.	.	O	.	_	0	SENT_303	[p15l1643t3494r2103b3573],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_304	[p15l11t3603r219b3653],
2	GEN	NN	O	gen	nn	3	SENT_304	[p15l261t3603r427b3653],
3	E	NN	O	e	nsubj	4	SENT_304	[p15l451t3603r485b3652],
4	AM	VBP	O	be	_	0	SENT_304	[p15l523t3603r640b3653],
5	PLI	NNP	O	PLI	nn	7	SENT_304	[p15l665t3603r777b3652],
6	FICATION	NNP	O	FICATION	nn	7	SENT_304	[p15l800t3602r1193b3653],
7	FISH	NN	O	fish	nsubj	8	SENT_304	[p15l8t3709r222b3783],
8	showed	VBD	O	show	ccomp	4	SENT_304	[p15l258t3704r584b3784],
9	—	CD	NUMBER	—	dobj	8	SENT_304	[p15l614t3749r722b3757],
10	and	CC	O	and	_	0	SENT_304	[p15l751t3704r908b3783],
11	real	JJ	O	real	amod	14	SENT_304	[p15l942t3703r1325b3783],
12	—	JJ	O	—	amod	14	SENT_304	[p15l942t3703r1325b3783],
13	time	NN	O	time	nn	14	SENT_304	[p15l942t3703r1325b3783],
14	PCR	NN	O	pcr	conj_and	9	SENT_304	[p15l1358t3709r1551b3788],
15	conﬁrmed	JJ	O	conﬁrmed	amod	16	SENT_304	[p15l1574t3703r2016b3783],
16	—	NN	O	—	dep	14	SENT_304	[p15l2046t3749r2154b3757],

1	that	IN	O	that	dep	6	SENT_305	[p16l10t30r178b108],
2	the	DT	O	the	det	4	SENT_305	[p16l205t30r334b108],
3	EGFR	NN	ORGANIZATION	egfr	nn	4	SENT_305	[p16l364t36r578b109],
4	gene	NN	O	gene	nsubjpass	6	SENT_305	[p16l603t55r803b130],
5	was	VBD	O	be	auxpass	6	SENT_305	[p16l830t56r992b109],
6	ampliﬁed	VBN	O	ampliﬁed	csubj	14	SENT_305	[p16l1025t29r1432b130],
7	in	IN	O	in	_	0	SENT_305	[p16l1462t30r1544b107],
8	12	CD	NUMBER	12	prep_in	6	SENT_305	[p16l1578t35r1676b107],
9	of	IN	O	of	_	0	SENT_305	[p16l1709t29r1810b108],
10	25	CD	NUMBER	25	num	13	SENT_305	[p16l1822t35r1921b108],
11	glio	NN	O	glio	nn	13	SENT_305	[p16l1955t30r2149b130],
12	—	NN	O	—	nn	13	SENT_305	[p16l1955t30r2149b130],
13	blastomas	NNS	O	blastoma	prep_of	8	SENT_305	[p16l10t157r438b236],
14	(	VBP	O	(	_	0	SENT_305	[p16l469t163r597b249],
15	48	CD	PERCENT	48	num	17	SENT_305	[p16l469t163r597b249],
16	percent	JJ	PERCENT	percent	amod	17	SENT_305	[p16l621t164r994b258],
17	)	NN	O	)	dobj	14	SENT_305	[p16l621t164r994b258],
18	;	:	O	;	_	0	SENT_305	[p16l621t164r994b258],
19	7	CD	NUMBER	7	nsubj	23	SENT_305	[p16l1023t165r1069b236],
20	of	IN	O	of	_	0	SENT_305	[p16l1094t157r1195b236],
21	these	DT	O	these	det	22	SENT_305	[p16l1199t158r1417b236],
22	12	CD	NUMBER	12	prep_of	19	SENT_305	[p16l1444t163r1542b235],
23	demonstrated	VBD	O	demonstrate	parataxis	14	SENT_305	[p16l1566t157r2151b236],
24	polysomy	NN	O	polysomy	dobj	23	SENT_305	[p16l8t286r433b386],
25	.	.	O	.	_	0	SENT_305	[p16l8t286r433b386],

1	No	DT	O	no	det	2	SENT_306	[p16l482t293r610b364],
2	association	NN	O	association	nsubjpass	14	SENT_306	[p16l657t286r1136b364],
3	between	IN	O	between	_	0	SENT_306	[p16l1183t285r1535b365],
4	ampliﬁcation	NN	O	ampliﬁcation	prep_between	2	SENT_306	[p16l1580t285r2150b386],
5	of	IN	O	of	_	0	SENT_306	[p16l10t413r112b492],
6	EGFR	NN	ORGANIZATION	egfr	prep_of	4	SENT_306	[p16l136t420r351b493],
7	and	CC	O	and	_	0	SENT_306	[p16l388t414r545b492],
8	a	DT	O	a	det	9	SENT_306	[p16l590t440r634b492],
9	response	NN	O	response	prep_between	2	SENT_306	[p16l678t439r1060b514],
10	to	TO	O	to	_	0	SENT_306	[p16l1106t430r1186b492],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_306	[p16l1231t419r1492b497],
12	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_306	[p16l1526t413r1943b492],
13	was	VBD	O	be	auxpass	14	SENT_306	[p16l1986t440r2148b493],
14	found	VBN	O	find	_	0	SENT_306	[p16l10t542r262b622],
15	(	RB	O	(	advmod	14	SENT_306	[p16l292t543r547b634],
16	Table	NNP	O	Table	dobj	14	SENT_306	[p16l292t543r547b634],
17	3	CD	NUMBER	3	num	16	SENT_306	[p16l574t547r767b634],
18	)	CD	NUMBER	)	num	19	SENT_306	[p16l574t547r767b634],
19	.16	CD	NUMBER	.16	dep	16	SENT_306	[p16l574t547r767b634],

1	EXPRESSION	NN	O	expression	nn	4	SENT_307	[p16l15t829r529b879],
2	or	CC	O	or	_	0	SENT_307	[p16l575t829r681b879],
3	EGFRVI	NN	O	egfrvus	nn	4	SENT_307	[p16l725t829r1005b879],
4	n	NN	O	n	nsubj	10	SENT_307	[p16l1027t829r1075b879],
5	AN	DT	O	a	det	8	SENT_307	[p16l1117t829r1226b879],
6	D	NN	O	d	nn	8	SENT_307	[p16l1249t829r1296b879],
7	PTEN	NN	O	pten	nn	8	SENT_307	[p16l1341t829r1540b879],
8	PROTEIN	NN	O	protein	dep	4	SENT_307	[p16l1591t829r1949b879],
9	We	PRP	O	we	dep	4	SENT_307	[p16l6t935r140b1006],
10	used	VBD	O	use	_	0	SENT_307	[p16l171t927r368b1007],
11	immunohistochemical	JJ	O	immunohistochemical	amod	12	SENT_307	[p16l398t928r1369b1007],
12	analysis	NN	O	analysis	dobj	10	SENT_307	[p16l1399t928r1732b1028],
13	to	TO	O	to	_	0	SENT_307	[p16l1766t944r1846b1006],
14	screen	NN	O	screen	prep_to	10	SENT_307	[p16l1879t953r2150b1006],
15	for	IN	O	for	_	0	SENT_307	[p16l10t1053r134b1133],
16	EGFRVIII	NN	O	egfrviius	prep_for	10	SENT_307	[p16l157t1059r551b1138],
17	and	CC	O	and	_	0	SENT_307	[p16l578t1054r734b1133],
18	Validated	VBD	O	validate	conj_and	10	SENT_307	[p16l758t1054r1141b1134],
19	the	DT	O	the	det	20	SENT_307	[p16l1169t1054r1299b1133],
20	results	NNS	O	result	dobj	18	SENT_307	[p16l1327t1054r1607b1134],
21	with	IN	O	with	_	0	SENT_307	[p16l1632t1054r1823b1134],
22	the	DT	O	the	det	23	SENT_307	[p16l1852t1054r1981b1133],
23	use	NN	O	use	prep_with	18	SENT_307	[p16l2010t1080r2150b1134],

1	ENGLJ	NNP	O	ENGLJ	nn	2	SENT_308	[p16l504t1214r588b1236],
2	MED	NNP	O	MED	_	0	SENT_308	[p16l603t1215r655b1230],
3	;	:	O	;	_	0	SENT_308	[p16l711t1214r746b1236],
4	'	''	O	'	_	0	SENT_308	[p16l711t1214r746b1236],
5	|	CD	NUMBER	|	number	6	SENT_308	[p16l711t1214r746b1236],
6	9	CD	NUMBER	9	dep	2	SENT_308	[p16l711t1214r746b1236],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_308	[p16l781t1214r992b1236],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	6	SENT_308	[p16l1031t1214r1173b1230],
9	10,200	CD	NUMBER	10,200	num	8	SENT_308	[p16l1186t1214r1285b1234],

1	he	PRP	O	he	_	0	SENT_309	[p16l722t1247r752b1271],
2	New	NNP	O	New	nn	4	SENT_309	[p16l762t1248r824b1271],
3	England	NNP	O	England	nn	4	SENT_309	[p16l833t1247r944b1278],
4	Journal	NNP	O	Journal	dep	1	SENT_309	[p16l952t1247r1050b1271],
5	of	IN	O	of	_	0	SENT_309	[p16l1060t1247r1088b1271],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_309	[p16l1095t1247r1220b1271],

1	Downloaded	VBN	O	download	_	0	SENT_310	[p16l144t1288r314b1311],
2	from	IN	O	from	_	0	SENT_310	[p16l322t1288r387b1311],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_310	[p16l396t1288r514b1318],
4	at	IN	O	at	_	0	SENT_310	[p16l524t1292r547b1311],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_310	[p16l556t1288r738b1311],
6	on	IN	O	on	_	0	SENT_310	[p16l748t1295r780b1311],
7	January	NNP	DATE	January	prep_on	1	SENT_310	[p16l789t1288r892b1318],
8	5	CD	DATE	5	num	7	SENT_310	[p16l902t1288r924b1315],
9	,	,	DATE	,	_	0	SENT_310	[p16l902t1288r924b1315],
10	2014	CD	DATE	2014	num	7	SENT_310	[p16l935t1288r1007b1311],
11	.	.	O	.	_	0	SENT_310	[p16l935t1288r1007b1311],

1	For	IN	O	for	_	0	SENT_311	[p16l1018t1288r1064b1311],
2	personal	JJ	O	personal	amod	3	SENT_311	[p16l1072t1288r1184b1318],
3	use	NN	O	use	pobj	1	SENT_311	[p16l1194t1295r1237b1311],
4	only	RB	O	only	advmod	3	SENT_311	[p16l1247t1288r1312b1318],
5	.	.	O	.	_	0	SENT_311	[p16l1247t1288r1312b1318],

1	No	DT	O	no	det	3	SENT_312	[p16l1322t1288r1362b1311],
2	other	JJ	O	other	amod	3	SENT_312	[p16l1372t1288r1440b1311],
3	uses	NNS	O	use	_	0	SENT_312	[p16l1448t1295r1504b1311],
4	without	IN	O	without	_	0	SENT_312	[p16l1515t1288r1616b1311],
5	permission	NN	O	permission	prep_without	3	SENT_312	[p16l1624t1288r1777b1318],
6	.	.	O	.	_	0	SENT_312	[p16l1624t1288r1777b1318],

1	Copyright	NN	O	copyright	_	0	SENT_313	[p16l494t1329r628b1360],
2	©	CD	NUMBER	©	num	6	SENT_313	[p16l638t1329r661b1353],
3	2005	CD	DATE	2005	num	6	SENT_313	[p16l671t1329r735b1353],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_313	[p16l746t1329r937b1353],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_313	[p16l947t1329r1055b1353],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_313	[p16l1065t1329r1170b1360],
7	.	.	O	.	_	0	SENT_313	[p16l1065t1329r1170b1360],

1	All	DT	O	all	det	2	SENT_314	[p16l1181t1329r1222b1353],
2	rights	NNS	O	rights	nsubj	3	SENT_314	[p16l1232t1329r1306b1360],
3	reserved	VBN	O	reserve	_	0	SENT_314	[p16l1316t1329r1435b1353],
4	.	.	O	.	_	0	SENT_314	[p16l1316t1329r1435b1353],

1	Th	NN	O	th	_	0	SENT_315	[p16l715t1435r742b1456],
2	e	SYM	O	e	dep	4	SENT_315	[p16l744t1442r752b1456],
3	N	NN	O	n	nn	4	SENT_315	[p16l764t1437r788b1456],
4	E	NN	O	e	rcmod	1	SENT_315	[p16l794t1437r811b1456],
5	W	NN	O	w	nn	14	SENT_315	[p16l815t1437r845b1456],
6	E	NN	O	e	nn	14	SENT_315	[p16l859t1437r876b1456],
7	N	NN	O	n	nn	14	SENT_315	[p16l881t1437r905b1456],
8	G	NN	O	g	nn	14	SENT_315	[p16l911t1437r933b1456],
9	L	NN	O	l	nn	14	SENT_315	[p16l938t1437r955b1456],
10	A	NN	O	a	nn	14	SENT_315	[p16l957t1437r978b1456],
11	ND	NN	O	nd	nn	14	SENT_315	[p16l982t1437r1060b1463],
12	]	CD	NUMBER	]	num	14	SENT_315	[p16l982t1437r1060b1463],
13	OOOOO	NN	O	ooooo	nn	14	SENT_315	[p16l1065t1437r1193b1456],
14	L	NN	O	l	dep	1	SENT_315	[p16l1197t1437r1214b1456],
15	of	IN	O	of	_	0	SENT_315	[p16l1228t1435r1252b1462],
16	IIIIII	NNP	O	IIIIII	nn	17	SENT_315	[p16l1257t1437r1390b1456],
17	NE	NNS	O	ne	prep_of	14	SENT_315	[p16l1397t1437r1444b1456],

1	of	IN	O	of	_	0	SENT_316	[p16l11t1657r112b1736],
2	nucleic	JJ	O	nucleic	amod	4	SENT_316	[p16l117t1658r416b1737],
3	acid	NN	O	acid	nn	4	SENT_316	[p16l438t1658r909b1736],
4	—	NN	O	—	pobj	1	SENT_316	[p16l438t1658r909b1736],
5	based	VBN	O	base	partmod	4	SENT_316	[p16l438t1658r909b1736],
6	assays	NNS	O	assay	nsubj	8	SENT_316	[p16l932t1684r1192b1758],
7	(	CD	NUMBER	(	num	8	SENT_316	[p16l1223t1663r1597b1749],
8	RT	NN	O	rt	xcomp	5	SENT_316	[p16l1223t1663r1597b1749],
9	.	.	O	.	_	0	SENT_316	[p16l1223t1663r1597b1749],

1	—	NN	O	—	_	0	SENT_317	[p16l1223t1663r1597b1749],
2	.	.	O	.	_	0	SENT_317	[p16l1223t1663r1597b1749],

1	PCR	NN	O	pcr	_	0	SENT_318	[p16l1223t1663r1597b1749],
2	and	CC	O	and	_	0	SENT_318	[p16l1610t1657r1765b1736],
3	the	DT	O	the	det	4	SENT_318	[p16l1789t1658r1918b1736],
4	ratio	NN	O	ratio	conj_and	1	SENT_318	[p16l1942t1658r2134b1736],
5	of	IN	O	of	_	0	SENT_318	[p16l11t1786r112b1865],
6	EGFR	NN	ORGANIZATION	egfr	nn	7	SENT_318	[p16l113t1792r372b1870],
7	exon	NN	O	exon	prep_of	4	SENT_318	[p16l384t1812r583b1865],
8	9	CD	NUMBER	9	num	9	SENT_318	[p16l605t1792r651b1865],
9	DNA	NN	O	dna	dep	1	SENT_318	[p16l673t1793r885b1866],
10	to	TO	O	to	_	0	SENT_318	[p16l904t1803r983b1865],
11	exon	NN	O	exon	nn	14	SENT_318	[p16l1006t1812r1205b1865],
12	4	CD	NUMBER	4	num	14	SENT_318	[p16l1225t1792r1275b1865],
13	DNA	NN	O	dna	nn	14	SENT_318	[p16l1295t1793r1533b1878],
14	)	NN	O	)	prep_to	9	SENT_318	[p16l1295t1793r1533b1878],
15	and	CC	O	and	_	0	SENT_318	[p16l1559t1787r1715b1865],
16	immunoblotting	NN	O	immunoblotting	dep	1	SENT_318	[p16l1736t1787r2134b1866, p16l11t1915r344b2015],
17	in	IN	O	in	_	0	SENT_318	[p16l362t1915r443b1992],
18	the	DT	O	the	det	21	SENT_318	[p16l465t1915r593b1993],
19	15	CD	NUMBER	15	number	20	SENT_318	[p16l619t1920r712b1993],
20	available	JJ	O	available	amod	21	SENT_318	[p16l736t1915r1096b1994],
21	samples	NNS	O	sample	prep_in	16	SENT_318	[p16l1120t1914r1459b2015],
22	of	IN	O	of	_	0	SENT_318	[p16l1484t1914r1584b1993],
23	frozen	JJ	O	frozen	amod	26	SENT_318	[p16l1587t1914r1855b1993],
24	tumor	NN	O	tumor	nn	26	SENT_318	[p16l1878t1931r2139b1994],
25	(	NN	O	(	nn	26	SENT_318	[p16l15t2043r198b2143],
26	Fig	NN	O	fig	prep_of	21	SENT_318	[p16l15t2043r198b2143],
27	.	.	O	.	_	0	SENT_318	[p16l15t2043r198b2143],

1	2A	NN	O	2a	_	0	SENT_319	[p16l237t2048r352b2120],
2	and	CC	O	and	_	0	SENT_319	[p16l381t2043r537b2121],
3	2B	NN	O	2b	conj_and	1	SENT_319	[p16l569t2048r676b2121],
4	and	CC	O	and	_	0	SENT_319	[p16l710t2043r866b2121],
5	Table	NNP	O	Table	conj_and	1	SENT_319	[p16l895t2043r1123b2121],
6	2	CD	NUMBER	2	number	7	SENT_319	[p16l1155t2048r1262b2134],
7	)	CD	NUMBER	)	dep	5	SENT_319	[p16l1155t2048r1262b2134],
8	.	.	O	.	_	0	SENT_319	[p16l1155t2048r1262b2134],

1	We	PRP	O	we	nsubj	2	SENT_320	[p16l1296t2050r1430b2121],
2	found	VBD	O	find	_	0	SENT_320	[p16l1463t2042r1713b2122],
3	complete	JJ	O	complete	amod	4	SENT_320	[p16l1747t2043r2135b2143],
4	agreement	NN	O	agreement	dobj	2	SENT_320	[p16l10t2186r463b2270],
5	between	IN	O	between	_	0	SENT_320	[p16l492t2171r841b2249],
6	the	DT	O	the	det	9	SENT_320	[p16l875t2171r1004b2248],
7	nucleic	JJ	O	nucleic	amod	9	SENT_320	[p16l1037t2171r1337b2249],
8	acid	NN	O	acid	nn	9	SENT_320	[p16l1369t2171r1840b2248],
9	—	NN	O	—	prep_between	4	SENT_320	[p16l1369t2171r1840b2248],
10	based	VBN	O	base	partmod	9	SENT_320	[p16l1369t2171r1840b2248],
11	assays	NNS	O	assay	dobj	10	SENT_320	[p16l1872t2196r2133b2270],
12	and	CC	O	and	_	0	SENT_320	[p16l10t2299r167b2376],
13	immunohistochemical	JJ	O	immunohistochemical	amod	14	SENT_320	[p16l217t2299r1200b2377],
14	analysis	NN	O	analysis	dobj	10	SENT_320	[p16l1248t2299r1587b2398],
15	(	CD	NUMBER	(	number	16	SENT_320	[p16l1643t2304r1969b2393],
16	K	NN	O	k	dep	14	SENT_320	[p16l1643t2304r1969b2393],
17	=	JJ	O	=	amod	4	SENT_320	[p16l1643t2304r1969b2393],
18	1.0	CD	NUMBER	1.0	tmod	17	SENT_320	[p16l1643t2304r1969b2393],
19	,	,	O	,	_	0	SENT_320	[p16l1643t2304r1969b2393],
20	P	NN	O	p	dep	21	SENT_320	[p16l2023t2305r2129b2376],
21	<	JJR	O	<	conj_and	4	SENT_320	[p16l2023t2305r2129b2376],
22	0.001	CD	NUMBER	0.001	num	23	SENT_320	[p16l11t2432r273b2518],
23	)	NN	O	)	dep	21	SENT_320	[p16l11t2432r273b2518],
24	and	CC	O	and	_	0	SENT_320	[p16l300t2426r454b2505],
25	between	IN	O	between	_	0	SENT_320	[p16l477t2427r823b2506],
26	immunoblotting	NN	O	immunoblotting	nn	29	SENT_320	[p16l845t2426r1546b2527],
27	and	CC	O	and	_	0	SENT_320	[p16l1563t2427r1718b2505],
28	immunohistochemical	JJ	O	immunohistochemical	nn	29	SENT_320	[p16l1740t2427r2135b2506, p16l10t2554r610b2633],
29	analysis	NN	O	analysis	prep_between	31	SENT_320	[p16l632t2555r970b2655],
30	(	CD	NUMBER	(	number	31	SENT_320	[p16l1000t2562r1082b2646],
31	K	NN	O	k	dobj	2	SENT_320	[p16l1000t2562r1082b2646],
32	=	JJ	O	=	amod	31	SENT_320	[p16l1099t2591r1154b2620],
33	1.0	CD	NUMBER	1.0	tmod	32	SENT_320	[p16l1172t2560r1325b2650],
34	,	,	O	,	_	0	SENT_320	[p16l1172t2560r1325b2650],
35	P	NN	O	p	dep	36	SENT_320	[p16l1353t2560r1739b2646],
36	<	JJR	O	<	appos	4	SENT_320	[p16l1353t2560r1739b2646],
37	0.001	CD	NUMBER	0.001	num	38	SENT_320	[p16l1353t2560r1739b2646],
38	)	NN	O	)	dep	36	SENT_320	[p16l1353t2560r1739b2646],
39	(	CD	NUMBER	(	num	40	SENT_320	[p16l1773t2555r1956b2655],
40	Fig	NN	O	fig	dep	36	SENT_320	[p16l1773t2555r1956b2655],
41	.	.	O	.	_	0	SENT_320	[p16l1773t2555r1956b2655],

1	3	CD	NUMBER	3	_	0	SENT_321	[p16l1984t2560r2027b2633],
2	of	IN	O	of	_	0	SENT_321	[p16l2053t2554r2153b2633],
3	the	DT	O	the	det	6	SENT_321	[p16l11t2683r139b2761],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_321	[p16l184t2683r827b2783],
5	Appendix	NNP	O	Appendix	nn	6	SENT_321	[p16l860t2683r1327b2783],
6	)	NN	O	)	prep_of	1	SENT_321	[p16l860t2683r1327b2783],
7	.	.	O	.	_	0	SENT_321	[p16l860t2683r1327b2783],

1	These	DT	O	these	det	2	SENT_322	[p16l1375t2683r1630b2761],
2	results	NNS	O	result	nsubj	12	SENT_322	[p16l1675t2683r1959b2762],
3	are	VBP	O	be	cop	4	SENT_322	[p16l2006t2709r2134b2761],
4	consistent	JJ	O	consistent	_	0	SENT_322	[p16l11t2811r441b2889],
5	with	IN	O	with	_	0	SENT_322	[p16l463t2811r649b2890],
6	recent	JJ	O	recent	amod	7	SENT_322	[p16l679t2827r936b2889],
7	ﬁndings	NNS	O	ﬁndings	prep_with	4	SENT_322	[p16l962t2810r1303b2911],
8	by	IN	O	by	_	0	SENT_322	[p16l1337t2811r1433b2911],
9	another	DT	O	another	det	10	SENT_322	[p16l1459t2811r1782b2889],
10	group21	NN	O	group21	prep_by	4	SENT_322	[p16l1809t2816r2135b2911],
11	and	CC	O	and	_	0	SENT_322	[p16l10t2938r165b3017],
12	provide	VB	O	provide	conj_and	4	SENT_322	[p16l199t2939r516b3039],
13	support	NN	O	support	dobj	12	SENT_322	[p16l553t2955r885b3039],
14	for	IN	O	for	_	0	SENT_322	[p16l916t2938r1040b3017],
15	the	DT	O	the	det	16	SENT_322	[p16l1073t2939r1201b3017],
16	use	NN	O	use	prep_for	13	SENT_322	[p16l1238t2965r1376b3018],
17	of	IN	O	of	_	0	SENT_322	[p16l1414t2938r1514b3017],
18	immunohistochemical	JJ	O	immunohistochemical	amod	19	SENT_322	[p16l1531t2939r2135b3018, p16l11t3067r380b3145],
19	analysis	NN	O	analysis	prep_of	16	SENT_322	[p16l410t3067r731b3167],
20	to	TO	O	to	aux	21	SENT_322	[p16l764t3083r841b3145],
21	determine	VB	O	determine	xcomp	12	SENT_322	[p16l873t3067r1292b3145],
22	the	DT	O	the	det	24	SENT_322	[p16l1323t3067r1449b3145],
23	EGFRVIII	NN	O	egfrviius	nn	24	SENT_322	[p16l1478t3072r1860b3150],
24	status	NN	O	status	dobj	21	SENT_322	[p16l1891t3083r2133b3146],
25	in	IN	O	in	_	0	SENT_322	[p16l10t3195r91b3272],
26	the	DT	O	the	det	29	SENT_322	[p16l126t3195r254b3273],
27	remaining	VBG	O	remain	amod	29	SENT_322	[p16l289t3195r730b3295],
28	11	CD	NUMBER	11	num	29	SENT_322	[p16l764t3200r862b3272],
29	patients	NNS	O	patient	prep_in	24	SENT_322	[p16l895t3195r1229b3295],
30	for	IN	O	for	_	0	SENT_322	[p16l1266t3194r1389b3273],
31	whom	WP	O	whom	dobj	36	SENT_322	[p16l1416t3195r1688b3274],
32	no	DT	O	no	det	34	SENT_322	[p16l1722t3220r1828b3273],
33	frozen	JJ	O	frozen	amod	34	SENT_322	[p16l1864t3194r2135b3273],
34	tissue	NN	O	tissue	nsubj	36	SENT_322	[p16l11t3324r252b3403],
35	was	VBD	O	be	cop	36	SENT_322	[p16l273t3350r433b3403],
36	available	JJ	O	available	prepc_for	4	SENT_322	[p16l460t3324r849b3403],
37	.	.	O	.	_	0	SENT_322	[p16l460t3324r849b3403],

1	EGFRVIII	NN	O	egfrviius	nsubjpass	3	SENT_323	[p16l138t3457r537b3535],
2	was	VBD	O	be	auxpass	3	SENT_323	[p16l570t3478r733b3531],
3	detected	VBN	O	detect	dep	10	SENT_323	[p16l774t3452r1131b3530],
4	in	IN	O	in	_	0	SENT_323	[p16l1169t3452r1251b3529],
5	12	CD	NUMBER	12	prep_in	3	SENT_323	[p16l1293t3457r1391b3529],
6	of	IN	O	of	_	0	SENT_323	[p16l1431t3451r1533b3530],
7	26	CD	NUMBER	26	num	9	SENT_323	[p16l1552t3457r1654b3530],
8	malignant	JJ	O	malignant	amod	9	SENT_323	[p16l1692t3452r2139b3552],
9	gliomas	NNS	O	glioma	prep_of	5	SENT_323	[p16l10t3580r345b3679],
10	(	VBP	O	(	_	0	SENT_323	[p16l376t3585r506b3670],
11	46	CD	PERCENT	46	num	12	SENT_323	[p16l376t3585r506b3670],
12	percent	NN	PERCENT	percent	dobj	10	SENT_323	[p16l529t3586r873b3679],
13	)	CD	NUMBER	)	number	14	SENT_323	[p16l529t3586r873b3679],
14	(	CD	NUMBER	(	nsubj	10	SENT_323	[p16l908t3580r1161b3670],
15	Table	NNP	O	Table	nsubj	25	SENT_323	[p16l908t3580r1161b3670],
16	2	CD	NUMBER	2	number	17	SENT_323	[p16l1185t3585r1291b3674],
17	)	CD	NUMBER	)	amod	15	SENT_323	[p16l1185t3585r1291b3674],
18	,	,	O	,	_	0	SENT_323	[p16l1185t3585r1291b3674],
19	similar	JJ	O	similar	dep	17	SENT_323	[p16l1322t3580r1617b3657],
20	to	TO	O	to	_	0	SENT_323	[p16l1638t3595r1717b3657],
21	the	DT	O	the	det	23	SENT_323	[p16l1743t3580r1872b3657],
22	previ	NN	O	prevus	nn	23	SENT_323	[p16l1895t3580r2134b3679],
23	—	NN	O	—	prep_to	19	SENT_323	[p16l1895t3580r2134b3679],
24	ously	RB	O	ously	advmod	25	SENT_323	[p16l11t3708r233b3808],
25	reported	VBD	O	report	rcmod	14	SENT_323	[p16l265t3708r624b3808],
26	frequency	NN	O	frequency	dobj	25	SENT_323	[p16l661t3707r1078b3808],
27	in	IN	O	in	_	0	SENT_323	[p16l1110t3708r1191b3785],
28	glioblastomas.-7-1	NN	O	glioblastomas.-7-1	prep_in	25	SENT_323	[p16l1228t3708r2038b3808],
29	»	CD	NUMBER	»	num	28	SENT_323	[p16l1228t3708r2038b3808],
30	?	.	O	?	_	0	SENT_323	[p16l1228t3708r2038b3808],

1	-7	CD	NUMBER	-7	_	0	SENT_324	[p16l1228t3708r2038b3808],
2	It	PRP	O	it	dep	1	SENT_324	[p16l2074t3715r2139b3786],

1	Was	VBD	O	be	auxpass	2	SENT_325	[p17l6t48r166b101],
2	found	VBN	O	find	_	0	SENT_325	[p17l197t21r448b101],
3	only	RB	O	only	advmod	2	SENT_325	[p17l477t22r659b122],
4	in	IN	O	in	_	0	SENT_325	[p17l682t22r763b99],
5	tumors	NNS	O	tumor	prep_in	2	SENT_325	[p17l792t38r1093b101],
6	with	IN	O	with	_	0	SENT_325	[p17l1119t22r1308b101],
7	EGFR	NN	ORGANIZATION	egfr	nn	8	SENT_325	[p17l1335t28r1547b101],
8	ampliﬁcation	NN	O	ampliﬁcation	prep_with	5	SENT_325	[p17l1568t21r2135b122],
9	or	CC	O	or	_	0	SENT_325	[p17l11t175r100b228],
10	a	DT	O	a	det	11	SENT_325	[p17l128t176r172b228],
11	gain	NN	O	gain	prep_in	2	SENT_325	[p17l202t150r384b250],
12	of	IN	O	of	_	0	SENT_325	[p17l416t149r517b228],
13	chromosome	NN	O	chromosome	prep_of	11	SENT_325	[p17l531t150r1092b228],
14	7	CD	NUMBER	7	num	13	SENT_325	[p17l1125t157r1195b228],
15	.	.	O	.	_	0	SENT_325	[p17l1125t157r1195b228],

1	Of	IN	O	of	_	0	SENT_326	[p17l1232t149r1353b228],
2	12	CD	NUMBER	12	num	3	SENT_326	[p17l1369t155r1466b227],
3	patients	NNS	O	patient	prep_of	10	SENT_326	[p17l1497t150r1832b250],
4	whose	WP$	O	whose	poss	5	SENT_326	[p17l1861t150r2135b229],
5	tumors	NNS	O	tumor	nsubj	6	SENT_326	[p17l11t294r317b356],
6	expressed	VBD	O	express	rcmod	3	SENT_326	[p17l355t278r779b377],
7	EGFRVIII	NN	O	egfrviius	dobj	6	SENT_326	[p17l813t283r1235b372],
8	,	,	O	,	_	0	SENT_326	[p17l813t283r1235b372],
9	6	CD	NUMBER	6	nsubj	10	SENT_326	[p17l1277t283r1324b355],
10	had	VBD	O	have	dep	35	SENT_326	[p17l1359t278r1517b355],
11	a	DT	O	a	det	12	SENT_326	[p17l1552t304r1596b355],
12	response	NN	O	response	dobj	10	SENT_326	[p17l1629t302r2016b377],
13	to	TO	O	to	_	0	SENT_326	[p17l2052t293r2133b355],
14	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_326	[p17l9t411r268b489],
15	kinase	NN	O	kinase	nn	16	SENT_326	[p17l293t406r564b485],
16	inhibitors	NNS	O	inhibitor	prep_to	10	SENT_326	[p17l598t406r1038b501],
17	,	,	O	,	_	0	SENT_326	[p17l598t406r1038b501],
18	whereas	IN	O	whereas	mark	29	SENT_326	[p17l1075t406r1423b485],
19	1	CD	TIME	1	nsubj	29	SENT_326	[p17l1464t411r1508b483],
20	of	IN	TIME	of	_	0	SENT_326	[p17l1545t405r1646b484],
21	14	CD	TIME	14	num	22	SENT_326	[p17l1666t411r1764b484],
22	patients	NNS	O	patient	prep_of	19	SENT_326	[p17l1798t406r2133b506],
23	Whose	WP$	O	whose	poss	24	SENT_326	[p17l6t534r280b613],
24	tumors	NNS	O	tumor	nsubj	27	SENT_326	[p17l314t550r615b613],
25	did	VBD	O	do	aux	27	SENT_326	[p17l651t534r784b612],
26	not	RB	O	not	neg	27	SENT_326	[p17l817t550r960b612],
27	express	VB	O	express	rcmod	22	SENT_326	[p17l989t560r1301b634],
28	EGFRVIII	NN	O	egfrviius	dobj	27	SENT_326	[p17l1335t539r1726b617],
29	had	VBD	O	have	advcl	10	SENT_326	[p17l1758t534r1913b612],
30	a	DT	O	a	det	31	SENT_326	[p17l1946t560r1990b612],
31	response	NN	O	response	dobj	29	SENT_326	[p17l2022t560r2134b612, p17l12t686r306b761],
32	to	TO	O	to	_	0	SENT_326	[p17l333t677r412b739],
33	EGFRkinase	NN	O	egfrkinase	nn	34	SENT_326	[p17l438t662r983b744],
34	inhibitors	NNS	O	inhibitor	prep_to	31	SENT_326	[p17l1009t662r1423b739],
35	(	VBP	O	(	_	0	SENT_326	[p17l1456t667r1855b752],
36	P	NN	O	p	nsubj	37	SENT_326	[p17l1456t667r1855b752],
37	=	JJ	O	=	xcomp	35	SENT_326	[p17l1456t667r1855b752],
38	0.03	CD	NUMBER	0.03	num	39	SENT_326	[p17l1456t667r1855b752],
39	)	NN	O	)	nsubj	35	SENT_326	[p17l1456t667r1855b752],
40	.	.	O	.	_	0	SENT_326	[p17l1456t667r1855b752],

1	These	DT	O	these	det	2	SENT_327	[p17l1884t662r2135b739],
2	data	NNS	O	datum	nsubj	3	SENT_327	[p17l11t790r188b868],
3	suggested	VBD	O	suggest	_	0	SENT_327	[p17l212t790r625b890],
4	that	IN	O	that	complm	9	SENT_327	[p17l650t790r813b868],
5	the	DT	O	the	det	6	SENT_327	[p17l833t790r960b868],
6	expression	NN	O	expression	nsubj	9	SENT_327	[p17l985t790r1428b890],
7	of	IN	O	of	_	0	SENT_327	[p17l1453t789r1552b868],
8	EGFRVIII	NN	O	egfrviius	prep_of	6	SENT_327	[p17l1557t795r1940b873],
9	sensitizes	VBZ	O	sensitize	ccomp	3	SENT_327	[p17l1965t815r2135b868, p17l12t918r266b995],
10	gliomas	NNS	O	glioma	dobj	9	SENT_327	[p17l287t918r618b1017],
11	to	TO	O	to	_	0	SENT_327	[p17l640t933r718b995],
12	EGFRkinase	NN	O	egfrkinase	nn	13	SENT_327	[p17l737t918r1269b1000],
13	inhibitors	NNS	O	inhibitor	prep_to	9	SENT_327	[p17l1288t918r1720b995],
14	.	.	O	.	_	0	SENT_327	[p17l1288t918r1720b995],

1	However	RB	O	however	advmod	17	SENT_328	[p17l1744t924r2130b1012],
2	,	,	O	,	_	0	SENT_328	[p17l1744t924r2130b1012],
3	the	DT	O	the	det	4	SENT_328	[p17l11t1046r139b1124],
4	lack	NN	O	lack	nsubj	17	SENT_328	[p17l168t1046r343b1125],
5	of	IN	O	of	_	0	SENT_328	[p17l368t1045r469b1124],
6	response	NN	O	response	prep_of	4	SENT_328	[p17l479t1071r859b1146],
7	in	IN	O	in	_	0	SENT_328	[p17l888t1046r969b1123],
8	50	CD	PERCENT	50	num	9	SENT_328	[p17l1001t1051r1099b1124],
9	percent	NN	PERCENT	percent	prep_in	6	SENT_328	[p17l1128t1062r1449b1146],
10	of	IN	O	of	_	0	SENT_328	[p17l1474t1045r1574b1124],
11	patients	NNS	O	patient	prep_of	9	SENT_328	[p17l1584t1046r1918b1146],
12	with	IN	O	with	_	0	SENT_328	[p17l1946t1046r2135b1125],
13	EGFRvIII	NN	O	egfrviius	prep_with	11	SENT_328	[p17l9t1174r896b1274],
14	—	CD	NUMBER	—	num	13	SENT_328	[p17l9t1174r896b1274],
15	expressing	VBG	O	express	partmod	13	SENT_328	[p17l9t1174r896b1274],
16	tumors	NNS	O	tumor	dobj	15	SENT_328	[p17l938t1190r1238b1253],
17	indicates	VBZ	O	indicate	_	0	SENT_328	[p17l1285t1174r1659b1252],
18	that	IN	O	that	complm	21	SENT_328	[p17l1707t1174r1873b1252],
19	other	JJ	O	other	amod	20	SENT_328	[p17l1914t1174r2138b1252],
20	factors	NNS	O	factor	nsubj	21	SENT_328	[p17l10t1301r295b1380],
21	inﬂuence	VBP	O	inﬂuence	ccomp	17	SENT_328	[p17l322t1301r712b1381],
22	the	DT	O	the	det	23	SENT_328	[p17l739t1302r867b1380],
23	outcome	NN	O	outcome	dobj	21	SENT_328	[p17l893t1318r1261b1381],
24	of	IN	O	of	_	0	SENT_328	[p17l1287t1301r1387b1380],
25	treatment	NN	O	treatment	prep_of	23	SENT_328	[p17l1394t1318r1827b1380],
26	.	.	O	.	_	0	SENT_328	[p17l1394t1318r1827b1380],

1	Since	IN	O	since	mark	5	SENT_329	[p17l141t1430r363b1508],
2	PTEN	NN	O	pten	nsubjpass	5	SENT_329	[p17l397t1435r642b1508],
3	may	MD	O	may	aux	5	SENT_329	[p17l676t1456r853b1530],
4	be	VB	O	be	auxpass	5	SENT_329	[p17l884t1430r979b1508],
5	required	VBN	O	require	advcl	17	SENT_329	[p17l1015t1430r1371b1530],
6	for	IN	O	for	_	0	SENT_329	[p17l1406t1429r1529b1508],
7	a	DT	O	a	det	8	SENT_329	[p17l1561t1456r1605b1508],
8	response	NN	O	response	prep_for	5	SENT_329	[p17l1639t1455r2018b1530],
9	to	TO	O	to	_	0	SENT_329	[p17l2055t1446r2134b1508],
10	the	DT	O	the	det	12	SENT_329	[p17l11t1558r139b1636],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_329	[p17l165t1563r424b1641],
12	family	NN	O	family	prep_to	5	SENT_329	[p17l440t1557r705b1658],
13	of	IN	O	of	_	0	SENT_329	[p17l728t1557r828b1636],
14	kinase	NN	O	kinase	nn	15	SENT_329	[p17l836t1557r1107b1637],
15	inhibitors,-33	NN	O	inhibitors,-33	prep_of	12	SENT_329	[p17l1132t1558r1656b1653],
16	we	PRP	O	we	nsubj	17	SENT_329	[p17l1681t1584r1798b1637],
17	studied	VBD	O	study	_	0	SENT_329	[p17l1827t1558r2135b1637],
18	this	DT	O	this	det	19	SENT_329	[p17l11t1686r163b1764],
19	protein	NN	O	protein	dobj	17	SENT_329	[p17l192t1686r499b1786],
20	in	IN	O	in	_	0	SENT_329	[p17l527t1686r607b1763],
21	glioblastomas	NNS	O	glioblastoma	prep_in	19	SENT_329	[p17l635t1685r1230b1786],
22	using	VBG	O	use	partmod	21	SENT_329	[p17l1260t1686r1497b1786],
23	immunohisto	JJ	O	immunohisto	amod	26	SENT_329	[p17l1521t1686r2134b1765],
24	—	NN	O	—	nn	26	SENT_329	[p17l1521t1686r2134b1765],
25	chemical	NN	O	chemical	nn	26	SENT_329	[p17l11t1814r389b1892],
26	analysis	NN	O	analysis	dobj	22	SENT_329	[p17l425t1814r756b1914],
27	and	CC	O	and	_	0	SENT_329	[p17l794t1814r950b1892],
28	immunoblotting	NN	O	immunoblotting	nn	30	SENT_329	[p17l986t1814r1694b1914],
29	(	CD	NUMBER	(	num	30	SENT_329	[p17l1732t1814r1916b1914],
30	Fig	NN	O	fig	conj_and	26	SENT_329	[p17l1732t1814r1916b1914],
31	.	.	O	.	_	0	SENT_329	[p17l1732t1814r1916b1914],

1	2C	NN	O	2c	_	0	SENT_330	[p17l1958t1819r2130b1905],
2	)	NN	O	)	dep	1	SENT_330	[p17l1958t1819r2130b1905],
3	.	.	O	.	_	0	SENT_330	[p17l1958t1819r2130b1905],

1	The	DT	O	the	det	2	SENT_331	[p17l7t1941r169b2020],
2	results	NNS	O	result	nsubj	17	SENT_331	[p17l247t1942r524b2021],
3	of	IN	O	of	_	0	SENT_331	[p17l606t1941r706b2020],
4	both	DT	O	both	det	5	SENT_331	[p17l767t1942r960b2020],
5	assays	NNS	O	assay	prep_of	2	SENT_331	[p17l1037t1968r1298b2042],
6	were	VBD	O	be	cop	17	SENT_331	[p17l1375t1968r1576b2021],
7	concordant	JJ	O	concordant	amod	9	SENT_331	[p17l1656t1942r2140b2020],
8	(	NN	O	(	nn	9	SENT_331	[p17l15t2075r334b2165],
9	K	NN	O	k	nn	17	SENT_331	[p17l15t2075r334b2165],
10	=	JJ	O	=	amod	9	SENT_331	[p17l15t2075r334b2165],
11	O.	NNP	O	O.	tmod	10	SENT_331	[p17l15t2075r334b2165],
12	8	CD	NUMBER	8	num	11	SENT_331	[p17l15t2075r334b2165],
13	,	,	O	,	_	0	SENT_331	[p17l15t2075r334b2165],
14	P	NN	O	p	appos	11	SENT_331	[p17l373t2075r797b2161],
15	=	JJ	O	=	amod	17	SENT_331	[p17l373t2075r797b2161],
16	0.005	CD	NUMBER	0.005	tmod	15	SENT_331	[p17l373t2075r797b2161],
17	)	NN	O	)	_	0	SENT_331	[p17l373t2075r797b2161],
18	.	.	O	.	_	0	SENT_331	[p17l373t2075r797b2161],

1	None	NN	O	none	nsubj	9	SENT_332	[p17l834t2077r1066b2148],
2	of	IN	O	of	_	0	SENT_332	[p17l1101t2069r1202b2148],
3	13	CD	NUMBER	13	num	4	SENT_332	[p17l1221t2075r1316b2148],
4	patients	NNS	O	patient	prep_of	1	SENT_332	[p17l1352t2070r1686b2170],
5	whose	WP$	O	whose	poss	6	SENT_332	[p17l1719t2070r1989b2149],
6	tumors	NNS	O	tumor	nsubj	7	SENT_332	[p17l2022t2086r2134b2149, p17l10t2222r223b2275],
7	lacked	VBD	O	lack	rcmod	4	SENT_332	[p17l251t2198r518b2276],
8	PTEN	NNP	ORGANIZATION	PTEN	dobj	7	SENT_332	[p17l544t2203r787b2276],
9	had	VBD	O	have	_	0	SENT_332	[p17l812t2198r966b2275],
10	a	DT	O	a	det	11	SENT_332	[p17l993t2224r1037b2275],
11	response	NN	O	response	dobj	9	SENT_332	[p17l1063t2222r1436b2297],
12	to	TO	O	to	_	0	SENT_332	[p17l1464t2213r1542b2275],
13	EGFRinhibi	NN	O	egfrinhibus	nn	15	SENT_332	[p17l1570t2198r2133b2280],
14	—	CD	NUMBER	—	num	15	SENT_332	[p17l1570t2198r2133b2280],
15	tors	NNS	O	tor	prep_to	9	SENT_332	[p17l11t2342r200b2421],
16	,	,	O	,	_	0	SENT_332	[p17l11t2342r200b2421],
17	whereas	IN	O	whereas	mark	27	SENT_332	[p17l230t2326r584b2405],
18	7	CD	TIME	7	nsubj	27	SENT_332	[p17l618t2333r664b2404],
19	of	IN	TIME	of	_	0	SENT_332	[p17l695t2325r797b2404],
20	13	CD	TIME	13	num	21	SENT_332	[p17l812t2331r907b2404],
21	patients	NNS	O	patient	prep_of	18	SENT_332	[p17l939t2326r1281b2426],
22	with	IN	O	with	_	0	SENT_332	[p17l1308t2326r1501b2405],
23	PTEN	NN	O	pten	npadvmod	25	SENT_332	[p17l1529t2326r2135b2426],
24	—	CD	NUMBER	—	num	23	SENT_332	[p17l1529t2326r2135b2426],
25	positive	JJ	O	positive	amod	26	SENT_332	[p17l1529t2326r2135b2426],
26	tumors	NNS	O	tumor	prep_with	21	SENT_332	[p17l11t2470r308b2533],
27	had	VBD	O	have	advcl	9	SENT_332	[p17l335t2454r488b2532],
28	a	DT	O	a	det	38	SENT_332	[p17l512t2480r557b2532],
29	response	NN	O	response	nn	38	SENT_332	[p17l580t2479r953b2554],
30	(	CD	NUMBER	(	num	38	SENT_332	[p17l983t2459r1398b2545],
31	P	NN	O	p	nn	38	SENT_332	[p17l983t2459r1398b2545],
32	=	JJ	O	=	amod	38	SENT_332	[p17l983t2459r1398b2545],
33	0.005	CD	NUMBER	0.005	num	38	SENT_332	[p17l983t2459r1398b2545],
34	)	CD	NUMBER	)	num	38	SENT_332	[p17l983t2459r1398b2545],
35	(	CD	NUMBER	(	num	38	SENT_332	[p17l1433t2454r1683b2545],
36	Table	NNP	O	Table	nn	38	SENT_332	[p17l1433t2454r1683b2545],
37	3	CD	NUMBER	3	num	38	SENT_332	[p17l1709t2459r1813b2545],
38	)	NN	O	)	dobj	27	SENT_332	[p17l1709t2459r1813b2545],
39	.	.	O	.	_	0	SENT_332	[p17l1709t2459r1813b2545],

1	To	TO	O	to	aux	2	SENT_333	[p17l1841t2459r1945b2532],
2	rule	VB	O	rule	purpcl	16	SENT_333	[p17l1973t2454r2135b2533],
3	out	RP	O	out	prt	2	SENT_333	[p17l11t2598r151b2661],
4	the	DT	O	the	det	5	SENT_333	[p17l181t2582r310b2660],
5	possibility	NN	O	possibility	dobj	2	SENT_333	[p17l343t2582r782b2682],
6	that	IN	O	that	complm	10	SENT_333	[p17l812t2582r979b2660],
7	the	DT	O	the	det	9	SENT_333	[p17l1009t2582r1138b2660],
8	immunohistochemical	JJ	O	immunohistochemical	amod	9	SENT_333	[p17l1172t2582r2135b2661],
9	assay	NN	O	assay	nsubj	10	SENT_333	[p17l10t2736r233b2810],
10	detected	VBD	O	detect	ccomp	2	SENT_333	[p17l282t2709r632b2788],
11	a	DT	O	a	det	13	SENT_333	[p17l683t2736r728b2788],
12	mutant	JJ	O	mutant	amod	13	SENT_333	[p17l779t2726r1090b2789],
13	protein	NN	O	protein	dobj	10	SENT_333	[p17l1136t2710r1466b2810],
14	,	,	O	,	_	0	SENT_333	[p17l1136t2710r1466b2810],
15	we	PRP	O	we	nsubj	16	SENT_333	[p17l1519t2736r1638b2789],
16	sequenced	VBD	O	sequence	_	0	SENT_333	[p17l1692t2710r2135b2810],
17	PTEN	NN	O	pten	dobj	16	SENT_333	[p17l9t2843r276b2933],
18	;	:	O	;	_	0	SENT_333	[p17l9t2843r276b2933],
19	no	DT	O	no	det	20	SENT_333	[p17l313t2863r419b2916],
20	mutations	NNS	O	mutation	nsubjpass	22	SENT_333	[p17l453t2838r884b2917],
21	were	VBD	O	be	auxpass	22	SENT_333	[p17l915t2864r1116b2917],
22	detected	VBN	O	detect	parataxis	16	SENT_333	[p17l1150t2838r1501b2916],
23	in	IN	O	in	_	0	SENT_333	[p17l1533t2838r1614b2915],
24	the	DT	O	the	det	26	SENT_333	[p17l1648t2838r1777b2916],
25	responsive	JJ	O	responsive	amod	26	SENT_333	[p17l1811t2863r2134b2938, p17l12t2966r165b3045],
26	tumors	NNS	O	tumor	prep_in	22	SENT_333	[p17l188t2982r515b3045],
27	.	.	O	.	_	0	SENT_333	[p17l188t2982r515b3045],

1	The	DT	O	the	det	3	SENT_334	[p17l540t2966r701b3044],
2	greatest	JJS	O	greatest	amod	3	SENT_334	[p17l724t2982r1060b3066],
3	likelihood	NN	O	likelihood	nsubjpass	13	SENT_334	[p17l1077t2966r1506b3045],
4	of	IN	O	of	_	0	SENT_334	[p17l1530t2965r1630b3044],
5	a	DT	O	a	det	7	SENT_334	[p17l1633t2992r1677b3044],
6	clinical	JJ	O	clinical	amod	7	SENT_334	[p17l1699t2966r2000b3044],
7	response	NN	O	response	prep_of	3	SENT_334	[p17l2022t2992r2134b3044, p17l12t3119r306b3194],
8	to	TO	O	to	_	0	SENT_334	[p17l344t3110r423b3172],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_334	[p17l459t3099r718b3177],
10	kinase	NN	O	kinase	nn	11	SENT_334	[p17l744t3094r1014b3173],
11	inhibitors	NNS	O	inhibitor	prep_to	7	SENT_334	[p17l1051t3093r1464b3172],
12	was	VBD	O	be	auxpass	13	SENT_334	[p17l1499t3120r1660b3173],
13	associated	VBN	O	associate	_	0	SENT_334	[p17l1699t3094r2135b3172],
14	with	IN	O	with	_	0	SENT_334	[p17l6t3222r195b3301],
15	coexpression	NN	O	coexpression	prep_with	13	SENT_334	[p17l219t3222r773b3322],
16	of	IN	O	of	_	0	SENT_334	[p17l797t3221r897b3300],
17	EGFRVIII	NN	O	egfrviius	prep_of	15	SENT_334	[p17l901t3227r1292b3305],
18	and	CC	O	and	_	0	SENT_334	[p17l1314t3222r1470b3300],
19	PTEN	NN	O	pten	conj_and	17	SENT_334	[p17l1492t3227r1737b3300],
20	(	CD	NUMBER	(	num	21	SENT_334	[p17l1764t3222r1996b3313],
21	odds	NNS	O	odds	dep	42	SENT_334	[p17l1764t3222r1996b3313],
22	ra	NN	O	ra	nn	24	SENT_334	[p17l2021t3248r2134b3300],
23	—	CD	NUMBER	—	num	24	SENT_334	[p17l2021t3248r2134b3300],
24	tio	NN	O	tio	dep	21	SENT_334	[p17l11t3350r143b3445],
25	,	,	O	,	_	0	SENT_334	[p17l11t3350r143b3445],
26	51	CD	NUMBER	51	appos	24	SENT_334	[p17l191t3355r315b3445],
27	;	:	O	;	_	0	SENT_334	[p17l191t3355r315b3445],
28	95	CD	PERCENT	95	num	31	SENT_334	[p17l359t3355r457b3428],
29	percent	NN	PERCENT	percent	nn	31	SENT_334	[p17l500t3366r820b3450],
30	conﬁdence	NN	O	conﬁdence	nn	31	SENT_334	[p17l857t3349r1318b3428],
31	interval	NN	O	interval	dep	24	SENT_334	[p17l1359t3350r1695b3445],
32	,	,	O	,	_	0	SENT_334	[p17l1359t3350r1695b3445],
33	4	CD	NUMBER	4	number	35	SENT_334	[p17l1740t3355r1790b3428],
34	to	TO	O	to	dep	35	SENT_334	[p17l1831t3366r1909b3428],
35	669	CD	NUMBER	669	appos	31	SENT_334	[p17l1953t3355r2131b3445],
36	;	:	O	;	_	0	SENT_334	[p17l1953t3355r2131b3445],
37	P	NN	O	p	dep	24	SENT_334	[p17l9t3484r388b3570],
38	<	JJR	O	<	dep	37	SENT_334	[p17l9t3484r388b3570],
39	0.001	CD	NUMBER	0.001	num	40	SENT_334	[p17l9t3484r388b3570],
40	)	NN	O	)	dep	42	SENT_334	[p17l9t3484r388b3570],
41	(	CD	NUMBER	(	num	42	SENT_334	[p17l424t3479r677b3570],
42	Table	NNP	O	Table	dep	15	SENT_334	[p17l424t3479r677b3570],
43	3	CD	NUMBER	3	num	42	SENT_334	[p17l704t3484r809b3570],
44	)	NN	O	)	dep	42	SENT_334	[p17l704t3484r809b3570],
45	.	.	O	.	_	0	SENT_334	[p17l704t3484r809b3570],

1	Ten	CD	NUMBER	ten	num	2	SENT_335	[p17l136t3612r291b3685],
2	patients	NNS	O	patient	nsubjpass	28	SENT_335	[p17l318t3607r653b3707],
3	who	WP	O	who	nsubj	4	SENT_335	[p17l679t3607r863b3686],
4	had	VBD	O	have	rcmod	2	SENT_335	[p17l892t3607r1047b3685],
5	neither	DT	O	neither	det	7	SENT_335	[p17l1076t3607r1378b3685],
6	tumor	NN	O	tumor	nn	7	SENT_335	[p17l1404t3623r1667b3686],
7	regression	NN	O	regression	dobj	4	SENT_335	[p17l1692t3607r2135b3707],
8	nor	CC	O	nor	_	0	SENT_335	[p18l10t45r157b98],
9	substantial	JJ	O	substantial	amod	11	SENT_335	[p18l197t21r660b99],
10	tumor	NN	O	tumor	nn	11	SENT_335	[p18l701t36r965b99],
11	growth	NN	O	growth	conj_nor	7	SENT_335	[p18l1002t21r1305b120],
12	while	IN	O	while	mark	13	SENT_335	[p18l1341t21r1574b99],
13	receiving	VBG	O	receive	dep	11	SENT_335	[p18l1615t21r1997b120],
14	an	DT	O	a	det	15	SENT_335	[p18l2034t46r2135b98],
15	EGFRl	NN	O	egfrl	dobj	13	SENT_335	[p18l9t149r556b232],
16	<	JJR	O	<	amod	19	SENT_335	[p18l9t149r556b232],
17	inase	NN	O	inase	nn	19	SENT_335	[p18l9t149r556b232],
18	inhibitor	NN	O	inhibitor	nn	19	SENT_335	[p18l585t148r961b227],
19	(	NN	O	(	dep	13	SENT_335	[p18l992t149r1245b240],
20	Table	NNP	O	Table	dep	19	SENT_335	[p18l992t149r1245b240],
21	1	CD	NUMBER	1	num	20	SENT_335	[p18l1278t154r1322b226],
22	of	IN	O	of	_	0	SENT_335	[p18l1352t148r1453b227],
23	the	DT	O	the	det	26	SENT_335	[p18l1464t149r1592b227],
24	Supplementary	NNP	O	Supplementary	nn	26	SENT_335	[p18l1624t149r2134b249, p18l11t293r174b377],
25	Appendix	NNP	O	Appendix	nn	26	SENT_335	[p18l208t277r655b377],
26	)	NN	O	)	prep_of	2	SENT_335	[p18l208t277r655b377],
27	were	VBD	O	be	auxpass	28	SENT_335	[p18l699t303r903b356],
28	excluded	VBN	O	exclude	_	0	SENT_335	[p18l948t276r1326b356],
29	from	IN	O	from	_	0	SENT_335	[p18l1370t276r1580b355],
30	the	DT	O	the	det	32	SENT_335	[p18l1623t277r1754b355],
31	original	JJ	O	original	amod	32	SENT_335	[p18l1798t277r2134b377],
32	analysis	NN	O	analysis	prep_from	28	SENT_335	[p18l10t405r340b505],
33	because	IN	O	because	mark	37	SENT_335	[p18l376t405r708b484],
34	they	PRP	O	they	nsubj	37	SENT_335	[p18l741t405r917b505],
35	did	VBD	O	do	aux	37	SENT_335	[p18l946t404r1080b483],
36	not	RB	O	not	neg	37	SENT_335	[p18l1112t421r1255b483],
37	ﬁt	VB	O	ﬁt	advcl	28	SENT_335	[p18l1283t404r1375b483],
38	the	DT	O	the	det	39	SENT_335	[p18l1403t405r1532b483],
39	extremes	NNS	O	extreme	dobj	37	SENT_335	[p18l1566t421r1943b483],
40	of	IN	O	of	_	0	SENT_335	[p18l1978t404r2078b483],
41	a	DT	O	a	det	43	SENT_335	[p18l2092t431r2136b483],
42	clear	JJ	O	clear	amod	43	SENT_335	[p18l11t533r211b611],
43	response	NN	O	response	prep_of	39	SENT_335	[p18l240t558r619b633],
44	or	CC	O	or	_	0	SENT_335	[p18l652t558r741b611],
45	treatment	NN	O	treatment	nn	46	SENT_335	[p18l770t549r1184b611],
46	failure	NN	O	failure	prep_of	39	SENT_335	[p18l1211t532r1504b612],
47	.	.	O	.	_	0	SENT_335	[p18l1211t532r1504b612],

1	None	NN	O	none	_	0	SENT_336	[p18l1539t540r1770b611],
2	of	IN	O	of	_	0	SENT_336	[p18l1802t532r1903b611],
3	these	DT	O	these	det	4	SENT_336	[p18l1916t533r2135b611],
4	patients	NNS	O	patient	prep_of	1	SENT_336	[p18l9t661r369b761],
5	,	,	O	,	_	0	SENT_336	[p18l9t661r369b761],
6	who	WP	O	who	nsubj	7	SENT_336	[p18l397t661r579b740],
7	had	VBD	O	have	rcmod	4	SENT_336	[p18l607t661r762b739],
8	a	DT	O	a	det	10	SENT_336	[p18l788t687r832b739],
9	median	JJ	O	median	amod	10	SENT_336	[p18l856t660r1173b739],
10	time	NN	O	time	dobj	7	SENT_336	[p18l1199t661r1386b739],
11	to	TO	O	to	_	0	SENT_336	[p18l1412t677r1491b739],
12	progression	NN	O	progression	prep_to	10	SENT_336	[p18l1518t661r2027b761],
13	of	IN	O	of	prep	7	SENT_336	[p18l2053t660r2153b739],

1	Figure	NNP	O	Figure	nn	3	SENT_337	[p18l84t1052r301b1134],
2	3	CD	NUMBER	3	num	3	SENT_337	[p18l325t1056r359b1114],
3	(	NN	O	(	_	0	SENT_337	[p18l392t1049r626b1135],
4	facing	VBG	O	face	partmod	3	SENT_337	[p18l392t1049r626b1135],
5	page	NN	O	page	nn	6	SENT_337	[p18l652t1056r862b1135],
6	)	NN	O	)	dobj	4	SENT_337	[p18l652t1056r862b1135],
7	.	.	O	.	_	0	SENT_337	[p18l652t1056r862b1135],

1	Loss	NN	O	loss	_	0	SENT_338	[p18l894t1056r1047b1114],
2	of	IN	O	of	_	0	SENT_338	[p18l1072t1049r1153b1114],
3	PTEN	NN	ORGANIZATION	pten	prep_of	1	SENT_338	[p18l1166t1056r1357b1114],
4	and	CC	O	and	_	0	SENT_338	[p18l1388t1050r1514b1114],
5	Resistance	NN	O	resistance	prep_of	1	SENT_338	[p18l1546t1052r1919b1114],
6	to	TO	O	to	_	0	SENT_338	[p18l76t1168r145b1222],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_338	[p18l174t1163r368b1222],
8	Kinase	NN	O	kinase	nn	9	SENT_338	[p18l396t1159r625b1222],
9	Inhibitors	NNS	O	inhibitor	prep_to	1	SENT_338	[p18l653t1158r988b1222],
10	in	IN	O	in	_	0	SENT_338	[p18l1016t1159r1074b1221],
11	EGFR-Sensitized	JJ	O	egfr-sensitized	amod	12	SENT_338	[p18l1107t1158r1684b1222],
12	Cells	NNS	O	cell	prep_in	1	SENT_338	[p18l1711t1158r1897b1222],
13	.	.	O	.	_	0	SENT_338	[p18l1711t1158r1897b1222],

1	In	IN	O	in	_	0	SENT_339	[p18l85t1293r142b1350],
2	Panel	NN	O	panel	nn	3	SENT_339	[p18l178t1287r359b1351],
3	A	NN	O	a	prep_in	11	SENT_339	[p18l386t1291r452b1363],
4	,	,	O	,	_	0	SENT_339	[p18l386t1291r452b1363],
5	the	DT	O	the	det	6	SENT_339	[p18l479t1287r589b1351],
6	coexpression	NN	O	coexpression	nsubj	11	SENT_339	[p18l614t1293r1070b1371],
7	of	IN	O	of	_	0	SENT_339	[p18l1101t1286r1177b1351],
8	EGFRVIII	NN	O	egfrviius	prep_of	6	SENT_339	[p18l1196t1292r1496b1351],
9	and	CC	O	and	_	0	SENT_339	[p18l1529t1287r1653b1351],
10	PTEN	NN	ORGANIZATION	pten	prep_of	6	SENT_339	[p18l1688t1293r1876b1350],
11	sensitizes	VBZ	O	sensitize	_	0	SENT_339	[p18l1910t1310r2051b1351, p18l81t1400r297b1459],
12	U87MG	NN	O	u87mg	nn	14	SENT_339	[p18l327t1399r594b1460],
13	glioblastoma	NN	O	glioblastoma	nn	14	SENT_339	[p18l623t1394r1078b1479],
14	cells	NNS	O	cell	dobj	11	SENT_339	[p18l1103t1394r1253b1459],
15	to	TO	O	to	_	0	SENT_339	[p18l1276t1407r1345b1459],
16	the	DT	O	the	det	18	SENT_339	[p18l1366t1394r1475b1459],
17	antiproliferative	JJ	O	antiproliferative	amod	18	SENT_339	[p18l1500t1394r2053b1478],
18	effects	NNS	O	effect	prep_to	11	SENT_339	[p18l79t1501r304b1566],
19	of	IN	O	of	_	0	SENT_339	[p18l332t1501r408b1566],
20	erlotinib	NN	O	erlotinib	prep_of	18	SENT_339	[p18l422t1502r732b1566],
21	.	.	O	.	_	0	SENT_339	[p18l422t1502r732b1566],

1	The	DT	O	the	det	2	SENT_340	[p18l757t1502r887b1566],
2	graph	NN	O	graph	nsubj	3	SENT_340	[p18l914t1502r1110b1586],
3	shows	VBZ	O	show	_	0	SENT_340	[p18l1141t1502r1358b1566],
4	the	DT	O	the	det	5	SENT_340	[p18l1383t1502r1493b1566],
5	effect	NN	O	effect	dobj	3	SENT_340	[p18l1519t1501r1708b1566],
6	of	IN	O	of	_	0	SENT_340	[p18l1733t1501r1809b1566],
7	erlotinib	NN	O	erlotinib	prep_of	5	SENT_340	[p18l1823t1502r1976b1566, p18l77t1609r234b1674],
8	on	IN	O	on	_	0	SENT_340	[p18l261t1632r344b1674],
9	the	DT	O	the	det	11	SENT_340	[p18l371t1609r480b1674],
10	mean	JJ	O	mean	amod	11	SENT_340	[p18l510t1632r697b1674],
11	(	NN	O	(	prep_on	7	SENT_340	[p18l735t1614r931b1693],
12	:	:	O	:	_	0	SENT_340	[p18l735t1614r931b1693],
13	SD	NN	O	sd	nn	16	SENT_340	[p18l735t1614r931b1693],
14	)	CD	NUMBER	)	num	16	SENT_340	[p18l735t1614r931b1693],
15	growth	NN	O	growth	nn	16	SENT_340	[p18l965t1609r1203b1694],
16	ofthe	NN	O	ofthe	dep	5	SENT_340	[p18l1232t1608r1430b1674],
17	parental	JJ	O	parental	amod	19	SENT_340	[p18l1459t1609r1738b1693],
18	cell	NN	O	cell	nn	19	SENT_340	[p18l1767t1609r1877b1674],
19	line	NN	O	line	dep	16	SENT_340	[p18l1911t1609r2030b1674],
20	and	CC	O	and	_	0	SENT_340	[p18l80t1716r204b1781],
21	U87MG	NN	O	u87mg	nn	22	SENT_340	[p18l238t1721r505b1782],
22	sublines	NNS	O	subline	conj_and	19	SENT_340	[p18l538t1716r847b1781],
23	.	.	O	.	_	0	SENT_340	[p18l538t1716r847b1781],

1	The	DT	O	the	det	3	SENT_341	[p18l872t1716r1002b1781],
2	immunoblot	NN	O	immunoblot	nn	3	SENT_341	[p18l1031t1716r1468b1781],
3	ofthe	NN	O	ofthe	nsubj	10	SENT_341	[p18l1493t1716r1689b1781],
4	parental	JJ	O	parental	amod	6	SENT_341	[p18l1720t1716r1997b1800],
5	cell	NN	O	cell	nn	6	SENT_341	[p18l79t1824r189b1888],
6	line	NN	O	line	dep	3	SENT_341	[p18l221t1824r340b1888],
7	and	CC	O	and	_	0	SENT_341	[p18l365t1824r488b1888],
8	U87MG	NN	O	u87mg	nn	9	SENT_341	[p18l520t1828r788b1889],
9	sublines	NNS	O	subline	dep	3	SENT_341	[p18l818t1824r1106b1889],
10	shows	VBZ	O	show	conj_and	10	SENT_341	[p18l1134t1824r1351b1888],
11	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_341	[p18l1382t1829r1573b1888],
12	(	NN	O	(	dobj	10	SENT_341	[p18l1604t1828r1752b1909],
13	170	CD	NUMBER	170	num	15	SENT_341	[p18l1604t1828r1752b1909],
14	kD	NN	O	kd	nn	15	SENT_341	[p18l1778t1824r1893b1909],
15	)	NN	O	)	dep	12	SENT_341	[p18l1778t1824r1893b1909],
16	and	CC	O	and	_	0	SENT_341	[p18l1925t1824r2049b1888],
17	EGFRVIII	NN	O	egfrviius	nn	18	SENT_341	[p18l85t1937r385b1996],
18	(	NN	O	(	dobj	10	SENT_341	[p18l422t1935r570b2016],
19	140	CD	NUMBER	140	num	21	SENT_341	[p18l422t1935r570b2016],
20	kD	NN	O	kd	nn	21	SENT_341	[p18l595t1932r710b2016],
21	)	NN	O	)	dep	18	SENT_341	[p18l595t1932r710b2016],
22	in	IN	O	in	_	0	SENT_341	[p18l743t1938r799b1995],
23	cells	NNS	O	cell	prep_in	10	SENT_341	[p18l826t1932r976b1996],
24	with	IN	O	with	_	0	SENT_341	[p18l999t1932r1143b1996],
25	PTEN	NN	O	pten	prep_with	23	SENT_341	[p18l1176t1938r1364b1995],
26	and	CC	O	and	_	0	SENT_341	[p18l1394t1932r1518b1996],
27	without	IN	O	without	_	0	SENT_341	[p18l1542t1932r1810b1996],
28	PTEN	NNP	ORGANIZATION	PTEN	prep_without	10	SENT_341	[p18l1837t1938r2050b1996],
29	.	.	O	.	_	0	SENT_341	[p18l1837t1938r2050b1996],

1	In	IN	O	in	_	0	SENT_342	[p18l85t2045r142b2102],
2	Panel	NN	O	panel	nn	3	SENT_342	[p18l177t2039r358b2103],
3	B	NN	O	b	prep_in	9	SENT_342	[p18l392t2045r450b2115],
4	,	,	O	,	_	0	SENT_342	[p18l392t2045r450b2115],
5	the	DT	O	the	det	6	SENT_342	[p18l476t2039r585b2103],
6	loss	NN	O	loss	nsubj	9	SENT_342	[p18l613t2039r745b2103],
7	of	IN	O	of	_	0	SENT_342	[p18l773t2039r849b2103],
8	PTEN	NN	ORGANIZATION	pten	prep_of	6	SENT_342	[p18l867t2045r1055b2103],
9	nullifies	VBZ	O	nullify	_	0	SENT_342	[p18l1090t2039r1359b2104],
10	the	DT	O	the	det	12	SENT_342	[p18l1383t2039r1492b2103],
11	induction	NN	O	induction	nn	12	SENT_342	[p18l1520t2039r1847b2104],
12	ofapoptosis	NN	O	ofapoptosis	dobj	9	SENT_342	[p18l1876t2038r2070b2123, p18l79t2152r335b2231],
13	by	IN	O	by	_	0	SENT_342	[p18l365t2147r438b2231],
14	two	CD	NUMBER	two	num	18	SENT_342	[p18l459t2159r584b2211],
15	EG	NN	O	eg	nn	18	SENT_342	[p18l616t2151r706b2211],
16	FR	NN	O	fr	nn	18	SENT_342	[p18l723t2152r807b2210],
17	kinase	NN	O	kinase	nn	18	SENT_342	[p18l835t2147r1053b2211],
18	inhibitors	NNS	O	inhibitor	prep_by	9	SENT_342	[p18l1080t2147r1431b2222],
19	,	,	O	,	_	0	SENT_342	[p18l1080t2147r1431b2222],
20	erlotinib	NN	O	erlotinib	nn	23	SENT_342	[p18l1461t2147r1751b2211],
21	and	CC	O	and	_	0	SENT_342	[p18l1778t2147r1901b2211],
22	PK	NN	O	pk	nn	23	SENT_342	[p18l1935t2152r2070b2210, p18l84t2259r221b2319],
23	|	NN	O	|	appos	18	SENT_342	[p18l1935t2152r2070b2210, p18l84t2259r221b2319],
24	166	CD	NUMBER	166	dep	23	SENT_342	[p18l1935t2152r2070b2210, p18l84t2259r221b2319],
25	.	.	O	.	_	0	SENT_342	[p18l1935t2152r2070b2210, p18l84t2259r221b2319],

1	PKI-166	NN	MISC	pki-166	nsubj	2	SENT_343	[p18l256t2259r519b2319],
2	inhibits	VBZ	O	inhibit	_	0	SENT_343	[p18l548t2254r804b2319],
3	both	CC	O	both	preconj	4	SENT_343	[p18l836t2254r986b2319],
4	EGFR	NN	ORGANIZATION	egfr	dobj	2	SENT_343	[p18l1022t2259r1213b2319],
5	and	CC	O	and	_	0	SENT_343	[p18l1240t2254r1363b2319],
6	Her2	NN	O	her2	dobj	2	SENT_343	[p18l1398t2260r1583b2330],
7	,	,	O	,	_	0	SENT_343	[p18l1398t2260r1583b2330],
8	but	CC	O	but	_	0	SENT_343	[p18l1616t2254r1727b2319],
9	the	DT	O	the	det	11	SENT_343	[p18l1749t2254r1858b2319],
10	50	CD	PERCENT	50	num	11	SENT_343	[p18l1885t2258r1965b2319],
11	percent	NN	PERCENT	percent	conj_but	4	SENT_343	[p18l83t2374r343b2445],
12	inhibitory	JJ	O	inhibitory	amod	13	SENT_343	[p18l366t2361r697b2447],
13	concentration	NN	O	concentration	nsubj	15	SENT_343	[p18l716t2368r1188b2426],
14	is	VBZ	O	be	cop	15	SENT_343	[p18l1214t2368r1261b2426],
15	less	RBR	O	less	rcmod	4	SENT_343	[p18l1286t2361r1408b2426],
16	by	IN	O	by	_	0	SENT_343	[p18l1433t2361r1505b2446],
17	a	DT	O	a	det	19	SENT_343	[p18l1523t2384r1555b2426],
18	factor	NN	O	factor	nn	19	SENT_343	[p18l1574t2361r1771b2426],
19	of1O	NN	O	of1o	prep_by	15	SENT_343	[p18l1787t2361r1948b2426],
20	for	IN	O	for	_	0	SENT_343	[p18l1965t2361r2060b2426],
21	EG	NN	O	eg	nn	22	SENT_343	[p18l85t2474r175b2533],
22	FR	NN	O	fr	prep_for	19	SENT_343	[p18l190t2475r272b2533],
23	than	IN	O	than	mark	30	SENT_343	[p18l292t2469r442b2533],
24	for	IN	O	for	_	0	SENT_343	[p18l466t2468r562b2533],
25	Her2	NN	O	her2	prep_for	30	SENT_343	[p18l587t2475r833b2533],
26	.41	CD	NUMBER	.41	num	28	SENT_343	[p18l587t2475r833b2533],
27	Cell	NN	O	cell	nn	28	SENT_343	[p18l861t2469r981b2533],
28	death	NN	O	death	nsubjpass	30	SENT_343	[p18l1010t2469r1200b2533],
29	was	VBD	O	be	auxpass	30	SENT_343	[p18l1227t2491r1359b2533],
30	detected	VBN	O	detect	advcl	15	SENT_343	[p18l1386t2469r1681b2533],
31	at	IN	O	at	_	0	SENT_343	[p18l1711t2481r1773b2533],
32	concentrations	NNS	O	concentration	prep_at	30	SENT_343	[p18l1797t2491r2071b2533, p18l77t2583r347b2641],

1	of	IN	O	of	_	0	SENT_344	[p18l375t2575r452b2641],
2	PKI-166	NN	O	pki-166	prep_of	17	SENT_344	[p18l471t2582r734b2641],
3	that	WDT	O	that	nsubj	7	SENT_344	[p18l758t2576r896b2641],
4	primarily	RB	O	primarily	advmod	7	SENT_344	[p18l924t2576r1233b2662],
5	or	CC	O	or	_	0	SENT_344	[p18l1257t2600r1328b2641],
6	exclusively	RB	O	exclusively	conj_or	4	SENT_344	[p18l1351t2576r1721b2662],
7	inhibit	VBP	O	inhibit	rcmod	2	SENT_344	[p18l1748t2576r1969b2641],
8	EG	NN	O	eg	nn	9	SENT_344	[p18l85t2689r176b2748],
9	FR	NN	O	fr	dobj	7	SENT_344	[p18l193t2690r450b2748],
10	.42	CD	NUMBER	.42	num	11	SENT_344	[p18l193t2690r450b2748],
11	'44	CD	NUMBER	'44	nsubj	17	SENT_344	[p18l193t2690r450b2748],
12	The	DT	O	the	det	16	SENT_344	[p18l467t2684r597b2748],
13	upper	JJ	O	upper	amod	16	SENT_344	[p18l621t2707r824b2768],
14	part	NN	O	part	nn	16	SENT_344	[p18l846t2696r981b2768],
15	ofPanel	NN	O	ofpanel	nn	16	SENT_344	[p18l1001t2683r1267b2748],
16	B	NN	O	b	dep	11	SENT_344	[p18l1297t2690r1333b2747],
17	shows	VBZ	O	show	_	0	SENT_344	[p18l1357t2684r1570b2748],
18	the	DT	O	the	det	19	SENT_344	[p18l1589t2684r1697b2748],
19	viability	NN	O	viability	nsubj	24	SENT_344	[p18l1715t2684r1976b2769],
20	of	IN	O	of	_	0	SENT_344	[p18l1994t2683r2070b2748],
21	A431	NN	O	a431	nn	22	SENT_344	[p18l77t2796r247b2855],
22	cells	NNS	O	cell	prep_of	19	SENT_344	[p18l272t2792r419b2856],
23	stably	RB	O	stably	advmod	24	SENT_344	[p18l443t2792r640b2876],
24	expressing	VBG	O	express	dep	17	SENT_344	[p18l658t2797r1027b2876],
25	PTEN	NN	ORGANIZATION	pten	nn	30	SENT_344	[p18l1054t2797r1242b2855],
26	sh	NN	O	sh	nn	30	SENT_344	[p18l1272t2792r1346b2856],
27	RNA	NN	O	rna	nn	30	SENT_344	[p18l1361t2796r1518b2855],
28	(	CD	NUMBER	(	num	30	SENT_344	[p18l1546t2796r1696b2876],
29	A43	NN	O	a43	nn	30	SENT_344	[p18l1546t2796r1696b2876],
30	1-PR	NN	O	1-pr	dobj	24	SENT_344	[p18l1712t2797r1866b2855],
31	[	CD	NUMBER	[	num	32	SENT_344	[p18l1890t2797r2046b2876],
32	PR	NN	O	pr	dep	30	SENT_344	[p18l1890t2797r2046b2876],
33	]	CD	NUMBER	]	number	34	SENT_344	[p18l1890t2797r2046b2876],
34	)	CD	NUMBER	)	num	32	SENT_344	[p18l1890t2797r2046b2876],
35	or	CC	O	or	_	0	SENT_344	[p18l79t2922r151b2964],
36	vector	NN	O	vector	nn	37	SENT_344	[p18l172t2912r389b2964],
37	control	NN	O	control	conj_or	30	SENT_344	[p18l413t2899r656b2964],
38	(	CD	NUMBER	(	num	40	SENT_344	[p18l693t2903r1136b2983],
39	A431-vector	NN	O	a431-vector	nn	40	SENT_344	[p18l693t2903r1136b2983],
40	[	NN	O	[	dep	37	SENT_344	[p18l1161t2904r1271b2983],
41	C	NN	O	c	num	45	SENT_344	[p18l1161t2904r1271b2983],
42	]	CD	NUMBER	]	number	41	SENT_344	[p18l1161t2904r1271b2983],
43	)	CD	NUMBER	)	number	41	SENT_344	[p18l1161t2904r1271b2983],
44	five	CD	DURATION	five	number	41	SENT_344	[p18l1303t2898r1423b2964],
45	days	NNS	NUMBER	day	tmod	40	SENT_344	[p18l1449t2899r1601b2983],
46	after	IN	O	after	_	0	SENT_344	[p18l1631t2898r1787b2964],
47	the	DT	O	the	det	52	SENT_344	[p18l1809t2899r1917b2964],
48	addition	NN	O	addition	nn	52	SENT_344	[p18l1945t2899r2049b2964, p18l79t3006r278b3071],
49	of3	NN	O	of3	nn	52	SENT_344	[p18l308t3006r430b3071],
50	[	CD	NUMBER	[	num	52	SENT_344	[p18l456t3012r568b3090],
51	JlVl	NN	O	jlvl	nn	52	SENT_344	[p18l456t3012r568b3090],
52	oferlotinib	NN	O	oferlotinib	prep_after	24	SENT_344	[p18l600t3006r981b3071],
53	or	CC	O	or	_	0	SENT_344	[p18l1008t3029r1079b3071],
54	PKI-166	NN	O	pki-166	prep_after	24	SENT_344	[p18l1108t3012r1390b3071],
55	.	.	O	.	_	0	SENT_344	[p18l1108t3012r1390b3071],

1	The	DT	O	the	det	2	SENT_345	[p18l1416t3006r1546b3071],
2	inset	NN	O	inset	nsubj	8	SENT_345	[p18l1574t3012r1741b3071],
3	shows	VBZ	O	show	_	0	SENT_345	[p18l1767t3006r1983b3071],
4	immunoblots	NNS	O	immunoblot	dobj	3	SENT_345	[p18l82t3114r554b3179],
5	of	IN	O	of	_	0	SENT_345	[p18l582t3113r659b3178],
6	PTEN	NN	ORGANIZATION	pten	prep_of	4	SENT_345	[p18l678t3120r866b3178],
7	and	CC	O	and	_	0	SENT_345	[p18l899t3114r1022b3178],
8	phosphorylated	VBN	O	phosphorylate	conj_and	3	SENT_345	[p18l1056t3114r1596b3199],
9	Akt	NN	O	akt	dobj	8	SENT_345	[p18l1624t3114r1738b3178],
10	from	IN	O	from	_	0	SENT_345	[p18l1761t3113r1925b3178],
11	A431-vector	NN	O	a431-vector	nn	16	SENT_345	[p18l77t3225r498b3286],
12	and	CC	O	and	_	0	SENT_345	[p18l523t3221r646b3286],
13	A431-PR	NN	O	a431-pr	nn	16	SENT_345	[p18l673t3225r972b3286],
14	stable	JJ	O	stable	amod	16	SENT_345	[p18l999t3221r1204b3286],
15	cell	NN	O	cell	nn	16	SENT_345	[p18l1230t3221r1340b3286],
16	lines	NNS	O	line	prep_from	8	SENT_345	[p18l1373t3221r1550b3286],
17	.	.	O	.	_	0	SENT_345	[p18l1373t3221r1550b3286],

1	The	DT	O	the	det	2	SENT_346	[p18l1575t3221r1705b3286],
2	graph	NN	O	graph	nsubj	10	SENT_346	[p18l1732t3221r1928b3307],
3	on	IN	O	on	_	0	SENT_346	[p18l1957t3244r2040b3286],
4	the	DT	O	the	det	6	SENT_346	[p18l77t3329r186b3393],
5	bottom	JJ	O	bottom	amod	6	SENT_346	[p18l216t3329r465b3393],
6	left	NN	O	left	prep_on	2	SENT_346	[p18l499t3328r603b3393],
7	of	IN	O	of	_	0	SENT_346	[p18l627t3328r704b3393],
8	Panel	NN	ORGANIZATION	panel	nn	9	SENT_346	[p18l723t3329r904b3393],
9	B	NN	ORGANIZATION	b	prep_of	6	SENT_346	[p18l939t3335r977b3392],
10	shows	VBZ	O	show	_	0	SENT_346	[p18l1006t3329r1222b3393],
11	that	IN	O	that	complm	13	SENT_346	[p18l1249t3329r1386b3393],
12	PKI-166	NN	MISC	pki-166	nsubj	13	SENT_346	[p18l1417t3335r1680b3393],
13	induces	VBZ	O	induce	ccomp	10	SENT_346	[p18l1709t3329r1976b3393],
14	cell	NN	O	cell	nn	15	SENT_346	[p18l79t3437r189b3501],
15	death	NN	O	death	dobj	13	SENT_346	[p18l217t3437r407b3501],
16	in	IN	O	in	_	0	SENT_346	[p18l438t3442r493b3500],
17	PTEN	NN	O	pten	prep_in	15	SENT_346	[p18l527t3433r840b3512],
18	+	CC	O	+	_	0	SENT_346	[p18l527t3433r840b3512],
19	/	:	O	/	punct	31	SENT_346	[p18l527t3433r840b3512],
20	+	CC	O	+	cc	29	SENT_346	[p18l527t3433r840b3512],
21	,	,	O	,	_	0	SENT_346	[p18l527t3433r840b3512],
22	but	CC	O	but	dep	29	SENT_346	[p18l871t3437r981b3501],
23	not	RB	O	not	neg	24	SENT_346	[p18l1007t3448r1118b3501],
24	PTEN	NN	O	pten	dep	22	SENT_346	[p18l1146t3442r1334b3500],
25	“	CD	NUMBER	“	dep	24	SENT_346	[p18l1362t3433r1449b3494],
26	/	:	O	/	punct	28	SENT_346	[p18l1362t3433r1449b3494],
27	*	CD	NUMBER	*	dep	28	SENT_346	[p18l1362t3433r1449b3494],
28	mouseembryonic	JJ	O	mouseembryonic	dep	25	SENT_346	[p18l1475t3437r2071b3521, p18l82t3550r135b3609],
29	fibroblasts	NNS	O	fibroblast	dep	31	SENT_346	[p18l158t3543r527b3609],
30	(	CD	NUMBER	(	dep	29	SENT_346	[p18l563t3549r649b3628],
31	M	NN	O	m	dep	32	SENT_346	[p18l563t3549r649b3628],
32	EFs	NNS	O	ef	dobj	13	SENT_346	[p18l667t3549r831b3628],
33	)	CD	NUMBER	)	dep	32	SENT_346	[p18l667t3549r831b3628],
34	.	.	O	.	_	0	SENT_346	[p18l667t3549r831b3628],

1	The	DT	O	the	det	2	SENT_347	[p18l857t3544r987b3609],
2	number	NN	O	number	nsubjpass	6	SENT_347	[p18l1017t3544r1291b3609],
3	ofviable	JJ	O	ofviable	amod	4	SENT_347	[p18l1314t3543r1604b3609],
4	cells	NNS	O	cell	dep	2	SENT_347	[p18l1631t3544r1781b3609],
5	was	VBD	O	be	auxpass	6	SENT_347	[p18l1806t3567r1938b3609],
6	determined	VBN	O	determine	conj_and	6	SENT_347	[p18l1965t3544r2070b3609, p18l77t3651r393b3716],
7	by	IN	O	by	_	0	SENT_347	[p18l423t3651r496b3736],
8	means	NNS	O	means	agent	6	SENT_347	[p18l521t3674r749b3716],
9	oftrypan	JJ	O	oftrypan	amod	11	SENT_347	[p18l773t3651r1075b3736],
10	blue	JJ	O	blue	amod	11	SENT_347	[p18l1106t3651r1249b3716],
11	exclusion	NN	O	exclusion	dep	8	SENT_347	[p18l1272t3651r1595b3716],
12	immediately	RB	O	immediately	advmod	6	SENT_347	[p18l1624t3651r2056b3736],
13	before	IN	O	before	_	0	SENT_347	[p18l83t3758r292b3823],
14	(	CD	NUMBER	(	num	16	SENT_347	[p18l320t3764r516b3834],
15	start	NN	O	start	nn	16	SENT_347	[p18l320t3764r516b3834],
16	)	NN	O	)	prep_before	6	SENT_347	[p18l320t3764r516b3834],
17	and	CC	O	and	_	0	SENT_347	[p18l546t3759r666b3823],
18	four	CD	DURATION	four	num	19	SENT_347	[p18l689t3758r830b3824],
19	days	NNS	NUMBER	day	npadvmod	6	SENT_347	[p18l848t3759r996b3834],
20	after	IN	O	after	_	0	SENT_347	[p18l1021t3758r1172b3823],
21	(	CD	NUMBER	(	num	22	SENT_347	[p18l1198t3764r1340b3834],
22	D4	NN	O	d4	prep_after	6	SENT_347	[p18l1198t3764r1340b3834],
23	)	CD	NUMBER	)	dep	22	SENT_347	[p18l1198t3764r1340b3834],
24	the	DT	O	the	det	27	SENT_347	[p18l1366t3759r1472b3823],
25	addition	NN	O	addition	nn	27	SENT_347	[p18l1495t3759r1770b3823],
26	of5	NN	O	of5	nn	27	SENT_347	[p18l1795t3758r1917b3823],
27	uM	NN	O	um	dep	6	SENT_347	[p18l1940t3764r2049b3834],

1	ofPK	NN	O	ofpk	nsubj	3	SENT_348	[p19l79t37r445b103],
2	|	SYM	O	|	dep	3	SENT_348	[p19l79t37r445b103],
3	-166	CD	NUMBER	-166	_	0	SENT_348	[p19l79t37r445b103],
4	.	.	O	.	_	0	SENT_348	[p19l79t37r445b103],

1	Immunoblots	NNS	O	immunoblot	nsubj	2	SENT_349	[p19l477t38r937b103],
2	ofcleaved	VBD	O	ofcleave	_	0	SENT_349	[p19l963t37r1297b103],
3	poly	NN	O	poly	nn	7	SENT_349	[p19l1328t38r1848b123],
4	(	NN	O	(	nn	7	SENT_349	[p19l1328t38r1848b123],
5	adenosine	NN	O	adenosine	nn	7	SENT_349	[p19l1328t38r1848b123],
6	diphosphate	NN	O	diphosphate	nn	7	SENT_349	[p19l79t146r519b230],
7	ribose	NN	O	ribose	dobj	2	SENT_349	[p19l548t146r782b231],
8	)	CD	NUMBER	)	num	9	SENT_349	[p19l548t146r782b231],
9	polymerase	NN	O	polymerase	dep	7	SENT_349	[p19l820t146r1220b231],
10	(	CD	NUMBER	(	num	12	SENT_349	[p19l1253t150r1492b231],
11	PARP	NN	O	parp	nn	12	SENT_349	[p19l1253t150r1492b231],
12	)	NN	O	)	nsubjpass	14	SENT_349	[p19l1253t150r1492b231],
13	were	VBD	O	be	auxpass	14	SENT_349	[p19l1522t169r1686b210],
14	obtained	VBN	O	obtain	rcmod	9	SENT_349	[p19l1712t146r2016b210],
15	eight	CD	DURATION	eight	num	16	SENT_349	[p19l79t253r253b338],
16	hours	NNS	NUMBER	hour	tmod	14	SENT_349	[p19l280t253r475b318],
17	after	IN	O	after	_	0	SENT_349	[p19l504t252r661b317],
18	the	DT	O	the	det	20	SENT_349	[p19l682t253r791b318],
19	addition	NN	O	addition	nn	20	SENT_349	[p19l818t253r1102b318],
20	of5	NN	O	of5	prep_after	14	SENT_349	[p19l1133t252r1256b317],
21	;	:	O	;	_	0	SENT_349	[p19l1281t259r1393b337],
22	1M	NN	O	1m	nn	23	SENT_349	[p19l1281t259r1393b337],
23	ofPK	NN	O	ofpk	dep	9	SENT_349	[p19l1426t252r1804b318],
24	|	CD	NUMBER	|	num	25	SENT_349	[p19l1426t252r1804b318],
25	-166	CD	NUMBER	-166	dep	23	SENT_349	[p19l1426t252r1804b318],
26	.	.	O	.	_	0	SENT_349	[p19l1426t252r1804b318],

1	The	DT	O	the	det	2	SENT_350	[p19l1829t253r1959b317],
2	graph	NN	O	graph	nsubj	10	SENT_350	[p19l80t361r276b446],
3	on	IN	O	on	_	0	SENT_350	[p19l306t384r389b426],
4	the	DT	O	the	det	6	SENT_350	[p19l416t361r526b426],
5	bottom	JJ	O	bottom	amod	6	SENT_350	[p19l555t361r804b426],
6	right	NN	O	right	prep_on	2	SENT_350	[p19l838t361r996b446],
7	of	IN	O	of	_	0	SENT_350	[p19l1021t360r1097b426],
8	Panel	NN	O	panel	nn	9	SENT_350	[p19l1116t361r1298b426],
9	B	NN	O	b	prep_of	6	SENT_350	[p19l1333t367r1370b424],
10	shows	VBZ	O	show	_	0	SENT_350	[p19l1400t361r1616b426],
11	that	IN	O	that	complm	24	SENT_350	[p19l1642t361r1780b426],
12	stable	JJ	O	stable	amod	13	SENT_350	[p19l1806t361r2010b426],
13	overexpression	NN	O	overexpression	nsubj	24	SENT_350	[p19l79t474r605b552],
14	of	IN	O	of	_	0	SENT_350	[p19l635t468r711b533],
15	PTEN	NN	O	pten	nn	18	SENT_350	[p19l730t474r919b533],
16	(	CD	NUMBER	(	num	18	SENT_350	[p19l958t473r1449b553],
17	SF295-PTEN	NN	O	sf295-pten	nn	18	SENT_350	[p19l958t473r1449b553],
18	)	NN	O	)	prep_of	13	SENT_350	[p19l958t473r1449b553],
19	in	IN	O	in	_	0	SENT_350	[p19l1485t474r1541b532],
20	PTEN-null	NN	O	pten-null	nn	23	SENT_350	[p19l1576t468r1925b533],
21	SF295	NN	O	sf295	nn	23	SENT_350	[p19l80t581r289b641],
22	glioblastoma	NN	O	glioblastoma	nn	23	SENT_350	[p19l320t576r775b661],
23	cells	NNS	O	cell	prep_in	18	SENT_350	[p19l802t576r952b640],
24	enhances	VBZ	O	enhance	ccomp	10	SENT_350	[p19l980t576r1310b640],
25	the	DT	O	the	det	27	SENT_350	[p19l1335t576r1445b640],
26	apoptotic	JJ	O	apoptotic	amod	27	SENT_350	[p19l1472t581r1805b660],
27	response	NN	O	response	dobj	24	SENT_350	[p19l1833t598r1916b640, p19l81t706r330b767],
28	to	TO	O	to	_	0	SENT_350	[p19l354t696r422b748],
29	PKI-166	NN	O	pki-166	prep_to	24	SENT_350	[p19l454t688r736b748],
30	.	.	O	.	_	0	SENT_350	[p19l454t688r736b748],

1	Apoptosis	NN	O	apoptosis	nsubj	9	SENT_351	[p19l763t687r1118b767],
2	was	VBD	O	be	auxpass	3	SENT_351	[p19l1143t706r1275b748],
3	determined	VBN	O	determine	rcmod	1	SENT_351	[p19l1303t683r1703b748],
4	with	IN	O	with	_	0	SENT_351	[p19l1730t683r1875b748],
5	the	DT	O	the	det	8	SENT_351	[p19l1902t683r2012b748],
6	use	NN	O	use	nn	8	SENT_351	[p19l83t814r199b855],
7	offlow	NN	O	offlow	nn	8	SENT_351	[p19l225t790r460b855],
8	cytometry	NN	O	cytometry	prep_with	3	SENT_351	[p19l483t803r828b876],
9	(	VBZ	O	(	_	0	SENT_351	[p19l859t791r990b876],
10	the	DT	O	the	det	12	SENT_351	[p19l859t791r990b876],
11	sub-G1	NN	O	sub-g1	nn	12	SENT_351	[p19l1018t791r1257b870],
12	fraction	NN	O	fraction	nsubjpass	14	SENT_351	[p19l1284t790r1548b855],
13	was	VBD	O	be	auxpass	14	SENT_351	[p19l1575t814r1707b855],
14	counted	VBN	O	count	ccomp	9	SENT_351	[p19l1735t790r2043b876],
15	)	RB	O	)	advmod	17	SENT_351	[p19l1735t790r2043b876],
16	24	CD	DURATION	24	num	17	SENT_351	[p19l79t904r159b962],
17	hours	NNS	NUMBER	hour	tmod	14	SENT_351	[p19l189t898r383b963],
18	after	IN	O	after	_	0	SENT_351	[p19l412t897r569b962],
19	the	DT	O	the	det	21	SENT_351	[p19l590t898r700b962],
20	addition	NN	O	addition	nn	21	SENT_351	[p19l727t898r1011b962],
21	ofPK	NN	O	ofpk	prep_after	14	SENT_351	[p19l1041t897r1419b963],
22	|	CD	NUMBER	|	num	23	SENT_351	[p19l1041t897r1419b963],
23	-166	CD	NUMBER	-166	dep	21	SENT_351	[p19l1041t897r1419b963],
24	.	.	O	.	_	0	SENT_351	[p19l1041t897r1419b963],

1	The	DT	O	the	det	2	SENT_352	[p19l1445t898r1574b962],
2	inset	NN	O	inset	nsubj	3	SENT_352	[p19l1603t904r1769b962],
3	shows	VBZ	O	show	_	0	SENT_352	[p19l1796t898r2012b962],
4	immunoblots	NNS	O	immunoblot	dobj	3	SENT_352	[p19l82t1006r554b1070],
5	for	IN	O	for	_	0	SENT_352	[p19l576t1005r673b1070],
6	PTEN	NNP	ORGANIZATION	PTEN	prep_for	4	SENT_352	[p19l697t1012r909b1082],
7	,	,	O	,	_	0	SENT_352	[p19l697t1012r909b1082],
8	phosphorylated	VBN	O	phosphorylate	partmod	4	SENT_352	[p19l937t1006r1478b1091],
9	Akt	NNP	O	Akt	dobj	8	SENT_352	[p19l1500t1006r1631b1082],
10	,	,	O	,	_	0	SENT_352	[p19l1500t1006r1631b1082],
11	and	CC	O	and	_	0	SENT_352	[p19l1657t1006r1780b1070],
12	actin	NN	O	actin	dobj	3	SENT_352	[p19l1806t1012r1969b1070],
13	in	IN	O	in	_	0	SENT_352	[p19l1996t1012r2052b1069],
14	the	DT	O	the	det	17	SENT_352	[p19l77t1113r186b1178],
15	isogenic	JJ	O	isogenic	amod	17	SENT_352	[p19l216t1119r504b1198],
16	SF295	NN	O	sf295	nn	17	SENT_352	[p19l529t1118r737b1178],
17	pair	NN	O	pair	prep_in	12	SENT_352	[p19l772t1119r911b1197],
18	.	.	O	.	_	0	SENT_352	[p19l772t1119r911b1197],

1	Panel	NN	O	panel	nn	2	SENT_353	[p19l947t1113r1130b1178],
2	C	NN	O	c	nsubj	3	SENT_353	[p19l1162t1118r1208b1178],
3	shows	VBZ	O	show	_	0	SENT_353	[p19l1236t1113r1456b1178],
4	that	IN	O	that	complm	8	SENT_353	[p19l1482t1113r1622b1178],
5	stable	JJ	O	stable	amod	7	SENT_353	[p19l1650t1113r1858b1178],
6	overexpression	NN	O	overexpression	nn	7	SENT_353	[p19l1885t1136r2058b1178, p19l79t1226r456b1305],
7	ofan	NN	O	ofan	nsubj	8	SENT_353	[p19l482t1220r647b1285],
8	activated	VBD	O	activate	ccomp	3	SENT_353	[p19l674t1221r987b1285],
9	Akt	NN	O	akt	nn	10	SENT_353	[p19l1010t1221r1126b1285],
10	allele	NN	O	allele	dobj	8	SENT_353	[p19l1147t1221r1326b1285],
11	(	CD	NUMBER	(	num	13	SENT_353	[p19l1356t1221r1723b1305],
12	A431-Akt	NN	O	a431-akt	nn	13	SENT_353	[p19l1356t1221r1723b1305],
13	)	NN	O	)	nsubj	16	SENT_353	[p19l1356t1221r1723b1305],
14	does	VBZ	O	do	aux	16	SENT_353	[p19l1752t1221r1916b1285],
15	not	RB	O	not	neg	16	SENT_353	[p19l1944t1233r2056b1285],
16	block	VB	O	block	rcmod	10	SENT_353	[p19l83t1328r266b1393],
17	cell	NN	O	cell	nn	18	SENT_353	[p19l291t1328r402b1393],
18	death	NN	O	death	dobj	16	SENT_353	[p19l433t1328r625b1393],
19	induced	VBN	O	induce	partmod	18	SENT_353	[p19l658t1328r934b1393],
20	by	IN	O	by	_	0	SENT_353	[p19l968t1328r1041b1413],
21	five	CD	DURATION	five	num	23	SENT_353	[p19l1065t1327r1184b1393],
22	days	NNS	NUMBER	day	nn	23	SENT_353	[p19l1210t1328r1363b1413],
23	ofincubation	NN	O	ofincubation	agent	19	SENT_353	[p19l1391t1327r1850b1393],
24	with	IN	O	with	_	0	SENT_353	[p19l1878t1328r2022b1393],
25	5	CD	NUMBER	5	prep_with	19	SENT_353	[p19l80t1442r112b1500],
26	;	:	O	;	_	0	SENT_353	[p19l138t1442r250b1519],
27	4M	CD	NUMBER	4m	num	28	SENT_353	[p19l138t1442r250b1519],
28	ofPK	NN	O	ofpk	dep	18	SENT_353	[p19l282t1435r660b1500],
29	|	CD	NUMBER	|	num	30	SENT_353	[p19l282t1435r660b1500],
30	-166	CD	NUMBER	-166	dep	28	SENT_353	[p19l282t1435r660b1500],
31	.	.	O	.	_	0	SENT_353	[p19l282t1435r660b1500],

1	Figure	NNP	O	Figure	nsubj	9	SENT_354	[p19l695t1442r909b1521],
2	5	CD	NUMBER	5	num	3	SENT_354	[p19l935t1442r968b1500],
3	ofthe	NN	O	ofthe	dep	1	SENT_354	[p19l998t1435r1195b1500],
4	Supplementary	NNP	O	Supplementary	nn	5	SENT_354	[p19l1222t1435r1755b1521],
5	Appendix	NNP	O	Appendix	dep	1	SENT_354	[p19l1776t1440r2028b1520, p19l79t1543r177b1607],
6	(	CD	NUMBER	(	num	8	SENT_354	[p19l209t1549r759b1628],
7	www.nejm.org	NN	O	www.nejm.org	nn	8	SENT_354	[p19l209t1549r759b1628],
8	)	NN	O	)	dep	5	SENT_354	[p19l209t1549r759b1628],
9	shows	VBZ	O	show	_	0	SENT_354	[p19l794t1543r1011b1607],
10	the	DT	O	the	det	12	SENT_354	[p19l1036t1543r1145b1607],
11	corresponding	JJ	O	corresponding	amod	12	SENT_354	[p19l1172t1543r1685b1628],
12	immunoblots	NNS	O	immunoblot	dobj	9	SENT_354	[p19l1712t1549r2033b1608, p19l83t1651r269b1715],
13	.	.	O	.	_	0	SENT_354	[p19l1712t1549r2033b1608, p19l83t1651r269b1715],

1	In	IN	O	in	_	0	SENT_355	[p19l302t1657r359b1714],
2	each	DT	O	each	det	3	SENT_355	[p19l389t1651r545b1715],
3	panel	NN	O	panel	prep_in	10	SENT_355	[p19l577t1651r781b1735],
4	,	,	O	,	_	0	SENT_355	[p19l577t1651r781b1735],
5	plus	CC	O	plus	_	0	SENT_355	[p19l813t1651r1222b1735],
6	—	CD	NUMBER	—	nsubj	10	SENT_355	[p19l813t1651r1222b1735],
7	minus	CC	O	minus	_	0	SENT_355	[p19l813t1651r1222b1735],
8	values	NNS	O	value	nsubj	10	SENT_355	[p19l1248t1651r1467b1715],
9	are	VBP	O	be	cop	10	SENT_355	[p19l1494t1674r1598b1715],
10	means	NNS	O	means	_	0	SENT_355	[p19l1627t1674r1854b1715],
11	:	:	O	:	_	0	SENT_355	[p19l1881t1656r2049b1715],
12	SD	NN	O	sd	dep	10	SENT_355	[p19l1881t1656r2049b1715],
13	.	.	O	.	_	0	SENT_355	[p19l1881t1656r2049b1715],

1	The	DT	O	the	det	2	SENT_356	[p19l76t1758r206b1823],
2	asterisk	NN	O	asterisk	nsubj	3	SENT_356	[p19l234t1758r502b1823],
3	denotes	VBZ	O	denote	_	0	SENT_356	[p19l527t1758r803b1823],
4	the	DT	O	the	dobj	3	SENT_356	[p19l828t1758r938b1823],
5	cleaved	VBN	O	cleave	partmod	4	SENT_356	[p19l964t1758r1220b1823],
6	product	NN	O	product	dobj	5	SENT_356	[p19l1253t1758r1541b1842],
7	.	.	O	.	_	0	SENT_356	[p19l1253t1758r1541b1842],

1	3.7	CD	DURATION	3.7	dep	4	SENT_357	[p19l11t2141r138b2214],
2	months	NNS	DURATION	month	dep	1	SENT_357	[p19l161t2136r508b2231],
3	,	,	O	,	_	0	SENT_357	[p19l161t2136r508b2231],
4	had	VBD	O	have	_	0	SENT_357	[p19l536t2136r690b2214],
5	tumors	NNS	O	tumor	dobj	4	SENT_357	[p19l712t2152r1010b2215],
6	that	WDT	O	that	nsubj	7	SENT_357	[p19l1035t2136r1200b2214],
7	coexpressed	VBD	O	coexpress	rcmod	5	SENT_357	[p19l1218t2136r1727b2236],
8	EGFRVIII	NN	O	egfrviius	nn	11	SENT_357	[p19l1748t2141r2135b2219],
9	and	CC	O	and	_	0	SENT_357	[p19l9t2264r163b2342],
10	PT	NN	O	pt	nn	11	SENT_357	[p19l181t2269r292b2341],
11	EN	NN	O	en	dobj	7	SENT_357	[p19l292t2271r423b2342],
12	(	CD	NUMBER	(	num	13	SENT_357	[p19l445t2264r694b2355],
13	Table	NNP	O	Table	nsubj	4	SENT_357	[p19l445t2264r694b2355],
14	1	CD	NUMBER	1	num	13	SENT_357	[p19l717t2269r762b2341],
15	of	IN	O	of	_	0	SENT_357	[p19l782t2263r882b2342],
16	the	DT	O	the	det	19	SENT_357	[p19l883t2264r1010b2342],
17	Supplementary	NNP	O	Supplementary	nn	19	SENT_357	[p19l1032t2264r1661b2364],
18	Appendix	NNP	O	Appendix	nn	19	SENT_357	[p19l1672t2264r2129b2364],
19	)	NN	O	)	prep_of	13	SENT_357	[p19l1672t2264r2129b2364],
20	.	.	O	.	_	0	SENT_357	[p19l1672t2264r2129b2364],

1	VALIDATION	NNP	O	VALIDATION	nn	2	SENT_358	[p19l8t2548r519b2598],
2	SET	NNP	O	SET	nsubj	4	SENT_358	[p19l566t2548r705b2597],
3	We	PRP	O	we	dep	2	SENT_358	[p19l7t2655r140b2726],
4	analyzed	VBD	O	analyze	_	0	SENT_358	[p19l164t2648r532b2748],
5	the	DT	O	the	det	6	SENT_358	[p19l557t2648r686b2726],
6	expression	NN	O	expression	dobj	4	SENT_358	[p19l712t2648r1165b2748],
7	of	IN	O	of	_	0	SENT_358	[p19l1191t2647r1292b2726],
8	EGFRVIII	NN	O	egfrviius	nn	11	SENT_358	[p19l1297t2653r1688b2731],
9	and	CC	O	and	_	0	SENT_358	[p19l1711t2648r1867b2726],
10	PT	NN	O	pt	nn	11	SENT_358	[p19l1890t2653r2003b2725],
11	EN	NN	O	en	prep_of	6	SENT_358	[p19l2004t2655r2135b2726],
12	in	IN	O	in	_	0	SENT_358	[p19l9t2776r91b2853],
13	33	CD	NUMBER	33	num	14	SENT_358	[p19l118t2781r215b2854],
14	gliomas	NNS	O	glioma	prep_in	4	SENT_358	[p19l244t2776r580b2876],
15	from	IN	O	from	_	0	SENT_358	[p19l608t2775r815b2854],
16	patients	NNS	O	patient	prep_from	14	SENT_358	[p19l840t2776r1174b2876],
17	who	WP	O	who	nsubjpass	19	SENT_358	[p19l1199t2776r1382b2855],
18	Were	VBD	O	be	auxpass	19	SENT_358	[p19l1405t2802r1607b2855],
19	treated	VBN	O	treat	rcmod	16	SENT_358	[p19l1634t2775r1923b2854],
20	with	IN	O	with	_	0	SENT_358	[p19l1945t2776r2134b2855],
21	erlotinib	NN	O	erlotinib	prep_with	19	SENT_358	[p19l11t2903r368b2981],
22	at	IN	O	at	_	0	SENT_358	[p19l394t2919r473b2980],
23	a	DT	O	a	det	25	SENT_358	[p19l490t2929r535b2980],
24	different	JJ	O	different	amod	25	SENT_358	[p19l558t2902r924b2981],
25	institution	NN	O	institution	prep_at	19	SENT_358	[p19l943t2903r1407b2997],
26	,	,	O	,	_	0	SENT_358	[p19l943t2903r1407b2997],
27	UCSF	NNP	ORGANIZATION	UCSF	appos	25	SENT_358	[p19l1436t2908r1671b2981],
28	(	CD	NUMBER	(	num	27	SENT_358	[p19l1702t2902r1955b2993],
29	Table	NNP	O	Table	dep	27	SENT_358	[p19l1702t2902r1955b2993],
30	2	CD	NUMBER	2	num	29	SENT_358	[p19l1979t2908r2026b2979],
31	of	IN	O	of	_	0	SENT_358	[p19l2052t2902r2152b2981],
32	the	DT	O	the	det	35	SENT_358	[p19l11t3031r139b3109],
33	Supplementary	NNP	O	Supplementary	nn	35	SENT_358	[p19l198t3030r839b3131],
34	Appendix	NNP	O	Appendix	nn	35	SENT_358	[p19l886t3030r1353b3131],
35	)	NN	O	)	prep_of	29	SENT_358	[p19l886t3030r1353b3131],
36	.	.	O	.	_	0	SENT_358	[p19l886t3030r1353b3131],

1	Of	IN	O	of	_	0	SENT_359	[p19l1413t3030r1534b3109],
2	these	DT	O	these	det	4	SENT_359	[p19l1571t3030r1790b3109],
3	33	CD	NUMBER	33	num	4	SENT_359	[p19l1846t3036r1943b3109],
4	patients	NNS	O	patient	prep_of	7	SENT_359	[p19l2000t3057r2133b3131, p19l11t3159r265b3253],
5	,	,	O	,	_	0	SENT_359	[p19l2000t3057r2133b3131, p19l11t3159r265b3253],
6	8	CD	NUMBER	8	nsubj	7	SENT_359	[p19l293t3164r338b3236],
7	had	VBD	O	have	_	0	SENT_359	[p19l362t3159r517b3236],
8	a	DT	O	a	det	10	SENT_359	[p19l537t3184r581b3236],
9	clinical	JJ	O	clinical	amod	10	SENT_359	[p19l602t3159r902b3236],
10	response	NN	O	response	dobj	7	SENT_359	[p19l923t3183r1325b3258],
11	.	.	O	.	_	0	SENT_359	[p19l923t3183r1325b3258],

1	A	DT	O	a	det	3	SENT_360	[p19l1348t3165r1414b3235],
2	clinical	JJ	O	clinical	amod	3	SENT_360	[p19l1433t3159r1734b3236],
3	response	NN	O	response	nsubjpass	10	SENT_360	[p19l1755t3183r2134b3258],
4	in	IN	O	in	_	0	SENT_360	[p19l9t3287r91b3364],
5	this	DT	O	this	det	6	SENT_360	[p19l115t3287r268b3365],
6	group	NN	O	group	prep_in	3	SENT_360	[p19l294t3312r545b3387],
7	was	VBD	O	be	auxpass	10	SENT_360	[p19l567t3313r727b3366],
8	also	RB	O	also	advmod	10	SENT_360	[p19l754t3287r920b3365],
9	signiﬁcantly	RB	O	signiﬁcantly	advmod	10	SENT_360	[p19l948t3286r1469b3387],
10	associated	VBN	O	associate	_	0	SENT_360	[p19l1489t3287r1925b3365],
11	with	IN	O	with	_	0	SENT_360	[p19l1945t3287r2134b3366],
12	the	DT	O	the	det	13	SENT_360	[p19l11t3415r139b3493],
13	coexpression	NN	O	coexpression	prep_with	10	SENT_360	[p19l172t3415r725b3515],
14	of	IN	O	of	_	0	SENT_360	[p19l757t3414r857b3493],
15	EGFRVIII	NN	O	egfrviius	prep_of	13	SENT_360	[p19l869t3420r1260b3498],
16	and	CC	O	and	_	0	SENT_360	[p19l1290t3415r1446b3493],
17	PTEN	NN	O	pten	prep_of	13	SENT_360	[p19l1476t3420r1720b3493],
18	(	CD	NUMBER	(	num	19	SENT_360	[p19l1756t3415r1986b3506],
19	odds	NNS	O	odds	dep	15	SENT_360	[p19l1756t3415r1986b3506],
20	ra	NN	O	ra	nn	22	SENT_360	[p19l2020t3441r2133b3493],
21	—	CD	NUMBER	—	num	22	SENT_360	[p19l2020t3441r2133b3493],
22	tio	NN	O	tio	dep	19	SENT_360	[p19l11t3543r142b3638],
23	,	,	O	,	_	0	SENT_360	[p19l11t3543r142b3638],
24	40	CD	NUMBER	40	appos	22	SENT_360	[p19l186t3548r314b3638],
25	;	:	O	;	_	0	SENT_360	[p19l186t3548r314b3638],
26	95	CD	PERCENT	95	num	29	SENT_360	[p19l359t3548r456b3621],
27	percent	NN	PERCENT	percent	nn	29	SENT_360	[p19l500t3559r820b3643],
28	conﬁdence	NN	O	conﬁdence	nn	29	SENT_360	[p19l856t3542r1318b3621],
29	interval	NN	O	interval	dep	22	SENT_360	[p19l1358t3543r1694b3638],
30	,	,	O	,	_	0	SENT_360	[p19l1358t3543r1694b3638],
31	3	CD	NUMBER	3	number	33	SENT_360	[p19l1742t3548r1786b3621],
32	to	TO	O	to	dep	33	SENT_360	[p19l1830t3559r1909b3621],
33	468	CD	NUMBER	468	appos	29	SENT_360	[p19l1949t3548r2130b3638],
34	;	:	O	;	_	0	SENT_360	[p19l1949t3548r2130b3638],
35	P	NN	O	p	dep	22	SENT_360	[p19l8t3676r403b3761],
36	=	JJ	O	=	amod	35	SENT_360	[p19l8t3676r403b3761],
37	0.001	CD	NUMBER	0.001	tmod	36	SENT_360	[p19l8t3676r403b3761],
38	)	CD	NUMBER	)	number	39	SENT_360	[p19l8t3676r403b3761],
39	(	CD	NUMBER	(	num	42	SENT_360	[p19l439t3671r693b3761],
40	Table	NNP	O	Table	nn	42	SENT_360	[p19l439t3671r693b3761],
41	3	CD	NUMBER	3	num	42	SENT_360	[p19l719t3676r824b3761],
42	)	NN	O	)	dep	35	SENT_360	[p19l719t3676r824b3761],
43	.	.	O	.	_	0	SENT_360	[p19l719t3676r824b3761],

1	2020	CD	DATE	2020	num	4	SENT_361	[p20l149t45r226b66],
2	N	NN	O	n	nn	4	SENT_361	[p20l868t47r881b62],
3	ENGLJ	NN	O	englj	nn	4	SENT_361	[p20l897t46r981b68],
4	MED	NN	O	med	_	0	SENT_361	[p20l996t47r1048b62],
5	353	CD	NUMBER	353	dep	4	SENT_361	[p20l1060t46r1139b68],
6	;	:	O	;	_	0	SENT_361	[p20l1060t46r1139b68],
7	19	CD	NUMBER	19	dep	4	SENT_361	[p20l1060t46r1139b68],
8	WWW	NNP	O	WWW	dep	7	SENT_361	[p20l1174t47r1294b68],
9	.	.	O	.	_	0	SENT_361	[p20l1174t47r1294b68],

1	NEj	NN	O	nej	nn	2	SENT_362	[p20l1174t47r1294b68],
2	M.ORG	NN	O	m.org	_	0	SENT_362	[p20l1302t46r1385b62],
3	NOVEMBER	NNP	DATE	NOVEMBER	dep	2	SENT_362	[p20l1424t46r1566b62],
4	10	CD	DATE	10	num	3	SENT_362	[p20l1579t46r1614b66],
5	,	,	DATE	,	_	0	SENT_362	[p20l1579t46r1614b66],
6	2005	CD	DATE	2005	num	3	SENT_362	[p20l1627t46r1691b68],

1	The	DT	O	the	det	4	SENT_363	[p20l936t79r987b103],
2	New	NNP	O	New	nn	4	SENT_363	[p20l996t80r1058b103],
3	England	NNP	O	England	nn	4	SENT_363	[p20l1067t79r1178b110],
4	Journal	NNP	O	Journal	_	0	SENT_363	[p20l1187t79r1284b103],
5	of	IN	O	of	_	0	SENT_363	[p20l1294t79r1323b103],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_363	[p20l1330t79r1455b103],

1	Downloaded	VBN	O	download	_	0	SENT_364	[p20l378t120r548b143],
2	from	IN	O	from	_	0	SENT_364	[p20l557t120r621b143],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_364	[p20l630t120r748b150],
4	at	IN	O	at	_	0	SENT_364	[p20l759t124r782b143],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_364	[p20l790t120r973b143],
6	on	IN	O	on	_	0	SENT_364	[p20l982t127r1015b143],
7	January	NNP	DATE	January	prep_on	1	SENT_364	[p20l1023t120r1126b150],
8	5	CD	DATE	5	num	7	SENT_364	[p20l1136t120r1159b147],
9	,	,	DATE	,	_	0	SENT_364	[p20l1136t120r1159b147],
10	2014	CD	DATE	2014	num	7	SENT_364	[p20l1169t120r1242b143],
11	.	.	O	.	_	0	SENT_364	[p20l1169t120r1242b143],

1	For	IN	O	for	_	0	SENT_365	[p20l1252t120r1299b143],
2	personal	JJ	O	personal	amod	3	SENT_365	[p20l1307t120r1419b150],
3	use	NN	O	use	pobj	1	SENT_365	[p20l1428t127r1472b143],
4	only	RB	O	only	advmod	3	SENT_365	[p20l1482t120r1546b150],
5	.	.	O	.	_	0	SENT_365	[p20l1482t120r1546b150],

1	No	DT	O	no	det	3	SENT_366	[p20l1557t120r1597b143],
2	other	JJ	O	other	amod	3	SENT_366	[p20l1607t120r1675b143],
3	uses	NNS	O	use	_	0	SENT_366	[p20l1683t127r1739b143],
4	without	IN	O	without	_	0	SENT_366	[p20l1749t120r1850b143],
5	permission	NN	O	permission	prep_without	3	SENT_366	[p20l1859t120r2011b150],
6	.	.	O	.	_	0	SENT_366	[p20l1859t120r2011b150],

1	Copyright	NN	O	copyright	_	0	SENT_367	[p20l728t161r863b192],
2	©	CD	NUMBER	©	num	6	SENT_367	[p20l872t161r896b185],
3	2005	CD	DATE	2005	num	6	SENT_367	[p20l906t161r970b185],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_367	[p20l980t161r1172b185],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_367	[p20l1181t161r1289b185],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_367	[p20l1300t161r1405b192],
7	.	.	O	.	_	0	SENT_367	[p20l1300t161r1405b192],

1	All	DT	O	all	det	2	SENT_368	[p20l1416t161r1457b185],
2	rights	NNS	O	rights	nsubj	3	SENT_368	[p20l1466t161r1541b192],
3	reserved	VBN	O	reserve	_	0	SENT_368	[p20l1551t161r1670b185],
4	.	.	O	.	_	0	SENT_368	[p20l1551t161r1670b185],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_369	[p20l527t204r614b223],
2	I	PRP	O	I	nsubj	3	SENT_369	[p20l627t204r751b223],
3	(	VBP	O	(	rcmod	1	SENT_369	[p20l627t204r751b223],
4	INASE	JJ	O	inase	amod	5	SENT_369	[p20l627t204r751b223],
5	INHIBITORS	NNS	O	inhibitor	dobj	3	SENT_369	[p20l765t204r973b223],
6	FOR	IN	O	for	_	0	SENT_369	[p20l988t204r1054b223],
7	GLIOBLASTOMAS	NNS	O	glioblastoma	prep_for	5	SENT_369	[p20l1066t204r1343b223],

1	-	:	O	-	_	0	SENT_370	[p20l286t382r335b396],
2	o	NN	O	o	_	0	SENT_370	[p20l286t382r335b396],
3	-	:	O	-	_	0	SENT_370	[p20l286t382r335b396],
4	Parental	JJ	O	parental	dep	2	SENT_370	[p20l347t376r442b398],
5	.	.	O	.	_	0	SENT_370	[p20l510t383r559b395],

1	—	NN	O	—	_	0	SENT_371	[p20l510t383r559b395],
2	.	.	O	.	_	0	SENT_371	[p20l510t383r559b395],

1	A	DT	O	a	det	2	SENT_372	[p20l510t383r559b395],
2	PTEN	NN	O	pten	_	0	SENT_372	[p20l573t378r727b398],
3	.	.	O	.	_	0	SENT_372	[p20l573t378r727b398],

1	—	NN	O	—	_	0	SENT_373	[p20l573t378r727b398],
2	.	.	O	.	_	0	SENT_373	[p20l573t378r727b398],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_374	[p20l573t378r727b398],
2	--	:	O	--	_	0	SENT_374	[p20l286t426r334b443],
3	o	NN	O	o	dep	1	SENT_374	[p20l286t426r334b443],
4	--	:	O	--	_	0	SENT_374	[p20l286t426r334b443],
5	PTEN	NN	O	pten	dep	3	SENT_374	[p20l347t424r412b444],
6	+	CC	O	+	_	0	SENT_374	[p20l510t429r559b440],
7	EGFRVIII	NN	O	egfrviius	dep	3	SENT_374	[p20l573t423r676b444],
8	.	.	O	.	_	0	SENT_374	[p20l286t475r335b487],

1	—	NN	O	—	_	0	SENT_375	[p20l286t475r335b487],
2	.	.	O	.	_	0	SENT_375	[p20l286t475r335b487],

1	-	:	O	-	_	0	SENT_376	[p20l286t475r335b487],
2	I	PRP	O	I	_	0	SENT_376	[p20l286t475r335b487],
3	-	:	O	-	_	0	SENT_376	[p20l286t475r335b487],
4	EGFR	NN	ORGANIZATION	egfr	dep	2	SENT_376	[p20l347t469r412b490],
5	-	:	O	-	_	0	SENT_376	[p20l510t474r559b487],
6	I	PRP	O	I	dep	4	SENT_376	[p20l510t474r559b487],
7	-	:	O	-	_	0	SENT_376	[p20l510t474r559b487],
8	PTEN	NN	O	pten	dep	6	SENT_376	[p20l573t469r764b490],
9	.	.	O	.	_	0	SENT_376	[p20l573t469r764b490],

1	—	NN	O	—	_	0	SENT_377	[p20l573t469r764b490],
2	.	.	O	.	_	0	SENT_377	[p20l573t469r764b490],

1	EGFRv	NNP	O	EGFRv	nn	2	SENT_378	[p20l573t469r764b490],
2	|	NNP	O	|	nsubj	3	SENT_378	[p20l573t469r764b490],
3	|	VBD	O	|	_	0	SENT_378	[p20l573t469r764b490],
4	|	CD	NUMBER	|	dobj	3	SENT_378	[p20l573t469r764b490],

1	>	JJR	O	>	_	0	SENT_379	[p20l192t501r202b521, p20l205t501r217b521],
2	.	.	O	.	_	0	SENT_379	[p20l192t501r202b521, p20l205t501r217b521],

1	—	NN	O	—	_	0	SENT_380	[p20l192t501r202b521, p20l205t501r217b521],
2	.	.	O	.	_	0	SENT_380	[p20l192t501r202b521, p20l205t501r217b521],

1	Ix	NN	O	ix	_	0	SENT_381	[p20l192t501r202b521, p20l205t501r217b521],
2	)	CD	NUMBER	)	num	4	SENT_381	[p20l192t501r202b521, p20l205t501r217b521],
3	O	NN	O	o	nn	4	SENT_381	[p20l219t501r233b522],
4	|	NN	O	|	dep	1	SENT_381	[p20l192t557r202b577],
5	.	.	O	.	_	0	SENT_381	[p20l192t557r202b577],

1	—	NN	O	—	_	0	SENT_382	[p20l192t557r202b577],
2	.	.	O	.	_	0	SENT_382	[p20l192t557r202b577],
3	'	''	O	'	_	0	SENT_382	[p20l192t557r202b577],

1	O	NN	O	o	nn	4	SENT_383	[p20l204t556r218b577],
2	O	NN	O	o	nn	4	SENT_383	[p20l219t556r233b577],
3	oo	NN	O	oo	nn	4	SENT_383	[p20l205t611r217b632],
4	O	NN	O	o	_	0	SENT_383	[p20l219t611r233b632],
5	O	NN	O	o	nn	8	SENT_383	[p20l205t667r217b688],
6	‘	CD	NUMBER	‘	num	8	SENT_383	[p20l205t667r217b688],
7	|	NN	O	|	nn	8	SENT_383	[p20l205t667r217b688],
8	O	NN	O	o	dep	4	SENT_383	[p20l219t667r233b688],
9	-	:	O	-	_	0	SENT_383	[p20l204t722r217b742],
10	B	NN	O	b	nn	11	SENT_383	[p20l204t722r217b742],
11	o	NN	O	o	dep	8	SENT_383	[p20l219t722r233b743],

1	Growth	NN	O	growth	_	0	SENT_384	[p20l130t781r154b877],
2	(	CD	PERCENT	(	num	3	SENT_384	[p20l131t736r161b769],
3	%	NN	PERCENT	%	dep	1	SENT_384	[p20l131t736r161b769],
4	of	IN	O	of	_	0	SENT_384	[p20l130t697r154b727],
5	control	NN	O	control	prep_of	3	SENT_384	[p20l130t595r161b693],
6	)	CD	NUMBER	)	num	5	SENT_384	[p20l130t595r161b693],

1	l	NN	O	l	nsubj	6	SENT_385	[p20l205t778r217b798],
2	\	SYM	O	\	dep	6	SENT_385	[p20l205t778r217b798],
3	}	CD	NUMBER	}	num	6	SENT_385	[p20l205t778r217b798],
4	O	NN	O	o	nn	6	SENT_385	[p20l219t832r233b853],
5	o	NN	O	o	nn	6	SENT_385	[p20l219t777r233b798],
6	IL	NN	O	il	_	0	SENT_385	[p20l190t888r217b908],
7	!	.	O	!	_	0	SENT_385	[p20l190t888r217b908],

1	o	NN	O	o	_	0	SENT_386	[p20l219t888r233b909],

1	Erlotinib	NNP	O	Erlotinib	_	0	SENT_387	[p20l439t969r546b993],
2	(	CD	NUMBER	(	num	4	SENT_387	[p20l557t971r616b1001],
3	pM	NN	O	pm	nn	4	SENT_387	[p20l557t971r616b1001],
4	)	NN	O	)	dep	1	SENT_387	[p20l557t971r616b1001],

1	|	NN	O	|	_	0	SENT_388	[p20l194t1185r204b1205],
2	.	.	O	.	_	0	SENT_388	[p20l194t1185r204b1205],

1	—	NN	O	—	_	0	SENT_389	[p20l194t1185r204b1205],
2	.	.	O	.	_	0	SENT_389	[p20l194t1185r204b1205],

1	‘	NN	O	‘	_	0	SENT_390	[p20l194t1185r204b1205],
2	O	NN	O	o	nn	3	SENT_390	[p20l207t1184r220b1205],
3	o	NN	O	o	dep	1	SENT_390	[p20l221t1185r235b1205],

1	I	PRP	O	I	_	0	SENT_391	[p20l1467t1200r1491b1225],
2	:	:	O	:	_	0	SENT_391	[p20l1467t1200r1491b1225],
3	Vehicle	NNP	O	Vehicle	dep	1	SENT_391	[p20l1505t1200r1590b1222],
4	l	NN	O	l	tmod	3	SENT_391	[p20l1467t1246r1491b1271],
5	:	:	O	:	_	0	SENT_391	[p20l1467t1246r1491b1271],
6	PKI-166	NN	O	pki-166	dep	3	SENT_391	[p20l1507t1248r1604b1272],
7	,	,	O	,	_	0	SENT_391	[p20l1507t1248r1604b1272],
8	0.6	CD	NUMBER	0.6	num	9	SENT_391	[p20l1614t1247r1649b1268],
9	]	CD	NUMBER	]	appos	6	SENT_391	[p20l1657t1248r1696b1274],
10	JlVl	NN	O	jlvl	dep	9	SENT_391	[p20l1657t1248r1696b1274],
11	|	CD	NUMBER	|	num	10	SENT_391	[p20l1467t1290r1493b1316],
12	:	:	O	:	_	0	SENT_391	[p20l1467t1290r1493b1316],
13	|	CD	NUMBER	|	num	14	SENT_391	[p20l1467t1290r1493b1316],
14	PKI-166	NN	O	pki-166	dep	3	SENT_391	[p20l1507t1292r1604b1317],
15	,	,	O	,	_	0	SENT_391	[p20l1507t1292r1604b1317],
16	1.25	CD	NUMBER	1.25	num	17	SENT_391	[p20l1616t1292r1663b1313],
17	yM	NN	O	ym	appos	14	SENT_391	[p20l1672t1292r1710b1319],
18	I	PRP	O	I	dep	19	SENT_391	[p20l1467t1335r1493b1361],
19	PKI-166	NN	O	pki-166	dep	17	SENT_391	[p20l1507t1337r1604b1361],
20	,	,	O	,	_	0	SENT_391	[p20l1507t1337r1604b1361],
21	2.5	CD	NUMBER	2.5	num	22	SENT_391	[p20l1615t1337r1648b1357],
22	pIM	NN	O	pim	dep	3	SENT_391	[p20l1657t1337r1696b1364],
23	I	PRP	O	I	nsubj	24	SENT_391	[p20l1467t1380r1493b1406],
24	PKl	VBP	O	pkl	rcmod	22	SENT_391	[p20l1507t1382r1604b1406],
25	—	NN	O	—	dobj	24	SENT_391	[p20l1507t1382r1604b1406],
26	166	CD	NUMBER	166	num	25	SENT_391	[p20l1507t1382r1604b1406],
27	,	,	O	,	_	0	SENT_391	[p20l1507t1382r1604b1406],
28	5.0	CD	NUMBER	5.0	num	29	SENT_391	[p20l1615t1381r1650b1402],
29	pIlVl	NN	O	pilvl	appos	25	SENT_391	[p20l1657t1382r1696b1409],

1	KO	NN	O	ko	nn	2	SENT_392	[p20l207t1255r219b1276],
2	o	NN	O	o	_	0	SENT_392	[p20l221t1255r235b1276],

1	CPR	NNP	O	CPR	_	0	SENT_393	[p20l567t1394r645b1414],
2	IE	JJ	O	ie	amod	3	SENT_393	[p20l541t1422r657b1470],
3	FE	NNP	O	FE	dep	1	SENT_393	[p20l541t1477r655b1525],

1	Viability	NN	O	viability	_	0	SENT_394	[p20l132t1335r163b1439],
2	(	CD	PERCENT	(	num	3	SENT_394	[p20l134t1283r164b1325],
3	%	NN	PERCENT	%	dep	1	SENT_394	[p20l134t1283r164b1325],
4	)	CD	NUMBER	)	dep	1	SENT_394	[p20l134t1283r164b1325],

1	C1	NN	O	c1	nn	2	SENT_395	[p20l207t1466r220b1486],
2	\	NN	O	\	_	0	SENT_395	[p20l208t1396r220b1416],
3	l	NN	O	l	nn	4	SENT_395	[p20l208t1396r220b1416],
4	oo	NN	O	oo	dep	2	SENT_395	[p20l207t1325r219b1346],
5	O	NN	O	o	nn	7	SENT_395	[p20l221t1466r235b1486],
6	C	NN	O	c	nn	7	SENT_395	[p20l221t1395r235b1416],
7	O	NN	O	o	dep	2	SENT_395	[p20l221t1325r235b1346],

1	Viability	NN	O	viability	_	0	SENT_396	[p20l844t1335r875b1439],
2	(	CD	PERCENT	(	num	3	SENT_396	[p20l846t1283r876b1325],
3	%	NN	PERCENT	%	dep	1	SENT_396	[p20l846t1283r876b1325],
4	)	CD	NUMBER	)	dep	1	SENT_396	[p20l846t1283r876b1325],

1	S	NN	O	s	_	0	SENT_397	[p20l1133t1600r1149b1622],
2	F295	NN	O	f295	nn	3	SENT_397	[p20l1152t1600r1211b1622],
3	Cells	NNS	O	cell	dep	1	SENT_397	[p20l1222t1598r1282b1622],

1	[	NN	O	[	nn	3	SENT_398	[p20l541t1658r567b1684],
2	I	CD	NUMBER	i	num	3	SENT_398	[p20l541t1658r567b1684],
3	Start	NNP	O	Start	dep	10	SENT_398	[p20l580t1660r636b1681],
4	|	CD	NUMBER	|	num	6	SENT_398	[p20l1467t1658r1493b1684],
5	:	:	O	:	_	0	SENT_398	[p20l1467t1658r1493b1684],
6	|	CD	NUMBER	|	dep	3	SENT_398	[p20l1467t1658r1493b1684],
7	SF295	NN	O	sf295	dep	10	SENT_398	[p20l1506t1660r1577b1681],
8	|	CD	NUMBER	|	num	10	SENT_398	[p20l541t1704r567b1730],
9	:	:	O	:	_	0	SENT_398	[p20l541t1704r567b1730],
10	|	CD	NUMBER	|	dep	13	SENT_398	[p20l541t1704r567b1730],
11	D4	NN	O	d4	dep	10	SENT_398	[p20l581t1706r613b1726],
12	Vehicle	NNP	O	Vehicle	nn	13	SENT_398	[p20l622t1704r707b1727],
13	SF295-PTEN	NN	O	sf295-pten	_	0	SENT_398	[p20l1506t1706r1655b1727],
14	I	PRP	O	I	nsubj	15	SENT_398	[p20l541t1750r567b1776],
15	D4	VBP	O	d4	rcmod	13	SENT_398	[p20l581t1752r613b1772],
16	PKI-166	NN	O	pki-166	dobj	15	SENT_398	[p20l624t1752r715b1773],

1	|	NN	O	|	_	0	SENT_399	[p20l1467t1828r1584b1871],
2	:	:	O	:	_	0	SENT_399	[p20l1467t1828r1584b1871],
3	|	CD	NUMBER	|	dep	1	SENT_399	[p20l1467t1828r1584b1871],
4	PTEN	NN	O	pten	nn	6	SENT_399	[p20l1594t1839r1658b1859],
5	"	''	O	"	punct	6	SENT_399	[p20l1467t1870r1728b1926],
6	“	NN	O	“	dep	3	SENT_399	[p20l1467t1870r1728b1926],
7	r	NN	O	r	dep	6	SENT_399	[p20l1467t1870r1728b1926],
8	:	:	O	:	_	0	SENT_399	[p20l1467t1870r1728b1926],
9	.	.	O	.	_	0	SENT_399	[p20l1467t1870r1728b1926],

1	:	:	O	:	_	0	SENT_400	[p20l1467t1870r1728b1926],
2	:	:	O	:	_	0	SENT_400	[p20l1467t1870r1728b1926],
3	’	CD	NUMBER	’	dep	5	SENT_400	[p20l1467t1870r1728b1926],
4	.5	CD	NUMBER	.5	dep	3	SENT_400	[p20l1467t1870r1728b1926],
5	“	NN	O	“	_	0	SENT_400	[p20l1467t1870r1728b1926],
6	:	:	O	:	_	0	SENT_400	[p20l1467t1870r1728b1926],
7	{	CD	NUMBER	{	num	9	SENT_400	[p20l1467t1870r1728b1926],
8	k	NN	O	k	nn	9	SENT_400	[p20l1467t1870r1728b1926],
9	’	NN	O	’	dep	5	SENT_400	[p20l1467t1870r1728b1926],
10	;	:	O	;	_	0	SENT_400	[p20l1467t1870r1728b1926],

1	100	CD	NUMBER	100	number	2	SENT_401	[p20l194t1840r235b1861],
2	50	CD	NUMBER	50	num	3	SENT_401	[p20l207t1906r235b1927],
3	|	NNS	O	|	_	0	SENT_401	[p20l541t1887r657b1932],
4	:	:	O	:	_	0	SENT_401	[p20l541t1887r657b1932],
5	|	CD	NUMBER	|	num	6	SENT_401	[p20l541t1887r657b1932],
6	PARP	NN	O	parp	dep	3	SENT_401	[p20l667t1898r746b1918],
7	*	CD	NUMBER	*	num	8	SENT_401	[p20l667t1898r746b1918],
8	O	NN	O	o	dep	6	SENT_401	[p20l221t1971r235b1992],
9	E	NN	O	e	nn	11	SENT_401	[p20l541t1938r657b1984],
10	Actin	NN	O	actin	nn	11	SENT_401	[p20l665t1950r725b1971],
11	PTEN	NN	O	pten	dep	8	SENT_401	[p20l270t1993r368b2016],
12	+	CC	O	+	rcmod	11	SENT_401	[p20l270t1993r368b2016],
13	/	:	O	/	punct	15	SENT_401	[p20l270t1993r368b2016],
14	+	CC	O	+	dep	15	SENT_401	[p20l270t1993r368b2016],
15	PTEN	SYM	ORGANIZATION	pten	dep	11	SENT_401	[p20l398t1993r494b2016],
16	-	:	O	-	_	0	SENT_401	[p20l398t1993r494b2016],
17	/	:	O	/	punct	6	SENT_401	[p20l398t1993r494b2016],
18	-	:	O	-	_	0	SENT_401	[p20l398t1993r494b2016],
19	(	NN	O	(	nsubj	21	SENT_401	[p20l562t1996r589b2026],
20	‘	CD	NUMBER	‘	num	19	SENT_401	[p20l562t1996r589b2026],
21	go	VBP	O	go	dep	3	SENT_401	[p20l562t1996r589b2026],
22	be	VB	O	be	cop	23	SENT_401	[p20l608t1996r635b2026],
23	5	CD	NUMBER	5	xcomp	21	SENT_401	[p20l1202t1996r1213b2017],

1	5	CD	NUMBER	5	_	0	SENT_402	[p20l549t2020r569b2040],
2	.	.	O	.	_	0	SENT_402	[p20l595t2020r615b2041],

1	~	NN	O	~	dep	10	SENT_403	[p20l595t2020r615b2041],
2	<	JJR	O	<	dep	1	SENT_403	[p20l514t2034r553b2073],
3	2	CD	NUMBER	2	number	4	SENT_403	[p20l514t2034r553b2073],
4	‘	CD	NUMBER	‘	num	5	SENT_403	[p20l514t2034r553b2073],
5	)	NN	O	)	npadvmod	6	SENT_403	[p20l514t2034r553b2073],
6	<	JJR	O	<	amod	2	SENT_403	[p20l559t2034r598b2073],
7	29	CD	NUMBER	29	num	8	SENT_403	[p20l559t2034r598b2073],
8	PKI-166	NN	O	pki-166	dep	10	SENT_403	[p20l1124t2053r1222b2075],
9	(	CD	NUMBER	(	num	10	SENT_403	[p20l1233t2053r1292b2082],
10	yM	NN	O	ym	dep	13	SENT_403	[p20l1233t2053r1292b2082],
11	)	CD	MONEY	)	dep	10	SENT_403	[p20l1233t2053r1292b2082],
12	$	$	MONEY	$	dep	13	SENT_403	[p20l482t2074r517b2105],
13	o	NN	MONEY	o	_	0	SENT_403	[p20l482t2074r517b2105],

1	No.	NN	O	no.	_	0	SENT_404	[p20l134t1892r156b1936],
2	of	IN	O	of	_	0	SENT_404	[p20l132t1852r156b1882],
3	Viable	JJ	O	viable	amod	4	SENT_404	[p20l132t1770r156b1849],
4	Cells	NNS	O	cell	prep_of	1	SENT_404	[p20l132t1700r156b1761],

1	Sub-G1	NN	O	sub-g1	_	0	SENT_405	[p20l844t1836r876b1927],
2	Peak	JJ	O	peak	amod	1	SENT_405	[p20l844t1764r868b1824],
3	(	CD	PERCENT	(	num	4	SENT_405	[p20l846t1712r876b1754],
4	%	NN	PERCENT	%	dep	1	SENT_405	[p20l846t1712r876b1754],
5	)	CD	NUMBER	)	dep	1	SENT_405	[p20l846t1712r876b1754],

1	El	NNP	O	El	nn	4	SENT_406	[p20l1025t2265r1051b2291],
2	Vehicle	NNP	O	Vehicle	nn	4	SENT_406	[p20l1062t2265r1147b2288],
3	El	NNP	O	El	nn	4	SENT_406	[p20l1025t2311r1051b2337],
4	PKI-166	NNP	O	PKI-166	_	0	SENT_406	[p20l1065t2313r1155b2333],

1	Viability	NN	O	viability	_	0	SENT_407	[p20l616t2400r647b2504],
2	(	CD	PERCENT	(	num	3	SENT_407	[p20l618t2348r648b2390],
3	%	NN	PERCENT	%	dep	1	SENT_407	[p20l618t2348r648b2390],
4	)	CD	NUMBER	)	dep	1	SENT_407	[p20l618t2348r648b2390],

1	A431	NN	O	a431	_	0	SENT_408	[p20l796t2603r870b2625],
2	-	:	O	-	_	0	SENT_408	[p20l796t2603r870b2625],
3	A431Vector	NN	O	a431vector	nn	4	SENT_408	[p20l930t2603r1004b2625, p20l792t2639r875b2661],
4	Akt	NN	O	akt	dep	1	SENT_408	[p20l938t2637r997b2660],
5	*	CD	NUMBER	*	dep	4	SENT_408	[p20l938t2637r997b2660],

1	N	NN	O	n	nn	3	SENT_409	[p20l526t2777r539b2792],
2	ENGLJ	NN	O	englj	nn	3	SENT_409	[p20l555t2776r639b2798],
3	MED	NN	O	med	_	0	SENT_409	[p20l654t2777r706b2792],
4	353	CD	NUMBER	353	dep	3	SENT_409	[p20l718t2776r797b2798],
5	;	:	O	;	_	0	SENT_409	[p20l718t2776r797b2798],
6	19	CD	NUMBER	19	dep	3	SENT_409	[p20l718t2776r797b2798],
7	WWW	NNP	O	WWW	dep	6	SENT_409	[p20l832t2777r926b2792],
8	.	.	O	.	_	0	SENT_409	[p20l832t2777r926b2792],

1	N	NN	O	n	nn	2	SENT_410	[p20l832t2777r926b2792],
2	E	NN	O	e	_	0	SENT_410	[p20l934t2777r952b2798],
3	]	CD	NUMBER	]	num	5	SENT_410	[p20l934t2777r952b2798],
4	M.ORG	NNP	O	M.ORG	nn	5	SENT_410	[p20l960t2776r1043b2792],
5	NOVEMBER	NNP	DATE	NOVEMBER	dep	2	SENT_410	[p20l1082t2776r1223b2792],
6	10,2005	CD	DATE	10,2005	number	7	SENT_410	[p20l1237t2776r1348b2798],
7	2021	CD	DATE	2021	dep	5	SENT_410	[p20l1990t2775r2067b2796],

1	The	DT	O	the	det	4	SENT_411	[p20l752t2809r803b2833],
2	New	NNP	O	New	nn	4	SENT_411	[p20l812t2810r874b2833],
3	England	NNP	O	England	nn	4	SENT_411	[p20l884t2809r994b2840],
4	Journal	NNP	O	Journal	_	0	SENT_411	[p20l1003t2809r1100b2833],
5	of	IN	O	of	_	0	SENT_411	[p20l1110t2809r1139b2833],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_411	[p20l1146t2809r1271b2833],

1	Downloaded	VBN	O	download	_	0	SENT_412	[p20l195t2850r365b2873],
2	from	IN	O	from	_	0	SENT_412	[p20l373t2850r438b2873],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_412	[p20l446t2850r565b2880],
4	at	IN	O	at	_	0	SENT_412	[p20l575t2853r598b2873],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_412	[p20l607t2850r789b2873],
6	on	IN	O	on	_	0	SENT_412	[p20l799t2857r831b2873],
7	January	NNP	DATE	January	prep_on	1	SENT_412	[p20l840t2850r942b2880],
8	5	CD	DATE	5	num	7	SENT_412	[p20l952t2850r975b2877],
9	,	,	DATE	,	_	0	SENT_412	[p20l952t2850r975b2877],
10	2014	CD	DATE	2014	num	7	SENT_412	[p20l986t2850r1058b2873],
11	.	.	O	.	_	0	SENT_412	[p20l986t2850r1058b2873],

1	For	IN	O	for	_	0	SENT_413	[p20l1068t2850r1115b2873],
2	personal	JJ	O	personal	amod	3	SENT_413	[p20l1123t2850r1235b2880],
3	use	NN	O	use	pobj	1	SENT_413	[p20l1244t2857r1288b2873],
4	only	RB	O	only	advmod	3	SENT_413	[p20l1298t2850r1362b2880],
5	.	.	O	.	_	0	SENT_413	[p20l1298t2850r1362b2880],

1	No	DT	O	no	det	3	SENT_414	[p20l1373t2850r1413b2873],
2	other	JJ	O	other	amod	3	SENT_414	[p20l1423t2850r1491b2873],
3	uses	NNS	O	use	_	0	SENT_414	[p20l1499t2857r1555b2873],
4	without	IN	O	without	_	0	SENT_414	[p20l1565t2850r1666b2873],
5	permission	NN	O	permission	prep_without	3	SENT_414	[p20l1675t2850r1827b2880],
6	.	.	O	.	_	0	SENT_414	[p20l1675t2850r1827b2880],

1	Copyright	NN	O	copyright	_	0	SENT_415	[p20l545t2891r679b2922],
2	©	CD	NUMBER	©	num	6	SENT_415	[p20l689t2891r712b2915],
3	2005	CD	DATE	2005	num	6	SENT_415	[p20l722t2891r786b2915],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_415	[p20l797t2891r988b2915],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_415	[p20l997t2891r1106b2915],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_415	[p20l1116t2891r1221b2922],
7	.	.	O	.	_	0	SENT_415	[p20l1116t2891r1221b2922],

1	All	DT	O	all	det	2	SENT_416	[p20l1232t2891r1273b2915],
2	rights	NNS	O	rights	nsubj	3	SENT_416	[p20l1282t2891r1357b2922],
3	reserved	VBN	O	reserve	_	0	SENT_416	[p20l1367t2891r1486b2915],
4	.	.	O	.	_	0	SENT_416	[p20l1367t2891r1486b2915],

1	The	DT	O	the	det	4	SENT_417	[p20l715t2997r752b3018],
2	NEW	NNP	O	NEW	nn	4	SENT_417	[p20l764t2999r845b3018],
3	ENGLAND	NNP	O	ENGLAND	nn	4	SENT_417	[p20l859t2999r1034b3018],
4	JOURNAL	NNP	O	JOURNAL	_	0	SENT_417	[p20l1048t2999r1214b3025],
5	ufMEDICINE	NN	O	ufmedicine	dep	4	SENT_417	[p20l1228t2997r1444b3024],

1	IN	IN	O	in	amod	3	SENT_418	[p20l16t3220r96b3269],
2	VITRO	NNP	O	VITRO	dep	1	SENT_418	[p20l140t3219r388b3269],
3	STUDIES	NNPS	O	STUDIES	_	0	SENT_418	[p20l427t3220r776b3269],
4	OF	IN	O	of	_	0	SENT_418	[p20l816t3219r921b3269],
5	THE	DT	O	the	det	6	SENT_418	[p20l957t3220r1118b3268],
6	COEXPRESSION	NN	O	coexpression	prep_of	3	SENT_418	[p20l1158t3219r1794b3269],
7	OF	IN	O	of	_	0	SENT_418	[p20l11t3303r116b3353],
8	EGFRVIII	NN	MISC	egfrviius	prep_of	3	SENT_418	[p20l159t3303r507b3353],
9	AND	CC	O	and	_	0	SENT_418	[p20l549t3304r726b3352],
10	PTEN	NN	O	pten	prep_of	3	SENT_418	[p20l771t3304r969b3352],

1	We	PRP	O	we	nsubj	2	SENT_419	[p20l7t3418r139b3489],
2	induced	VBD	O	induce	_	0	SENT_419	[p20l158t3410r489b3490],
3	the	DT	O	the	det	4	SENT_419	[p20l509t3411r636b3489],
4	expression	NN	O	expression	dobj	2	SENT_419	[p20l656t3411r1100b3511],
5	of	IN	O	of	_	0	SENT_419	[p20l1121t3410r1220b3489],
6	relevant	JJ	O	relevant	amod	7	SENT_419	[p20l1221t3410r1549b3490],
7	combinations	NNS	O	combination	prep_of	4	SENT_419	[p20l1564t3410r2134b3489],
8	of	IN	O	of	_	0	SENT_419	[p20l11t3538r112b3617],
9	PT	NN	O	pt	nn	10	SENT_419	[p20l116t3544r229b3616],
10	EN	NN	O	en	prep_of	7	SENT_419	[p20l229t3546r361b3618],
11	,	,	O	,	_	0	SENT_419	[p20l365t3603r379b3634],
12	EGFR	NN	ORGANIZATION	egfr	appos	10	SENT_419	[p20l408t3544r680b3634],
13	,	,	O	,	_	0	SENT_419	[p20l408t3544r680b3634],
14	and	CC	O	and	_	0	SENT_419	[p20l709t3539r865b3617],
15	EGFRVIII	NN	O	egfrviius	nsubj	19	SENT_419	[p20l888t3544r1279b3622],
16	in	IN	O	in	_	0	SENT_419	[p20l1301t3539r1383b3616],
17	U87MG	NN	O	u87mg	nn	18	SENT_419	[p20l1406t3544r1742b3617],
18	glioblas	NNS	O	gliobla	prep_in	15	SENT_419	[p20l1767t3538r2134b3639],
19	—	VBP	O	—	conj_and	2	SENT_419	[p20l1767t3538r2134b3639],
20	toma	NN	O	toma	nn	21	SENT_419	[p20l11t3682r227b3744],
21	cells	NNS	O	cell	dobj	19	SENT_419	[p20l247t3665r455b3744],
22	.	.	O	.	_	0	SENT_419	[p20l247t3665r455b3744],

1	U87MG	NN	O	u87mg	nn	2	SENT_420	[p20l481t3671r816b3744],
2	cells	NNS	O	cell	nsubj	5	SENT_420	[p20l838t3665r1021b3743],
3	are	VBP	O	be	cop	5	SENT_420	[p20l1043t3692r1169b3743],
4	deﬁcientin	JJ	O	deﬁcientin	amod	5	SENT_420	[p20l1191t3665r1657b3744],
5	PTEN	NN	O	pten	_	0	SENT_420	[p20l1676t3671r2133b3760],
6	,35	CD	NUMBER	,35	number	7	SENT_420	[p20l1676t3671r2133b3760],
7	‘	CD	NUMBER	‘	dep	5	SENT_420	[p20l1676t3671r2133b3760],
8	38	CD	NUMBER	38	dep	7	SENT_420	[p20l1676t3671r2133b3760],

1	express	VB	O	express	_	0	SENT_421	[p21l11t50r332b124],
2	low	JJ	O	low	amod	3	SENT_421	[p21l377t23r535b103],
3	levels	NNS	O	level	dobj	1	SENT_421	[p21l575t24r811b103],
4	of	IN	O	of	_	0	SENT_421	[p21l857t23r960b102],
5	wild	JJ	O	wild	amod	8	SENT_421	[p21l980t23r1387b124],
6	—	NN	O	—	nn	8	SENT_421	[p21l980t23r1387b124],
7	type	NN	O	type	nn	8	SENT_421	[p21l980t23r1387b124],
8	EGFR	NN	ORGANIZATION	egfr	prep_of	3	SENT_421	[p21l1430t29r1708b119],
9	,	,	O	,	_	0	SENT_421	[p21l1430t29r1708b119],
10	and	CC	O	and	_	0	SENT_421	[p21l1757t23r1916b102],
11	lack	VBP	O	lack	conj_and	1	SENT_421	[p21l1959t23r2138b103],
12	EGFRvIII	NN	O	egfrviius	nn	14	SENT_421	[p21l9t157r603b235],
13	.39	CD	NUMBER	.39	num	14	SENT_421	[p21l9t157r603b235],
14	»	NN	O	»	dobj	11	SENT_421	[p21l9t157r603b235],
15	4	CD	NUMBER	4	number	16	SENT_421	[p21l9t157r603b235],
16	°	CD	NUMBER	°	num	17	SENT_421	[p21l9t157r603b235],
17	Coexpression	NN	O	coexpression	nsubj	27	SENT_421	[p21l625t152r1190b252],
18	of	IN	O	of	_	0	SENT_421	[p21l1212t151r1312b230],
19	EGFRVIII	NN	O	egfrviius	nn	22	SENT_421	[p21l1314t157r1700b235],
20	and	CC	O	and	_	0	SENT_421	[p21l1720t152r1874b230],
21	PT	NN	O	pt	conj_and	19	SENT_421	[p21l1895t157r2007b229],
22	EN	NN	O	en	prep_of	17	SENT_421	[p21l2007t159r2137b230],
23	in	IN	O	in	_	0	SENT_421	[p21l10t280r91b357],
24	these	DT	O	these	det	26	SENT_421	[p21l130t280r348b358],
25	glioblastoma	NN	O	glioblastoma	nn	26	SENT_421	[p21l387t279r942b380],
26	cells	NNS	O	cell	prep_in	22	SENT_421	[p21l979t279r1162b358],
27	rendered	VBD	O	render	rcmod	14	SENT_421	[p21l1202t279r1578b358],
28	them	PRP	O	they	nsubj	30	SENT_421	[p21l1617t279r1833b358],
29	highly	RB	O	highly	advmod	30	SENT_421	[p21l1872t280r2139b380],
30	susceptible	JJ	O	susceptible	xcomp	27	SENT_421	[p21l12t407r477b508],
31	to	TO	O	to	_	0	SENT_421	[p21l500t424r579b486],
32	arrest	NN	O	arrest	prep_to	30	SENT_421	[p21l603t424r843b486],
33	of	IN	O	of	_	0	SENT_421	[p21l862t407r962b486],
34	growth	NN	O	growth	prep_of	32	SENT_421	[p21l966t408r1267b508],
35	by	IN	O	by	_	0	SENT_421	[p21l1291t408r1387b508],
36	erlotinib	NN	O	erlotinib	prep_by	11	SENT_421	[p21l1406t407r1784b503],
37	,	,	O	,	_	0	SENT_421	[p21l1406t407r1784b503],
38	as	IN	O	as	advmod	11	SENT_421	[p21l1812t434r1896b486],
39	compared	VBN	O	compare	_	0	SENT_421	[p21l1922t433r2135b486, p21l9t536r247b636],
40	with	IN	O	with	prepc_compared_with	11	SENT_421	[p21l265t536r454b615],
41	control	NN	O	control	nn	42	SENT_421	[p21l477t535r780b614],
42	cells	NNS	O	cell	pobj	11	SENT_421	[p21l803t535r985b614],
43	and	CC	O	and	_	0	SENT_421	[p21l1009t536r1165b614],
44	U87MG	NN	O	u87mg	nn	45	SENT_421	[p21l1186t541r1522b614],
45	cells	NNS	O	cell	pobj	11	SENT_421	[p21l1546t535r1728b614],
46	that	WDT	O	that	nsubjpass	48	SENT_421	[p21l1753t536r1920b614],
47	were	VBD	O	be	auxpass	48	SENT_421	[p21l1933t562r2135b615],
48	transfected	VBN	O	transfect	rcmod	42	SENT_421	[p21l11t663r478b742],
49	with	IN	O	with	_	0	SENT_421	[p21l510t664r699b743],
50	other	JJ	O	other	amod	51	SENT_421	[p21l736t663r960b742],
51	components	NNS	O	component	prep_with	48	SENT_421	[p21l993t680r1518b764],
52	of	IN	O	of	_	0	SENT_421	[p21l1557t663r1658b742],
53	the	DT	O	the	det	57	SENT_421	[p21l1675t663r1805b742],
54	PTENEGFR	NN	O	ptenegfr	nn	57	SENT_421	[p21l1839t669r2138b742, p21l9t797r268b875],
55	system	NN	O	system	nn	57	SENT_421	[p21l283t808r571b892],
56	(	CD	NUMBER	(	num	57	SENT_421	[p21l599t792r783b892],
57	Fig	NN	O	fig	prep_of	51	SENT_421	[p21l599t792r783b892],
58	.	.	O	.	_	0	SENT_421	[p21l599t792r783b892],

1	3A	NN	O	3a	_	0	SENT_422	[p21l813t797r983b883],
2	)	NN	O	)	dep	1	SENT_422	[p21l813t797r983b883],
3	.	.	O	.	_	0	SENT_422	[p21l813t797r983b883],

1	In	IN	O	in	_	0	SENT_423	[p21l1011t799r1098b869],
2	these	DT	O	these	det	3	SENT_423	[p21l1123t792r1342b870],
3	experiments	NNS	O	experiment	prep_in	6	SENT_423	[p21l1367t792r1910b892],
4	,	,	O	,	_	0	SENT_423	[p21l1367t792r1910b892],
5	erlotinib	NN	O	erlotinib	nsubj	6	SENT_423	[p21l1940t792r2134b870, p21l11t920r204b998],
6	caused	VBD	O	cause	_	0	SENT_423	[p21l232t920r518b999],
7	the	DT	O	the	det	8	SENT_423	[p21l544t920r673b998],
8	arrest	NN	O	arrest	dobj	6	SENT_423	[p21l699t936r942b998],
9	of	IN	O	of	_	0	SENT_423	[p21l963t919r1063b998],
10	growth	NN	O	growth	prep_of	8	SENT_423	[p21l1070t920r1374b1020],
11	but	CC	O	but	_	0	SENT_423	[p21l1400t920r1541b999],
12	not	RB	O	not	_	0	SENT_423	[p21l1562t936r1705b998],
13	apoptosis	NN	O	apoptosis	conj_negcc	8	SENT_423	[p21l1726t920r2133b1020],
14	in	IN	O	in	_	0	SENT_423	[p21l10t1048r91b1125],
15	U87MG	NN	O	u87mg	nn	16	SENT_423	[p21l123t1053r458b1126],
16	cells	NNS	O	cell	prep_in	13	SENT_423	[p21l492t1047r700b1126],
17	.	.	O	.	_	0	SENT_423	[p21l492t1047r700b1126],

1	Because	IN	O	because	mark	6	SENT_424	[p21l737t1054r1077b1127],
2	U87MG	NN	O	u87mg	nn	3	SENT_424	[p21l1109t1053r1445b1126],
3	cells	NNS	O	cell	nsubj	6	SENT_424	[p21l1479t1047r1661b1126],
4	do	VBP	O	do	aux	6	SENT_424	[p21l1696t1048r1800b1126],
5	not	RB	O	not	neg	6	SENT_424	[p21l1833t1064r1977b1126],
6	depend	VB	O	depend	_	0	SENT_424	[p21l2005t1047r2134b1126, p21l9t1176r220b1276],

1	on	IN	O	on	_	0	SENT_425	[p21l246t1201r352b1254],
2	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_425	[p21l376t1181r636b1259],
3	signaling	NN	O	signaling	prep_on	8	SENT_425	[p21l651t1175r1046b1276],
4	for	IN	O	for	_	0	SENT_425	[p21l1068t1175r1191b1254],
5	survival	NN	O	survival	prep_for	3	SENT_425	[p21l1215t1176r1556b1271],
6	,	,	O	,	_	0	SENT_425	[p21l1215t1176r1556b1271],
7	we	PRP	O	we	nsubj	8	SENT_425	[p21l1582t1202r1700b1255],
8	examined	VBD	O	examine	_	0	SENT_425	[p21l1726t1176r2135b1254],
9	the	DT	O	the	det	10	SENT_425	[p21l11t1304r139b1382],
10	effect	NN	O	effect	dobj	8	SENT_425	[p21l173t1303r406b1382],
11	of	IN	O	of	_	0	SENT_425	[p21l434t1303r535b1382],
12	a	DT	O	a	det	13	SENT_425	[p21l548t1330r592b1382],
13	lack	NN	O	lack	prep_of	10	SENT_425	[p21l621t1303r796b1383],
14	of	IN	O	of	_	0	SENT_425	[p21l824t1303r924b1382],
15	PTEN	NNP	ORGANIZATION	PTEN	prep_of	13	SENT_425	[p21l936t1309r1182b1383],
16	in	IN	O	in	_	0	SENT_425	[p21l1211t1304r1292b1381],
17	three	CD	NUMBER	three	num	19	SENT_425	[p21l1325t1303r1537b1382],
18	cell	NN	O	cell	nn	19	SENT_425	[p21l1570t1303r1712b1382],
19	lines	NNS	O	line	prep_in	8	SENT_425	[p21l1742t1304r1939b1382],
20	that	WDT	O	that	nsubj	21	SENT_425	[p21l1973t1303r2140b1382],
21	undergo	VBP	O	undergo	rcmod	19	SENT_425	[p21l10t1431r364b1532],
22	apoptosis	NN	O	apoptosis	dobj	21	SENT_425	[p21l390t1432r797b1532],
23	in	IN	O	in	_	0	SENT_425	[p21l824t1432r906b1509],
24	the	DT	O	the	det	25	SENT_425	[p21l931t1432r1060b1510],
25	presence	NN	O	presence	prep_in	22	SENT_425	[p21l1085t1457r1458b1532],
26	of	IN	O	of	_	0	SENT_425	[p21l1485t1431r1585b1510],
27	EGFR	NN	ORGANIZATION	egfr	nn	29	SENT_425	[p21l1590t1437r1850b1515],
28	kinase	NN	O	kinase	nn	29	SENT_425	[p21l1864t1432r2135b1511],
29	inhibitors	NNS	O	inhibitor	prep_of	25	SENT_425	[p21l10t1560r442b1638],
30	:	:	O	:	_	0	SENT_425	[p21l10t1560r442b1638],
31	SF295	NN	O	sf295	dep	22	SENT_425	[p21l469t1565r720b1638],
32	human	JJ	O	human	amod	34	SENT_425	[p21l745t1560r1041b1639],
33	glioblastoma	NN	O	glioblastoma	nn	34	SENT_425	[p21l1061t1559r1607b1660],
34	cells	NNS	O	cell	dep	31	SENT_425	[p21l1628t1560r1831b1655],
35	,	,	O	,	_	0	SENT_425	[p21l1628t1560r1831b1655],
36	mouse	NN	O	mouse	nn	38	SENT_425	[p21l1858t1585r2135b1639],
37	embryonic	JJ	O	embryonic	amod	38	SENT_425	[p21l11t1687r455b1788],
38	ﬁbroblasts	NNS	O	ﬁbroblasts	appos	22	SENT_425	[p21l476t1687r920b1766],
39	from	IN	O	from	_	0	SENT_425	[p21l944t1687r1149b1766],
40	mice	NNS	O	mouse	prep_from	38	SENT_425	[p21l1171t1688r1370b1766],
41	in	IN	O	in	_	0	SENT_425	[p21l1392t1688r1472b1765],
42	which	WDT	O	which	rel	49	SENT_425	[p21l1489t1688r1748b1767],
43	the	DT	O	the	det	45	SENT_425	[p21l1770t1687r1898b1766],
44	PTEN	NN	ORGANIZATION	pten	nn	45	SENT_425	[p21l1917t1694r2140b1766],
45	gene	NN	O	gene	nsubjpass	49	SENT_425	[p21l10t1841r206b1916],
46	has	VBZ	O	have	aux	49	SENT_425	[p21l228t1816r367b1894],
47	been	VBN	O	be	auxpass	49	SENT_425	[p21l391t1816r587b1894],
48	conditionally	RB	O	conditionally	advmod	49	SENT_425	[p21l610t1815r1154b1916],
49	inactivated	VBN	O	inactivate	rcmod	40	SENT_425	[p21l1171t1816r1721b1911],
50	,45	CD	NUMBER	,45	dobj	49	SENT_425	[p21l1171t1816r1721b1911],
51	and	CC	O	and	_	0	SENT_425	[p21l1745t1816r1899b1894],
52	A431	NN	O	a431	nn	53	SENT_425	[p21l1915t1821r2135b1894],
53	cells	NNS	O	cell	conj_and	50	SENT_425	[p21l11t1943r193b2022],
54	with	IN	O	with	_	0	SENT_425	[p21l228t1944r418b2023],
55	stable	JJ	O	stable	amod	59	SENT_425	[p21l456t1944r703b2022],
56	PTEN	NN	O	pten	nn	59	SENT_425	[p21l739t1949r984b2022],
57	RNAi	NN	O	rnaus	nn	59	SENT_425	[p21l1019t1944r1250b2027],
58	(	CD	NUMBER	(	num	59	SENT_425	[p21l1291t1944r1474b2044],
59	Fig	NN	O	fig	prep_with	49	SENT_425	[p21l1291t1944r1474b2044],
60	.	.	O	.	_	0	SENT_425	[p21l1291t1944r1474b2044],

1	3B	NN	O	3b	_	0	SENT_426	[p21l1518t1949r1684b2035],
2	)	NN	O	)	dep	1	SENT_426	[p21l1518t1949r1684b2035],
3	.	.	O	.	_	0	SENT_426	[p21l1518t1949r1684b2035],

1	These	DT	O	these	det	2	SENT_427	[p21l1723t1943r1975b2022],
2	experiments	NNS	O	experiment	nsubj	3	SENT_427	[p21l2013t1970r2134b2022, p21l9t2072r436b2172],
3	were	VBD	O	be	_	0	SENT_427	[p21l466t2098r668b2151],
4	performed	VBN	O	perform	dep	3	SENT_427	[p21l699t2071r1148b2172],
5	with	IN	O	with	_	0	SENT_427	[p21l1176t2072r1366b2151],
6	two	CD	NUMBER	two	num	9	SENT_427	[p21l1398t2088r1551b2151],
7	EGFR	NN	ORGANIZATION	egfr	nn	9	SENT_427	[p21l1584t2077r1842b2155],
8	kinase	NN	O	kinase	nn	9	SENT_427	[p21l1864t2072r2135b2151],
9	inhibitors	NNS	O	inhibitor	prep_with	4	SENT_427	[p21l10t2200r449b2295],
10	,	,	O	,	_	0	SENT_427	[p21l10t2200r449b2295],
11	erlotinib	NN	O	erlotinib	nsubj	25	SENT_427	[p21l478t2199r836b2278],
12	and	CC	O	and	_	0	SENT_427	[p21l859t2200r1015b2278],
13	PKI	NN	O	pkus	conj_and	11	SENT_427	[p21l1035t2205r1490b2281],
14	—	CD	NUMBER	—	number	15	SENT_427	[p21l1035t2205r1490b2281],
15	166.41	CD	NUMBER	166.41	num	11	SENT_427	[p21l1035t2205r1490b2281],
16	In	IN	O	in	_	0	SENT_427	[p21l1510t2207r1597b2277],
17	all	DT	O	all	det	19	SENT_427	[p21l1619t2200r1718b2278],
18	three	CD	NUMBER	three	num	19	SENT_427	[p21l1740t2200r1953b2278],
19	systems	NNS	O	system	prep_in	11	SENT_427	[p21l1977t2226r2133b2300, p21l11t2344r237b2423],
20	,	,	O	,	_	0	SENT_427	[p21l1977t2226r2133b2300, p21l11t2344r237b2423],
21	the	DT	O	the	det	22	SENT_427	[p21l274t2328r404b2406],
22	lack	NN	O	lack	appos	19	SENT_427	[p21l435t2328r609b2407],
23	of	IN	O	of	_	0	SENT_427	[p21l637t2327r737b2406],
24	PTEN	NN	ORGANIZATION	pten	prep_of	22	SENT_427	[p21l749t2333r994b2407],
25	abrogated	VBD	O	abrogate	rcmod	9	SENT_427	[p21l1024t2328r1447b2428],
26	or	CC	O	or	_	0	SENT_427	[p21l1480t2353r1569b2406],
27	markedly	RB	O	markedly	dep	3	SENT_427	[p21l1598t2327r1995b2428],
28	reduced	VBD	O	reduce	dep	27	SENT_427	[p21l2022t2354r2134b2406, p21l11t2455r262b2535],
29	the	DT	O	the	det	30	SENT_427	[p21l298t2456r427b2534],
30	extent	NN	O	extent	dobj	28	SENT_427	[p21l463t2472r722b2534],
31	of	IN	O	of	_	0	SENT_427	[p21l753t2455r854b2534],
32	apoptosis	NN	O	apoptosis	prep_of	30	SENT_427	[p21l869t2456r1277b2556],
33	induced	VBN	O	induce	partmod	32	SENT_427	[p21l1314t2455r1652b2535],
34	by	IN	O	by	_	0	SENT_427	[p21l1688t2456r1784b2556],
35	the	DT	O	the	det	37	SENT_427	[p21l1816t2456r1945b2534],
36	two	CD	NUMBER	two	num	37	SENT_427	[p21l1981t2472r2134b2535],
37	inhibitors	NNS	O	inhibitor	agent	33	SENT_427	[p21l10t2584r423b2662],
38	of	IN	O	of	_	0	SENT_427	[p21l451t2583r552b2662],
39	EGFR	NN	ORGANIZATION	egfr	nn	40	SENT_427	[p21l557t2589r816b2667],
40	kinase	NN	O	kinase	prep_of	37	SENT_427	[p21l830t2583r1101b2663],
41	(	CD	NUMBER	(	num	42	SENT_427	[p21l1131t2584r1314b2684],
42	Fig	NN	O	fig	nsubj	28	SENT_427	[p21l1131t2584r1314b2684],
43	.	.	O	.	_	0	SENT_427	[p21l1131t2584r1314b2684],

1	3B	NN	O	3b	_	0	SENT_428	[p21l1346t2589r1512b2675],
2	)	NN	O	)	dep	1	SENT_428	[p21l1346t2589r1512b2675],
3	.	.	O	.	_	0	SENT_428	[p21l1346t2589r1512b2675],

1	We	PRP	O	we	nsubj	2	SENT_429	[p21l136t2719r269b2790],
2	examined	VBD	O	examine	_	0	SENT_429	[p21l301t2712r709b2790],
3	the	DT	O	the	det	4	SENT_429	[p21l741t2712r870b2790],
4	contribution	NN	O	contribution	dobj	2	SENT_429	[p21l902t2712r1431b2791],
5	of	IN	O	of	_	0	SENT_429	[p21l1463t2711r1562b2790],
6	Akt	NN	O	akt	prep_of	4	SENT_429	[p21l1571t2712r1724b2791],
7	to	TO	O	to	_	0	SENT_429	[p21l1750t2728r1829b2790],
8	the	DT	O	the	det	9	SENT_429	[p21l1862t2711r1992b2790],
9	resistance	NN	O	resistance	prep_to	2	SENT_429	[p21l2023t2738r2134b2790, p21l12t2840r345b2918],

1	to	TO	O	to	_	0	SENT_430	[p21l370t2856r448b2918],
2	EGFRkinase	NN	O	egfrkinase	nn	3	SENT_430	[p21l471t2840r1008b2923],
3	inhibitors	NNS	O	inhibitor	prep_to	4	SENT_430	[p21l1031t2839r1440b2918],
4	conferred	VBD	O	confer	_	0	SENT_430	[p21l1466t2839r1868b2918],
5	by	IN	O	by	_	0	SENT_430	[p21l1892t2840r1988b2940],
6	the	DT	O	the	det	7	SENT_430	[p21l2007t2840r2135b2918],
7	loss	NN	O	loss	prep_by	4	SENT_430	[p21l9t2968r173b3046],
8	of	IN	O	of	_	0	SENT_430	[p21l203t2967r304b3046],
9	PT	NN	O	pt	prep_of	7	SENT_430	[p21l313t2973r425b3045],
10	EN	NN	O	en	nsubj	4	SENT_430	[p21l426t2975r557b3046],
11	,	,	O	,	_	0	SENT_430	[p21l562t3032r576b3063],
12	because	IN	O	because	mark	49	SENT_430	[p21l611t2968r943b3047],
13	many	JJ	O	many	nsubj	49	SENT_430	[p21l971t2993r1205b3068],
14	of	IN	O	of	_	0	SENT_430	[p21l1230t2967r1330b3046],
15	the	DT	O	the	det	16	SENT_430	[p21l1341t2968r1469b3046],
16	effects	NNS	O	effect	prep_of	13	SENT_430	[p21l1499t2967r1769b3046],
17	that	WDT	O	that	nsubj	18	SENT_430	[p21l1800t2967r1967b3046],
18	follow	VBP	O	follow	rcmod	16	SENT_430	[p21l1990t2967r2134b3046, p21l9t3096r165b3175],
19	the	DT	O	the	det	20	SENT_430	[p21l192t3096r321b3174],
20	loss	NN	O	loss	nsubj	23	SENT_430	[p21l350t3095r514b3174],
21	of	IN	O	of	_	0	SENT_430	[p21l548t3095r647b3174],
22	PTEN	NNP	ORGANIZATION	PTEN	prep_of	20	SENT_430	[p21l659t3101r904b3174],
23	occur	VBP	O	occur	ccomp	18	SENT_430	[p21l933t3121r1167b3175],
24	through	IN	O	through	_	0	SENT_430	[p21l1195t3095r1537b3196],
25	the	DT	O	the	det	26	SENT_430	[p21l1568t3095r1697b3174],
26	activation	NN	O	activation	prep_through	23	SENT_430	[p21l1727t3096r2135b3175],
27	of	IN	O	of	_	0	SENT_430	[p21l11t3223r112b3302],
28	the	DT	O	the	det	31	SENT_430	[p21l116t3224r245b3302],
29	downstream	JJ	O	downstream	amod	31	SENT_430	[p21l268t3224r795b3303],
30	kinase	NN	O	kinase	nn	31	SENT_430	[p21l817t3224r1087b3303],
31	Akt	NN	O	akt	prep_of	26	SENT_430	[p21l1106t3223r1363b3303],
32	.45	CD	NUMBER	.45	num	34	SENT_430	[p21l1106t3223r1363b3303],
33	Erlotinib	NN	O	erlotinib	nn	34	SENT_430	[p21l1385t3223r2135b3303],
34	—	NN	O	—	nsubj	35	SENT_430	[p21l1385t3223r2135b3303],
35	induced	VBD	O	induce	rcmod	31	SENT_430	[p21l1385t3223r2135b3303],
36	inhibition	NN	O	inhibition	nsubj	42	SENT_430	[p21l10t3352r430b3430],
37	of	IN	O	of	_	0	SENT_430	[p21l455t3351r555b3430],
38	the	DT	O	the	det	39	SENT_430	[p21l561t3352r690b3430],
39	phosphorylation	NN	O	phosphorylation	prep_of	36	SENT_430	[p21l713t3351r1415b3452],
40	of	IN	O	of	_	0	SENT_430	[p21l1439t3351r1539b3430],
41	Akt	NN	O	akt	prep_of	39	SENT_430	[p21l1541t3351r1694b3431],
42	correlated	VBD	O	correlate	ccomp	35	SENT_430	[p21l1713t3352r2135b3430],
43	with	IN	O	with	_	0	SENT_430	[p21l6t3480r195b3559],
44	growth	NN	O	growth	nn	45	SENT_430	[p21l231t3480r534b3580],
45	inhibition	NN	O	inhibition	prep_with	42	SENT_430	[p21l570t3480r991b3558],
46	in	IN	O	in	_	0	SENT_430	[p21l1026t3480r1108b3557],
47	U87MG	NN	O	u87mg	nn	48	SENT_430	[p21l1143t3485r1478b3558],
48	cells	NNS	O	cell	prep_in	42	SENT_430	[p21l1517t3479r1699b3558],
49	(	VBP	O	(	dep	10	SENT_430	[p21l1743t3480r1926b3580],
50	Fig	NN	O	fig	dobj	49	SENT_430	[p21l1743t3480r1926b3580],
51	.	.	O	.	_	0	SENT_430	[p21l1743t3480r1926b3580],

1	4	CD	NUMBER	4	_	0	SENT_431	[p21l1966t3485r2016b3558],
2	of	IN	O	of	prep	1	SENT_431	[p21l2053t3479r2153b3558],
3	the	DT	O	the	det	6	SENT_431	[p21l11t3607r142b3686],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_431	[p21l181t3608r836b3708],
5	Appendix	NNP	O	Appendix	nn	6	SENT_431	[p21l864t3608r1340b3708],
6	)	NNP	O	)	pobj	2	SENT_431	[p21l864t3608r1340b3708],
7	,	,	O	,	_	0	SENT_431	[p21l864t3608r1340b3708],
8	but	CC	O	but	_	0	SENT_431	[p21l1384t3608r1526b3687],
9	not	RB	O	not	conj_but	2	SENT_431	[p21l1558t3624r1703b3686],
10	in	IN	O	in	dep	2	SENT_431	[p21l1734t3608r1816b3685],
11	all	DT	O	all	det	13	SENT_431	[p21l1852t3607r1953b3686],
12	cell	NN	O	cell	nn	13	SENT_431	[p21l1989t3608r2134b3686],
13	lines	NNS	O	line	pobj	10	SENT_431	[p22l9t21r232b99],
14	.	.	O	.	_	0	SENT_431	[p22l9t21r232b99],

1	For	IN	O	for	_	0	SENT_432	[p22l264t28r408b99],
2	example	NN	O	example	prep_for	16	SENT_432	[p22l434t20r809b121],
3	,	,	O	,	_	0	SENT_432	[p22l434t20r809b121],
4	in	IN	O	in	_	0	SENT_432	[p22l842t21r923b98],
5	A431	NN	O	a431	nn	6	SENT_432	[p22l948t26r1169b99],
6	cells	NNS	O	cell	nsubj	7	SENT_432	[p22l1198t20r1380b99],
7	expressing	VBG	O	express	prepc_in	16	SENT_432	[p22l1411t21r1868b121],
8	PT	NN	O	pt	dobj	7	SENT_432	[p22l1891t26r2004b98],
9	EN	IN	O	en	_	0	SENT_432	[p22l2005t28r2136b99],
10	shRNA	NN	O	shrna	prep_en	7	SENT_432	[p22l12t149r341b244],
11	,	,	O	,	_	0	SENT_432	[p22l12t149r341b244],
12	phosphorylation	NN	O	phosphorylation	nsubjpass	16	SENT_432	[p22l386t148r1103b249],
13	of	IN	O	of	_	0	SENT_432	[p22l1145t148r1247b227],
14	Akt	NNP	O	Akt	prep_of	12	SENT_432	[p22l1266t148r1421b228],
15	Was	VBD	O	be	auxpass	16	SENT_432	[p22l1453t175r1616b228],
16	blocked	VBN	O	block	_	0	SENT_432	[p22l1660t148r1998b228],
17	by	IN	O	by	_	0	SENT_432	[p22l2041t149r2139b249],
18	EGFRl	NN	O	egfrl	agent	16	SENT_432	[p22l9t277r560b360],
19	<	JJR	O	<	amod	21	SENT_432	[p22l9t277r560b360],
20	inase	NN	O	inase	nn	21	SENT_432	[p22l9t277r560b360],
21	inhibitors	NNS	O	inhibitor	nsubj	22	SENT_432	[p22l592t277r1005b355],
22	(	VBP	O	(	rcmod	18	SENT_432	[p22l1045t277r1228b377],
23	Fig	NN	O	fig	dobj	22	SENT_432	[p22l1045t277r1228b377],
24	.	.	O	.	_	0	SENT_432	[p22l1045t277r1228b377],

1	5	CD	NUMBER	5	nsubj	19	SENT_433	[p22l1268t284r1310b355],
2	of	IN	O	of	_	0	SENT_433	[p22l1346t276r1447b355],
3	the	DT	O	the	det	5	SENT_433	[p22l1461t276r1590b355],
4	Supplementary	NNP	O	Supplementary	nn	5	SENT_433	[p22l1625t277r2134b377, p22l11t421r169b505],
5	Appendix	NNP	O	Appendix	prep_of	1	SENT_433	[p22l180t405r606b505],
6	,	,	O	,	_	0	SENT_433	[p22l180t405r606b505],
7	lanes	NNS	O	lane	appos	5	SENT_433	[p22l630t404r843b483],
8	3	CD	NUMBER	3	num	7	SENT_433	[p22l866t410r910b483],
9	and	CC	O	and	_	0	SENT_433	[p22l933t405r1087b483],
10	4	CD	NUMBER	4	appos	5	SENT_433	[p22l1105t410r1211b500],
11	)	NN	O	)	dep	7	SENT_433	[p22l1105t410r1211b500],
12	,	,	O	,	_	0	SENT_433	[p22l1105t410r1211b500],
13	but	CC	O	but	prep	5	SENT_433	[p22l1238t405r1377b484],
14	the	DT	O	the	det	15	SENT_433	[p22l1393t404r1520b483],
15	cells	NNS	O	cell	dep	13	SENT_433	[p22l1541t405r1720b483],
16	remained	VBD	O	remain	cop	19	SENT_433	[p22l1742t404r2136b483],
17	viable	JJ	O	viable	amod	19	SENT_433	[p22l6t533r252b612],
18	(	CD	NUMBER	(	tmod	17	SENT_433	[p22l288t533r472b633],
19	Fig	NN	O	fig	_	0	SENT_433	[p22l288t533r472b633],
20	.	.	O	.	_	0	SENT_433	[p22l288t533r472b633],

1	3B	NN	O	3b	_	0	SENT_434	[p22l510t538r676b624],
2	)	NN	O	)	dep	1	SENT_434	[p22l510t538r676b624],
3	.	.	O	.	_	0	SENT_434	[p22l510t538r676b624],

1	Furthermore	RB	O	furthermore	advmod	8	SENT_435	[p22l712t533r1274b628],
2	,	,	O	,	_	0	SENT_435	[p22l712t533r1274b628],
3	overexpression	NN	O	overexpression	nsubj	11	SENT_435	[p22l1313t533r1947b633],
4	of	IN	O	of	_	0	SENT_435	[p22l1979t532r2080b611],
5	a	DT	O	a	det	7	SENT_435	[p22l2092t559r2136b611],
6	membrane	NN	O	membrane	nn	7	SENT_435	[p22l10t661r841b761],
7	—	NN	O	—	prep_of	3	SENT_435	[p22l10t661r841b761],
8	targeted	VBN	O	target	_	0	SENT_435	[p22l10t661r841b761],
9	and	CC	O	and	_	0	SENT_435	[p22l863t660r1016b739],
10	persistently	RB	O	persistently	advmod	11	SENT_435	[p22l1038t661r1520b761],
11	activated	VBN	O	activate	conj_and	8	SENT_435	[p22l1537t660r1900b740],
12	allele	NN	O	allele	dobj	11	SENT_435	[p22l1922t660r2135b739],
13	of	IN	O	of	_	0	SENT_435	[p22l11t788r112b867],
14	Akt47	NN	O	akt47	nn	16	SENT_435	[p22l131t789r361b868],
15	(	CD	NUMBER	(	num	16	SENT_435	[p22l399t789r583b889],
16	Fig	NN	O	fig	prep_of	12	SENT_435	[p22l399t789r583b889],
17	.	.	O	.	_	0	SENT_435	[p22l399t789r583b889],

1	5	CD	NUMBER	5	nsubj	25	SENT_436	[p22l633t796r675b867],
2	of	IN	O	of	_	0	SENT_436	[p22l722t788r822b867],
3	the	DT	O	the	det	5	SENT_436	[p22l847t789r975b867],
4	Supplementary	NNP	O	Supplementary	nn	5	SENT_436	[p22l1020t789r1663b889],
5	Appendix	NNP	O	Appendix	prep_of	1	SENT_436	[p22l1697t788r2129b889],
6	,	,	O	,	_	0	SENT_436	[p22l1697t788r2129b889],
7	lanes	NNS	O	lane	appos	5	SENT_436	[p22l9t917r225b995],
8	5	CD	NUMBER	5	num	7	SENT_436	[p22l258t924r300b995],
9	and	CC	O	and	_	0	SENT_436	[p22l332t917r488b995],
10	6	CD	NUMBER	6	appos	5	SENT_436	[p22l517t922r593b1008],
11	)	NN	O	)	nsubj	14	SENT_436	[p22l517t922r593b1008],
12	did	VBD	O	do	aux	14	SENT_436	[p22l628t916r761b995],
13	not	RB	O	not	neg	14	SENT_436	[p22l789t933r933b995],
14	prevent	VB	O	prevent	rcmod	7	SENT_436	[p22l954t933r1273b1017],
15	A431	NN	O	a431	nn	16	SENT_436	[p22l1292t922r1514b995],
16	cells	NNS	O	cell	dobj	14	SENT_436	[p22l1544t916r1726b995],
17	from	IN	O	from	_	0	SENT_436	[p22l1757t916r1965b995],
18	undergoing	VBG	O	undergo	prepc_from	14	SENT_436	[p22l1993t942r2134b996, p22l11t1045r396b1145],
19	apoptosis	NN	O	apoptosis	dobj	18	SENT_436	[p22l428t1045r836b1145],
20	mediated	VBN	O	mediate	partmod	19	SENT_436	[p22l874t1045r1265b1123],
21	by	IN	O	by	_	0	SENT_436	[p22l1301t1045r1398b1145],
22	EGFR	NN	ORGANIZATION	egfr	nn	24	SENT_436	[p22l1429t1050r1688b1128],
23	kinase	NN	O	kinase	nn	24	SENT_436	[p22l1713t1044r1984b1124],
24	inhibitors	NNS	O	inhibitor	agent	20	SENT_436	[p22l2020t1045r2134b1122, p22l10t1173r338b1251],
25	(	VBP	O	(	_	0	SENT_436	[p22l368t1173r552b1273],
26	Fig	NN	O	fig	dobj	25	SENT_436	[p22l368t1173r552b1273],
27	.	.	O	.	_	0	SENT_436	[p22l368t1173r552b1273],

1	3C	NN	O	3c	_	0	SENT_437	[p22l581t1178r751b1264],
2	)	NN	O	)	dep	1	SENT_437	[p22l581t1178r751b1264],
3	.	.	O	.	_	0	SENT_437	[p22l581t1178r751b1264],

1	These	DT	O	these	det	2	SENT_438	[p22l776t1173r1027b1251],
2	ﬁndings	NNS	O	ﬁndings	nsubj	3	SENT_438	[p22l1051t1172r1401b1273],
3	suggest	VBP	O	suggest	_	0	SENT_438	[p22l1428t1189r1753b1273],
4	that	IN	O	that	complm	12	SENT_438	[p22l1772t1173r1939b1251],
5	Aktindependent	JJ	O	aktindependent	amod	6	SENT_438	[p22l1953t1173r2134b1252, p22l10t1301r547b1401],
6	branches	NNS	O	branch	nsubj	12	SENT_438	[p22l581t1300r962b1379],
7	of	IN	O	of	_	0	SENT_438	[p22l1004t1300r1104b1379],
8	the	DT	O	the	det	10	SENT_438	[p22l1126t1301r1254b1379],
9	PTEN	NN	ORGANIZATION	pten	nn	10	SENT_438	[p22l1292t1306r1537b1379],
10	pathway	NN	O	pathway	prep_of	6	SENT_438	[p22l1572t1301r1929b1401],
11	may	MD	O	may	aux	12	SENT_438	[p22l1963t1327r2139b1401],
12	contribute	VB	O	contribute	ccomp	3	SENT_438	[p22l11t1428r446b1508],
13	to	TO	O	to	_	0	SENT_438	[p22l475t1445r553b1507],
14	the	DT	O	the	det	15	SENT_438	[p22l584t1429r713b1507],
15	effects	NNS	O	effect	prep_to	12	SENT_438	[p22l743t1428r1013b1507],
16	of	IN	O	of	_	0	SENT_438	[p22l1044t1428r1144b1507],
17	PTEN	NN	ORGANIZATION	pten	prep_of	15	SENT_438	[p22l1153t1434r1398b1507],
18	on	IN	O	on	_	0	SENT_438	[p22l1425t1454r1532b1507],
19	the	DT	O	the	det	20	SENT_438	[p22l1561t1428r1690b1507],
20	sensitivity	NN	O	sensitivity	prep_on	12	SENT_438	[p22l1719t1429r2139b1529],
21	of	IN	O	of	_	0	SENT_438	[p22l11t1556r111b1635],
22	tumors	NNS	O	tumor	prep_of	20	SENT_438	[p22l115t1573r414b1636],
23	to	TO	O	to	_	0	SENT_438	[p22l438t1573r516b1635],
24	EGFRkinase	NN	O	egfrkinase	nn	25	SENT_438	[p22l538t1557r1075b1640],
25	inhibitors	NNS	O	inhibitor	prep_to	22	SENT_438	[p22l1096t1557r1530b1635],
26	.	.	O	.	_	0	SENT_438	[p22l1096t1557r1530b1635],

1	We	PRP	O	we	nsubj	3	SENT_439	[p22l1554t1564r1687b1635],
2	also	RB	O	also	advmod	3	SENT_439	[p22l1709t1556r1875b1635],
3	noted	VBD	O	note	_	0	SENT_439	[p22l1898t1556r2135b1635],
4	that	IN	O	that	complm	28	SENT_439	[p22l11t1685r178b1763],
5	the	DT	O	the	det	6	SENT_439	[p22l197t1685r326b1763],
6	levels	NNS	O	level	nsubj	28	SENT_439	[p22l348t1685r576b1764],
7	of	IN	O	of	_	0	SENT_439	[p22l603t1684r703b1763],
8	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_439	[p22l707t1690r966b1768],
9	and	CC	O	and	_	0	SENT_439	[p22l979t1684r1135b1763],
10	EGFRVIII	NN	O	egfrviius	nn	11	SENT_439	[p22l1157t1690r1548b1768],
11	phosphoryla	NN	O	phosphorylum	prep_of	6	SENT_439	[p22l1570t1684r2134b1785],
12	—	CD	NUMBER	—	num	13	SENT_439	[p22l1570t1684r2134b1785],
13	tion	NN	O	tion	dep	11	SENT_439	[p22l11t1813r173b1891],
14	were	VBD	O	be	aux	28	SENT_439	[p22l188t1839r387b1892],
15	consistently	RB	O	consistently	advmod	16	SENT_439	[p22l406t1813r902b1913],
16	higher	JJR	O	higher	advmod	28	SENT_439	[p22l916t1812r1189b1913],
17	in	IN	O	in	_	0	SENT_439	[p22l1205t1813r1285b1890],
18	PT	NN	O	pt	nn	19	SENT_439	[p22l1302t1818r1414b1890],
19	EN	NN	O	en	prep_in	16	SENT_439	[p22l1414t1820r1544b1892],
20	—	CD	NUMBER	—	num	22	SENT_439	[p22l1548t1812r1941b1891],
21	deﬁcient	JJ	O	deﬁcient	amod	22	SENT_439	[p22l1548t1812r1941b1891],
22	cells	NNS	O	cell	npadvmod	23	SENT_439	[p22l1956t1812r2134b1891],
23	than	IN	O	than	advmod	16	SENT_439	[p22l11t1941r199b2019],
24	in	IN	O	in	_	0	SENT_439	[p22l234t1941r315b2018],
25	their	PRP$	O	they	poss	26	SENT_439	[p22l350t1941r548b2019],
26	PTEN	NN	O	pten	prep_in	16	SENT_439	[p22l579t1941r1320b2041],
27	—	CD	NUMBER	—	tmod	16	SENT_439	[p22l579t1941r1320b2041],
28	expressing	VBG	O	express	ccomp	3	SENT_439	[p22l579t1941r1320b2041],
29	counterparts	NNS	O	counterpart	dobj	28	SENT_439	[p22l1353t1957r1912b2041],
30	,	,	O	,	_	0	SENT_439	[p22l1353t1957r1912b2041],
31	suggesting	VBG	O	suggest	dep	28	SENT_439	[p22l1954t1967r2134b2041, p22l10t2069r323b2169],
32	that	IN	O	that	complm	34	SENT_439	[p22l341t2069r508b2147],
33	PTEN	NN	ORGANIZATION	pten	nsubj	34	SENT_439	[p22l523t2074r768b2147],
34	affects	VBZ	O	affect	ccomp	31	SENT_439	[p22l787t2068r1059b2147],
35	the	DT	O	the	det	37	SENT_439	[p22l1083t2069r1212b2147],
36	receptor	NN	O	receptor	nn	37	SENT_439	[p22l1234t2085r1585b2169],
37	protein	NN	O	protein	dobj	34	SENT_439	[p22l1602t2069r1909b2169],
38	itself	PRP	O	itself	nsubj	39	SENT_439	[p22l1930t2068r2153b2147],
39	(	VBD	O	(	rcmod	37	SENT_439	[p22l15t2197r200b2297],
40	Fig	NN	O	fig	dobj	39	SENT_439	[p22l15t2197r200b2297],
41	.	.	O	.	_	0	SENT_439	[p22l15t2197r200b2297],

1	6	CD	NUMBER	6	_	0	SENT_440	[p22l233t2202r280b2275],
2	of	IN	O	of	_	0	SENT_440	[p22l310t2196r411b2275],
3	the	DT	O	the	det	6	SENT_440	[p22l421t2196r550b2275],
4	Supplementary	NNP	O	Supplementary	nn	6	SENT_440	[p22l581t2197r1228b2297],
5	Appendix	NNP	O	Appendix	nn	6	SENT_440	[p22l1247t2197r1717b2297],
6	)	NN	O	)	prep_of	1	SENT_440	[p22l1247t2197r1717b2297],
7	.	.	O	.	_	0	SENT_440	[p22l1247t2197r1717b2297],

1	Taken	VBN	O	take	partmod	6	SENT_441	[p22l1747t2196r2004b2276],
2	together	RB	O	together	advmod	1	SENT_441	[p22l2032t2213r2147b2275, p22l10t2325r298b2425],
3	,	,	O	,	_	0	SENT_441	[p22l2032t2213r2147b2275, p22l10t2325r298b2425],
4	these	DT	O	these	det	5	SENT_441	[p22l327t2325r546b2403],
5	results	NNS	O	result	nsubj	6	SENT_441	[p22l569t2324r848b2404],
6	suggest	VBP	O	suggest	_	0	SENT_441	[p22l874t2341r1202b2425],
7	the	DT	O	the	det	8	SENT_441	[p22l1220t2325r1350b2403],
8	existence	NN	O	existence	dobj	6	SENT_441	[p22l1373t2325r1760b2403],
9	of	IN	O	of	_	0	SENT_441	[p22l1783t2324r1884b2403],
10	multiple	JJ	O	multiple	amod	11	SENT_441	[p22l1888t2325r2147b2404, p22l9t2452r138b2553],
11	mechanisms	NNS	O	mechanism	prep_of	8	SENT_441	[p22l174t2453r722b2531],
12	by	IN	O	by	_	0	SENT_441	[p22l761t2453r859b2553],
13	which	WDT	O	which	rel	18	SENT_441	[p22l886t2452r1153b2532],
14	the	DT	O	the	det	15	SENT_441	[p22l1190t2453r1321b2531],
15	loss	NN	O	loss	nsubj	18	SENT_441	[p22l1356t2453r1524b2531],
16	of	IN	O	of	_	0	SENT_441	[p22l1563t2452r1665b2531],
17	PTEN	NN	ORGANIZATION	pten	prep_of	15	SENT_441	[p22l1681t2458r1931b2531],
18	promotes	VBZ	O	promote	rcmod	8	SENT_441	[p22l1964t2478r2145b2553, p22l10t2597r271b2659],
19	resistance	NN	O	resistance	dobj	18	SENT_441	[p22l326t2581r761b2659],
20	to	TO	O	to	_	0	SENT_441	[p22l815t2597r895b2659],
21	EGFR	NN	ORGANIZATION	egfr	nn	23	SENT_441	[p22l948t2586r1212b2664],
22	kinase	NN	O	kinase	nn	23	SENT_441	[p22l1253t2580r1531b2660],
23	inhibitors	NNS	O	inhibitor	prep_to	18	SENT_441	[p22l1584t2580r2009b2659],
24	in	IN	O	in	_	0	SENT_441	[p22l2064t2581r2147b2658],
25	glioblastoma	NN	O	glioblastoma	nn	26	SENT_441	[p22l10t2708r568b2809],
26	cells	NNS	O	cell	prep_in	23	SENT_441	[p22l593t2708r802b2787],
27	.	.	O	.	_	0	SENT_441	[p22l593t2708r802b2787],

1	DISCUSSION	NN	O	discussion	_	0	SENT_442	[p22l721t3025r1424b3085],

1	In	IN	O	in	_	0	SENT_443	[p22l9t3230r97b3300],
2	this	DT	O	this	det	3	SENT_443	[p22l134t3222r288b3301],
3	study	NN	O	study	prep_in	17	SENT_443	[p22l329t3223r555b3323],
4	of	IN	O	of	_	0	SENT_443	[p22l589t3222r690b3301],
5	glioblastomas	NNS	O	glioblastoma	prep_of	3	SENT_443	[p22l708t3223r1307b3323],
6	from	IN	O	from	_	0	SENT_443	[p22l1346t3222r1555b3301],
7	patients	NNS	O	patient	prep_from	5	SENT_443	[p22l1591t3223r1927b3323],
8	who	WP	O	who	nsubjpass	10	SENT_443	[p22l1962t3223r2147b3302],
9	were	VBD	O	be	auxpass	10	SENT_443	[p22l6t3377r209b3430],
10	treated	VBN	O	treat	rcmod	7	SENT_443	[p22l246t3351r537b3429],
11	with	IN	O	with	_	0	SENT_443	[p22l569t3351r759b3430],
12	gefitinib	NN	O	gefitinib	prep_with	10	SENT_443	[p22l796t3350r1153b3451],
13	or	CC	O	or	_	0	SENT_443	[p22l1192t3376r1282b3429],
14	erlotinib	NN	O	erlotinib	conj_or	12	SENT_443	[p22l1316t3351r1702b3446],
15	,	,	O	,	_	0	SENT_443	[p22l1316t3351r1702b3446],
16	We	PRP	O	we	nsubj	17	SENT_443	[p22l1740t3377r1859b3430],
17	found	VBD	O	find	_	0	SENT_443	[p22l1896t3350r2148b3430],
18	that	IN	O	that	complm	27	SENT_443	[p22l11t3478r179b3557],
19	responsiveness	NN	O	responsiveness	nn	21	SENT_443	[p22l198t3479r841b3579],
20	to	TO	O	to	dep	21	SENT_443	[p22l868t3495r947b3557],
21	EGFRl	NN	O	egfrl	nsubjpass	27	SENT_443	[p22l973t3479r1520b3562],
22	<	JJR	O	<	amod	24	SENT_443	[p22l973t3479r1520b3562],
23	inase	NN	O	inase	nn	24	SENT_443	[p22l973t3479r1520b3562],
24	inhibitors	NNS	O	inhibitor	dep	21	SENT_443	[p22l1544t3479r1961b3557],
25	was	VBD	O	be	auxpass	27	SENT_443	[p22l1984t3505r2145b3558],
26	strongly	RB	O	strongly	advmod	27	SENT_443	[p22l12t3607r357b3707],
27	associated	VBN	O	associate	ccomp	17	SENT_443	[p22l376t3606r811b3685],
28	with	IN	O	with	_	0	SENT_443	[p22l830t3607r1019b3686],
29	coexpression	NN	O	coexpression	prep_with	27	SENT_443	[p22l1043t3607r1594b3707],
30	by	IN	O	by	_	0	SENT_443	[p22l1618t3607r1716b3707],
31	the	DT	O	the	det	32	SENT_443	[p22l1735t3607r1864b3685],
32	tumor	NN	O	tumor	agent	27	SENT_443	[p22l1889t3623r2152b3686],
33	of	IN	O	of	_	0	SENT_443	[p23l11t20r112b99],
34	EGFRVIII	NN	O	egfrviius	prep_of	32	SENT_443	[p23l127t26r520b104],
35	and	CC	O	and	_	0	SENT_443	[p23l554t20r710b99],
36	PTEN	NN	ORGANIZATION	pten	conj_and	34	SENT_443	[p23l743t26r1008b100],
37	.	.	O	.	_	0	SENT_443	[p23l743t26r1008b100],

1	EGFRS	NNS	O	egfr	nsubj	10	SENT_444	[p23l1048t26r1339b104],
2	with	IN	O	with	_	0	SENT_444	[p23l1372t21r1562b100],
3	mutations	NNS	O	mutation	prep_with	1	SENT_444	[p23l1597t21r2030b100],
4	in	IN	O	in	_	0	SENT_444	[p23l2066t21r2148b98],
5	the	DT	O	the	det	8	SENT_444	[p23l11t148r140b227],
6	tyrosine	NN	O	tyrosine	nn	8	SENT_444	[p23l164t149r501b249],
7	kinase	NN	O	kinase	nn	8	SENT_444	[p23l524t149r796b228],
8	domain	NN	O	domain	prep_in	3	SENT_444	[p23l820t149r1146b227],
9	selectively	RB	O	selectively	advmod	10	SENT_444	[p23l1170t148r1598b249],
10	activate	VBP	O	activate	_	0	SENT_444	[p23l1615t149r1930b228],
11	antiapoptotic	JJ	O	antiapoptotic	amod	12	SENT_444	[p23l1953t149r2147b227, p23l10t277r411b377],
12	signals	NNS	O	signal	dobj	10	SENT_444	[p23l447t277r742b377],
13	through	IN	O	through	_	0	SENT_444	[p23l779t276r1123b377],
14	the	DT	O	the	det	15	SENT_444	[p23l1157t277r1287b355],
15	PI3K	NN	O	pi3k	prep_through	10	SENT_444	[p23l1321t276r1723b358],
16	.	.	O	.	_	0	SENT_444	[p23l1321t276r1723b358],

1	—	NN	O	—	_	0	SENT_445	[p23l1321t276r1723b358],
2	.	.	O	.	_	0	SENT_445	[p23l1321t276r1723b358],

1	Akt	NN	PERSON	akt	nn	3	SENT_446	[p23l1321t276r1723b358],
2	signaling	NN	O	signaling	nn	3	SENT_446	[p23l1754t277r2151b377],
3	pathway	NN	O	pathway	_	0	SENT_446	[p23l9t405r367b505],
4	(	CD	NUMBER	(	num	5	SENT_446	[p23l398t405r581b505],
5	Fig	NN	O	fig	dep	3	SENT_446	[p23l398t405r581b505],
6	.	.	O	.	_	0	SENT_446	[p23l398t405r581b505],

1	1	CD	NUMBER	1	number	2	SENT_447	[p23l621t409r811b496],
2	)	CD	NUMBER	)	nsubjpass	16	SENT_447	[p23l621t409r811b496],
3	.26	CD	NUMBER	.26	num	4	SENT_447	[p23l621t409r811b496],
4	Akt	NN	O	akt	dep	2	SENT_447	[p23l838t405r1011b500],
5	,	,	O	,	_	0	SENT_447	[p23l838t405r1011b500],
6	a	DT	O	a	det	7	SENT_447	[p23l1046t431r1090b483],
7	kinase	NN	O	kinase	appos	2	SENT_447	[p23l1119t405r1391b484],
8	involved	VBN	O	involve	partmod	7	SENT_447	[p23l1421t404r1774b484],
9	in	IN	O	in	_	0	SENT_447	[p23l1803t405r1885b482],
10	cellular	JJ	O	cellular	amod	11	SENT_447	[p23l1916t404r2146b484, p23l10t533r122b611],
11	proliferation	NN	O	proliferation	prep_in	8	SENT_447	[p23l147t532r685b633],
12	and	CC	O	and	_	0	SENT_447	[p23l714t532r871b611],
13	apoptosis	NN	O	apoptosis	conj_and	11	SENT_447	[p23l900t533r1335b633],
14	,	,	O	,	_	0	SENT_447	[p23l900t533r1335b633],
15	is	VBZ	O	be	auxpass	16	SENT_447	[p23l1370t533r1436b611],
16	activated	VBN	O	activate	_	0	SENT_447	[p23l1467t533r1839b612],
17	by	IN	O	by	_	0	SENT_447	[p23l1869t532r1966b633],
18	signals	NNS	O	signal	agent	16	SENT_447	[p23l1993t533r2147b633, p23l10t661r180b739],
19	generated	VBN	O	generate	partmod	18	SENT_447	[p23l211t660r629b761],
20	by	IN	O	by	_	0	SENT_447	[p23l659t661r756b761],
21	PI3K	NN	O	pi3k	agent	19	SENT_447	[p23l779t666r1007b742],
22	.	.	O	.	_	0	SENT_447	[p23l779t666r1007b742],

1	Inhibition	NN	O	inhibition	nsubj	10	SENT_448	[p23l1040t660r1469b739],
2	of	IN	O	of	_	0	SENT_448	[p23l1499t660r1600b739],
3	this	DT	O	this	det	7	SENT_448	[p23l1611t661r1764b739],
4	antiapo	JJ	O	antiapo	amod	7	SENT_448	[p23l1794t661r2147b761],
5	—	NN	O	—	nn	7	SENT_448	[p23l1794t661r2147b761],
6	ptotic	JJ	O	ptotic	amod	7	SENT_448	[p23l9t789r253b889],
7	signal	NN	O	signal	prep_of	1	SENT_448	[p23l293t789r546b889],
8	by	IN	O	by	_	0	SENT_448	[p23l586t789r684b889],
9	geﬁtinib	NN	O	geﬁtinib	prep_by	7	SENT_448	[p23l718t788r1075b889],
10	appears	VBZ	O	appear	ccomp	41	SENT_448	[p23l1115t815r1443b889],
11	to	TO	O	to	aux	13	SENT_448	[p23l1486t805r1565b867],
12	be	VB	O	be	cop	13	SENT_448	[p23l1606t789r1702b867],
13	critical	JJ	O	critical	xcomp	10	SENT_448	[p23l1743t789r2028b867],
14	to	TO	O	to	_	0	SENT_448	[p23l2067t805r2147b867],
15	the	DT	O	the	det	16	SENT_448	[p23l11t916r140b995],
16	efﬁcacy	NN	O	efﬁcacy	prep_to	13	SENT_448	[p23l164t916r484b1017],
17	of	IN	O	of	_	0	SENT_448	[p23l503t916r603b995],
18	the	DT	O	the	det	25	SENT_448	[p23l608t916r738b995],
19	drug	NN	O	drug	dep	25	SENT_448	[p23l760t917r1068b1017],
20	.26	CD	NUMBER	.26	num	19	SENT_448	[p23l760t917r1068b1017],
21	Like	IN	O	like	_	0	SENT_448	[p23l1090t917r1267b996],
22	the	DT	O	the	det	23	SENT_448	[p23l1290t917r1420b995],
23	EGFRkinase	NN	MISC	egfrkinase	prep_like	19	SENT_448	[p23l1441t917r1985b1000],
24	domain	NN	O	domain	nn	25	SENT_448	[p23l2008t917r2146b995, p23l10t1045r227b1123],
25	mutants	NNS	O	mutant	prep_of	16	SENT_448	[p23l249t1061r599b1124],
26	in	IN	O	in	_	0	SENT_448	[p23l623t1045r705b1122],
27	lung	NN	O	lung	nn	28	SENT_448	[p23l726t1044r921b1145],
28	cancer	NN	O	cancer	prep_in	13	SENT_448	[p23l942t1070r1234b1140],
29	,	,	O	,	_	0	SENT_448	[p23l942t1070r1234b1140],
30	EGFRVIII	NN	LOCATION	egfrviius	nsubj	41	SENT_448	[p23l1261t1050r1677b1140],
31	,	,	O	,	_	0	SENT_448	[p23l1261t1050r1677b1140],
32	a	DT	O	a	det	36	SENT_448	[p23l1705t1071r1749b1123],
33	constitutively	RB	O	constitutively	advmod	34	SENT_448	[p23l1771t1045r2147b1124, p23l11t1173r229b1273],
34	active	JJ	O	active	amod	36	SENT_448	[p23l253t1173r489b1252],
35	mutant	JJ	O	mutant	amod	36	SENT_448	[p23l519t1189r833b1252],
36	variant	NN	O	variant	appos	30	SENT_448	[p23l851t1173r1148b1252],
37	of	IN	O	of	_	0	SENT_448	[p23l1173t1172r1274b1251],
38	EGFR	NN	ORGANIZATION	egfr	prep_of	36	SENT_448	[p23l1283t1178r1556b1268],
39	,	,	O	,	_	0	SENT_448	[p23l1283t1178r1556b1268],
40	preferentially	RB	O	preferentially	advmod	41	SENT_448	[p23l1589t1172r2153b1273],
41	activates	VBZ	O	activate	_	0	SENT_448	[p23l10t1301r363b1380],
42	PI3K	NN	O	pi3k	dobj	41	SENT_448	[p23l384t1301r783b1382],
43	.	.	O	.	_	0	SENT_448	[p23l384t1301r783b1382],

1	—	NN	O	—	_	0	SENT_449	[p23l384t1301r783b1382],
2	.	.	O	.	_	0	SENT_449	[p23l384t1301r783b1382],

1	Akt	NN	O	akt	nsubj	2	SENT_450	[p23l384t1301r783b1382],
2	signaling	NN	O	signaling	_	0	SENT_450	[p23l800t1300r1193b1401],
3	and	CC	O	and	_	0	SENT_450	[p23l1209t1300r1365b1379],
4	can	MD	O	can	aux	5	SENT_450	[p23l1387t1326r1530b1379],
5	sensitize	VB	O	sensitize	conj_and	2	SENT_450	[p23l1553t1301r1923b1379],
6	glioblastoma	NN	O	glioblastoma	nn	7	SENT_450	[p23l1947t1301r2145b1401, p23l11t1429r411b1507],
7	cells	NNS	O	cell	nsubj	22	SENT_450	[p23l468t1428r655b1507],
8	to	TO	O	to	_	0	SENT_450	[p23l717t1445r798b1507],
9	EGFR	NN	ORGANIZATION	egfr	nn	11	SENT_450	[p23l856t1434r1120b1512],
10	kinase	NN	O	kinase	nn	11	SENT_450	[p23l1167t1429r1445b1508],
11	inhibitors	NNS	O	inhibitor	prep_to	7	SENT_450	[p23l1503t1429r2147b1507],
12	.25	CD	NUMBER	.25	dep	7	SENT_450	[p23l1503t1429r2147b1507],
13	'	''	O	'	_	0	SENT_450	[p23l1503t1429r2147b1507],
14	3	CD	NUMBER	3	number	15	SENT_450	[p23l1503t1429r2147b1507],
15	°	CD	NUMBER	°	num	16	SENT_450	[p23l1503t1429r2147b1507],
16	Loss	NN	O	loss	dep	7	SENT_450	[p23l9t1564r199b1635],
17	of	IN	O	of	_	0	SENT_450	[p23l229t1556r331b1635],
18	PTEN	NNP	ORGANIZATION	PTEN	prep_of	16	SENT_450	[p23l338t1562r585b1636],
19	,	,	O	,	_	0	SENT_450	[p23l589t1621r603b1652],
20	a	DT	O	a	det	22	SENT_450	[p23l636t1583r681b1635],
21	tumor-suppressor	JJ	O	tumor-suppressor	amod	22	SENT_450	[p23l707t1573r1482b1657],
22	protein	NN	O	protein	xcomp	5	SENT_450	[p23l1505t1557r1814b1657],
23	that	WDT	O	that	nsubj	24	SENT_450	[p23l1842t1557r2010b1635],
24	inhibits	VBZ	O	inhibit	rcmod	22	SENT_450	[p23l2031t1557r2147b1634, p23l10t1684r248b1763],
25	the	DT	O	the	det	28	SENT_450	[p23l293t1685r423b1763],
26	PI3K	NN	O	pi3k	nn	28	SENT_450	[p23l465t1690r673b1766],
27	signaling	NN	O	signaling	nn	28	SENT_450	[p23l715t1685r1111b1785],
28	pathway	NN	O	pathway	dobj	24	SENT_450	[p23l1150t1685r1519b1785],
29	,	,	O	,	_	0	SENT_450	[p23l1150t1685r1519b1785],
30	may	MD	O	may	aux	31	SENT_450	[p23l1567t1711r1745b1785],
31	promote	VB	O	promote	dep	5	SENT_450	[p23l1783t1701r2148b1785],
32	resistance	NN	O	resistance	dobj	31	SENT_450	[p23l10t1813r435b1891],
33	to	TO	O	to	_	0	SENT_450	[p23l469t1829r548b1891],
34	EGFR	NN	ORGANIZATION	egfr	nn	36	SENT_450	[p23l581t1818r842b1896],
35	kinase	NN	O	kinase	nn	36	SENT_450	[p23l864t1813r1137b1892],
36	inhibitors.-33	NN	O	inhibitors.-33	prep_to	31	SENT_450	[p23l1169t1812r1696b1891],
37	We	PRP	O	we	nsubj	38	SENT_450	[p23l1727t1820r1862b1891],
38	found	VBD	O	find	rcmod	36	SENT_450	[p23l1895t1812r2148b1892],
39	that	IN	O	that	complm	47	SENT_450	[p23l11t1940r179b2019],
40	the	DT	O	the	det	41	SENT_450	[p23l200t1941r330b2019],
41	lack	NN	O	lack	nsubjpass	47	SENT_450	[p23l355t1940r531b2020],
42	of	IN	O	of	_	0	SENT_450	[p23l553t1940r654b2019],
43	PTEN	NNP	ORGANIZATION	PTEN	prep_of	41	SENT_450	[p23l660t1946r907b2020],
44	in	IN	O	in	_	0	SENT_450	[p23l931t1941r1012b2018],
45	gliomas	NNS	O	glioma	prep_in	43	SENT_450	[p23l1038t1941r1376b2041],
46	is	VBZ	O	be	auxpass	47	SENT_450	[p23l1404t1941r1469b2019],
47	associated	VBN	O	associate	ccomp	38	SENT_450	[p23l1496t1940r1936b2019],
48	with	IN	O	with	_	0	SENT_450	[p23l1958t1941r2148b2020],
49	resistance	NN	O	resistance	prep_with	47	SENT_450	[p23l10t2069r435b2147],
50	to	TO	O	to	_	0	SENT_450	[p23l461t2085r541b2147],
51	EGFRl	NN	O	egfrl	prep_to	47	SENT_450	[p23l567t2069r1114b2152],
52	<	JJR	O	<	amod	54	SENT_450	[p23l567t2069r1114b2152],
53	inase	NN	O	inase	nn	54	SENT_450	[p23l567t2069r1114b2152],
54	inhibitors	NNS	O	inhibitor	dobj	5	SENT_450	[p23l1140t2069r1582b2147],
55	.	.	O	.	_	0	SENT_450	[p23l1140t2069r1582b2147],

1	Moreover	RB	O	moreover	advmod	13	SENT_451	[p23l1610t2076r2035b2164],
2	,	,	O	,	_	0	SENT_451	[p23l1610t2076r2035b2164],
3	in	IN	O	in	_	0	SENT_451	[p23l2066t2069r2148b2146],
4	four	CD	NUMBER	four	num	7	SENT_451	[p23l10t2197r189b2277],
5	isogenic	JJ	O	isogenic	amod	7	SENT_451	[p23l215t2198r571b2298],
6	cell	NN	O	cell	nn	7	SENT_451	[p23l600t2197r742b2276],
7	lines	NNS	O	line	prep_in	13	SENT_451	[p23l770t2197r994b2293],
8	,	,	O	,	_	0	SENT_451	[p23l770t2197r994b2293],
9	loss	NN	O	loss	nsubj	13	SENT_451	[p23l1029t2198r1193b2276],
10	of	IN	O	of	_	0	SENT_451	[p23l1225t2197r1326b2276],
11	PTEN	NN	ORGANIZATION	pten	prep_of	9	SENT_451	[p23l1336t2203r1582b2276],
12	markedly	RB	O	markedly	advmod	13	SENT_451	[p23l1610t2197r2009b2298],
13	diminished	VBD	O	diminish	_	0	SENT_451	[p23l2035t2198r2147b2276, p23l10t2325r411b2404],
14	responsiveness	NN	O	responsiveness	dobj	13	SENT_451	[p23l451t2326r1094b2426],
15	to	TO	O	to	_	0	SENT_451	[p23l1138t2342r1217b2404],
16	EGFR	NN	ORGANIZATION	egfr	nn	18	SENT_451	[p23l1258t2331r1519b2409],
17	kinase	NN	O	kinase	nn	18	SENT_451	[p23l1549t2326r1821b2405],
18	inhibitors	NNS	O	inhibitor	prep_to	13	SENT_451	[p23l1862t2325r2147b2404, p23l11t2470r197b2532],
19	.	.	O	.	_	0	SENT_451	[p23l1862t2325r2147b2404, p23l11t2470r197b2532],

1	Our	PRP$	O	we	poss	2	SENT_452	[p23l238t2459r403b2533],
2	evidence	NN	O	evidence	nsubj	3	SENT_452	[p23l437t2453r800b2533],
3	suggests	VBZ	O	suggest	_	0	SENT_452	[p23l838t2470r1203b2554],
4	that	IN	O	that	complm	20	SENT_452	[p23l1242t2454r1409b2532],
5	both	CC	O	both	preconj	6	SENT_452	[p23l1441t2454r1635b2532],
6	Al	NNP	O	Al	nsubj	20	SENT_452	[p23l1667t2454r2147b2554],
7	<	JJR	O	<	amod	8	SENT_452	[p23l1667t2454r2147b2554],
8	t	NN	O	t	dep	6	SENT_452	[p23l1667t2454r2147b2554],
9	—	CD	NUMBER	—	num	12	SENT_452	[p23l1667t2454r2147b2554],
10	depen	NN	O	depen	nn	12	SENT_452	[p23l1667t2454r2147b2554],
11	—	NN	O	—	nn	12	SENT_452	[p23l1667t2454r2147b2554],
12	dent	NN	O	dent	dep	6	SENT_452	[p23l11t2581r202b2660],
13	and	CC	O	and	_	0	SENT_452	[p23l242t2582r399b2660],
14	Al	NNP	PERSON	Al	conj_and	6	SENT_452	[p23l442t2581r1169b2682],
15	<	JJR	PERSON	<	amod	16	SENT_452	[p23l442t2581r1169b2682],
16	t	NN	O	t	dep	14	SENT_452	[p23l442t2581r1169b2682],
17	—	CD	NUMBER	—	num	19	SENT_452	[p23l442t2581r1169b2682],
18	independent	JJ	O	independent	amod	19	SENT_452	[p23l442t2581r1169b2682],
19	mechanisms	NNS	O	mechanism	dep	14	SENT_452	[p23l1210t2582r1749b2660],
20	underlie	VBP	O	underlie	ccomp	3	SENT_452	[p23l1797t2581r2147b2661],
21	the	DT	O	the	det	22	SENT_452	[p23l11t2709r141b2788],
22	resistance	NN	O	resistance	dobj	20	SENT_452	[p23l166t2710r591b2788],
23	caused	VBN	O	cause	partmod	22	SENT_452	[p23l617t2710r905b2789],
24	by	IN	O	by	_	0	SENT_452	[p23l931t2710r1028b2810],
25	a	DT	O	a	det	26	SENT_452	[p23l1048t2736r1093b2788],
26	loss	NN	O	loss	agent	23	SENT_452	[p23l1116t2710r1280b2788],
27	of	IN	O	of	_	0	SENT_452	[p23l1308t2709r1409b2788],
28	PTEN	NN	ORGANIZATION	pten	prep_of	26	SENT_452	[p23l1414t2715r1661b2788],
29	.	.	O	.	_	0	SENT_452	[p23l1665t2774r1679b2788],

1	These	DT	O	these	det	2	SENT_453	[p23l137t2837r389b2916],
2	results	NNS	O	result	nsubj	3	SENT_453	[p23l421t2838r699b2917],
3	suggest	VBP	O	suggest	_	0	SENT_453	[p23l735t2854r1063b2938],
4	that	IN	O	that	complm	13	SENT_453	[p23l1090t2838r1257b2916],
5	screening	NN	O	screening	nsubjpass	13	SENT_453	[p23l1286t2838r1699b2938],
6	of	IN	O	of	_	0	SENT_453	[p23l1728t2837r1830b2916],
7	tumors	NNS	O	tumor	prep_of	5	SENT_453	[p23l1843t2854r2145b2917],
8	for	IN	O	for	_	0	SENT_453	[p23l10t2965r133b3044],
9	PTEN	NN	ORGANIZATION	pten	nn	10	SENT_453	[p23l151t2971r396b3044],
10	protein	NN	O	protein	prep_for	7	SENT_453	[p23l416t2966r721b3066],
11	may	MD	O	may	aux	13	SENT_453	[p23l743t2992r920b3066],
12	be	VB	O	be	auxpass	13	SENT_453	[p23l939t2966r1034b3044],
13	warranted	VBN	O	warrant	ccomp	3	SENT_453	[p23l1052t2965r1482b3045],
14	in	IN	O	in	_	0	SENT_453	[p23l1504t2966r1586b3043],
15	patients	NNS	O	patient	prep_in	13	SENT_453	[p23l1606t2966r1939b3066],
16	with	IN	O	with	_	0	SENT_453	[p23l1960t2966r2148b3045],
17	cancers	NNS	O	cancer	prep_with	15	SENT_453	[p23l11t3119r327b3172],
18	with	IN	O	with	_	0	SENT_453	[p23l363t3093r553b3173],
19	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_453	[p23l590t3099r851b3177],
20	kinase	NN	O	kinase	nn	21	SENT_453	[p23l878t3094r1150b3173],
21	mutations	NNS	O	mutation	prep_with	13	SENT_453	[p23l1189t3094r1622b3173],
22	that	WDT	O	that	nsubj	25	SENT_453	[p23l1663t3094r1831b3172],
23	do	VBP	O	do	aux	25	SENT_453	[p23l1865t3094r1969b3172],
24	not	RB	O	not	neg	25	SENT_453	[p23l2009t3110r2153b3172],
25	respond	VB	O	respond	rcmod	21	SENT_453	[p23l10t3222r358b3322],
26	to	TO	O	to	_	0	SENT_453	[p23l386t3238r465b3300],
27	geﬁtinib	NN	O	geﬁtinib	prep_to	25	SENT_453	[p23l494t3221r876b3322],
28	,	,	O	,	_	0	SENT_453	[p23l494t3221r876b3322],
29	erlotinib	NN	O	erlotinib	prep_to	25	SENT_453	[p23l911t3221r1296b3317],
30	,	,	O	,	_	0	SENT_453	[p23l911t3221r1296b3317],
31	or	CC	O	or	_	0	SENT_453	[p23l1330t3247r1420b3300],
32	related	JJ	O	related	amod	35	SENT_453	[p23l1444t3221r1733b3300],
33	EGFR	NN	ORGANIZATION	egfr	nn	35	SENT_453	[p23l1758t3227r2019b3305],
34	kinase	NN	O	kinase	nn	35	SENT_453	[p23l2036t3222r2147b3301, p23l10t3375r200b3428],
35	inhibitors	NNS	O	inhibitor	prep_to	25	SENT_453	[p23l233t3349r675b3428],
36	.	.	O	.	_	0	SENT_453	[p23l233t3349r675b3428],

1	Our	PRP$	O	we	poss	2	SENT_454	[p23l713t3355r879b3429],
2	data	NNS	O	datum	nsubj	4	SENT_454	[p23l909t3349r1090b3428],
3	also	RB	O	also	advmod	4	SENT_454	[p23l1121t3350r1289b3428],
4	suggest	VBP	O	suggest	_	0	SENT_454	[p23l1325t3366r1652b3450],
5	that	IN	O	that	complm	26	SENT_454	[p23l1680t3350r1848b3428],
6	downstream	JJ	O	downstream	amod	7	SENT_454	[p23l1877t3350r2147b3429, p23l12t3494r299b3556],
7	inhibition	NN	O	inhibition	nsubj	26	SENT_454	[p23l330t3477r754b3556],
8	of	IN	O	of	_	0	SENT_454	[p23l786t3477r887b3556],
9	the	DT	O	the	det	11	SENT_454	[p23l900t3477r1030b3556],
10	PI3K	NN	O	pi3k	nn	11	SENT_454	[p23l1060t3483r1269b3559],
11	pathway	NN	O	pathway	prep_of	7	SENT_454	[p23l1295t3477r1665b3578],
12	,	,	O	,	_	0	SENT_454	[p23l1295t3477r1665b3578],
13	perhaps	RB	O	perhaps	advmod	11	SENT_454	[p23l1701t3477r2040b3578],
14	at	IN	O	at	_	0	SENT_454	[p23l2074t3494r2153b3556],
15	the	DT	O	the	det	16	SENT_454	[p23l11t3605r141b3684],
16	level	NN	O	level	prep_at	11	SENT_454	[p23l169t3606r358b3685],
17	of	IN	O	of	_	0	SENT_454	[p23l389t3605r489b3684],
18	the	DT	O	the	det	20	SENT_454	[p23l502t3606r631b3684],
19	mammalian	JJ	O	mammalian	amod	20	SENT_454	[p23l661t3605r1176b3684],
20	target	NN	O	target	prep_of	16	SENT_454	[p23l1206t3622r1457b3706],
21	of	IN	O	of	_	0	SENT_454	[p23l1483t3605r1583b3684],
22	rapamycin	NN	O	rapamycin	prep_of	20	SENT_454	[p23l1595t3606r2040b3706],
23	(	CD	NUMBER	(	num	22	SENT_454	[p23l2075t3613r2149b3697],
24	a	DT	O	a	det	25	SENT_454	[p23l2075t3613r2149b3697],
25	kinase	NN	O	kinase	dep	11	SENT_454	[p24l10t21r282b100],
26	related	JJ	O	related	ccomp	4	SENT_454	[p24l307t20r594b99],
27	to	TO	O	to	_	0	SENT_454	[p24l619t37r698b99],
28	PI3K	NN	O	pi3k	prep_to	26	SENT_454	[p24l722t26r957b112],
29	)	CD	NUMBER	)	num	28	SENT_454	[p24l722t26r957b112],
30	(	CD	NUMBER	(	num	31	SENT_454	[p24l991t21r1176b121],
31	Fig	NN	O	fig	dep	28	SENT_454	[p24l991t21r1176b121],
32	.	.	O	.	_	0	SENT_454	[p24l991t21r1176b121],

1	1	CD	NUMBER	1	num	2	SENT_455	[p24l1209t26r1312b116],
2	)	NN	O	)	dep	6	SENT_455	[p24l1209t26r1312b116],
3	,	,	O	,	_	0	SENT_455	[p24l1209t26r1312b116],
4	could	MD	O	could	aux	6	SENT_455	[p24l1343t21r1577b100],
5	be	VB	O	be	auxpass	6	SENT_455	[p24l1601t21r1697b99],
6	combined	VBN	O	combine	_	0	SENT_455	[p24l1722t21r2148b99],
7	with	IN	O	with	_	0	SENT_455	[p24l6t148r194b228],
8	EGFRl	NN	O	egfrl	prep_with	6	SENT_455	[p24l215t149r754b232],
9	<	JJR	O	<	amod	11	SENT_455	[p24l215t149r754b232],
10	inase	NN	O	inase	nn	11	SENT_455	[p24l215t149r754b232],
11	inhibitors	NNS	O	inhibitor	nsubjpass	6	SENT_455	[p24l774t148r1186b227],
12	in	IN	O	in	_	0	SENT_455	[p24l1209t149r1290b226],
13	patients	NNS	O	patient	prep_in	11	SENT_455	[p24l1310t149r1643b249],
14	with	IN	O	with	_	0	SENT_455	[p24l1662t148r1851b228],
15	PTEN	NN	O	pten	prep_with	13	SENT_455	[p24l1871t154r2147b227],
16	—	CD	NUMBER	—	num	15	SENT_455	[p24l1871t154r2147b227],
17	deﬁcient	JJ	O	deﬁcient	amod	18	SENT_455	[p24l11t276r391b355],
18	tumors	NNS	O	tumor	dep	11	SENT_455	[p24l442t293r751b356],
19	to	TO	O	to	aux	20	SENT_455	[p24l809t293r890b355],
20	promote	VB	O	promote	infmod	18	SENT_455	[p24l947t293r1318b377],
21	responsiveness	NN	O	responsiveness	dobj	20	SENT_455	[p24l1374t277r2145b377],
22	.48	CD	NUMBER	.48	num	21	SENT_455	[p24l1374t277r2145b377],
23	These	DT	O	these	det	24	SENT_455	[p24l7t405r263b483],
24	studies	NNS	O	study	nsubj	26	SENT_455	[p24l304t404r600b484],
25	also	RB	O	also	advmod	26	SENT_455	[p24l639t404r807b483],
26	raise	VBP	O	raise	rcmod	21	SENT_455	[p24l847t405r1045b483],
27	the	DT	O	the	det	28	SENT_455	[p24l1083t405r1213b483],
28	possibility	NN	O	possibility	dobj	26	SENT_455	[p24l1250t404r1692b505],
29	that	IN	O	that	complm	35	SENT_455	[p24l1726t405r1894b483],
30	more	JJR	O	more	amod	33	SENT_455	[p24l1926t430r2148b483],
31	complete	JJ	O	complete	amod	33	SENT_455	[p24l11t533r401b633],
32	inhibition	NN	O	inhibition	nn	33	SENT_455	[p24l424t532r847b611],
33	ofEGFRphosphorylation	NN	O	ofegfrphosphorylation	nsubj	35	SENT_455	[p24l870t532r1952b633],
34	may	MD	O	may	aux	35	SENT_455	[p24l1975t559r2152b633],
35	overcome	VB	O	overcome	ccomp	26	SENT_455	[p24l11t686r417b740],
36	the	DT	O	the	det	37	SENT_455	[p24l439t660r568b739],
37	resistance	NN	O	resistance	dobj	35	SENT_455	[p24l591t661r1011b739],
38	to	TO	O	to	_	0	SENT_455	[p24l1034t677r1112b739],
39	kinase	NN	O	kinase	nn	40	SENT_455	[p24l1135t661r1405b740],
40	inhibitors	NNS	O	inhibitor	prep_to	35	SENT_455	[p24l1426t661r1838b739],
41	caused	VBN	O	cause	partmod	40	SENT_455	[p24l1863t660r2148b740],
42	by	IN	O	by	_	0	SENT_455	[p24l11t789r109b889],
43	a	DT	O	a	det	44	SENT_455	[p24l128t815r173b867],
44	deﬁciency	NN	O	deﬁciency	agent	41	SENT_455	[p24l198t788r625b889],
45	of	IN	O	of	_	0	SENT_455	[p24l646t788r747b867],
46	PT	NN	O	pt	nn	47	SENT_455	[p24l752t794r866b866],
47	EN	NN	O	en	prep_of	44	SENT_455	[p24l867t796r999b868],
48	.	.	O	.	_	0	SENT_455	[p24l1003t853r1018b867],

1	In	IN	O	in	_	0	SENT_456	[p24l138t924r227b994],
2	summary	NN	O	summary	prep_in	6	SENT_456	[p24l262t943r673b1017],
3	,	,	O	,	_	0	SENT_456	[p24l262t943r673b1017],
4	we	PRP	O	we	nsubj	6	SENT_456	[p24l708t943r827b996],
5	have	VBP	O	have	aux	6	SENT_456	[p24l861t916r1050b996],
6	implicated	VBN	O	implicate	_	0	SENT_456	[p24l1083t916r1534b1017],
7	EGFRVIII	NN	O	egfrviius	dobj	6	SENT_456	[p24l1565t922r1959b1000],
8	and	CC	O	and	_	0	SENT_456	[p24l1991t916r2148b995],
9	PTEN	NN	ORGANIZATION	pten	dobj	6	SENT_456	[p24l9t1050r255b1123],
10	as	IN	O	as	_	0	SENT_456	[p24l284t1071r368b1123],
11	molecular	JJ	O	molecular	amod	12	SENT_456	[p24l401t1044r829b1124],
12	determinants	NNS	O	determinant	prep_as	6	SENT_456	[p24l858t1044r1421b1123],
13	of	IN	O	of	_	0	SENT_456	[p24l1454t1044r1555b1123],
14	the	DT	O	the	det	15	SENT_456	[p24l1567t1045r1698b1123],
15	sensitivity	NN	O	sensitivity	prep_of	12	SENT_456	[p24l1730t1045r2152b1145],
16	of	IN	O	of	_	0	SENT_456	[p24l11t1172r113b1251],
17	glioblastomas	NNS	O	glioblastoma	prep_of	15	SENT_456	[p24l126t1172r737b1273],
18	to	TO	O	to	_	0	SENT_456	[p24l772t1189r852b1251],
19	EGFR	NN	ORGANIZATION	egfr	nn	21	SENT_456	[p24l883t1178r1147b1256],
20	kinase	NN	O	kinase	nn	21	SENT_456	[p24l1169t1173r1446b1252],
21	inhibitors	NNS	O	inhibitor	prep_to	6	SENT_456	[p24l1478t1173r1930b1251],
22	.	.	O	.	_	0	SENT_456	[p24l1478t1173r1930b1251],

1	Prozozz	NNP	O	Prozozz	_	0	SENT_457	[p24l1966t1179r2145b1251, p24l149t1348r226b1369],

1	N	NN	O	n	nn	3	SENT_458	[p24l868t1350r881b1365],
2	ENGL	NN	ORGANIZATION	engl	nn	3	SENT_458	[p24l897t1349r963b1365],
3	MED	NN	O	med	_	0	SENT_458	[p24l996t1350r1048b1365],
4	353	CD	NUMBER	353	num	6	SENT_458	[p24l1061t1349r1139b1371],
5	;	:	O	;	_	0	SENT_458	[p24l1061t1349r1139b1371],
6	19	CD	NUMBER	19	dep	3	SENT_458	[p24l1061t1349r1139b1371],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_458	[p24l1174t1349r1385b1371],
8	NOVEMBERIO	NNP	LOCATION	NOVEMBERIO	dep	3	SENT_458	[p24l1424t1349r1614b1369],
9	,	,	O	,	_	0	SENT_458	[p24l1424t1349r1614b1369],
10	2005	CD	DATE	2005	appos	8	SENT_458	[p24l1628t1349r1691b1371],

1	e	LS	O	e	dep	4	SENT_459	[p24l973t1390r987b1406],
2	New	NNP	O	New	nn	4	SENT_459	[p24l996t1383r1058b1406],
3	England	NNP	O	England	nn	4	SENT_459	[p24l1067t1382r1178b1413],
4	Journal	NNP	O	Journal	_	0	SENT_459	[p24l1187t1382r1284b1406],
5	of	IN	O	of	prep	4	SENT_459	[p24l1294t1382r1323b1406],
6	Medicine	NNP	O	Medicine	dep	4	SENT_459	[p24l1330t1382r1455b1406],

1	Downloaded	VBN	O	download	_	0	SENT_460	[p24l378t1423r548b1446],
2	from	IN	O	from	_	0	SENT_460	[p24l557t1423r621b1446],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_460	[p24l630t1423r748b1453],
4	at	IN	O	at	_	0	SENT_460	[p24l759t1427r782b1446],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_460	[p24l790t1423r973b1446],
6	on	IN	O	on	_	0	SENT_460	[p24l982t1430r1015b1446],
7	Janu	NNP	DATE	Janu	prep_on	1	SENT_460	[p24l1023t1423r1084b1446],
8	5	CD	DATE	5	num	7	SENT_460	[p24l1136t1423r1159b1450],
9	,	,	DATE	,	_	0	SENT_460	[p24l1136t1423r1159b1450],
10	2014	CD	DATE	2014	num	7	SENT_460	[p24l1170t1423r1242b1446],
11	.	.	O	.	_	0	SENT_460	[p24l1170t1423r1242b1446],

1	For	IN	O	for	_	0	SENT_461	[p24l1252t1423r1299b1446],
2	personal	JJ	O	personal	amod	3	SENT_461	[p24l1307t1423r1419b1453],
3	use	NN	O	use	pobj	1	SENT_461	[p24l1428t1430r1472b1446],
4	only	RB	O	only	advmod	3	SENT_461	[p24l1482t1423r1546b1453],
5	.	.	O	.	_	0	SENT_461	[p24l1482t1423r1546b1453],

1	No	DT	O	no	det	3	SENT_462	[p24l1557t1423r1597b1446],
2	other	JJ	O	other	amod	3	SENT_462	[p24l1607t1423r1675b1446],
3	uses	NNS	O	use	_	0	SENT_462	[p24l1683t1430r1739b1446],
4	without	IN	O	without	_	0	SENT_462	[p24l1749t1423r1850b1446],
5	permission	NN	O	permission	prep_without	3	SENT_462	[p24l1859t1423r2011b1453],
6	.	.	O	.	_	0	SENT_462	[p24l1859t1423r2011b1453],

1	Copyright	NN	O	copyright	nsubj	6	SENT_463	[p24l728t1464r863b1495],
2	©	CD	NUMBER	©	num	1	SENT_463	[p24l872t1464r896b1488],
3	2005	CD	DATE	2005	num	5	SENT_463	[p24l906t1464r970b1488],
4	Massa	NNP	PERSON	Massa	nn	5	SENT_463	[p24l980t1465r1065b1488],
5	u	NN	O	u	dep	1	SENT_463	[p24l1097t1472r1113b1488],
6	etts	VBZ	O	ett	_	0	SENT_463	[p24l1127t1468r1171b1488],
7	Medical	NNP	ORGANIZATION	Medical	nn	8	SENT_463	[p24l1181t1464r1289b1488],
8	Society	NNP	ORGANIZATION	Society	dobj	6	SENT_463	[p24l1300t1464r1405b1495],
9	.	.	O	.	_	0	SENT_463	[p24l1300t1464r1405b1495],

1	All	DT	O	all	det	2	SENT_464	[p24l1416t1464r1457b1488],
2	rights	NNS	O	rights	nsubj	3	SENT_464	[p24l1466t1464r1541b1495],
3	reserved	VBN	O	reserve	_	0	SENT_464	[p24l1551t1464r1670b1488],
4	.	.	O	.	_	0	SENT_464	[p24l1551t1464r1670b1488],

1	EGFR	NN	ORGANIZATION	egfr	_	0	SENT_465	[p24l672t1570r759b1589],
2	KINASE	NN	O	kinase	nn	3	SENT_465	[p24l771t1570r895b1589],
3	INHIBITORS	NNS	O	inhibitor	dep	1	SENT_465	[p24l910t1570r1118b1589],
4	FOR	IN	O	for	_	0	SENT_465	[p24l1133t1570r1198b1589],
5	GLIOBLASTOMAS	NNS	O	glioblastoma	prep_for	3	SENT_465	[p24l1210t1570r1488b1588],

1	spective	JJ	O	spective	amod	2	SENT_466	[p24l12t1785r353b1885],
2	validation	NN	O	validation	nsubjpass	23	SENT_466	[p24l380t1785r811b1864],
3	of	IN	O	of	_	0	SENT_466	[p24l843t1784r945b1863],
4	EGFRVIII	NN	O	egfrviius	nn	7	SENT_466	[p24l956t1790r1358b1868],
5	and	CC	O	and	_	0	SENT_466	[p24l1387t1784r1547b1863],
6	PT	NN	O	pt	nn	7	SENT_466	[p24l1576t1790r1691b1862],
7	EN	NN	O	en	prep_of	2	SENT_466	[p24l1692t1792r1826b1864],
8	as	IN	O	as	_	0	SENT_466	[p24l1855t1811r1940b1863],
9	predictors	NNS	O	predictor	prep_as	7	SENT_466	[p24l1972t1811r2145b1885, p24l11t1913r300b1992],
10	of	IN	O	of	_	0	SENT_466	[p24l332t1913r433b1992],
11	the	DT	O	the	det	13	SENT_466	[p24l443t1914r573b1992],
12	clinical	JJ	O	clinical	amod	13	SENT_466	[p24l603t1914r906b1992],
13	response	NN	O	response	prep_of	9	SENT_466	[p24l934t1939r1315b2014],
14	to	TO	O	to	_	0	SENT_466	[p24l1344t1930r1424b1992],
15	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_466	[p24l1453t1919r1713b1997],
16	kinase	NN	O	kinase	nn	17	SENT_466	[p24l1731t1914r2004b1993],
17	inhibitors	NNS	O	inhibitor	prep_to	13	SENT_466	[p24l2032t1914r2147b1991, p24l11t2049r341b2128],
18	in	IN	O	in	_	0	SENT_466	[p24l367t2050r449b2127],
19	independent	JJ	O	independent	amod	21	SENT_466	[p24l473t2050r1014b2150],
20	data	NNS	O	datum	nn	21	SENT_466	[p24l1034t2050r1215b2128],
21	sets	NNS	O	set	prep_in	17	SENT_466	[p24l1240t2066r1396b2128],
22	is	VBZ	O	be	auxpass	23	SENT_466	[p24l1423t2050r1488b2128],
23	warranted	VBN	O	warrant	_	0	SENT_466	[p24l1511t2050r1969b2129],
24	.	.	O	.	_	0	SENT_466	[p24l1511t2050r1969b2129],

1	Supported	VBN	O	support	dep	186	SENT_467	[p24l98t2180r428b2256],
2	by	IN	O	by	dep	186	SENT_467	[p24l447t2180r520b2256],
3	grants	NNS	O	grant	dep	186	SENT_467	[p24l535t2193r735b2257],
4	from	IN	O	from	dep	186	SENT_467	[p24l756t2180r912b2240],
5	the	DT	O	the	dep	186	SENT_467	[p24l931t2180r1029b2240],
6	National	NNP	ORGANIZATION	National	dep	186	SENT_467	[p24l1047t2180r1323b2240],
7	Institute	NNP	ORGANIZATION	Institute	dep	186	SENT_467	[p24l1341t2181r1607b2240],
8	for	IN	ORGANIZATION	for	dep	186	SENT_467	[p24l1626t2180r1719b2240],
9	Neurological	JJ	ORGANIZATION	neurological	dep	186	SENT_467	[p24l1735t2180r2150b2257],
10	Disorders	NNS	ORGANIZATION	disorder	dep	186	SENT_467	[p24l9t2277r320b2337],
11	and	CC	O	and	dep	186	SENT_467	[p24l339t2277r457b2337],
12	Stroke	NNP	O	Stroke	dep	186	SENT_467	[p24l477t2278r679b2337],
13	(	CD	NUMBER	(	dep	186	SENT_467	[p24l701t2283r778b2346],
14	N	NN	O	n	dep	186	SENT_467	[p24l701t2283r778b2346],
15	S050151	NN	O	s050151	dep	186	SENT_467	[p24l782t2282r1056b2337],
16	and	CC	O	and	dep	186	SENT_467	[p24l1074t2277r1192b2337],
17	NS43147	NN	O	ns43147	dep	186	SENT_467	[p24l1209t2282r1521b2350],
18	,	,	O	,	_	0	SENT_467	[p24l1209t2282r1521b2350],
19	to	TO	O	to	dep	186	SENT_467	[p24l1544t2290r1604b2337],
20	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1622t2282r1716b2337],
21	Mischel	NNP	PERSON	Mischel	dep	186	SENT_467	[p24l1736t2278r2009b2346],
22	)	NN	O	)	dep	186	SENT_467	[p24l1736t2278r2009b2346],
23	and	CC	O	and	dep	186	SENT_467	[p24l2031t2278r2149b2337],
24	the	DT	O	the	dep	186	SENT_467	[p24l10t2375r107b2434],
25	National	NNP	ORGANIZATION	National	dep	186	SENT_467	[p24l124t2374r401b2434],
26	Cancer	NNP	ORGANIZATION	Cancer	dep	186	SENT_467	[p24l418t2379r642b2434],
27	Institute	NNP	ORGANIZATION	Institute	dep	186	SENT_467	[p24l656t2375r922b2434],
28	(	NN	O	(	dep	186	SENT_467	[p24l943t2379r1278b2447],
29	CA95616	NN	O	ca95616	dep	186	SENT_467	[p24l943t2379r1278b2447],
30	,	,	O	,	_	0	SENT_467	[p24l943t2379r1278b2447],
31	to	TO	O	to	dep	186	SENT_467	[p24l1300t2387r1360b2434],
32	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1377t2379r1470b2434],
33	Cavenee	NNP	PERSON	Cavenee	dep	186	SENT_467	[p24l1492t2379r1772b2447],
34	;	:	O	;	_	0	SENT_467	[p24l1492t2379r1772b2447],
35	CA108633	NN	O	ca108633	dep	186	SENT_467	[p24l1793t2379r2144b2447],
36	,	,	O	,	_	0	SENT_467	[p24l1793t2379r2144b2447],
37	to	TO	O	to	dep	186	SENT_467	[p24l10t2484r70b2531],
38	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l106t2476r201b2531],
39	Mischel	NNP	PERSON	Mischel	dep	186	SENT_467	[p24l239t2471r510b2544],
40	;	:	O	;	_	0	SENT_467	[p24l239t2471r510b2544],
41	CA62399	NN	O	ca62399	dep	186	SENT_467	[p24l549t2476r861b2544],
42	,	,	O	,	_	0	SENT_467	[p24l549t2476r861b2544],
43	to	TO	O	to	dep	186	SENT_467	[p24l902t2484r962b2531],
44	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l998t2476r1092b2531],
45	Prados	NNP	PERSON	Prados	dep	186	SENT_467	[p24l1131t2471r1368b2544],
46	;	:	O	;	_	0	SENT_467	[p24l1131t2471r1368b2544],
47	and	CC	O	and	dep	186	SENT_467	[p24l1407t2471r1525b2531],
48	CA105695	NN	O	ca105695	dep	186	SENT_467	[p24l1561t2476r1913b2544],
49	,	,	O	,	_	0	SENT_467	[p24l1561t2476r1913b2544],
50	to	TO	O	to	dep	186	SENT_467	[p24l1954t2484r2014b2531],
51	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l2050t2476r2144b2531],
52	Cloughesy	NNP	O	Cloughesy	dep	186	SENT_467	[p24l10t2568r388b2645],
53	)	NN	O	)	dep	186	SENT_467	[p24l10t2568r388b2645],
54	;	:	O	;	_	0	SENT_467	[p24l10t2568r388b2645],
55	Accelerate	VB	O	accelerate	dep	186	SENT_467	[p24l404t2569r732b2628],
56	Brain	NN	O	brain	dep	186	SENT_467	[p24l747t2569r921b2628],
57	Cancer	NN	O	cancer	dep	186	SENT_467	[p24l939t2573r1167b2628],
58	Cure	NN	O	cure	dep	186	SENT_467	[p24l1182t2573r1334b2628],
59	Awards	NNS	O	award	dep	186	SENT_467	[p24l1349t2569r1592b2628],
60	(	CD	NUMBER	(	dep	186	SENT_467	[p24l1615t2574r1699b2637],
61	to	TO	O	to	dep	186	SENT_467	[p24l1615t2574r1699b2637],
62	Drs.	NNP	O	Drs.	dep	186	SENT_467	[p24l1717t2573r1850b2628],
63	Mischel	NNP	PERSON	Mischel	dep	186	SENT_467	[p24l1870t2568r2144b2641],
64	,	,	O	,	_	0	SENT_467	[p24l1870t2568r2144b2641],
65	Mellinghoff	NNP	PERSON	Mellinghoff	dep	186	SENT_467	[p24l7t2665r415b2742],
66	,	,	O	,	_	0	SENT_467	[p24l7t2665r415b2742],
67	and	CC	O	and	dep	186	SENT_467	[p24l441t2665r560b2725],
68	Sawyers	NNP	PERSON	Sawyers	dep	186	SENT_467	[p24l585t2670r889b2742],
69	)	CD	NUMBER	)	dep	186	SENT_467	[p24l585t2670r889b2742],
70	;	:	O	;	_	0	SENT_467	[p24l585t2670r889b2742],
71	the	DT	O	the	dep	186	SENT_467	[p24l914t2666r1012b2725],
72	Goldhirsh	NNP	ORGANIZATION	Goldhirsh	dep	186	SENT_467	[p24l1034t2665r1360b2725],
73	Foundation	NNP	ORGANIZATION	Foundation	dep	186	SENT_467	[p24l1379t2665r1749b2725],
74	(	CD	NUMBER	(	dep	186	SENT_467	[p24l1774t2671r1856b2734],
75	to	TO	O	to	dep	186	SENT_467	[p24l1774t2671r1856b2734],
76	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1877t2670r1970b2725],
77	Sawyers	NNP	PERSON	Sawyers	dep	186	SENT_467	[p24l1997t2670r2147b2725, p24l6t2768r179b2839],
78	)	NN	O	)	dep	186	SENT_467	[p24l1997t2670r2147b2725, p24l6t2768r179b2839],
79	;	:	O	;	_	0	SENT_467	[p24l1997t2670r2147b2725, p24l6t2768r179b2839],
80	a	DT	O	a	dep	186	SENT_467	[p24l202t2783r236b2822],
81	Fellow	NNP	O	Fellow	dep	186	SENT_467	[p24l254t2762r467b2822],
82	Award	NN	O	award	dep	186	SENT_467	[p24l482t2762r690b2823],
83	from	IN	O	from	dep	186	SENT_467	[p24l711t2762r867b2822],
84	the	DT	O	the	dep	186	SENT_467	[p24l888t2763r985b2822],
85	National	NNP	ORGANIZATION	National	dep	186	SENT_467	[p24l1004t2762r1281b2822],
86	Foundation	NNP	ORGANIZATION	Foundation	dep	186	SENT_467	[p24l1300t2762r1670b2822],
87	for	IN	ORGANIZATION	for	dep	186	SENT_467	[p24l1691t2762r1783b2822],
88	Cancer	NNP	ORGANIZATION	Cancer	dep	186	SENT_467	[p24l1801t2767r2025b2822],
89	Research	NNP	ORGANIZATION	Research	dep	186	SENT_467	[p24l2042t2767r2149b2826, p24l11t2860r215b2919],
90	(	CD	NUMBER	(	dep	186	SENT_467	[p24l277t2864r359b2928],
91	to	TO	O	to	dep	186	SENT_467	[p24l277t2864r359b2928],
92	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l417t2864r511b2919],
93	Cavenee	NNP	PERSON	Cavenee	dep	186	SENT_467	[p24l574t2864r880b2932],
94	)	NN	O	)	dep	186	SENT_467	[p24l574t2864r880b2932],
95	;	:	O	;	_	0	SENT_467	[p24l574t2864r880b2932],
96	a	DT	O	a	dep	186	SENT_467	[p24l940t2880r974b2919],
97	UCSF	NNP	ORGANIZATION	UCSF	dep	186	SENT_467	[p24l1030t2864r1209b2919],
98	brain	NN	O	brain	dep	186	SENT_467	[p24l1269t2859r1435b2919],
99	tumor	NN	O	tumor	dep	186	SENT_467	[p24l1493t2872r1691b2919],
100	spore	NN	O	spore	dep	186	SENT_467	[p24l1749t2879r1923b2936],
101	grant	NN	O	grant	dep	186	SENT_467	[p24l1981t2872r2153b2936],
102	(	CD	NUMBER	(	dep	186	SENT_467	[p24l14t2961r415b3029],
103	CA097257	NN	O	ca097257	dep	186	SENT_467	[p24l14t2961r415b3029],
104	)	NN	O	)	dep	186	SENT_467	[p24l14t2961r415b3029],
105	;	:	O	;	_	0	SENT_467	[p24l14t2961r415b3029],
106	a	DT	O	a	dep	186	SENT_467	[p24l434t2977r467b3016],
107	Young	JJ	O	young	dep	186	SENT_467	[p24l480t2962r684b3033],
108	Investigator	NN	O	investigator	dep	186	SENT_467	[p24l697t2957r1078b3033],
109	Award	NN	O	award	dep	186	SENT_467	[p24l1090t2956r1299b3016],
110	from	IN	O	from	dep	186	SENT_467	[p24l1315t2956r1472b3016],
111	the	DT	O	the	dep	186	SENT_467	[p24l1488t2957r1586b3016],
112	American	NNP	ORGANIZATION	American	dep	186	SENT_467	[p24l1600t2957r1910b3016],
113	Society	NNP	ORGANIZATION	Society	dep	186	SENT_467	[p24l1928t2957r2153b3033],
114	of	IN	ORGANIZATION	of	dep	186	SENT_467	[p24l10t3053r87b3113],
115	Clinical	JJ	ORGANIZATION	clinical	dep	186	SENT_467	[p24l93t3053r336b3113],
116	Oncology	NN	ORGANIZATION	oncology	dep	186	SENT_467	[p24l355t3053r665b3130],
117	(	CD	NUMBER	(	dep	186	SENT_467	[p24l686t3058r768b3122],
118	to	TO	O	to	dep	186	SENT_467	[p24l686t3058r768b3122],
119	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l789t3058r882b3113],
120	Mellinghoff	NNP	PERSON	Mellinghoff	dep	186	SENT_467	[p24l905t3053r1343b3130],
121	)	NN	O	)	dep	186	SENT_467	[p24l905t3053r1343b3130],
122	;	:	O	;	_	0	SENT_467	[p24l905t3053r1343b3130],
123	a	DT	O	a	dep	186	SENT_467	[p24l1365t3074r1399b3113],
124	Translational	JJ	ORGANIZATION	translational	dep	186	SENT_467	[p24l1416t3054r1839b3113],
125	Research	NN	ORGANIZATION	research	dep	186	SENT_467	[p24l1858t3054r2149b3117],
126	Grant	NNP	ORGANIZATION	Grant	dep	186	SENT_467	[p24l10t3155r198b3210],
127	from	IN	O	from	dep	186	SENT_467	[p24l219t3150r375b3210],
128	American	NNP	ORGANIZATION	American	dep	186	SENT_467	[p24l397t3151r707b3210],
129	Brain	NNP	ORGANIZATION	Brain	dep	186	SENT_467	[p24l730t3151r903b3210],
130	Tumor	NN	ORGANIZATION	tumor	dep	186	SENT_467	[p24l924t3155r1143b3210],
131	Association	NNP	ORGANIZATION	Association	dep	186	SENT_467	[p24l1163t3151r1537b3210],
132	(	CD	NUMBER	(	dep	186	SENT_467	[p24l1565t3156r1648b3219],
133	to	TO	O	to	dep	186	SENT_467	[p24l1565t3156r1648b3219],
134	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1671t3155r1766b3210],
135	Wang	NNP	PERSON	Wang	dep	186	SENT_467	[p24l1792t3156r2023b3227],
136	)	NN	O	)	dep	186	SENT_467	[p24l1792t3156r2023b3227],
137	;	:	O	;	_	0	SENT_467	[p24l1792t3156r2023b3227],
138	the	DT	O	the	dep	186	SENT_467	[p24l2050t3151r2148b3210],
139	Medical	NNP	MISC	Medical	dep	186	SENT_467	[p24l7t3247r260b3307],
140	Scientist	NNP	MISC	Scientist	dep	186	SENT_467	[p24l298t3248r570b3307],
141	Training	NNP	MISC	Training	dep	186	SENT_467	[p24l600t3248r877b3324],
142	Program	NNP	MISC	Program	dep	186	SENT_467	[p24l909t3252r1187b3324],
143	at	IN	O	at	dep	186	SENT_467	[p24l1223t3260r1283b3307],
144	UCLA	NNP	ORGANIZATION	UCLA	dep	186	SENT_467	[p24l1315t3252r1506b3307],
145	(	CD	NUMBER	(	dep	186	SENT_467	[p24l1544t3252r1626b3316],
146	to	TO	O	to	dep	186	SENT_467	[p24l1544t3252r1626b3316],
147	Ms.	NNP	O	Ms.	dep	186	SENT_467	[p24l1661t3253r1776b3307],
148	Huang	NNP	PERSON	Huang	dep	186	SENT_467	[p24l1816t3253r2078b3324],
149	)	NN	O	)	dep	186	SENT_467	[p24l1816t3253r2078b3324],
150	;	:	O	;	_	0	SENT_467	[p24l1816t3253r2078b3324],
151	a	DT	O	a	dep	186	SENT_467	[p24l2117t3268r2150b3307],
152	UCLA	NNP	ORGANIZATION	UCLA	dep	186	SENT_467	[p24l9t3349r200b3404],
153	Tumor	NN	ORGANIZATION	tumor	dep	186	SENT_467	[p24l223t3349r443b3404],
154	Cell	NN	ORGANIZATION	cell	dep	186	SENT_467	[p24l468t3344r591b3404],
155	Biology	NNP	ORGANIZATION	Biology	dep	186	SENT_467	[p24l617t3345r862b3421],
156	Training	NNP	ORGANIZATION	Training	dep	186	SENT_467	[p24l883t3345r1160b3421],
157	Grant	NNP	ORGANIZATION	Grant	dep	186	SENT_467	[p24l1186t3349r1374b3404],
158	funded	VBN	O	fund	dep	186	SENT_467	[p24l1397t3344r1622b3404],
159	by	IN	O	by	dep	186	SENT_467	[p24l1650t3344r1724b3421],
160	the	DT	O	the	dep	186	SENT_467	[p24l1748t3344r1846b3404],
161	National	NNP	ORGANIZATION	National	dep	186	SENT_467	[p24l1872t3344r2149b3404],
162	Cancer	NNP	ORGANIZATION	Cancer	dep	186	SENT_467	[p24l10t3446r233b3501],
163	Institute	NNP	ORGANIZATION	Institute	dep	186	SENT_467	[p24l259t3442r524b3501],
164	(	NN	O	(	dep	186	SENT_467	[p24l556t3446r1056b3514],
165	5T32CA09056	NN	O	5t32ca09056	dep	186	SENT_467	[p24l556t3446r1056b3514],
166	,	,	O	,	_	0	SENT_467	[p24l556t3446r1056b3514],
167	to	TO	O	to	dep	186	SENT_467	[p24l1089t3454r1148b3501],
168	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1177t3446r1270b3501],
169	Lu	NNP	PERSON	Lu	dep	186	SENT_467	[p24l1302t3447r1426b3514],
170	)	NN	O	)	dep	186	SENT_467	[p24l1302t3447r1426b3514],
171	;	:	O	;	_	0	SENT_467	[p24l1302t3447r1426b3514],
172	a	DT	O	a	dep	186	SENT_467	[p24l1457t3462r1490b3501],
173	Ruth	NNP	PERSON	Ruth	dep	186	SENT_467	[p24l1517t3441r1672b3505],
174	L.	NNP	PERSON	L.	dep	186	SENT_467	[p24l1699t3447r1754b3501],
175	Kirschstein	NNP	PERSON	Kirschstein	dep	186	SENT_467	[p24l1786t3441r2149b3502],
176	National	NNP	ORGANIZATION	National	dep	186	SENT_467	[p24l8t3538r285b3598],
177	Research	NNP	ORGANIZATION	Research	dep	186	SENT_467	[p24l302t3538r592b3602],
178	Service	NNP	ORGANIZATION	Service	dep	186	SENT_467	[p24l612t3539r830b3598],
179	Award	NN	O	award	dep	186	SENT_467	[p24l846t3538r1054b3598],
180	(	CD	NUMBER	(	dep	186	SENT_467	[p24l1075t3543r1635b3611],
181	5F31GM067600	NN	O	5f31gm067600	dep	186	SENT_467	[p24l1075t3543r1635b3611],
182	,	,	O	,	_	0	SENT_467	[p24l1075t3543r1635b3611],
183	to	TO	O	to	dep	186	SENT_467	[p24l1658t3551r1718b3598],
184	Dr.	NNP	O	Dr.	dep	186	SENT_467	[p24l1736t3543r1829b3598],
185	Vivanco	NNP	PERSON	Vivanco	dep	186	SENT_467	[p24l1849t3539r2145b3611],
186	)	NN	O	)	_	0	SENT_467	[p24l1849t3539r2145b3611],
187	;	:	O	;	_	0	SENT_467	[p24l1849t3539r2145b3611],

1	REFERENCES	NNS	O	reference	_	0	SENT_468	[p25l14t97r486b139],

1	1	LS	NUMBER	1	_	0	SENT_469	[p25l12t196r48b235],
2	.	.	O	.	_	0	SENT_469	[p25l12t196r48b235],

1	Pawson	NN	PERSON	pawson	nn	2	SENT_470	[p25l105t194r288b235],
2	T	NN	PERSON	t	_	0	SENT_470	[p25l300t194r342b244],
3	,	,	O	,	_	0	SENT_470	[p25l300t194r342b244],
4	Nash	NNP	PERSON	Nash	nn	6	SENT_470	[p25l359t191r483b235],
5	P.	NNP	PERSON	P.	nn	6	SENT_470	[p25l497t194r532b235],
6	Assembly	NNP	PERSON	Assembly	appos	2	SENT_470	[p25l548t191r780b247],
7	of	IN	O	of	_	0	SENT_470	[p25l792t190r849b235],
8	cell	NN	O	cell	nn	10	SENT_470	[p25l854t191r933b235],
9	regulatory	JJ	O	regulatory	amod	10	SENT_470	[p25l948t205r1041b247, p25l10t262r175b318],
10	systems	NNS	O	system	prep_of	6	SENT_470	[p25l189t271r373b318],
11	through	IN	O	through	_	0	SENT_470	[p25l391t262r582b318],
12	protein	NN	O	protein	nn	14	SENT_470	[p25l597t262r769b318],
13	interaction	NN	O	interaction	nn	14	SENT_470	[p25l785t262r1042b306],
14	domains	NNS	O	domain	prep_through	10	SENT_470	[p25l10t333r229b377],
15	.	.	O	.	_	0	SENT_470	[p25l10t333r229b377],

1	Science	NNP	O	Science	_	0	SENT_471	[p25l247t333r422b377],
2	2003	CD	DATE	2003	num	1	SENT_471	[p25l436t336r853b386],
3	;	:	O	;	_	0	SENT_471	[p25l436t336r853b386],
4	300:445	CD	NUMBER	300:445	number	5	SENT_471	[p25l436t336r853b386],
5	—	CD	NUMBER	—	dep	1	SENT_471	[p25l436t336r853b386],
6	52	CD	NUMBER	52	dep	5	SENT_471	[p25l436t336r853b386],
7	.	.	O	.	_	0	SENT_471	[p25l436t336r853b386],

1	2	LS	NUMBER	2	_	0	SENT_472	[p25l9t409r48b448],
2	.	.	O	.	_	0	SENT_472	[p25l9t409r48b448],

1	Manning	VBG	O	man	_	0	SENT_473	[p25l104t404r323b460],
2	BD	NN	O	bd	dobj	1	SENT_473	[p25l348t407r431b457],
3	,	,	O	,	_	0	SENT_473	[p25l348t407r431b457],
4	Cantley	NNP	PERSON	Cantley	nn	5	SENT_473	[p25l462t404r640b460],
5	LC	NNP	O	LC	appos	2	SENT_473	[p25l664t407r741b448],
6	.	.	O	.	_	0	SENT_473	[p25l664t407r741b448],

1	Hitting	VBG	O	hit	_	0	SENT_474	[p25l771t404r943b460],
2	the	DT	O	the	det	3	SENT_474	[p25l969t404r1041b448],
3	target	NN	O	target	dobj	1	SENT_474	[p25l10t484r161b531],
4	:	:	O	:	_	0	SENT_474	[p25l10t484r161b531],
5	emerging	VBG	O	emerge	amod	6	SENT_474	[p25l179t475r408b531],
6	technologies	NNS	O	technology	dep	1	SENT_474	[p25l422t475r723b531],
7	in	IN	O	in	_	0	SENT_474	[p25l740t475r785b518],
8	the	DT	O	the	det	9	SENT_474	[p25l801t475r874b519],
9	search	NN	O	search	prep_in	6	SENT_474	[p25l890t475r1042b519],
10	for	IN	O	for	_	0	SENT_474	[p25l10t545r79b590],
11	kinase	NN	O	kinase	nn	12	SENT_474	[p25l95t546r247b590],
12	substrates	NNS	O	substrate	prep_for	9	SENT_474	[p25l266t546r519b590],
13	.	.	O	.	_	0	SENT_474	[p25l266t546r519b590],

1	Sci	NNP	O	Sci	nn	2	SENT_475	[p25l541t546r608b590],
2	STKE	NNP	O	STKE	_	0	SENT_475	[p25l627t549r755b591],
3	2002	CD	DATE	2002	num	5	SENT_475	[p25l775t549r1039b599],
4	;	:	DATE	;	_	0	SENT_475	[p25l775t549r1039b599],
5	2002	CD	DATE	2002	dep	2	SENT_475	[p25l775t549r1039b599],
6	:	:	O	:	_	0	SENT_475	[p25l775t549r1039b599],
7	PE49	NN	O	pe49	dep	2	SENT_475	[p25l9t620r142b661],
8	.	.	O	.	_	0	SENT_475	[p25l9t620r142b661],

1	3	LS	NUMBER	3	_	0	SENT_476	[p25l10t693r48b732],
2	.	.	O	.	_	0	SENT_476	[p25l10t693r48b732],

1	Sawyers	NNP	O	Sawyers	_	0	SENT_477	[p25l107t691r294b744],
2	CL	NN	O	cl	dep	1	SENT_477	[p25l328t691r404b732],
3	.	.	O	.	_	0	SENT_477	[p25l328t691r404b732],

1	Opportunities	NNPS	O	Opportunities	_	0	SENT_478	[p25l441t688r771b744],
2	and	CC	O	and	_	0	SENT_478	[p25l805t688r893b732],
3	challenges	NNS	O	challenge	conj_and	1	SENT_478	[p25l926t688r1041b732, p25l9t759r160b815],
4	in	IN	O	in	_	0	SENT_478	[p25l177t759r223b802],
5	the	DT	O	the	det	6	SENT_478	[p25l240t759r313b803],
6	development	NN	O	development	prep_in	3	SENT_478	[p25l330t759r638b815],
7	of	IN	O	of	_	0	SENT_478	[p25l652t758r708b803],
8	kinase	NN	O	kinase	prep_of	6	SENT_478	[p25l715t759r866b803],
9	inhibitor	NN	O	inhibitor	nn	10	SENT_478	[p25l883t759r1041b803, p25l10t839r78b874],
10	therapy	NN	O	therapy	dep	1	SENT_478	[p25l95t830r272b886],
11	for	IN	O	for	_	0	SENT_478	[p25l289t829r358b874],
12	cancer	NN	O	cancer	prep_for	10	SENT_478	[p25l375t844r538b874],
13	.	.	O	.	_	0	SENT_478	[p25l375t844r538b874],

1	Genes	NNS	O	gene	_	0	SENT_479	[p25l560t833r707b874],
2	Dev	JJ	O	dev	amod	1	SENT_479	[p25l726t833r817b874],
3	2003	CD	DATE	2003	tmod	2	SENT_479	[p25l834t833r1039b883],
4	;	:	O	;	_	0	SENT_479	[p25l834t833r1039b883],
5	17	CD	NUMBER	17	num	7	SENT_479	[p25l834t833r1039b883],
6	:	:	O	:	_	0	SENT_479	[p25l834t833r1039b883],
7	2998-3010	CD	DURATION	2998-3010	dep	1	SENT_479	[p25l10t905r277b946],
8	.	.	O	.	_	0	SENT_479	[p25l10t905r277b946],

1	4	LS	NUMBER	4	_	0	SENT_480	[p25l9t977r48b1016],
2	.	.	O	.	_	0	SENT_480	[p25l9t977r48b1016],

1	van	NN	PERSON	van	nn	3	SENT_481	[p25l103t986r186b1016],
2	Oosterom	NNP	PERSON	Oosterom	nn	3	SENT_481	[p25l201t975r438b1016],
3	AT	NNP	O	AT	_	0	SENT_481	[p25l451t975r526b1025],
4	,	,	O	,	_	0	SENT_481	[p25l451t975r526b1025],
5	Judson	NNP	PERSON	Judson	nn	6	SENT_481	[p25l538t972r707b1023],
6	I	NNP	O	I	appos	3	SENT_481	[p25l721t976r751b1025],
7	,	,	O	,	_	0	SENT_481	[p25l721t976r751b1025],
8	Verweij	NNP	O	Verweij	nn	9	SENT_481	[p25l767t972r937b1028],
9	J	NNP	O	J	appos	3	SENT_481	[p25l949t976r982b1025],
10	,	,	O	,	_	0	SENT_481	[p25l949t976r982b1025],
11	et	FW	O	et	nn	12	SENT_481	[p25l1001t981r1044b1016],
12	al.	FW	O	al.	appos	3	SENT_481	[p25l9t1043r62b1087],
13	.	.	O	.	_	0	SENT_481	[p25l9t1043r62b1087],

1	Safety	NN	O	safety	_	0	SENT_482	[p25l87t1042r227b1099],
2	and	CC	O	and	_	0	SENT_482	[p25l244t1043r331b1087],
3	efﬁcacy	NN	O	efﬁcacy	conj_and	1	SENT_482	[p25l352t1042r531b1099],
4	of	IN	O	of	_	0	SENT_482	[p25l549t1042r605b1087],
5	imatinib	NN	O	imatinib	nn	8	SENT_482	[p25l615t1043r814b1087],
6	(	CD	NUMBER	(	num	8	SENT_482	[p25l838t1046r1039b1094],
7	STI571	NN	O	sti571	nn	8	SENT_482	[p25l838t1046r1039b1094],
8	)	NN	O	)	prep_of	1	SENT_482	[p25l838t1046r1039b1094],
9	in	IN	O	in	_	0	SENT_482	[p25l10t1114r55b1157],
10	metastatic	JJ	O	metastatic	amod	13	SENT_482	[p25l87t1114r332b1158],
11	gastrointestinal	JJ	O	gastrointestinal	amod	13	SENT_482	[p25l363t1114r732b1170],
12	stromal	JJ	O	stromal	amod	13	SENT_482	[p25l765t1114r945b1158],
13	tumours	NNS	O	tumour	prep_in	1	SENT_482	[p25l977t1123r1041b1158, p25l10t1199r176b1229],
14	:	:	O	:	_	0	SENT_482	[p25l977t1123r1041b1158, p25l10t1199r176b1229],
15	a	DT	O	a	det	16	SENT_482	[p25l205t1199r229b1229],
16	phase	NN	O	phase	dep	1	SENT_482	[p25l254t1185r392b1241],
17	I	PRP	O	I	nsubj	18	SENT_482	[p25l418t1189r435b1228],
18	study	VBP	O	study	rcmod	16	SENT_482	[p25l462t1185r594b1241],
19	.	.	O	.	_	0	SENT_482	[p25l462t1185r594b1241],

1	Lancet	NNP	O	Lancet	_	0	SENT_483	[p25l623t1189r780b1229],
2	2001	CD	DATE	2001	num	1	SENT_483	[p25l804t1188r1039b1238],
3	;	:	O	;	_	0	SENT_483	[p25l804t1188r1039b1238],
4	358	CD	NUMBER	358	num	6	SENT_483	[p25l804t1188r1039b1238],
5	:	:	O	:	_	0	SENT_483	[p25l804t1188r1039b1238],
6	1421-3	CD	NUMBER	1421-3	dep	1	SENT_483	[p25l12t1259r188b1300],
7	.	.	O	.	_	0	SENT_483	[p25l12t1259r188b1300],

1	5	CD	NUMBER	5	_	0	SENT_484	[p25l11t1332r48b1371],
2	.	.	O	.	_	0	SENT_484	[p25l11t1332r48b1371],

1	Demetri	NNP	PERSON	Demetri	nn	2	SENT_485	[p25l105t1327r298b1371],
2	GD	NN	O	gd	_	0	SENT_485	[p25l310t1330r401b1380],
3	,	,	O	,	_	0	SENT_485	[p25l310t1330r401b1380],
4	von	NNP	PERSON	von	nn	6	SENT_485	[p25l413t1341r500b1371],
5	Mehren	NNP	PERSON	Mehren	nn	6	SENT_485	[p25l510t1327r694b1371],
6	M	NN	O	m	appos	2	SENT_485	[p25l704t1331r765b1380],
7	,	,	O	,	_	0	SENT_485	[p25l704t1331r765b1380],
8	Blanke	NNP	PERSON	Blanke	nn	9	SENT_485	[p25l779t1327r941b1371],
9	CD	NNP	O	CD	appos	2	SENT_485	[p25l953t1330r1038b1380],
10	,	,	O	,	_	0	SENT_485	[p25l953t1330r1038b1380],
11	et	FW	O	et	nn	12	SENT_485	[p25l10t1407r53b1442],
12	al.	FW	O	al.	appos	2	SENT_485	[p25l62t1398r115b1442],
13	.	.	O	.	_	0	SENT_485	[p25l62t1398r115b1442],

1	Efﬁcacy	NN	O	efﬁcacy	_	0	SENT_486	[p25l128t1397r314b1454],
2	and	CC	O	and	_	0	SENT_486	[p25l323t1398r410b1442],
3	safety	NN	O	safety	conj_and	1	SENT_486	[p25l423t1397r558b1454],
4	of	IN	O	of	_	0	SENT_486	[p25l567t1397r624b1442],
5	imatinib	NN	O	imatinib	nn	6	SENT_486	[p25l625t1398r824b1442],
6	mesylate	NN	O	mesylate	prep_of	1	SENT_486	[p25l837t1398r1042b1454],
7	in	IN	O	in	_	0	SENT_486	[p25l9t1469r54b1512],
8	advanced	JJ	O	advanced	amod	11	SENT_486	[p25l66t1469r282b1513],
9	gastrointestinal	JJ	O	gastrointestinal	amod	11	SENT_486	[p25l294t1469r656b1525],
10	stromal	JJ	O	stromal	amod	11	SENT_486	[p25l669t1469r847b1513],
11	tumors	NNS	O	tumor	prep_in	1	SENT_486	[p25l859t1478r1039b1513],
12	.	.	O	.	_	0	SENT_486	[p25l859t1478r1039b1513],

1	N	NN	O	n	nn	2	SENT_487	[p25l9t1544r50b1584],
2	EnglJ	NN	O	englj	nsubj	3	SENT_487	[p25l63t1540r201b1596],
3	Med	VBD	O	med	_	0	SENT_487	[p25l212t1540r316b1584],
4	2002	CD	DATE	2002	dobj	3	SENT_487	[p25l330t1543r748b1593],
5	;	:	O	;	_	0	SENT_487	[p25l330t1543r748b1593],
6	347:472	CD	NUMBER	347:472	number	7	SENT_487	[p25l330t1543r748b1593],
7	—	CD	NUMBER	—	dep	4	SENT_487	[p25l330t1543r748b1593],
8	80	CD	NUMBER	80	dep	7	SENT_487	[p25l330t1543r748b1593],
9	.	.	O	.	_	0	SENT_487	[p25l330t1543r748b1593],

1	6	CD	NUMBER	6	_	0	SENT_488	[p25l10t1616r48b1655],
2	.	.	O	.	_	0	SENT_488	[p25l10t1616r48b1655],

1	Druker	NNP	PERSON	Druker	nn	2	SENT_489	[p25l105t1611r273b1655],
2	BJ	NNP	O	BJ	_	0	SENT_489	[p25l287t1614r349b1664],
3	,	,	O	,	_	0	SENT_489	[p25l287t1614r349b1664],
4	Sawyers	NNP	ORGANIZATION	Sawyers	nn	5	SENT_489	[p25l368t1614r554b1667],
5	CL	NN	ORGANIZATION	cl	appos	2	SENT_489	[p25l571t1614r647b1664],
6	,	,	O	,	_	0	SENT_489	[p25l571t1614r647b1664],
7	Kantarjian	JJ	O	kantarjian	amod	8	SENT_489	[p25l666t1611r913b1667],
8	H	NN	O	h	appos	2	SENT_489	[p25l928t1615r982b1664],
9	,	,	O	,	_	0	SENT_489	[p25l928t1615r982b1664],
10	et	FW	O	et	nn	11	SENT_489	[p25l1001t1620r1044b1655],
11	al.	FW	O	al.	appos	2	SENT_489	[p25l10t1682r62b1726],
12	.	.	O	.	_	0	SENT_489	[p25l10t1682r62b1726],

1	Activity	NN	O	activity	_	0	SENT_490	[p25l77t1682r253b1738],
2	of	IN	O	of	_	0	SENT_490	[p25l265t1681r321b1726],
3	a	DT	O	a	det	5	SENT_490	[p25l324t1696r349b1726],
4	speciﬁc	NN	O	speciﬁc	nn	5	SENT_490	[p25l362t1681r540b1738],
5	inhibitor	NN	O	inhibitor	prep_of	1	SENT_490	[p25l553t1682r763b1726],
6	of	IN	O	of	_	0	SENT_490	[p25l775t1681r832b1726],
7	the	DT	O	the	det	10	SENT_490	[p25l835t1682r907b1726],
8	BCRABL	NNP	O	BCRABL	nn	10	SENT_490	[p25l920t1685r1040b1729, p25l8t1756r108b1797],
9	tyrosine	NN	O	tyrosine	nn	10	SENT_490	[p25l135t1753r323b1809],
10	kinase	NN	O	kinase	prep_of	1	SENT_490	[p25l351t1753r502b1797],
11	in	IN	O	in	_	0	SENT_490	[p25l530t1753r575b1796],
12	the	DT	O	the	det	14	SENT_490	[p25l604t1753r676b1797],
13	blast	NN	O	blast	nn	14	SENT_490	[p25l705t1753r819b1797],
14	crisis	NN	O	crisis	prep_in	1	SENT_490	[p25l844t1753r966b1797],
15	of	IN	O	of	_	0	SENT_490	[p25l996t1752r1052b1797],
16	chronic	JJ	O	chronic	amod	18	SENT_490	[p25l10t1824r189b1868],
17	myeloid	JJ	O	myeloid	amod	18	SENT_490	[p25l216t1824r404b1880],
18	leukemia	NN	O	leukemia	prep_of	14	SENT_490	[p25l430t1824r647b1868],
19	and	CC	O	and	_	0	SENT_490	[p25l673t1824r760b1868],
20	acute	JJ	O	acute	amod	22	SENT_490	[p25l787t1833r910b1868],
21	lymphoblastic	JJ	O	lymphoblastic	amod	22	SENT_490	[p25l936t1824r1041b1880, p25l9t1895r257b1951],
22	leukemia	NN	O	leukemia	conj_and	14	SENT_490	[p25l281t1895r498b1939],
23	with	IN	O	with	_	0	SENT_490	[p25l519t1895r625b1939],
24	the	DT	O	the	det	26	SENT_490	[p25l650t1895r722b1939],
25	Philadelphia	NNP	LOCATION	Philadelphia	nn	26	SENT_490	[p25l746t1895r1043b1951],
26	chromosome	NN	O	chromosome	prep_with	22	SENT_490	[p25l10t1966r338b2010],
27	.	.	O	.	_	0	SENT_490	[p25l10t1966r338b2010],

1	N	NN	O	n	nn	2	SENT_491	[p25l352t1970r394b2010],
2	EnglJ	NN	O	englj	nsubj	3	SENT_491	[p25l404t1966r541b2022],
3	Med	VBD	O	med	_	0	SENT_491	[p25l550t1966r654b2010],
4	2001	CD	DATE	2001	dobj	3	SENT_491	[p25l666t1969r1041b2019],
5	;	:	O	;	_	0	SENT_491	[p25l666t1969r1041b2019],
6	344:1038	CD	NUMBER	344:1038	number	7	SENT_491	[p25l666t1969r1041b2019],
7	—	CD	NUMBER	—	dep	4	SENT_491	[p25l666t1969r1041b2019],
8	42	CD	NUMBER	42	dep	7	SENT_491	[p25l9t2040r80b2081],
9	.	.	O	.	_	0	SENT_491	[p25l9t2040r80b2081],

1	[	NN	O	[	nn	2	SENT_492	[p25l102t2040r325b2090],
2	Erratum	NN	O	erratum	_	0	SENT_492	[p25l102t2040r325b2090],
3	,	,	O	,	_	0	SENT_492	[p25l102t2040r325b2090],
4	N	NN	O	n	appos	2	SENT_492	[p25l341t2041r383b2081],
5	EnglJ	NNP	O	EnglJ	nn	6	SENT_492	[p25l395t2037r533b2093],
6	Med	NNP	O	Med	dep	2	SENT_492	[p25l544t2037r648b2081],
7	2001	CD	DATE	2001	rcmod	6	SENT_492	[p25l662t2040r1021b2090],
8	;	:	O	;	_	0	SENT_492	[p25l662t2040r1021b2090],
9	345:232	CD	NUMBER	345:232	dep	7	SENT_492	[p25l662t2040r1021b2090],
10	.	.	O	.	_	0	SENT_492	[p25l662t2040r1021b2090],
11	]	SYM	O	]	dep	7	SENT_492	[p25l662t2040r1021b2090],

1	7	CD	NUMBER	7	_	0	SENT_493	[p25l11t2113r48b2152],
2	.	.	O	.	_	0	SENT_493	[p25l11t2113r48b2152],

1	Druker	NNP	PERSON	Druker	nn	2	SENT_494	[p25l105t2108r274b2152],
2	BJ	NNP	O	BJ	_	0	SENT_494	[p25l287t2111r349b2161],
3	,	,	O	,	_	0	SENT_494	[p25l287t2111r349b2161],
4	Talpaz	NNP	O	Talpaz	nn	5	SENT_494	[p25l366t2108r521b2164],
5	M	NNP	O	M	appos	2	SENT_494	[p25l535t2112r596b2161],
6	,	,	O	,	_	0	SENT_494	[p25l535t2112r596b2161],
7	Resta	NNP	ORGANIZATION	Resta	nn	8	SENT_494	[p25l614t2111r745b2154],
8	DJ	NNP	ORGANIZATION	DJ	appos	2	SENT_494	[p25l759t2111r827b2161],
9	,	,	O	,	_	0	SENT_494	[p25l759t2111r827b2161],
10	et	FW	O	et	nn	11	SENT_494	[p25l847t2117r890b2152],
11	al.	FW	O	al.	appos	2	SENT_494	[p25l902t2108r955b2152],
12	.	.	O	.	_	0	SENT_494	[p25l902t2108r955b2152],

1	Efficacy	NN	O	efficacy	_	0	SENT_495	[p25l973t2107r1040b2151, p25l10t2178r144b2235],
2	and	CC	O	and	_	0	SENT_495	[p25l154t2179r242b2223],
3	safety	NN	O	safety	conj_and	1	SENT_495	[p25l255t2178r391b2235],
4	of	IN	O	of	_	0	SENT_495	[p25l401t2178r458b2223],
5	a	DT	O	a	det	7	SENT_495	[p25l460t2193r485b2223],
6	speciﬁc	NN	O	speciﬁc	nn	7	SENT_495	[p25l498t2178r676b2235],
7	inhibitor	NN	O	inhibitor	prep_of	1	SENT_495	[p25l688t2179r898b2223],
8	of	IN	O	of	_	0	SENT_495	[p25l910t2178r966b2223],
9	the	DT	O	the	det	10	SENT_495	[p25l969t2179r1042b2223],
10	BCR	NN	O	bcr	prep_of	1	SENT_495	[p25l9t2253r230b2297],
11	.	.	O	.	_	0	SENT_495	[p25l9t2253r230b2297],

1	—	NN	O	—	_	0	SENT_496	[p25l9t2253r230b2297],
2	.	.	O	.	_	0	SENT_496	[p25l9t2253r230b2297],

1	ABL	NN	ORGANIZATION	abl	nn	3	SENT_497	[p25l9t2253r230b2297],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_497	[p25l241t2250r429b2306],
3	kinase	NN	O	kinase	_	0	SENT_497	[p25l441t2250r593b2294],
4	in	IN	O	in	_	0	SENT_497	[p25l605t2250r650b2293],
5	chronic	JJ	O	chronic	amod	7	SENT_497	[p25l663t2250r842b2294],
6	myeloid	JJ	O	myeloid	amod	7	SENT_497	[p25l853t2250r1042b2306],
7	leukemia	NN	O	leukemia	prep_in	3	SENT_497	[p25l9t2321r239b2365],
8	.	.	O	.	_	0	SENT_497	[p25l9t2321r239b2365],

1	N	NN	O	n	nn	2	SENT_498	[p25l255t2325r297b2365],
2	EnglJ	NN	O	englj	nsubj	3	SENT_498	[p25l309t2321r447b2377],
3	Med	VBD	O	med	_	0	SENT_498	[p25l457t2321r562b2365],
4	2001	CD	DATE	2001	dobj	3	SENT_498	[p25l576t2324r994b2374],
5	;	:	O	;	_	0	SENT_498	[p25l576t2324r994b2374],
6	344:1031	CD	NUMBER	344:1031	num	7	SENT_498	[p25l576t2324r994b2374],
7	—	NN	O	—	dep	4	SENT_498	[p25l576t2324r994b2374],
8	7	CD	NUMBER	7	dep	7	SENT_498	[p25l576t2324r994b2374],
9	.	.	O	.	_	0	SENT_498	[p25l576t2324r994b2374],

1	8	CD	NUMBER	8	_	0	SENT_499	[p25l9t2396r48b2436],
2	.	.	O	.	_	0	SENT_499	[p25l9t2396r48b2436],

1	Dancey	NNP	O	Dancey	nn	2	SENT_500	[p25l105t2395r279b2448],
2	JE	NNP	O	JE	nsubj	14	SENT_500	[p25l287t2396r352b2445],
3	,	,	O	,	_	0	SENT_500	[p25l287t2396r352b2445],
4	Freidlin	NNP	O	Freidlin	nn	7	SENT_500	[p25l370t2392r554b2436],
5	B.	NNP	O	B.	nn	7	SENT_500	[p25l569t2395r615b2436],
6	Targeting	NN	O	targeting	nn	7	SENT_500	[p25l632t2392r861b2448],
7	epider	NN	O	epider	appos	2	SENT_500	[p25l875t2392r1040b2448],
8	—	CD	NUMBER	—	num	11	SENT_500	[p25l875t2392r1040b2448],
9	mal	JJ	O	mal	amod	11	SENT_500	[p25l10t2463r98b2507],
10	growth	NN	O	growth	nn	11	SENT_500	[p25l115t2463r285b2519],
11	factor	NN	O	factor	dep	7	SENT_500	[p25l303t2462r440b2507],
12	receptor	NN	O	receptor	nn	13	SENT_500	[p25l457t2472r653b2519],
13	—	NN	O	—	dep	7	SENT_500	[p25l667t2488r727b2492],
14	are	VBP	O	be	_	0	SENT_500	[p25l742t2477r813b2507],
15	we	PRP	O	we	nsubj	16	SENT_500	[p25l828t2477r894b2507],
16	missing	VBG	O	miss	dep	14	SENT_500	[p25l912t2463r1041b2507, p25l10t2535r87b2591],
17	the	DT	O	the	det	18	SENT_500	[p25l99t2535r172b2579],
18	mark	NN	O	mark	dobj	16	SENT_500	[p25l186t2533r330b2579],
19	?	.	O	?	_	0	SENT_500	[p25l186t2533r330b2579],

1	Lancet	NNP	O	Lancet	_	0	SENT_501	[p25l344t2539r501b2579],
2	2003	CD	DATE	2003	num	1	SENT_501	[p25l512t2538r871b2588],
3	;	:	O	;	_	0	SENT_501	[p25l512t2538r871b2588],
4	362:62	CD	NUMBER	362:62	number	5	SENT_501	[p25l512t2538r871b2588],
5	—	CD	NUMBER	—	dep	1	SENT_501	[p25l512t2538r871b2588],
6	4	CD	NUMBER	4	dep	5	SENT_501	[p25l512t2538r871b2588],
7	.	.	O	.	_	0	SENT_501	[p25l512t2538r871b2588],

1	9	CD	NUMBER	9	_	0	SENT_502	[p25l10t2612r48b2651],
2	.	.	O	.	_	0	SENT_502	[p25l10t2612r48b2651],

1	Kris	NNP	PERSON	Kris	nn	2	SENT_503	[p25l106t2607r200b2652],
2	MG	NN	PERSON	mg	_	0	SENT_503	[p25l212t2610r315b2660],
3	,	,	O	,	_	0	SENT_503	[p25l212t2610r315b2660],
4	Natale	NNP	PERSON	Natale	nn	5	SENT_503	[p25l329t2607r483b2651],
5	RB	NN	O	rb	appos	2	SENT_503	[p25l494t2610r576b2660],
6	,	,	O	,	_	0	SENT_503	[p25l494t2610r576b2660],
7	Herbst	NNP	ORGANIZATION	Herbst	nn	8	SENT_503	[p25l591t2607r754b2651],
8	RS	NN	ORGANIZATION	r	appos	2	SENT_503	[p25l762t2610r839b2660],
9	,	,	O	,	_	0	SENT_503	[p25l762t2610r839b2660],
10	et	FW	O	et	nn	11	SENT_503	[p25l855t2616r898b2651],
11	al.	FW	O	al.	appos	2	SENT_503	[p25l907t2607r959b2651],
12	.	.	O	.	_	0	SENT_503	[p25l907t2607r959b2651],

1	Efﬁcacy	NN	O	efﬁcacy	dep	16	SENT_504	[p25l973t2606r1041b2650, p25l10t2676r144b2733],
2	of	IN	O	of	_	0	SENT_504	[p25l155t2676r211b2721],
3	geﬁtinib	NN	O	geﬁtinib	prep_of	1	SENT_504	[p25l213t2676r425b2733],
4	,	,	O	,	_	0	SENT_504	[p25l213t2676r425b2733],
5	an	DT	O	a	det	6	SENT_504	[p25l441t2691r497b2721],
6	inhibitor	NN	O	inhibitor	appos	3	SENT_504	[p25l510t2677r720b2721],
7	of	IN	O	of	_	0	SENT_504	[p25l731t2676r787b2721],
8	the	DT	O	the	det	10	SENT_504	[p25l790t2677r862b2721],
9	epider	NN	O	epider	nn	10	SENT_504	[p25l875t2677r1041b2733],
10	—	NN	O	—	prep_of	6	SENT_504	[p25l875t2677r1041b2733],
11	mal	JJ	O	mal	amod	12	SENT_504	[p25l10t2748r98b2792],
12	growth	NN	O	growth	dep	16	SENT_504	[p25l115t2748r285b2804],
13	factor	NN	O	factor	nn	16	SENT_504	[p25l302t2747r440b2792],
14	receptor	NN	O	receptor	nn	16	SENT_504	[p25l456t2757r653b2804],
15	tyrosine	NN	O	tyrosine	nn	16	SENT_504	[p25l669t2748r856b2804],
16	kinase	NN	O	kinase	dep	31	SENT_504	[p25l874t2748r1038b2801],
17	,	,	O	,	_	0	SENT_504	[p25l874t2748r1038b2801],
18	in	IN	O	in	_	0	SENT_504	[p25l10t2819r55b2862],
19	symptomatic	JJ	O	symptomatic	amod	20	SENT_504	[p25l69t2819r375b2875],
20	patients	NNS	O	patient	prep_in	16	SENT_504	[p25l388t2819r575b2875],
21	with	IN	O	with	_	0	SENT_504	[p25l588t2819r693b2863],
22	non	JJ	O	non	amod	27	SENT_504	[p25l707t2819r949b2863],
23	—	JJ	O	—	amod	27	SENT_504	[p25l707t2819r949b2863],
24	small	JJ	O	small	amod	27	SENT_504	[p25l707t2819r949b2863],
25	cell	NN	O	cell	nn	27	SENT_504	[p25l963t2819r1042b2863],
26	lung	NN	O	lung	nn	27	SENT_504	[p25l9t2890r118b2946],
27	cancer	NN	O	cancer	prep_with	20	SENT_504	[p25l128t2904r295b2934],
28	:	:	O	:	_	0	SENT_504	[p25l128t2904r295b2934],
29	a	DT	O	a	det	31	SENT_504	[p25l308t2904r333b2934],
30	randomized	JJ	O	randomized	amod	31	SENT_504	[p25l344t2890r630b2934],
31	trial	NN	O	trial	_	0	SENT_504	[p25l642t2890r748b2934],
32	.	.	O	.	_	0	SENT_504	[p25l642t2890r748b2934],

1	JAMA	NNP	O	JAMA	_	0	SENT_505	[p25l757t2894r899b2941],
2	2003	CD	DATE	2003	num	1	SENT_505	[p25l910t2893r1039b2943],
3	;	:	O	;	_	0	SENT_505	[p25l910t2893r1039b2943],
4	290:2149	CD	NUMBER	290:2149	number	5	SENT_505	[p25l10t2964r322b3005],
5	—	CD	NUMBER	—	dep	1	SENT_505	[p25l10t2964r322b3005],
6	58	CD	NUMBER	58	dep	5	SENT_505	[p25l10t2964r322b3005],
7	.	.	O	.	_	0	SENT_505	[p25l10t2964r322b3005],

1	10	CD	NUMBER	10	_	0	SENT_506	[p25l12t3036r76b3076],
2	.	.	O	.	_	0	SENT_506	[p25l12t3036r76b3076],

1	Fukuoka	NNP	LOCATION	Fukuoka	nn	2	SENT_507	[p25l105t3032r312b3076],
2	M	NNP	O	M	_	0	SENT_507	[p25l329t3036r390b3085],
3	,	,	O	,	_	0	SENT_507	[p25l329t3036r390b3085],
4	Yano	NNP	PERSON	Yano	nn	5	SENT_507	[p25l411t3036r526b3076],
5	S	NNP	O	S	appos	2	SENT_507	[p25l548t3035r586b3085],
6	,	,	O	,	_	0	SENT_507	[p25l548t3035r586b3085],
7	Giaccone	NNP	PERSON	Giaccone	nn	8	SENT_507	[p25l609t3032r829b3076],
8	G	NNP	O	G	appos	2	SENT_507	[p25l849t3035r902b3085],
9	,	,	O	,	_	0	SENT_507	[p25l849t3035r902b3085],
10	et	FW	O	et	nn	11	SENT_507	[p25l926t3041r969b3076],
11	al.	FW	O	al.	appos	2	SENT_507	[p25l986t3032r1038b3076],
12	.	.	O	.	_	0	SENT_507	[p25l986t3032r1038b3076],

1	Multi	JJ	O	multi	amod	2	SENT_508	[p25l8t3103r440b3147],
2	—	NN	O	—	nsubj	12	SENT_508	[p25l8t3103r440b3147],
3	institutional	JJ	O	institutional	amod	5	SENT_508	[p25l8t3103r440b3147],
4	randomized	JJ	O	randomized	amod	5	SENT_508	[p25l454t3103r737b3147],
5	phase	NN	O	phase	dep	2	SENT_508	[p25l751t3103r888b3159],
6	II	CD	NUMBER	ii	num	7	SENT_508	[p25l901t3107r936b3146],
7	trial	NN	O	trial	dep	2	SENT_508	[p25l950t3103r1042b3147],
8	of	IN	O	of	_	0	SENT_508	[p25l10t3173r67b3218],
9	geﬁtinib	NN	O	geﬁtinib	prep_of	7	SENT_508	[p25l82t3173r280b3230],
10	for	IN	O	for	prep	9	SENT_508	[p25l307t3173r376b3218],
11	previously	RB	DATE	previously	pcomp	10	SENT_508	[p25l400t3174r643b3230],
12	treated	VBN	O	treat	_	0	SENT_508	[p25l666t3174r828b3218],
13	patients	NNS	O	patient	dobj	12	SENT_508	[p25l853t3174r1041b3230],
14	with	IN	O	with	_	0	SENT_508	[p25l7t3245r115b3289],
15	advanced	JJ	O	advanced	amod	17	SENT_508	[p25l137t3245r360b3289],
16	non	JJ	O	non	amod	17	SENT_508	[p25l382t3245r733b3289],
17	—	NN	O	—	prep_with	13	SENT_508	[p25l382t3245r733b3289],
18	small	JJ	O	small	amod	19	SENT_508	[p25l382t3245r733b3289],
19	—	NN	O	—	dep	25	SENT_508	[p25l382t3245r733b3289],
20	cell	NN	O	cell	nn	21	SENT_508	[p25l382t3245r733b3289],
21	lung	NN	O	lung	dep	19	SENT_508	[p25l755t3245r865b3301],
22	cancer	NN	O	cancer	dep	25	SENT_508	[p25l886t3259r1043b3289],
23	(	CD	NUMBER	(	num	22	SENT_508	[p25l13t3316r120b3367],
24	The	DT	O	the	det	25	SENT_508	[p25l13t3316r120b3367],
25	IDEAL	NN	O	ideal	dep	13	SENT_508	[p25l139t3319r295b3359],
26	1	CD	NUMBER	1	num	28	SENT_508	[p25l315t3319r340b3359],
27	Trial	NN	O	trial	nn	28	SENT_508	[p25l358t3316r499b3367],
28	)	NN	O	)	dep	25	SENT_508	[p25l358t3316r499b3367],
29	.	.	O	.	_	0	SENT_508	[p25l358t3316r499b3367],

1	J	NNP	O	J	nn	3	SENT_509	[p25l516t3320r537b3367],
2	Clin	NNP	O	Clin	nn	3	SENT_509	[p25l556t3316r652b3360],
3	Oncol	NNP	O	Oncol	_	0	SENT_509	[p25l672t3316r814b3360],
4	2003	CD	DATE	2003	num	3	SENT_509	[p25l834t3319r1039b3369],
5	;	:	O	;	_	0	SENT_509	[p25l834t3319r1039b3369],
6	21	CD	NUMBER	21	num	8	SENT_509	[p25l834t3319r1039b3369],
7	:	:	O	:	_	0	SENT_509	[p25l834t3319r1039b3369],
8	2237-46	CD	NUMBER	2237-46	dep	3	SENT_509	[p25l10t3390r222b3431],
9	.	.	O	.	_	0	SENT_509	[p25l10t3390r222b3431],

1	[	NNP	O	[	nn	6	SENT_510	[p25l252t3390r480b3440],
2	Erratum	NNP	O	Erratum	nn	6	SENT_510	[p25l252t3390r480b3440],
3	,	,	O	,	_	0	SENT_510	[p25l252t3390r480b3440],
4	J	NNP	O	J	appos	6	SENT_510	[p25l500t3391r521b3438],
5	Clin	NNP	O	Clin	nn	6	SENT_510	[p25l542t3387r641b3431],
6	Oncol	NNP	O	Oncol	_	0	SENT_510	[p25l663t3387r807b3431],
7	2004	CD	DATE	2004	num	6	SENT_510	[p25l829t3390r1039b3440],
8	;	:	O	;	_	0	SENT_510	[p25l829t3390r1039b3440],
9	22	CD	NUMBER	22	dep	6	SENT_510	[p25l829t3390r1039b3440],
10	:	:	O	:	_	0	SENT_510	[p25l829t3390r1039b3440],
11	4811	CD	NUMBER	4811	dep	9	SENT_510	[p25l9t3461r158b3508],
12	.	.	O	.	_	0	SENT_510	[p25l9t3461r158b3508],
13	]	SYM	O	]	dep	6	SENT_510	[p25l9t3461r158b3508],

1	11	CD	NUMBER	11	_	0	SENT_511	[p25l1117t196r1181b235],
2	.	.	O	.	_	0	SENT_511	[p25l1117t196r1181b235],

1	Miller	NNP	ORGANIZATION	Miller	nn	2	SENT_512	[p25l1210t191r1353b235],
2	VA	NNP	ORGANIZATION	VA	_	0	SENT_512	[p25l1363t195r1442b244],
3	,	,	O	,	_	0	SENT_512	[p25l1363t195r1442b244],
4	Kris	NNP	PERSON	Kris	nn	5	SENT_512	[p25l1459t191r1553b236],
5	MG	NN	PERSON	mg	appos	2	SENT_512	[p25l1567t194r1671b244],
6	,	,	O	,	_	0	SENT_512	[p25l1567t194r1671b244],
7	Shah	NNP	PERSON	Shah	nn	8	SENT_512	[p25l1689t191r1805b235],
8	N	NNP	O	N	appos	2	SENT_512	[p25l1818t195r1870b244],
9	,	,	O	,	_	0	SENT_512	[p25l1818t195r1870b244],
10	et	FW	O	et	nn	11	SENT_512	[p25l1888t200r1931b235],
11	al.	FW	O	al.	appos	2	SENT_512	[p25l1942t191r1995b235],
12	.	.	O	.	_	0	SENT_512	[p25l1942t191r1995b235],

1	Bronchioloalveolar	JJ	PERSON	bronchioloalveolar	amod	3	SENT_513	[p25l2012t194r2146b235, p25l1116t262r1443b306],
2	pathologic	JJ	O	pathologic	amod	3	SENT_513	[p25l1452t262r1701b318],
3	subtype	NN	O	subtype	nsubj	7	SENT_513	[p25l1713t262r1891b318],
4	and	CC	O	and	_	0	SENT_513	[p25l1903t262r1989b306],
5	smoking	NN	O	smoking	nn	6	SENT_513	[p25l2002t262r2146b306, p25l1115t333r1193b389],
6	history	NN	O	history	conj_and	3	SENT_513	[p25l1209t333r1373b389],
7	predict	VBP	O	predict	_	0	SENT_513	[p25l1388t333r1556b389],
8	sensitivity	NN	O	sensitivity	dobj	7	SENT_513	[p25l1572t333r1807b389],
9	to	TO	O	to	_	0	SENT_513	[p25l1822t342r1867b377],
10	geﬁtinib	NN	O	geﬁtinib	prep_to	7	SENT_513	[p25l1885t332r2084b389],
11	in	IN	O	in	_	0	SENT_513	[p25l2102t333r2147b376],
12	advanced	JJ	O	advanced	amod	14	SENT_513	[p25l1115t404r1334b448],
13	non	JJ	O	non	amod	14	SENT_513	[p25l1351t404r1695b448],
14	—	NN	O	—	prep_in	10	SENT_513	[p25l1351t404r1695b448],
15	small	JJ	O	small	amod	19	SENT_513	[p25l1351t404r1695b448],
16	—	NN	O	—	nn	19	SENT_513	[p25l1351t404r1695b448],
17	cell	NN	O	cell	nn	19	SENT_513	[p25l1351t404r1695b448],
18	lung	NN	O	lung	nn	19	SENT_513	[p25l1711t404r1820b460],
19	cancer	NN	O	cancer	dep	14	SENT_513	[p25l1836t418r1998b448],
20	.	.	O	.	_	0	SENT_513	[p25l1836t418r1998b448],

1	J	NNP	O	J	nn	3	SENT_514	[p25l2013t408r2034b455],
2	Clin	NNP	O	Clin	nn	3	SENT_514	[p25l2050t404r2147b448],
3	Oncol	NNP	O	Oncol	_	0	SENT_514	[p25l1115t475r1258b519],
4	2004	CD	DATE	2004	num	3	SENT_514	[p25l1271t478r1660b528],
5	;	:	O	;	_	0	SENT_514	[p25l1271t478r1660b528],
6	22:1103	CD	NUMBER	22:1103	number	7	SENT_514	[p25l1271t478r1660b528],
7	—	CD	NUMBER	—	dep	3	SENT_514	[p25l1271t478r1660b528],
8	9	CD	NUMBER	9	dep	7	SENT_514	[p25l1271t478r1660b528],
9	.	.	O	.	_	0	SENT_514	[p25l1271t478r1660b528],

1	12	CD	NUMBER	12	_	0	SENT_515	[p25l1117t551r1181b590],
2	.	.	O	.	_	0	SENT_515	[p25l1117t551r1181b590],

1	Lynch	NNP	PERSON	Lynch	nn	2	SENT_516	[p25l1211t546r1352b602],
2	TJ	NNP	PERSON	TJ	_	0	SENT_516	[p25l1362t549r1424b599],
3	,	,	O	,	_	0	SENT_516	[p25l1362t549r1424b599],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_516	[p25l1439t546r1528b590],
5	DVV	NNP	ORGANIZATION	DVV	appos	2	SENT_516	[p25l1539t549r1636b599],
6	,	,	O	,	_	0	SENT_516	[p25l1539t549r1636b599],
7	Sordella	NNP	PERSON	Sordella	nn	8	SENT_516	[p25l1652t546r1844b590],
8	R	NNP	PERSON	R	appos	2	SENT_516	[p25l1854t549r1902b599],
9	,	,	O	,	_	0	SENT_516	[p25l1854t549r1902b599],
10	et	FW	O	et	nn	11	SENT_516	[p25l1917t555r1960b590],
11	al.	FW	O	al.	appos	2	SENT_516	[p25l1969t546r2021b590],
12	.	.	O	.	_	0	SENT_516	[p25l1969t546r2021b590],

1	Activating	VBG	O	activate	amod	2	SENT_517	[p25l2034t546r2146b590, p25l1113t617r1260b673],
2	mutations	NNS	O	mutation	_	0	SENT_517	[p25l1283t617r1523b661],
3	in	IN	O	in	_	0	SENT_517	[p25l1549t617r1594b660],
4	the	DT	O	the	det	7	SENT_517	[p25l1618t617r1691b661],
5	epidermal	JJ	O	epidermal	amod	7	SENT_517	[p25l1715t617r1953b673],
6	growth	NN	O	growth	nn	7	SENT_517	[p25l1978t617r2147b673],
7	factor	NN	O	factor	prep_in	2	SENT_517	[p25l1115t687r1253b732],
8	receptor	NN	O	receptor	nn	10	SENT_517	[p25l1281t697r1477b744],
9	underlying	VBG	O	underlie	amod	10	SENT_517	[p25l1505t688r1762b744],
10	responsiveness	NN	O	responsiveness	dep	2	SENT_517	[p25l1789t688r2146b744],
11	of	IN	O	of	_	0	SENT_517	[p25l1116t758r1172b803],
12	non	JJ	O	non	amod	18	SENT_517	[p25l1187t759r1530b803],
13	—	JJ	O	—	amod	18	SENT_517	[p25l1187t759r1530b803],
14	small	JJ	O	small	amod	18	SENT_517	[p25l1187t759r1530b803],
15	—	NN	O	—	nn	18	SENT_517	[p25l1187t759r1530b803],
16	cell	NN	O	cell	nn	18	SENT_517	[p25l1187t759r1530b803],
17	lung	NN	O	lung	nn	18	SENT_517	[p25l1554t759r1662b815],
18	cancer	NN	O	cancer	prep_of	10	SENT_517	[p25l1685t773r1839b803],
19	to	TO	O	to	_	0	SENT_517	[p25l1862t768r1907b803],
20	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_517	[p25l1932t758r2144b815],
21	.	.	O	.	_	0	SENT_517	[p25l1932t758r2144b815],

1	N	NN	O	n	nn	2	SENT_518	[p25l1114t834r1156b874],
2	EnglJ	NN	O	englj	nsubj	3	SENT_518	[p25l1169t830r1307b886],
3	Med	VBD	O	med	_	0	SENT_518	[p25l1318t830r1422b874],
4	2004	CD	DATE	2004	dobj	3	SENT_518	[p25l1436t833r1884b883],
5	;	:	O	;	_	0	SENT_518	[p25l1436t833r1884b883],
6	350:2129	CD	NUMBER	350:2129	number	7	SENT_518	[p25l1436t833r1884b883],
7	—	CD	NUMBER	—	dep	4	SENT_518	[p25l1436t833r1884b883],
8	39	CD	NUMBER	39	dep	7	SENT_518	[p25l1436t833r1884b883],
9	.	.	O	.	_	0	SENT_518	[p25l1436t833r1884b883],

1	13	CD	NUMBER	13	_	0	SENT_519	[p25l1117t907r1181b946],
2	.	.	O	.	_	0	SENT_519	[p25l1117t907r1181b946],

1	Paez	NNP	PERSON	Paez	nn	2	SENT_520	[p25l1211t905r1318b946],
2	JG	NNP	O	JG	_	0	SENT_520	[p25l1333t905r1409b955],
3	,	,	O	,	_	0	SENT_520	[p25l1333t905r1409b955],
4	Janne	NNP	PERSON	Janne	nn	5	SENT_520	[p25l1427t906r1564b953],
5	PA	NN	PERSON	pa	appos	2	SENT_520	[p25l1584t905r1659b955],
6	,	,	O	,	_	0	SENT_520	[p25l1584t905r1659b955],
7	Lee	NNP	PERSON	Lee	nn	8	SENT_520	[p25l1682t906r1761b946],
8	JC	NNP	PERSON	JC	appos	2	SENT_520	[p25l1777t905r1846b955],
9	,	,	O	,	_	0	SENT_520	[p25l1777t905r1846b955],
10	et	FW	O	et	nn	11	SENT_520	[p25l1871t911r1914b946],
11	al.	FW	O	al.	appos	2	SENT_520	[p25l1932t902r1984b946],
12	.	.	O	.	_	0	SENT_520	[p25l1932t902r1984b946],

1	EGFR	NN	ORGANIZATION	egfr	nn	2	SENT_521	[p25l2008t905r2153b948],
2	mutations	NNS	O	mutation	_	0	SENT_521	[p25l1115t972r1361b1016],
3	in	IN	O	in	_	0	SENT_521	[p25l1380t972r1426b1015],
4	lung	NN	O	lung	nn	5	SENT_521	[p25l1443t972r1553b1028],
5	cancer	NN	O	cancer	prep_in	2	SENT_521	[p25l1570t986r1740b1016],
6	:	:	O	:	_	0	SENT_521	[p25l1570t986r1740b1016],
7	correlation	NN	O	correlation	dep	2	SENT_521	[p25l1760t972r2023b1016],
8	with	IN	O	with	_	0	SENT_521	[p25l2039t972r2147b1016],
9	clinical	JJ	O	clinical	amod	10	SENT_521	[p25l1116t1043r1288b1087],
10	response	NN	O	response	prep_with	7	SENT_521	[p25l1338t1057r1555b1099],
11	to	TO	O	to	_	0	SENT_521	[p25l1605t1052r1650b1087],
12	geﬁtinib	NN	O	geﬁtinib	nn	13	SENT_521	[p25l1701t1042r1904b1099],
13	therapy	NN	O	therapy	prep_to	10	SENT_521	[p25l1956t1043r2143b1099],
14	.	.	O	.	_	0	SENT_521	[p25l1956t1043r2143b1099],

1	Science	NNP	O	Science	_	0	SENT_522	[p25l1117t1114r1292b1158],
2	2004	CD	DATE	2004	num	1	SENT_522	[p25l1306t1117r1783b1167],
3	;	:	O	;	_	0	SENT_522	[p25l1306t1117r1783b1167],
4	304:1497	CD	NUMBER	304:1497	number	5	SENT_522	[p25l1306t1117r1783b1167],
5	—	CD	NUMBER	—	dep	1	SENT_522	[p25l1306t1117r1783b1167],
6	500	CD	NUMBER	500	dep	5	SENT_522	[p25l1306t1117r1783b1167],
7	.	.	O	.	_	0	SENT_522	[p25l1306t1117r1783b1167],

1	14	CD	NUMBER	14	_	0	SENT_523	[p25l1117t1190r1181b1229],
2	.	.	O	.	_	0	SENT_523	[p25l1117t1190r1181b1229],

1	Pao	NNP	O	Pao	nn	2	SENT_524	[p25l1211t1188r1295b1229],
2	W	NNP	O	W	_	0	SENT_524	[p25l1310t1189r1368b1238],
3	,	,	O	,	_	0	SENT_524	[p25l1310t1189r1368b1238],
4	Miller	NNP	PERSON	Miller	nn	5	SENT_524	[p25l1385t1185r1528b1229],
5	V	NNP	O	V	appos	2	SENT_524	[p25l1540t1189r1579b1238],
6	,	,	O	,	_	0	SENT_524	[p25l1540t1189r1579b1238],
7	Zakowski	NNP	O	Zakowski	nn	8	SENT_524	[p25l1597t1185r1825b1229],
8	M	NNP	O	M	appos	2	SENT_524	[p25l1838t1189r1899b1238],
9	,	,	O	,	_	0	SENT_524	[p25l1838t1189r1899b1238],
10	et	FW	O	et	nn	11	SENT_524	[p25l1918t1194r1961b1229],
11	al.	FW	O	al.	appos	2	SENT_524	[p25l1974t1185r2026b1229],
12	.	.	O	.	_	0	SENT_524	[p25l1974t1185r2026b1229],

1	EGF	NN	ORGANIZATION	egf	nn	4	SENT_525	[p25l2045t1188r2146b1229],
2	receptor	NN	O	receptor	nn	4	SENT_525	[p25l1115t1265r1312b1312],
3	gene	NN	O	gene	nn	4	SENT_525	[p25l1341t1270r1452b1312],
4	mutations	NNS	O	mutation	nsubjpass	17	SENT_525	[p25l1484t1256r1724b1300],
5	are	VBP	O	be	cop	6	SENT_525	[p25l1756t1270r1826b1300],
6	common	JJ	O	common	_	0	SENT_525	[p25l1858t1270r2071b1300],
7	in	IN	O	in	_	0	SENT_525	[p25l2102t1256r2147b1299],
8	lung	NN	O	lung	nn	9	SENT_525	[p25l1115t1327r1223b1383],
9	cancers	NNS	O	cancer	prep_in	6	SENT_525	[p25l1238t1341r1413b1371],
10	from	IN	O	from	_	0	SENT_525	[p25l1431t1326r1546b1371],
11	“	CD	NUMBER	“	prep_from	9	SENT_525	[p25l1564t1329r1716b1371],
12	never	RB	O	never	advmod	9	SENT_525	[p25l1564t1329r1716b1371],
13	smokers	NNS	O	smoker	dep	9	SENT_525	[p25l1731t1327r1956b1371],
14	”	CD	NUMBER	”	tmod	6	SENT_525	[p25l1731t1327r1956b1371],
15	and	CC	O	and	_	0	SENT_525	[p25l1974t1327r2061b1371],
16	are	VBP	O	be	auxpass	17	SENT_525	[p25l2077t1341r2147b1371],
17	associated	VBN	O	associate	conj_and	6	SENT_525	[p25l1115t1398r1360b1442],
18	with	IN	O	with	_	0	SENT_525	[p25l1371t1398r1477b1442],
19	sensitivity	NN	O	sensitivity	prep_with	17	SENT_525	[p25l1491t1398r1726b1454],
20	of	IN	O	of	_	0	SENT_525	[p25l1738t1397r1794b1442],
21	tumors	NNS	O	tumor	prep_of	19	SENT_525	[p25l1798t1407r1967b1442],
22	to	TO	O	to	aux	23	SENT_525	[p25l1982t1407r2026b1442],
23	geﬁ	VB	O	geﬁ	xcomp	17	SENT_525	[p25l2040t1397r2147b1454],
24	tinib	NN	O	tinib	dobj	23	SENT_525	[p25l1116t1469r1224b1513],
25	and	CC	O	and	_	0	SENT_525	[p25l1239t1469r1326b1513],
26	erlotinib	NN	O	erlotinib	conj_and	24	SENT_525	[p25l1341t1469r1556b1513],
27	.	.	O	.	_	0	SENT_525	[p25l1341t1469r1556b1513],

1	Proc	NNP	O	Proc	nn	7	SENT_526	[p25l1573t1472r1678b1513],
2	Natl	NNP	O	Natl	nn	7	SENT_526	[p25l1692t1469r1792b1513],
3	Acad	NNP	O	Acad	nn	7	SENT_526	[p25l1805t1469r1923b1513],
4	Sci	NNP	O	Sci	nn	7	SENT_526	[p25l1939t1469r2005b1513],
5	U	NNP	O	U	nn	7	SENT_526	[p25l2020t1473r2059b1513],
6	S	NNP	O	S	nn	7	SENT_526	[p25l2074t1472r2097b1513],
7	A	NNP	O	A	_	0	SENT_526	[p25l2112t1473r2149b1512],

1	2004	CD	DATE	2004	_	0	SENT_527	[p25l1115t1543r1593b1593],
2	;	:	O	;	_	0	SENT_527	[p25l1115t1543r1593b1593],
3	101:13306	CD	NUMBER	101:13306	number	4	SENT_527	[p25l1115t1543r1593b1593],
4	—	CD	NUMBER	—	dep	1	SENT_527	[p25l1115t1543r1593b1593],
5	11	CD	NUMBER	11	dep	4	SENT_527	[p25l1115t1543r1593b1593],
6	.	.	O	.	_	0	SENT_527	[p25l1115t1543r1593b1593],

1	15	CD	NUMBER	15	_	0	SENT_528	[p25l1117t1616r1181b1655],
2	.	.	O	.	_	0	SENT_528	[p25l1117t1616r1181b1655],

1	Prados	NNP	PERSON	Prados	nn	2	SENT_529	[p25l1211t1611r1371b1655],
2	M	NNP	PERSON	M	_	0	SENT_529	[p25l1400t1615r1461b1664],
3	,	,	O	,	_	0	SENT_529	[p25l1400t1615r1461b1664],
4	Chang	NNP	PERSON	Chang	nn	5	SENT_529	[p25l1494t1611r1651b1667],
5	S	NNP	O	S	appos	2	SENT_529	[p25l1680t1614r1719b1664],
6	,	,	O	,	_	0	SENT_529	[p25l1680t1614r1719b1664],
7	Burton	NNP	PERSON	Burton	nn	8	SENT_529	[p25l1751t1614r1915b1655],
8	E	NNP	O	E	appos	2	SENT_529	[p25l1945t1615r1988b1664],
9	,	,	O	,	_	0	SENT_529	[p25l1945t1615r1988b1664],
10	et	FW	O	et	nn	11	SENT_529	[p25l2021t1620r2065b1655],
11	al.	FW	O	al.	appos	2	SENT_529	[p25l2091t1611r2144b1655],
12	.	.	O	.	_	0	SENT_529	[p25l2091t1611r2144b1655],

1	Phase	NN	O	phase	nn	3	SENT_530	[p25l1115t1682r1250b1726],
2	I	CD	NUMBER	i	num	3	SENT_530	[p25l1263t1686r1280b1725],
3	study	NN	O	study	_	0	SENT_530	[p25l1293t1682r1418b1738],
4	of	IN	O	of	_	0	SENT_530	[p25l1429t1681r1485b1726],
5	OSI	NNP	O	OSI	nn	13	SENT_530	[p25l1488t1685r1680b1726],
6	—	CD	NUMBER	—	num	7	SENT_530	[p25l1488t1685r1680b1726],
7	774	CD	NUMBER	774	npadvmod	8	SENT_530	[p25l1488t1685r1680b1726],
8	alone	RB	O	alone	dep	13	SENT_530	[p25l1693t1682r1820b1726],
9	or	CC	O	or	_	0	SENT_530	[p25l1833t1696r1883b1726],
10	with	IN	O	with	conj_or	8	SENT_530	[p25l1892t1682r1997b1726],
11	temo	NN	O	temo	pobj	10	SENT_530	[p25l2010t1691r2147b1726],
12	—	NN	O	—	nn	13	SENT_530	[p25l2010t1691r2147b1726],
13	zolomide	NN	O	zolomide	prep_of	3	SENT_530	[p25l1115t1753r1335b1797],
14	in	IN	O	in	_	0	SENT_530	[p25l1347t1753r1392b1796],
15	patients	NNS	O	patient	prep_in	3	SENT_530	[p25l1404t1753r1589b1809],
16	with	IN	O	with	_	0	SENT_530	[p25l1600t1753r1705b1797],
17	malignant	JJ	O	malignant	amod	18	SENT_530	[p25l1717t1753r1959b1809],
18	glioma	NN	O	glioma	prep_with	15	SENT_530	[p25l1969t1753r2144b1809],
19	.	.	O	.	_	0	SENT_530	[p25l1969t1753r2144b1809],

1	Proc	NNP	O	Proc	nn	5	SENT_531	[p25l1115t1827r1218b1868],
2	Am	NNP	O	Am	nn	5	SENT_531	[p25l1226t1828r1309b1867],
3	Soc	NNP	O	Soc	nn	5	SENT_531	[p25l1320t1827r1400b1868],
4	Clin	NNP	O	Clin	nn	5	SENT_531	[p25l1410t1824r1505b1868],
5	Oncol	NNP	O	Oncol	_	0	SENT_531	[p25l1515t1824r1655b1868],
6	2003	CD	DATE	2003	num	5	SENT_531	[p25l1665t1827r1777b1868],
7	;	:	O	;	_	0	SENT_531	[p25l1784t1827r1938b1877],
8	22:99	CD	NUMBER	22:99	dep	5	SENT_531	[p25l1784t1827r1938b1877],
9	.	.	O	.	_	0	SENT_531	[p25l1784t1827r1938b1877],

1	abstract	JJ	O	abstract	_	0	SENT_532	[p25l1951t1824r2145b1868],
2	.	.	O	.	_	0	SENT_532	[p25l1951t1824r2145b1868],

1	16	CD	NUMBER	16	_	0	SENT_533	[p25l1117t1900r1181b1939],
2	.	.	O	.	_	0	SENT_533	[p25l1117t1900r1181b1939],

1	Rich	NNP	O	Rich	nn	2	SENT_534	[p25l1211t1895r1319b1942],
2	JN	NN	O	jn	_	0	SENT_534	[p25l1342t1899r1416b1948],
3	,	,	O	,	_	0	SENT_534	[p25l1342t1899r1416b1948],
4	Reardon	NNP	ORGANIZATION	Reardon	nn	5	SENT_534	[p25l1448t1895r1649b1942],
5	DA	NNP	ORGANIZATION	DA	appos	2	SENT_534	[p25l1677t1898r1764b1948],
6	,	,	O	,	_	0	SENT_534	[p25l1677t1898r1764b1948],
7	Peery	NNP	PERSON	Peery	nn	8	SENT_534	[p25l1796t1898r1922b1951],
8	T	NN	O	t	appos	2	SENT_534	[p25l1947t1898r1989b1948],
9	,	,	O	,	_	0	SENT_534	[p25l1947t1898r1989b1948],
10	et	FW	O	et	nn	11	SENT_534	[p25l2022t1904r2065b1939],
11	al.	FW	O	al.	appos	2	SENT_534	[p25l2091t1895r2144b1939],
12	.	.	O	.	_	0	SENT_534	[p25l2091t1895r2144b1939],

1	Phase	NN	O	phase	nn	3	SENT_535	[p25l1115t1966r1251b2010],
2	II	CD	NUMBER	ii	num	3	SENT_535	[p25l1273t1970r1308b2009],
3	trial	NN	O	trial	_	0	SENT_535	[p25l1330t1966r1423b2010],
4	of	IN	O	of	_	0	SENT_535	[p25l1445t1965r1501b2010],
5	geﬁtinib	NN	O	geﬁtinib	prep_of	3	SENT_535	[p25l1512t1965r1711b2022],
6	in	IN	O	in	_	0	SENT_535	[p25l1733t1966r1778b2009],
7	recurrent	JJ	O	recurrent	amod	8	SENT_535	[p25l1800t1975r2020b2010],
8	glioblastoma	NN	O	glioblastoma	prep_in	3	SENT_535	[p25l2039t1966r2147b2022, p25l1116t2037r1346b2081],
9	.	.	O	.	_	0	SENT_535	[p25l2039t1966r2147b2022, p25l1116t2037r1346b2081],

1	J	NNP	O	J	nn	3	SENT_536	[p25l1358t2041r1379b2088],
2	Clin	NNP	O	Clin	nn	3	SENT_536	[p25l1391t2037r1488b2081],
3	Oncol	NNP	O	Oncol	_	0	SENT_536	[p25l1502t2037r1644b2081],
4	2004	CD	DATE	2004	num	3	SENT_536	[p25l1658t2040r2046b2090],
5	;	:	O	;	_	0	SENT_536	[p25l1658t2040r2046b2090],
6	22:133	CD	NUMBER	22:133	number	7	SENT_536	[p25l1658t2040r2046b2090],
7	-42	CD	NUMBER	-42	dep	3	SENT_536	[p25l1658t2040r2046b2090],
8	.	.	O	.	_	0	SENT_536	[p25l1658t2040r2046b2090],

1	17	CD	NUMBER	17	_	0	SENT_537	[p25l1117t2113r1181b2152],
2	.	.	O	.	_	0	SENT_537	[p25l1117t2113r1181b2152],

1	Barber	NNP	O	Barber	nn	2	SENT_538	[p25l1211t2108r1370b2152],
2	TD	NNP	O	TD	_	0	SENT_538	[p25l1392t2111r1476b2161],
3	,	,	O	,	_	0	SENT_538	[p25l1392t2111r1476b2161],
4	Vogelstein	NNP	PERSON	Vogelstein	nn	5	SENT_538	[p25l1504t2108r1751b2164],
5	B	NNP	PERSON	B	appos	2	SENT_538	[p25l1777t2111r1822b2161],
6	,	,	O	,	_	0	SENT_538	[p25l1777t2111r1822b2161],
7	Kinzler	NNP	PERSON	Kinzler	nn	8	SENT_538	[p25l1851t2108r2025b2153],
8	KW	NNP	O	KW	appos	2	SENT_538	[p25l2049t2112r2143b2161],
9	,	,	O	,	_	0	SENT_538	[p25l2049t2112r2143b2161],
10	Velculescu	NNP	O	Velculescu	nn	11	SENT_538	[p25l1113t2179r1362b2223],
11	VE	NNP	O	VE	appos	2	SENT_538	[p25l1383t2183r1461b2223],
12	.	.	O	.	_	0	SENT_538	[p25l1383t2183r1461b2223],

1	Somatic	JJ	MISC	somatic	amod	2	SENT_539	[p25l1488t2179r1677b2223],
2	mutations	NNS	O	mutation	_	0	SENT_539	[p25l1699t2179r1940b2223],
3	of	IN	O	of	_	0	SENT_539	[p25l1964t2178r2020b2223],
4	EGFR	NN	ORGANIZATION	egfr	prep_of	2	SENT_539	[p25l2031t2182r2150b2223],

1	in	IN	O	in	_	0	SENT_540	[p25l1115t2250r1161b2293],
2	colorectal	JJ	O	colorectal	amod	3	SENT_540	[p25l1196t2250r1428b2294],
3	cancers	NNS	O	cancer	pobj	1	SENT_540	[p25l1463t2264r1639b2294],
4	and	CC	O	and	_	0	SENT_540	[p25l1675t2250r1762b2294],
5	glioblastomas	NNS	O	glioblastoma	conj_and	3	SENT_540	[p25l1797t2250r2144b2306],
6	.	.	O	.	_	0	SENT_540	[p25l1797t2250r2144b2306],

1	N	NN	O	n	nn	2	SENT_541	[p25l1114t2325r1156b2365],
2	EnglJ	NN	O	englj	nsubj	3	SENT_541	[p25l1169t2321r1307b2377],
3	Med	VBD	O	med	_	0	SENT_541	[p25l1318t2321r1422b2365],
4	2004	CD	DATE	2004	dobj	3	SENT_541	[p25l1436t2324r1805b2374],
5	;	:	O	;	_	0	SENT_541	[p25l1436t2324r1805b2374],
6	351:2883	CD	NUMBER	351:2883	dep	4	SENT_541	[p25l1436t2324r1805b2374],
7	.	.	O	.	_	0	SENT_541	[p25l1436t2324r1805b2374],

1	18	CD	NUMBER	18	_	0	SENT_542	[p25l1117t2396r1181b2436],
2	.	.	O	.	_	0	SENT_542	[p25l1117t2396r1181b2436],

1	Marie	NNP	PERSON	Marie	nn	2	SENT_543	[p25l1210t2392r1344b2436],
2	Y	NN	PERSON	y	_	0	SENT_543	[p25l1355t2396r1393b2445],
3	,	,	O	,	_	0	SENT_543	[p25l1355t2396r1393b2445],
4	Carpentier	NNP	PERSON	Carpentier	nn	5	SENT_543	[p25l1408t2392r1655b2448],
5	AF	NNP	O	AF	appos	2	SENT_543	[p25l1664t2396r1735b2445],
6	,	,	O	,	_	0	SENT_543	[p25l1664t2396r1735b2445],
7	Omuro	NNP	ORGANIZATION	Omuro	nn	8	SENT_543	[p25l1751t2395r1918b2436],
8	AM	NNP	ORGANIZATION	AM	appos	2	SENT_543	[p25l1929t2396r2025b2445],
9	,	,	O	,	_	0	SENT_543	[p25l1929t2396r2025b2445],
10	et	FW	O	et	nn	11	SENT_543	[p25l2041t2401r2083b2436],
11	al.	FW	O	al.	appos	2	SENT_543	[p25l2092t2392r2144b2436],
12	.	.	O	.	_	0	SENT_543	[p25l2092t2392r2144b2436],

1	EGFR	NN	ORGANIZATION	egfr	nn	3	SENT_544	[p25l1115t2466r1258b2510],
2	tyrosine	NN	O	tyrosine	nn	3	SENT_544	[p25l1273t2463r1457b2519],
3	kinase	NN	O	kinase	_	0	SENT_544	[p25l1477t2463r1626b2507],
4	domain	NN	O	domain	nn	5	SENT_544	[p25l1646t2463r1825b2507],
5	mutations	NNS	O	mutation	dep	3	SENT_544	[p25l1845t2463r2081b2507],
6	in	IN	O	in	_	0	SENT_544	[p25l2102t2463r2147b2506],
7	human	JJ	O	human	amod	8	SENT_544	[p25l1115t2535r1281b2579],
8	gliomas	NNS	O	glioma	prep_in	5	SENT_544	[p25l1293t2535r1492b2591],
9	.	.	O	.	_	0	SENT_544	[p25l1293t2535r1492b2591],

1	Neurology	NNP	O	Neurology	_	0	SENT_545	[p25l1506t2535r1754b2591],
2	2005	CD	DATE	2005	num	1	SENT_545	[p25l1763t2538r2145b2588],
3	;	:	O	;	_	0	SENT_545	[p25l1763t2538r2145b2588],
4	64:1444	CD	NUMBER	64:1444	number	5	SENT_545	[p25l1763t2538r2145b2588],
5	—	CD	NUMBER	—	dep	1	SENT_545	[p25l1763t2538r2145b2588],
6	5	CD	NUMBER	5	dep	5	SENT_545	[p25l1763t2538r2145b2588],
7	.	.	O	.	_	0	SENT_545	[p25l1763t2538r2145b2588],

1	19	CD	NUMBER	19	_	0	SENT_546	[p25l1117t2612r1181b2651],
2	.	.	O	.	_	0	SENT_546	[p25l1117t2612r1181b2651],

1	Rich	NNP	O	Rich	_	0	SENT_547	[p25l1211t2607r1319b2653],
2	JN	NN	O	jn	nn	10	SENT_547	[p25l1330t2611r1404b2660],
3	,	,	O	,	_	0	SENT_547	[p25l1330t2611r1404b2660],
4	Rasheed	NN	PERSON	rasheed	dep	1	SENT_547	[p25l1423t2607r1623b2653],
5	BK	NN	PERSON	bk	nn	10	SENT_547	[p25l1640t2610r1723b2660],
6	,	,	O	,	_	0	SENT_547	[p25l1640t2610r1723b2660],
7	Yan	NNP	PERSON	Yan	conj_and	10	SENT_547	[p25l1742t2611r1827b2651],
8	H.	NNP	PERSON	H.	nn	10	SENT_547	[p25l1844t2611r1898b2651],
9	EGFR	NN	PERSON	egfr	nn	10	SENT_547	[p25l1918t2610r2037b2651],
10	mutations	NNS	O	mutation	dep	1	SENT_547	[p25l2050t2621r2146b2651, p25l1116t2677r1277b2721],
11	and	CC	O	and	_	0	SENT_547	[p25l1296t2677r1383b2721],
12	sensitivity	NN	O	sensitivity	conj_and	10	SENT_547	[p25l1402t2677r1637b2733],
13	to	TO	O	to	_	0	SENT_547	[p25l1653t2686r1697b2721],
14	geﬁtinib	NN	O	geﬁtinib	prep_to	10	SENT_547	[p25l1716t2676r1928b2733],
15	.	.	O	.	_	0	SENT_547	[p25l1716t2676r1928b2733],

1	N	NN	O	n	nn	2	SENT_548	[p25l1948t2681r1990b2721],
2	EnglJ	NN	O	englj	nsubj	3	SENT_548	[p25l2007t2677r2149b2733],
3	Med	VBD	O	med	_	0	SENT_548	[p25l1114t2748r1218b2792],
4	2004	CD	DATE	2004	dobj	3	SENT_548	[p25l1232t2751r1601b2801],
5	;	:	O	;	_	0	SENT_548	[p25l1232t2751r1601b2801],
6	351:1260	CD	NUMBER	351:1260	dep	4	SENT_548	[p25l1232t2751r1601b2801],
7	.	.	O	.	_	0	SENT_548	[p25l1232t2751r1601b2801],

1	20	CD	NUMBER	20	_	0	SENT_549	[p25l1115t2823r1181b2863],
2	.	.	O	.	_	0	SENT_549	[p25l1115t2823r1181b2863],

1	Smith	NNP	ORGANIZATION	Smith	nn	2	SENT_550	[p25l1213t2819r1352b2863],
2	JS	NNP	ORGANIZATION	JS	_	0	SENT_550	[p25l1367t2822r1429b2872],
3	,	,	O	,	_	0	SENT_550	[p25l1367t2822r1429b2872],
4	Tachibana	NNP	O	Tachibana	nn	5	SENT_550	[p25l1452t2819r1696b2863],
5	I	NNP	O	I	appos	2	SENT_550	[p25l1715t2823r1745b2872],
6	,	,	O	,	_	0	SENT_550	[p25l1715t2823r1745b2872],
7	Passe	NNP	O	Passe	nn	8	SENT_550	[p25l1768t2822r1897b2863],
8	SM	NNP	O	SM	appos	2	SENT_550	[p25l1919t2822r2006b2872],
9	,	,	O	,	_	0	SENT_550	[p25l1919t2822r2006b2872],
10	et	FW	O	et	nn	11	SENT_550	[p25l2031t2828r2073b2863],
11	al.	FW	O	al.	appos	2	SENT_550	[p25l2091t2819r2144b2863],
12	.	.	O	.	_	0	SENT_550	[p25l2091t2819r2144b2863],

1	PTEN	NN	ORGANIZATION	pten	nn	2	SENT_551	[p25l1115t2893r1252b2934],
2	mutation	NN	O	mutation	_	0	SENT_551	[p25l1277t2890r1508b2943],
3	,	,	O	,	_	0	SENT_551	[p25l1277t2890r1508b2943],
4	EGFR	NN	ORGANIZATION	egfr	nn	5	SENT_551	[p25l1537t2893r1681b2937],
5	ampliﬁcation	NN	O	ampliﬁcation	conj_and	2	SENT_551	[p25l1701t2889r2031b2946],
6	,	,	O	,	_	0	SENT_551	[p25l1701t2889r2031b2946],
7	and	CC	O	and	_	0	SENT_551	[p25l2060t2890r2147b2934],
8	outcome	NN	O	outcome	conj_and	2	SENT_551	[p25l1116t2970r1321b3005],
9	in	IN	O	in	_	0	SENT_551	[p25l1335t2961r1380b3004],
10	patients	NNS	O	patient	prep_in	8	SENT_551	[p25l1392t2961r1580b3017],
11	with	IN	O	with	_	0	SENT_551	[p25l1592t2961r1698b3005],
12	anaplastic	JJ	O	anaplastic	amod	15	SENT_551	[p25l1711t2961r1949b3017],
13	astrocy	NN	O	astrocy	nn	15	SENT_551	[p25l1962t2970r2147b3017],
14	—	NN	O	—	nn	15	SENT_551	[p25l1962t2970r2147b3017],
15	toma	NN	O	toma	prep_with	10	SENT_551	[p25l1116t3041r1237b3076],
16	and	CC	O	and	_	0	SENT_551	[p25l1259t3032r1346b3076],
17	glioblastoma	NN	O	glioblastoma	nn	18	SENT_551	[p25l1369t3032r1679b3088],
18	multiforme	NN	O	multiforme	prep_with	10	SENT_551	[p25l1702t3031r1985b3076],
19	.	.	O	.	_	0	SENT_551	[p25l1702t3031r1985b3076],

1	J	NNP	O	J	nn	4	SENT_552	[p25l2005t3036r2026b3083],
2	Natl	NNP	O	Natl	nn	4	SENT_552	[p25l2047t3032r2147b3076],
3	Cancer	NNP	O	Cancer	nn	4	SENT_552	[p25l1115t3106r1281b3147],
4	Inst	NNP	O	Inst	_	0	SENT_552	[p25l1293t3107r1386b3147],
5	2001	CD	DATE	2001	num	4	SENT_552	[p25l1397t3106r1815b3156],
6	;	:	O	;	_	0	SENT_552	[p25l1397t3106r1815b3156],
7	93:1246	CD	NUMBER	93:1246	number	8	SENT_552	[p25l1397t3106r1815b3156],
8	—	CD	NUMBER	—	dep	4	SENT_552	[p25l1397t3106r1815b3156],
9	56	CD	NUMBER	56	dep	8	SENT_552	[p25l1397t3106r1815b3156],
10	.	.	O	.	_	0	SENT_552	[p25l1397t3106r1815b3156],

1	21	CD	NUMBER	21	_	0	SENT_553	[p25l1115t3179r1181b3218],
2	.	.	O	.	_	0	SENT_553	[p25l1115t3179r1181b3218],

1	Aldape	NNP	ORGANIZATION	Aldape	nn	2	SENT_554	[p25l1210t3174r1372b3230],
2	KD	NN	ORGANIZATION	kd	_	0	SENT_554	[p25l1383t3177r1469b3227],
3	,	,	O	,	_	0	SENT_554	[p25l1383t3177r1469b3227],
4	Ballman	NNP	PERSON	Ballman	nn	5	SENT_554	[p25l1483t3174r1677b3218],
5	K	NNP	PERSON	K	appos	2	SENT_554	[p25l1688t3178r1736b3227],
6	,	,	O	,	_	0	SENT_554	[p25l1688t3178r1736b3227],
7	Furth	NNP	PERSON	Furth	nn	8	SENT_554	[p25l1749t3174r1876b3218],
8	A	NNP	O	A	appos	2	SENT_554	[p25l1886t3178r1934b3227],
9	,	,	O	,	_	0	SENT_554	[p25l1886t3178r1934b3227],
10	et	FW	O	et	nn	11	SENT_554	[p25l1948t3183r1991b3218],
11	al.	FW	O	al.	appos	2	SENT_554	[p25l1999t3174r2050b3218],
12	.	.	O	.	_	0	SENT_554	[p25l1999t3174r2050b3218],

1	Immunohistochemical	JJ	O	immunohistochemical	amod	2	SENT_555	[p25l2064t3178r2147b3217, p25l1115t3245r1590b3289],
2	detection	NN	O	detection	_	0	SENT_555	[p25l1615t3245r1833b3289],
3	of	IN	O	of	_	0	SENT_555	[p25l1858t3244r1915b3289],
4	EGFRVIII	NN	O	egfrviius	prep_of	2	SENT_555	[p25l1929t3248r2148b3291],
5	in	IN	O	in	_	0	SENT_555	[p25l1115t3316r1161b3359],
6	high	JJ	O	high	amod	9	SENT_555	[p25l1175t3316r1283b3372],
7	malignancy	NN	O	malignancy	nn	9	SENT_555	[p25l1298t3316r1574b3372],
8	grade	NN	O	grade	nn	9	SENT_555	[p25l1586t3316r1718b3372],
9	astrocytomas	NNS	O	astrocytoma	prep_in	2	SENT_555	[p25l1732t3325r2045b3372],
10	and	CC	O	and	_	0	SENT_555	[p25l2060t3316r2147b3360],
11	evaluation	NN	O	evaluation	conj_and	9	SENT_555	[p25l1116t3387r1357b3431],
12	of	IN	O	of	_	0	SENT_555	[p25l1369t3386r1425b3431],
13	prognostic	JJ	O	prognostic	amod	14	SENT_555	[p25l1426t3387r1683b3443],
14	signiﬁcance	NN	O	signiﬁcance	prep_of	2	SENT_555	[p25l1695t3386r1991b3443],
15	.	.	O	.	_	0	SENT_555	[p25l1695t3386r1991b3443],

1	J	NNP	O	J	nn	4	SENT_556	[p25l2000t3391r2021b3438],
2	Neuropathol	NNP	O	Neuropathol	nn	4	SENT_556	[p25l2031t3391r2147b3431, p25l1115t3458r1318b3514],
3	Exp	NN	O	exp	nn	4	SENT_556	[p25l1331t3462r1418b3514],
4	N	NN	O	n	_	0	SENT_556	[p25l1431t3462r1473b3502],
5	eurol	NN	O	eurol	dep	4	SENT_556	[p25l1475t3458r1596b3502],
6	2004	CD	DATE	2004	num	5	SENT_556	[p25l1610t3461r1968b3511],
7	;	:	O	;	_	0	SENT_556	[p25l1610t3461r1968b3511],
8	63:700	CD	NUMBER	63:700	num	9	SENT_556	[p25l1610t3461r1968b3511],
9	—	NN	O	—	dep	4	SENT_556	[p25l1610t3461r1968b3511],
10	7	CD	NUMBER	7	dep	9	SENT_556	[p25l1610t3461r1968b3511],
11	.	.	O	.	_	0	SENT_556	[p25l1610t3461r1968b3511],

1	the	DT	O	the	det	4	SENT_557	[p26l10t105r107b163],
2	Harry	NNP	ORGANIZATION	Harry	nn	4	SENT_557	[p26l127t110r310b180],
3	Allgauer	NNP	ORGANIZATION	Allgauer	nn	4	SENT_557	[p26l324t105r597b180],
4	Foundation	NNP	ORGANIZATION	Foundation	_	0	SENT_557	[p26l613t104r983b164],
5	through	IN	O	through	_	0	SENT_557	[p26l1003t104r1261b180],
6	the	DT	O	the	det	10	SENT_557	[p26l1281t105r1379b163],
7	Doris	NNP	PERSON	Doris	nn	10	SENT_557	[p26l1398t105r1572b163],
8	R.	NNP	PERSON	R.	nn	10	SENT_557	[p26l1592t109r1657b167],
9	Ullmann	NNP	PERSON	Ullmann	nn	10	SENT_557	[p26l1681t104r1962b163],
10	Fund	NNP	O	Fund	prep_through	4	SENT_557	[p26l1981t105r2144b164],
11	for	IN	O	for	_	0	SENT_557	[p26l10t200r102b259],
12	Brain	NNP	ORGANIZATION	Brain	nn	15	SENT_557	[p26l133t201r304b259],
13	Tumor	NN	ORGANIZATION	tumor	nn	15	SENT_557	[p26l335t205r554b260],
14	Research	NNP	ORGANIZATION	Research	nn	15	SENT_557	[p26l584t200r874b263],
15	Technologies	NNPS	ORGANIZATION	Technologies	prep_for	10	SENT_557	[p26l905t200r1350b276],
16	;	:	O	;	_	0	SENT_557	[p26l905t200r1350b276],
17	the	DT	O	the	det	22	SENT_557	[p26l1387t201r1484b259],
18	Henry	NNP	ORGANIZATION	Henry	nn	22	SENT_557	[p26l1517t206r1714b276],
19	E.	NNP	ORGANIZATION	E.	nn	22	SENT_557	[p26l1743t206r1802b259],
20	Singleton	NNP	ORGANIZATION	Singleton	nn	22	SENT_557	[p26l1841t200r2144b276],
21	Brain	NN	ORGANIZATION	brain	nn	22	SENT_557	[p26l8t297r181b355],
22	Tumor	NN	ORGANIZATION	tumor	conj_and	10	SENT_557	[p26l207t301r426b356],
23	Foundation	NNP	ORGANIZATION	Foundation	dep	22	SENT_557	[p26l452t296r840b368],
24	;	:	O	;	_	0	SENT_557	[p26l452t296r840b368],
25	the	DT	O	the	det	26	SENT_557	[p26l873t297r970b355],
26	Phase	NN	O	phase	prep_through	4	SENT_557	[p26l998t296r1182b355],
27	One	CD	NUMBER	one	num	28	SENT_557	[p26l1211t301r1341b355],
28	Foundation	NNP	O	Foundation	dep	26	SENT_557	[p26l1369t296r1758b368],
29	;	:	O	;	_	0	SENT_557	[p26l1369t296r1758b368],
30	a	DT	O	a	det	32	SENT_557	[p26l1789t316r1823b355],
31	generous	JJ	O	generous	amod	32	SENT_557	[p26l1851t315r2143b372],
32	donation	NN	O	donation	prep_through	4	SENT_557	[p26l10t392r296b451],
33	from	IN	O	from	_	0	SENT_557	[p26l327t392r484b451],
34	the	DT	O	the	det	37	SENT_557	[p26l516t392r612b451],
35	Ziering	NNP	ORGANIZATION	Ziering	nn	37	SENT_557	[p26l643t393r875b468],
36	Family	NNP	ORGANIZATION	Family	nn	37	SENT_557	[p26l902t393r1118b468],
37	Foundation	NNP	ORGANIZATION	Foundation	prep_from	32	SENT_557	[p26l1145t392r1515b452],
38	in	IN	O	in	_	0	SENT_557	[p26l1545t393r1607b450],
39	memory	NN	O	memory	prep_in	37	SENT_557	[p26l1637t411r1905b468],
40	of	IN	O	of	_	0	SENT_557	[p26l1933t392r2008b451],
41	Sigi	NNP	PERSON	Sigi	nn	42	SENT_557	[p26l2027t393r2145b468],
42	Ziering	NNP	PERSON	Ziering	prep_of	39	SENT_557	[p26l8t489r257b564],
43	;	:	O	;	_	0	SENT_557	[p26l8t489r257b564],
44	and	CC	O	and	_	0	SENT_557	[p26l275t489r392b547],
45	the	DT	O	the	det	46	SENT_557	[p26l409t489r506b547],
46	Art	NN	MISC	art	prep_through	4	SENT_557	[p26l520t494r623b547],
47	of	IN	MISC	of	_	0	SENT_557	[p26l635t488r711b547],
48	the	DT	MISC	the	det	49	SENT_557	[p26l713t488r811b547],
49	Brain	NN	MISC	brain	prep_of	46	SENT_557	[p26l826t489r998b547],
50	and	CC	O	and	_	0	SENT_557	[p26l1013t488r1130b547],
51	the	DT	O	the	det	54	SENT_557	[p26l1147t489r1244b547],
52	Roven	NNP	PERSON	Roven	nn	54	SENT_557	[p26l1259t493r1458b551],
53	Family	NNP	O	Family	nn	54	SENT_557	[p26l1472t489r1688b564],
54	Fund	NNP	O	Fund	conj_and	10	SENT_557	[p26l1700t488r1863b548],
55	in	IN	O	in	_	0	SENT_557	[p26l1879t489r1941b546],
56	memory	NN	O	memory	prep_in	54	SENT_557	[p26l1956t508r2144b547, p26l10t603r111b660],
57	of	IN	O	of	_	0	SENT_557	[p26l127t584r203b643],
58	Dawn	NNP	TIME	Dawn	nn	59	SENT_557	[p26l206t589r392b644],
59	Steel	NNP	O	Steel	prep_of	4	SENT_557	[p26l412t584r578b643],
60	.	.	O	.	_	0	SENT_557	[p26l412t584r578b643],

1	Dr.	NNP	O	Dr.	nn	2	SENT_558	[p26l95t685r192b739],
2	Sawyers	NNP	PERSON	Sawyers	nsubj	5	SENT_558	[p26l224t685r482b756],
3	is	VBZ	O	be	cop	5	SENT_558	[p26l509t681r559b739],
4	an	DT	O	a	det	5	SENT_558	[p26l586t699r664b739],
5	investigator	NN	O	investigator	_	0	SENT_558	[p26l688t681r1078b756],
6	of	IN	O	of	_	0	SENT_558	[p26l1103t680r1180b739],
7	the	DT	O	the	det	11	SENT_558	[p26l1192t680r1292b739],
8	Howard	NNP	ORGANIZATION	Howard	nn	11	SENT_558	[p26l1318t680r1581b740],
9	Hughes	NNP	ORGANIZATION	Hughes	nn	11	SENT_558	[p26l1606t680r1859b756],
10	Medical	NNP	ORGANIZATION	Medical	nn	11	SENT_558	[p26l1884t680r2144b739],
11	Institute	NNP	ORGANIZATION	Institute	prep_of	5	SENT_558	[p26l8t777r284b836],
12	and	CC	O	and	_	0	SENT_558	[p26l318t776r437b835],
13	a	DT	O	a	det	18	SENT_558	[p26l471t796r504b835],
14	Doris	NNP	PERSON	Doris	nn	18	SENT_558	[p26l535t777r713b835],
15	Duke	NNP	PERSON	Duke	nn	18	SENT_558	[p26l747t776r919b836],
16	Distinguished	NNP	O	Distinguished	nn	18	SENT_558	[p26l951t777r1415b852],
17	Clinical	JJ	O	clinical	amod	18	SENT_558	[p26l1449t776r1700b835],
18	Investigator	NN	O	investigator	conj_and	11	SENT_558	[p26l1732t777r2138b852],
19	.	.	O	.	_	0	SENT_558	[p26l1732t777r2138b852],

1	Drs.	NNP	O	Drs.	nn	2	SENT_559	[p26l8t877r143b931],
2	Sawyers	NNP	PERSON	Sawyers	nsubj	5	SENT_559	[p26l168t877r426b948],
3	and	CC	O	and	_	0	SENT_559	[p26l445t872r565b931],
4	Mischel	NNP	PERSON	Mischel	nsubj	5	SENT_559	[p26l581t873r840b931],
5	report	NN	O	report	_	0	SENT_559	[p26l858t885r1062b948],
6	having	VBG	O	have	aux	7	SENT_559	[p26l1077t873r1298b948],
7	received	VBN	O	receive	xcomp	5	SENT_559	[p26l1314t872r1580b932],
8	lecture	NN	O	lecture	nn	9	SENT_559	[p26l1597t872r1819b932],
9	fees	NNS	O	fee	dobj	7	SENT_559	[p26l1838t872r1963b931],
10	from	IN	O	from	_	0	SENT_559	[p26l1983t872r2144b931],
11	Genentech	NNP	ORGANIZATION	Genentech	prep_from	7	SENT_559	[p26l10t970r383b1029],
12	.	.	O	.	_	0	SENT_559	[p26l10t970r383b1029],

1	A	DT	O	a	det	3	SENT_560	[p26l94t1071r143b1123],
2	patent	NN	O	patent	nn	3	SENT_560	[p26l164t1078r368b1141],
3	application	NN	O	application	nsubjpass	18	SENT_560	[p26l388t1065r744b1141],
4	entitled	VBN	O	entitle	partmod	3	SENT_560	[p26l770t1065r1008b1124],
5	“	CD	NUMBER	“	num	7	SENT_560	[p26l1035t1065r1389b1125],
6	Molecular	JJ	O	molecular	amod	7	SENT_560	[p26l1035t1065r1389b1125],
7	Determinants	NNS	O	determinant	dobj	4	SENT_560	[p26l1410t1066r1846b1124],
8	of	IN	O	of	_	0	SENT_560	[p26l1872t1065r1948b1124],
9	EGFR	NN	ORGANIZATION	egfr	nn	12	SENT_560	[p26l1957t1070r2153b1128],
10	Kinase	NN	O	kinase	nn	12	SENT_560	[p26l9t1162r224b1222],
11	Inhibitor	NNP	O	Inhibitor	nn	12	SENT_560	[p26l249t1161r537b1220],
12	Response	NNP	O	Response	prep_of	7	SENT_560	[p26l559t1166r867b1237],
13	in	IN	O	in	_	0	SENT_560	[p26l893t1162r954b1219],
14	Glioblastoma	NNP	O	Glioblastoma	nn	15	SENT_560	[p26l980t1161r1445b1220],
15	”	NNP	O	”	prep_in	12	SENT_560	[p26l980t1161r1445b1220],
16	has	VBZ	O	have	aux	18	SENT_560	[p26l1474t1162r1581b1220],
17	been	VBN	O	be	auxpass	18	SENT_560	[p26l1609t1161r1759b1220],
18	ﬁled	VBN	O	ﬁled	_	0	SENT_560	[p26l1785t1161r1925b1220],
19	by	IN	O	by	_	0	SENT_560	[p26l1951t1161r2024b1237],
20	the	DT	O	the	det	21	SENT_560	[p26l2047t1162r2144b1220],
21	University	NNP	ORGANIZATION	University	agent	18	SENT_560	[p26l9t1258r339b1333],
22	of	IN	ORGANIZATION	of	_	0	SENT_560	[p26l369t1257r445b1316],
23	California	NNP	ORGANIZATION	California	prep_of	21	SENT_560	[p26l464t1257r806b1316],
24	.	.	O	.	_	0	SENT_560	[p26l464t1257r806b1316],

1	The	DT	O	the	det	2	SENT_561	[p26l841t1258r964b1316],
2	patent	NN	O	patent	nsubj	3	SENT_561	[p26l995t1270r1204b1333],
3	includes	VBZ	O	include	_	0	SENT_561	[p26l1231t1257r1502b1317],
4	the	DT	O	the	det	5	SENT_561	[p26l1536t1257r1635b1316],
5	names	NNS	O	name	dobj	3	SENT_561	[p26l1668t1277r1878b1316],
6	of	IN	O	of	_	0	SENT_561	[p26l1912t1257r1989b1316],
7	Drs.	NNP	O	Drs.	nn	14	SENT_561	[p26l2006t1262r2139b1316],
8	Mischel	NNP	PERSON	Mischel	nn	14	SENT_561	[p26l7t1354r278b1425],
9	,	,	O	,	_	0	SENT_561	[p26l7t1354r278b1425],
10	Mellinghoff	NNP	PERSON	Mellinghoff	appos	14	SENT_561	[p26l299t1353r697b1429],
11	,	,	O	,	_	0	SENT_561	[p26l299t1353r697b1429],
12	Wang	NNP	PERSON	Wang	appos	14	SENT_561	[p26l717t1359r920b1429],
13	,	,	O	,	_	0	SENT_561	[p26l717t1359r920b1429],
14	Sawyers	NNP	PERSON	Sawyers	prep_of	5	SENT_561	[p26l945t1358r1214b1429],
15	,	,	O	,	_	0	SENT_561	[p26l945t1358r1214b1429],
16	and	CC	O	and	_	0	SENT_561	[p26l1237t1353r1354b1412],
17	Cloughesy	NNP	O	Cloughesy	prep_of	5	SENT_561	[p26l1373t1353r1717b1429],
18	.	.	O	.	_	0	SENT_561	[p26l1373t1353r1717b1429],

1	We	PRP	O	we	nsubj	3	SENT_562	[p26l94t1455r194b1508],
2	are	VBP	O	be	cop	3	SENT_562	[p26l226t1469r321b1508],
3	indebted	JJ	O	indebted	conj_and	3	SENT_562	[p26l353t1449r633b1508],
4	to	TO	O	to	_	0	SENT_562	[p26l665t1462r725b1508],
5	Drs.	NNP	O	Drs.	nn	7	SENT_562	[p26l757t1454r888b1508],
6	Stanley	NNP	PERSON	Stanley	nn	7	SENT_562	[p26l926t1449r1155b1525],
7	Nelson	NNP	PERSON	Nelson	prep_to	3	SENT_562	[p26l1182t1449r1428b1521],
8	,	,	O	,	_	0	SENT_562	[p26l1182t1449r1428b1521],
9	Jonathan	NNP	PERSON	Jonathan	nn	10	SENT_562	[p26l1457t1449r1749b1518],
10	Braun	NNP	PERSON	Braun	conj_and	7	SENT_562	[p26l1780t1454r1990b1521],
11	,	,	O	,	_	0	SENT_562	[p26l1780t1454r1990b1521],
12	and	CC	O	and	_	0	SENT_562	[p26l2026t1449r2144b1508],
13	Harry	NNP	PERSON	Harry	nn	14	SENT_562	[p26l9t1551r192b1621],
14	Vinters	NNP	PERSON	Vinters	conj_and	7	SENT_562	[p26l204t1546r430b1604],
15	at	IN	O	at	_	0	SENT_562	[p26l449t1558r509b1604],
16	UCLA	NNP	ORGANIZATION	UCLA	prep_at	14	SENT_562	[p26l522t1550r712b1604],
17	and	CC	O	and	_	0	SENT_562	[p26l727t1545r845b1604],
18	Drs.	NNP	O	Drs.	nn	20	SENT_562	[p26l862t1550r992b1604],
19	David	NNP	PERSON	David	nn	20	SENT_562	[p26l1013t1546r1196b1605],
20	Eberhard	NNP	PERSON	Eberhard	conj_and	7	SENT_562	[p26l1213t1545r1506b1604],
21	and	CC	O	and	_	0	SENT_562	[p26l1523t1545r1641b1604],
22	Barbara	NNP	PERSON	Barbara	nn	23	SENT_562	[p26l1657t1545r1907b1604],
23	Klenke	NNP	PERSON	Klenke	conj_and	7	SENT_562	[p26l1922t1545r2144b1606],
24	at	IN	O	at	_	0	SENT_562	[p26l10t1654r69b1700],
25	Genentech	NNP	ORGANIZATION	Genentech	prep_at	20	SENT_562	[p26l90t1641r435b1700],
26	for	IN	O	for	_	0	SENT_562	[p26l459t1641r552b1700],
27	helpﬁil	JJ	O	helpﬁil	amod	28	SENT_562	[p26l574t1641r800b1717],
28	discussions	NNS	O	discussion	prep_for	3	SENT_562	[p26l824t1641r1213b1713],
29	;	:	O	;	_	0	SENT_562	[p26l824t1641r1213b1713],
30	to	TO	O	to	_	0	SENT_562	[p26l1241t1654r1301b1700],
31	Jennifer	NNP	PERSON	Jennifer	nn	32	SENT_562	[p26l1319t1641r1578b1709],
32	Cloud	NNP	PERSON	Cloud	prep_to	3	SENT_562	[p26l1600t1641r1791b1701],
33	and	CC	O	and	_	0	SENT_562	[p26l1815t1641r1932b1700],
34	Ralph	NNP	PERSON	Ralph	nn	35	SENT_562	[p26l1956t1641r2145b1717],
35	Debiasi	NNP	PERSON	Debiasi	conj_and	32	SENT_562	[p26l8t1738r248b1796],
36	for	IN	O	for	_	0	SENT_562	[p26l271t1737r365b1796],
37	technical	JJ	O	technical	amod	38	SENT_562	[p26l387t1738r673b1796],
38	assistance	NN	O	assistance	prep_for	35	SENT_562	[p26l697t1738r1040b1809],
39	;	:	O	;	_	0	SENT_562	[p26l697t1738r1040b1809],
40	and	CC	O	and	_	0	SENT_562	[p26l1067t1737r1184b1796],
41	to	TO	O	to	_	0	SENT_562	[p26l1209t1750r1269b1796],
42	Dr.	NNP	O	Dr.	nn	44	SENT_562	[p26l1293t1742r1388b1796],
43	Darrell	NNP	PERSON	Darrell	nn	44	SENT_562	[p26l1415t1737r1636b1796],
44	Bigner	NNP	PERSON	Bigner	prep_to	3	SENT_562	[p26l1659t1738r1872b1813],
45	for	IN	O	for	_	0	SENT_562	[p26l1895t1737r1987b1796],
46	providing	VBG	O	provide	prepc_for	44	SENT_562	[p26l2009t1756r2143b1813, p26l6t1833r208b1909],
47	L8A4	NN	O	l8a4	nn	48	SENT_562	[p26l223t1838r389b1892],
48	antibody	NN	O	antibody	dobj	46	SENT_562	[p26l407t1833r695b1909],
49	.	.	O	.	_	0	SENT_562	[p26l407t1833r695b1909],

1	22	CD	NUMBER	22	_	0	SENT_563	[p26l8t2218r147b2298],
2	.	.	O	.	_	0	SENT_563	[p26l8t2218r147b2298],

1	Frederick	NNP	PERSON	Frederick	nn	2	SENT_564	[p26l207t2208r673b2300],
2	L	NNP	PERSON	L	_	0	SENT_564	[p26l691t2216r775b2318],
3	,	,	O	,	_	0	SENT_564	[p26l691t2216r775b2318],
4	Wang	NNP	PERSON	Wang	nn	5	SENT_564	[p26l803t2216r1092b2324],
5	XY	NN	O	xy	appos	2	SENT_564	[p26l1109t2216r1257b2318],
6	,	,	O	,	_	0	SENT_564	[p26l1109t2216r1257b2318],
7	Eley	NNP	PERSON	Eley	nn	8	SENT_564	[p26l1286t2208r1490b2324],
8	G	NNP	O	G	appos	2	SENT_564	[p26l1509t2214r1619b2318],
9	,	,	O	,	_	0	SENT_564	[p26l1509t2214r1619b2318],
10	James	NNP	PERSON	James	nn	11	SENT_564	[p26l1637t2216r1936b2312],
11	CD	NNP	O	CD	appos	2	SENT_564	[p26l1962t2214r2139b2298],
12	.	.	O	.	_	0	SENT_564	[p26l1962t2214r2139b2298],

1	Diversity	NN	O	diversity	_	0	SENT_565	[p26l8t2358r435b2474],
2	and	CC	O	and	_	0	SENT_565	[p26l456t2358r636b2448],
3	frequency	NN	O	frequency	conj_and	1	SENT_565	[p26l661t2356r1141b2474],
4	of	IN	O	of	_	0	SENT_565	[p26l1163t2356r1279b2448],
5	epidermal	JJ	O	epidermal	amod	9	SENT_565	[p26l1285t2358r1773b2474],
6	growth	NN	O	growth	nn	9	SENT_565	[p26l1800t2358r2147b2474],
7	factor	NN	O	factor	nn	9	SENT_565	[p26l10t2506r295b2598],
8	receptor	NN	O	receptor	nn	9	SENT_565	[p26l348t2526r755b2624],
9	mutations	NNS	O	mutation	prep_of	1	SENT_565	[p26l809t2508r1307b2600],
10	in	IN	O	in	_	0	SENT_565	[p26l1366t2508r1460b2596],
11	human	JJ	O	human	amod	14	SENT_565	[p26l1518t2508r1864b2600],
12	glio	NN	O	glio	nn	14	SENT_565	[p26l1922t2508r2145b2624],
13	—	NN	O	—	nn	14	SENT_565	[p26l1922t2508r2145b2624],
14	blastomas	NNS	O	blastoma	prep_in	9	SENT_565	[p26l10t2658r538b2748],
15	.	.	O	.	_	0	SENT_565	[p26l10t2658r538b2748],

1	Cancer	NNP	O	Cancer	nn	2	SENT_566	[p26l573t2664r916b2748],
2	Res	NNP	O	Res	_	0	SENT_566	[p26l940t2664r1113b2754],
3	2000	CD	DATE	2000	num	2	SENT_566	[p26l1143t2664r1948b2768],
4	;	:	O	;	_	0	SENT_566	[p26l1143t2664r1948b2768],
5	60:1383	CD	NUMBER	60:1383	num	6	SENT_566	[p26l1143t2664r1948b2768],
6	—	NN	O	—	dep	2	SENT_566	[p26l1143t2664r1948b2768],
7	7	CD	NUMBER	7	dep	6	SENT_566	[p26l1143t2664r1948b2768],
8	.	.	O	.	_	0	SENT_566	[p26l1143t2664r1948b2768],

1	23	CD	NUMBER	23	_	0	SENT_567	[p26l8t2818r147b2898],
2	.	.	O	.	_	0	SENT_567	[p26l8t2818r147b2898],

1	Wong	NNP	PERSON	Wong	nn	2	SENT_568	[p26l205t2816r504b2924],
2	AJ	NNP	PERSON	AJ	_	0	SENT_568	[p26l530t2816r665b2918],
3	,	,	O	,	_	0	SENT_568	[p26l530t2816r665b2918],
4	Ruppert	NNP	PERSON	Ruppert	nn	5	SENT_568	[p26l705t2816r1110b2924],
5	JM	NN	O	jm	appos	2	SENT_568	[p26l1127t2816r1297b2918],
6	,	,	O	,	_	0	SENT_568	[p26l1127t2816r1297b2918],
7	Bigner	NNP	PERSON	Bigner	nn	8	SENT_568	[p26l1338t2808r1665b2924],
8	SH	NNP	O	SH	appos	2	SENT_568	[p26l1701t2814r1870b2918],
9	,	,	O	,	_	0	SENT_568	[p26l1701t2814r1870b2918],
10	et	FW	O	et	nn	11	SENT_568	[p26l1914t2826r2002b2898],
11	al.	FW	O	al.	appos	2	SENT_568	[p26l2031t2808r2141b2898],
12	.	.	O	.	_	0	SENT_568	[p26l2031t2808r2141b2898],

1	Structural	JJ	MISC	structural	amod	2	SENT_569	[p26l12t2958r502b3050],
2	alterations	NNS	O	alteration	_	0	SENT_569	[p26l591t2958r1118b3048],
3	of	IN	O	of	_	0	SENT_569	[p26l1213t2956r1330b3048],
4	the	DT	O	the	det	9	SENT_569	[p26l1400t2958r1552b3048],
5	epidermal	JJ	O	epidermal	amod	9	SENT_569	[p26l1643t2958r2147b3074],
6	growth	NN	O	growth	nn	9	SENT_569	[p26l10t3108r367b3224],
7	factor	NN	O	factor	nn	9	SENT_569	[p26l400t3106r687b3198],
8	receptor	NN	O	receptor	nn	9	SENT_569	[p26l717t3126r1123b3224],
9	gene	NN	O	gene	prep_of	2	SENT_569	[p26l1153t3138r1382b3224],
10	in	IN	O	in	_	0	SENT_569	[p26l1416t3108r1510b3196],
11	human	JJ	O	human	amod	14	SENT_569	[p26l1542t3108r1890b3200],
12	glio	NN	O	glio	nn	14	SENT_569	[p26l1922t3108r2145b3224],
13	—	NN	O	—	nn	14	SENT_569	[p26l1922t3108r2145b3224],
14	mas	NNS	O	ma	prep_in	2	SENT_569	[p26l10t3288r237b3348],
15	.	.	O	.	_	0	SENT_569	[p26l10t3288r237b3348],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_570	[p26l301t3264r518b3348],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_570	[p26l574t3258r783b3348],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_570	[p26l837t3258r1082b3348],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_570	[p26l1143t3258r1281b3348],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_570	[p26l1338t3266r1418b3348],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_570	[p26l1478t3264r1526b3348],
7	A	NNP	O	A	_	0	SENT_570	[p26l1585t3266r1661b3346],
8	1992	CD	DATE	1992	num	7	SENT_570	[p26l1721t3264r2143b3368],
9	;	:	O	;	_	0	SENT_570	[p26l1721t3264r2143b3368],
10	89	CD	NUMBER	89	dep	7	SENT_570	[p26l1721t3264r2143b3368],
11	:	:	O	:	_	0	SENT_570	[p26l1721t3264r2143b3368],

1	24	CD	NUMBER	24	_	0	SENT_571	[p26l8t3568r147b3648],
2	.	.	O	.	_	0	SENT_571	[p26l8t3568r147b3648],

1	Sugawa	FW	PERSON	sugawa	_	0	SENT_572	[p26l211t3564r586b3674],
2	N	NN	PERSON	n	dep	1	SENT_572	[p26l615t3566r723b3668],
3	,	,	O	,	_	0	SENT_572	[p26l615t3566r723b3668],
4	Ekstrand	NNP	PERSON	Ekstrand	nn	5	SENT_572	[p26l761t3558r1201b3650],
5	AJ	NNP	PERSON	AJ	appos	2	SENT_572	[p26l1229t3566r1364b3668],
6	,	,	O	,	_	0	SENT_572	[p26l1229t3566r1364b3668],
7	James	NNP	PERSON	James	nn	8	SENT_572	[p26l1392t3566r1689b3662],
8	CD	NNP	O	CD	appos	2	SENT_572	[p26l1725t3564r1900b3668],
9	,	,	O	,	_	0	SENT_572	[p26l1725t3564r1900b3668],
10	Collins	NNP	PERSON	Collins	appos	2	SENT_572	[p26l1940t3558r2143b3648, p27l8t25r183b115],

1	VP	NN	O	vp	_	0	SENT_573	[p27l207t31r353b115],
2	.	.	O	.	_	0	SENT_573	[p27l207t31r353b115],

1	Identical	JJ	O	identical	amod	2	SENT_574	[p27l382t25r809b115],
2	splicing	NN	O	splicing	_	0	SENT_574	[p27l834t25r1225b141],
3	of	IN	O	of	_	0	SENT_574	[p27l1247t23r1363b115],
4	aberrant	JJ	O	aberrant	amod	9	SENT_574	[p27l1366t25r1783b115],
5	epidermal	JJ	O	epidermal	amod	9	SENT_574	[p27l1802t25r2145b141, p27l10t175r193b265],
6	growth	NN	O	growth	nn	9	SENT_574	[p27l223t175r574b291],
7	factor	NN	O	factor	nn	9	SENT_574	[p27l605t173r890b265],
8	receptor	NN	O	receptor	nn	9	SENT_574	[p27l918t193r1325b291],
9	transcripts	NNS	O	transcript	prep_of	2	SENT_574	[p27l1352t175r1874b291],
10	from	IN	O	from	_	0	SENT_574	[p27l1906t173r2147b265],
11	ampliﬁed	JJ	O	ampliﬁed	amod	13	SENT_574	[p27l10t323r478b441],
12	rearranged	JJ	O	rearranged	amod	13	SENT_574	[p27l516t325r1048b441],
13	genes	NNS	O	gene	prep_from	9	SENT_574	[p27l1087t355r1365b441],
14	in	IN	O	in	_	0	SENT_574	[p27l1406t325r1500b413],
15	human	JJ	O	human	amod	16	SENT_574	[p27l1537t325r1884b417],
16	glioblastomas	NNS	O	glioblastoma	prep_in	2	SENT_574	[p27l1922t325r2145b441, p27l10t475r538b565],
17	.	.	O	.	_	0	SENT_574	[p27l1922t325r2145b441, p27l10t475r538b565],

1	Proc	NNP	ORGANIZATION	Proc	nn	7	SENT_575	[p27l583t481r801b565],
2	Natl	NNP	ORGANIZATION	Natl	nn	7	SENT_575	[p27l838t475r1048b565],
3	Acad	NNP	ORGANIZATION	Acad	nn	7	SENT_575	[p27l1083t475r1328b565],
4	Sci	NNP	ORGANIZATION	Sci	nn	7	SENT_575	[p27l1370t475r1510b565],
5	U	NNP	ORGANIZATION	U	nn	7	SENT_575	[p27l1548t483r1628b565],
6	S	NNP	ORGANIZATION	S	nn	7	SENT_575	[p27l1669t481r1719b565],
7	A	NNP	O	A	_	0	SENT_575	[p27l1759t483r1836b563],
8	1990	CD	DATE	1990	num	7	SENT_575	[p27l1878t481r2143b585],
9	;	:	O	;	_	0	SENT_575	[p27l1878t481r2143b585],
10	87:8602	CD	NUMBER	87:8602	number	11	SENT_575	[p27l10t631r534b715],
11	—	CD	NUMBER	—	dep	7	SENT_575	[p27l10t631r534b715],
12	6	CD	NUMBER	6	dep	11	SENT_575	[p27l10t631r534b715],
13	.	.	O	.	_	0	SENT_575	[p27l10t631r534b715],

1	23	CD	NUMBER	23	_	0	SENT_576	[p27l8t785r147b865],
2	.	.	O	.	_	0	SENT_576	[p27l8t785r147b865],

1	Ekstrand	NNP	PERSON	Ekstrand	nn	2	SENT_577	[p27l207t775r647b867],
2	A	NNP	O	A	_	0	SENT_577	[p27l697t783r833b885],
3	]	NN	O	]	dep	2	SENT_577	[p27l697t783r833b885],
4	,	,	O	,	_	0	SENT_577	[p27l697t783r833b885],
5	James	NNP	PERSON	James	nn	6	SENT_577	[p27l882t783r1179b879],
6	CD	NNP	O	CD	appos	3	SENT_577	[p27l1237t781r1414b885],
7	,	,	O	,	_	0	SENT_577	[p27l1237t781r1414b885],
8	Cayenee	NNP	ORGANIZATION	Cayenee	nn	9	SENT_577	[p27l1476t781r1875b865],
9	WK	NNP	ORGANIZATION	WK	appos	3	SENT_577	[p27l1926t783r2139b885],
10	,	,	O	,	_	0	SENT_577	[p27l1926t783r2139b885],
11	Seliger	NNP	PERSON	Seliger	nn	12	SENT_577	[p27l12t925r345b1041],
12	B	NNP	PERSON	B	appos	3	SENT_577	[p27l380t933r474b1035],
13	,	,	O	,	_	0	SENT_577	[p27l380t933r474b1035],
14	Pettersson	NNP	PERSON	Pettersson	nn	15	SENT_577	[p27l520t931r1032b1015],
15	RF	NNP	O	RF	appos	3	SENT_577	[p27l1069t933r1217b1035],
16	,	,	O	,	_	0	SENT_577	[p27l1069t933r1217b1035],
17	Collins	NNP	ORGANIZATION	Collins	nn	18	SENT_577	[p27l1265t925r1608b1015],
18	VP	NNP	ORGANIZATION	VP	appos	3	SENT_577	[p27l1647t931r1793b1015],
19	.	.	O	.	_	0	SENT_577	[p27l1647t931r1793b1015],

1	Genes	NNS	O	gene	nsubj	8	SENT_578	[p27l1840t931r2143b1015],
2	for	IN	O	for	_	0	SENT_578	[p27l10t1073r152b1165],
3	epidermal	JJ	O	epidermal	amod	6	SENT_578	[p27l181t1075r673b1191],
4	growth	NN	O	growth	nn	6	SENT_578	[p27l703t1075r1056b1191],
5	factor	NN	O	factor	nn	6	SENT_578	[p27l1085t1073r1372b1165],
6	receptor	NN	O	receptor	prep_for	1	SENT_578	[p27l1398t1093r1823b1191],
7	,	,	O	,	_	0	SENT_578	[p27l1398t1093r1823b1191],
8	transforming	VBG	O	transform	_	0	SENT_578	[p27l1862t1093r2143b1165, p27l10t1223r416b1341],
9	growth	NN	O	growth	nn	10	SENT_578	[p27l438t1225r789b1341],
10	factor	NN	O	factor	dobj	8	SENT_578	[p27l814t1223r1100b1315],
11	alpha	NN	O	alpha	amod	10	SENT_578	[p27l1121t1225r1416b1341],
12	,	,	O	,	_	0	SENT_578	[p27l1121t1225r1416b1341],
13	and	CC	O	and	_	0	SENT_578	[p27l1448t1225r1629b1315],
14	epidermal	JJ	O	epidermal	amod	16	SENT_578	[p27l1655t1225r2147b1341],
15	growth	NN	O	growth	nn	16	SENT_578	[p27l10t1375r361b1491],
16	factor	NN	O	factor	conj_and	10	SENT_578	[p27l413t1373r699b1465],
17	and	CC	O	and	_	0	SENT_578	[p27l747t1375r928b1465],
18	their	PRP$	O	they	poss	19	SENT_578	[p27l980t1375r1209b1465],
19	expression	NN	O	expression	conj_and	10	SENT_578	[p27l1259t1375r1785b1491],
20	in	IN	O	in	_	0	SENT_578	[p27l1836t1375r1930b1463],
21	human	JJ	O	human	amod	22	SENT_578	[p27l1982t1375r2145b1467, p27l10t1555r227b1615],
22	gliomas	NNS	O	glioma	prep_in	8	SENT_578	[p27l271t1525r660b1641],
23	in	IN	O	in	_	0	SENT_578	[p27l707t1525r801b1613],
24	yiyo	NN	O	yiyo	prep_in	22	SENT_578	[p27l840t1525r1062b1617],
25	.	.	O	.	_	0	SENT_578	[p27l840t1525r1062b1617],

1	Cancer	NNP	O	Cancer	nn	2	SENT_579	[p27l1113t1531r1456b1615],
2	Res	NNP	O	Res	_	0	SENT_579	[p27l1496t1531r1669b1621],
3	1991	CD	DATE	1991	num	2	SENT_579	[p27l1721t1531r2143b1635],
4	;	:	O	;	_	0	SENT_579	[p27l1721t1531r2143b1635],
5	51	CD	NUMBER	51	num	7	SENT_579	[p27l1721t1531r2143b1635],
6	:	:	O	:	_	0	SENT_579	[p27l1721t1531r2143b1635],
7	2164-72	CD	NUMBER	2164-72	dep	2	SENT_579	[p27l10t1681r440b1765],
8	.	.	O	.	_	0	SENT_579	[p27l10t1681r440b1765],

1	26	CD	NUMBER	26	_	0	SENT_580	[p27l8t1835r147b1915],
2	.	.	O	.	_	0	SENT_580	[p27l8t1835r147b1915],

1	Sordella	NN	O	sordellum	nn	2	SENT_581	[p27l211t1825r609b1915],
2	R	NN	O	r	_	0	SENT_581	[p27l647t1833r747b1935],
3	,	,	O	,	_	0	SENT_581	[p27l647t1833r747b1935],
4	Bell	NNP	ORGANIZATION	Bell	nn	5	SENT_581	[p27l795t1825r980b1915],
5	DW	NNP	ORGANIZATION	DW	appos	2	SENT_581	[p27l1021t1833r1221b1935],
6	,	,	O	,	_	0	SENT_581	[p27l1021t1833r1221b1935],
7	Haber	NNP	ORGANIZATION	Haber	nn	8	SENT_581	[p27l1269t1825r1574b1915],
8	DA	NNP	ORGANIZATION	DA	appos	2	SENT_581	[p27l1611t1833r1791b1935],
9	,	,	O	,	_	0	SENT_581	[p27l1611t1833r1791b1935],
10	Settleman	NNP	O	Settleman	nn	12	SENT_581	[p27l1842t1825r2143b1915, p27l10t2005r227b2065],
11	J.	NNP	O	J.	nn	12	SENT_581	[p27l281t1983r349b2079],
12	Gefitinib	NNP	O	Gefitinib	appos	2	SENT_581	[p27l420t1973r1440b2091],
13	—	CD	NUMBER	—	num	16	SENT_581	[p27l420t1973r1440b2091],
14	sensitizing	VBG	O	sensitize	amod	16	SENT_581	[p27l420t1973r1440b2091],
15	EGFR	NN	ORGANIZATION	egfr	nn	16	SENT_581	[p27l1500t1981r1801b2071],
16	mutations	NNS	O	mutation	nsubj	20	SENT_581	[p27l1854t1993r2143b2067, p27l10t2125r251b2215],
17	in	IN	O	in	_	0	SENT_581	[p27l295t2125r389b2213],
18	lung	NN	O	lung	nn	19	SENT_581	[p27l428t2125r654b2241],
19	cancer	NN	O	cancer	prep_in	16	SENT_581	[p27l693t2155r1012b2215],
20	activate	VBP	O	activate	rcmod	12	SENT_581	[p27l1050t2125r1414b2217],
21	anti-apoptotic	JJ	O	anti-apoptotic	amod	22	SENT_581	[p27l1456t2125r2147b2241],
22	pathways	NNS	O	pathway	dobj	20	SENT_581	[p27l8t2275r492b2391],
23	.	.	O	.	_	0	SENT_581	[p27l8t2275r492b2391],

1	Science	NNP	O	Science	_	0	SENT_582	[p27l530t2275r892b2365],
2	2004	CD	DATE	2004	num	1	SENT_582	[p27l922t2281r1787b2385],
3	;	:	O	;	_	0	SENT_582	[p27l922t2281r1787b2385],
4	305:1163	CD	NUMBER	305:1163	num	5	SENT_582	[p27l922t2281r1787b2385],
5	—	NN	O	—	dep	1	SENT_582	[p27l922t2281r1787b2385],
6	7	CD	NUMBER	7	dep	5	SENT_582	[p27l922t2281r1787b2385],
7	.	.	O	.	_	0	SENT_582	[p27l922t2281r1787b2385],

1	27	CD	NUMBER	27	_	0	SENT_583	[p27l8t2435r147b2515],
2	.	.	O	.	_	0	SENT_583	[p27l8t2435r147b2515],

1	Choe	NNP	PERSON	Choe	nn	2	SENT_584	[p27l209t2425r462b2515],
2	G	NNP	PERSON	G	_	0	SENT_584	[p27l494t2431r604b2535],
3	,	,	O	,	_	0	SENT_584	[p27l494t2431r604b2535],
4	Horyath	NNP	PERSON	Horyath	nn	5	SENT_584	[p27l641t2425r1040b2515],
5	S	NNP	O	S	appos	2	SENT_584	[p27l1075t2431r1154b2535],
6	,	,	O	,	_	0	SENT_584	[p27l1075t2431r1154b2535],
7	Cloughesy	NNP	O	Cloughesy	nn	8	SENT_584	[p27l1193t2425r1709b2541],
8	TF	NN	O	tf	appos	2	SENT_584	[p27l1733t2431r1876b2535],
9	,	,	O	,	_	0	SENT_584	[p27l1733t2431r1876b2535],
10	et	FW	O	et	nn	11	SENT_584	[p27l1916t2443r2004b2515],
11	al.	FW	O	al.	appos	2	SENT_584	[p27l2030t2425r2139b2515],
12	.	.	O	.	_	0	SENT_584	[p27l2030t2425r2139b2515],

1	Analysis	NN	O	analysis	_	0	SENT_585	[p27l6t2575r412b2691],
2	of	IN	O	of	_	0	SENT_585	[p27l502t2573r618b2665],
3	the	DT	O	the	det	8	SENT_585	[p27l683t2575r833b2665],
4	phosphatidylinositol	NN	O	phosphatidylinositol	nn	8	SENT_585	[p27l918t2575r1936b2691],
5	3	CD	NUMBER	3	num	8	SENT_585	[p27l2023t2581r2145b2667, p27l10t2725r319b2817],
6	'	''	O	'	_	0	SENT_585	[p27l2023t2581r2145b2667, p27l10t2725r319b2817],
7	kinase	NN	O	kinase	nn	8	SENT_585	[p27l2023t2581r2145b2667, p27l10t2725r319b2817],
8	signaling	NN	O	signaling	nn	9	SENT_585	[p27l384t2725r837b2841],
9	pathway	NN	O	pathway	prep_of	1	SENT_585	[p27l892t2725r1302b2841],
10	in	IN	O	in	_	0	SENT_585	[p27l1358t2725r1452b2813],
11	glioblastoma	NN	O	glioblastoma	nn	12	SENT_585	[p27l1514t2725r2149b2841],
12	patients	NNS	O	patient	prep_in	9	SENT_585	[p27l8t2875r392b2991],
13	in	IN	O	in	_	0	SENT_585	[p27l420t2875r514b2963],
14	yiyo	NN	O	yiyo	prep_in	1	SENT_585	[p27l534t2875r753b2967],
15	.	.	O	.	_	0	SENT_585	[p27l534t2875r753b2967],

1	Cancer	NN	O	cancer	_	0	SENT_586	[p27l785t2881r1124b2965],
2	Res	NNP	O	Res	dep	1	SENT_586	[p27l1145t2881r1317b2971],
3	2003	CD	DATE	2003	num	2	SENT_586	[p27l1346t2881r1580b2967],
4	;	:	O	;	_	0	SENT_586	[p27l1595t2881r1735b2985],
5	63	CD	NUMBER	63	number	6	SENT_586	[p27l1595t2881r1735b2985],
6	:2742	CD	NUMBER	:2742	dep	1	SENT_586	[p27l1750t2881r2141b2965],
7	—	NN	O	—	dep	6	SENT_586	[p27l1750t2881r2141b2965],
8	6	CD	NUMBER	6	num	7	SENT_586	[p27l1750t2881r2141b2965],
9	.	.	O	.	_	0	SENT_586	[p27l1750t2881r2141b2965],

1	28	CD	NUMBER	28	_	0	SENT_587	[p27l8t3033r147b3117],
2	.	.	O	.	_	0	SENT_587	[p27l8t3033r147b3117],

1	Li	NNP	PERSON	Li	nn	2	SENT_588	[p27l207t3025r299b3113],
2	B	NNP	PERSON	B	_	0	SENT_588	[p27l326t3033r420b3135],
3	,	,	O	,	_	0	SENT_588	[p27l326t3033r420b3135],
4	Yuan	NNP	O	Yuan	nn	5	SENT_588	[p27l452t3033r695b3117],
5	M	NNP	O	M	appos	2	SENT_588	[p27l721t3033r848b3135],
6	,	,	O	,	_	0	SENT_588	[p27l721t3033r848b3135],
7	Kim	NNP	PERSON	Kim	nn	8	SENT_588	[p27l884t3025r1092b3117],
8	IA	NNP	O	IA	appos	5	SENT_588	[p27l1119t3033r1255b3135],
9	,	,	O	,	_	0	SENT_588	[p27l1119t3033r1255b3135],
10	Chang	NNP	PERSON	Chang	nn	11	SENT_588	[p27l1293t3025r1617b3141],
11	CM	NN	O	cm	appos	5	SENT_588	[p27l1643t3031r1841b3135],
12	,	,	O	,	_	0	SENT_588	[p27l1643t3031r1841b3135],
13	Bernhard	NNP	PERSON	Bernhard	nn	14	SENT_588	[p27l1876t3031r2145b3115, p27l10t3175r233b3265],
14	EJ	NNP	PERSON	EJ	appos	5	SENT_588	[p27l265t3183r390b3285],
15	,	,	O	,	_	0	SENT_588	[p27l265t3183r390b3285],
16	Shu	NNP	O	Shu	nn	17	SENT_588	[p27l432t3175r616b3267],
17	HK	NNP	O	HK	appos	5	SENT_588	[p27l649t3183r839b3267],
18	.	.	O	.	_	0	SENT_588	[p27l649t3183r839b3267],

1	Mutant	JJ	O	mutant	amod	6	SENT_589	[p27l876t3183r1239b3267],
2	epidermal	JJ	O	epidermal	amod	6	SENT_589	[p27l1269t3175r1762b3291],
3	growth	NN	O	growth	nn	6	SENT_589	[p27l1794t3175r2147b3291],
4	factor	NN	O	factor	nn	6	SENT_589	[p27l10t3323r295b3415],
5	receptor	NN	O	receptor	nn	6	SENT_589	[p27l327t3343r733b3441],
6	displays	NNS	O	display	nsubj	18	SENT_589	[p27l767t3325r1155b3441],
7	increased	VBD	O	increase	_	0	SENT_589	[p27l1193t3325r1657b3415],
8	signaling	NN	O	signaling	iobj	7	SENT_589	[p27l1695t3325r2151b3441],
9	through	IN	O	through	_	0	SENT_589	[p27l10t3475r407b3591],
10	the	DT	O	the	det	12	SENT_589	[p27l448t3475r598b3565],
11	phosphatidylinositol	NN	O	phosphatidylinositol	nn	12	SENT_589	[p27l639t3475r1753b3591],
12	—	NN	O	—	prep_through	8	SENT_589	[p27l639t3475r1753b3591],
13	3	CD	NUMBER	3	num	16	SENT_589	[p27l639t3475r1753b3591],
14	kinasel	NN	O	kinasel	nn	16	SENT_589	[p27l1798t3475r2145b3579],
15	AKT	NN	O	akt	nn	16	SENT_589	[p27l6t3631r229b3717],
16	pathway	NN	O	pathway	dobj	7	SENT_589	[p27l255t3625r667b3741],
17	and	CC	O	and	_	0	SENT_589	[p27l691t3625r871b3715],
18	promotes	VBZ	O	promote	conj_and	7	SENT_589	[p27l898t3643r1368b3741],
19	radioresistance	NN	O	radioresistance	dobj	18	SENT_589	[p27l1400t3625r2145b3715],
20	in	IN	O	in	_	0	SENT_589	[p28l10t25r104b113],
21	cells	NNS	O	cell	prep_in	18	SENT_589	[p28l133t25r343b115],
22	of	IN	O	of	_	0	SENT_589	[p28l375t23r492b115],
23	astrocytic	JJ	O	astrocytic	amod	24	SENT_589	[p28l498t25r964b141],
24	origin	NN	O	origin	prep_of	21	SENT_589	[p28l992t25r1313b141],
25	.	.	O	.	_	0	SENT_589	[p28l992t25r1313b141],

1	Oncogene	NN	O	oncogene	_	0	SENT_590	[p28l1348t31r1845b141],
2	2004	CD	DATE	2004	num	1	SENT_590	[p28l1874t31r2143b135],
3	;	:	O	;	_	0	SENT_590	[p28l1874t31r2143b135],
4	23:4594	CD	NUMBER	23:4594	num	5	SENT_590	[p28l10t181r657b265],
5	—	NN	O	—	dep	1	SENT_590	[p28l10t181r657b265],
6	602	CD	NUMBER	602	dep	5	SENT_590	[p28l10t181r657b265],
7	.	.	O	.	_	0	SENT_590	[p28l10t181r657b265],

1	29	CD	NUMBER	29	_	0	SENT_591	[p28l8t335r147b415],
2	.	.	O	.	_	0	SENT_591	[p28l8t335r147b415],

1	Huang	NNP	PERSON	Huang	nn	2	SENT_592	[p28l209t333r546b441],
2	HS	NN	O	h	_	0	SENT_592	[p28l575t331r747b435],
3	,	,	O	,	_	0	SENT_592	[p28l575t331r747b435],
4	Nagane	NN	O	nagane	nn	5	SENT_592	[p28l787t333r1163b441],
5	M	NN	O	m	appos	2	SENT_592	[p28l1195t333r1321b435],
6	,	,	O	,	_	0	SENT_592	[p28l1195t333r1321b435],
7	Klingbeil	NNP	ORGANIZATION	Klingbeil	nn	8	SENT_592	[p28l1362t325r1812b441],
8	CK	NNP	ORGANIZATION	CK	appos	2	SENT_592	[p28l1846t331r2022b435],
9	,	,	O	,	_	0	SENT_592	[p28l1846t331r2022b435],
10	et	FW	O	et	nn	11	SENT_592	[p28l2063t343r2153b415],
11	al.	FW	O	al.	appos	2	SENT_592	[p28l10t475r118b565],
12	.	.	O	.	_	0	SENT_592	[p28l10t475r118b565],

1	The	DT	O	the	_	0	SENT_593	[p28l169t475r355b565],
2	enhanced	VBN	O	enhance	partmod	1	SENT_593	[p28l404t475r875b565],
3	tumorigenic	JJ	O	tumorigenic	amod	4	SENT_593	[p28l922t475r1524b591],
4	activity	NN	O	activity	nsubjpass	17	SENT_593	[p28l1569t475r1912b591],
5	of	IN	O	of	_	0	SENT_593	[p28l1956t473r2072b565],
6	a	DT	O	a	det	11	SENT_593	[p28l2097t505r2149b565],
7	mutant	JJ	O	mutant	amod	11	SENT_593	[p28l10t643r371b717],
8	epidermal	JJ	O	epidermal	amod	11	SENT_593	[p28l430t625r922b741],
9	growth	NN	O	growth	nn	11	SENT_593	[p28l984t625r1336b741],
10	factor	NN	O	factor	nn	11	SENT_593	[p28l1398t623r1683b715],
11	receptor	NN	O	receptor	prep_of	4	SENT_593	[p28l1743t643r2151b741],
12	common	JJ	O	common	amod	11	SENT_593	[p28l10t803r452b865],
13	in	IN	O	in	_	0	SENT_593	[p28l492t775r586b863],
14	human	JJ	O	human	amod	15	SENT_593	[p28l628t775r976b867],
15	cancers	NNS	O	cancer	prep_in	12	SENT_593	[p28l1018t805r1381b865],
16	is	VBZ	O	be	auxpass	17	SENT_593	[p28l1424t775r1500b865],
17	mediated	VBN	O	mediate	ccomp	2	SENT_593	[p28l1543t775r1998b865],
18	by	IN	O	by	_	0	SENT_593	[p28l2039t775r2153b891],
19	threshold	NN	O	threshold	nn	20	SENT_593	[p28l10t925r480b1015],
20	levels	NNS	O	level	agent	17	SENT_593	[p28l566t925r831b1015],
21	of	IN	O	of	_	0	SENT_593	[p28l922t923r1038b1015],
22	constitutive	JJ	O	constitutive	amod	24	SENT_593	[p28l1105t925r1669b1017],
23	tyrosine	NN	O	tyrosine	nn	24	SENT_593	[p28l1758t925r2147b1041],
24	phosphorylation	NN	O	phosphorylation	prep_of	20	SENT_593	[p28l8t1075r822b1191],
25	and	CC	O	and	_	0	SENT_593	[p28l878t1075r1058b1165],
26	unattenuated	JJ	O	unattenuated	amod	27	SENT_593	[p28l1115t1075r1757b1167],
27	signaling	NN	O	signaling	prep_of	20	SENT_593	[p28l1816t1075r2145b1191, p28l10t1225r193b1341],
28	.	.	O	.	_	0	SENT_593	[p28l1816t1075r2145b1191, p28l10t1225r193b1341],
29	]	SYM	O	]	dep	1	SENT_593	[p28l217t1233r261b1329],

1	Biol	NNP	ORGANIZATION	Biol	nn	2	SENT_594	[p28l285t1225r480b1315],
2	Chem	NNP	ORGANIZATION	Chem	_	0	SENT_594	[p28l508t1225r799b1315],
3	1997	CD	DATE	1997	num	2	SENT_594	[p28l832t1231r1755b1335],
4	;	:	O	;	_	0	SENT_594	[p28l832t1231r1755b1335],
5	272:2927	CD	NUMBER	272:2927	number	6	SENT_594	[p28l832t1231r1755b1335],
6	—	CD	NUMBER	—	dep	2	SENT_594	[p28l832t1231r1755b1335],
7	35	CD	NUMBER	35	dep	6	SENT_594	[p28l832t1231r1755b1335],
8	.	.	O	.	_	0	SENT_594	[p28l832t1231r1755b1335],

1	30	CD	NUMBER	30	_	0	SENT_595	[p28l10t1383r147b1465],
2	.	.	O	.	_	0	SENT_595	[p28l10t1383r147b1465],

1	Batra	NNP	PERSON	Batra	nn	2	SENT_596	[p28l207t1381r460b1465],
2	SK	NNP	O	SK	_	0	SENT_596	[p28l486t1381r641b1485],
3	,	,	O	,	_	0	SENT_596	[p28l486t1381r641b1485],
4	Castelino	NNP	O	Castelino	appos	2	SENT_596	[p28l671t1375r1508b1467],
5	—	CD	NUMBER	—	num	7	SENT_596	[p28l671t1375r1508b1467],
6	l3rabhu	NN	O	l3rabhu	nn	7	SENT_596	[p28l671t1375r1508b1467],
7	S	NN	O	s	dep	4	SENT_596	[p28l1534t1381r1613b1485],
8	,	,	O	,	_	0	SENT_596	[p28l1534t1381r1613b1485],
9	Wikstrand	NN	O	wikstrand	nn	11	SENT_596	[p28l1639t1375r2147b1467],
10	C	NN	O	c	nn	11	SENT_596	[p28l10t1531r144b1635],
11	]	NN	O	]	appos	2	SENT_596	[p28l10t1531r144b1635],
12	,	,	O	,	_	0	SENT_596	[p28l10t1531r144b1635],
13	et	FW	O	et	nn	14	SENT_596	[p28l197t1543r287b1615],
14	al.	FW	O	al.	appos	2	SENT_596	[p28l327t1525r438b1615],
15	.	.	O	.	_	0	SENT_596	[p28l327t1525r438b1615],

1	Epidermal	JJ	O	epidermal	amod	3	SENT_597	[p28l490t1525r1008b1641],
2	growth	NN	O	growth	nn	3	SENT_597	[p28l1054t1525r1412b1641],
3	factor	NN	O	factor	nsubj	10	SENT_597	[p28l1458t1523r1749b1615],
4	ligandindependent	JJ	O	ligandindependent	amod	6	SENT_597	[p28l1790t1525r2145b1641, p28l10t1675r655b1791],
5	,	,	O	,	_	0	SENT_597	[p28l1790t1525r2145b1641, p28l10t1675r655b1791],
6	unregulated	JJ	O	unregulated	amod	3	SENT_597	[p28l723t1675r1338b1791],
7	,	,	O	,	_	0	SENT_597	[p28l723t1675r1338b1791],
8	cell	NN	O	cell	nn	9	SENT_597	[p28l1408t1673r2145b1765],
9	—	NN	O	—	appos	3	SENT_597	[p28l1408t1673r2145b1765],
10	transform	VBP	O	transform	_	0	SENT_597	[p28l1408t1673r2145b1765],
11	—	NN	O	—	dobj	10	SENT_597	[p28l1408t1673r2145b1765],

1	IIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIIII	CD	NUMBER	iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii	npadvmod	2	SENT_598	[p28l672t2088r1449b2107],
2	AS	JJ	O	as	_	0	SENT_598	[p28l1452t2088r1488b2107],

1	ing	VBG	O	ing	_	0	SENT_599	[p28l8t2408r170b2524],
2	potential	NN	O	potential	dobj	1	SENT_599	[p28l189t2406r626b2522],
3	of	IN	O	of	_	0	SENT_599	[p28l652t2406r770b2498],
4	a	DT	O	a	det	10	SENT_599	[p28l773t2436r824b2498],
5	naturally	RB	O	naturally	amod	10	SENT_599	[p28l849t2406r1280b2522],
6	occurring	VBG	O	occur	dep	5	SENT_599	[p28l1302t2408r1780b2524],
7	human	JJ	O	human	amod	9	SENT_599	[p28l1802t2406r2149b2498],
8	mutant	JJ	O	mutant	amod	9	SENT_599	[p28l10t2576r371b2648],
9	EGFRVIII	NN	O	egfrviius	dobj	6	SENT_599	[p28l407t2564r861b2654],
10	gene	NN	O	gene	prep_of	2	SENT_599	[p28l903t2586r1162b2674],
11	.	.	O	.	_	0	SENT_599	[p28l903t2586r1162b2674],

1	Cell	NN	O	cell	nn	2	SENT_600	[p28l1212t2558r1400b2648],
2	Growth	NN	O	growth	nsubj	3	SENT_600	[p28l1443t2558r1820b2648],
3	Differ	VBP	O	differ	_	0	SENT_600	[p28l1862t2556r2151b2648],
4	1995	CD	DATE	1995	dobj	3	SENT_600	[p28l14t2714r752b2816],
5	;	:	O	;	_	0	SENT_600	[p28l14t2714r752b2816],
6	6:1251	CD	NUMBER	6:1251	number	7	SENT_600	[p28l14t2714r752b2816],
7	—	CD	NUMBER	—	dep	4	SENT_600	[p28l14t2714r752b2816],
8	9	CD	NUMBER	9	dep	7	SENT_600	[p28l14t2714r752b2816],
9	.	.	O	.	_	0	SENT_600	[p28l14t2714r752b2816],

1	31	CD	NUMBER	31	_	0	SENT_601	[p28l10t2868r146b2948],
2	.	.	O	.	_	0	SENT_601	[p28l10t2868r146b2948],

1	Weinstein	NNP	PERSON	Weinstein	_	0	SENT_602	[p28l205t2858r698b2948],
2	TB	NN	O	tb	dep	1	SENT_602	[p28l749t2864r881b2948],
3	.	.	O	.	_	0	SENT_602	[p28l749t2864r881b2948],

1	Addiction	NN	O	addiction	nsubj	4	SENT_603	[p28l937t2856r1422b2948],
2	to	TO	O	to	_	0	SENT_603	[p28l1475t2876r1567b2948],
3	oncogenes	NNS	O	oncogene	prep_to	1	SENT_603	[p28l1623t2886r2145b2974],
4	—	VBP	O	—	_	0	SENT_603	[p28l6t3060r130b3068],
5	the	DT	O	the	det	6	SENT_603	[p28l155t3008r305b3098],
6	Achilles	NNPS	MISC	Achilles	nsubj	7	SENT_603	[p28l329t3006r720b3098],
7	heal	VBP	O	heal	ccomp	4	SENT_603	[p28l751t3006r953b3098],
8	of	IN	O	of	_	0	SENT_603	[p28l983t3006r1099b3098],
9	cancer	NN	O	cancer	prep_of	7	SENT_603	[p28l1106t3036r1444b3098],
10	.	.	O	.	_	0	SENT_603	[p28l1106t3036r1444b3098],

1	Science	NNP	O	Science	_	0	SENT_604	[p28l1481t3008r1844b3098],
2	2002	CD	DATE	2002	num	1	SENT_604	[p28l1874t3014r2143b3116],
3	;	:	O	;	_	0	SENT_604	[p28l1874t3014r2143b3116],
4	297:63	CD	NUMBER	297:63	number	5	SENT_604	[p28l10t3164r473b3248],
5	—	CD	NUMBER	—	dep	1	SENT_604	[p28l10t3164r473b3248],
6	4	CD	NUMBER	4	dep	5	SENT_604	[p28l10t3164r473b3248],
7	.	.	O	.	_	0	SENT_604	[p28l10t3164r473b3248],

1	32	CD	NUMBER	32	_	0	SENT_605	[p28l10t3318r146b3398],
2	.	.	O	.	_	0	SENT_605	[p28l10t3318r146b3398],

1	Ermoian	JJ	O	ermoian	amod	2	SENT_606	[p28l207t3308r630b3398],
2	RP	NN	O	rp	_	0	SENT_606	[p28l670t3314r820b3418],
3	,	,	O	,	_	0	SENT_606	[p28l670t3314r820b3418],
4	Furniss	NNP	PERSON	Furniss	nn	5	SENT_606	[p28l865t3308r1228b3398],
5	CS	NNP	O	CS	appos	2	SENT_606	[p28l1270t3314r1428b3418],
6	,	,	O	,	_	0	SENT_606	[p28l1270t3314r1428b3418],
7	Lamborn	NNP	O	Lamborn	nn	8	SENT_606	[p28l1475t3306r1924b3398],
8	KR	NNP	O	KR	appos	2	SENT_606	[p28l1965t3314r2141b3418],
9	,	,	O	,	_	0	SENT_606	[p28l1965t3314r2141b3418],
10	et	FW	O	et	nn	11	SENT_606	[p28l10t3476r100b3548],
11	al.	FW	O	al.	appos	2	SENT_606	[p28l123t3458r232b3548],
12	.	.	O	.	_	0	SENT_606	[p28l123t3458r232b3548],

1	Dysregulation	NN	O	dysregulation	nsubjpass	10	SENT_607	[p28l267t3458r957b3574],
2	of	IN	O	of	_	0	SENT_607	[p28l987t3456r1105b3548],
3	PT	NN	O	pt	nn	4	SENT_607	[p28l1112t3464r1242b3546],
4	EN	NN	O	en	prep_of	1	SENT_607	[p28l1244t3466r1396b3548],
5	and	CC	O	and	_	0	SENT_607	[p28l1423t3456r1605b3548],
6	protein	NN	O	protein	nn	8	SENT_607	[p28l1633t3458r1990b3574],
7	kinase	NN	O	kinase	nn	8	SENT_607	[p28l2019t3458r2147b3550, p28l10t3636r228b3698],
8	B	NN	O	b	conj_and	4	SENT_607	[p28l271t3614r335b3698],
9	is	VBZ	O	be	auxpass	10	SENT_607	[p28l381t3608r457b3698],
10	associated	VBN	O	associate	_	0	SENT_607	[p28l504t3608r1009b3698],
11	With	IN	O	with	_	0	SENT_607	[p28l1048t3606r1268b3698],
12	glioma	NN	O	glioma	nn	13	SENT_607	[p28l1312t3608r1655b3724],
13	histology	NN	O	histology	prep_with	10	SENT_607	[p28l1697t3608r2153b3724],
14	and	CC	O	and	_	0	SENT_607	[p29l8t23r190b115],
15	patient	NN	O	patient	nn	16	SENT_607	[p29l225t25r572b141],
16	survival	NN	O	survival	conj_and	13	SENT_607	[p29l606t25r1001b115],
17	.	.	O	.	_	0	SENT_607	[p29l606t25r1001b115],

1	Clin	NNP	O	Clin	nn	3	SENT_608	[p29l1046t25r1246b115],
2	Cancer	NNP	O	Cancer	nn	3	SENT_608	[p29l1284t31r1627b115],
3	Res	NNP	O	Res	_	0	SENT_608	[p29l1660t31r1834b121],
4	2002	CD	DATE	2002	num	3	SENT_608	[p29l1874t31r2143b135],
5	;	:	O	;	_	0	SENT_608	[p29l1874t31r2143b135],
6	8:1100	CD	NUMBER	8:1100	number	7	SENT_608	[p29l10t181r473b265],
7	—	CD	NUMBER	—	dep	3	SENT_608	[p29l10t181r473b265],
8	6	CD	NUMBER	6	dep	7	SENT_608	[p29l10t181r473b265],
9	.	.	O	.	_	0	SENT_608	[p29l10t181r473b265],

1	33	CD	NUMBER	33	_	0	SENT_609	[p29l10t335r146b415],
2	.	.	O	.	_	0	SENT_609	[p29l10t335r146b415],

1	Bianco	NNP	PERSON	Bianco	nn	2	SENT_610	[p29l207t325r548b415],
2	R	NNP	PERSON	R	_	0	SENT_610	[p29l588t331r688b435],
3	,	,	O	,	_	0	SENT_610	[p29l588t331r688b435],
4	Shin	NNP	PERSON	Shin	nn	8	SENT_610	[p29l736t323r959b415],
5	I	PRP	PERSON	I	dep	8	SENT_610	[p29l997t333r1059b435],
6	,	,	O	,	_	0	SENT_610	[p29l997t333r1059b435],
7	Ritter	NNP	PERSON	Ritter	dep	8	SENT_610	[p29l1102t325r1386b421],
8	CA	NNP	O	CA	appos	2	SENT_610	[p29l1421t331r1595b435],
9	,	,	O	,	_	0	SENT_610	[p29l1421t331r1595b435],
10	et	FW	O	et	nn	11	SENT_610	[p29l1643t343r1733b415],
11	al.	FW	O	al.	appos	8	SENT_610	[p29l1766t323r1878b415],
12	.	.	O	.	_	0	SENT_610	[p29l1766t323r1878b415],

1	Loss	NN	O	loss	nsubj	9	SENT_611	[p29l1922t331r2145b415],
2	of	IN	O	of	_	0	SENT_611	[p29l10t473r128b565],
3	PTENIMMACIITEP	NN	O	ptenimmaciitep	prep_of	1	SENT_611	[p29l180t481r1160b577],
4	in	IN	O	in	_	0	SENT_611	[p29l1234t475r1328b563],
5	EGF	NN	ORGANIZATION	egf	nn	8	SENT_611	[p29l1402t481r1615b565],
6	receptorexpressing	JJ	O	receptorexpressing	amod	8	SENT_611	[p29l1692t493r2145b591, p29l10t625r542b741],
7	tumor	NN	O	tumor	nn	8	SENT_611	[p29l570t643r873b715],
8	cells	NNS	O	cell	prep_in	3	SENT_611	[p29l903t625r1113b715],
9	counteracts	VBZ	O	counteract	_	0	SENT_611	[p29l1148t643r1711b715],
10	the	DT	O	the	det	12	SENT_611	[p29l1744t623r1894b715],
11	antitumor	JJ	O	antitumor	amod	12	SENT_611	[p29l1924t625r2147b715, p29l10t793r315b865],
12	action	NN	O	action	dobj	9	SENT_611	[p29l337t775r636b865],
13	of	IN	O	of	_	0	SENT_611	[p29l664t773r780b865],
14	EGFR	NN	ORGANIZATION	egfr	nn	17	SENT_611	[p29l783t781r1084b871],
15	tyrosine	NN	O	tyrosine	nn	17	SENT_611	[p29l1098t775r1486b889],
16	kinase	NN	O	kinase	nn	17	SENT_611	[p29l1513t775r1826b865],
17	inhibitors	NNS	O	inhibitor	prep_of	12	SENT_611	[p29l1852t775r2147b865, p29l8t925r257b1015],
18	.	.	O	.	_	0	SENT_611	[p29l1852t775r2147b865, p29l8t925r257b1015],

1	Oncogene	NN	O	oncogene	_	0	SENT_612	[p29l291t931r790b1041],
2	2003	CD	DATE	2003	num	1	SENT_612	[p29l819t931r1685b1033],
3	;	:	O	;	_	0	SENT_612	[p29l819t931r1685b1033],
4	22:2812	CD	NUMBER	22:2812	number	5	SENT_612	[p29l819t931r1685b1033],
5	—	CD	NUMBER	—	dep	1	SENT_612	[p29l819t931r1685b1033],
6	22	CD	NUMBER	22	dep	5	SENT_612	[p29l819t931r1685b1033],
7	.	.	O	.	_	0	SENT_612	[p29l819t931r1685b1033],

1	34	CD	NUMBER	34	_	0	SENT_613	[p29l10t1085r146b1165],
2	.	.	O	.	_	0	SENT_613	[p29l10t1085r146b1165],

1	Stephens	NNP	PERSON	Stephens	nn	2	SENT_614	[p29l211t1073r652b1189],
2	P	NN	O	p	_	0	SENT_614	[p29l697t1081r771b1183],
3	,	,	O	,	_	0	SENT_614	[p29l697t1081r771b1183],
4	Hunter	NNP	PERSON	Hunter	nn	5	SENT_614	[p29l819t1081r1172b1165],
5	C	NNP	O	C	appos	2	SENT_614	[p29l1212t1081r1308b1185],
6	,	,	O	,	_	0	SENT_614	[p29l1212t1081r1308b1185],
7	Bignell	NNP	PERSON	Bignell	nn	8	SENT_614	[p29l1356t1073r1704b1191],
8	G	NNP	O	G	appos	2	SENT_614	[p29l1746t1081r1856b1185],
9	,	,	O	,	_	0	SENT_614	[p29l1746t1081r1856b1185],
10	et	FW	O	et	nn	11	SENT_614	[p29l1907t1093r1996b1165],
11	al.	FW	O	al.	appos	2	SENT_614	[p29l2033t1073r2141b1165],
12	.	.	O	.	_	0	SENT_614	[p29l2033t1073r2141b1165],

1	Lung	NN	O	lung	nn	2	SENT_615	[p29l8t1233r263b1341],
2	cancer	NN	O	cancer	_	0	SENT_615	[p29l297t1253r642b1315],
3	:	:	O	:	_	0	SENT_615	[p29l297t1253r642b1315],
4	intragenic	JJ	O	intragenic	amod	7	SENT_615	[p29l684t1225r1180b1341],
5	ERBB2	NN	O	erbb2	nn	7	SENT_615	[p29l1216t1231r1557b1321],
6	kinase	NN	O	kinase	nn	7	SENT_615	[p29l1597t1223r1910b1317],
7	mutations	NNS	O	mutation	dep	2	SENT_615	[p29l1949t1253r2147b1315, p29l10t1375r343b1465],
8	in	IN	O	in	_	0	SENT_615	[p29l373t1375r469b1463],
9	tumours	NNS	O	tumour	prep_in	7	SENT_615	[p29l497t1393r939b1465],
10	.	.	O	.	_	0	SENT_615	[p29l497t1393r939b1465],

1	Nature	NNP	O	Nature	_	0	SENT_616	[p29l973t1383r1308b1465],
2	2004	CD	DATE	2004	num	1	SENT_616	[p29l1337t1381r2141b1483],
3	;	:	O	;	_	0	SENT_616	[p29l1337t1381r2141b1483],
4	431:525	CD	NUMBER	431:525	number	5	SENT_616	[p29l1337t1381r2141b1483],
5	—	CD	NUMBER	—	dep	1	SENT_616	[p29l1337t1381r2141b1483],
6	6	CD	NUMBER	6	dep	5	SENT_616	[p29l1337t1381r2141b1483],
7	.	.	O	.	_	0	SENT_616	[p29l1337t1381r2141b1483],

1	35	CD	NUMBER	35	_	0	SENT_617	[p29l10t1535r146b1615],
2	.	.	O	.	_	0	SENT_617	[p29l10t1535r146b1615],

1	Steck	NNP	ORGANIZATION	Steck	nn	2	SENT_618	[p29l211t1523r473b1615],
2	PA	NN	ORGANIZATION	pa	_	0	SENT_618	[p29l490t1531r644b1635],
3	,	,	O	,	_	0	SENT_618	[p29l490t1531r644b1635],
4	Pershouse	NNP	PERSON	Pershouse	nn	5	SENT_618	[p29l674t1523r1177b1615],
5	MA	NNP	PERSON	MA	appos	2	SENT_618	[p29l1198t1533r1400b1635],
6	,	,	O	,	_	0	SENT_618	[p29l1198t1533r1400b1635],
7	Jasser	NNP	PERSON	Jasser	nn	8	SENT_618	[p29l1419t1533r1715b1629],
8	SA	NNP	O	SA	appos	2	SENT_618	[p29l1739t1531r1894b1633],
9	,	,	O	,	_	0	SENT_618	[p29l1739t1531r1894b1633],
10	et	FW	O	et	nn	11	SENT_618	[p29l1926t1543r2014b1615],
11	al.	FW	O	al.	appos	2	SENT_618	[p29l2033t1523r2141b1615],
12	.	.	O	.	_	0	SENT_618	[p29l2033t1523r2141b1615],

1	Identification	NN	O	identification	_	0	SENT_619	[p29l8t1673r670b1765],
2	of	IN	O	of	_	0	SENT_619	[p29l727t1673r844b1765],
3	a	DT	O	a	det	7	SENT_619	[p29l879t1705r929b1765],
4	candidate	NN	O	candidate	nn	7	SENT_619	[p29l985t1673r1456b1765],
5	tumour	NN	O	tumour	nn	7	SENT_619	[p29l1513t1693r1882b1765],
6	suppressor	NN	O	suppressor	nn	7	SENT_619	[p29l1937t1703r2147b1791, p29l8t1853r383b1941],
7	gene	NN	O	gene	prep_of	1	SENT_619	[p29l455t1853r718b1941],
8	,	,	O	,	_	0	SENT_619	[p29l455t1853r718b1941],
9	MMAC1	NN	O	mmac1	appos	1	SENT_619	[p29l797t1831r1238b1935],
10	,	,	O	,	_	0	SENT_619	[p29l797t1831r1238b1935],
11	at	IN	O	at	_	0	SENT_619	[p29l1320t1843r1414b1915],
12	chromosome	NN	O	chromosome	nn	14	SENT_619	[p29l1483t1825r2145b1915],
13	10q23	NN	O	10q23	nn	14	SENT_619	[p29l14t1981r399b2091],
14	.3	NN	NUMBER	.3	prep_at	1	SENT_619	[p29l14t1981r399b2091],
15	that	WDT	O	that	nsubjpass	17	SENT_619	[p29l427t1975r618b2065],
16	is	VBZ	O	be	auxpass	17	SENT_619	[p29l634t1975r708b2065],
17	mutated	VBN	O	mutate	rcmod	14	SENT_619	[p29l735t1973r1136b2065],
18	in	IN	O	in	_	0	SENT_619	[p29l1158t1975r1252b2063],
19	multiple	JJ	O	multiple	amod	21	SENT_619	[p29l1274t1975r1679b2091],
20	advanced	JJ	O	advanced	amod	21	SENT_619	[p29l1702t1973r2149b2065],
21	cancers	NNS	O	cancer	prep_in	17	SENT_619	[p29l10t2153r403b2215],
22	.	.	O	.	_	0	SENT_619	[p29l10t2153r403b2215],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_620	[p29l436t2133r618b2215],
2	Genet	NNP	PERSON	Genet	_	0	SENT_620	[p29l642t2131r939b2215],
3	1997	CD	DATE	1997	num	2	SENT_620	[p29l965t2131r1766b2235],
4	;	:	O	;	_	0	SENT_620	[p29l965t2131r1766b2235],
5	15:356	CD	NUMBER	15:356	number	6	SENT_620	[p29l965t2131r1766b2235],
6	—	CD	NUMBER	—	dep	2	SENT_620	[p29l965t2131r1766b2235],
7	62	CD	NUMBER	62	dep	6	SENT_620	[p29l965t2131r1766b2235],
8	.	.	O	.	_	0	SENT_620	[p29l965t2131r1766b2235],

1	36	CD	NUMBER	36	_	0	SENT_621	[p29l10t2285r146b2365],
2	.	.	O	.	_	0	SENT_621	[p29l10t2285r146b2365],

1	Li	NNP	PERSON	Li	nn	2	SENT_622	[p29l207t2275r297b2363],
2	J	NNP	PERSON	J	_	0	SENT_622	[p29l321t2283r389b2385],
3	,	,	O	,	_	0	SENT_622	[p29l321t2283r389b2385],
4	Yen	NNP	O	Yen	nn	5	SENT_622	[p29l428t2281r602b2365],
5	C	NNP	O	C	appos	2	SENT_622	[p29l638t2281r736b2383],
6	,	,	O	,	_	0	SENT_622	[p29l638t2281r736b2383],
7	Liavv	NNP	O	Liavv	nn	8	SENT_622	[p29l777t2275r1010b2365],
8	D	NNP	O	D	appos	2	SENT_622	[p29l1040t2281r1143b2385],
9	,	,	O	,	_	0	SENT_622	[p29l1040t2281r1143b2385],
10	et	FW	O	et	nn	11	SENT_622	[p29l1188t2293r1276b2365],
11	al.	FW	O	al.	appos	2	SENT_622	[p29l1306t2273r1416b2365],
12	.	.	O	.	_	0	SENT_622	[p29l1306t2273r1416b2365],

1	PTEN	NNP	ORGANIZATION	PTEN	_	0	SENT_623	[p29l1457t2281r1762b2383],
2	,	,	O	,	_	0	SENT_623	[p29l1457t2281r1762b2383],
3	a	DT	O	a	det	8	SENT_623	[p29l1804t2303r1856b2365],
4	putative	JJ	O	putative	amod	8	SENT_623	[p29l1888t2293r2145b2389, p29l10t2425r174b2515],
5	protein	NN	O	protein	nn	8	SENT_623	[p29l209t2425r564b2541],
6	tyrosine	NN	O	tyrosine	nn	8	SENT_623	[p29l600t2425r989b2539],
7	phosphatase	NN	O	phosphatase	nn	8	SENT_623	[p29l1023t2423r1647b2541],
8	gene	NN	O	gene	appos	1	SENT_623	[p29l1682t2453r1912b2541],
9	mutated	VBN	O	mutate	partmod	8	SENT_623	[p29l1948t2453r2145b2515, p29l10t2573r251b2665],
10	in	IN	O	in	_	0	SENT_623	[p29l293t2575r387b2663],
11	human	JJ	O	human	amod	14	SENT_623	[p29l430t2575r778b2665],
12	brain	NN	O	brain	nn	14	SENT_623	[p29l821t2575r1103b2685],
13	,	,	O	,	_	0	SENT_623	[p29l821t2575r1103b2685],
14	breast	NN	O	breast	prep_in	9	SENT_623	[p29l1154t2573r1476b2685],
15	,	,	O	,	_	0	SENT_623	[p29l1154t2573r1476b2685],
16	and	CC	O	and	_	0	SENT_623	[p29l1525t2573r1706b2665],
17	prostate	NN	O	prostate	nn	18	SENT_623	[p29l1746t2593r2147b2691],
18	cancer	NN	O	cancer	prep_in	9	SENT_623	[p29l10t2753r347b2815],
19	.	.	O	.	_	0	SENT_623	[p29l10t2753r347b2815],

1	Science	NNP	O	Science	_	0	SENT_624	[p29l386t2725r748b2815],
2	1997	CD	DATE	1997	num	1	SENT_624	[p29l781t2731r1643b2833],
3	;	:	O	;	_	0	SENT_624	[p29l781t2731r1643b2833],
4	275:1943	CD	NUMBER	275:1943	num	5	SENT_624	[p29l781t2731r1643b2833],
5	—	NN	O	—	dep	1	SENT_624	[p29l781t2731r1643b2833],
6	7	CD	NUMBER	7	dep	5	SENT_624	[p29l781t2731r1643b2833],
7	.	.	O	.	_	0	SENT_624	[p29l781t2731r1643b2833],

1	37	CD	NUMBER	37	_	0	SENT_625	[p29l10t2885r146b2965],
2	.	.	O	.	_	0	SENT_625	[p29l10t2885r146b2965],

1	Furnari	NNP	PERSON	Furnari	nn	2	SENT_626	[p29l207t2875r570b2965],
2	FB	NNP	O	FB	_	0	SENT_626	[p29l630t2881r786b2985],
3	,	,	O	,	_	0	SENT_626	[p29l630t2881r786b2985],
4	Huang	NNP	PERSON	Huang	nn	6	SENT_626	[p29l855t2883r1192b2991],
5	H	NNP	O	H	nn	6	SENT_626	[p29l1252t2883r1398b2985],
6	]	NN	O	]	appos	2	SENT_626	[p29l1252t2883r1398b2985],
7	,	,	O	,	_	0	SENT_626	[p29l1252t2883r1398b2985],
8	Cavenee	NNP	O	Cavenee	nn	9	SENT_626	[p29l1469t2881r1868b2965],
9	WK	NNP	DURATION	WK	appos	6	SENT_626	[p29l1928t2881r2141b2967],
10	.	.	O	.	_	0	SENT_626	[p29l1928t2881r2141b2967],

1	The	DT	O	the	det	4	SENT_627	[p29l6t3023r192b3115],
2	phosphoinositol	NN	O	phosphoinositol	nn	4	SENT_627	[p29l253t3025r1066b3141],
3	phosphatase	NN	O	phosphatase	nn	4	SENT_627	[p29l1124t3025r1748b3141],
4	activity	NN	O	activity	nsubj	7	SENT_627	[p29l1810t3025r2153b3139],
5	of	IN	O	of	_	0	SENT_627	[p29l10t3173r126b3265],
6	PTEN	NN	ORGANIZATION	pten	prep_of	4	SENT_627	[p29l175t3181r460b3265],
7	mediates	VBZ	O	mediate	_	0	SENT_627	[p29l530t3173r967b3265],
8	a	DT	O	a	det	12	SENT_627	[p29l1040t3205r1093b3265],
9	serum	NN	O	serum	nn	12	SENT_627	[p29l1164t3175r1932b3265],
10	—	NN	O	—	nn	12	SENT_627	[p29l1164t3175r1932b3265],
11	sensitive	JJ	O	sensitive	amod	12	SENT_627	[p29l1164t3175r1932b3265],
12	G1	NN	O	g1	dobj	7	SENT_627	[p29l2005t3181r2147b3265],

1	growth	NN	O	growth	nn	2	SENT_628	[p30l9t80r178b136],
2	arrest	NN	O	arrest	_	0	SENT_628	[p30l203t89r339b124],
3	in	IN	O	in	_	0	SENT_628	[p30l361t80r406b123],
4	glioma	NN	O	glioma	nn	5	SENT_628	[p30l431t79r597b136],
5	cells	NNS	O	cell	prep_in	2	SENT_628	[p30l621t79r737b124],
6	.	.	O	.	_	0	SENT_628	[p30l621t79r737b124],

1	Cancer	NNP	O	Cancer	nn	2	SENT_629	[p30l766t83r932b124],
2	Res	NNP	O	Res	_	0	SENT_629	[p30l954t83r1038b126],
3	1998	CD	DATE	1998	num	2	SENT_629	[p30l11t154r396b204],
4	;	:	O	;	_	0	SENT_629	[p30l11t154r396b204],
5	58:5002	CD	NUMBER	58:5002	number	6	SENT_629	[p30l11t154r396b204],
6	—	CD	NUMBER	—	dep	2	SENT_629	[p30l11t154r396b204],
7	8	CD	NUMBER	8	dep	6	SENT_629	[p30l11t154r396b204],
8	.	.	O	.	_	0	SENT_629	[p30l11t154r396b204],

1	38	CD	NUMBER	38	_	0	SENT_630	[p30l9t226r74b266],
2	.	.	O	.	_	0	SENT_630	[p30l9t226r74b266],

1	Furnari	NNP	PERSON	Furnari	nn	2	SENT_631	[p30l104t222r278b266],
2	FB	NNP	O	FB	_	0	SENT_631	[p30l296t225r371b275],
3	,	,	O	,	_	0	SENT_631	[p30l296t225r371b275],
4	Lin	NNP	PERSON	Lin	nn	5	SENT_631	[p30l392t222r467b265],
5	H	NNP	PERSON	H	appos	2	SENT_631	[p30l486t225r540b275],
6	,	,	O	,	_	0	SENT_631	[p30l486t225r540b275],
7	Huang	NNP	PERSON	Huang	nn	8	SENT_631	[p30l562t225r724b278],
8	HS	NN	O	h	appos	2	SENT_631	[p30l740t225r824b275],
9	,	,	O	,	_	0	SENT_631	[p30l740t225r824b275],
10	Cavenee	NNP	O	Cavenee	nn	11	SENT_631	[p30l846t225r1038b266],
11	WK	NNP	DURATION	WK	appos	2	SENT_631	[p30l7t296r110b338],
12	.	.	O	.	_	0	SENT_631	[p30l7t296r110b338],

1	Growth	NN	O	growth	nn	2	SENT_632	[p30l139t293r323b337],
2	suppression	NN	O	suppression	nsubj	8	SENT_632	[p30l350t293r643b349],
3	of	IN	O	of	_	0	SENT_632	[p30l668t292r725b337],
4	glioma	NN	O	glioma	nn	5	SENT_632	[p30l740t292r908b349],
5	cells	NNS	O	cell	prep_of	2	SENT_632	[p30l933t293r1037b337],
6	by	IN	O	by	_	0	SENT_632	[p30l9t364r64b420],
7	PTEN	NN	ORGANIZATION	pten	prep_by	5	SENT_632	[p30l79t367r216b408],
8	requires	VBZ	O	require	_	0	SENT_632	[p30l231t364r422b420],
9	a	DT	O	a	det	13	SENT_632	[p30l440t378r465b407],
10	functional	JJ	O	functional	amod	13	SENT_632	[p30l480t363r722b408],
11	phosphatase	NN	O	phosphatase	nn	13	SENT_632	[p30l738t363r1038b420],
12	catalytic	JJ	O	catalytic	amod	13	SENT_632	[p30l9t435r200b491],
13	domain	NN	O	domain	dobj	8	SENT_632	[p30l220t434r414b479],
14	.	.	O	.	_	0	SENT_632	[p30l220t434r414b479],

1	Proc	NNP	O	Proc	nn	7	SENT_633	[p30l436t438r541b479],
2	Natl	NNP	O	Natl	nn	7	SENT_633	[p30l560t434r660b479],
3	Acad	NNP	O	Acad	nn	7	SENT_633	[p30l678t434r795b479],
4	Sci	NNP	O	Sci	nn	7	SENT_633	[p30l816t435r883b479],
5	U	NNP	O	U	nn	7	SENT_633	[p30l902t439r940b479],
6	S	NNP	O	S	nn	7	SENT_633	[p30l960t438r984b479],
7	A	NNP	O	A	_	0	SENT_633	[p30l1004t439r1040b478],
8	1997	CD	DATE	1997	num	7	SENT_633	[p30l11t509r455b559],
9	;	:	O	;	_	0	SENT_633	[p30l11t509r455b559],
10	94:12479	CD	NUMBER	94:12479	number	11	SENT_633	[p30l11t509r455b559],
11	—	CD	NUMBER	—	dep	7	SENT_633	[p30l11t509r455b559],
12	84	CD	NUMBER	84	dep	11	SENT_633	[p30l11t509r455b559],
13	.	.	O	.	_	0	SENT_633	[p30l11t509r455b559],

1	39	CD	NUMBER	39	_	0	SENT_634	[p30l9t581r74b620],
2	.	.	O	.	_	0	SENT_634	[p30l9t581r74b620],

1	Han	NNP	O	Han	nn	2	SENT_635	[p30l104t580r204b620],
2	Y	NN	O	y	_	0	SENT_635	[p30l229t580r267b630],
3	,	,	O	,	_	0	SENT_635	[p30l229t580r267b630],
4	Caday	NNP	O	Caday	nn	5	SENT_635	[p30l298t576r441b632],
5	CG	NNP	O	CG	appos	2	SENT_635	[p30l466t580r555b630],
6	,	,	O	,	_	0	SENT_635	[p30l466t580r555b630],
7	Nanda	NNP	PERSON	Nanda	nn	8	SENT_635	[p30l585t576r742b621],
8	A	NNP	O	A	appos	2	SENT_635	[p30l767t580r815b630],
9	,	,	O	,	_	0	SENT_635	[p30l767t580r815b630],
10	Cavenee	NNP	O	Cavenee	nn	11	SENT_635	[p30l846t580r1038b621],
11	WK	NNP	DURATION	WK	appos	2	SENT_635	[p30l7t652r109b701],
12	,	,	O	,	_	0	SENT_635	[p30l7t652r109b701],
13	Huang	NNP	PERSON	Huang	nn	14	SENT_635	[p30l127t652r289b704],
14	H	NNP	O	H	appos	2	SENT_635	[p30l302t652r372b698],
15	]	NN	O	]	dep	14	SENT_635	[p30l302t652r372b698],
16	.	.	O	.	_	0	SENT_635	[p30l302t652r372b698],

1	Tyrphostin	NN	O	tyrphostin	nsubj	5	SENT_636	[p30l388t648r645b704],
2	AG	NNP	O	AG	dep	1	SENT_636	[p30l657t651r733b692],
3	1478	CD	DATE	1478	num	2	SENT_636	[p30l750t651r863b692],
4	preferentially	RB	O	preferentially	advmod	5	SENT_636	[p30l878t647r1038b704, p30l9t718r178b775],
5	inhibits	VBZ	O	inhibit	_	0	SENT_636	[p30l187t718r365b763],
6	human	JJ	O	human	amod	8	SENT_636	[p30l379t718r545b763],
7	glioma	NN	O	glioma	nn	8	SENT_636	[p30l557t719r721b775],
8	cells	NNS	O	cell	dobj	5	SENT_636	[p30l732t718r833b763],
9	expressing	VBG	O	express	partmod	8	SENT_636	[p30l847t733r1038b775, p30l8t790r87b846],
10	truncated	VBN	O	truncate	dep	9	SENT_636	[p30l102t789r330b834],
11	rather	RB	O	rather	advmod	10	SENT_636	[p30l346t789r491b834],
12	than	IN	O	than	_	0	SENT_636	[p30l506t789r613b833],
13	wild	JJ	O	wild	amod	19	SENT_636	[p30l627t789r852b846],
14	—	NN	O	—	nn	19	SENT_636	[p30l627t789r852b846],
15	type	NN	O	type	nn	19	SENT_636	[p30l627t789r852b846],
16	epidermal	JJ	O	epidermal	amod	19	SENT_636	[p30l868t789r1038b846, p30l9t861r98b904],
17	growth	NN	O	growth	nn	19	SENT_636	[p30l125t860r297b917],
18	factor	NN	O	factor	nn	19	SENT_636	[p30l325t860r465b905],
19	receptors	NNS	O	receptor	prep_than	10	SENT_636	[p30l491t870r728b917],
20	.	.	O	.	_	0	SENT_636	[p30l491t870r728b917],

1	Cancer	NNP	O	Cancer	nn	2	SENT_637	[p30l759t864r927b905],
2	Res	NNP	O	Res	_	0	SENT_637	[p30l953t864r1037b907],
3	1996	CD	DATE	1996	num	2	SENT_637	[p30l11t935r426b985],
4	;	:	O	;	_	0	SENT_637	[p30l11t935r426b985],
5	56:3859	CD	NUMBER	56:3859	number	6	SENT_637	[p30l11t935r426b985],
6	—	CD	NUMBER	—	dep	2	SENT_637	[p30l11t935r426b985],
7	61	CD	NUMBER	61	dep	6	SENT_637	[p30l11t935r426b985],
8	.	.	O	.	_	0	SENT_637	[p30l11t935r426b985],

1	40	CD	NUMBER	40	_	0	SENT_638	[p30l7t1008r74b1047],
2	.	.	O	.	_	0	SENT_638	[p30l7t1008r74b1047],

1	Mishima	NNP	PERSON	Mishima	nn	2	SENT_639	[p30l103t1003r314b1047],
2	K	NNP	PERSON	K	_	0	SENT_639	[p30l330t1007r379b1057],
3	,	,	O	,	_	0	SENT_639	[p30l330t1007r379b1057],
4	Johns	NNP	PERSON	Johns	nn	5	SENT_639	[p30l394t1003r531b1054],
5	TG	NN	PERSON	tg	appos	2	SENT_639	[p30l548t1007r636b1057],
6	,	,	O	,	_	0	SENT_639	[p30l548t1007r636b1057],
7	Luwor	NNP	O	Luwor	nn	8	SENT_639	[p30l656t1007r808b1048],
8	RB	NN	O	rb	appos	2	SENT_639	[p30l823t1007r905b1057],
9	,	,	O	,	_	0	SENT_639	[p30l823t1007r905b1057],
10	et	FW	O	et	nn	11	SENT_639	[p30l926t1012r969b1047],
11	al.	FW	O	al.	appos	2	SENT_639	[p30l983t1003r1036b1047],
12	.	.	O	.	_	0	SENT_639	[p30l983t1003r1036b1047],

1	Growth	NN	O	growth	nn	2	SENT_640	[p30l9t1074r190b1118],
2	suppression	NN	O	suppression	_	0	SENT_640	[p30l219t1074r506b1130],
3	of	IN	O	of	_	0	SENT_640	[p30l534t1073r591b1118],
4	intracranial	JJ	O	intracranial	amod	6	SENT_640	[p30l608t1073r880b1117],
5	Xenografted	JJ	O	xenografted	amod	6	SENT_640	[p30l906t1088r1038b1118, p30l9t1144r176b1201],
6	glioblastomas	NNS	O	glioblastoma	prep_of	2	SENT_640	[p30l202t1145r534b1201],
7	overexpressing	VBG	O	overexpress	partmod	6	SENT_640	[p30l563t1145r918b1201],
8	mutant	JJ	O	mutant	amod	12	SENT_640	[p30l943t1159r1038b1189, p30l9t1225r103b1259],
9	epidermal	JJ	O	epidermal	amod	12	SENT_640	[p30l126t1215r364b1272],
10	growth	NN	O	growth	nn	12	SENT_640	[p30l388t1215r557b1272],
11	factor	NN	O	factor	nn	12	SENT_640	[p30l582t1215r720b1260],
12	receptors	NNS	O	receptor	dobj	7	SENT_640	[p30l743t1225r961b1272],
13	by	IN	O	by	_	0	SENT_640	[p30l987t1215r1041b1272],
14	systemic	JJ	O	systemic	amod	15	SENT_640	[p30l10t1287r209b1343],
15	administration	NN	O	administration	agent	7	SENT_640	[p30l221t1286r568b1331],
16	of	IN	O	of	_	0	SENT_640	[p30l581t1286r637b1331],
17	monoclonal	JJ	O	monoclonal	amod	20	SENT_640	[p30l639t1286r920b1331],
18	antibody	NN	O	antibody	nn	20	SENT_640	[p30l932t1287r1038b1330, p30l9t1357r124b1414],
19	(	CD	NUMBER	(	num	20	SENT_640	[p30l145t1358r291b1408],
20	mAb	NN	O	mab	prep_of	15	SENT_640	[p30l145t1358r291b1408],
21	)	NN	O	)	dep	2	SENT_640	[p30l145t1358r291b1408],
22	806	CD	NUMBER	806	num	21	SENT_640	[p30l314t1361r413b1411],
23	,	,	O	,	_	0	SENT_640	[p30l314t1361r413b1411],
24	a	DT	O	a	det	27	SENT_640	[p30l436t1372r461b1401],
25	novel	JJ	O	novel	amod	27	SENT_640	[p30l481t1358r606b1402],
26	monoclonal	JJ	O	monoclonal	amod	27	SENT_640	[p30l626t1357r911b1402],
27	antibody	NN	O	antibody	appos	21	SENT_640	[p30l931t1358r1038b1401, p30l9t1428r124b1485],
28	directed	VBN	O	direct	partmod	27	SENT_640	[p30l148t1428r337b1473],
29	to	TO	O	to	_	0	SENT_640	[p30l363t1437r407b1473],
30	the	DT	O	the	det	31	SENT_640	[p30l434t1428r506b1473],
31	receptor	NN	O	receptor	prep_to	28	SENT_640	[p30l531t1438r736b1485],
32	.	.	O	.	_	0	SENT_640	[p30l531t1438r736b1485],

1	Cancer	NNP	O	Cancer	nn	2	SENT_641	[p30l765t1432r931b1473],
2	Res	NNP	O	Res	_	0	SENT_641	[p30l954t1432r1037b1475],
3	2001	CD	DATE	2001	num	2	SENT_641	[p30l9t1503r435b1553],
4	;	:	O	;	_	0	SENT_641	[p30l9t1503r435b1553],
5	61:5349	CD	NUMBER	61:5349	number	6	SENT_641	[p30l9t1503r435b1553],
6	—	CD	NUMBER	—	dep	2	SENT_641	[p30l9t1503r435b1553],
7	54	CD	NUMBER	54	dep	6	SENT_641	[p30l9t1503r435b1553],
8	.	.	O	.	_	0	SENT_641	[p30l9t1503r435b1553],

1	[	NNP	O	[	nn	5	SENT_642	[p30l480t1503r708b1553],
2	Erratum	NNP	O	Erratum	nn	5	SENT_642	[p30l480t1503r708b1553],
3	,	,	O	,	_	0	SENT_642	[p30l480t1503r708b1553],
4	Cancer	NNP	O	Cancer	appos	5	SENT_642	[p30l749t1503r917b1544],
5	Res	NNP	O	Res	_	0	SENT_642	[p30l953t1503r1037b1546],
6	2001	CD	DATE	2001	num	5	SENT_642	[p30l9t1574r418b1624],
7	;	:	O	;	_	0	SENT_642	[p30l9t1574r418b1624],
8	61:7703	CD	NUMBER	61:7703	num	9	SENT_642	[p30l9t1574r418b1624],
9	—	CD	NUMBER	—	dep	5	SENT_642	[p30l9t1574r418b1624],
10	5	CD	NUMBER	5	rcmod	9	SENT_642	[p30l9t1574r418b1624],
11	.	.	O	.	_	0	SENT_642	[p30l9t1574r418b1624],
12	]	SYM	O	]	dep	5	SENT_642	[p30l9t1574r418b1624],

1	41	CD	NUMBER	41	_	0	SENT_643	[p30l7t1647r74b1685],
2	.	.	O	.	_	0	SENT_643	[p30l7t1647r74b1685],

1	Traxler	NNP	PERSON	Traxler	nn	2	SENT_644	[p30l103t1641r270b1685],
2	P	NN	O	p	_	0	SENT_644	[p30l287t1645r323b1695],
3	,	,	O	,	_	0	SENT_644	[p30l287t1645r323b1695],
4	Bold	JJ	O	bold	amod	5	SENT_644	[p30l345t1641r454b1685],
5	G	NN	O	g	appos	2	SENT_644	[p30l473t1645r526b1695],
6	,	,	O	,	_	0	SENT_644	[p30l473t1645r526b1695],
7	Buchdunger	NNP	O	Buchdunger	nn	8	SENT_644	[p30l548t1641r840b1698],
8	E	NNP	O	E	appos	2	SENT_644	[p30l857t1645r901b1695],
9	,	,	O	,	_	0	SENT_644	[p30l857t1645r901b1695],
10	et	FW	O	et	nn	11	SENT_644	[p30l924t1650r967b1685],
11	al.	FW	O	al.	appos	2	SENT_644	[p30l983t1641r1035b1685],
12	.	.	O	.	_	0	SENT_644	[p30l983t1641r1035b1685],

1	Tyrosine	NN	O	tyrosine	nn	3	SENT_645	[p30l7t1713r208b1769],
2	kinase	NN	O	kinase	nn	3	SENT_645	[p30l220t1712r371b1757],
3	inhibitors	NNS	O	inhibitor	_	0	SENT_645	[p30l383t1712r629b1757],
4	:	:	O	:	_	0	SENT_645	[p30l383t1712r629b1757],
5	from	IN	O	from	_	0	SENT_645	[p30l644t1712r760b1757],
6	rational	JJ	O	rational	amod	7	SENT_645	[p30l772t1712r954b1757],
7	design	NN	O	design	prep_from	3	SENT_645	[p30l966t1712r1038b1757, p30l10t1784r108b1840],
8	to	TO	O	to	_	0	SENT_645	[p30l124t1793r168b1828],
9	clinical	JJ	O	clinical	amod	10	SENT_645	[p30l184t1783r352b1827],
10	trials	NNS	O	trial	prep_to	7	SENT_645	[p30l368t1783r497b1828],
11	.	.	O	.	_	0	SENT_645	[p30l368t1783r497b1828],

1	Med	NNP	O	Med	nn	3	SENT_646	[p30l514t1783r619b1828],
2	Res	NNP	O	Res	nn	3	SENT_646	[p30l633t1787r717b1830],
3	Rev	NN	O	rev	_	0	SENT_646	[p30l732t1787r819b1830],
4	2001	CD	DATE	2001	num	3	SENT_646	[p30l832t1787r1037b1837],
5	;	:	O	;	_	0	SENT_646	[p30l832t1787r1037b1837],
6	21	CD	NUMBER	21	num	8	SENT_646	[p30l832t1787r1037b1837],
7	:	:	O	:	_	0	SENT_646	[p30l832t1787r1037b1837],
8	499-512	CD	NUMBER	499-512	dep	3	SENT_646	[p30l8t1858r216b1899],
9	.	.	O	.	_	0	SENT_646	[p30l8t1858r216b1899],

1	42	CD	NUMBER	42	_	0	SENT_647	[p30l7t1931r74b1969],
2	.	.	O	.	_	0	SENT_647	[p30l7t1931r74b1969],

1	Mellinghoff	NNP	O	Mellinghoff	nn	2	SENT_648	[p30l103t1925r395b1982],
2	IK	NNP	O	IK	_	0	SENT_648	[p30l416t1929r483b1979],
3	,	,	O	,	_	0	SENT_648	[p30l416t1929r483b1979],
4	Tran	NNP	O	Tran	nn	5	SENT_648	[p30l516t1929r626b1969],
5	C	NNP	O	C	appos	2	SENT_648	[p30l657t1929r704b1979],
6	,	,	O	,	_	0	SENT_648	[p30l657t1929r704b1979],
7	Sawyers	NNP	O	Sawyers	nn	8	SENT_648	[p30l740t1929r926b1981],
8	CL	NN	O	cl	appos	5	SENT_648	[p30l959t1929r1035b1970],
9	.	.	O	.	_	0	SENT_648	[p30l959t1929r1035b1970],

1	Growth	NN	O	growth	nn	3	SENT_649	[p30l9t1997r190b2041],
2	inhibitory	JJ	O	inhibitory	amod	3	SENT_649	[p30l204t1997r438b2053],
3	effects	NNS	O	effect	_	0	SENT_649	[p30l450t1996r601b2041],
4	of	IN	O	of	_	0	SENT_649	[p30l616t1996r673b2041],
5	the	DT	O	the	det	7	SENT_649	[p30l676t1996r748b2041],
6	dual	JJ	O	dual	amod	7	SENT_649	[p30l763t1996r864b2041],
7	ErbB1	NN	O	erbb1	prep_of	3	SENT_649	[p30l877t1996r1038b2047],
8	/	:	O	/	punct	3	SENT_649	[p30l877t1996r1038b2047],
9	ErbB2	NN	O	erbb2	nn	14	SENT_649	[p30l8t2068r153b2112],
10	tyrosine	NN	O	tyrosine	nn	14	SENT_649	[p30l171t2068r358b2124],
11	kinase	NN	O	kinase	nn	14	SENT_649	[p30l376t2067r527b2112],
12	inhibitor	NN	O	inhibitor	nn	14	SENT_649	[p30l544t2067r754b2112],
13	PKI	NN	O	pkus	nn	14	SENT_649	[p30l769t2071r961b2113],
14	—	NN	O	—	dep	3	SENT_649	[p30l769t2071r961b2113],
15	166	CD	NUMBER	166	dep	14	SENT_649	[p30l769t2071r961b2113],
16	on	IN	O	on	_	0	SENT_649	[p30l979t2082r1039b2112],
17	human	JJ	O	human	amod	20	SENT_649	[p30l9t2139r176b2183],
18	prostate	NN	O	prostate	nn	20	SENT_649	[p30l197t2148r390b2195],
19	cancer	NN	O	cancer	nn	20	SENT_649	[p30l413t2153r567b2182],
20	Xenografts	NNS	MISC	xenograft	prep_on	14	SENT_649	[p30l586t2138r849b2195],
21	.	.	O	.	_	0	SENT_649	[p30l586t2138r849b2195],

1	Cancer	NNP	O	Cancer	nn	2	SENT_650	[p30l875t2142r1040b2183],
2	Res	NNP	O	Res	_	0	SENT_650	[p30l8t2213r91b2256],
3	2002	CD	DATE	2002	num	2	SENT_650	[p30l107t2213r494b2263],
4	;	:	O	;	_	0	SENT_650	[p30l107t2213r494b2263],
5	62:5254	CD	NUMBER	62:5254	number	6	SENT_650	[p30l107t2213r494b2263],
6	-9	CD	NUMBER	-9	dep	2	SENT_650	[p30l107t2213r494b2263],
7	.	.	O	.	_	0	SENT_650	[p30l107t2213r494b2263],

1	43	CD	NUMBER	43	_	0	SENT_651	[p30l1112t85r1179b123],
2	.	.	O	.	_	0	SENT_651	[p30l1112t85r1179b123],

1	Holbro	NNP	ORGANIZATION	Holbro	nn	2	SENT_652	[p30l1208t79r1377b124],
2	T	NN	ORGANIZATION	t	_	0	SENT_652	[p30l1389t83r1430b133],
3	,	,	O	,	_	0	SENT_652	[p30l1389t83r1430b133],
4	Beerli	NNP	ORGANIZATION	Beerli	nn	5	SENT_652	[p30l1445t79r1581b123],
5	RR	NNP	ORGANIZATION	RR	appos	2	SENT_652	[p30l1593t83r1677b133],
6	,	,	O	,	_	0	SENT_652	[p30l1593t83r1677b133],
7	Maurer	NNP	PERSON	Maurer	nn	8	SENT_652	[p30l1692t83r1865b124],
8	F	NN	O	f	appos	5	SENT_652	[p30l1876t83r1911b133],
9	,	,	O	,	_	0	SENT_652	[p30l1876t83r1911b133],
10	Koziczak	NN	O	koziczak	nn	11	SENT_652	[p30l1926t79r2145b125],
11	M	NN	O	m	appos	5	SENT_652	[p30l1111t155r1172b204],
12	,	,	O	,	_	0	SENT_652	[p30l1111t155r1172b204],
13	Barbas	NNP	PERSON	Barbas	nn	14	SENT_652	[p30l1201t150r1361b195],
14	CF	NN	O	cf	appos	5	SENT_652	[p30l1390t154r1452b195],
15	111	CD	NUMBER	111	num	14	SENT_652	[p30l1479t155r1546b204],
16	,	,	O	,	_	0	SENT_652	[p30l1479t155r1546b204],
17	Hynes	NNP	PERSON	Hynes	nn	18	SENT_652	[p30l1576t155r1722b207],
18	NE	NNS	O	ne	appos	5	SENT_652	[p30l1749t155r1835b195],
19	.	.	O	.	_	0	SENT_652	[p30l1749t155r1835b195],

1	The	DT	O	the	det	2	SENT_653	[p30l1864t150r1954b194],
2	ErbB2	NN	O	erbb2	_	0	SENT_653	[p30l1981t151r2142b201],
3	/	:	O	/	punct	2	SENT_653	[p30l1981t151r2142b201],
4	ErbB3	NN	O	erbb3	nn	6	SENT_653	[p30l1112t222r1256b266],
5	heterodimer	NN	O	heterodimer	nn	6	SENT_653	[p30l1284t221r1577b266],
6	ﬁmctions	NNS	O	ﬁmctions	nsubj	13	SENT_653	[p30l1602t221r1824b266],
7	as	IN	O	as	_	0	SENT_653	[p30l1851t236r1899b265],
8	an	DT	O	a	det	12	SENT_653	[p30l1926t236r1982b265],
9	oncogenic	JJ	O	oncogenic	amod	12	SENT_653	[p30l2009t236r2142b266, p30l1113t293r1239b349],
10	unit	NN	O	unit	nn	12	SENT_653	[p30l1265t293r1372b337],
11	:	:	O	:	_	0	SENT_653	[p30l1265t293r1372b337],
12	ErbB2	NN	O	erbb2	prep_as	6	SENT_653	[p30l1399t293r1544b337],
13	requires	VBZ	O	require	dep	2	SENT_653	[p30l1570t293r1761b349],
14	ErbB3	NN	O	erbb3	dobj	13	SENT_653	[p30l1787t293r1930b337],
15	to	TO	O	to	aux	16	SENT_653	[p30l1959t302r2002b337],
16	drive	VB	O	drive	xcomp	13	SENT_653	[p30l2029t292r2143b337],
17	breast	NN	O	breast	nn	20	SENT_653	[p30l1113t363r1258b408],
18	tumor	NN	O	tumor	nn	20	SENT_653	[p30l1285t373r1432b408],
19	cell	NN	O	cell	nn	20	SENT_653	[p30l1460t363r1539b407],
20	proliferation	NN	O	proliferation	dobj	16	SENT_653	[p30l1567t363r1879b420],
21	.	.	O	.	_	0	SENT_653	[p30l1567t363r1879b420],

1	Proc	NNP	O	Proc	nn	7	SENT_654	[p30l1910t367r2015b408],
2	Natl	NNP	O	Natl	nn	7	SENT_654	[p30l2043t364r2143b408],
3	Acad	NNP	O	Acad	nn	7	SENT_654	[p30l1111t434r1228b479],
4	Sci	NNP	O	Sci	nn	7	SENT_654	[p30l1243t435r1310b479],
5	U	NNP	O	U	nn	7	SENT_654	[p30l1323t439r1362b479],
6	S	NNP	O	S	nn	7	SENT_654	[p30l1376t438r1399b479],
7	A	NNP	O	A	_	0	SENT_654	[p30l1413t439r1450b478],
8	2003	CD	DATE	2003	num	7	SENT_654	[p30l1462t438r1879b488],
9	;	:	O	;	_	0	SENT_654	[p30l1462t438r1879b488],
10	100:8933	CD	NUMBER	100:8933	number	11	SENT_654	[p30l1462t438r1879b488],
11	—	CD	NUMBER	—	dep	7	SENT_654	[p30l1462t438r1879b488],
12	8	CD	NUMBER	8	dep	11	SENT_654	[p30l1462t438r1879b488],
13	.	.	O	.	_	0	SENT_654	[p30l1462t438r1879b488],

1	44	CD	NUMBER	44	_	0	SENT_655	[p30l1112t511r1179b549],
2	.	.	O	.	_	0	SENT_655	[p30l1112t511r1179b549],

1	Fabian	NNP	PERSON	Fabian	nn	2	SENT_656	[p30l1208t505r1367b549],
2	MA	NNP	PERSON	MA	_	0	SENT_656	[p30l1377t509r1474b559],
3	,	,	O	,	_	0	SENT_656	[p30l1377t509r1474b559],
4	Biggs	NNP	PERSON	Biggs	nn	6	SENT_656	[p30l1488t506r1620b562],
5	WH	NNP	PERSON	WH	nn	6	SENT_656	[p30l1631t509r1726b549],
6	III	NNP	PERSON	III	appos	2	SENT_656	[p30l1737t509r1804b559],
7	,	,	O	,	_	0	SENT_656	[p30l1737t509r1804b559],
8	Treiber	NNP	ORGANIZATION	Treiber	nn	9	SENT_656	[p30l1817t505r1988b549],
9	DK	NNP	ORGANIZATION	DK	appos	2	SENT_656	[p30l1998t509r2087b559],
10	,	,	O	,	_	0	SENT_656	[p30l1998t509r2087b559],
11	et	FW	O	et	nn	12	SENT_656	[p30l2103t515r2145b549],
12	al.	FW	O	al.	appos	2	SENT_656	[p30l1112t576r1165b621],
13	.	.	O	.	_	0	SENT_656	[p30l1112t576r1165b621],

1	A	DT	O	a	det	5	SENT_657	[p30l1179t581r1216b620],
2	small	JJ	O	small	amod	5	SENT_657	[p30l1229t576r1356b620],
3	molecule-kinase	JJ	O	molecule-kinase	amod	5	SENT_657	[p30l1369t576r1757b621],
4	interaction	NN	O	interaction	nn	5	SENT_657	[p30l1770t577r2026b621],
5	map	NN	O	map	_	0	SENT_657	[p30l2040t591r2142b633],
6	for	IN	O	for	_	0	SENT_657	[p30l1113t647r1182b692],
7	clinical	JJ	O	clinical	amod	9	SENT_657	[p30l1203t647r1371b691],
8	kinase	NN	O	kinase	nn	9	SENT_657	[p30l1394t648r1545b692],
9	inhibitors	NNS	O	inhibitor	prep_for	5	SENT_657	[p30l1568t647r1813b692],
10	.	.	O	.	_	0	SENT_657	[p30l1568t647r1813b692],

1	Nat	NNP	PERSON	Nat	nn	2	SENT_658	[p30l1839t652r1926b692],
2	Biotechnol	NNP	PERSON	Biotechnol	_	0	SENT_658	[p30l1945t648r2142b692, p30l1113t718r1188b763],
3	2005	CD	DATE	2005	num	2	SENT_658	[p30l1202t722r1590b772],
4	;	:	O	;	_	0	SENT_658	[p30l1202t722r1590b772],
5	23:329	CD	NUMBER	23:329	number	6	SENT_658	[p30l1202t722r1590b772],
6	—	CD	NUMBER	—	dep	2	SENT_658	[p30l1202t722r1590b772],
7	36	CD	NUMBER	36	dep	6	SENT_658	[p30l1202t722r1590b772],
8	.	.	O	.	_	0	SENT_658	[p30l1202t722r1590b772],

1	45	CD	NUMBER	45	_	0	SENT_659	[p30l1112t795r1179b833],
2	.	.	O	.	_	0	SENT_659	[p30l1112t795r1179b833],

1	Lilientall	NNP	PERSON	Lilientall	_	0	SENT_660	[p30l1208t789r1442b843],
2	,	,	O	,	_	0	SENT_660	[p30l1208t789r1442b843],
3	Moon	NNP	PERSON	Moon	nn	4	SENT_660	[p30l1458t793r1599b834],
4	SY	NNP	PERSON	SY	appos	1	SENT_660	[p30l1614t793r1678b843],
5	,	,	O	,	_	0	SENT_660	[p30l1614t793r1678b843],
6	Lesche	NNP	O	Lesche	nn	7	SENT_660	[p30l1695t789r1855b833],
7	R	NNP	O	R	appos	1	SENT_660	[p30l1869t793r1916b843],
8	,	,	O	,	_	0	SENT_660	[p30l1869t793r1916b843],
9	et	FW	O	et	nn	10	SENT_660	[p30l1934t798r1977b833],
10	al.	FW	O	al.	appos	1	SENT_660	[p30l1988t789r2041b833],
11	.	.	O	.	_	0	SENT_660	[p30l1988t789r2041b833],

1	Genetic	JJ	O	genetic	amod	2	SENT_661	[p30l2058t793r2142b833, p30l1113t861r1226b904],
2	deletion	NN	O	deletion	nsubj	9	SENT_661	[p30l1243t860r1433b905],
3	of	IN	O	of	_	0	SENT_661	[p30l1450t860r1506b905],
4	the	DT	O	the	det	8	SENT_661	[p30l1512t861r1585b905],
5	Pten	NN	MISC	pten	nn	8	SENT_661	[p30l1600t864r1704b905],
6	tumor	NN	O	tumor	nn	8	SENT_661	[p30l1721t870r1867b905],
7	suppressor	NN	O	suppressor	nn	8	SENT_661	[p30l1883t875r2145b917],
8	gene	NN	O	gene	prep_of	2	SENT_661	[p30l1113t946r1224b988],
9	promotes	VBZ	O	promote	_	0	SENT_661	[p30l1241t941r1467b988],
10	cell	NN	O	cell	nn	11	SENT_661	[p30l1486t931r1565b976],
11	motility	NN	O	motility	dobj	9	SENT_661	[p30l1582t932r1767b988],
12	by	IN	O	by	_	0	SENT_661	[p30l1782t931r1837b988],
13	activation	NN	O	activation	prep_by	9	SENT_661	[p30l1851t932r2079b976],
14	of	IN	O	of	_	0	SENT_661	[p30l2097t931r2153b976],
15	Racl	NN	LOCATION	racl	nn	18	SENT_661	[p30l1112t1007r1227b1050],
16	and	CC	O	and	_	0	SENT_661	[p30l1249t1003r1336b1048],
17	Cdc42	NN	O	cdc42	conj_and	15	SENT_661	[p30l1358t1003r1506b1048],
18	GTPases	NNS	O	gtpase	prep_of	13	SENT_661	[p30l1528t1007r1744b1048],
19	.	.	O	.	_	0	SENT_661	[p30l1528t1007r1744b1048],

1	Curr	NNP	O	Curr	nn	2	SENT_662	[p30l1769t1007r1877b1048],
2	Biol	NNP	O	Biol	_	0	SENT_662	[p30l1896t1003r1990b1048],
3	2000	CD	DATE	2000	num	2	SENT_662	[p30l2011t1007r2141b1057],
4	;	:	O	;	_	0	SENT_662	[p30l2011t1007r2141b1057],
5	10:401	CD	NUMBER	10:401	number	6	SENT_662	[p30l1115t1077r1336b1118],
6	—	CD	NUMBER	—	dep	2	SENT_662	[p30l1115t1077r1336b1118],
7	4	CD	NUMBER	4	dep	6	SENT_662	[p30l1115t1077r1336b1118],
8	.	.	O	.	_	0	SENT_662	[p30l1115t1077r1336b1118],

1	46	CD	NUMBER	46	_	0	SENT_663	[p30l1112t1149r1179b1189],
2	.	.	O	.	_	0	SENT_663	[p30l1112t1149r1179b1189],

1	Cantley	NNP	PERSON	Cantley	nn	2	SENT_664	[p30l1209t1144r1389b1200],
2	LC	NNP	O	LC	_	0	SENT_664	[p30l1439t1148r1518b1189],
3	.	.	O	.	_	0	SENT_664	[p30l1439t1148r1518b1189],

1	The	DT	O	the	det	5	SENT_665	[p30l1572t1144r1663b1188],
2	phosphoinositide	JJ	O	phosphoinositide	amod	5	SENT_665	[p30l1716t1144r2142b1200],
3	3	CD	NUMBER	3	num	5	SENT_665	[p30l1113t1215r1309b1260],
4	—	NN	O	—	nn	5	SENT_665	[p30l1113t1215r1309b1260],
5	l	NN	O	l	_	0	SENT_665	[p30l1113t1215r1309b1260],
6	<	JJR	O	<	amod	8	SENT_665	[p30l1113t1215r1309b1260],
7	inase	NN	O	inase	nn	8	SENT_665	[p30l1113t1215r1309b1260],
8	pathway	NN	O	pathway	dep	5	SENT_665	[p30l1321t1215r1522b1272],
9	.	.	O	.	_	0	SENT_665	[p30l1321t1215r1522b1272],

1	Science	NNP	O	Science	_	0	SENT_666	[p30l1540t1216r1711b1260],
2	2002	CD	DATE	2002	num	1	SENT_666	[p30l1724t1219r2134b1269],
3	;	:	O	;	_	0	SENT_666	[p30l1724t1219r2134b1269],
4	296:1655	CD	NUMBER	296:1655	number	5	SENT_666	[p30l1724t1219r2134b1269],
5	-7	CD	NUMBER	-7	dep	1	SENT_666	[p30l1724t1219r2134b1269],
6	.	.	O	.	_	0	SENT_666	[p30l1724t1219r2134b1269],

1	47	CD	NUMBER	47	_	0	SENT_667	[p30l1112t1292r1179b1330],
2	.	.	O	.	_	0	SENT_667	[p30l1112t1292r1179b1330],

1	Sonoda	NNP	PERSON	Sonoda	nn	2	SENT_668	[p30l1210t1286r1384b1331],
2	Y	NN	PERSON	y	_	0	SENT_668	[p30l1392t1290r1430b1340],
3	,	,	O	,	_	0	SENT_668	[p30l1392t1290r1430b1340],
4	Ozawa	NN	PERSON	ozawa	nn	5	SENT_668	[p30l1444t1290r1602b1331],
5	T	NN	PERSON	t	appos	2	SENT_668	[p30l1610t1290r1651b1340],
6	,	,	O	,	_	0	SENT_668	[p30l1610t1290r1651b1340],
7	Aldape	NNP	ORGANIZATION	Aldape	nn	8	SENT_668	[p30l1662t1286r1825b1342],
8	KD	NN	ORGANIZATION	kd	appos	5	SENT_668	[p30l1835t1290r1921b1340],
9	,	,	O	,	_	0	SENT_668	[p30l1835t1290r1921b1340],
10	Deen	NNP	PERSON	Deen	nn	11	SENT_668	[p30l1935t1290r2055b1330],
11	DF	NNP	PERSON	DF	appos	5	SENT_668	[p30l2065t1290r2140b1340],
12	,	,	O	,	_	0	SENT_668	[p30l2065t1290r2140b1340],
13	Berger	NNP	PERSON	Berger	nn	14	SENT_668	[p30l1112t1361r1266b1414],
14	MS	NN	O	m	appos	5	SENT_668	[p30l1274t1361r1363b1411],
15	,	,	O	,	_	0	SENT_668	[p30l1274t1361r1363b1411],
16	Pieper	NNP	PERSON	Pieper	nn	17	SENT_668	[p30l1376t1358r1522b1414],
17	RO	NN	O	ro	appos	5	SENT_668	[p30l1531t1361r1614b1404],
18	.	.	O	.	_	0	SENT_668	[p30l1531t1361r1614b1404],

1	Akt	NN	PERSON	akt	nn	3	SENT_669	[p30l1626t1357r1710b1402],
2	pathway	NN	O	pathway	nn	3	SENT_669	[p30l1718t1358r1913b1414],
3	activation	NN	O	activation	nsubj	4	SENT_669	[p30l1921t1358r2143b1402],
4	converts	VBZ	O	convert	_	0	SENT_669	[p30l1113t1438r1308b1473],
5	anaplastic	JJ	O	anaplastic	amod	6	SENT_669	[p30l1324t1428r1562b1485],
6	astrocytoma	NN	O	astrocytoma	dobj	4	SENT_669	[p30l1576t1438r1865b1485],
7	to	TO	O	to	_	0	SENT_669	[p30l1879t1438r1923b1473],
8	glioblas	FW	O	glioblas	nn	11	SENT_669	[p30l1938t1428r2142b1485],
9	—	FW	O	—	nn	11	SENT_669	[p30l1938t1428r2142b1485],
10	toma	FW	O	toma	nn	11	SENT_669	[p30l1113t1509r1234b1544],
11	multiforme	FW	O	multiforme	prep_to	4	SENT_669	[p30l1245t1499r1514b1544],
12	in	IN	O	in	_	0	SENT_669	[p30l1525t1500r1570b1543],
13	a	DT	O	a	det	16	SENT_669	[p30l1582t1514r1607b1543],
14	human	JJ	O	human	amod	16	SENT_669	[p30l1617t1499r1785b1544],
15	astrocyte	NN	O	astrocyte	nn	16	SENT_669	[p30l1796t1509r2005b1556],
16	model	NN	O	model	prep_in	11	SENT_669	[p30l2016t1499r2142b1544, p30l1113t1571r1152b1615],
17	of	IN	O	of	_	0	SENT_669	[p30l1166t1570r1222b1615],
18	glioma	NN	O	glioma	prep_of	16	SENT_669	[p30l1225t1570r1403b1627],
19	.	.	O	.	_	0	SENT_669	[p30l1225t1570r1403b1627],

1	Cancer	NNP	O	Cancer	nn	2	SENT_670	[p30l1420t1574r1585b1615],
2	Res	NNP	O	Res	_	0	SENT_670	[p30l1596t1574r1680b1617],
3	2001	CD	DATE	2001	num	2	SENT_670	[p30l1695t1574r2083b1624],
4	;	:	O	;	_	0	SENT_670	[p30l1695t1574r2083b1624],
5	61:6674	CD	NUMBER	61:6674	number	6	SENT_670	[p30l1695t1574r2083b1624],
6	—	CD	NUMBER	—	dep	2	SENT_670	[p30l1695t1574r2083b1624],
7	8	CD	NUMBER	8	dep	6	SENT_670	[p30l1695t1574r2083b1624],
8	.	.	O	.	_	0	SENT_670	[p30l1695t1574r2083b1624],

1	48	CD	NUMBER	48	_	0	SENT_671	[p30l1112t1646r1179b1686],
2	.	.	O	.	_	0	SENT_671	[p30l1112t1646r1179b1686],

1	Goudar	JJ	O	goudar	amod	2	SENT_672	[p30l1209t1641r1390b1686],
2	RK	NN	O	rk	_	0	SENT_672	[p30l1408t1645r1493b1695],
3	,	,	O	,	_	0	SENT_672	[p30l1408t1645r1493b1695],
4	Shi	NNP	O	Shi	nn	5	SENT_672	[p30l1518t1641r1592b1685],
5	Q	NNP	O	Q	appos	2	SENT_672	[p30l1612t1645r1662b1696],
6	,	,	O	,	_	0	SENT_672	[p30l1612t1645r1662b1696],
7	Hjelmeland	NNP	O	Hjelmeland	nn	8	SENT_672	[p30l1685t1641r1960b1697],
8	MD	NNP	O	MD	appos	2	SENT_672	[p30l1979t1645r2078b1695],
9	,	,	O	,	_	0	SENT_672	[p30l1979t1645r2078b1695],
10	et	FW	O	et	nn	11	SENT_672	[p30l2102t1651r2145b1685],
11	al.	FW	O	al.	appos	2	SENT_672	[p30l1112t1712r1165b1757],
12	.	.	O	.	_	0	SENT_672	[p30l1112t1712r1165b1757],

1	Combination	NN	O	combination	nn	2	SENT_673	[p30l1180t1712r1494b1757],
2	therapy	NN	O	therapy	nsubj	29	SENT_673	[p30l1506t1712r1683b1769],
3	of	IN	O	of	_	0	SENT_673	[p30l1693t1712r1750b1757],
4	inhibitors	NNS	O	inhibitor	prep_of	2	SENT_673	[p30l1751t1712r1982b1757],
5	of	IN	O	of	_	0	SENT_673	[p30l1996t1712r2052b1757],
6	epi	FW	O	epi	nn	9	SENT_673	[p30l2055t1713r2142b1769],
7	—	FW	O	—	nn	9	SENT_673	[p30l2055t1713r2142b1769],
8	dermal	JJ	O	dermal	amod	9	SENT_673	[p30l1113t1783r1278b1828],
9	growth	NN	O	growth	prep_of	4	SENT_673	[p30l1298t1783r1468b1840],
10	factor	NN	O	factor	nn	15	SENT_673	[p30l1488t1783r1625b1828],
11	receptor/vascular	JJ	O	receptor/vascular	amod	15	SENT_673	[p30l1644t1783r2050b1840],
12	endothelial	JJ	O	endothelial	amod	15	SENT_673	[p30l2069t1798r2142b1828, p30l1113t1854r1320b1899],
13	growth	NN	O	growth	nn	15	SENT_673	[p30l1334t1854r1503b1911],
14	factor	NN	O	factor	nn	15	SENT_673	[p30l1517t1854r1655b1899],
15	receptor	NN	O	receptor	dep	9	SENT_673	[p30l1668t1864r1864b1911],
16	2	CD	NUMBER	2	number	17	SENT_673	[p30l1877t1858r1903b1898],
17	(	CD	NUMBER	(	num	19	SENT_673	[p30l1921t1858r2140b1905],
18	AEE788	NN	O	aee788	nn	19	SENT_673	[p30l1921t1858r2140b1905],
19	)	NN	O	)	dep	15	SENT_673	[p30l1921t1858r2140b1905],
20	and	CC	O	and	_	0	SENT_673	[p30l1112t1925r1200b1970],
21	the	DT	O	the	det	23	SENT_673	[p30l1231t1925r1303b1970],
22	mammalian	JJ	O	mammalian	amod	23	SENT_673	[p30l1334t1926r1619b1969],
23	target	NN	O	target	prep_of	4	SENT_673	[p30l1651t1935r1790b1982],
24	of	IN	O	of	_	0	SENT_673	[p30l1818t1925r1875b1970],
25	rapamycin	NN	O	rapamycin	nn	28	SENT_673	[p30l1895t1926r2143b1982],
26	(	CD	NUMBER	(	num	28	SENT_673	[p30l1116t2000r1347b2047],
27	RAD001	NN	O	rad001	nn	28	SENT_673	[p30l1116t2000r1347b2047],
28	)	NN	O	)	prep_of	23	SENT_673	[p30l1116t2000r1347b2047],
29	offers	VBZ	O	offer	_	0	SENT_673	[p30l1365t1996r1499b2041],
30	improved	VBN	O	improve	dep	29	SENT_673	[p30l1515t1996r1740b2053],
31	glioblastoma	NN	O	glioblastoma	nn	34	SENT_673	[p30l1754t1996r2065b2053],
32	tumor	NN	O	tumor	nn	34	SENT_673	[p30l2079t2006r2142b2041, p30l1113t2082r1212b2112],
33	growth	NN	O	growth	nn	34	SENT_673	[p30l1240t2068r1409b2124],
34	inhibition	NN	O	inhibition	dobj	30	SENT_673	[p30l1438t2067r1686b2112],
35	.	.	O	.	_	0	SENT_673	[p30l1438t2067r1686b2112],

1	Mol	NNP	O	Mol	nn	3	SENT_674	[p30l1717t2068r1811b2112],
2	Cancer	NNP	O	Cancer	nn	3	SENT_674	[p30l1841t2071r2006b2112],
3	Ther	NNP	O	Ther	_	0	SENT_674	[p30l2032t2067r2145b2112],
4	2005	CD	DATE	2005	num	3	SENT_674	[p30l1113t2142r1471b2192],
5	;	:	O	;	_	0	SENT_674	[p30l1113t2142r1471b2192],
6	4:101	CD	NUMBER	4:101	number	7	SENT_674	[p30l1113t2142r1471b2192],
7	—	CD	NUMBER	—	dep	3	SENT_674	[p30l1113t2142r1471b2192],
8	12	CD	NUMBER	12	dep	7	SENT_674	[p30l1113t2142r1471b2192],
9	.	.	O	.	_	0	SENT_674	[p30l1113t2142r1471b2192],

1	Copyright	NN	O	copyright	_	0	SENT_675	[p30l1114t2217r1292b2265],
2	©	CD	NUMBER	©	num	6	SENT_675	[p30l1308t2221r1348b2261],
3	2005	CD	DATE	2005	num	6	SENT_675	[p30l1365t2219r1459b2253],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_675	[p30l1474t2217r1743b2253],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_675	[p30l1759t2217r1906b2253],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_675	[p30l1920t2218r2055b2264],
7	.	.	O	.	_	0	SENT_675	[p30l1920t2218r2055b2264],

1	The	DT	O	the	det	2	SENT_676	[p30l822t2428r879b2455],
2	journal	NN	O	journal	nsubj	4	SENT_676	[p30l885t2428r988b2463],
3	is	VBZ	O	be	aux	4	SENT_676	[p30l998t2428r1022b2455],
4	seeking	VBG	O	seek	_	0	SENT_676	[p30l1034t2428r1150b2463],
5	a	DT	O	a	det	6	SENT_676	[p30l1160t2437r1175b2455],
6	physician	NN	O	physician	dobj	4	SENT_676	[p30l1186t2428r1329b2463],
7	with	IN	O	with	_	0	SENT_676	[p30l1339t2428r1406b2455],
8	substantial	JJ	O	substantial	amod	9	SENT_676	[p30l1418t2428r1583b2455],
9	reporting	NN	O	reporting	prep_with	4	SENT_676	[p30l1594t2428r1737b2463],

1	PHYSICIAN-JOURNALIST	NN	O	physician-journalist	_	0	SENT_677	[p30l1102t2382r1460b2409],

1	experience	NN	O	experience	_	0	SENT_678	[p30l766t2474r926b2509],
2	to	TO	O	to	aux	3	SENT_678	[p30l937t2479r965b2501],
3	write	VB	O	write	dep	1	SENT_678	[p30l976t2474r1052b2501],
4	articles	NNS	O	article	dobj	3	SENT_678	[p30l1063t2474r1171b2501],
5	on	IN	O	on	_	0	SENT_678	[p30l1183t2483r1220b2501],
6	timely	JJ	O	timely	amod	7	SENT_678	[p30l1232t2474r1325b2509],
7	topics	NNS	O	topic	prep_on	3	SENT_678	[p30l1335t2474r1424b2509],
8	in	IN	O	in	_	0	SENT_678	[p30l1436t2474r1465b2501],
9	medicine	NN	O	medicine	prep_in	7	SENT_678	[p30l1476t2474r1614b2501],
10	and	CC	O	and	_	0	SENT_678	[p30l1625t2474r1681b2501],
11	society	NN	O	society	conj_and	9	SENT_678	[p30l1692t2474r1795b2509],
12	for	IN	O	for	_	0	SENT_678	[p30l757t2519r801b2547],
13	the	DT	O	the	det	15	SENT_678	[p30l810t2520r855b2547],
14	Perspective	NNP	O	Perspective	nn	15	SENT_678	[p30l865t2520r1030b2555],
15	section	NN	O	section	prep_for	3	SENT_678	[p30l1041t2520r1154b2547],
16	.	.	O	.	_	0	SENT_678	[p30l1041t2520r1154b2547],

1	Send	VB	O	send	_	0	SENT_679	[p30l1167t2520r1238b2547],
2	curriculum	NN	O	curriculum	nn	3	SENT_679	[p30l1249t2520r1412b2547],
3	vitae	NNS	O	vita	dobj	1	SENT_679	[p30l1421t2520r1489b2547],
4	and	CC	O	and	_	0	SENT_679	[p30l1500t2520r1554b2547],
5	writing	VBG	O	write	amod	6	SENT_679	[p30l1563t2520r1672b2555],
6	samples	NNS	O	sample	dobj	1	SENT_679	[p30l1682t2520r1801b2555],
7	to	TO	O	to	_	0	SENT_679	[p30l759t2571r787b2593],
8	Perspective	NNP	O	Perspective	nn	9	SENT_679	[p30l798t2566r967b2601],
9	Editor	NNP	O	Editor	prep_to	6	SENT_679	[p30l977t2565r1077b2599],
10	,	,	O	,	_	0	SENT_679	[p30l977t2565r1077b2599],
11	New	NNP	ORGANIZATION	New	nn	13	SENT_679	[p30l1090t2568r1149b2593],
12	England	NNP	ORGANIZATION	England	nn	13	SENT_679	[p30l1159t2565r1269b2601],
13	Journal	NNP	ORGANIZATION	Journal	appos	9	SENT_679	[p30l1275t2565r1378b2601],
14	of	IN	ORGANIZATION	of	_	0	SENT_679	[p30l1389t2565r1421b2601],
15	Medicine	NNP	ORGANIZATION	Medicine	prep_of	13	SENT_679	[p30l1423t2565r1549b2599],
16	,	,	O	,	_	0	SENT_679	[p30l1423t2565r1549b2599],
17	10	CD	NUMBER	10	num	19	SENT_679	[p30l1563t2567r1598b2593],
18	Shattuck	NNP	PERSON	Shattuck	nn	19	SENT_679	[p30l1610t2565r1742b2593],
19	St.	NNP	PERSON	St.	appos	15	SENT_679	[p30l1752t2567r1798b2599],
20	,	,	O	,	_	0	SENT_679	[p30l1752t2567r1798b2599],

1	Boston	NNP	LOCATION	Boston	_	0	SENT_680	[p30l953t2614r1068b2645],
2	,	,	O	,	_	0	SENT_680	[p30l953t2614r1068b2645],
3	MA	NNP	O	MA	appos	1	SENT_680	[p30l1080t2614r1134b2639],
4	02115	CD	DATE	02115	num	3	SENT_680	[p30l1144t2613r1245b2645],
5	,	,	O	,	_	0	SENT_680	[p30l1144t2613r1245b2645],
6	or	CC	O	or	_	0	SENT_680	[p30l1258t2620r1290b2639],
7	at	IN	O	at	advmod	3	SENT_680	[p30l1300t2617r1328b2639],
8	writer@nejm.org	NN	O	writer@nejm.org	appos	1	SENT_680	[p30l1336t2612r1604b2647],
9	.	.	O	.	_	0	SENT_680	[p30l1336t2612r1604b2647],

1	N	NN	O	n	nn	3	SENT_681	[p30l868t2774r881b2789],
2	ENGLJ	NN	O	englj	nn	3	SENT_681	[p30l897t2773r981b2795],
3	MED	NN	O	med	_	0	SENT_681	[p30l996t2774r1048b2789],
4	353	CD	NUMBER	353	num	6	SENT_681	[p30l1061t2773r1139b2795],
5	;	:	O	;	_	0	SENT_681	[p30l1061t2773r1139b2795],
6	19	CD	NUMBER	19	dep	3	SENT_681	[p30l1061t2773r1139b2795],
7	WWW.NEjM.ORG	NNP	O	WWW.NEjM.ORG	nn	8	SENT_681	[p30l1174t2773r1385b2795],
8	NOVEMBER	NNP	DATE	NOVEMBER	dep	3	SENT_681	[p30l1424t2773r1566b2789],
9	10	CD	DATE	10	num	8	SENT_681	[p30l1579t2773r1614b2793],
10	,	,	DATE	,	_	0	SENT_681	[p30l1579t2773r1614b2793],
11	2005	CD	DATE	2005	num	8	SENT_681	[p30l1628t2773r1691b2795],

1	The	DT	O	the	det	4	SENT_682	[p30l936t2806r987b2830],
2	New	NNP	O	New	nn	4	SENT_682	[p30l996t2807r1058b2830],
3	England	NNP	O	England	nn	4	SENT_682	[p30l1067t2806r1178b2837],
4	Journal	NNP	O	Journal	_	0	SENT_682	[p30l1187t2806r1284b2830],
5	of	IN	O	of	_	0	SENT_682	[p30l1294t2806r1323b2830],
6	Medicine	NNP	O	Medicine	prep_of	4	SENT_682	[p30l1330t2806r1455b2830],

1	Downloaded	VBN	O	download	_	0	SENT_683	[p30l378t2847r548b2870],
2	from	IN	O	from	_	0	SENT_683	[p30l557t2847r621b2870],
3	nejm.org	NN	O	nejm.org	prep_from	1	SENT_683	[p30l630t2847r748b2877],
4	at	IN	O	at	_	0	SENT_683	[p30l759t2851r782b2870],
5	UW-Madison	NN	O	uw-madison	prep_at	1	SENT_683	[p30l790t2847r973b2870],
6	on	IN	O	on	_	0	SENT_683	[p30l982t2854r1015b2870],
7	January	NNP	DATE	January	prep_on	1	SENT_683	[p30l1023t2847r1126b2877],
8	5	CD	DATE	5	num	7	SENT_683	[p30l1136t2847r1159b2874],
9	,	,	DATE	,	_	0	SENT_683	[p30l1136t2847r1159b2874],
10	2014	CD	DATE	2014	num	7	SENT_683	[p30l1170t2847r1242b2870],
11	.	.	O	.	_	0	SENT_683	[p30l1170t2847r1242b2870],

1	For	IN	O	for	_	0	SENT_684	[p30l1252t2847r1299b2870],
2	personal	JJ	O	personal	amod	3	SENT_684	[p30l1307t2847r1419b2877],
3	use	NN	O	use	pobj	1	SENT_684	[p30l1428t2854r1472b2870],
4	only	RB	O	only	advmod	3	SENT_684	[p30l1482t2847r1546b2877],
5	.	.	O	.	_	0	SENT_684	[p30l1482t2847r1546b2877],

1	No	DT	O	no	det	3	SENT_685	[p30l1557t2847r1597b2870],
2	other	JJ	O	other	amod	3	SENT_685	[p30l1607t2847r1675b2870],
3	uses	NNS	O	use	_	0	SENT_685	[p30l1683t2854r1739b2870],
4	without	IN	O	without	_	0	SENT_685	[p30l1749t2847r1850b2870],
5	permission	NN	O	permission	prep_without	3	SENT_685	[p30l1859t2847r2011b2877],
6	.	.	O	.	_	0	SENT_685	[p30l1859t2847r2011b2877],

1	Copyright	NN	O	copyright	_	0	SENT_686	[p30l728t2888r863b2919],
2	©	CD	NUMBER	©	num	6	SENT_686	[p30l872t2888r896b2912],
3	2005	CD	DATE	2005	num	6	SENT_686	[p30l906t2888r970b2912],
4	Massachusetts	NNP	ORGANIZATION	Massachusetts	nn	6	SENT_686	[p30l980t2888r1171b2912],
5	Medical	NNP	ORGANIZATION	Medical	nn	6	SENT_686	[p30l1181t2888r1289b2912],
6	Society	NNP	ORGANIZATION	Society	dep	1	SENT_686	[p30l1300t2888r1405b2919],
7	.	.	O	.	_	0	SENT_686	[p30l1300t2888r1405b2919],

1	All	DT	O	all	det	2	SENT_687	[p30l1416t2888r1457b2912],
2	rights	NNS	O	rights	nsubj	3	SENT_687	[p30l1466t2888r1541b2919],
3	reserved	VBN	O	reserve	_	0	SENT_687	[p30l1551t2888r1670b2912],
4	.	.	O	.	_	0	SENT_687	[p30l1551t2888r1670b2912],

